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I. Abstract 
Genome sequencing projects provide a wealth of knowledge about the inventory of the 
respective organism. However, life evolves through an incredible complex interplay of all 
gene products of an organism. Only high-throughput approaches can cope with this 
complexity and only integration of various large-scale datasets into a comprehensive systems 
biology framework will eventually provide insights on the organization of life’s complexity. 
Large-scale protein interaction datasets make a major contribution to this ultimate aim. 
In this thesis, a proteome-wide binary protein interaction map for Treponema pallidum, the 
Syphilis spirochete, is presented. About 1,000,000 protein combinations were tested in an 
array-based yeast-two-hybrid system. 3,684 protein interactions were identified, from which a 
filtered set of 1,634 interactions was selected. 726 (70% of the proteome) and 601 (58% of 
the proteome) distinct proteins were incorporated in these two networks. In parallel to this 
study, the Y2H interaction map of Campylobacter jejuni was analyzed (Parish et al., pers. comm.). 
These two bacterial networks are the first proteome-wide binary interaction maps for 
bacteria, and constitute the most comprehensive available binary interaction maps for any 
living organism.   
Biological insights from all levels of the network can be gained ranging from the topology, 
over protein complexes, to individual proteins. 
Bioinformatical predictions support a significant fraction of the interactions. However, in 
concordance with other studies only a limited overlap with other interaction datasets is 
observed (max. 5%). 
The network topology shows scale-free properties and an optimization of the network for 
information processing is demonstrated by the central position of regulatory proteins.  
Protein domains are the interacting entities. The protein domain network of T. pallidum 
shows the wide range of interactions of the TPR domain and an interesting link of 
peptidoglycan metabolism and the flagellum. 
The network demonstrates, for the first time, that different genomic locations are linked by 
protein interactions, e.g., a region flanking FliS is associated to a region flanking TP0048 via 
six interactions among six proteins – a link probably involved in motility related processes.  
The interaction network provides starting points for the investigation of the pathogenesis of 
Syphilis. Several interactions for pathogenicity-related and (predicted) essential proteins were 
identified. 
Based on their interactions, functions of proteins can be predicted (“guilt-by-association” 
approach). These predictions include a function of TP0183 in “DNA replication, 
recombination, and repair” and a function of TP0496 in linking tRNA metabolism and DNA 
replication. 
Several associations of functional categories are found including a striking self-association of 
DNA metabolism and motility proteins. 
For assessing the functional relevance of proteins for motility, a whole-genome motility 
phenotyping for Escherichia coli was conducted. 3,985 mutant strains were tested and 159 
showed reduced motility. A majority were known motility proteins. The intersection with a 
large-scale motility dataset for B. subtilis indicated that most well conserved genuine motility 
proteins are already known. However, intersection with the interaction dataset indicated the 
presence of additional group-specific or regulatory motility proteins – one example is the 
protein TP0658. 
Based on its interactions with flagellin proteins (FlaB1, FlaB2, FlaB3) a flagellin-related 
function for the conserved hypothetical protein TP0658 (DUF180/COG1699) was 
anticipated. TP0658 has homologs in at least 34 sequenced genomes and its interaction with 
flagellin is conserved in at least four species (including Bacillus subtilis yviF-hag, Campylobacter 
jejuni Cj1075- Cj0720c, and Helicobacter pylori HP1154-flaA and HP1377-flaA). TP0658 binds 
an epitope of FlaB1 comprising a peptide from Leu231 to Asp247 (the cs loop of flagellin). This 
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interaction epitope is conserved in B. subtilis and other bacteria. One well-conserved 
Asparagine residue of flagellins (Asn237 of FlaB1 and Asn255 of its B. subtilis homolog hag) is 
crucial for binding of TP0658/YviF. A B. subtilis ∆yviF mutant showed strongly reduced 
motility, which was rescued by YviF over-expression. Co-expression of TP0658 and FlaB1 in 
E. coli suggests that TP0658 stabilizes flagellin and thus appears to act like the known flagellin 
assembly factor, FliS. It is suggested that TP0658 is another assembly factor for flagellin 
proteins, complementing the function of FliS or replacing it in certain subsets of bacterial 
species. 
A second detailed analysis revealed the in vivo “house-cleaning” function of YjjG. House-
cleaning enzymes protect cells from the adverse effects of non-canonical metabolic chemical 
compounds. The Escherichia coli nucleotide phosphatase YjjG (B4374, JW4336) functions as a 
house-cleaning phosphatase in vivo. YjjG protects the cell against non-canonical pyrimidine 
derivatives such as 5-fluoro-2’-deoxyuridine, 5-fluorouridine, 5-fluoroorotic acid (5-FOA), 5-
fluorouracil (5-FU), and 5-aza-2’-deoxycytidine. YjjG prevents the incorporation of 
potentially mutagenic nucleotides into DNA as shown for 5-bromo-2’-deoxyuridine (BrdU). 
Its enzymatic activity in vitro towards non-canonical 5-fluoro-2’-deoxyuridine monophosphate 
(5-FdUMP) is higher than towards canonical thymidine monophosphate (dTMP). The 
closest homolog in humans, HDHD4, does not show a protective effect against non-
canonical nucleotides, excluding an involvement of HDHD4 in resistance against non-
canonical nucleotides used for cancer chemotherapy. 
Finally, the Y2H system was used to analyze the properties of transcription activation 
domains. Eukaryotic transcription activation domains are not well defined on the proteome 
scale. As a prerequisite of two large-scale Y2H studies, ~6000 yeast proteins have been 
analyzed for transcriptional activity using a yeast one-hybrid system. 451 transcriptional 
activators were identified. Here, their transcription activation strength was determined using 
fusions to the Gal4 DNA-binding domain and a His3 reporter gene which contained a 
promoter with a Gal4-binding site. Among the 132 strongest activators, 32 are known 
transcription factors while another 35 have no known function. Although zinc fingers, helix-
loop-helix domains and several other domains are highly over-represented among the 
activators, only few contain characterized activation domains. Some striking correlations were 
found: the stronger the activation activity, the more acidic, glutamine-rich, proline-rich, or 
asparagine-rich the activators were. About 29% of the activators have been previously found 
to specifically interact with the transcription machinery, while 10% are known to be 
components of transcription regulatory complexes. Based on their transcriptional activity, 
localization, and interaction patterns, at least four previously uncharacterized proteins are 
suggested to be bona fide transcriptional regulators (namely YFL049W, YGL066W/Sgf73, 
YKR064W, and YCR082W/ Ahc2). 
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II. Zusammenfassung 
Genomsequenzierungsprojekte liefern eine umfassende Übersicht über die Gene eines 
Organismus, aber erst das unglaublich komplexe Zusammenspiel aller Genprodukte lässt 
Leben entstehen. Dieser Komplexität kann nur mit Hochdurchsatzansätzen begegnet werden 
und nur die Integration zahlreicher  umfassender Datensätze in einem Systembiologiekontext 
wird schlussendlich Einblicke in die Organisation der Komplexität des Lebens liefern. 
Großflächige Protein-Interaktionsdatensätze werden einen großen Beitrag zu diesem Ziel 
liefern. 
In dieser Arbeit wird eine Proteom-weite, binäre Proteininteraktionskarte für Treponema 
pallidum, den Erreger der Syphilis, präsentiert. Ungefähr 1.000.000 Proteinkombinationen 
wurden in einem Matrix-basierten Hefe-Zwei-Hybrid-System getestet. Insgesamt 3.684 
Proteininteraktionen wurden identifiziert. Von diesen wurde ein gefilterter Satz von 1.634 
Interaktionen ausgewählt. 726 (70% des Proteoms), resp. 601 (58% des Proteoms) Proteine 
waren in diesen Netzwerken enthalten. Zeitgleich wurde eine Hefe-Zwei-Hybrid 
Interaktionskarte für Campylobacter jejuni (Parish et al., pers. Komm.) erstellt. Diese beiden 
bakteriellen Netwerke stellen die ersten Proteom-weiten binären Interaktionskarten für 
Bakterien und die umfangreichsten binären Interaktionskarten für einen lebenden 
Organismus insgesamt dar. 
Einblicke in die Biologie können auf allen Ebenen des Netzwerkes gewonnen werden: von 
der Topologie, über Proteinkomplexe, bis hin zu individuellen Proteinen. 
Ein signifikanter Anteil der Interaktionen wird durch bioinformatische Vorhersagen gestützt. 
In Übereinstimmung mit anderen Studien wurde jedoch nur eine begrenzte Überlappung 
(max. 5%) mit anderen Interaktionsdatensätzen gefunden. 
Die Netzwerktopologie zeigt skalenfreie Eigenschaften und eine Optimierung des Netzwerks 
für die Informationsverarbeitung wird durch die zentrale Position, die von regulatorischen 
Proteinen eingenommen wird, demonstriert. 
Proteininteraktionen basieren auf der Interaktion von einzelnen Proteindomänen. Das 
Domäneninteraktionsnetzwerk für T. pallidum zeigt z.B. das weite Spektrum an Interaktionen 
der TPR Domäne und eine interessante Verbindung zwischen dem 
Peptidoglykanmetabolismus und der bakteriellen Flagelle. 
In dieser Arbeit wird zum ersten Mal gezeigt, dass verschiedene genomische Lokationen über 
Proteininteraktionen verbunden sind, z.B.  ist die Region um FliS mit der Region um TP0048 
über sechs Interaktionen zwischen sechs Proteinen verknüpft – diese Verbindung steht 
wahrscheinlich mit der bakteriellen Motilität in Verbindung. 
Das Interaktionsnetzwerk liefert Ansatzpunkte für die Untersuchung der Pathogenität der 
Syphilis. Es wurden zahlreiche Interaktionen für Pathogenitäts-relevante und (vorhergesagte) 
essentielle Proteine identifiziert. 
Basierend auf den Interaktionen können Vorhersagen über die Funktion von Proteinen 
getroffen werden. So kann z.B. eine Funktion für TP0183 bei der „DNA Replikation, 
Rekombination und Reparatur“ und für TP0496 eine verbindende Funktion zwischen tRNA 
Metabolismus und DNA Reparatur vorhergesagt werden. 
Zahlreiche Assoziationen von funktionellen Kategorien wurden gefunden; diese beinhalten 
eine Selbstassoziation von DNA Metabolismus Proteinen und Motilitätsproteinen. 
Um die funktionelle Relevanz von Proteinen für die bakterielle Motilität zu ermitteln, wurde 
das gesamte Genom von Escherichia coli auf einen Einfluss auf die Motilität getestet: 3.985 
Mutantenstämme wurden getestet und 159 zeigten eine reduzierte Motilität. Ein Großteil 
waren bekannte Motilitätsproteine. Ein Abgleich mit einem großflächigen Motilitätstest für 
Bacillus subtilis wies darauf hin, dass die meisten stark konservierten Motilitätsproteine bereits 
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bekannt sind. Es existieren allerdings zusätzliche Gruppen-spezifische oder regulatorische 
Motilitätsproteine – ein Beispiel hierfür ist das Protein TP0658. 
Basierend auf seinen Interaktionen mit allen Flagellinproteinen (FlaB1, FlaB2 und FlaB3) 
konnte eine Funktion des konserviert-hypothetischen Proteins TP0658 
(DUF180/COG1699) im engen Zusammenhang mit diesen Flagellinproteinen angenommen 
werden. TP0658 hat Homologe in wenigstens 34 sequenzierten Genomen und seine 
Interaktion mit Flagellinproteinen ist in wenigstens vier Spezies konserviert (einschließlich 
Bacillus subtilis yviF-hag, Campylobacter jejuni Cj1075- Cj0720c und Helicobacter pylori HP1154-
flaA and HP1377-flaA). TP0658 bindet ein Epitop von FlaB1, welches ein Peptid von Leu231 
bis Asp247 (cs Schleife des Flagellins) einschließt. Dieses Interaktionsepitop ist in B. subtilis und 
anderen Bakterien konserviert. Ein stark konserviertes Asparagin (Asn237 von FlaB1 und 
Asn255 seines B. subtilis Homologes hag) ist essentiell für die Bindung von TP0658/YviF. Eine 
B. subtilis ∆yviF Mutante zeigt eine stark verminderte Motilität, die durch Widereinführen von 
YviF wiederhergestellt werden kann. Die Koexpression von TP0658 und FlaB1 in E. coli legt 
nahe, dass TP0658 das Flagellinprotein stabilisiert und damit eine ähnliche Funktion wie der 
bekannte Assemblierungsfaktor, FliS, ausführt. Es wird vorgeschlagen, dass TP0658 ein 
weiterer Assemblierungsfaktor für Flagellinproteine ist, welcher die Funktion von FliS 
komplementiert oder in einer gewissen Untergruppe von bakteriellen Spezies ersetzt. 
Eine zweite detaillierte Analyse zeigte eine “Hausreinigungsfunktion” des Proteins YjjG in 
vivo. “Hausreinigungsenzyme” schützen Zellen vor den schädlichen Einflüssen von nicht 
kanonischen metabolischen Molekülen. Die Escherichia coli Nukleotidphosphatase YjjG 
(B4374, JW4336) arbeitet als „Hausreinigungsphosphatase“ in vivo. YjjG schützt die Zelle vor 
nicht kanonischen Pyrimidinderivaten wie 5-Fluor-2’-desoxyuridin, 5-Fluor-uridin, 5-Fluor-
orothsäure (5-FOA), 5-Fluor-uracil (5-FU), and 5-Aza-2’-desoxycytidin. YjjG verhindert die 
Inkorporation von potentiell mutagenen Nukleotiden wie es anhand von 5-Brom-2’-
desoxyuridin (BrdU) gezeigt wurde. Seine enzymatische Funktion gegenüber nicht 
kanonischem 5-Fluor-2’-Deoxyuridinmonophosphat ist höher als gegenüber nicht 
kanonischem Thymidinmonophosphat (dTMP). Das am nächsten verwandte homologe 
Protein im Menschen, HDHD4, zeigt keinen schützenden Effekt gegen nicht kanonische 
Nukleotide. Dieses schließt eine Funktion von HDHD4 bei der Resistenz gegenüber nicht 
kanonischen Nukleotiden bei der Chemotherapie von Krebs aus. 
Schließlich wurde das Hefe-Zwei-Hybrid System zur Analyse der Eigenschaften von 
Transkriptionsaktivierungsdomänen verwendet. Eukaryotische Transkriptionsaktivierungs-
domänen sind im Proteom-weiten Maßstab schlecht definiert. Als Voraussetzung für zwei 
großflächige Y2H Studien wurden ~6000 Hefeproteine auf Transkriptionsaktivierung in 
einem Hefe-Ein-Hybrid System analysiert. 451 Transkriptionsaktivatoren wurden 
identifiziert. In dieser Arbeit wurde ihre Aktivierungsstärke gemessen. Hierfür wurden 
Fusionen dieser Protein mit der Gal4-DNA-Bindungsdomäne und ein His3-Reporter unter 
der Kontrolle eines Gal4-Promoters verwendet. Unter den 132 stärksten Aktivatoren waren 
32 bekannte Transkriptionsfaktoren, während 34 keinerlei bekannte Funktion hatten. 
Obwohl Zinkfinger, Helix-Drehung-Helix und zahlreiche andere Domänen hochgeradig 
überrepräsentiert im Satz der Aktivatoren waren, trugen nur wenige eine bekannte 
Aktivierungsdomäne. Einige interessante Korrelationen wurden entdeckt: je stärker die 
Aktivatoren waren, desto saurer, Glutamin-reicher, Prolin-reicher und Asparagin-reicher 
waren sie. Für ca. 29% der Aktivatoren wurde zuvor eine spezifische Interaktion mit der 
Transkriptionsmaschinerie gezeigt und 10% sind bekannte Komponenten von 
Transkriptions-regulierenden Komplexen. Basierend auf ihrer Transkriptionsaktivierungs-
stärke, Lokalisation und des Interaktionsmusters wurde für wenigsten vier zuvor 
uncharakterisierte Proteine eine wirkliche Transkriptions-regulierende Funktion vorhergesagt 
(dieses sind: YFL049W, YGL066W/Sgf73, YKR064W und YCR082W/ Ahc2). 
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INTRODUCTION 
1. Introduction 
1.1. The Starting Point 
Today more than 300 bacterial and about 20 eukaryotic genomes have been completely 
sequenced and these sequencing projects provided us with a wealth of information about 
these organisms. Theoretically, most gene products of these genomes can be predicted from 
their sequence. Nevertheless, the biochemical activities and biological roles of many gene 
products remain unclear. Surprisingly, even in new genome sequences about 1/3 of the genes 
cannot be annotated functionally, either because there is only ambiguous homology or 
because homologous genes lack sufficient annotation. 
In order to turn the significant number of uncharacterized open reading frames into 
biological knowledge, high-throughput functional analysis appears to be a perfect tool. 
Although high-throughput screening (HTS) usually will not yield a detailed understanding of 
a protein’s function, it often provides first evidence for function and therefore an in-route to 
further characterization.  
Currently established HTS methodology includes expression profiling using DNA microarray 
technology, systematic knock-out studies, high-throughput localization studies and protein-
protein interaction mapping approaches (Ge et al. 2003). Eventually, only the combination of 
all these approaches together with integration into a comprehensive systems biology 
framework will let us understand how life can evolve from the intrinsic complexity of 
biological systems. 
In this thesis, the protein interaction network of Treponema pallidum, the bacterium causing 
Syphilis, is presented. Already, a glimpse on this network gives an impression of the 
complexity of this organism with only about 1000 genes. The network itself reveals biological 
building principles; even well understood protein complexes like the bacterial flagellum 
appear to be still more sophisticated; functions of individual proteins can be elucidated by 
analyzing their molecular context; and finally, the interactions of pathogenicity factors can 
provide new insights for the Syphilis disease. 
 
1.2. Background 
Treponema pallidum 
Treponema pallidum subspecies pallidum is the causative agent of veneral syphilis, a sexually 
transmitted disease. T. pallidum belongs to a group of bacteria called spirochetes. These are 
Gram-negative bacteria, which are characterized by their helical to sinusoidal shape. T. 
pallidum has an outer and a cytoplasmic membrane, a thin peptidoglycan layer, and 
periplasmic flagella. Outside its host, T. pallidum only survives for a short period and cannot 
be cultured continuously in vitro. Other members of the spirochete group are Borrelia and 
Leptospira. Other Treponemes that cause human diseases include T. pallidum subspecies pertenue, 
the causative agent of yaws, and T. pallidum subspecies endemicium, the causative agent of 
endemic syphilis.   
 
Genome 
The genome of T. pallidum was sequenced in 1998 by “The Institute of Genome Research” 
(Fraser et al. 1998). An overview (status: August 2006) is given in Table 1 (Peterson et al. 
2001) 
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Feature Value 
Genome size 1138012 bp 
G+C content 52.77% 
Protein coding genes 1039 
…with role category 580 (55.82%) 
…conserved hypothetical 176 (16.93%) 
…hypothetical 283 (27.23%) 
tRNA genes 45 
rRNA genes 6 
Table 1 T. pallidum genome summary 
Strikingly, a large number of ORFs (176) is conserved in other bacterial species, but still does 
not have a functional assignment (“conserved hypothetical” proteins) and an even higher 
number of ORFs (283) is uncharacterized and specific to T. pallidum. These two groups of 
proteins will be of special interest in this study, since the functional characterization of the 
former group will reveal functions valid for several species and characterization of the latter 
is the basis to understand specific features of T. pallidum. An overview of the functional 
classifications of all ORFs is shown in Fig. 1.  
 
 
Hypothetical proteinsHypothetical proteins - Conserved
Protein synthesis
Cellular processes
Transport and binding proteins
Energy metabolism
Cell envelope DNA metabolism
Protein fate
Unknown function
Transcription
Regulatory functions
Purines, pyrimidines, nucleosides, and nucleotides
Biosynthesis of cofactors, prosthetic groups, and carriers
Fatty acid and phospholipid metabolism
Amino acid biosynthesis
Central intermediary metabolism
27%17%
10%
7%
6%
5%5%5%
5%
 
Fig. 1 Genome of T. pallidum – functional classifications. TIGR roles were taken 
from the TIGR-CMR database (Peterson et al. 2001). 
The most abundant functional categories of proteins with known function are “protein 
synthesis” (9.5%), “cellular processes” (7.4%), and “transport and binding” (5.7 %). 
T. pallidum contains a basic set of genes involved in transcription and translation (Fraser et al. 
1998). This set includes RNA polymerase genes, several sigma factors (both rpoS for the 
stationary phase and σ32 for heat-shock response were not identified), and proteins necessary 
for elongation and termination. The major DNA replication proteins are present. Unlike B. 
burgdorferi, topoisomerase IV, which is involved in chromosome segregation, is lacking. DNA 
repair in T. pallidum includes the major known pathways of uvr excision repair, mutL/mutS 
mismatch repair, mutY, and dat. RecBCD is missing, but the recF pathway of recombination is 
conserved. As an obligate human parasite, T. pallidum has only limited biosynthetic 
capabilities. T. pallidum is unable to synthesize enzyme co-factors, fatty acids, and nucleotides 
de novo. In contrast, it has a large number of transporter proteins to obtain the required 
factors from its host. 57 ORFs forming 18 distinct transporters have been identified in the 
initial genome sequencing study; these include ABC transporters for the import of sugars. T. 
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pallidum has all enzymes of the glycolytic pathway, but none of the enzymes of the 
tricarboxylic acid cycle or oxidative phosphorylation. It contains a minimal set of regulatory 
genes that include two two-component systems and several putative transcriptional regulators 
of unknown specificity. Even though, T. pallidum does not have a sugar-specific PTS 
(phosphotransferase system), it contains enzymes of this pathway, which probably function 
as regulators. 
However, the outstanding feature of T. pallidum is its limited genome size with 1,039 genes 
compared to ~4,500 in Escherichia coli or Bacillus subtilis. This strong genome reduction, which 
resulted in the loss of essential enzymes, explains the strict dependency of T. pallidum on its 
human host. 
Syphilis 
Venereal syphilis was first reported in Europe in the late 1400s, coincident with the return of 
Columbus from the New World. The disease quickly reached epidemic proportions in 
Europe and spread across the world during the early 16th century. Since the introduction of 
penicillin, effective therapies have been available. However, syphilis remains an important 
global health problem.  
The World Health Organization estimates 12 million syphilis infections worldwide for 1999 
(Table 2) (World Health Organization 2001). Whereas the incidence is below 5 per 100,000 in 
the majority of Western European countries, there has been an alarming increase of the rates 
in the newly independent states of the former Soviet Union; in 1996, 120-170 cases per 
100,000 have been reported. In Africa, syphilis prevalence among pregnant women varies 
from 2.5% (Burkina Faso) to 17.4% (Cameroon). 
 
Region  Male Female Total 
North America  0.054 0.053 0.107 
Western Europe  0.069 0.066 0.136 
North Africa & Middle East  0.167 0.197 0.364 
Eastern Europe & Central Asia  0.053 0.052 0.105 
Sub Saharan Africa  1.683 2.144 3.828 
South and South East Asia  1.851 2.187 4.038 
East Asia & Pacific  0.112 0.132 0.244 
Australia & New Zealand  0.004 0.004 0.008 
Latin America & Caribbean  1.294 1.634 2.928 
Total  5.29 6.47 11.76 
Table 2 Estimated new cases of Syphilis (in million) among adults for 1999. 
Source: World Health Organization ( 2001) 
In Germany (like in other industrial states), the infection rate of Syphilis declined strongly, 
especially since the seventies of the last century (Robert Koch Institut 2003) (Fig. 2). 
However, since the nineties the incidence is steadily increasing and reached a level of 2.8 
infected persons per 100,000 in 2002. The majority of these are men having sex with men 
(MSM). The higher infection rate in Eastern Europe was also found to have an influence on 
Syphilis in Germany. In addition, Syphilis has an importance when coinfection with HIV 
occurs. In 2006 an outbreak of Syphilis among heterosexuals in the region of Aachen has 
been reported by the Robert Koch Institut (Robert Koch Institut 2006); during this 
“outbreak” 138 cases were reported in total. 
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Fig. 2 Syphilis cases reported in Germany. Source: Robert Koch Institut. In 2001, a 
new law on reporting of infectious diseases (“Infektionsschutzgesetz”, IfSG) has been 
issued explaining the increase of the reported number of cases.  Source: Robert Koch 
Institut 
Syphilis is characterized by multiple clinical stages and long periods of latent, asymptomatic 
infection. It is acquired by sexual intercourse or by transmission from the mother to the baby 
(Goh 2005). Sexual transmission is probably by inoculation into tiny abrasions from sexual 
trauma. This results in erosion, then an ulcer, which is called “chancre” and appears 9-90 
days after infection. The chancre is classically painless and indurated and may not be apparent 
and recognized by the patient. This ulcer is commonly accompanied by a regional 
lymphadenopathy. Systemic dissemination results in immune response against T. pallidum 
leading to secondary syphilis. Immune complexes are formed which may be deposited in 
organs such as kidney or joints. Secondary syphilis presents with generalized rash affecting 
soles and palms, generalized lympadenopathy, and oro-genital mucosal lesions. This is 
followed by a latent stage that develops into tertiary syphilis in 40% of untreated patients. 
This stage is characterized by gummatous, cardiovascular, and neurological involvement; the 
latter two are also classified as quartary syphilis. Gummatous syphilis can involve the organs 
and the supporting structure and can lead to destructive lesions and organomegaly. Late 
neurosyphilis can lead to stroke syndromes and general paresis. Cardiovascular syphilis can 
lead to angina and aortic aneurysm. 
Diagnosis is by identification of T. pallidum by dark field microscopy, direct fluorescent 
antibody stain, staining in histological specimen, and by serological tests. 
Treatment is done by intramuscular injection of benzathine penicillin either as a single dose 
or weekly in two or three doses. In patients allergic to penicillin, doxycycline, tetracycline, or 
azithromycine can be used alternatively. 
Despite several attempts, the development of an effective vaccine for Syphilis was not 
successful (Brinkman et al. 2006). However, in principle the development of a vaccine should 
be possible, because in a proof-of-principle study the immunization of rabbits with large-
numbers of gamma-irradiated treponemes was successful (Miller 1973). Although, the 
applied protocol is impractical for human vaccine development, it is hoped that new vaccines 
based on recombinant proteins or peptides can overcome the encountered challenges 
(Brinkman et al. 2006).   
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Molecular Pathogenesis of Syphilis 
T. pallidum has only few outer membrane proteins and does not have lipopolysaccharide. Due 
to the lack of these immune targets, T. pallidum is also commonly called the “stealth 
pathogen” (Radolf et al. 1989; Peeling and Hook 2006). Important pathogenicity factors 
belong to a family of Tpr proteins, which encode homologs to the major surface protein of 
T. denticola that mediates attachment to the host tissue and function as porins (Edwards et al. 
2005). One member of this family is TprK, which is a cell-surface or periplasmic protein and 
could be a target for opsonic antibodies (Centurion-Lara et al. 1999; Hazlett et al. 2001). 
TprK has variable regions and variability in these regions is observed with successive passage 
(Centurion-Lara et al. 2004). Antigenic variation through gene conversion is thought to be a 
second mechanism of immune evasion. The genome encodes for putative virulence factors 
similar to known hemolysins and cytotoxins, but a secretion system for these has not been 
identified. 
Infection with T. pallidum provokes a strong humoral and cell-mediated immune response. 
Antibodies against T. pallidum are readily detected throughout the course of infection. A 
certain degree of protective immunity is formed in human as well as in animal models, 
although this does not completely protect from reinfection. However, the antigens eliciting 
this protective immune response are not known. A candidate is the previously mentioned 
protein TprK; immunization with this protein leads to a significant, but incomplete 
protection against infection in the rabbit model (Centurion-Lara et al. 1999). However, it 
should be mentioned that this finding has been questioned (Hazlett et al. 2001). 
 
1.3. Approaches for and Lessons from Large-Scale Interaction Mapping 
Parts of this section have been published in Expert Reviews 
on Proteomics (Titz et al. 2004). The text has been modified 
and updated. 
The aim of this thesis is the analysis of protein-protein interactions of T. pallidum at the 
genome-wide scale. The employed method for identification of protein interactions is the 
yeast-two-hybrid system, a genetic screen in yeast cells. In the following paragraphs, an 
overview of protein-interaction mapping approaches and lessons that can be learnt is given. 
The Biological Significance of Protein-Protein Interactions 
Proteins usually function in the context of other proteins. Protein-protein interactions greatly 
expand the flexibility of proteins beyond their individual activities. For example, the dimeric 
transcription factors Myc and Max have to associate in order to recognize their DNA-
binding motif. The Myc-Max dimer allows regulation by changing the protein concentration 
of each protein but also by the expression of competitive inhibitors such as mad which binds 
to and blocks Max. Such combinatorial regulation expands the evolutionary flexibility too 
because each genes encoding binding partner can duplicate and these additional proteins can 
adopt different specificities and eventually biological roles. For an extensive discussion of 
protein interactions and their biological significance, the reader is referred to standard 
textbooks of molecular biology. 
How Protein-Protein Interaction Data are generated 
Although a number of methods are available for high-throughput analysis of protein-protein 
interactions, the yeast-two-hybrid system (Y2H) and a combination of protein-complex 
purification and subsequent analysis by mass-spectrometry (coAP/MS) are the most 
commonly used ones (Fields and Bartel 2001; Mann et al. 2001). 
The yeast-two-hybrid-system was developed by Fields et al. (1989). This genetic assay takes 
place in living yeast cells and employs a transcription factor that can activate a reporter gene 
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when its DNA-binding domain (DBD) and its transcriptional activation domain (AD) are 
linked (e.g. the transcription factor GAL4 is used). When both domains are separated from 
each other, they do not have the capability to activate transcription of the reporter gene. To 
answer the question whether a protein A interacts with protein B, each protein is fused to 
one of these transcription factor domains: AD and DBD, respectively. If protein A binds to 
protein B, an active transcription activator complex is re-established, the reporter gene is 
transcribed and its gene product can be used to detect the protein-protein interaction. The 
protein linked to the DNA-binding domain is called bait; the protein linked to the activation 
domain is called prey. This assay is applied in a high-throughput manner to screen for 
protein-protein interactions. 
Various modifications of this assay were developed (e.g., the use of different transcription 
activators) and this assay was the first protein-protein interaction assay to be employed at a 
genome-wide scale. Uetz et al. (Uetz et al. 2000) used a special type of this system, the array-
based Y2H system, to screen for interactions in the yeast proteome. In this system individual 
prey strains are systematically arranged on culture plates with 384 positions, individual bait 
strains are mated with the prey strains at each position of this array, the positions of these 
bait-prey combinations are retained throughout the assay, and individual protein-interactions 
can easily be identified by their reporter-gene activation at a specific positions of the array 
(Fig. 3).  
 
systematic prey library…
…~1039 preys
…as duplicates/quadruplicates
…on 384-well-plates
~T. pallidum baits
screened individually against…
X
HIS3DBD
X
Y AD
HIS3DBD
X ADY
1 “bait” vs. 384 “preys” selective medium
 
Fig. 3 Array-based yeast-two-hybrid system. This system is based on the procedure 
employed for interaction mapping of yeast proteins (Uetz et al. 2000) and was used for 
the generation of the T. pallidum interaction map in this thesis. The Y2H system is a 
genetic screen in living yeast cells, which is based on a split transcription regulator (lower 
left); only if the two tested proteins interact, an active transcriptional activation complex 
is formed, which activates a reporter gene. All prey strains of the proteome are arranged 
on plates with 384 defined positions (lower right) – this set of plates is called “prey 
array”. For each screen, the whole “prey array” is mated with an individual bait strain. 
After mating each position of the array carries a yeast colony with a specific prey (defined 
by array position) and always the same bait (from the mating). Handling of colonies is 
done with a laboratory robot (upper right). Yeast colonies are transferred to selective 
plates, on which only bait/prey combinations, that activate the reporter gene, can grow. 
Colony growth at a specific position of the array (lower right) is indicative for a specific 
protein interaction of the tested bait and the prey at this specific position.  
Another method for identifying protein-protein interactions makes use of mass spectrometry 
(MS) for the identification of protein-interaction partners (Rigaut et al. 1999). In these 
approaches, which are commonly called co-affinity-purification/MS (coAP/MS) approaches, 
a purification tag is added to the protein of interest. By means of this tag, this protein is 
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subsequently purified from a whole cell lysate. Proteins, which interact with the purified 
protein in the selected cell-type, stick to this protein and are co-purified. These co-purified 
proteins can be identified by mass-spectrometry to define the set of interacting proteins. 
Several genome-wide protein interaction studies have been conducted (Table 3). The first 
“genome-wide” two-hybrid screen was carried out by Bartel et al. (Bartel et al. 1996) for the 
study of protein interactions in bacteriophage T7. The first genome-wide protein-protein 
interaction study of a free-living organism has been published by Uetz et al. (Uetz et al. 2000) 
using the yeast Saccharomyces cerevisiae. 
At present, these interaction studies cover a wide range of organisms ranging from viruses, 
over yeast, to human. Note that – despite the recent publication of two coAP/MS studies for 
E. coli (Butland et al. 2005; Arifuzzaman et al. 2006) – only a partial Y2H interaction map 
(with 261 tested baits) is available for bacteria (Rain et al. 2001).  
Some key differences of the resulting two-hybrid and coAP/MS datasets are illustrated in Fig. 
4. 
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Fig. 4 Interaction data gained by Y2H and coAP/MS are complementary. Skp1 is 
a protein involved in ubiquitin-mediated protein degradation and has been epitope-
tagged for both two-hybrid screens and mass spectrometry analysis. The purified 
complexes of Skp1 from three independent MS studies and the binary interactions from 
two Y2H studies are compared. Despite the differences in the data sets, most of the 
found interactions seem to be plausible: All proteins colored red are known to be 
involved in protein degradation. Skp1 is directed to its target proteins via so-called F-box 
proteins, which contain a short peptide motif, the F-box (F). Data from (Uetz et al. 2000; 
Ito et al. 2001; Seol et al. 2001; Ho et al. 2002) and R. Aebersold (pers. comm.). This 
figure was published in (Titz et al. 2004). 
These experimental approaches for high-throughput interaction analyses have taught us 
already one important lesson: Y2H and MS datasets are strikingly different but also highly 
complementary. This difference between datasets – even between datasets derived by a 
similar method for the same species – is exemplified by two recent coAP/MS studies for 
yeast (Gavin et al. 2006; Krogan et al. 2006). Goll and Uetz (Goll and Uetz 2006) found, that 
only 28% of the core complexes from Gavin et al. are completely contained in the complexes 
identified by Krogan et al..  
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Interestingly, transient interactions are more often found by yeast-two-hybrid analysis, 
whereas stable interactions (such as those in protein complexes) are more reliably identified 
by in vivo pull-down techniques (Aloy and Russell 2002). This finding is not surprising, given 
the highly cooperative forces that stabilize a protein complex: many interactions in a complex 
will not be detected by Y2H analysis as long as only pairs of proteins are tested that are not 
stabilized by the other subunits of a complex. 
 
Organism 
(genes) 
Method Interactions  
(or complexes) 
Proteins 
(% genome) 
Reference 
Y2H 967 1004 (~16%) (Uetz et al. 2000) 
Y2H 4549 3278 (~55%) (Ito et al. 2001) 
Co-
AP/MS 
9421 1665 (~28%) (Gavin et al. 2002) 
Co-
AP/MS 
3878 1578 (~26%) (Ho et al. 2002) 
Co-
AP/MS 
491 complexes 2760 (~46%) (Gavin et al. 2006) 
Yeast 
Co-
AP/MS 
547 complexes 4087 (2708 in 
core set) (~68%) 
(Krogan et al. 2006) 
Y2H 20405 
(4680 in high 
confidence set) 
7048 
(4679 in high 
confidence set) 
(~52%) 
(Giot et al. 2003) 
Y2H 1814 488 (~4%) (Stanyon et al. 2004) 
Drosophila 
Y2H 2338 1727 (~13%) (Formstecher et al. 2005) 
C. elegans Y2H 4027 1926 (~10%) (Li et al. 2004) 
Y2H 2800 NA (Rual et al. 2005) Human 
Y2H 3186 1705 (Stelzl et al. 2005) 
H. pylori Y2H 1465 732 (~47%) (Rain et al. 2001) 
E. coli Co-
AP/MS 
5253 NA (Butland et al. 2005) 
 Co-
AP/MS 
11511 NA (Arifuzzaman et al. 2006) 
KSHV Y2H 123 50 (Uetz et al. 2006) 
VZV Y2H 173 55 (Uetz et al. 2006) 
Table 3 High-throughput protein-interaction studies. For yeast-two-hybrid (Y2H) 
screens, the approximate number of binary interactions is shown. For co-affinity-
purification/mass-spectrometry approaches, the number of predicted binary interactions 
based on the spoke model is shown. The table is based on and extends a table from Uetz 
et al. (Uetz and Finley 2005). 
No matter how they are generated, interaction data have been used by both experimentalists 
and theorists for further analysis. A breakdown of such uses is shown in Fig. 5 and discussed 
below in more detail. 
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Fig. 5 The use of large scale protein interaction data sets as shown by the number 
of citations that Uetz et al. (Uetz et al. 2000) received during 4 years after publication 
(grouped into 4 categories). The high level of citation by experimental (small-scale in-
depth) studies indicate the usefulness of high-throughput interaction data for more 
focused analyses. The increasing citation rate by bioinformatics studies, which mainly 
focus on the high level organization of protein interaction networks, however, illustrates 
that both a bottom-up, as well as a top-down view of biological systems are encouraged 
by these high-throughput studies. This figure was published in Titz et al. (Titz et al. 2004). 
Special Focus: Transcriptional Activation 
The yeast-two-hybrid system is based on the reconstitution of a split transcription factor. The 
underlying principles of transcriptional activation are, therefore, essential for understanding 
this system. Conversely, the yeast-two-hybrid system can form the basis for a better 
understanding of transcriptional activation.  
Transcriptional regulators that activate transcription are usually composed of a DNA-binding 
domain (DBD) and an activation domain (AD). The DNA binding domain targets these 
proteins to a specific binding site in the promoter or enhancer region of a gene and the 
activation domain mediates transcription initiation (Kadonaga 2004). 
Transcriptional activators in yeast were among the first to be studied in detail. In all known 
cases they recruit additional proteins or whole complexes to the pertinent promoters, 
eventually leading to the binding of one of the three RNA polymerases. For example, the 
yeast transcription regulator Gal4 is involved in regulation of galactose metabolism and 
activates transcription by recruitment of the basal transcription machinery (Ptashne and 
Gann 1997; Koh et al. 1998; Bhaumik and Green 2001; Bhaumik and Green 2003; Bhaumik 
et al. 2004). 
The Gal4-AD can recruit Tra1, a component of the SAGA complex, to the upstream 
activating sequence (UAS), where Gal4 itself is bound. SAGA, in turn, recruits the Mediator 
complex to the UAS. The Gal4-AD can also directly recruit the mediator complex. In any 
case, the UAS bound Mediator is required for recruitment of general transcription factors 
(GTFs) to the core promoter and assembly of the pre-initiation complex (PIC). 
While DNA-binding domains are extremely well characterized both functionally and 
structurally, activation domains do not share easily recognizable motifs or structures 
(Triezenberg 1995):  Accordingly, no specific pattern or motif for the identification of an 
activation domain has been defined in pattern/domain databases such as Prosite (Hulo et al. 
2004) or SMART (Letunic et al. 2004). In contrast, more than 50 patterns for DNA binding 
domains have been documented in the SMART database. 
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Because the activation properties of transcriptional activators cannot easily be recognized by 
sequence homology, several studies tried to identify more general sequence features resulting 
in a number of different activation domain classes (Mitchell and Tjian 1989), e.g. acidic 
activators (Sadowski et al. 1988), glutamine-rich activators (Courey et al. 1989) and proline-
rich activators (Mermod et al. 1989). In addition, a few rather unspecific properties like 
hydrophobic patches interspersed with hydrophilic residues (Regier et al. 1993) or amphipatic 
alpha-helices (Giniger and Ptashne 1987) have been identified. These analyses culminated in 
the finding that even small chemical compounds with a certain pattern of hydrophobic and 
hydrophilic residues are sufficient for transcriptional activation (Minter et al. 2004). 
Only a few proteins have been identified as specific interaction partners of transcriptional 
activators, including TATA-box binding protein (TBP), TFIIB, TFIIH (Stringer et al. 1990; 
Ingles et al. 1991; Goodrich et al. 1993; Melcher and Johnston 1995; Koh et al. 1998; Neely 
et al. 1999), and several others. 
An in detail analysis of transcriptional regulators will be presented in this thesis (chapter 3.2). 
Reliability of High-Throughput Data 
No method is able to identify all protein-protein interactions. That is, each experimental 
strategy generates a significant number of false negatives. The sources of this systematic 
error are poorly understood. Two-hybrid false negatives might be caused by sterical effects 
due to the usage of two fusion proteins (“two-hybrid”) or involve weak interactions within 
complexes that require cooperative effects to be stabilized (Aloy and Russell 2002). 
Conversely, a major bottleneck for mass spectrometry analysis is low abundance proteins and 
proteins that are only weakly associated with protein complexes and hence tend to get lost 
during purification.  
False positives are usually a more serious problem because they result in erroneous data and 
thus misleading conclusions. In yeast-two-hybrid studies, some bait constructs activate the 
reporter gene without interacting with a prey and so may generate large numbers of 
“technical false positives”. On the other hand “biological false positives” represent true 
interactions that take place in the Y2H system but have no biological relevance (Ito et al. 
2002). A case in point are interacting proteins that are usually expressed in different cell 
types. 
Several approaches were used to minimize the number of false positives in high-throughput 
studies. Uetz et al. (Uetz et al. 2000) discarded yeast-two-hybrid interactions which could not 
be reproduced and Ito et al. (Ito et al. 2001) defined interacting protein pairs found three or 
more times as (supposedly reliable) “core” dataset.  
More elaborate statistical scores were proposed by Rain et al. (Rain et al. 2001) for the 
Helicobacter interaction map and by Bader et al. (Bader et al. 2004) for yeast and other data 
sets. 
Rain et al. screened bait proteins against a genomic fragment prey library and considered 
overlapping prey fragments as the most reliable. This approach combines reproducibility and 
identifies the interacting domain at the same time. 
The critical point of any attempt to estimate the number of true and false positives in a HTS 
interaction study is the choice of the “true positive” data set against which the new 
interactions are evaluated. Bader et al. (Bader et al. 2004) used the dataset of known protein 
complexes to derive other parameters that allow the scoring of Y2H data. A similar statistical 
model was applied to the whole Drosophila data set resulting in a high confidence protein 
interaction network which the authors estimated to retain 40% interactions of “biological 
significance” (Giot et al. 2003). 
Edwards et al. (Edwards et al. 2002) selected known interactions from 3D-structures (RNA 
polymerase II, proteasome and the Arp2/3 complex), and additionally, complexes from the 
literature. The crystal structures of complexes approximate the “absolute truth” about stable 
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protein interactions because they reveal all interactions in atomic detail, at least for the 
proteins that have been co-crystallized. Based on crystal structures, Edwards et al. found a 
false negative rate of 51%-96% for yeast-two-hybrid and of 15-50% for in vivo pull-down 
experiments, respectively. In this context it is remarkable that conventional “low throughput” 
methods also produce a large fraction of false positives - for example 61% in a pull-down 
study of RNA polymerase II (Edwards et al. 2002). 
Several studies showed that interacting proteins tend to be co-expressed at the mRNA level 
under various experimental conditions (Ge et al. 2001; Grigoriev 2001). However, while co-
expression of the two partners increases the confidence in a protein-protein interaction, it is 
only an indirect measure of its reliability. While proteins in a complex need to be expressed at 
similar levels in order to maintain their stochiometric ratios, this is not necessarily true for 
transient interactions that are often found in Y2H screens. 
Overall, it is impossible to reliably estimate the false positive rate of the Y2H system – 
especially, because all “gold standards” are biased themselves. However, recent large-scale 
studies found that between 50% and 70% of the identified interactions can be reproduced by 
an independent method (which also has a certain false-negative rate) (Rual et al. 2005; Uetz et 
al. 2006). Thus, the question is not, whether these proteins do interact, but whether and 
under which physiological conditions their interactions are biological meaningful. 
The Topology of Protein Interaction Networks 
Protein interactions identified on a genome wide scale are most commonly visualized as 
protein interaction networks. These networks are graphs with proteins as nodes, which are 
connected by edges (interactions) (Fig. 6 A). This representation is vivid and allows for the 
analysis of certain graph properties. 
Many biological networks, including protein interaction networks and metabolic networks, 
have a so-called scale-free topology (or at least a scale-free node-degree distribution) 
(Barabasi and Albert 1999). Scale-free networks are characterized by a few highly connected 
nodes (“hubs”) and many less well connected peripheral nodes. The distribution of the node 
degree k follows a power law (P(k)~k-γ
  
with power coefficient γ, and probability/frequency 
of a node degree P(k)) (Jeong et al. 2000; Wagner and Fell 2001) (Fig. 6 A). 
The scale-free nature explains several properties of protein interaction networks. For 
example, highly connected hubs often appear to have central roles in a network, which would 
make them vulnerable to attack by mutation or drugs. Indeed, Jeong et al. (Jeong et al. 2001) 
have shown based on the yeast network that the inhomogeneous structure of a network 
results in tolerance to errors. Random mutations in the yeast genome do not appear to affect 
the overall topology of the network. By contrast, when the most connected proteins are 
computationally eliminated, the network diameter increases rapidly (that is, the minimum 
number of nodes between two arbitrary proteins). Although proteins with five or fewer links 
constitute about 93% of the total number of proteins in the dataset of Jeong et al., they 
found that only about 21% of them are essential. By contrast, only some 0.7% of the yeast 
proteins with known phenotypic profiles had more than 15 links, but a deletion of 62% of 
these proves lethal. This finding has been confirmed for yeast, the fly, and the nematode 
networks (Yu et al. 2004; Hahn and Kern 2005). This phenomenon is commonly referred to 
as the centrality-lethality rule (Jeong et al. 2001). However, this rule has also been disputed in 
the literature. Coulomb et al. state that this observation is an artifact of the underlying biased 
data – though, it should be noted that their conclusion relies on a single yeast-two-hybrid 
dataset generated by Ito et al. (Ito et al. 2001). He et al. (He and Zhang 2006) challenge the 
notion that the functional importance of a node arises from its structural importance in the 
network. They explain the basis of this observation by the existence of essential protein-
interactions rather than individual essential proteins. The existence of a certain fraction of 
essential network links would lead to a higher probability for hubs to be essential. In a recent 
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study, however, Batada et al. reinvestigated the importance of hub proteins based on a 
comprehensive literature curated interaction set for yeast (Batada et al. 2006b); they found a 
robust correlation of essentiality and connectivity of proteins (Batada et al. 2006a) – however, 
literature derived interactions were suggested to be highly biased (Coulomb et al. 2005). 
B
A Exponential Scale-free
D
C
<k>
P
(K
)
K log k
lo
g
 P
(K
)
U PF3
CR M1
CIT2
MU S81
Y MR3 17 W
RIM1 1
KA R9
Y LR26 6C
CC Z1
SA P18 5
RO M2
RPC4 0
TPD 3
SN F4
K TR3
ECM2 1
A IP2
G CN 5
ZD S2
Y KL1 83 W
NIF3
SM D1
Y D R49 3W
H SL 7
DED 1
BU B 3
RV S1 67
Y MR 06 8W
PU P2
YIL00 1W
D ST1
CD C 20
PCL9
Y H L02 3C
DBF 20
RN A 15
Y OL 10 1C
SAC 7
STI1
Y N L12 2C
Y NR 04 8W
PEX 18
SEC2 2
Y MD 8
SFT2
CIN 5
V MA 6
YLR 26 9C
YB R1 34 W
FU R1
INO8 0
A SH 1
Y OR 20 6W
R VS16 1
Y NL 05 0C
YA P1 80 1
ARP 1
CKS1
BET 1
YPR 04 0W
TSM 1
CK A2
Y PR 00 8W
CYP 2
PA C1 0
Y OR0 62 C
Y LR37 6C
E SR 1
PK C1
Y DR 20 0C
TIF5
PTP2
FPR 4
UBR 1
MED 6
PX A2
SE C2 0
SR O 77
H Y R1
N PL4
Y PR11 5W
RPT6
H D R1
W SC3
N PI4 6
RAD 2
SP C19
PEX 14
SIR 1
CA F17
SP C98
Y G R29 0W
Y IL0 07 C
LY S5
YCR 0 45 C
Y O R31 5W
TIF4 63 2
Y K U7 0
PR P8
Y O R13 8C
YIL11 2W
Y MR2 85 C
SEC 66
A MI1
ISY 1
Y OL1 06 W
Y N L1 27 W
Y DR1 30 C
SM Y2
Y LR37 9W
CD C 23
YIL11 3W
Y KR0 30 W
Y OL0 34 W
BN I4
KA P12 3
Y D R13 1C
YD R0 26 C
SAP4
INO 4
MC K1
BUB 1
YCL 01 6C
R AD 7
SWI4
BET5
YD R1 32 C
N UP15 9
CLB 2
D UN1
YJL2 00 C
Y G R29 4W
CD C 55
REG 1
H SH 49
TFB1
LSM 4
EBS1
PA C2
SR B8
R CK 1
SW I1
RH O 2
SIN4
STB1
Y ER1 13 C
TEF1
U ME 6
M ED4
TA H 18
Y OL0 70 C
Y NL1 64 C
YO R3 53 C
YK L0 02 W
YPR0 49 C
GL N3
Y DR 06 1W
Y CR 08 2W
MA D 1
YN L0 91 W
D A L80
D N A43
PIB 1
BOI2
MN N 9
Y JR05 6C
PR P9
SFB3
D IB 1
A PC 5
PIG 2
IME4
RH O 3
NTF2
Y OL 14 4W
YN L0 92 W
CTF1 9
T UP1
BNI1
Y PL0 19 C
PR P2 1
RRN 7
Y D R06 3W
M ET30
A RL3
N IP29
YLR 01 5W
IPK1
YER 11 6C
SY G1
TRA 1
G D S1
SEC 2
GRR 1
SPC34
Y IL15 2W
GA C1
YBR 2 84 W
GRF 10
SSA 3
Y N L09 4W
SEC 7
JSN1
SPB1
RPC82
Y DR 42 1W
YC R0 86 W
TO F1
MEU 1
SIP1
Y ER04 5C
SH O1
Y MR1 02 C
Y OR 28 4W
RU B 1
YLR 12 3C
SP T20
VA C8
K A R4
A BF1
Y G R00 3W
SPI1
HSP42
PEX 5
R PO2 1
SSO 1
Y CR 08 7W
YCL 05 6C
LA C1
SUA 7
K RE6
SIS2
TB F1
FIP1
K IN 2 8
N UP82
Y IL0 82 W
SUP3 5
M NN 1 0
MC M21
Y DL 21 4C
MD S3
Y LR12 4W
A BP1
D CP1
A UT7
A RG R3
SA P1
BEM4
Y O R35 9W
IM E1
Y EL01 5W
RAS2
CSE2
TRS23
MET 17
G DH2
Y G L1 98 W
YL R05 2W
Y LR1 25 W
A N C1
SPA 2
SPC4 2
N U P1 70
PRP18
H MO 1
H O F1
Y DL2 16 C
SN F5
K RR1
GL G2
C DC 14
STT4
Y KU8 0
A PC 2
BD F2
CC T4
Y PT7
Y JL06 4W
R RP45
Y MR2 11 W
Y D L0 71 C
YAR 01 4C
YD L1 44 C
YD R5 32 C
YJL0 65 C
EST1
SP T8
K SS1
D A M1
SB A 1
BNR 1
N G G1
UBC 1 2
SU I3
YLR 12 8W
GR X5
SSA2
Y ER00 7C A
Y N L27 9W
SEC 9
Y PL23 8C
V M A8
Y D L21 8W
TFB 3
CE F1
IMP2
TO P3
Y GR1 15 C
V PH2
TIF3 5
N U F1
SCJ1
C OQ 5
N OG 1
MY O5
Y H R0 22 C
RFA3
CRC1
Y DR 35 7C
Y DR1 79 C
A CC 1
REV 3
RP N5
RPN 1 0
H SP1 04
SPT6
X DJ1
K IN 3
YG R1 17 C
U BA 2
BU L2
RPL3 1A
M YO 1
STP1
PD R1
RA S1
FKS1
TIM2 3
Y DL0 76 C
CSE4
LY S9
Y MR3 22 C
Y MR0 71 C
TSP1
Y BR 1 03 W
YA P1
TEF4
SPP41
Y LR23 8W
Y K L15 5C
SW I3
N U P5 7
N Y V1SEC1 0
CC R4
Y G R04 6W
A DP1
SPT3
YG L0 15 C
A RK 1
Y ML1 14 C
MD H 3
RSR1
RPA 1 35
TFC 4
POP 2
PT C2
TIF3 4
RPO 41
IST3
A ME1
Y LR34 5W
RPS3 1
VA N1PAN1
Y PR0 11C
Y JL17 8C
Y NR 05 3C
PIG 1
Y LR09 5C
TU B2
H DA1
CAT2
TW F1
Y G R15 3W
N AB 2
UFD1
RPT3
Y O R10 5W
Y PT1
Y M R32 5W
YL R41 9W
RR N 11
H TB2
C TL1
TLG 1
SST2
K AP95
PH O 80
LTE1
VM A2 2
CNB 1
SK N 7
IRA1
SCM 4
PFD 1
SX M1
VA M 3
YN L2 01 C
A CT1
CD C 46
FA P1
G IC 1
A KR 2
Y MR1 81 C
RIF2
YLR 09 7C
Y BR 10 8W
CY S4
STE4
Y D R46 9W
CM D1
SM D2
YCK 1
G CD 2
SM I1
YM R07 7C
CH A 4
CKB 1
MSL 1
GO S1
SFL1
G FD 1
SSN 8
PPH 22
SDS2 2
CLB5
PD R 3
Y D R10 0W
SSO2
Y SH1
SIN 3
PR P39
Y HR2 09 W
SU P4 5
PEP1 2
YD R3 98 W
RPB11
RPL11 B
MTR3
YIL01 1W
SC S3
LSM 8
SLA 1
Y CR 05 0C
MIF2
SO H 1
Y LR4 56 W
TO P1
SEC 1 4
G YP1
D SS4
YAL0 28 W
HIR2
IKI3
NBP 1
A PG 12
PA P1
N MD 3
CR Z1
MY O 4
HIP1
PD R11
SBP1
RSE1
Y KT 6
HIR1
ST E5
SEC1 5
A PG 7
YD R1 04 C
Y GL 16 1C
YM R29 1W
CK B 2
H SC 82
YCL 02 0W
CLP1
RSC6
RD H5 4
RFA2
SPC9 7
Y DR 03 2C
CD C 54
G CD 10
FPR1
Y O R32 4C
YLR3 87 C
D U T1
MN S1
RA D 54
Y D L00 1W
ECM 13
Y G R26 8C
RRP4
G CD 6
PR E1
A RP10
SRB6
N H P1 0
RA D6
N MD 5
SKI6
TRS2 0
JN M1
Y DJ1
TU B1
DCI1
PR P22
RAD 1
CBF1
XPT1
Y K R00 7W
Y GR2 69 W
SM K1
SM P1
MY O 2
U FE1
YBR 0 77 C
Y CL02 4W
SEC 63
SN C2
PC L7
SKI7
SIM1
N U P1 45
CSE1
SLA2
SRV 2
LA S1 7
Y DR0 36 C
Y GL 23 9C
SU I1
MA D2 Y D R21 4W
Y DL 11 0C
MED 2
RP L34 B
PEX 7
PA N2
Y PL0 25 C
RPG 1
PR C1
PRT 1
SCD 5
K GD 1
BIM1
RR P42
PKA 3
APC 1
YM L08 8W
Y DR 07 0C
STB 5
CDC 5
V PS45
Y O R07 8W
PR E1 0
TIF3
FU S1
PEX2
STH 1
A D R1
Y K E2
HRR 2 5
Y JL2 11 C
CCT 5
YD R0 71 C
O Y E2
SPC2 5
RA D 9
CD C 31
AR P3
RPL1 6B
SN F2
PR P40
G SP2
Y BL0 49 W
Y DL11 3C
Y CL0 61 C
Y G L09 6W
YPL02 7WB IK 1
A RC 19
Y NL2 47 W
PO T1
Y ER1 24 C
PEP7
SPR2 8
Y PL1 33 C
A PC 11
K AR 2
RPT4
M ET18
TAF6 1
CD C 39
SR M1
IRA 2
TO R1
HO M3
SW I5
RH O1
N TC2 0
Y PR 09 3C
Y OR 29 2C
RS P5
SN F11
SIR 2
M V P1
Y G L09 8W
Y O L08 2W
CD C 27
YA K 1
LPP1
H SP82
SED 5
Y CL0 63 W
PU T3
SN X4
PR P11
MP T1
Y OL0 83 W
Q CR6
Y IL1 63 C
M ET3 2
G IP2
YD R3 26 C CD C2 5
K G D2
CIN 2
N A P1
B OI1
SC C2
LCP5
YEL 02 3C
M TD 1
H CS1
PH O4
YJL0 38 C
ME D1 1
IQG 1
Y D L117 W
TIM1 7
N PL3
M SH4
RA D 55
A1
ENT2
SPT2
YD R2 55 C
SKP 1
R AD 1 7
A DH1
RIP1
A LPHA 1
M SB2
PD C 5
SEC 35
ALPH A2
RA D 4
GIN4
PEX 3
SPH1
YD R0 78 C
Y CR 09 9C
Y K R08 3C
Y JL21 8W
CD C 26
Y D R18 3W
YH R1 00 C
SE C1 3
Y MR0 09 W
Y K L05 2C
C US2
RSC 8
ATC1
CD C3
H BS1
SEC 4
Y DL 22 5W
SPT5
SIT4
IDS2
A RG R1
GC S1
Y N R02 2C
Y PL 24 6C
PC L6
MC M1
Y LR3 15 W
PPT1
YN L2 88 W
CD C4 0
YFR 03 9C
N IP1 00
SPC24
MTW 1
CO Q 1
MSH5
E RV25
N RK 1
M BF1
Y ER0 92 W
PA B1
SN F12
Y LR2 43 W
Y MR 04 4W
SLT2
PC L1
IMP1
G A L4
CLB 3
N ET1
Y SP3
Y K L16 1C
M YO 3
PU P3
YN R0 25 C
Y LR4 23 C
M R E1 1
PE T30 9
NPR 2
CD C 4
Y D L15 6W
SSB1
LRS4
Y D L15 7C
SFT1
TAF4 0
PRP19
N U P1 16
BU D 6
Y BR 00 6W
YA R02 7W
Y H R03 2W
YH R1 05 W
EMP2 4
M NN 1 1
TRS3 1
TFC7
SSN 6
RAD 5 1
U FD 2
YLR4 24 W
SLY1
PPZ1
YO R0 06 C
N A M7
Y MR 22 6C
Y N L1 00 W
G TR1
SQ T1
FLO 5
YK L0 90 W
YG R2 32 W
TRR 2
M C M6
Y JL18 4W
TOA 2
Y LR35 2W
P53
YM R04 8W
MU D 13
PH O 81
YH R0 34 C
CDC 1 2
YJL1 85 C
X RS2
Y H L00 2W
FIG 1
Y BR 113 W
ST E7
Y GR 16 0W
H HF1
CB F5
U BI4
SN C 1
Y N R02 9C
A RO 8
RFX 1
Y GL0 24 W
R AD 16
YB L01 0C
Y H R14 0W
Y IR 01 4WY H R03 5W
RSC1
SY F2
PGD 1
MTF 1
TU B3
A SM4
RPL4 2B
YE F3
TPK3
LST7
SW E1
CEG1
HH F2
M ET4
PRP45
G AL8 0
TIF46 31
ATP2 0
PD B1
Y CR 0 22 C
YBR 0 43 C
H HT2
Y EL0 68 C
LEU 4
TRS33
SN F3
Y D L08 9W
PHO 12
YH L0 06 C
YG R0 58 W
SN F1
TCM 62
TK L2
BFR2
C RN 1
MET2 8
SG S1
Y RB1
E CI1
SEC 3 1
YH R2 16 W
Y JU 2
FIL1
ST E20
CH C1
SPR3
G IP1
SCW 11
YM R26 3W
HTA3
RSC2
CY B 2
KEL 2
YH R0 39 C
Y GL 06 0W
Y LR35 8C
A PG 16
TE F2
RR N6
PC L5 DB F2
D U O1
RPT5
ECM 19
YH R1 45 C
PEX2 1
RA D5 7
PC L1 0
M U D1
YA L0 36 C
YA P3
TOF2
YM R08 7W
RPB2
CC L1
FO B 1
Y LR3 92 C
D O C1
Y MR 08 8C
SIP 2
C LC1
SEC1 8
RS G1
FU S3
RP B3
STD1
Y N R0 68 C
YH L0 42 W
M EC3
CPR 7
PEX 1 7
N CE1 03
CM P2
Y G L24 2C
SPT7
CM K2
Y JR03 3C
PPA 2TA F1 45
Y H R07 5C
Y O R33 1C
Y G R16 9C
CD C 19
TIM 44
Y N R06 9C
PO P8
EN A 1
YG L1 70 C
SEC 17
CN S1
RA P1
PET1 91
Y PT52
TL G2
Y MR2 69 W
N MD 2
V TI1
V PS3 3
G A L3
H RP1
TFC 5
G CD 1
YH L0 46 C
CPA 2
YFL00 2W A N FI1
YIL13 0W
NU P49
YCR 0 63 W
Y D L011 C
RA D 50
G A L11
G ZF3
M FA 2
Y NL2 18 W
N RG 1
K EM 1
FCY 1
TEL2
PH O 85
N RD 1
W TM2
CIK1
STE 50
IRE1
PUP1
CYR 1
SR B4
Y BR 19 0W
Y LR1 00 W
Y D L01 2C
Y NL 14 6W
GIM 5
SS P1
YIL13 2C
YG R2 78 W
YO R2 62 W
Y PL1 05 C
CLN 1
RA D 10
AD Y1
NIC9 6
Y GL1 74 W
BDF 1
LSM 7
RPL16 A
SA E2
APC 9
RHO 5
A LF1
HEX 3
SM E1
Y IL0 28 W
A PC 4
NIP7
RA D 18
R PL25
SNP 1
CTH 1
H TB1
RIS1
MED 8
Y OR2 64 W
CD 45
SE D4
YJR0 72 C
V PS9
MR S6
G CD 11
ZIP2
SPT23
A RC 15
MK K 2
RB L2
NSP1
Y JL1 14 W
Y DR1 52 W
H TA 1
LEA 1
Y O L1 29 W
PM D1
Y RB2
TAF1 9
GA L8 3
TH I6
A RG R2
ND D1
TO A1
M HP1
V PS 21
CLB 4
MPT5
RA D 5
MO G 1
CD C1 6
Y N L07 8W
PG I1
SIP3
CD C 7
SM T3
YBL 05 9W
YJL0 43 W
G LC7
SIR4
CLU 1
CBP3
MN N 4
H O C1
A RG 1
YIL06 5C
TPM 2
PC F1 1
SM B1
NU D1
TU B4
CD C 11
SA P15 5
Y KL 02 3W
YFR 00 8W
YPL07 0W
SPO 21
ROX 3
RH O4
V MA 7
M ET31
G PD2
REV 7
CR R1
TA F9 0 YL A1
MIR1
G D H1
Y PL1 44 W
SHE2
TO R2
YJL1 51 C
PA N3
Y IL1 72 C
Y D R08 4C
AD E8
Y BL1 01 WA
Y FR0 42 W
MSN5
G DI1
CD C 48
SA R1
A HP1
Y NL1 87 W
R TT10 1
A FR 1
Y PL14 6C
MC M3
Y MR31 6C B
Y K L20 4W
V TH1
Y D R40 9W
Y KR0 90 W
PCL8
KA R1
A K R1
Y JL 04 8C
IC L1
SFH1
CPR 6
PC L2
LO S1
YA R03 0C
DH H1
PX A1
Y GR 02 4C
SR P1
N UP42
RR P1V IK 1
RGR 1
SRP40
RA D 3
TFA1
Y LR3 22 W
G CR 1
BR R2
Y FR0 46 C
R NA 12
Y MR05 1C
SLU 7
YLR3 23 C
H HT 1
YA R03 1W
EN T1
MB P1
Y G R20 3W
Y K L06 1W
A N P1
YPD1
H FI1
SD H 2
STB 4
A PG 5
G PA1
A PL2
YD R4 45 C
Y FR0 47 C
SSK2
MD J1
SIG 1
FA R3
STO 1
RA D2 3
Y LR32 4W
Y JL08 4C
FAR 1
STB 2
CL N2
SM D3
PH O 13
Y O R0 11 W
FR Q 1
ECM1 1
REF2
PEP5
SEN 1
PPG 1
G NA1
RA D5 9
RPS22 A
CLA 4
EX O 70
FU S2
RP L10
PEP 3
EFB 1
BU B 2
Y LR07 6C
CD C 36
D IG 2
AD A2
Y MR2 33 W
Y LR43 2W
Y D L23 9C
SR B2
CN A 1
A RC 35
A PM 1
SSA 1
YH R1 14 W
Y G L1 04 C
RT S1
BM H1
A RH 1
SWI6
PO M15 2
YA P1 80 2
SPT4
RN P1
Y D R48 2C
PSE1
YM R05 7C
BO S1
HRB 1
Y CR 10 1C
Y GR1 36 W
A RG 3
K A P1 04
BA S1
LSM 6
NIP1
SNU 1 14
CD C 6
NU P10 0
REG2
TFC1
SIP4
D MC1
STE1 1
TA F17
SIC 1
PFY1
N PL6
N MD 4
MLC1
CLN 3
SN T3 09
Y CR 03 0C
PET1 27
RPL3 7A
RPN 6
GSY 2
G IF 1
RPL11 A
Y D R48 5C
RR N9
A IP1
G CD 7
VAM 7
H SP60
DBP 2
TSA1
YLL0 49 W
M IG1
Y BR 05 2C
PTC 4
AA D6
DFG5
Y IP1
CD C 24
SE C7 2
R PC19
Y IR0 25 W
SET1
PR E2
Y MR09 3W
BRF1
Y GR0 68 C
G SP1
SCM 2
A PL1
SPO1 2
Y G R17 3W
W TM1
CPA1
D IS3
CTF13
MR PL 4
Y CR 08 7CA
STE3
Y PR 10 5
ZD S1
SNO 1
Y LR29 4C
CEP3
CL G1
Y CR 03 3W
MC M2
BO P3
SR O 7
M KK 1
PR P6
RPS22 B
R PL34 A
TE M1
CDC 2 8
PB P2
SNZ3
Y NL 11 6W
SU I2
MG E1
RRP43
A RC 40
RG A 1
SN Z1
Y LR3 68 W
Y TH1
Y LSM3
A D E2
BU L1
Y HL 01 8W
Y IP3
O RC 1
M TR10
MG A 1
APM2
MU M2
D CP2
RR N1 0
T IP20
A U T2
SPC7 2
Y H R08 3W
Y D R01 6C
ABD 1
RPC3 1
KA R3
PB P1
LSM 2
U BC6
H SF1
A LR1
ST E12
Y IL10 5C
K CS1
YPL11 0C
RP D3
SG T1
Y K R02 2C
CNM 67
YN L0 47 C
K EL1
Y G R17 9C
K IN 1
PR P5
N O P1 0
YA L0 49 C
SRA 1
Y ML0 68 W
INO2
Y BR 27 0C
RPA 1 90
G IM 3
Y OR1 64 C
RPS8 B
APG 1
MO B1
CA R 1
SK T5
STE 24
MA D3
CAP2
ME D1
A M I3
YCK 2
Y NL2 27 C
SSC1
GLK 1
V PH1
SSA4
FZF1
RPN 4
H RT1
ILV 6
Y PT31
YM EL1
CK A1
D BF4
SSK2 2
Y BR 09 4W
SNZ2
YN L1 55 W
Y FR 0 11 C
N UP15 7
SEC 24
N OT5
A SN1
MED 7
SNO 2
G CN 3
U RE2
K IP1
G A R1
Y IL1 41 W
RPS28 A
FIR 1 SSL1
CD C 34
SSN 3
SSK 1
PFK 27
END 3
C HK 1
Y NL3 35 W
MA M 33
SSL2
G LE2
N OT 3
RIF1
REV1
Y IF1
H SL1
Y D R12 8W
YK R0 60 W
SAP1 90
CM K1
A OS1
SA C6
PAT 1
YL R00 8C
G IM 4
SEC2 3
YO R2 75 C
PUT4
YD R4 12 W
TID3
Y DL2 03 C
Y PL2 22 W
H OG1
U BP13
LA P4
Y NL 08 6W
LSM 1
YH R1 97 W
Y ER0 36 C
SRB 7
Y JR 08 3C
CD C 33
RPP1B
YH R1 98 C
Y CL04 6W
H O P1
N U P1
Y JL01 9W
TFA 2
V PS16
G CD 14
FM N1
SM X3
G IC 2PR P4 6
C AF2 0
Y PR 07 8C
C CC1
TO P2
SLN 1
CD C5 3
DD I1
MPS1
M SL5
RA D1 4
RA D 53
PD C1
SY F3
Y D L13 3W
SY F1
PPH2 1
STE1 8
SOR 1
PBS2
RPC34
APG1 3
IFH 1
ST U2
D IG 1
G LE1
A RP2
STM 1
RD I1
G CN 4
DO A1
SRB 5
Y JR0 87 W
M OT1
Y LR0 46 C
N HP2
Y LL0 14 W
RPN 1 2
LSM 5
TA F25
YPL26 0W
Y MR0 25 W
Y LR2 24 W
CET1
Y JL16 2C
IKS1
Y NR 00 5C
RPO 26
BET3
SD H 3
GSC 2
Y D R27 3W
R FA 1
Y PL2 29 W
BIR1
PTP3
YJL0 58 C
STB 3
A CS2
G CR 2
U BC 9
SD C 25
SPT 15
V PS27
PEX 1 9
G LC8
PEA 2
AU T1
Y LR0 49 C
SM X2
RG T2
SE C1 6
TA P42
CO F1
RPC2 5
RPL31 B
SR L2
G A L1
CB F2
SPO1 3
H PR 5
CLB 1
PTM 1
R NA 1 4
NU P18 8
K N S1
CLB 6
H SP10
CU S1
M TH 1
Y LR2 61 C
Y PL19 2C
CDC 4 2
STB6
RP T1R PP2 B
YFR0 57 W
BM H2
Y D L24 6C
M DM 1
A QY 2
YSC 84
Y DR3 83 C
YL R44 0C
QC R7
BEM1
N D C1
CD C 10
CH S3
Y ER0 79 W
PR E5
N U P2
RA D5 2
MU D2
RLM 1
TA F6 0
BCK 1
SN O 3
TO M1
CA F16
Y LR1 90 W
RED 1
DD C1
Y K L07 5C
SDH 1
A H C1
SIR 3
V RP1
CDC 4 7
YCP 4
PEX1 3
CA K 1
K AR5
RPS28 B
CIN 4
PLC 1
A RC 18
Y FL0 61 W
20
15
20
32
20
18
20
30
19
17
110
32
101
27
19
52
27
47
30
38
29
19
36
25
22
21
23
98
15
26
24
15
21
20
19
19
19
26 27
45
20
77 97
24
19
18
1925
24
28
2318
3918
16
31
136 32
Amino-acid-metabolism (23/68)
Carbohydrate-metabolism
               (30/78)
Cell-cycle-control
     (90/113)
Cell-polarity (54/52)
Cell-stress (27/75)
Cell-structure (39/54)
Chromatin/chromosome
   structure (72/102)
Cytokinesis (18)
DNA-repair (37/65)
DNA-synthesis (41/50)
Differentiation
      (4/20)
Lipid/fatty-acid and
sterol-metabolism (18/27)
Mating-response
       (41/66)
Meiosis (17/55)Membrane-fusion (23/21)
Mitosis (81/75)
Nuclear-cytoplasmic-transport
              (106/56)
Pol-I-transcription (9/17)
Pol-II-transcription (184/177)
Pol-III-transcription (14/21)
Protein-degradation (77/84)
Protein-folding (18/32)
     Protein
modification
     (28/65)
Protein-synthesis (54/89)
Protein-translocation (51/54)
RNA-processing/modification
                      (117/132)
RNA-splicing (65/65)
RNA-turnover
       (9/16)
Recombination (9/28)
Signal-transduction (42/66)
Vesicular-transport (141/141)
 
Fig. 6 Network classification and analysis. (A) Protein interaction networks are scale-
free networks. In contrast to exponential random networks, in which all proteins (nodes) 
are regarded as equal, in scale-free networks highly connected proteins are more likely to 
interact with new proteins added to the network. Exponential networks are therefore 
statistically homogenous, whereas scale-free networks have a few highly connected 
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proteins (hubs) and many proteins with few interactions. The signature of scale-free 
networks is the power law distribution of the node degree (k) (number of interacting 
partners of a protein), P (k) ~k-γ, whereas the node degree follows a Poisson distribution 
in the exponential network model. Figures taken from (Jeong et al. 2001; Spirin and 
Mirny 2003). (B-D) The protein interaction network of yeast (B) reveals different levels 
of organization. (C) Computer algorithms can deduce molecular modules (protein 
complexes and pathways) directly from the topology of protein interaction networks 
(Spirin and Mirny 2003). (D) Complex protein interaction networks can be collapsed into 
a meta-network showing the interactions between functional categories. Numbers in 
parenthesis denote, first, the number of interactions of a group, and second, the number 
of proteins in a group. The numbers at the edges denote the number of linking 
interactions. (B) and (D) after (Schwikowski et al. 2000). Figures reprinted by permission 
from Macmillan Publishers Ltd. and Copyright 2003 National Academy of Sciences, 
U.S.A. This figure was published in (Titz et al. 2004). 
Experimentally derived interaction networks such as that shown in Fig. 6 B can be extremely 
complex and biological meaning is not immediately obvious in them. However, biological 
systems are hierarchically organized into functional modules and sub modules (Hartwell et 
al. 1999). For example, cells produce ATP via a set of modules such as the glycolytic 
pathway, the Krebs cycle and the protein complexes involved in oxidative phosphorylation. 
Even if their annotation cannot be used for clustering as shown in Fig. 6 C, several groups 
have developed algorithms to identify functional clusters (“cliques”) in protein interaction 
networks. For example, Spirin and Mirny (Spirin and Mirny 2003) developed an algorithm 
that was able to recover many previously known protein complexes (e.g. the anaphase 
promoting complex) and functional modules, e.g. the yeast pheromone response pathway. In 
addition, new complexes (e.g. a complex of six proteins including a YIP1 Golgi membrane 
protein) and new members of complexes (e.g. two 40S small ribosomal subunits in the Lsm 
splicing complex) were identified, and thereby these methods can provide information about 
single proteins and their biological context. 
The interconnections between different modules can be derived from individual protein 
interactions and their functional annotation (Fig. 6 D): when all proteins of a certain 
functional class (or module) are collapsed into one node each, then the protein interactions 
can be used to visualize their relations. For example, in Fig. 6 D (top middle) the 68 proteins 
involved in amino acid metabolism are connected by 23 protein interactions. More 
importantly, this class of proteins also interacts with proteins involved in protein degradation 
(arguably to generate amino acids!), the cell cycle (which controls almost everything and 
therefore is highly connected by definition), and, surprisingly, chromatin structure. 
Unexpected interactions like the one between amino acid metabolism and chromatin 
structure point to hitherto unnoticed crosstalk between biological pathways and functions, 
which in this case may be regulatory in nature. The fact that some groups (such as the cell 
cycle proteins) are highly connected indicates their central regulatory role for most other 
processes in a cell. 
Another method for the detection of complexes in protein interaction networks based on k-
cores (Tong et al. 2002) was used to detect a novel nucleolar network in yeast (Bader and 
Hogue 2002). A k-core is a sub network of the protein interaction network in which each 
protein is connected to at least k proteins of this sub network, and therefore this set of 
proteins forms a highly connected complex in the protein interaction network. The identified 
nucleolar protein interaction network showed a structure corresponding to the known 
electron microscopic substructure of the nucleolus (Bader and Hogue 2002) (fibrillar 
component, dense fibrillar component and granular component) which illustrates that the 
close examination of protein interaction networks can reveal molecular structures, without a 
priori knowledge of protein functions. 
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Lessons from Single Interactions 
The ultimate goal of molecular biology is the mechanistic explanation of specific biological 
phenotypes. For such explanations, a detailed understanding of single proteins is necessary. 
Protein interaction data often provide critical information about the molecular behavior of a 
protein and almost always allow the formulation of some biological hypothesis. The 
chromosome cohesion proteins illustrate this point: a few interactions of the Smc and Scc 
proteins in yeast and their predicted coil-coil structure suggested a model that explained their 
ability to hold chromatids together. 
Obviously, the lower reliability of high-throughput interaction data has to be taken into 
account and hypothesis building should start with the most plausible interaction and then 
proceed to less likely ones. However, the power of interaction mapping is also based on the 
fact that it is not dependent on previous knowledge of a certain protein and therefore 
completely unexpected interactions may lead to spectacular new discoveries. For example, 
interactions between membrane proteins and transcription factors usually have been 
considered as false positives. However, during the past couple of years in a number of cases 
it has been shown that such interactions represent novel ways of regulating transcription 
directly by membrane receptors. Well-studied examples include the SREBPs (Hoppe et al. 
2001), the Alzheimer protein APP and the signaling protein Notch (Kimberly et al. 2001). In 
this way, protein interactions can uncover new connections between previously unlinked 
processes or pathways. Striking examples are “moonlight” proteins. These proteins posses 
multiple functions that are not due to gene fusions, splice variants or multiple proteolytic 
fragments. Clf1p, for example, is a protein involved in pre-mRNA splicing or assembly of 
splicing complexes in yeast. In addition to its interaction with the U5 and U6 subunits of the 
spliceosome an interaction with the replication initiation protein Orc2p was shown in a two-
hybrid assay. This interaction together with a DNA replication phenotype makes Clf1p a 
protein involved in splicing and in DNA replication initiation, and thus represents a link 
between these putative unrelated processes (Zhu et al. 2002). 
An important goal of proteomics is a functional assignment for proteins that cannot be 
annotated by homology alone. Several approaches for automated functional assignment from 
protein interaction networks have been developed. The “majority rule” assignment is based 
on the observation that 70-80% of the interacting proteins share at least one function, 
therefore an unclassified protein is assigned the most common function in the set of 
characterized interacting proteins (Schwikowski et al. 2000; Hishigaki et al. 2001). One 
disadvantage of this simple method is that interactions between two uncharacterized proteins 
are not taken into account. 
Such predictions also have been experimentally tested. Kemmeren et al. (Kemmeren et 
al. 2002) verified the predicted function of 5 proteins that had interactions with known 
proteins and which were co-expressed as well. For example, a deletion strain of an 
uncharacterized ORF (YLR270W) shown to interact with a protein required for 
thermotolerance (NTH1, neutral trehalase gene) indeed showed sensitivity to heat shock. 
Ideally, high-throughput interaction data are used by more “traditional” cell-biological studies 
and this seems to be the case (Fig. 5). For example, Tesse et al. (Tesse et al. 2003) examined 
the role of Ski8p in Soradia meiosis. A role of Ski8p in meiotic DNA recombination was 
suggested by the mutational phenotype, but because of its known role in cytoplasmic RNA 
degradation (non-poly(A) and double stranded RNA) a indirect role of Ski8p was assumed. 
However, a direct interaction between Ski8p and a protein involved in meiotic 
recombination, Spo11, in a comprehensive yeast-two-hybrid study (Uetz et al. 2000) led the 
authors to examine a direct effect of Ski8 on meiotic recombination which was subsequently 
proven. 
INTRODUCTION 
 31 
Evolution of Protein Interaction Networks 
It has been suggested that proteins with more interactions are more conserved than proteins 
with a smaller number of interaction partners (Fraser et al. 2002). However, Jordan et al. 
(Jordan et al. 2003) demonstrated that only proteins with the highest number of interactions 
(the hubs of the protein interaction network) show a slower evolution rate. In a recent study, 
a negative correlation between evolutionary rate and connectivity was only found in high-
throughput interaction data not in a literature curated dataset (Batada et al. 2006a). Thus, the 
correlation found by Fraser et al. (Fraser et al. 2002) may be an artifact caused by the specific 
underlying dataset rather than a general phenomenon. 
Comparative Interactomics: Predicting Homologous Interactions 
Proteins evolve and so do their interactions. If interacting proteins have only weak homology 
to another pair of interacting proteins, the interaction will support both their functional and 
evolutionary homology. In order to detect such homologous interactions and pathways, 
Kelley et al. (Kelley et al. 2003) developed the program “pathblast” (www.pathblast.org) 
which aligns two protein-protein interaction networks combining interaction topology and 
sequence similarity. Using this approach, it was possible to show that the protein-protein 
interaction networks of yeast and Helicobacter pylori harbor a significant number of 
evolutionary conserved pathways. One spectacular example among the conserved sub 
networks is a group of proteins that is involved in bacterial membrane transport and nuclear-
cytoplasmic transport in yeast. This finding indicates that nuclear-cytoplasmic transport may 
have originated from a homologous system in bacterial plasma membranes. 
Pathway comparison cannot only uncover conserved pathways but also identify additional 
components that have been found in one organism but not in another. We can exploit this 
information to predict yet unknown interaction partners based on homologs in another 
model. Such predictions are particularly supported by protein complexes that tend to be well 
conserved, especially because they usually require several conserved subunits for stability. 
With the availability of additional interaction maps, the pathblast algorithm was extended 
and, for example, used for comparison of the networks of fly, worm, yeast, plasmodium, and 
H. pylori (Suthram et al. 2005). 
In addition, new tools for the alignment of biological networks become available, e.g. 
Flannick et al. developed an algorithm which allows the alignment of multiple large 
interaction networks (Flannick et al. 2006).  
Integrating Protein Interaction Data with other HTS Data 
Obviously, high-throughput data is not sufficient to explain complex biological processes. 
However, it has been shown that the combination of several datasets improves their 
reliability. In addition, different features analyzed by high-throughput approaches can be 
joined to ameliorate their predictive power significantly.  
For example, it has been shown that the intersection of high-throughput interaction datasets 
contains more interactions from the same MIPS complex which are supposed to be of high 
quality (Edwards et al. 2002). 
A major drawback of this method is that all high-throughput datasets are far from being 
comprehensive which results in a very small intersection between different data sources, e.g. 
133 common interactions between Uetz’ and Ito’s core data set (Bader and Hogue 2002). 
Therefore, a very limited number of interactions are marked as “reliable” using this method. 
A more elaborate approach is the use of a Bayesian network that allows for the probabilistic 
combination of multiple data sets. It has been shown that the fraction of false positives and 
false negatives can be reduced with this method (Edwards et al. 2002). This approach has 
also been used in a comprehensive study by Jansen et al. (Jansen et al. 2002), in which the 
high-throughput interaction data sets for the yeast proteome (yeast-two-hybrid and in vivo 
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pull-down) were combined with genomic features only weakly associated with an interaction 
(e.g., co-expression of two proteins) to generate a more reliable interaction data set. 
In a recent publication, Hwang et al. present a method which allows for integration of several 
biological data sources based on combination of several p-values (Hwang et al. 2005a; Hwang 
et al. 2005b). 
Can a combination of high-throughput data replace traditional experiments? 
As we have seen, HTS data is often of lower quality than individually obtained data. On the 
other hand, HTS data is often better internally controlled because it has been collected under 
standard conditions. What if all kinds of data are collected under such standardized 
conditions and are then combined? For example, why don’t we study intracellular transport 
processes by (1) localizing all proteins in organelles such as the Golgi, (2) identify all protein 
interactions and complexes, (3) measure their transcription (4) degradation, and (5) 
posttranslational modifications under various conditions, (6) their mutant phenotypes etc. 
We can easily collect such data but they will not explain any biological mechanism unless we 
perform experiments that explicitly address defined causal relations. Most importantly, we are 
not able to distinguish between cause and effect in advance. For example, just deleting all 
genes in a genome is useful to investigate which proteins are essential. However, if a protein 
is not essential under the tested conditions it will not tell us much. For instance, we assume 
that a protein of previously unknown function (say YHR105W) is involved in vesicular 
transport, because it interacts only with other transport proteins in two-hybrid assays. 
However, one screen of a yeast mutant collection (Bonangelino et al. 2002) has not found 
YHR105W as being defective in transport. For further clarification we do need other 
hypotheses which reconcile the interaction data and the mutant phenotype and such 
hypotheses are often not foreseeable by standardized HTS analysis: the interaction screen 
was most likely not comprehensive (i.e. there are probably false positives and false negatives) 
and the mutant screen has only looked at one transport phenotype, namely carboxypeptidase 
Y export, which mainly affects Golgi to vacuole transport. Now we have to study more 
subtle effects of YHR105W on protein transport, because it is well possible that the 
interaction has a modulatory role in transport as opposed to being absolutely essential. One 
needs to remember that most mutations are not deleterious but rather show no or only subtle 
defects because gene functions can be either substituted on the single gene level by duplicate 
or redundant genes or a substitution occurs on the network level as an intrinsic property of a 
scale-free network (see above). Such special circumstances usually cannot be identified by 
high-throughput screening and thus have to be analyzed by a painstaking hypothesis-driven 
approach where the hypothesis is refined by each additional experiment. 
As an interesting new development, King et al. (Berriz et al. 2003) have devised algorithms to 
automate such “hypothesis-driven” research. Computer-algorithms can replace human 
reasoning to a certain extent and it may be possible to push HTS to a degree that its 
experimental conditions can be refined based on previous experiments and therefore do 
simulate hypothesis-driven experimentation. 
Protein Interaction Networks for Medical Research 
Most diseases are caused by malfunctioning proteins in one way or another. However, there 
are only few known examples of disease-causing defects in protein interactions. The best-
studied cases are probably receptors that bind (or do not bind) to peptide hormones or 
oncoproteins such as Ras, which may cause cancer when their signaling interactions are 
defective. 
When analyzing mutant proteins it is usually not easy to tell an impaired protein interaction 
apart from some unrelated effect, such as a folding problem. Hence, it is difficult to say if a 
certain phenotype arises from a defective protein interaction or some indirect cause such as 
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an instability that prevents a protein from interacting. However, this question can be decided 
by a detailed structural characterization of the mutated protein. 
Interestingly, Giot et al. (Giot et al. 2003) present a human-disease protein view in their 
Drosophila protein interaction map (PIM), in which proteins with sequence similarity to 
human disease genes are highlighted (Fig. 7 A). 74% of human disease genes in OMIM have 
strong matches (BLAST e-value < 10-10 ) to one or more sequences in the Drosophila database 
(Chien et al. 2002). This clearly shows the utility of PIMs in model organisms for medical 
research. 
Using protein interaction networks for drug discovery? 
The goal of drug discovery is to design or identify small molecular compounds that help to 
cure or at least ameliorate diseases. Protein interaction mapping can be useful at several levels 
of the drug discovery process. The first step should be the drug target identification. Protein 
interaction mapping can help to identify proteins of relevant molecular pathways or 
complexes that are involved in a specific disease. Dependent on the disease mechanism either 
a central protein (hub) for blocking a complete process (e.g. for an antibiotic) or a protein 
with a regulatory function for modulation of a process can be selected. 
 
A
B
CG12835
fs(2)ltoPP43
CG8159
CG3281
Spt5
CkIIbeta
CG16812
CG8569
Sry-beta
CG15729
CG18764
p38b
SelD
CG6724
CG10139
CG2926
CG12708
CG12620
BcDNA:GH09817
CG1553
CG17834
Src64B
CG32685
EG:BACR42I17.4
Pp1-87B
mei-S332
trbl
CG1792
Nnp-1
CG6459
CG5724
CG15436
CG14546
CG11799
CG14667
fl (2)d
CG13488
MAPk-Ak2
RhoGAP54D
CG31291
hug
CG1216
CG6276
yps
I-t
CG8301
CG4877
CG11756
Pi3K21B
CG13645
CG13289
CG7386
esg
CG15705
CG17360
CG9238
Pp1alpha-96A
CG9928
CG8316
CG14739
CG31029
CG4116
CG3016
CG5151
CG3838
EG:95B7.7
CG11876
I-2
fkh
Sir2
CG15415
ttk
CG14220
BcDNA:GH06717
CG17802
CG1475
CG11882
ng2
CG10654
l(2)35Ea
CG14853
CG7757
CG17855
Dsk
Taf12
CG3517
CG13083
CG32940
CG13280
CG11347
CG11696
CG8273
eIF2B-beta
CG9497
fan
CG14011
CG9927
CG7824
CG31224
lolal
l (2)06496
CDC45L
CG2446
AP-50
CG6866
CG14317
CG5478
CG7228
CG7958
CG4936
CG8191
CG8104
Tequi la
Dab
CG4854
aru
CG5410
CG17806
CG4729
CG3342
Pl i
CG7928
Eap
CG9759
CG4730
CG7085
CG17383
Sos
bip1
CG8319
DNApol -alpha50
CG12428
Clc
Thor
guf
tl l
CG14383
CG7010
CycG
Taf7
NiPp-1
CG30132
phyl
nop5
grau
CG8965
CG2046
BcDNA:LD34343
eIF-5C
CG15105
bip2
Gip
Trl
RpL22
Hrb27C
CG14551
NetA
CG3548
CG6686
crn
CG17364CG7164
CG5194
CG18292
BicC
SCAP
CG9394
CG6985
CG5522
CG3536
CG2199
CG13733
CG5146
CG7818
CG11299
eIF2B-delta
rib
14-3-3zeta
HLHm3
ken
CG10017
C15
CG13811
CG7778
CG32672
CG8079
CG11212
CG6689
CG3294
CG5662
CG31122
Caki
EG:BACR42I17.1
CG5140
RhoGAP18B
Mnt
CG3675
CG13737
CG14612
CG6629
CG18004
CG31121
CG12334
Osbp
CG12985
CG17801
raps
dx
sina
CG15169
CG11896
CG11184
CG7204
CG6854
CG11255
CG13477
CG17050
CG13434
EG:171E4.3
CG1513
CG10959
CG3529
CG13747
CG15478
CG11266
CG32626
sol
CG12589
CG10209
lt
U2af50
pfk
CG13949
CG4073
CG17143
CG10324
CG4983
CG9293
Syx7
CG3995
CG6654
CG2213
CG13599
BcDNA:GH11110
CG31756
CG8617
CG6340
CG7808
BG:DS00180.10
CG8134
tos
CG5757
CG12812
CG17599
Srp54
bsh
skpC
Pp2B-14D
CG31211
CG6664
CG14374
CG15884
CG15004
CG9040
CG5064
CG5953
Cyp4s3
CG5972
CG1621
CG31160
CG4617
CG11490
Pnn
RpL9
Rbp1
gro
CG30077
CG14126
U2af38
CG7047
cup
CG4066
yellow-e2
CG11698
zfh2
trio
CG14840
Rb97D
CG4798
beat-IIa
Prosbeta3
CG16947
CG12452
CG1135
CG15710
CG3124
CG13247
Traf3
CG16854
CG2950
numb
CG15370
Hsc70-5
CG9825
Arc32
lbl
EG:BACR42I17.8
CG7946
CG3649
CG3678
CG12491
krz
CG9393
l(2)k10201
CG5446
CG9381
CG31559
CG6946
CG9967
CG9373
CG9205
CG16896
CG15646
CG31111
Su(H)
sty
CG18259
Vap-33-1
CG15914
CG9948
CG1420
CG4323
CG13151
CG17564
CG2843
Glycogenin
Max
cato
CG11009
CG5933
gcl
CG15059
CG5732
CG15728
mtacp1
Taf4
CG15525
CG11761
CG5272
CG17362
CG32016
CG5623
EG:95B7.3
CG32100
CG4428
CG3085
CG1647
Abi
CG9795
CG16728
CG15458
G-oalpha47A
CG8768
CG14274
CG10126
CG10918
knrl
GM130
ftz
CG5828
Arp87C
BcDNA:GH01073
CG17744
CG11635
EG:132E8.4
CG15658
CG10949
eiger
CG31958
E(spl)
CG11560
CG5546
Eip63F-1
CG7220
CG11274
CG12581
ced-6
Prm
CG3925
CG7945
CG13678
CG7512
CG17666
CG33144
CG8092
CG9740
p16-ARC
Aly
CG14101
CG12863
tinc
CG3508
CG5877
Hmx
CG12975
Rep2
CG6707
CG7856
CG14905
CG13965
CG11982
CG12001
cactin
CG3918
CG13138
CG10103
Her
CG7737
CG15443
CG7447
CG9316
CG1259
CG14898
CG13298
CG12045
Spx
CG12511
CG13124
CG9921
CG17446
CG2774
CG11454
Bsg25D
SytIV
CG14490
CG6196
CG3847
CG5537
TULP
CG6470
CG6856
IFa
CG5445
sba
Lcp2
CG17377
me31B
Argk
CG5063
en
CG32206
CG5674
CG8277
CG6709
CG15593
CG6175
CG6619
CG15676
vas
CG8248
CG11905
BG:DS04095.3
CG12304
CG14224
CG11449
CG8004
Rm62
Arr1
EG:63B12.12
yellow-g
CG4221
Rsf1
HLHm5
su(w[a])
tra2
CG11188
pwn
so
side
HLHmdelta
Gycbeta100B
CBP
slp1
CG15167
CG14837
CG6254
CG10681
CG11656
BcDNA:GH07485
rtGEF
EG:171D11.5
Anxb11
CG10689
CG3162
CG10080
Tektin-A
CG15323
CG2129
skl
CG8936
CG6843
CG12682
dmrt99B
CG9399
CG32030
CG30011
inv
CG11964
CG14323
S6kII
CG9184
CG14079
CG15172
CG13651
CG15087
dm
CG15556
CG6126
TfIIA-L
CG9951
CG40460
CG1622
CG9843
l(3)01239
Sdic
CG10086
CG18553
Fer1HCH
CG12020
CG14487
CG16721
CG10621
CG7676
CG11786
CG31362
CG14869
CG7206
CG32086
CG17568
CG5343
BcDNA:GH02678
CG13458
skpA
mei- P26
c12.1
CG7357
CG9911
mRpL51
CG8991
eya
CG11165
CG16969
CG5110
CG10373
CG13476
CG32514
Os-C
CG10914
CG5011
CG9797
CG14133
ND23
EG:EG0007.7
CG14443
mRpS17
CG11200
CG1115
CG6066
CG17994
Cka
tap
Rep3
CG31682
CG8974
ple
CG7911
CG12679
opa
CG15109
EG:BACN32G11.5
TfIIA-S
CG31359
CG4398
RpII33
CG14071
CG1832
CG6683
Aats-asp
CG11722
CG31523
Cap
CG15468
Nipsnap
CG14410
CG15209
CG7970
CG5155
CG15482
CG7658
CG2560
TSG101
CG32737
CG9640
CG8368
Clp
CG12227
mus209
cype
CanA1
CG15124
CG13085
Sema-5c
Ets97D
CG14315
brk
Gas8
CG15032
CG3295
CG14053
EG:BACR7A4.12
CG4582
CG5547
CG11275
CG12992
PGRP-SC1a
CG15080
Aats-val
Doa
CG8282
CG32674
CG17803
CG7382
Prp18
CG13960
CG9173
CG17003
CG14112
EG:22E5.4
odd
CG10703
Or45a
CG8481
CG9312
CG15631
CG8145
Rep1
CG4622
CG5767
CG6418
Syx16
TfIIA-S-2
pUf68
CG8235
HBS1
CG13656
CG5160
Ela
CG10475
BcDNA:LD21503
CG31090
CG31550
CG5050
CG12082
CG1017
CG1138
CG13361
CG9775CG15071
CG6506
CG10508
CG12505
CG14166
CG11776
CG7605
CG4151
CG13032
dsx
Sin
CG15481
CG7809
CG10750
CG13705
CG33017
CG18396
CG11142
Rep4
CG13362
CG9663
Rlip
CG6615
Adf1
Msp-300
zfh1
CG6688
CG15623
LvpH
sip1
CG9025
Prosalpha6T
CG13197
CG15422
gammaTub37C
elB
CG8247
CG14569
Su(var)3-7
Tsp
CG7158
Fcp3C
GstE1
DNApol-alpha73
CG5094
CG7967
CG15634
CG13883
CG8228
Ubp64E
CG8493
BEST:GH09435
CHIP
BEST:CK02137
CG40285
CG6972
abs
CG14641
CG1638
CG14556
CG5189
CG6719
hoe1
Rpb11
KCNQ
CG13871
CG6357
Rox8
CG6283
CG7023
Ufd1-li ke
CG6156
CG18584
CG14419
mael
CG30342
CG5026
CG17129
CG10855
CG14149
CG8292
CG10032
CG6801
CG15912
eff
CG14154
CG7009
CG10685
Ubc-E2H
CG17266
CG11250
Dmn
CG3610
Su(var)205
CG5913
CG30115
CG8784
CG10034
CG11870
CG14708
CG1249
BcDNA:LD19168
CG32354
pnt
Chi
CG30420
CG5078
CG15578
CG8268
HLH4C
UbcD4
ppa
UbcD2
Klc
CG9083
CG10225
CG7180
asf1
CSN4
CG6617
Akt1
Taf10b
BcDNA:GH02536
Cas
CG8840
CG5147
CG10635
CG2247
Eip55E
CG4643
CG12433
CG9715
BcDNA:LD29885
HLHm7
l(3)07882
Tr xT
CG11228
alphaTub67C
CG9699
BcDNA:GH11415
CG12995
CanB
CG7570
CG7371
CG17826
Rca1
BEST:LD07122
CG6429
HLHmbeta
CG15663
CG5380
EG:140G11.5
Amph
Cyp6a22
CG32343
CG5447
CG31217
CG32130
CG10981
CG2256
CG32209
toc
Nmd3
CG11920
CG3075
CG4576
unc-119
CSN3
CG13843
FucTB
Nlp
Syx1A
CG4570
homer
CG8680
CG32392
CG1078
Mlc-c
dap
CG5107
CG17824
CG12857
BG:DS07295.5
cg
pelo
Fs(2)Ket
Hsc70-4
Lim3
CG12537
CG14867
cav
Pp2A-29B
CG1598
RpS3A
Ten-a
Fps85D
ap
CG12609
CG14931
BEST:GM02553
CG17018
CG17522
Lcp3
CG3213
CG13711
CG13097
CG8141
Nedd8
CG13349
CG6873
CG11989
CG5376
CG15753
CG10418
CG13031
CG13186
CG13227
Rala
CG11718
RnrS
CG14620
Fpps
Elongin-C
CG5358
CG13957
CG32352
CG7046
CG17025
CG15119
CG31036
mex1
CG18675
neur
Nle
CG32029
CG15452
Drip
CG1643
CG33193
CG9422
CG4335
CG14207
CG5053
CG9527
eIF2B-gamma
CG3891
EG:115C2.10
CG13133
CG8640
CG14151
Dip3
CG4829
CG10154
usnp
noi
CG14610
peb
chico
CG8086
CG11308
CG5780
CG2091
Su(var)3-9
ire-1
CG9121
CG17777
syt
Sox21b
CG12726
CG32140
kay
CG15764
CG6607
CG4349
CG14471
CG7878
CG11700
eg
CG4300
SamDC
CG12607
BG:DS00941.12
Tim10
CG7611
Cdlc2
Lim1
CG15782
Taf8
CG13200
And
alphaCop
CG31797
CG5468
CG13428
CG6610
CG13579
CG4673
CG17153
BcDNA:GH11023
sns
CG17531
CG14580
CG9283
bsk
Cam
CG6425
CG15234
CG10205
nmd
olf413
CG16719
skpB
CG3683
CG13822
Ccp84Ad
CG4328
CG31232
CG7056
CG5745
CG9938
CG7484
CG8979
CG3680
Ccp84Ab
Rpn12
CG33070
CG18468
CG33209
Taf10
CG11486
lola
CG32104
CG9924
DIP1
CG13857
CG3448
TBPH
DebB
EG:171E4.2
CG10947
CG32158
CG8562
CG12994
EG:22E5.12
tub
CG9757
CG12723
CG15489
Mst33A
CG6416
BG:DS04641.8
CG10396
Ady43A
CG1745
CG9871
CG17600
Hsromega
CG11695
CG9624
CG7840
CG13344
CG5639
CG15126
CG3756
CG9609
CG13047
CG15859
CG12721
Snap
CG13087
CG3560
CG6144
CG15284
CG11581
DnaJ-1
CG5708
CG15781
CG8044
CG4094
CG8541
CG5739
H2.0
emc
rl
Bj1
Or98b
CG2848
CG31961
Sep2
grp
CG14369
geminin
BG:DS07851.5
CG6182
CG31973
CG13045
Nacalpha
CG5315
CG7890
Acp29AB
CG31033
CG3492
CG2948
sage
CG17203
CG2944
CG17032
CG32677
CG14684
CG8902
CG30084
unc-13
EG:196F3.2
wupA
EG:115C2.6
Mat89Bb
CG4641
Mlp84B
Act88F
CG17019
Odc2
Dip-B
CG11253
CG3227
CG8232
CG17494
CG15636
Elongin-B
CstF-50
CG11033
CG7488
spir
CG18745
CG13277
CG13721
Dap160
Tom
CG14688
Prx2540-1
Tre
CG17440
X11L
CG14074
BEST:GH10766
CG15803
CG13504
CG12877
sc
CG18568
Rpn2
BG:DS07486.4
CG13511
CG30161
CG5454
CG5087
CG13935
Gr28b
CG17002
mbo
CG11505
BG:DS07486.5
dei
Hn
Act87E
Gnf1
CG12379
CG15707
CG11883
eRF1
FK506-bp2
CG18067
CG4164
CG11125
Oli
BcDNA:GH02439
CG2049
Tim8
CG31721
CG14544
CG31457
tup
CG8924
Vha44
CG14073
CG14119
metl
CG8738
CG10014
CG18375
CG14225
CG8253
CG18506
CG7360
CG4787
CG13972
CG9638
Mekk1
swa
Tm1
RpII18
CG12114
CG15576
CG5945
CG13740
CG2021
CG32756
nonA-l
CG14427
CG14711
CG30147
zen
CG16941
CG30493
eIF2B-epsilon
CG8907
CG10540
CG13339
CG4279
Syx4
EG:EG0003.5
CG14044
CG12567
CG32772
CG18591
Acp95EF
CG13114
CG1900
CG15533
CG32594
CG17765
CG17331
Dhod
CG1950
CG10263
BG:BACR48E02.3
noc
Mdr65
eIF-2alpha
CG31999
CG9344
inaC
snRNP69D
CG32530
CG4866
CG7381
CG15423
Socs44A
CG13541
msb1l
flw
CG13066
CG14855
TpnC47D
Dlc90F
Fmr1
Chrac-16
dik
CG8449
CG8584
Sap47
CG4213
CG9875
CG14870
CG13501
BG:BACR44L22.4
Snap24
CG32477
Ku80
nuf
CG7745
CG32779
CG8788
CG12140
Rad23
CG6333
CG3563
CG31990
CG14961
CG9596
CG14589
CG3279
CG7518
Prosbeta5
CG11301
CG10478
CG32601
ftz-f1
Cpn
skf
CG9572
CG3662
CG15249
Cp38
CG5338
ATPsyn-b
CG5494
imd
CG5104
EG:63B12.4
CG17086
ik2
CG6781
Kr-h2
CG14145
jdp
Acp26Aa
CG15735
CG40278
CG15549
CG13581
Rep
EG:BACR7A4.18
CG12229
CalpA
dup
BG:DS05639.1
bic
CG3645
Stam
CG13474
CG13321
BG:DS08249.3
Usf
CG7379
fd3F
CG10164
CG7101
CG11849
tsr
CG9727
l(3)73Ah
CG10978
CG13223
CG5994
CG9135
CG8500
CG13622
CG8116
CG7768
drongo
CG11835
vir
CG4053
CG12116
mRpS7
cpb
CG8223
NC2alpha
ERR
RhoGEF3
Cad99C
CG12984
CG4818
CG3214
CG13868
Mad
CG12784
ctp
Ssl1
CG2931
CG5903
CG32486
CG11594
CG11350
grim
CG9227
CG15889
NC2beta
Trap36
CG10527
CG6513
CG9933
CG5694
Cp18
CG13928
CG17244
CG7208
CG8993
CG13023
CG18066
CG12034
BG:BACR48E02.1
CG17601
ph-p
Pax
CG33213
CG32951
CG8783
Ubx
CG32169
E5
CG14506
pcl
Gst3-2
Hrs
CG4764
CG4270
CG8736
dia
Ogt
CG3884
drm
CG9837
CG17570
CG5359
CG1630
spag
CG3894
CG9773
CG5890
Odc1
vel i
CG7671
CG32956
CG5802
CG11814
Pkc98E
Ubc84D
CG5134
CG5156
CG5555
CG13074
CG4415
CG18349
CycJ
CG17292
CG11711
CG13113
CG3876
dock
CG15610
CG17121
shot
CG6301
CG12932
CG5744
CG5220
Hsp67Bc
cact
CG12724
CG2278
gp210
CG12107
CG12477
ena
CG31792
Hsp83
CG15580
CG13043
Lcp1
D19B
msl-3
CG4788
Ptp61F
CG14204
CG11086
ari -2
CG9282
RpL19
CG9929
CG5625
CG10151
CG9796
Taf11
dl
CG4546
how
CG3999
CG4830
CG17737
Vinc
CLIP-190
p130CAS
inaD
CG13503
lace
Dll
CG10737
jp
mod(mdg4)
CG2316
CG10664
br
lmg
CG9326
Aef1
CG31040
ScpX
CG13964
BcDNA:GH02340
CG12159
CG3338
bab1
Obp58c
UbcD10
CG8417
Hnf4
WASp
CG11362
CG3428
CG5525
CG4561
eIF3-S8
CG9098
CG11249
Nca
Coprox
CG10265
Taf13
CG17181
CG15330
CG7879
ref(2)P
EG:25E8.4
CG13776
BG4
CG32297
Dredd
CG13783
CG8407
rols
CG17625
gsb-n
vnd
CG7564
CG12362
hts
ct
l(3)82Fd
CG7251
ko
CG10208
clt
CG33047
CG11008
CG3353
BcDNA:LD21794
CycT
Nrg
Rpn1
Trfp
Uro
CG13070
CG3611
CG18811
CG5070
CG12333
Cha
CG13022
Peritrophin-15b
RpS9
CG7102
CG4998
CG3367
ATPCL
Aprt
cora
CG11509
CG6905
rec
CG15515
CG3687
BcDNA:GH07688
CG8129
CG8552
DptB
Rho1
BG:DS00797.5
CG4800
Ugt86Dg
rg
CG9665
CG8701
CG8484
E(z)
CG8198
Gl
BcDNA:LD27873
BcDNA:GH05582
CG17530
CG12377
CG15093
mRpL50
CG17985
CG13535
CG16734
CG15546
PGRP-LC
capt
CG5111
CG17108
CG40280
CG7375
Tfb2
CG8934
Obp56d
al
CG6017
CG17085
CG4537
CG4334
ESTS:39C10S
CG1427
meso18E
CG14568
ATPsyn-d
CG3808
CG13567
CG9650
CG10777
gammaTub23C
BEST:GH09393
CG18777
CG4835
CG12106
CG8778
CG7417
CG6762
CG10514
CG8366
Or74a
SelR
CG12656
cenG1A
CG7787
CG18666
CG8780
CG4509
CG32000
EG:BACN32G11.3
Pros26
CG13779
CG8093
fu2
CG17294
CG7236
CG18143CG8414
BcDNA:LD32788
CG7338
CG4804
CG7646
CG30492
CG9809
CG5382
CG11120
Crc
CG10252
CG1231
CG15544
Dref
cpo
CG3760
CG11727
CG9675
alpha-Est9
c(3)G
Tk
CG6767
CG14000
MAGE
snf
CycE
CG5484
CG13886
CG6523
lama
CG14864
Pp1-13C
CG17419
CG11591
HGTX
CG9235
CG15208
CG6755
CG7461
CG7168
CG3941
CG3499
CG11985
Pros45
Zw
CG31188
TfIIB
CG1690
RpL18A
CG2469
pav
CG31176
Trap220
CG31547
PGRP-LB
CG31738
CG13454
Idh
CG15772
Ance-3
CG6685
RpP1
CG3980
CG9342
prod
CG17041
CG7262
GstD6
L
ea
CG2158
mav
CG11769
su(f)
pie
CG31729
Cyp307a1
CG31361
CG8335
CG9288
CG9992
CG18343
CG6111
CG17227
CG14965
CG10494
CG16984
pug
CG5798
CG11438
CG15374
CG14584
CG7910
CG11887
CG8388
CG18186
VhaM9.7-1
CG15435
smo
gish
CG6509
Lectin-galC1
CG4563
CG13588
CG14359
CG31657
CG4461
CG33138
CG12560
CG12901
CG9463
CG31052
CG4225
CG6393
CycD
CG6933
CG7987
myotubularin
CG33091
betaggt-II
CG30019
y
CG3911
Cp16
CG6912
scra
CG32823
CG31688
CG6337
CG5984
CG31618
CG2209
Acp70A
CG30118
fax
CG15651
cnn
CG7742
ERp60
CG6904
frc
CG14043
CG17344
Cdk7
CG7949
CG14750
CG14806
CG14545
CG32783
CG11055
EG:171D11.1
CG7903
osk
blow
CG5735
CG10346
CG10465
CG6329
SP555
CG3382
CG13877
rad50
CG12000
CG3355
BEST:LD13441
mRpL11
CG17658
CG14820
RpL12
CG5001
CG15531
mRpL22-24
BcDNA:GH03163
PyK
CG1275
Prat2
Tim17a2
CG8036
CG31909
CG1461
kat80
Vha26
CG14829
CG5789
CG8188
put
CG5762
CG9313
Cyp4p2
CG11652
CG14671
CG33096
CG10889
CG7156
CG8841
regucalcin
CG6441
CG14210
l(2)06225
CG1120
Bap60
TfIIFalpha
CG5734
CG6488
CG7994
CG9853
CG8027
CG6764
CG17723
CG5288
CG15185
CG3501
CG7546
CG6187
CG32744
dynactin- subunit-p25
CG12432
jbug
Sin3A
CG10887
dpn
Sox14
CG11790
mbc
nesprin
CG9465
CG3815
CG5375
CG15459
CG9330
CG9926
CG12262
CG10306
CG1124
CG18646
CG4955
CG14514
Rpn9
CG14480
CG1841
CG15654
CG7335
CG9547
CG17540
CG14120
CSN5
glec
Eig71Ee
CG14102
spn-B
CG15116
CG14989
CG7675
CG15029
CG13636
CG7211
CG14830
can
CG7048
heph
Mst35Ba
CG10470
CG33005
Ahcy89E
DNaseII
CG13659
CG31760
Las
CG14899
lwr
CG7942
BcDNA:GH24095
CG15916
CG32485
CG9170
cad
CG9490
CG33203
CG13913
GABA-B-R2
CG6662
CG30437
rpr
CG13144
GATAe
CG5062
14-3-3epsilon
CG6745
CG10651
hth
SsRbeta
CG11148
CG6576
CG4332
l (2)35Bd
Tfb1
CG6195
CG14193
Cyp6a13
CG4575
CG9626
p115
CG3605
CG5630
CG4785
CG7940
CG9302
CG4612
CG32133
CG17637
Uba1
CG13117
CG4802
CG9192
CG14991
BG:DS01759.2
CG10927
CG9506
drk
CG7725
maf-S
BcDNA: SD06613
CG5973
CG10882
CG10943
CG7229
CG12936
AP-2
CG11305
CG1218
CG15456
RpIII128
CG14542
BcDNA:GH03377
CG17498
CG31191
pip
Aldh-II I
CG1213
CG3557
CG13950
CG5846
RpL40
JhI-1
RfC3
CG8025
CG10799
CG12030
CG13155
Idgf2
CG7738
CG33167
CG31102
CG11456
CG4022
CG10632
cl
CG13332
ewg
CG10340
CG14297
gammaSnap
CG3160
Gapdh2
CG32572
CG18178
CG7724
Spn6
RhoGAP88C
Spn1
CG11407
CG6907
Ahcy13
CG7638
z
Trxr-2
CG12375
FucTD
ed
CG14231
CG5844
CG11984
CG10924
CG5642
CG32680
CG12393
CG15863
CG7366
CG13862
CG3376
Ice
RpP0
CG6769
CG2258
CG13510
CG15198
CG5096
blot
Gdi
SH3PX1
CG5038
EG:BACR25B3.4
CG18806
por
robl62A
CG4069
ran-like
alien
CG10301
CG3259
Sry-alpha
Phm
CG6744
RpS14a
CG10534
Ark
l (2)05714
CG12703
CG1874
CG14652
CG11796
Trap80
nod
Obp49a
smt3
CG6950
CG9252
CG32791
Ercc1
CG10198
CG11893
CG18341
Tob
CG6394
sm
CG3842
CG4484
Med6
CG5919
smid
CG15717
CG10662
CG10155
CG17912
Pk61C
CG13966
CG8454
CG14536
Cks
CG11132
CG9603
CG10909
CG40105
e(r)
CG32317
CG3493
Rab2
CG9961
CG9295
CG10238
AnnIX
CG9027
rasp
Rpb10
da
Zpr1
CG12427
CG7239
CG7025
CG10153
Ndae1
CG1845
Tsf1
CG3916
CG14310
CG14985
CG15425
CG17734
CG10335
CG9522
CG31358
EG:BACH7M4.4
CG5280
l (2)02045
CG30393
CG5027
CG8515
CG10042
sfl
AP-1gamma
CG3332
Prosalpha7
Src42A
CG1041
CG4610
CG4661
CG17134
CG18528
ade2
Alp23B
CG31342
hig
BG:DS04095.2
CG3303
CREG
CG8851
CG7313
CG3248
CG14354
CG1814
CG40145
CG7433
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Fig. 7 Protein interaction networks can be used for drug discovery. (A) Drosophila 
interaction map with proteins that have a human ortholog and which have been reported 
to be involved in human disease (shown as stars). Such homologous interactions can help 
to identify potential drug targets. The insert shows the association of CG1832 with two 
calcium-dependent phosphatases CanA1 and Pp2B-14D, which is mediated by the 
calcium binding protein Eip63F-1. The homolog of CG1832 (BCL6) is a transcription 
factor involved in the pathogenesis of human B-cell non-Hodgkin lymphoma. Its 
association with phosphatases might point to a regulation of this factor akin to NFAT, 
which translocates into the nucleus after dephosphorylation. These phosphatases are 
potential new targets for the treatment of B-cell lymphomas (Giot et al. 2003). Figure 
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adapted from (Giot et al. 2003). Copyright 2003 AAAS. (B) Protein interaction surfaces 
have been proven to be potential drug targets. Degterev et al. (Degterev et al. 2001) 
designed a compound (BH3I-1) which inhibits the interaction of Bak to Bcl-xl (left: 
Structure of Bcl-xl in complex with the Bak BH3 peptide). It is hypothesized that BH3I-1 
binds to residues of Bcl-xl (colored red and blue on the Bcl-xl structure on the right-hand 
panel) and thereby blocks binding of Bak. Note that the structure of Bcl-xl differs 
depending on bound compounds (left with Bak peptide, right without bound interactor). 
Inhibition of Bcl-2 interactions leads to apoptosis. Inhibitors such as BH3I-1 can offer 
new options for anti-tumor therapy by sensitizing transformed cells to chemotherapy. 
Figure adapted from (Degterev et al. 2001). This figure was published in (Titz et al. 
2004). 
These proteins or their protein-protein interaction surfaces are promising targets for specific 
drugs, although only few published examples of interaction inhibitors are available. One 
example are agents which inhibit the interaction between the BH3 domain and Bcl-XL 
(Degterev et al. 2001) (Fig. 7 B). 
Another recently published example is the hepatitis C virus protease that cleaves the virus-
encoded polyprotein. Lamarre et al. (Lamarre et al. 2003) used interactions of the protease 
with a substrate to identify short peptides that are recognized by the protease. Starting from a 
6-amino-acid peptide that acted as a weak enzyme inhibitor, 3-amino-acid inhibitors were 
selected. These short peptides could then be used to design a specific chemical inhibitor of 
similar structure. The inhibitor had to be designed to enter the cell and indeed appears to be 
active in preliminary clinical trials. Theoretically, this approach can be applied to other 
interactions as well. The limiting problem is to find compounds that mimic peptides and that 
are able to enter epithelia or cells (Golemis et al. 2002). 
The diversity of interactions of a targeted protein might also help to estimate or explain side 
effects of a drug. Protein interaction maps indicate immediately which other proteins or 
processes may be affected by inhibiting a certain interaction. PIM therefore can help to 
design selective agents, which target specific interactions of a protein but do not affect 
others. 
Conclusions 
High-throughput protein-protein interaction data provides a starting point for the analysis of 
complexity, signaling and the structural and dynamic organization of cells. In addition, it 
illuminates an important aspect of the evolution of molecular systems. 
If combined with results from other high-throughput methods like microarray analysis, a 
systematic, global view of the molecular functioning of organisms can be gained which for 
the first time gives us a glimpse of an organism as a whole. By contrast, “conventional” 
biological methods are hardly comprehensive; no matter how detailed they are, because they 
always have to focus on certain selected aspects. 
Knowledge about biological networks will help us to understand the complexity of biological 
systems not only as an intellectual achievement. Eventually systems biology will facilitate the 
simulation and even manipulation of living systems, for example in order to cure diseases or 
for the generation of safe and healthy food. 
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1.4. Objectives of this Thesis 
- Generation of a proteome-wide Y2H-based protein-interaction map (PIM) for 
Treponema pallidum – one of the first comprehensive binary interaction maps 
for prokaryotes 
- Establishing of a supporting informatics platform (laboratory information 
management system) and high-throughput procedures, e.g. high-throughput 
cloning and protein-interaction verification. 
- In depth bioinformatical analysis of the PIM including: 
o Topological properties of the network including scale-free characteristics 
o Modules/clusters in the network 
o Biological links mediated by protein-interactions, e.g. between 
compartments, functional categories or genomic locations 
o Functional predictions for previously uncharacterized proteins 
o Comparison with other datasets 
o Properties of pathogenicity-related genes 
- Large-scale phenotyping assays for complementing the Y2H results – including 
genome-wide motility phenotyping of Escherichia coli 
- Detailed functional characterization of proteins selected from the high-
throughput datasets  
- Characterization of the properties of eukaryotic transcriptional activation 
domains to extend knowledge of the Y2H system and transcriptional activation in 
general
MATERIALS & METHODS 
2. Materials & Methods 
Chemicals and Enzymes 
1kb DNA-Ladder Invitrogen, Karlsruhe 
3AT Sigma-Aldrich, Taufkirchen 
5-azacytidine Sigma-Aldrich, Taufkirchen 
5-bromo-2’-deoxyuridine   Sigma-Aldrich, Taufkirchen 
5-fluoro-2’-deoxyuridine  Sigma-Aldrich, Taufkirchen 
5-fluorouridine Sigma-Aldrich, Taufkirchen 
5-fluoroorotate Sigma-Aldrich, Taufkirchen 
5-fluorouracil  Sigma-Aldrich, Taufkirchen 
5-iodo-2’-deoxyuridine Sigma-Aldrich, Taufkirchen 
acrylamide/N,N`-Methylenbisacrylamide Roth, Karlsruhe 
adenine Sigma.Aldrich, Taufkirchen 
agarose Peqlab, Erlangen 
amino acids Merck, Darmstadt 
ampicillin Roth, Karlsruhe 
anti-BrdU-POD Roche, Grenzbach 
anti-HA.11 IgG Invitrogen, Karlsruhe 
anti-rabbit 680nm IgG Invitrogen, Karlsruhe 
APS  Sigma-Aldrich, Taufkirchen 
Bacto-agar Otto-Nordwald KG, Hamburg 
CaCl2•2H2O  Merck, Darmstadt 
CdCl2   Merck, Darmstadt 
chloramphenicol Sigma-Aldrich, Taufkirchen 
chloroform Roth, Karlsruhe 
CoCl2  Merck, Darmstadt 
Cre-Recombinase enzyme BioLabs, New England 
CuSO4  Merck, Darmstadt 
D(+)-galactose Roth, Karlsruhe 
D(+)-glucose Roth, Karlsruhe 
DMSO  Fluka, Neu-Ulm 
dNTPs for PCR Metabion, Martinsried 
ECL-substrate Amersham, Freiburg 
ethanol Roth, Karlsruhe 
ethidiumbromid Roth, Karlsruhe 
glycerol Roth, Karlsruhe 
Yeast extract Roth, Karlsruhe 
isopropanol Roth, Karlsruhe 
K2SO4  Merck, Darmstadt 
kanamycine Roth, Karlsruhe 
KOH  Merck, Darmstadt 
L(+)-arabinose Sigma-Aldrich, Taufkirchen 
Salmon-sperm-DNA Sigma-Aldrich, Taufkirchen 
lysozyme Sigma-Aldrich, Taufkirchen 
MgCl2  Merck, Darmstadt 
milk powder Saliter, Obergünzburg 
MnCl2  Merck, Darmstadt 
NaCl  Roth, Karlsruhe 
NaOH  Roth, Karlsruhe 
NH4Cl  Merck, Darmstadt 
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PBS  Gibco, Karlsruhe 
PEG 4000  Peqlab, Erlangen 
Pfu DNA polymerase Promega, Mannheim 
phenol Roth, Karlsruhe 
Prestained protein marker 6-175 kDa BioLabs, New England 
restriction enzymes Promega, Mannheim 
rifampicin Boehringer, Mannheim 
succhrose Roth, Karlsruhe 
SDS Roth, Karlsruhe 
ß-mercaptoethanol Roth, Karlsruhe 
T4-DNA-ligase                                                                    Promega, Mannheim 
Taq-DNA-polymerase Promega, Mannheim 
TEMED  Roth, Karlsruhe 
tricine Roth, Karlsruhe 
tris base and tris-HCl Roth, Karlsruhe 
trypton Roth, Karlsruhe 
yeast nitrogen base Roth, Karlsruhe 
ZnSO4  Merck, Darmstadt 
 
Materials & Devices 
96-well plates Sarstedt, Nümbrecht 
96-deep-well plates Nalge Nunc, Wiesbaden 
Biomek 2000 laboratory robot Beckman Coulter, Krefeld 
BioRad photometer Biorad, München 
Bioruptor (ultrasonic bath) Diagenode, Liège 
Elisa-Reader ELx808 Biotek Instruments,  
Friedrichshall 
Hybond-N+-membrane Amersham, Freiburg 
Miniprep-KitSV A1640 Qiagen, Hilden 
Odyssey IR-scanner LI-COR Biosciences, Lincoln 
Omni tray-plates Nalge Nunc, Wiesbaden 
PCR high pure clean up system SV Wizard Promega, Mannheim 
PVDF-membrane Millipore, Billerica 
UV Stratalinker 2400 Stratagene, Heidelberg 
Whatman-Paper Bender und Hobein, Karlsruhe 
Used Primers 
Primer Sequence 5’-3’ 
981frag@202for AATT CT CGA GCA CAG CTT GCT GCT ATT GCC 
981frag@222rev AATT GAG CTC CTA CAT GTC AGT GGT AGC TTG 
CTC 
981frag@50for AATT CT CGA GCA CGA ATC TAT GAC CTC AAG CAG 
GSTyjjGfor AATTCACC ATG GCC AAGTGGG ACTGGATTTTC 
GSTyjjGrev AATT AAGCTT  TCA GTG TTT ACA CAG GAG CTG C 
GWY_PCR_B1for GGGGACAAGTTTGTACAAAAAAGCAGGCT 
GWY_PCR_B2rev GGGGACCACTTTGTACAAGAAAGCTGGGT 
hag_forward AATTCTCGAGGAATGAGAATTAACCACAATAT 
hag_reverse AATTGAGCTCTTAACGTAATAATTGAAGTA 
hagHAforward TACGACGTCCCAGACTACGC TGTTGACA 
TGGCTAAAGAGATGAG 
hagHAreverse AGCGTAGTCTGGGACGTCGT 
MATERIALS & METHODS 
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ATGGGTAAATTGTGTGCTCTAGACGATTTTGTAC 
hagN255Aforward AGCGCTTCTGGTGAAGCTTTGACAGCTGCTGAG 
hagN255Areverse CTCAGCAGCTGTCAAAGCTTCACCAGAAGCGCT 
I200forward TTGGCTCGAGGAATCGGCACCATCGATGCTGC 
L231forward TTGGCTCGAGGACTTGACATCGCTGCGGAGAA 
L59reverse GGTTGAGCTCAGAGGCCGCGGATTTGGCTGC 
M13forward_pDONR221 CGTTGTAAAACGACGGCCAG 
M13reverse_PDONR221 GCCAGGAAACAGCTATGACC 
N60forward TTGGCTCGAGGAAACCAGGCATCCACCAATGC 
pAS1forward TGGCTTACCCATACGATGTTCC 
pBad33HA3-loxSacFor AATT GAGCTC AGGAGG AATTCACC ATG GCA GGT 
TAC CCA TAC GAC 
pBadHDHD4for AATTCACC ATG GGG CTG AGC CGC GTG C 
pBadHDHD4rev AATT AAGCTT AGT GGA CAT ACT GAC TTT GC 
pBadYjjGfor AATT GAATTC ACC ATGAAGTGGGACTGGATTTTC 
pBadYjjGrev AATT AAGCTT GTG TTT ACA CAG GAG CTG C 
pBD@50_rev GCTTGGCTGCAGTAATACGACTC 
pBD@6450_for GACTGTATCGCCGGAATTCG 
pDONR207forward TCGCGTTAACGCT AGCATGGATCTC 
pDONR207reverse GTAACATCAGAGATTTTGAGACAC 
pETM30For TATTGCTCAGCGGTGGCAGC 
pETM30Rev ATAGCATGGCCTTTGCAGGGC 
pGADfor TTT AAT ACG ACT CAC TAT AGG GCG 
pGADrevat2080 AGATGGTGCACGATGCACAG 
pGBKfor GTA ATA CGA CTC ACT ATA GGG CG 
pGBKT7reverse TTTTCGTTTTAAAACCTAAGAGTC 
pHB-HA3_pDGforward AAGGAGGAAGCAGGTATGGCAGGTTACCCATACGAC 
pHB-HA3_pDGreverse GACACGCACGAGGTCAGTCGAGGCTGATAGCGAGCT 
pTagLoxRev GAG CTC CAC CGC GGC CCG 
pUniD_forward CTATCAACAGGTTGAACTG 
pUniD_reverse CAGTCGAGGCTGATAGCGAGCT 
pUniDfor CTA TCA ACA GGT TGA ACT G 
pUniDrev CAG TCG AGG CTG ATA GCG AGC T 
S141reverse GGTTGAGCTCAGGAGAAGCGGCCCGTGAGCA 
S199reverse GGTTGAGCTCAGCTCTTGTTGGCCGAGTCTG 
TP0658_pEGSTforward AATTGGATCCATGGAGATTCAGACGAAGACGC 
TP0658_pEGSTreverse AATTCTCGAGTCAACATTGTTCCTGCGCCCTTC 
TP0868_pAC28forward AATTGGATCCATGATTATCAATCACAACATGAG 
TP0868_pAC28reverse AATTGAGCTCCGGAGAATTGAGAGAATCGAC 
V118forward TTGGCTCGAGGAGTGGCAGAGGTAGACCGCAT 
yviF_forward AATTCTCGAGGAATGATCATTCATACGAAGTA 
yviF_p1 CATGGGTGTTGGAGGAAGG 
yviF_p2 AGTCGACCTGCAGGCATGCAAGCT 
GTTCTTCTTTTATGTTCATTTGGCC 
yviF_p3 CGAGCTCGAATTCACTGGCCGTCG 
TACCATGGCCAAATGAACATAAAAGA 
AGAAACAAAGCATCCGATTGGAGG 
yviF_p4 ATCGTTTATATCGACTAAGTCG 
yviF_reverse AATTGAGCTCCTAGCATGATTCTCCTCCAA 
yvzB_forward AATTCTCGAGGAATGGATGCGCTTATTGAGGA 
yvzB_reverse AATTGAGCTCTTAACGTAACAATTGAAGCA 
Table 4 Primers used in this study. 
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Bacterial Strains 
strain description source 
B. subtilis ∆flgM flgM∆80 pheA1 trpC2 BGSC 
B. subtilis ∆hag argF4 flaC51 hag-1 hisA1 ura BGSC 
B. subtilis ∆mot (SPbc2) motA::Tn917 trpC2 BGSC 
B. subtilis ∆upp strain used for yviF deletion Fabret et al. (Fabret et al. 
2002) 
B. subtilis ∆yviF yviF deletion by phleomycin-upp 
cassette integration (Fabret et al. 
2002) 
this thesis 
B. subtilis 168 trpC2 Bacillus Genetic Stock 
Center (BGSC) 
E. coli BD3.1 Competent cells suitable for 
propagation of plasmids containing 
the ccdB gene 
Invitrogen 
E. coli BL21 (DE3) T7 RNA polymerase gene under the 
control of IPTG 
Stratagene 
E. coli DH5α Chemically/heat Competent Cells Invitrogen 
E. coli gene deletion 
strains 
based on BW25113 Baba et al. 2006 
E. coli K12 BW25113   lacIq, rrnBT14 , ∆lacZWJ16, hsdR514, 
∆araBADAH33, ∆rha,BADLD78 
Datsenko und Wanner 
2000 
E. coli knock out library BW25113 E. coli strains http://ecoli.aist-nara.ac.jp 
E. coli PIR E. coli R6K gamma ori NEB 
MC4100 E. coli strains (Wexler et al., 2000) 
RP437 E. coli strains Victor Sourijik 
   
Table 5 Bacterial strains used in this study. 
Construct Primer 
forward 
Primer 
reverse 
Vector Restriction 
sites 
Comment 
GST-TPA 
(~50) 
Cre recombination pMM110  GST-Tag 
expression 
GST-yjjG GSTyjjGfor GSTyjjGrev pETM30 NcoI/HindIII expression 
hag-HA pUniDfor 
hagHAforward 
hagHAreverse 
pUniDrev 
pUniD/V5-His-
TOPO 
XhoI/SacI Mutation 
hag-N255A pUniDfor 
hagN255Aforward 
hagN255Areverse 
pUniDrev 
pUniD/V5-His-
TOPO 
XhoI/SacI Mutation 
pAC-
TP0868 
TP0868_pAC28forward TP0868_pAC28reverse pAC28 BamHI/SacI co-
expression 
pAS1-TPA 
(~800) 
Cre recombination pAS1-loxP  baits 
pBad24HA-
HDHD4 
pBadHDHD4for pBadHDHD4rev pBad24HA NcoI/HindIII rescue 
pBad24HA-
yjjG 
pBadYjjGfor pBadYjjGrev pBad24HA EcoRI/HindIII rescue 
pBad24Myc-
TPA 
(~10) 
Cre recombination pBad24MycloxP  coEXcoIP 
pBad33HA- Cre recombination pBad33HAloxP  coEXcoIP 
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TPA 
(~10) 
pDG-yviF pHB-
HA3_pDGforward 
pHB-
HA3_pDGreverse 
pDG148-Stu ligation 
independent 
 
pDONR-
TPA 
see Gateway cloning pDONR207  TM 
fragments 
pEGST-
TP0658 
TP0658_pEGSTforward TP0658_pEGSTreverse pEGST BamHI/XhoI co-
expression 
pGADT7-
DEST-TPA 
(~100) 
LR recombination pGADT7-
DEST 
 preys 
pGAD-TPA 
(~1000) 
Cre recombination pLP-GADT7  preys 
pGBKT7-
DEST-TPA 
(~100) 
LR recombination pGBKT7-
DEST 
 baits 
pGBK-TPA 
(~200) 
Cre recombination pLP-GBKT7-
Amp 
 baits 
pHBHA3-
TPA 
(~50) 
Cre recombination pHB-HA3  HA-Tag 
Expression 
pUni-hag hag_forward hag_reverse pUniD/V5-His-
TOPO 
XhoI/SacI flagellin 
pUni-TPA 
(~1000) 
- - pUniD/V5-His-
TOPO 
- T. pallidum 
ORFeome 
(McKevitt 
et al. 2003) 
pUni-yviF yviF_forward yviF_reverse pUniD/V5-His-
TOPO 
XhoI/SacI TP0658 
ortholog 
pUni-yvzB yvzB_forward yvzB_reverse pUniD/V5-His-
TOPO 
XhoI/SacI flagellin 
TP0868-T1 pUniDforward L59reverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T2 N60forward pUniDreverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T3 N60forward S141reverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T4 V118forward S141reverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T5 V118forward pUniDreverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T6 I200forward pUniDreverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T7 L231forward pUniDreverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0868-T8 N60forward S199reverse pUniD/V5-His-
TOPO 
XhoI/SacI Fragment 
TP0981-T1 pUniDfor 981frag@222rev pUniD/V5-His-
TOPO 
XhoI/SacI TP0981 
fragments 
TP0981-T2 981frag@50for 981frag@222rev pUniD/V5-His-
TOPO 
XhoI/SacI TP0981 
fragments 
TP0981-T3 981frag@50for pUniDrev pUniD/V5-His-
TOPO 
XhoI/SacI TP0981 
fragments 
TP0981-T4 981frag@202for pUniDrev pUniD/V5-His-
TOPO 
XhoI/SacI TP0981 
fragments 
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Table 6 Gene constructs. TPA is placeholder for several T. pallidum genes (approximate 
number in parenthesis). See Supplementary Table 34 for vector information. 
General procedures 
Bacteria culture media 
LB liquid medium for 1l culture medium: 
5g yeast extract 
10g peptone 
10g NaCl 
add H2O to 1l and autoclave 
2xTY Broth for 1l culture medium: 
10g yeast extract 
16g peptone 
10g NaCl 
add H2O to 1l and autoclave 
SOB Medium for 1l culture medium: 
5g yeast extract 
20g peptone 
0.58g NaCl 
0.18g KCl (or 10ml of 250mM stock) 
add H2O to 1l and autoclave 
2g MgCl2 (or 10ml of 1M stock) 
2.5g MgSO4 (or 10ml of 1M stock) 
SOC Medium SOB Medium 
with 20ml 1M glucose 
Solid medium 1l liquid medium with 
16g agar 
Antibiotics concentrations  
for bacterial media 
100µg/ml ampicillin 
50µg/ml kanamycine 
50µg/ml gentamycin 
34µg/ml chloramphenicol 
10µg/ml phleomycine 
General DNA related procedures 
Competent bacteria for DNA transformation I (TSS-method) (Chung und Miller 1988) 
TSS buffer 5ml DMSO 
10g PEG 6000 (Sigma) 
1M MgCl2 
90ml LB medium 
sterile filter for sterilization 
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Inoculate bacteria in LB medium (individual colony or from o/n culture) and incubate to 
OD600 = 0.3-0.4. Centrifuge culture (8,000rpm for 10min) and resuspend in 1/10Vol of ice-
cold TSS buffer. Proceed according to chemo-competent transformation protocol. 
 
Competent bacteria for DNA transformation (CaCl2 method) 
Inoculate 150ml LB medium with 1ml bacterial pre-culture. Incubate at 37°C to OD600 = 
0.35 and cool bacterial culture on ice for 10min. Centrifuge for 10min at 6000rpm 
(Beckmann J2-HS) and 4°C; discard supernatant. Wash cells with 30ml 100mM CaCl2, 
centrifuge, resuspend in 30ml 100mM CaCl2, and incubate for 1h on ice. Centrifuge again 
and resuspend in 3ml 100mM CaCl2 solution. Freeze 100µl aliquots in liquid nitrogen and 
store at -80°C. 
 
Competent bacteria for DNA transformation (“ultra competent”, Inoue method) 
Protocol is based on protocol published on www.molecularcloning.com. 
 
0.5M PIPES (pH6.7) 15.1 g of PIPES in 80 ml sterile H2O 
adjust the pH to 6.7 with 5 M KOH 
add H2O to 100 ml 
sterile filter the solution  
store at -20°C 
 
Inoue transformation buffer  
(chilled to 0°C before use) 
 
dissolve in 800ml sterile H2O: 
10.88g MnCl2.4H2O  
2.20g CaCl2.2H2O 
18.65g KCl 
add 20ml PIPES (0.5M, pH 6.7) 
adjust to 1l and sterilize by sterile filtering 
 
 
- Pick a single bacterial colony from a plate that has been incubated for 16-20 hrs. at 
37°C and transfer it to 25 ml of LB media 
- Incubate the culture for 6-8 hrs at 37°C with vigorous shaking (250-300 rpm) 
- Inoculate the starter bacterial culture to three 1-liter flasks, each containing 250 ml of 
SOB. The first flask receives 10 ml of starter culture, the second 4 ml and the third 2 
ml 
- Incubate all 3 flasks overnight at 18-22°C with moderate shaking 
- The following morning, read the OD600 of all 3 cultures. Continue to monitor every 
45 minutes 
- When the OD600 of one of the cultures reaches 0.55, transfer the culture vessel to 
an ice-water bath for 10 min. Discard the other 2 cultures 
- Harvest the cells by centrifugation at 2500 g (3900 rpm in a Sorvall GSA rotor) for 
10 min at 4°C 
- Pour off the medium and store the open centrifuge tube on a stack of paper towels 
for 2 min. Use a vacuum aspirator to remove any drops of remaining medium 
adhering to the walls of the centrifuge tube 
- Resuspend the cells gently in 20ml of ice-cold Inoue buffer 
- Add 1,5 ml of DMSO 
- Mix the bacterial suspension by swirling and store it on ice for 10 minutes 
MATERIALS & METHODS 
 43 
- Working quickly, dispense the aliquots (50µl) of the suspensions into chilled, sterile 
microfuge tubes or 96 deep well plates. Immediately snap-freeze the competent cells 
by immersing the tubes in a bath of liquid nitrogen 
- Store tubes at -80 °C until needed 
 
Transformation of chemical competent bacteria 
- Remove a tube or 96-deep well plate of competent cells form the -80 °C freezer 
- Thaw the cells by keeping the tube or 96 well plate on ice 
- Add the transforming DNA, swirl to mix and incubate on ice for 20-30 minutes 
- Transfer the tubes into a 42°C water both or heat block for 60s 
- Rapidly transfer the tubes to ice for 1-2 minutes 
- Add 600µl of SOC or LB medium (without antibiotic) and shake the cultures at 37°C 
for 1h 
- Centrifuge the cells at 13000 rpm for 1 min and resuspend in 200µl sterile H2O 
- Transfer the suspension onto a LB plate with appropriate antibiotic 
o For individual transformations: streak with spatula 
o For large plate numbers: use glass bead method 
- Incubate at 37°C 
 
Glass bead streaking method for high-throughput plating 
Add 3-4 glass beads to each plate. Swirl a whole stack of plates to spread bacteria. Recycle 
beads by washing in EtOH and water and autoclaving. Glass beads can be conveniently 
distributed from 50ml Falcon tube with small hole in lid. 
 
Plasmid preparation (small scale, individual tubes) 
buffer P1 50mM Tris-HCl; pH=8.0 
10mM EDTA 
100µg/ml RNase A (DNase-free) 
buffer P2 200mM NaOH 
1% (w/v) SDS 
buffer N 3M KOAc; pH=5.5 
 
- Pick individual bacterial colony from culture plate and inoculate in 2-5 ml LB liquid 
medium (with antibiotic for plasmid selection) 
- Incubate overnight with shaking at 37°C 
- Pellet 1.5ml of bacterial culture (centrifuge 1-2min at max. speed) 
- Resuspend pellet in 100 µl buffer P1 
- Add 200 µl buffer P2, mix gently by inverting the Eppendorf tube 5 times and 
incubate on ice for 5 minutes 
- Add 150 µl buffer N, mix by inverting 5 times centrifuge at max. speed for 10 
minutes. Transfer the supernatant to fresh Eppendorf tube 
- Add 1/10 Vol. of 3M NaOAc solution (pH = 5.5) 
- Add 0.7 Vol. isopropanol 
- Centrifuge at max. speed for 15 minutes at 4°C 
- Wash the pellet with 70% ethanol, air dry the pellet and dissolved in 100 µl H2O 
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- alternative: commercial available silica columns for DNA purification (e.g., Qiagen, 
Hilden) 
 
 Plasmid preparation (96-well plasmid preparation kit) 
For plasmid DNA isolation from 96-well cultures different isolation kits were used. These 
included the “Montage Plasmid Miniprep 96-well kit” (Millipore, Schwalbach) and the “96-
well miniprep kit” (Qiagen, Hilden). 
 
Determination of nucleic acid concentration 
The concentration of DNA was determined by the spectroscopic measurement of their 
optical density (OD) at 260 nm and 280 nm. The OD260 value of one is equivalent to 50 
µg/ml of double stranded DNA. Pure DNA in aqueous solution should have an 
OD260/OD280 ratio of 1.6-1.8. 
 
Restriction digestion of DNA 
Usually 2-3 units of a restriction enzyme for each µg of DNA were used. 1 to 10 µg of DNA 
was digested in buffer recommended by the supplier. The reaction was carried out between 2 
to 4 hours at enzyme supplier recommended temperature. The quality of the digestion was 
checked by DNA agarose gel electrophoresis. 
  
Nucleic acid analysis by agarose gel electrophoresis 
50x TAE buffer 2M Tris-base 
1M acetic acid 
0.1M EDTA 
adjust to pH=8.3 with acetic acid 
5x Sample buffer 50% (v/v) glycerol 
0.2% (w/v) SDS 
0.05% (w/v) bromophenolblue 
in 1xTAE buffer 
 
Agarose was (final concentration between 0.8 to 1.5 %) was dissolved in 1x TAE buffer and 
boiled in microwave until the agarose dissolved. Ethidium bromide was added at a 
concentration of 0.3 µg/ml. The molten gel was poured into a horizontal gel chamber. Load 
DNA sample with sample buffer. After separation of the samples DNA was visualized by 
transillumination with 302 nm ultraviolet radiation. 
 
Gel purification of DNA 
The DNA band of interest was isolated electrophoretically by running the gel until DNA 
band of interest is separated from adjacent contaminating fragments. Roche or Promega kit 
were used for the purification of DNA fragments from agarose gel to isolate the DNA of 
interest from the agarose gel. The purification was carried out according to supplier 
recommended protocol (Roche, Mannheim; Promega, Germany). 
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Ligation of DNA 
In all cases, the insert and vector were loaded on an agarose gel to check the DNA content 
before ligation. Ligation was performed in a total volume of 20 µl with insert-vector ratio 4:1 
in 1x ligation buffer with one unit of T4 DNA ligase and incubated for 2h at RT or at 16°C 
overnight (blunt end ligation).  
 
Polymerase chain reaction (PCR) 
A default PCR program is given. This program was modified according to specific PCR 
requirements. The PCR setup was as follows: 
 
1µl template DNA (20-200ng) 
1µl dNTP mix (each 10mM) 
Polymerase buffer (with MgCl2, diluted according to instructions) 
2µl forward primer (10 pmol/µl) 
2µl reverse primer (10 pmol/µl) 
0.5-1.0 µl polymerase (Taq polymerase for analytical, Pfu polymerase for preparative PCR) 
In a total of 50µl 
 
A commonly used PCR program is given below. 
5min at 95°C 
(30s at 95°C, 30s at annealing temperature, 2min at 72°C) for 30 cycles 
10min at 72°C 
Store at 4°C. 
 
The annealing temperature was commonly set to Tm – 5°C. 
 
Colony PCR (from yeast or bacterial cells) 
Resuspend small amount of colony in 20µl H2O. Incubate for 10min at 95°C. Add PCR mix 
and proceed with PCR. 
General protein related procedures 
SDS-PAGE (for 2 gels 10 cm x 8 cm with 1mm spacers)  
Required material 1M Tris-HCl pH 8.8 (Roth 3029.1) 
1M Tris-HCl pH 6.8 
0.5M EDTA 
20% SDS 
30% acrylamid solution (Roth) 
10% ammonium peroxodisulfate (APS) 
TEMED (Sigma) 
Gel chambers (2 gels 10 cm x 8 cm with 1mm 
spacers) 
Protein molecular weight marker 
Separating gel buffer (4x) 18.17g tris base 
4ml 10% (w/v) SDS 
adjust pH to 8.8 with HCl 
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add DDW (double distilled water) to 100 ml 
autoclave 
 
Stacking gel buffer (4x) 6.06g tris base 
4ml 10% (w/v) SDS 
adjust pH to 6.8 with HCl 
add DDW to 100 ml  
autoclave 
APS solution 10% (w/v) APS in DDW 
store at -20°C 
 
SDS-PAGE running buffer 30g tris base 
144 g glycine 
100ml 10% (w/v) SDS 
add DDW to 1 l 
 
SDS sample buffer 12.5% (w/v) SDS 
40% (v/v) glycerol 
20% (v/v) mercaptoethanol 
few cristalls bromophenolblue 
250mM Tris/HCl pH 6.8 
 
 
 stacking gel (5%) separating gel (10%) 
Acrylamid-bisacrylamid-
solution 
(37,5:1) (Roth, Karlsruhe) 
1.5ml 4ml 
Separation gel buffer (4x) - 3ml 
Stacking gel buffer (4x) 2ml - 
DDW 4.6ml 5ml 
APS solution 15µl 20µl 
TEMED 40µl 60µl 
 
 
Pour separating gel (add reagents as indicated above) into gel chamber (so that it fills up 2/3 
of the chamber) and cover with isopropanol and let solidify. 
Remove isopropanol and pour stacking gel. Immediately insert the combs and let solidify  
 
Coomassie Blue Staining of Acrylamide Gels 
Staining Solution 50% methanol 
10% acetic acid 
0.2% Coomassie Brilliant blue R250 
Destaining Solution 30% methanol 
10% acetic acid 
 
- After separation of protein samples, incubate the gel in Coomassie blue stain for 30 
minutes 
- Recover Coomassie stain (can be used several times) 
- Incubate the coomassie stained gel in destain solution (change several times the 
solution) until the background is sufficiently reduced 
MATERIALS & METHODS 
 47 
- Rinse in the gel in water and dry the gel for longer storage 
 
 2.2.6 Western Blot (semi-dry) 
Required material Transfer buffer (see buffers of protocol) 
Ponceau S (commercial) 
Blot chamber 
Whatman paper 
Nitrocellulose membrane (Immobilon-P, 
Millipore) 
Transfer buffer (Towbin buffer) 
 
3.03 g tris base 
14.27 g glycerol 
200ml methanol 
add DDW to 1 l 
 
Ponceau S solution 
 
dissolve 0.1% (w/v) Ponceau S in 5% acetic 
acid and filter 
 
X%-PBSM PBS with x% milkpowder 
PBST PBS with 0.05% Tween-20 
 
- Cut blot paper (8 sheets of Whatman paper per gel) and to the size of your gel and 
equilibrate in transfer buffer 
- Cut blotting membrane to the size of your gel, and activate in methanol for 2 minutes 
(in case of PVDF membrane), then equilibrate in transfer buffer 
- Disassemble electrophoresis chamber, lift short plate form saucer plate and carefully 
transfer gel (cut off stacking gel) into a tray with transfer buffer, shortly equilibrate 
- Build up blot: To bottom platinum anode of Trans-Blot-Semi-Dry-place: 
- Pre-wet filter paper (4 sheets of Whatman paper) 
- Pre-wet membrane 
- Gel 
- Pre-wet filter paper (4 sheets of Whatman paper) 
- Roll out air bubbles 
- Secure safety cover and connect to power supply 
- Run for 60min at 110mA per gel 
- Stop transfer, discard filter paper and briefly wash blot in H2O 
- Check transfer by staining blot in Ponceau S solution and destain in H2O. Omit 
Ponceau S staining for infra-red detection 
- For blocking: incubate membrane for 30min with 3-5%-PBSM 
- Incubate with 1st antibody (e.g., 1:2000) in 1%-PBSTM for 1h at room temperature 
- Wash three times with 1%-PBSTM; 5min each washing step 
- Incubate with 2nd antibody (e.g., 1:10000; with POD label or IR-label) in 1%-PBSTM 
for 1h at room temperature 
- Wash three times with 1%-PBSTM and conduct chemoluminescence detection or IR 
detection of bound antibodies. 
 
Expression of 96-constructs in parallel 
Lysis buffer 50 mM Tris-HCl, pH 8.0 
0.3 M NaCl 
1 mM EDTA 
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Lysis buffer + Brij-Lysozyme 
(50ml) 
 
45 ml Lysis buffer 
5 ml 1% Brij58 (Sigma) 
100µg/ml Lysozyme 
Proteinase inhibitors PMSF (200mM stock in isopropanol)  dilute 
1:200 
Aprotinin + Antipain (5µg/ml in DMSO)  
dilute 1:5000 
 
Elution buffer (for GST 
purification) 
120mM NaCl 
100mM Tris/HCl pH 8.0 
1mM PMSF 
20mM glutathione (reduced) 
5mM DTT 
SB    1 l/0.95 l 5 l/4.75 l 
Bactotryptone 12 g 60 g 
Yeast extract 24 g 120 g 
Glycerol 100% 4 ml 20 ml 
make up to 950 ml (4750 ml) 
autoclave 950 ml 
cool 
add 50 ml of 20x KPB 
 
1L 20x KPB:  
46 g KH2PO4 + 243 g K2HPO4 (Mw=174) 
 
4x SB concentrate    1 l 5 l 
 Bactotryptone 48 g 240 g 
 Yeast extract 96 g 480 g 
 Glycerol 100% 16 ml 80 ml 
    
Procedure 
- start with expression plasmid (e.g. pET) in expression strains (e.g. DE3) 
- o/n culture in LB + Kan at 37°C 
- next morning: dilute preculture in SB medium containing KPB + Kan 
- incubate at 37°C till OD600 = 0.6 
- induce with 1mM IPTG 
- shake 4-5h at selected temperature (e.g. 23°C) 
- spin 10min at 6000rpm 
- discard supernatant (storing at-80°C possible) and resuspend cells in 10ml lysis buffer 
+ Brij-Lysozyme + proteinase inhibitors 
- incubate for ~30min on ice 
- lyse cells by ultrasonic impuls (3* ~15s (in pulses), keep on ice) 
- remove 15µl aliquot for SDS-PAGE (whole cellular lysate) 
- aliquot into 2ml Eppendorf tubes 
- spin 15min atmax and at4°C 
- remove 15µl aliquot for SDS-PAGE (soluble protein extract) 
- transfer supernatants to new tube 
 
- For GST purification 
o add 30µl glutathione-beads (3x washed with PBS) 
o rotate 45min at4°C 
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o wash 4-5 times with PBS (rotate for 15min at4°C) 
o wash with elution buffer (w/o glutathione!) 
o add elution buffer (GST-658: 30µl) and rotate 30min at4°C 
o collect eluted fraction and elute for two more times 
 
2.1. Analysis of Transcriptional Activators in Yeast 
Selection of transcriptional activators 
Transcriptional activators were identified in two genome-wide Y2H studies of yeast proteins 
(Uetz et al. 2000; Ito et al. 2001). The “Ito screen” resulted in 392 auto-activators which were 
identified by testing essentially all yeast proteins for transcription activation when fused to the 
DNA binding domain of Gal4 as full-length open reading frames (Ito et al. 2001). The “Uetz 
set” contains 68 auto-activators and were identified in two-hybrid screens of ~600 yeast 
proteins (Uetz et al. 2000). 
For analysis of transcription activator properties activators identified by Ito et al. were 
selected from the Uetz bait library (Uetz et al. 2000) and combined with the Uetz activators 
to form a set of 451 proteins. These two independent selection steps ensured correct 
identification of activators. For further quality control, we sequenced 48 samples from the Ito 
collection and checked another 29 from the Uetz lab by colony PCR for correct insert size. 
Among these 77 clones only one (out of the 29 mentioned) did not match the expected 
identity and was thus excluded from further analysis. The activators of the “Ito set” were 
then divided into activation strength groups (see below). However, 79 strains did not grow 
well enough to be quantitated, although they were reported to be activators. Their activation 
strength has been annotated as “not available” (NA) in Supplementary Table 1. 
Yeast strains 
The activators were selected from the bait proteins described by Uetz et al. (2000) (Uetz et al. 
2000) and Hazbun et al. (2003) (Hazbun et al. 2003), and consisted of full length ORFs fused 
to the Gal4-DBD in the CEN4 plasmid pOBD2 (Cagney et al. 2000). These DBD-activator 
gene constructs were expressed in the strain YULH (MATa, ura3-52, trp1, lys2, his3, leu2, 
gal4∆, gal80∆, GAL1-URA3, GAL1-lacZ). This “activator strain” was re-arrayed onto 96-
well plates and mated with yeast cells of the opposite mating type (namely PJ69-4α: MAT α, 
trp1-901, leu2–3, ura3–52, his3–200, gal4∆, gal80∆, GAL2-ADE2, LYS::GAL1-HIS3, 
met2::GAL7-lacZ (James et al. 1996), (Uetz et al. 2000)) carrying an empty prey vector pLP-
GADT7 (Clontech). This mating was necessary in order to introduce the HIS3 reporter gene 
of the PJ69-4 α strain. 
The handling of yeast colonies was done by automated robotic procedures employing a 
Biomek 2000 robotic workstation (Beckman Coulter). 
Measurements of transcriptional activation strength 
The activation strength was measured by two different assays which measure the expression 
of two reporter genes: His3, which encodes imidazoleglycerol-phosphate dehydratase and 
catalyzes the sixth step in histidine biosynthesis (LTH assay) and beta-Galactosidase (bGal 
assay). 
His3 gene expression was measured (LTH assay) by growing yeast cells on selective media 
lacking leucine (L), tryptophane (T), and histidine (H) with the former two corresponding to 
markers on the two vectors pOBD2 and pLP-GADT7. Activity of the HIS3 reporter was 
quantitated by increasing amounts of 3-Aminotriazole (3-AT), a competitive inhibitor of 
His3. The lowest concentration of 3-AT that inhibited growth was considered as the 
activation strength of the gene construct (Cagney et al. 2000). This assay was done in 
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quadruplicate in order to ensure reproducibility (see Supplementary Table 1 for detailed 
results). 
The bGal assay was performed in 96-well plates using ONPG as a substrate (Serebriiskii and 
Golemis 2000). Briefly, diploid yeast cells were grown overnight at 30°C in 100µl selective 
media (leucine and tryptophane deficient), the media was replaced by 50µl Z-buffer (1.6% 
(w/v) Na2HPO4, 0.55% (w/v) NaH2PO4, 0.075% (w/v) KCl, 0.025% (w/v) MgSO4, pH=7) 
and the cells lyzed by two freeze-thaw cycles. For normalization of the cell density OD600 was 
measured using a microplate reader (Elx808, Bio-Tek Instruments, Vermont, USA). The 
assay was started by adding 50µl of 1.5 mg/ml ONPG in Z-buffer and the initial OD405i was 
measured immediately. The reaction was incubated at 37°C and OD405 measured at different 
time points. Time points still in the linear range were considered for calculation of the 
activation strength: 
(min)600
405)(405
tOD
ODOD
activitybGal it
⋅
−
= . 
Finally, the mean bGal activity of a randomly chosen set of genes not found to possess auto-
activation properties was subtracted. This assay was done in triplicates and mean and SEM 
(standard error mean) was calculated for each activator (Supplementary Table 1). 
Data sources and analysis 
General yeast protein properties, e.g. molecular mass and pI, protein annotations and gene 
ontology (GO) classification were downloaded from SGD (Balakrishnan et al.) (June 2005). 
Protein localization data was from Huh et al. (Huh et al. 2003), which was assumed to be less 
biased compared to curated data (e.g. GO component data). The abundance of proteins was 
compared using the genome-wide measurements by Ghaemmaghami et al. (Ghaemmaghami 
et al. 2003). Protein interaction data was downloaded from the MIPS database (Mewes et al. 
2004). 
Over-representation of certain GO terms was assessed using the program FuncAssociate 
(Berriz et al. 2003). For in detail analysis of known transcriptional regulator function and 
definition of the set of known transcriptional regulators (TR) the GO slim term 
“transcription regulator activity (F-GO 30528)” was used. Proteins annotated with the F-GO 
term “Transcriptional activator activity” (TermID 16563) from the YPD database (Biobase, 
Germany) served as an additional reference set.  
Physicochemical properties 
General physicochemical properties, e.g. molecular mass and isoelectric point, were taken 
directly from the datasets of the SGD (Balakrishnan et al.). Calculation of amino-acid groups 
and segments/clusters with specific physicochemical properties, e.g. charge, were done 
employing the SAPS program (Brendel et al. 1992). Frequencies of amino acids (aa) were 
directly calculated from SGD sequence data. The minimal and maximal pI of a protein was 
calculated as the lowest and highest pI of a 20 aa window, respectively. Amino-acid clusters 
in a protein were defined as the maximal count of a specific amino acid in a 20 aa window of 
the protein. GRAVY (Grand Average of Hydropathicity) values were calculated as the sum 
of hydropathy values for all of the amino acids, divided by the number of residues in the 
sequence (Lobry and Gautier 1994). Aromaticity is the relative frequency of aromatic amino-
acids (Lobry and Gautier 1994) and the codon adaptation index (CAI) is an empirical 
measure of synonymous codon usage bias, which is positively correlated with the expression 
level of genes (Sharp and Li 1987) (see also “http://www.yeastgenome.org/help 
/protein_page.html”). 
Protein domains 
The occurrence of protein domains in the set of Y2H activators was assessed using the 
SMART domain database (Letunic et al. 2004). The number of proteins with each domain in 
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the Y2H activator set and the whole genome was counted and the enrichment in the former 
set was calculated. Significance was tested using Fisher’s exact test and Holm’s procedure for 
multiple testing correction (Holm 1979). 
Protein interactions 
A protein-protein interaction map of transcription activators was generated using Cytoscape 
(Shannon et al. 2003). In the Cytoscape map only physical binary protein-interactions from 
the MIPS database were considered. Only activators and their direct interaction partners, 
bridging at least two activators, were selected. 
The percentage of activators that interacted with other transcription factors (i.e. proteins with 
the GO slim term “transcription {P-GO 6350})” was calculated using the set of physical 
binary protein-interactions from the MIPS database. Similarly, we counted with how many 
transcription complexes our activators interacted. A “transcription complex“ was defined as a 
protein complex with at least 50% of the proteins annotated as being involved in 
transcription. The protein interactions with these complexes were assessed by using the 
MIPS data of protein complexes filtered to contain only high-throughput data (for reduction 
of bias of well characterized proteins). 
Ranking of interaction partners was done by counting with how many proteins of a specific 
protein set a given yeast protein interacted (using high-throughput protein complex data 
from the MIPS database). 
Statistical analysis 
Data-processing was done with PERL (www.perl.org) and statistical calculations with R (R-
Development-Core-Team 2004). Correction for multiple testing was done with Holm’s 
procedure using the multtest package of R (Pollard et al.; Holm 1979). 
 
2.2. Generation and Analysis of the Protein-Interaction Network of T. pallidum 
The yeast-two-hybrid method described in this section will be 
published in the Methods of Microbiology series (Rajagopala 
et al. in press (2007)). 
ORF cloning into Y2H bait and prey vectors and Y2H array construction 
T. pallidum ORFs were kindly provided as pUni clones by T. Palzkill (McKevitt et al. 2003). 
ORFs were recombined into bait and prey vectors employing the univector-plasmid-fusion 
system (UPS) (Liu et al. 1998; Liu et al. 2000). Additional gene constructs were cloned by 
Gateway system mediated cloning (Invitrogen).  
The univector-plasmid-fusion system (UPS) 
The UPS is a site-specific recombination based vector system, which uses the Cre–lox site-
specific recombination to catalyze a plasmid fusion between an entry vector and a 
pHost/pAcceptor vector (Liu et al. 1998; Liu et al. 2000). The entry vector (pUniD vector) 
contains the gene of interest; the pHost vector is designed for the special expression needs, 
e.g. fusion-gene expression in yeast. The Cre-enzyme is a site-specific recombinase, which 
catalyzes the recombination between two 34 bp loxP sequences (Fig. 8). 
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34bp
ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA T
IR IRspacer  
Fig. 8 loxP-site 
 
The product of this recombination is a dimeric fusion plasmid. A crucial feature of the pUNI 
plasmid is its conditional origin of replication derived from the plasmid R6Kγ that allows its 
propagation only in bacterial hosts expressing the pir gene (encoding the essential replication 
protein p), and thereby the selection for and propagation of dimeric pUNI-pHOST vectors 
(Fig. 9). 
 
 
Fig. 9 Schematic representation of the UPS cloning system. A pUni vector is fused 
with a pAcceptor /pHost vector by the Cre-recombinase via their loxP sites. Source: 
Invitrogen 
Cre Recombination 
Cre-recombinase mediated recombination was used for creation of different host vector 
combinations. The reaction setup was as follows. 
 
2µl 10x Cre-recombinase buffer (NEB)  
1µl (1U/µl) Cre recombinase (NEB) 
100ng pUniD clones (entry vector constructs) 
100 ng UPS host vector (Y2H vectors, bacterial expression vectors) 
H2O -- 
In 20µl total volume 
 
Incubate the reaction at 37° C for 1 hour. Terminate the reaction by incubation at 70° for 10 
minutes. Use 10 µl of the reaction for bacterial transformation. 
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The Gateway® system 
The Gateway® system (Invitrogen) provides an universal technology to clone DNA 
sequences for functional analysis and expression in multiple systems. It is based on site-
specific recombination of bacteriophage lambda (Landy 1989). Similar to the UPS system, 
the lambda recombinase is employed to recombine attachment (att) sites from different 
vectors, which leads to the transfer of an ORF from one to the other vector. The advantages 
compared to the UPS system are the support of PCR product cloning, the feasibility of C-
terminal fusions, parallel transfer into several destination vectors, and the availability of a 
large number of vectors and clones for this system. However, the main disadvantage 
compared to the UPS system is its high cost. 
 
Cloning of ORFs with the Gateway system – the BP reaction 
The first step of ORF cloning is the primer design. The amplification of the ORFs will be 
done in two steps: in the 1st PCR the ORF is amplified with ORF-specific primers, in the 2nd 
PCR BP-sites for cloning are added to the resulting PCR product. 
For convenient design of primers, the “Express Primer Tool” from the Argonne National 
Lab is recommended: http://tools.bio.anl.gov/bioJAVA/jsp/ExpressPrimerTool/. The 
following parameters can serve as guidelines: optimal Tm is 55 °C, the Tm range is 10 °C 
above and below the optimal Tm, and the maximum Tm difference between forward and 
reverse primers is 5 °C. 
 
The primers for the 1st PCR are designed as follows: 
Forward Primer: 
5’ AA AAA GCA GGC TCC GCC atg –18-20nt (specific ORF sequence) 3’ 
Reverse Primer: 
5’ A GAA AGC TGG GTA  cta – 18-20nt (specific ORF sequence) 3’ 
atg: start codon 
cta: stop codon (example for TAG); can be omitted for C-terminal fusions 
 
The 1st PCR is done with a standard PCR protocol employing a proof-reading polymerase 
(e.g., Pfu polymerase) (see PCR protocol). However, the number of cycles in the 1st and 2nd 
PCR can be reduced if errors are expected.  
The PCR products are checked by agarose gel electrophoresis and 1-5µl product is used for 
the 2nd PCR reaction with the primer pair: 
Forward Primer (attB1): 
5’ G GGG ACA AGT TTG TAC AAA AAA GCA GGC T 3’ 
Reverse Primer (attB2): 
5’ GGG GAC CAC TTT GTA CAA GAA AGC TGG GT 3’ 
 
If unspecific bands are detected, the PCR product is gel purified. Otherwise, a column 
purification of the product is done. 
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Fig. 10 Gateway® system BP reaction. For generation of entry clones an attB 
substrate (PCR product) is recombined with an attP substrate (DONR vector) mediated 
by BP clonase® mix. Figure taken from Gateway manual (Invitrogen). 
The purified PCR product is used in a BP recombination to create the entry clone (Fig. 10): 
1µl BP Clonase (Invitrogen) 
1µl BP buffer 
1µl vector (pDONR207 / 150ng/µl) 
2µl PCR fragment (column purified) 
incubate o/n at 25°C 
add 1µl Proteinase K 
incubate for 10min at 37 °C 
transform into TOP10 cells 
select on Gentamicin plates 
 
Picking of a single colony is usually sufficient; the construct can be checked by PCR with the 
primer pair: pDONR207forward and pDONR207reverse. 
 
Destination vector creation with the Gateway system – the LR reaction 
The entry clones in pDONR207 can be transferred into different destination vectors with an 
LR reaction.  
 
 
Fig. 11 Gateway® system LR reaction. For generation of destination clones an attL 
substrate (entry clone) is recombined with an attP substrate (destination vector) mediated 
by LR clonase® mix. Figure taken from Gateway manual (Invitrogen). 
For the Y2H system the pGBKT7-DEST (bait) and pGADT7-DEST (prey) vectors are used 
(Uetz et al. 2006). The setup of the reaction is as follows: 
1µl LR Clonase (Invitrogen) 
1µl LR buffer 
1µl Entry vector (pENTR207)  
1µl Destination vector (150ng/µl) 
2µl H20 
incubate o/n at 25°C 
add 1µl Proteinase K 
incubate for 10min at 37°C 
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transform into TOP10 cells and select on Kanamycin plates  
 
Y2H vectors & Y2H fusion-protein creation 
For the prey constructs (Gal4-activation domain fusions) the vector pLP-GADT7 (Clontech) 
was used (Fig. 12). Two different bait vectors (Gal4-DNA-binding domain fusions) were 
selected. The pAS1-loxP vector (created by M. McKevitt) was generally used for the 
screening. We did not have any experience with this vector in our laboratory. Thus, a second 
bait vector, pLP-GBKT7-Amp, was adapted for the UPS system (Fig. 12) (Table 7). This bait 
vector was created from the pLP-GBKT7 vector (Clontech) by exchanging the KanR-gene 
with the AmpR-gene from the pAS1-loxP vector. For this, pLP-GBKT7 (Clontech) was 
digested with PvuII&XbaI and the 3.2kb fragment was gel purified. The vector pAS1-loxP 
was digested with BstXI & PstI and the 4.5kb fragment was gel purified. Both purified 
fragments were co-transformed into yeast cells and the recombined vector was selected on 
Trp-deficient plates. The use of these bait vectors and a comparison is presented in the 
results section. 
T. pallidum genes as pUni-clones (McKevitt et al. 2003) were recombined with these vectors, 
the constructs were checked by PCR or restriction digestion, and transformed into yeast cells. 
 
 
Fig. 12 Y2H vectors used for the interaction map of T. pallidum. The vectors pAS1-
loxP and pLP-GBK-AMP are bait vectors, the vector pLP-GADT7 is a prey vector. 
feature position 
TRP1 5343-5704 
Gal4BD 762-1202 
ADHp (trunc.) 30-736 
cMyc tag 1248-1280 
loxP 1305-1338 
bac. Promoter 1339-1465 
T7-term 1492-1538 
ADH term. 1571-1767 
pUC ori 1995-2793 
2µ ori 3931-5278 
F1 ori 6540-6556 
AmpR 2942-3578 
Table 7 Features of pLP-GBK-Amp 
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Verification experiments for gene construct 
The gene constructs for the Y2H system were checked by PCR, restriction digest, or DNA 
sequencing (GATC Biotech AG, München). 
Control PCRs were done with the following primer pairs: pUniDfor-pUniDrev (for pUniD 
constructs), pGADfor-pUniDrev (for preys in pLP-GADT7), pGBKfor-pUniDrev (for baits 
in pLP-GBKT7-Amp), and pAS1for-pUniDrev (for baits in pAS1). 
Restriction digests were done with the following enzyme pairs: XhoI-SacI (for pUniD 
constructs) and SmaI-NcoI (for pAS1 and pLP-GBKT7-Amp constructs).  
 
Y2H strains 
The Y187 strain was selected for transformation of the prey constructs and the AH109 strain 
was selected for bait construct transformation. 
 
Y187 (MATα, ura3- 52, his3- 200, ade2- 101, trp1- 901, leu2- 3, 112, gal4∆, met–, 
gal80∆,URA3 : : GAL1UAS -GAL1TATA -lacZ)  (Harper et al., 1993) 
AH109 (MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆ LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1 TATA-
lacZ)) (James et al., 1996) 
 
Yeast media and selective plates 
YEPD liquid medium 
 
10g  Yeast extract 
20g Peptone 
20g Glucose  
add H2O to 1 liter 
autoclave 
YEPD solid medium 
 
YEPD liquid medium with 
16g agar/l 
add 4ml 1% adenine solution (1% in 0.1M NaOH) after 
autoclaving 
Medium concentrate 8.5 g yeast nitrogen base 
25 g ammonium sulfate 
100g glucose 
7 g dropout mix (see below) 
add H2O to 1 liter 
sterile filter 
Selective plates autoclave 16g agar in 800ml water 
cool medium to 60°-70°C 
add 200ml medium concentrate 
add depending on plate type: 
-T plates (w/o Trp) 
  8.3ml Leu and 8.3ml His solution 
- L plates (w/o Leu) 
 8.3ml Trp and 8.3ml His solution 
- LT plates (w/o Trp and Leu) 
 8.3ml His solution 
- LTH plates (w/o Trp and Leu and His) 
 nothing 
-LTH + 3mM 3AT plates 
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 6 ml of 3AT (3-amino-1,2,4-triazole, 0.5 M) to a final  
concentration of 3mM. 
Dropout mix (-His, -Leu, 
-Trp) 
 
1 g Methionine  
1 g Arginine  
2.5 g Phenylalanine  
3 g Lysine  
3 g Tyrosine  
4 g Isoleucine  
5 g Glutamic acid  
5 g Aspartic acid  
7.5 g Valine  
10 g Threonine  
20 g Serine  
1g Adenine  
1 g Uracil  
Mix all components and store under dry, sterile conditions. 
 
Amino acid solutions Histidine (His): dissolve 4 g of Histidine in 1 liter sterile water 
and sterile filter 
Leucine (Leu): dissolve 7.2 g of Leucine in 1 liter sterile water and 
sterile filter 
Tryptophane (Trp): dissolve 4.8 g of Tryptophane in 1 liter sterile 
water and sterile filter 
 
Yeast Transformation 
Materials required salmon sperm DNA 
DMSO 
competent host yeast strains (AH109, Y187) 
Lithium Acetate (0.1M) 
selective plates (depending on the selective markers) 
96PEG solution 
competent yeast cell 
 
Carrier DNA  
(salmon sperm DNA) 
Dissolve 7.75mg/ml salmon sperm DNA Sigma (cat.No. D1626) in 
water and store at –20°C following a 15min 121°C autoclave cycle 
 
96 PEG solution  
(100ml) 
45.6g PEG (Sigma P3640)  
6.1ml 2M LiOAc  
1.14 ml 1M Tris pH 7.5 
232 µl 0.5M EDTA 
add H2O to 100 ml 
autoclave 
 
  
- Inoculate yeast strain (e.g. AH0109, Y187 or any other appropriate yeast strain; Y187 
strain is used for preys and AH109 is used for baits) into 50 ml YEPD liquid medium 
in a 250 ml flask (inoculation from fresh YEPD plate is beneficial) 
- Grow overnight with shaking at 30 ºC (minimum 15 h, max. 24 h) 
- Centrifuge in 50 ml conical tube (3,500 rpm, 5 min at RT), pour off supernatant, 
dissolve the pellet in 2 ml 0.1M LiOAc, and transfer resuspended yeast into two 1.5 
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ml microfuge tubes. Spin out yeast and resuspend in a total volume of 1.8 ml 0.1M 
LiOAc. 
- Prepare "CT110" for yeast transformation by mixing: 
o 20.73 ml 96PEG 
o 0.58 ml boiled salmon sperm DNA 
o 2.62 ml DMSO 
- Mix the above listed solutions in a 50 falcon tube; add DMSO last and mix quickly by 
shaking hard for 1min. 
- Add the total amount of competent yeast cells prepared above and mix hard by hand 
or by vortexing for 1 min. Pipet 200 µl into each well of a 96-well dish (e.g. Costar 
3596). 
- Add min. 100ng of plasmid and positive control (empty vector) and negative control 
(only CT110). Seal the 96 well plate with plastic or Aluminum tape and vortex for 4 
minutes. 
- Incubate at 42°C for 30 min. 
- Spin the 96 well plate for 10 min at 2,000 rpm; discard the supernatant by tapping on 
cotton napkin for couple of times. Add 100 µl of sterile water to all 96 wells, 
resuspend and plate them on selective plates 35 mm -Leu (or -Trp). Incubate the 
plates at 30ºC for 2-3 days. 
  
Setup of the prey array 
Preys rather than baits are arranged on an array, because the former do not generally result in 
self-activation of transcription. For creation of the prey array, the layout of the array is 
defined first. Each prey construct of the proteome is given a specific position of a particular 
96-well-plate, e.g. position A03 of prey plate #3. The wells of these 96-well-plates are filled 
with 100µl YEPD medium. Several colonies from a specific prey transformation are 
combined and manually transferred into the well at the previously defined position. These 
96-well plates carrying the prey strains are incubated o/n at 30°C and replicated to Omnitray 
plates with solid media – at least one selective Omnitray plate (-Leu) and one YEPD plate. 
50µl 50% (v/v) glycerol is added to the liquid culture plate; the plate is sealed and transferred 
to -80°C for long term storage. The solid prey plates with prey strains in the 96-format were 
quadruplicated to the 384-format using a robotic procedure (Biomek 2000 laboratory robot). 
For increased throughput, duplicates rather than quadruplicates from two 96-formatted 
plates can be combined on one 384-formatted plate. This prey array was generally stored on 
selective plates (-Leu). “Working” copies for Y2H screens on solid YEPD medium were 
created. 
 
Bait construction 
Baits are also constructed by Cre-mediated recombination of the respective pUni-constructs 
with the bait vectors described above. Baits were transformed into the AH109 yeast strain 
and stored on –Trp plates and as glycerol stocks. 
 
Self activation test 
Prior to the two-hybrid analyses, the bait yeast strains (DB-X) should be examined for self-
activation. Self-activation is defined as a detectable DB-X-dependent two-hybrid reporter 
gene activation in the absence of any prey (AD-Y) interaction partner. Weak to intermediate-
strength self-activator baits can be used in two-hybrid array screens because the 
corresponding DB-X/AD-Y interactions confer stronger readouts that are scoreable over the 
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self-activation background. In case of the HIS3 reporter gene the self-activation background 
can be titrated by adding different concentration of 3-AT, a competitive inhibitor of His3. 
Self-activation of all the baits is examined on plates containing different concentration of 3-
AT. The lowest concentration of 3-AT that suppresses growth in this test is, finally, used for 
the interaction screen (see below): background growth is suppressed, whereas true 
interactions are still detected. 
 
Materials 
required 
full medium and selective medium agar in single-well microtiter plates 
(Omnitray plates, Nunc): 
YEPD plates  
- LT plates 
Selective plates without Trp, Leu, and His, but with different concentrations 
of 3-AT, e.g., 0mM, 1mM, 3mM, 10mM, 50mM and 100mM (-LTH/3-AT 
plates) 
Prey strain carrying the empty prey plasmid, e.g., Y187 strain with pLP-
GADT7 plasmid (Clontech) 
 
- Bait strains are arrayed onto a single-well Omnitray agar plate; either the standard 96-
well format or the 384-well format is used. Baits are first inoculated at the different positions 
of a 96-well plate as liquid culture, and then cells are transferred (manually or with robot) to solid 
agar single-well plates (Omnitray plates). In this step the 96-well format can also be converted into 
the 384-well format, this will position each bait in quadruplicates on the 384-well formatted plate. 
Full medium agar (YEPD agar) can be used, however, for long term storage of the array selective 
agar (-Trp) is suggested to prevent loss of plasmids. 
- The arrayed bait strains are mated with a prey strain carrying the empty prey plasmid, 
e.g., Y187 strain with pLP-GADT7 plasmid (Clontech). Mating is conducted 
according to the standard screening protocol. Note: Compared to protocol 2 bait and prey 
strains are exchanged during mating. 
- After selecting for diploid yeast cells (on –LT agar) the cells are transferred to 
medium selecting for the His3p reporter gene activity (see below). The -LTH transfer 
is done to several selective plates with increasing concentrations of the competitive 
inhibitor of His3p, 3-Aminotriazole (3-AT). Suggested are 3-AT concentrations of 0mM, 
1mM, 3mM, 10mM, 25mM, and 50mM.  
- These –LTH/3-AT plates are incubated for 1 week at 30°C. The self-activation level 
of each bait is assessed: the lowest 3-AT concentration that completely prevents 
colony growth is noted. As this concentration of 3-AT suppresses reporter activation 
in absence of an interacting prey this 3-AT concentration is added to –LTH plates in 
the actual interaction screening. 
 
 
Screening for protein interactions using a yeast protein array 
The Y2H prey array is screened for protein interactions by a mating procedure that is carried 
out using robotic procedures. A strain expressing a single candidate protein as a DBD fusion 
(bait strain) is mated to all the colonies in the prey array. After mating, the colonies are 
transferred to diploid-selective medium (-Leu and –Trp), and then to two-hybrid selective 
medium (-Leu, -Trp, and –His). A robotic workstation (Biomek 2000, Beckman Coulter) was 
used for the screening procedure. A 384 pin stainless steel replicating tool (High-Density 
Replication Tool; Beckman Coulter) was used to transfer the colonies from one plate to 
another. Between the transfer steps, the pinning tool must be sterilized by sequential 
immersion into a 20% (v/v) bleach solution (20 seconds), sterile water (1 second), 95% (v/v) 
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ethanol (20 seconds), and sterile water (1 second). The level of these liquids should be 2 to 4 
mm from the base of the pin and care must be taken that the ethanol does not evaporate. 
It is important to ensure that plasticware is compatible with the movement of the robot. 
Here, the prey array was gridded on 86 x 128-mm single-well microtiter plate (OmniTray, 
Nalge Nunc International) in 384-colony format. 
 
Materials 
required 
 
20% (v/v) bleach (1 % sodium hypochlorite) 
95% (v/v) ethanol 
Single-well microtiter plate (OmniTray; Nalge Nunc international) containing 
solid YEPD + Adenine medium (see protocol), -Leu –Trp, –His –Leu –Trp 
and –His –Leu –Trp + different concentration of 3AT 
Bait liquid culture (DBD fusion-expressing yeast strain) 
yeast protein array on solid YEPD plates („working copy“ of prey array) 
 
 
- Sterilization: Sterilize the 384-pin replicator by dipping the pins into 20% bleach for 
20s, sterile water for 1s, 95% ethanol for 20s, and sterile water again for 1s. Repeat 
this sterilization before each transfer. 
- Preparing bait liquid culture (DBD fusion-expressing yeast strain): inoculate 20-30ml 
of liquid YEPD medium in a 250 ml conical flask with a bait strain and grow 
overnight in 30ºC shaker. If the Bait strains are frozen, it is streaked or pinned on a selective 
plate ( -Trp) solid medium and grown 1-2 days at 30ºC. Bait colonies from this plate are then used 
to inoculate the liquid YEPD medium.  
- Mating procedure: Pour the dense bait strain culture into sterile Omnitray plate. Dip 
the sterilized pins of the pin-replicator (thick pins should be used to pin baits) into 
the bait liquid culture and place directly onto a fresh single-well microtiter plate 
containing solid YEPD medium. Repeat with the number of plates needed for the 
whole prey array and allow the yeast to dry onto the plates for 10-20 minutes. 
- Pick up the prey array (i.e., AD) yeast colonies with sterilized pins (thin pins should 
be used to pin the preys) and transfer them directly onto the baits pinned onto the 
YEPD plate, so that each of the 384 bait spots per plate receives different prey  yeast 
cells (i.e., a different AD fusion protein). Incubate 1-2 days at 30ºC to allow mating. 
Mating will take place in <15 hr, but longer period is recommended, because some baits strains show 
poor mating efficiency. 
- Selection of Diploids: For the selection of diploids, transfer the colonies from YEPD 
mating plates to single-well microtiter plates containing –Leu-Trp medium using the 
sterilized pinning tool (thin pins should be used in this step). Grow for 2-3 days at 
30ºC until the colonies are >1 mm in diameter. This step is essential because only diploid cell 
containing Leu and Trp markers on  prey and bait vector, respectively, will grow on this medium. 
This step also helps recovery of the colonies and increase the efficiency of the next selection step. 
- Interaction selection: Transfer the colonies from –Leu-Trp plates to a single-well 
microtiter plate containing solid –His –Leu –Trp agar, using the sterilized pinning 
tool. If the baits are self-activating, they have to be transferred on –His –Leu –Trp 
with a specific concentration of 3AT and incubated at 30ºC for 6-10 days. 
- Score the interactions by looking for growing colonies that are significantly above the 
background by size and that are present for both duplicate colonies. The plates should 
be examined every day. Most two-hybrid positive colonies appear within 3 to 5 days, but occasionally 
positive interactions can be observed later. Very small colonies are usually designated as background; 
however, there is no absolute measure to distinguish between the background and real positives. When 
there are many (i.e., > 30) large colonies per array of 6000 positions, these baits are considered as 
random activators. In this case the screen should be repeated. 
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Evaluation of raw results 
Filtering of the obtained raw results significantly improves the data quality of the protein 
interaction set. For filtering at least three parameters should be considered. Detected protein 
interactions that can not be reproduced should be discarded. The reproducibility can either 
be assessed directly from the initial screen, e.g., by screening in quadruplicates, or by 
conducting an independent retest of initially detected protein interactions. For each prey the 
number of different interacting baits is calculated. Preys interacting with a significant high 
number of baits – judged by evaluating the distribution of these numbers – are assumed to 
interact unspecifically and are neglected (“sticky preys”). The last parameter is the 
background activation activity of the tested bait. The activation strength of interaction pairs 
must be significantly higher than with remaining pairs. In principle, at least with the His3p 
reporter, no activation (no colony growth) should be observed in non-interacting pairs. 
 
Protocol– Retest of protein interactions 
Testing for reproducibility of interactions greatly increases the reliability of the interaction 
data. This protocol is used for specifically retesting interaction pairs detected in an array 
screen. 
 
Materials 
required 
 
- 96-well microtiter plates (U- or V- shaped) 
- YEPD medium and YEPD agar in Omnitrays (Nunc) 
- selective agar plates (-LT, -LTH with 3-AT) 
- prey yeast strain carrying empty prey plasmid, e.g. pLP-GADT7 in 
Y187 strain 
- bait and prey strains to be retested 
 
 
- Bait and prey strains of each interaction pair to be tested are re-arrayed into 96-well 
microtiter plates. An individual 96-well plate is used for the baits, as well as for the 
preys. For each retested interaction one well of the bait plate and one corresponding 
well of the prey plate is filled with 150µl YEPD.  
- For each retested interaction the bait strain is inoculated into a well of the 96-well 
bait plate and the prey strain is inoculated at the corresponding position of the 96-
well prey plate. For example, bait at position B2 of bait plate and prey at position B2 of prey 
plate.  
- The plates are incubated o/n at 30°C. In addition, the prey strain with the empty prey 
vector, e.g. strain Y187 with plasmid pLP-GADT7, is inoculated into 50ml YEPD; 
this strain is incubated o/n in a shaker at 30°C.  
- The prepared baits grown in the bait plate are mated with their corresponding preys 
in the prey plate. In addition, each bait is mated with the prey strain carrying an 
empty prey vector as a background activation control. The mating is done as 
described above using the bait and prey 96-well plates directly as the source plates. 
First the baits are transferred from their 96-well plate to two YEPD plates (interaction test and 
control plate) using a 96-well replication tool. After drying the preys are transferred from their 96-
well plate onto the first YEPD plate and the empty prey vector control strain is transferred onto the 
second YEPD plate. 
- The transfers to selective plates and incubations are done as described above. As 
usually different baits with different activation strength are tested on a single plate, the diploid cells 
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are pinned to LTH plates with different concentrations of 3-AT. For choosing the 3-AT range the 
measured activation strengths (Protocol “Self activation test”) serve as a guideline.  
- After incubating for ~1 week at 30°C on –LTH/3-AT plates the interactions are 
scored. Positive interactions show a clear colony growth at a certain level of 3-AT, whereas no 
growth should be seen in the control (bait mated with empty vector strain). 
 
Co-immunoprecipitation of co-expressed proteins in E. coli (coEXcoIP) 
Proteins of T. pallidum expressed in E. coli often only showed a limited solubility, which 
reduces the throughput of protein interaction verification experiments. A commonly used 
strategy for the independent large-scale verification of protein interactions in the eukaryotic 
environment is the co-immunoprecipitation of proteins co-expressed in tissue culture cells 
(Uetz et al. 2006). Thus, a similar system for prokaryotic proteins relying on the co-
expression in E. coli cells was established. The vector selection is crucial for such a system as 
too high expression levels were found to be detrimental for protein solubility. Vectors of the 
pBad-series were selected and adapted for the UPS system (Guzman et al. 1995; Liu et al. 
1998). These vectors carry promoters regulated by L-arabinose and show a lower well 
regulated expression level. 
 
Vectors for the coEXcoIP system 
pBad33HAloxP – Chloramphenicol resistance, HA-tag, loxP-site, pBad promoter 
This vector was created by inserting a HA-tag fused to a loxP site from pTagloxPHA3 (PCR 
product employing the primers pBad33HA3-loxSacFor and pTagLoxRev) (kindly provided 
by Prof. Elledge) between the SacI and HindIII sites of pBad33 (Guzman et al. 1995).  
 
pBad24MycloxP – Ampicillin resistance, Myc-tag, loxP-site, pBad promoter 
This vector was created by inserting the NcoI/HindIII fragment containing a Myc-tag fused 
to a loxP-site from pTagloxPMyc3 (kindly provided by Prof. Elledge) between the NcoI and 
HindIII sites of pBad24. 
 
Material & Buffers 
NP-40 lysis buffer 
 
140mM NaCl 
5mM MgCl2 
20mM Tris/HCl, pH 7.6 
1mM PMSF 
1% NP-40 
Protein-G-beads (washed) 
 
- prepare 2*30µl / coIP (~15µl resin) 
- collect beads by centrifugation at 800g for 
2min 
- aspirate with 25-gauge needle 
- wash 3x with NP-40 buffer (don’t vortex) 
- adjust to n*40µl and store on ice 
- use 2*40µl for each pulldown 
 
Fusion-protein construction 
- Select respective pUni 
- Cre recombination : 
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o 2µl Miniprep DNA of pUni 
o 100ng destination vector 
o 1µl Cre buffer 
o 0.5µl Cre 
o add 10µl with water 
 1h at 37°C and 10min at70°C 
 Transformation (TOP10) and KanR (pUni) selection 
- Check DNA miniprep by RD (buffer : Promega E): 
o pBad33HaloxP : HindIII+SacI (additional band at 2.2kb and 300bp) 
o pBad24MycloxP:  
- Sequential co-transformation: 
o In TSS competent DE3 cells (freshly prepared) 
o Select on Kanamycine LB plates 
o Prepare TSS competent cells and do co-transformation (use empty vector as 
negative control for coIP!) 
o Select on LB plates with Ampicillin&Chloramphenicol 
 
CoIP procedure 
- Grow co-transformed DE3 cells o/n in Ampicillin&Chloramphenicol medium 
(always include co-transformation with empty vector, e.g. Myc vector, as a control) 
- Dilute 1:10 in fresh LB Ampicillin&Chloramphenicol 
- Incubate to OD=0.6 (~2h) at 37°C 
- Induce with 0.2% L-Arabinose 
- Incubate for 3h at 30°C 
- Collect 1.5ml by centrifugation in Eppendorf tube 
- Add 200µl of NP-40 buffer + 0.25mg/ml lysozyme 
- Incubate 20min at RT 
- Sonicate using bioruptor (7min total, 30s on, 30s off, max power)  collect 5µl total 
lysate 
- Centrifugate 20min at max at 4°C 
- Collect supernatant  collect 10µl soluble lysate (2x3µl for SDS-PAGE) 
- Mix 40µl washed beads with soluble supernatant 
- Incubate for 20min at 4°C (rotating)  preclearing 
- Centrifuge and use supernatant 
- Add co-IP antibody: 4µl anti-Myc (co-IP and control!) or 3µl anti-HA 
- Adjust to 500µl with NP-40 buffer 
- Incubate 2h at 4°C 
- Add 40µl washed Protein-G beads 
- Incubate 2h at 4°C 
- Wash 4 times with 1ml NP-40 buffer 
- Add 50µl of 2xSDS sample buffer and boil 
- Run on SDS-PAGE gel 
Fragmentation of TP0981 
Fragments of TP0981 were prepared (Fig. 40). The fragments were PCR amplified from the 
pUni clone of TP0981. For this the following primer pair combination were used: T1 
(pUniDfor/981frag@222rev), T2 (981frag@50for/981frag@222rev), T3 (981frag@50for/ 
pUniDrev), and T4 (981frag@202for/pUniDrev). The PCR products were cloned into the 
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pUniD vector mediated by XhoI and SacI. Preparation of bait and prey constructs were done 
according to procedures described for whole library. 
Bioinformatical Analysis 
General 
Protein interaction networks were visualized with the Cytoscape software package (Shannon 
et al. 2003). Data analysis was done with perl (www.perl.org) and R (R-Development-Core-
Team 2004). Statistical analysis was done with R and MS-Excel. Tightly connected clusters in 
networks were identified with the MCODE algorithm as implemented into the Cytoscape 
software package (Bader and Hogue 2003). Topological parameters of networks were 
computed with the NetworkAnalyzer plug-in for Cytoscape (MPI for Informatics, Germany, 
med.bioinf.mpi-inf.mpg.de/netanalyzer). Network centralities (node degree, centroid value) 
were calculated with CentiBiN (Junker et al. 2006). Paralogous gene families for T. pallidum 
were downloaded from the TIGR-CMR database (Peterson et al. 2001). Orthologous 
relationships between genes were taken from the String (von Mering et al. 2005) and MBGD 
databases (Uchiyama 2003). 
 
Randomization and evaluation 
For statistical filtering and significance estimations, the actual protein interaction network was 
compared to 1,000 randomized versions of this network. For randomization a rewiring 
algorithm as proposed by Maslov and Sneppen was employed (Maslov and Sneppen 2002). 
In these “null model” networks, all proteins have the same connectivity (in- and out-degrees 
of nodes) as in the actual protein network, whereas the identity of the interacting partners of 
all proteins is entirely randomized. Enrichment compared to the randomized networks was 
commonly expressed as a Z-score:
rand
randnnZ
σ
><−
=  with a particular parameter of the actual 
network n (e.g., the number of interactions between two functional classes), the average 
<nrand>, and the standard deviation σrand of this parameter in 1,000 randomized networks. 
The interaction dataset filtered for a certain prey count (in-degree) threshold was evaluated 
by calculating the percentage of interactions supported by bioinformatical association 
methods as provided by the String database (combined confidence score > 0.4) (von Mering 
et al. 2005). 
 
Motility dataset randomization 
For the motility subset a special randomization procedure was developed. The reason was 
that at the time of analysis of the motility set, the whole interaction network was not finished. 
Usually, networks are randomized under conditions where all in and out degrees are 
conserved. For a limited subset of protein interactions, the rewiring algorithm does not yield 
reliable results. For example, in the analysis of over-represented GO terms the same number 
of proteins for each functional class would be retained and the expected over-representation 
of motility proteins in the motility subset would be the same in the "random" set. 
The randomization algorithm developed for limited interaction networks tries to solve this 
problem, although rewiring of a complete network might still be the better choice. 
The following strategy was selected for randomization:  
- Retain all proteins of selected functional class, but don't add more proteins of same class 
- Retain the in and out degrees of selected class 
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- Select interacting proteins randomly until all in and out degrees of functional class are 
saturated 
The procedure was as follows: 
- Focus on proteins of specific functional class, e.g. KEGG motility proteins. 
- Define their in and out degrees 
- Remove all edges 
- Add random edges until all original in and out degrees are used 
- Select protein of selected class and an in or out degree randomly 
- Random sample interacting protein from whole genome 
 
Other datasets and orthology 
The following interaction studies were considered for comparison: two E. coli complex 
purification studies which were conducted by Arifuzzaman et al. and Butland et al. (Butland et 
al. 2005; Arifuzzaman et al. 2006), a partial yeast-two-hybrid interaction map for Helicobacter 
pylori generated by Rain et al. (Rain et al. 2001), and a comprehensive yeast-two-hybrid 
interaction map for C. jejuni produced by Parish et al. (kindley provided by the Finley group). 
For complex purification studies both the spoke model and a socio-affinity-index (SAI) 
model as described by Gavin et al. (Gavin et al. 2006) were considered.  
Dataset comparisons were based on orthology relationships between genes. Two sources for 
orthology relationships were chosen: clusters of orthologous groups (Tatusov et al. 2003) 
from the String database (von Mering et al. 2005) and orthology clusters from the MBGD 
database (with average alignment coverage > 50%) (Uchiyama 2003). 
 
Connections of functional classes 
Functional assignments for proteins were taken from the TIGR/CMR database (TIGR main 
roles & TIGR subroles) (Peterson et al. 2001) and from the GOA project (automatically 
generated GO terms) (Camon et al. 2003). GO terms were mapped onto GO slim terms 
(GO slim terms present in prokaryotic GO subset).  Interactions between functional 
categories were counted. Overrepresentation of a functional link compared to 1000 
randomized networks was assessed by calculating a Z-score (see above). Functional links 
based on at least two Y2H interactions with Z > 2 for TIGR roles and Z > 3 for GO terms 
were selected. Note that the filtering procedure is meant to reduce the influence of 
unspecifically interacting protein categories. However, in a biological network a single 
interaction can form a significant link between two categories. Thus, no more stringent 
statistical filtering, e.g. correction for multiple testing or ranking statistics, was applied.  
For the motility subset, the analysis was done slightly different. Associations of the class of 
known motility proteins (“motility”) (defined by the KEGG database, 
www.genome.jp/kegg/) to a certain functional class (TIGR sub role) defined by their protein 
interactions were evaluated by counting the number of links between these two classes. 
Known motility proteins were only counted for the class “motility” not for additional classes 
to prevent artificial links introduced by intra-motility interactions between proteins annotated 
with more than one functional class. Comparing the percentage of a link in the interaction set 
to the percentage of the respective functional class in the genome gives a first idea of its 
over-representation. For a further assessment of the significance of a specific link the number 
of interactions was compared to a random distribution of 1,000 randomized network (see 
motility dataset randomization). 
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Generation of domain centered network 
Domain/protein family information for T. pallidum proteins was taken from the Pfam 
database (Bateman et al. 2004). The number of interactions between pairs of domains was 
counted. Overrepresentation of a domain link compared to 1,000 randomized networks was 
assessed by calculating a Z-score (see above). Links based on at least two Y2H interactions, 
which were enriched compared to the randomized networks (Z > 2) were selected for 
visualization. Peptide chain links were defined when two domains were present in the same 
protein. Predictions of domain links from the InterDom database were integrated (Ng et al. 
2003). 
 
Links between genomic locations 
Y2H interaction-mediated links between genomic locations covering 20 neighboring genes 
were analyzed. The number of interactions between two genomic locations was counted 
(neighboring locations were overlapping and shifted by 5 genes). Overrepresentation of a link 
compared to 1000 randomized networks was assessed by calculating a Z-score (see above). 
Links based on at least three Y2H interactions, which were enriched compared to the 
randomized networks (Z > 2) were selected and the number of linking interactions was 
visualized in a matrix. The underlying interaction pattern for each genomic location link was 
inspected and a number of links were selected for detailed visualization. 
 
Essential and pathogenicity related genes 
Essential genes were predicted for T. pallidum based on essential gene datasets for three 
different species: E. coli (Baba et al. 2006), B. subtilis (Kobayashi et al. 2003), and M. genitalium 
(Glass et al. 2006). Orthologs as defined by the MBGD database (Uchiyama 2003) of these 
experimentally defined essential genes were assumed to be essential for T. pallidum.  
Possible virulence factors (pathogenicity related genes) were defined by Weinstock et al. 
(Weinstock et al. 1998) and divided into six groups: Tpr proteins, hemolysins, regulators, 
polysaccharide biosynthesis, potential membrane or surface-exposed proteins, and proteins 
with miscellaneous functions. 
Gene expression levels during experimental rabbit infection with T. pallidum were measured 
by Smajs et al. (Smajs et al. 2005). Genes with the highest expression levels (TOP 50) were 
selected. 
These datasets were analyzed with respect to graph centrality measures (e.g., node degree and 
centroid value) and connections to functional protein classes (as described above). 
 
Taxonomy tree & phylogenetic interaction profile 
The taxonomy tree was taken from the String database (von Mering et al. 2005) and pruned 
for the selected species. For species with more than one sequenced strain, only one 
representive genome was selected. The tree was drawn using Phylodendron 
(http://iubio.bio.indiana.edu/treeapp/). A subset of filtered Y2H interactions either 
supported by an association by the String database or overlapping with any interaction 
dataset (see network comparisons) was selected. Based on COG orthology, for each selected 
interaction and each selected species the presence of the interacting proteins in the genome 
was checked. A matrix (species vs. interactions) of these conservation values was defined. 
The interaction vectors were clustered by complete linkage clustering based on euclidean 
distance measures (treating interactions with one protein absent and one present as equal) as 
implemented in the R package (R-Development-Core-Team 2004). In addition, the ratio of 
the number of interactions that can be predicted for each species to the maximal possible 
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number of interactions in each species was calculated. For these predictions, the filtered T. 
pallidum dataset was taken as a basis. From this set, a protein interaction was predicted for a 
species, when orthologs for both interacting proteins were present in this species. Cluster of 
orthologous groups for these predictions were obtained from the String database (von 
Mering et al. 2005). The number of predicted interactions was provided by J. Goll. 
 
Annotation of proteins by Guilt-by-association approach 
Hypothetical and conserved hypothetical proteins of T. pallidum were selected and the 
connections of each protein to functional categories (GO slim mapping and TIGR sub roles) 
were analyzed. The fraction of interactions connecting a protein to a specific functional 
category was calculated. To remove unspecific links -- due to highly abundant or 
unspecifically interacting categories --, the number of links was compared to a random 
distribution from 1000 randomized networks. Only links with Z > 2 and involving at least 
50% (GO slim mapping) or 33% (TIGR sub roles) of the total number of interactions were 
considered. 
 
2.3. Whole Genome Phenotypic Motility Assay for Escherichia coli 
A systematic single-gene knockout collection of Escherichia coli, the Keio collection (Baba et al. 
2006), which contains 3985 individual mutant strains, was tested for reduced motility by a 
swarming assay. Each gene mutation was tested in two independent strains as provided by 
the Keio collection. Strains were grown till saturation in LB medium at 37°C and transferred 
to Omnitrays (Nunc) with swarming agar (LB medium with 0.25% Agar) in a 24 colonies per 
plate format by pin replication with a Biomek 2000 lab robot (Beckman-Coulter). The 
swarming diameters of the mutant strains were compared after ~8h incubation at 37°C. The 
swarming behavior of each mutant was classified as normal, reduced (reduction by at least 
50%) or none motile (reduction by at least 90%). Gene mutations with reproducible 
reduction in both strains were selected for a retest and mutants with reproduced swarming 
phenotype were selected for the “E. coli motility” dataset. 
 
2.4. Individual Gene I: TP0658 – a novel conserved assembly factor for the bacterial 
flagellum 
Expression and purification of GST-658 and GST-yviF 
For construction of GST fusions of TP0658 and yviF the UPS recombination system was 
used (Liu et al. 1998; Liu et al. 2000). The pUni entry clone of TP0658 was selected from the 
T. pallidum ORFeome collection (McKevitt et al. 2003). The yviF gene was PCR-amplified 
from B. subtilis genomic DNA using the primer pair yviF_forward/yviF_reverse and cloned 
into pUniD/V5-His-TOPO (Invitrogen, Carlsbad, USA) using XhoI and SacI. GST fusions 
for expression in E. coli were created by Cre mediated recombination of the pUni vectors 
with a GST host vector pMM110 (Liu et al. 1998; Liu et al. 2000; McKevitt et al. 2003). The 
GST fusions were termed GST-658 and GST-yviF, respectively. These constructs were 
transformed into E. coli BL21/DE3 cells (Novagen,  EMD Biosciences, CA, and USA). 
Overnight cultures of these E. coli cells were used to inoculate SB medium containing 
kanamycine. After incubating to an OD600 = 0.6 at 37°C, protein expression was induced for 
3h at 37°C with 1mM isopropyl p-D-thiogalactopyranoside (IPTG). The cells were collected, 
lyzed, and the GST fusion proteins were purified with glutathione-sepharose FF matrix 
(Amersham Biosciences, Freiburg, Germany) using standard procedures. 
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Overlay assay and peptide competition 
Entry clones of T. pallidum proteins (in pUniD/V5-His-TOPO vector) were taken from the 
T. pallidum ORFeome collection (McKevitt et al. 2003). The hag and yvzB genes of Bacillus 
subtilis were PCR-amplified from genomic DNA with primer pairs hag_forward/hag_reverse 
for the hag gene and yvzB_forward/yvzB_reverse for the yvzB gene. Site-directed 
mutagenesis of hag was done by a PCR based approach. For hag-HA two overlapping PCR 
products incorporating the mutation were amplified with primer pairs 
pUniDfor/hagHAreverse and hagHAforward/pUniDrev using pUniD-hag as a template. 
These products were joined in a second PCR reaction using the primer pair 
pUniDforward/pUniDreverse. The construct hag-N255A was produced accordingly using 
primer pairs pUniDforward/hagN255Areverse and hagN255Aforward/pUniDreverse in the 
first PCR reaction. These PCR products were cloned into pUniD/V5-His-TOPO 
(Invitrogen, Carlsbad, USA) using XhoI and SacI. HA-tag fusions for expression in E. coli 
were created by Cre-mediated recombination of the pUni vectors with a HA-tag host vector, 
pHB-HA3. 
HA-tagged fusion proteins were expressed in E. coli BL21/DE3 cells and the total lysate was 
electrophoretically separated on a SDS-polyacrylamide gel and transferred onto a PVDF 
membrane. The membrane was blocked overnight at 4 °C in blocking buffer (5% milk 
powder in PBS) and then incubated with 25nM purified GST fusion protein or 25nM GST 
control protein in overlay buffer (1% milk powder and 0.5% Tween in PBS) for 2h at RT. 
After washing three times with overlay buffer, the membranes were probed with an anti-GST 
antibody (G1160; Sigma-Aldrich, Germany), and additionally, with an anti-HA antibody 
(HA.11, Covance Research Products, CA, USA). 
The in vivo overlay assay using different B. subtilis mutants was done alike. Lysates of B. subtilis 
168 wild type and the given mutant strains were prepared, separated by SDS-PAGE, 
transferred onto a PVDF membrane and probed with GST-yviF or GST control protein as 
described above. 
For peptide competition HA-tagged flagellin proteins were transferred onto the PVDF 
membrane. Olaf Zwernemann (Forschungszentrum Karlsruhe) using standard peptide 
chemistry protocols synthesized the peptides for competition experiments. GST-658 was 
pre-incubated with the respective concentration of inhibitory peptide 
(VGLDIAAENLQAAESRIRD) or a control peptide (DRRLADHFCGKIHCG) in overlay 
buffer for 2h at 4°C. The overlay assay was done as described incubating the membrane with 
the GST-658/peptide mixtures.  
Cloning of flagellin fragments 
A pUni vector containing the TP0868 (flagellin) gene was used as PCR template (McKevitt et 
al. 2003). Specific fragments were PCR-amplified using the following primer pairs: 
pUniDforward/L59reverse for fragment T1, N60forward/pUniDreverse for fragment T2, 
N60forward/S141reverse for fragment T3, V118forward/S141reverse for fragment T4, 
V118forward/pUniDreverse for fragment T5, I200forward/ pUniDreverse for fragment T6, 
L231forward/pUniDreverse for fragment T7, and N60forward/S199reverse for fragment T8. 
The PCR products were cloned into pUniD/V5-His-TOPO (Invitrogen, Carlsbad, USA) 
using XhoI and SacI. HA fusions for expression in E. coli were created by Cre-mediated 
recombination of the pUni vectors with a HA-tag host vector, pHB-HA3. HA-tagged fusion 
proteins were produced in E. coli BL21/DE3 cells. An overlay assay with GST-TP0658 was 
done as described above. 
Epitope mapping by SPOT synthesis 
Cellulose membrane-bound peptides were prepared according to standard SPOT synthesis 
protocols (Rual et al. 2005) using an automated Spot synthesizer (MultiPep, Intavis, 
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Germany); Fmoc derivatives of amino-acids and further reagents for peptide synthesis were 
obtained from Novabiochem, Fluka, and Merck. The generated peptide arrays were 
synthesized on amino-PEG membranes (Intavis, Germany). After activation of the 
membrane with methanol the membrane-bound peptide arrays were blocked overnight at 4 
°C in blocking buffer (5% milk powder in PBS and 0.5% Tween) and then incubated with 
25nM purified GST fusion protein or 25nM GST control protein in overlay buffer (1% milk 
powder and 0.5% Tween in PBS) for 2h at RT. After washing three times with overlay 
buffer, the membranes were probed with an anti-GST antibody (G1160; Sigma-Aldrich, 
München, Germany). The membrane was washed three times with overlay buffer and the 
membrane was incubated for 1 h at RT with POD-labeled anti-mouse mAb (Sigma-Aldrich, 
München, Germany) in overlay buffer, followed by washing three times with washing buffer 
(0.5% Tween in PBS). Analysis and quantification of peptide-bound GST proteins were 
carried out using a chemoluminescence substrate (ECL, Amersham Biosciences, Freiburg, 
Germany). 
For mapping of the C-terminal interaction epitope of TP0658 on TP0868 (FlaB1) the C-
terminal amino-acid sequence of TP0868 starting from L231 was selected; this sequence was 
spotted as overlapping 15mer peptides with one amino-acid shifts from the beginning; the 
membrane was probed with GST-658 and GST as a control. 
An alanine scan was done for the TP0658-binding peptide (V229GLDIAAE 
NLQAAESRIRD247) of TP0868 (Treponema FliC). Each amino-acid position was 
systematically replaced by alanine. The peptides were probed with GST-658 and GST as a 
control. 
Deletion of yviF and cloning of rescue plasmid 
Deletion of yviF in B. subtilis was achieved by phleomycin-cassette integration as described by 
Fabret et al. (Fabret et al. 2002). Briefly, primer pairs yviF_p1/yviF_p2 and yviF_p3/yviF_p4 
were used to PCR-amplify the flanking regions of the yviF gene. Phleomycin-cassette DNA 
was mixed with both PCR products and subjected to a joining PCR reaction using primer 
pair yviF_p1/yviF_p4. B. subtilis 168 ∆upp competent cells were transformed and selected for 
phleomycin resistance. The presence of the phleomycin-cassette at the correct locus in the 
chromosome was checked by PCR. 
The vector pDG-yviF was created by ligation-independent cloning as described in Joseph et 
al. (Joseph et al. 2001). The pUni entry clone of yviF (pUniD-yviF) was recombined with 
Host vector pHB-HA3. The resulting HA-tagged yviF construct served as template for a 
PCR reaction with the primer pair pHB-HA3_pDGforward/ pHB-HA3_pDGreverse. The 
PCR product was, finally, cloned into the vector pDG148-Stu. This plasmid was used for 
rescue experiments of the ∆yviF strain described above. 
Swarming assay 
Swarming plates were prepared as LB plates with 0.25% agar. Bacteria were incubated 
overnight at 37°C in liquid culture and spotted onto the agar. Swarming plates were evaluated 
after incubating for 10h at 37°C. 
Test of yviF mutant for flagellin expression 
B.subtilis ∆upp (wild type for yviF cassette integration) cells and ∆yviF cells were transformed 
with empty expression vector, pDG148-Stu, or yviF rescue plasmid, pDG-yviF, and 
compared. For induction of yviF expression the bacterial cultures were incubated for 3h at 
37°C with 1mM IPTG. Cells were harvested and lyzed using standard procedures. Equal 
amounts of protein as judged by Coomassie staining of a SDS-PAGE gel were loaded. In a 
Western Blot the cell lysates were probed for the HA-tag (anti-HA antibody HA.11, Covance 
Research Products, CA, USA) and flagellin (using a GST-yviF overlay, see above). 
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Co-expression of TP0658 and TP0868 
TP0658 was PCR-amplified from its pUni clone (McKevitt et al. 2003), pUniD-TP0658, 
using the primer pair TP0658_pEGSTforward/TP0658_pEGSTreverse. The PCR product 
was cloned into pEGST (Kholod and Mustelin 2001) using BamHI and XhoI generating a 
GST fusion of TP0658. TP0868 was PCR-amplified from its pUni clone (McKevitt et al. 
2003) using the primer pair TP0868_pAC28forward/ TP0868_pAC28reverse. The PCR 
product was cloned into pAC28 (Kholod and Mustelin 2001) using BamHI and SacI 
generating a His-tag fusion of TP0868. E. coli BL21/DE3 cells (Novagen) were co-
transformed with both plasmids. After overnight incubation at 37°C –relying on the basal 
level expression of the promoters- the cells were lyzed, proteins separated by SDS-PAGE, 
blotted, and the blot probed for GST (antibody G1160, Sigma-Aldrich, München, Germany) 
or His (His probe H-15, Santa Cruz Biotechnology, CA, USA). 
 
2.5. Individual Gene II: YjjG – an in vivo house-cleaning nucleotidase 
Construction of pBad18HA &pBad24HA vectors 
For expression of HA-tagged proteins under the control of an L-arabinose promoter, the 
pBad24HA vector was constructed. By a DNA cassette mediated approach, a HA-tag 
(YPYDVPDY) was added to the HindIII site of pBad18 and pBad24 (Guzman et al. 1995). 
The HA-tag cassette was produced by annealing of oligo 1 (AG CT T TAC CCA TAC GAC 
GTC CCA GAC TAC GCT GGA TG) and oligo 2 (AGCTCATCCAGCGT 
AGTCTGGGACGTCGTA TGGGTAA). This strategy retains the HindIII site of both 
vectors (Fig. 13&Fig. 14). 
 
L  A  G  G  I  H  H  G  T  R  G  S  S  R  V  D  L  Q  A C  K  L  Y  P  Y  D  V
1       CTAGCAGGAGGAATTCACCATGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTTACCCATACGACGT   80
1       GATCGTCCTCCTTAAGTGGTACCATGGGCCCCTAGGAGATCTCAGCTGGACGTCCGTACGTTCGAAATGGGTATGCTGCA   80
EcoRI NcoI RsaI    BamHI      HinfI PstI SphI
StyI KpnI DpnI SalI HindIII
BanI SmaI XbaI AccI AluI              
AvaI TaqI                                 
NciI HincII
MspI                        
NciI
Sau3AI                  
P  D  Y  A  G *  A  
81      CCCAGACTACGCTGGATGAGCT   102
81      GGGTCTGATGCGACCTACTCGA   102
AatII
S.D. Kozak HA-Tag
FEATURES:
• based on pBAD24 (addition of HA tag @ HindIII site)
• pBad promoter
• Ampr
• pBR322 ori  
Fig. 13 Multiple cloning site and features of pBad24HA 
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HA-Tag
FEATURES:
• based on pBAD18 (addition of HA tag @ HindIII site)
• pBad promoter
• Ampr
• pBR322 ori
A  S  E  F  E  L  G  T  R  G  S  S  R  V  D  L  Q  A  C K  L  Y  P  Y  D  V  P
1       GCTAGCGAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTTACCCATACGACGTCCC   80
1       CGATCGCTTAAGCTCGAGCCATGGGCCCCTAGGAGATCTCAGCTGGACGTCCGTACGTTCGAAATGGGTATGCTGCAGGG   80
NheI EcoRI BanII SmaI XbaI SalI PstI SphI
Bsp1286I    BamHI         AccI HindIII
SacI KpnI HincII
BanI
AvaI
D  Y  A  G *  A  
81      AGACTACGCTGGATGAGCT   99
81      TCTGATGCGACCTACTCGA   99
 
Fig. 14 Multiple cloning site and features of pBad18HA 
Strains, Gene Cloning, and Protein Purification 
Single-gene knockout mutants of E. coli were taken from the KEIO Collection (Baba et al. 
2006) and tested for 5-fluoro-2’-deoxyuridine sensitivity. For further experiments, the gene 
inactivation cassette of the yjjG mutant was removed by Flp-recombinase-mediated 
recombination (Datsenko and Wanner 2000). 
For complementation of the phenotype, yjjG was amplified by PCR from genomic DNA (E. 
coli K-12 BW25113) and cloned into pBad24HA (pBad24 (Guzman et al. 1995) with an HA-
tag added at its C-terminus) using EcoRI and HindIII (forward primer: AATT GAATTC 
ACC ATGAAGTGGGACTGGATTTTC; reverse primer: AATT AAGCTT GTG TTT 
ACA CAG GAG CTG C). The resulting construct was named pBad24HA-yjjG. 
HDHD4, the closest human homolog of YjjG (see below), was PCR amplified from plasmid 
DNA (kindly provided by E. Van Schaftingen) (Maliekal et al. 2006) and cloned into 
pBad24HA using NcoI and HindIII (forward primer: AATTCACC ATG GGG CTG AGC 
CGC GTG C, reverse primer: AATT AAGCTT AGT GGA CAT ACT GAC TTT GC). 
The resulting construct was named pBad24HA-HDHD4. 
For protein expression and purification, yjjG was amplified by PCR from genomic DNA and 
cloned into pETM30 (EMBL-Heidelberg, Protein Expression Facility) using NcoI and 
HindIII (forward primer: AATTCACC ATG GCC AAGTGGG ACTGGATTTTC; reverse 
primer: AATT AAGCTT  TCA GTG TTT ACA CAG GAG CTG C). The recombinant 
GST fusion protein was expressed employing E. coli (BL21/DE3) and affinity-purified using 
glutathione-beads (Amersham Biosciences). 
Agar-plate based sensitivity screen 
The sensitivity of Escherichia coli single-gene deletion mutants (Baba et al. 2006) towards 5-
fluoro-2’-deoxyuridine was tested using an agar-plate based phenotyping assay. Selected gene 
mutants (Supplementary Table 21) were arrayed onto a 384-well plate. Saturated cultures of 
these mutants were inoculated in fresh LB growth medium and incubated for 1h. Cells were 
transferred to Omnitray plates (Nunc) with LB agar containing 0, 0.1, 0.5, and 1 µM 5-fluoro-
2’-deoxyuridine. Growth of mutant colonies was scored after overnight incubation. Liquid 
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handling and transfer of mutant cultures was done using a Biomek 2000 laboratory robot 
(Beckman-Coulter). 
Nucleotide Metabolism Sensitivity Tests 
For confirmation of the 5-fluoro-2’-deoxyuridine phenotype, ∆yjjG and the wild type 
(BW25113) were transformed with pBad24HA and pBad24HA-yjjG. As over-expression of 
YjjG was found to have a toxic effect, the following experiments relied on basal expression 
levels. Precultures were diluted to an OD600 of 0.01 with and without added 5-fluoro-2’-
deoxyuridine and the cell density was measured at OD600 in 1h-intervals (ELx808Biotek 
Instruments, Friedrichshall). The measurement was done in triplicates with 5-fluoro-2’-
deoxyuridine concentrations ranging from 0-1,000 µM. 
The sensitivity of ∆yjjG towards different types of nucleobase and nucleotide derivates was 
tested using untransformed strains. 
In vivo BrdU Incorporation 
The yjjG mutant strain and the wild type (E. coli K-12 BW25113) strain were tested directly as 
well as transformed with pBad24HA (vector control) and pBad24HA-yjjG (YjjG expression 
plasmid). The strains were inoculated in LB medium at an OD600 of 0.05; for transformed 
strains 0.2% L-arabinose was added to the medium. After 2h of incubation at 37°C, the 
cultures were checked for an equal OD600, and bromodeoxyuridine (BrdU) was added to the 
medium (10µM for untransformed strains and varying concentrations for the transformed 
strains). The cells were incubated for 2.5h at 37°C and total DNA was isolated using standard 
procedures. The DNA concentrations were adjusted to equal levels. The DNA was 
denatured by incubation with 0.5M NaOH for 20min at 42°C and 2µl were spotted onto a 
Hybond-N+ membrane (Amersham Biosciences). After drying the DNA was UV 
crosslinked (Stratalinker, Stratagene). BrdU incorporation was measured by usual Western 
Blot procedures with anti-BrdU-peroxidase (POD) (1:1000, Roche). Blocking, incubation and 
washing was done with 1% (w/v) BSA and 1% (w/v) milk powder in PBS. A 
chemiluminescence-based detection with ECL substrate (Amersham Biosciences) was used. 
In vitro Enzymatic Assay 
Nucleotidase activity towards thymidine monophosphate (dTMP) and 5-fluoro-2’-
deoxyuridine monophosphate (5-FdUMP) was measured in 400µl reaction buffer (50mM 
Tris/HCl, pH=7.5; 5mM MgCl2; 0.5mM MnCl2) with 0.25µg purified GST-YjjG and 
substrates at concentrations of 0-1,500 µM. After 20-30 min at 37°C the reaction was 
terminated and the free Pi concentration measured using 100µl Malachite reagent (Baykov et 
al. 1988). One unit of activity is defined as 1 µmol Pi/min. 
 
RESULTS 
3. Results 
3.1. Overview 
The following part is split into two major subdivisions: “Transcriptional Activators of Yeast” 
and the “Protein-Interaction Map of T. pallidum”. The first section deals with a more 
extended characterization of the properties of the Y2H-system used in this study, and 
exemplifies, how biological knowledge can be gained by an in detail analysis of Y2H high-
throughput datasets. The second section, the “Interaction Map of T. pallidum” presents the 
main topic of this thesis: the complete protein-interaction map of T. pallidum is generated, 
analyzed, and an in detail functional characterization based on these protein interactions is 
shown. 
 
3.2. Transcriptional Activators of Yeast 
Results of this section were published in the paper 
“Transcriptional activators in yeast” in Nucleic Acids 
Research (Titz et al. 2006b). 
Transcriptional activators are composed of at least two domains, a DNA-binding domain 
and an activation domain. Whereas the properties of several DNA-binding domains are well 
understood and patterns for these domains can easily be identified on the primary structure 
level, only rough ideas about the requirements of transcriptional activation domains exist (see 
introduction). 
In Y2H studies a subset of bait fusion proteins, Gal4-DBD fusion proteins, activate 
transcription of a reporter gene without requirement of a prey protein. These proteins are 
called “auto-activators” (or activators for short) and thereby possess properties of an 
activation domain.  
These activators are commonly identified in the course of large-scale Y2H studies, because 
high self-activation levels of proteins prevent their screening in the Y2H assay. Thus, 
genome-wide two-hybrid screens provide data about activation properties of nearly all 
proteins of a genome. Of special interest in this respect are Y2H screens of yeast proteins as 
the proteins are tested in their natural species context. Still, by design such screens do not 
necessarily identify physiological activators as the fusion partners are artificially targeted to 
the promoter of a single, arbitrarily selected reporter gene. 
Here, Y2H auto-activators from two large-scale screens are selected, their activation strength 
is measured, and their properties are analyzed in detail. 
Y2H Activators and their Activation Strength 
Datasets on self-activation properties of bait constructs from two large-scale Y2H studies of 
yeast proteins were taken as the basis. These consisted of about 450 Y2H activators which 
were not listed in the original publications and provided by P. Uetz and T. Ito 
(Supplementary Table 1) (Uetz et al. 2000; Ito et al. 2001). The activation strength of the 
activators was measured using two different reporter genes, whose expression depends on 
their level of transcription: His3 and beta-galactosidase (bGal assay) (Fig. 15, Supplementary 
Table 1). According to the activation strength in the LTH assay the activators were grouped 
into weak (3-25 mM 3-AT), medium (50-200 mM 3-AT) and strong (>200 mM 3-AT) 
activators. These groups were termed LTHw, LTHm and LTHs, respectively. The bGal assay 
distribution was divided into strong activators (bGalS) which activate above the median and 
weak activators that activate below the median (bGalW). 
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protein set description 
all yeast all yeast proteins 
non acts all yeast proteins not in the activator list 
TR known transcriptional activators (GO slim term “transcription 
activator activity”) 
all acts all Y2H activators 
nucleus nuclear proteins (Huh et al.) 
acts nucleus Y2H activators localized to the nucleus 
LTHw, LTHm, LTHs Weak (LTHw), medium (LTHm), and strong (LTHs) activators in 
LTH assay 
TR+1, nucleus+1, acts 
nucleus+1 
Protein sets as indicated above but including bridging proteins in 
the analysis of binary protein interactions. 
Table 8 Definition of datasets for analysis of activators. 
A comparison of activation strength in both assays revealed an intermediate (Pearson’s 
correlation coefficient of 0.58) but highly significant correlation (p<2.2e-16) of activation 
values (Fig. 15 B). Although the Gal1 promoter drives both reporters, the lacZ reporter is 
actually present in two copies with two different promoters (a GAL7 promoter in PJ69-4a 
and a GAL1 promoter in YULH). It was not tried to determine the contribution of each of 
the two lacZ genes and the following analysis is restricted to the His3 data. 
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Fig. 15 Activation strength in Y2H activators. (a) Number of activators showing the 
indicated activation strength in the LTH assay. They were divided into weak (LTHw), 
medium (LTHm) and strong (LTHs) activators as indicated. (b) Correlation of activation 
strength in LTH and bGal assays. The actually measured values are shown as dots, the 
median and two quartiles by an overlayed boxplot. Dotted lines indicate the median of 
bGal activity and LTH activity, respectively. See Table 8 for an explanation of data sets. 
Figures published in the paper “Transcriptional activators in yeast” in Nucleic Acids 
Research (Titz et al. 2006b). 
In summary, 72 weak, 179 medium, and 75 strong transcriptional activators were identified in 
these experiments (Supplementary Table 1). 
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Function, Localization, and Abundance of Activators 
Previous studies have identified several unspecific properties of proteins that lead to 
transcriptional activation, e.g. acidic stretches or glutamine-rich regions (Sadowski et al. 1988; 
Courey et al. 1989; Kunzler et al. 1994). On the other hand, known transcriptional regulators 
seem to be transcription activators also under Y2H settings. Therefore, the annotated 
function, localization and abundance of Y2H activators were analyzed. 
First, over-represented GO terms in the set of Y2H activators were assessed with the 
FuncAssociate program (Berriz et al. 2003). This indicated a clear over-representation of GO 
terms associated with a role in transcription and localization in the nucleus. Interestingly, the 
highest-ranking GO attribute was “transcription regulator activity” (GO 0030528) with 92 
occurrences among the 451 activators (Table 9).  
 
Rank N X LOD P P-adj GO Attribute 
1 92 319 0.816 5.7e-35 <0.001 0030528: transcription regulator 
activity 
2 105 461 0.684 3.4e-30 <0.001 0006350: transcription 
3 95 429 0.657 3.5e-26 <0.001 0006351: transcription, DNA-
dependent 
4 72 265 0.759 1.9e-25 <0.001 0006366: transcription from Pol II 
promoter 
5 47 123 0.959 8.9e-24 <0.001 0003702: RNA polymerase II 
transcription factor activity 
6 233 1940 0.430 1.9e-23 <0.001 0005634: nucleus 
7 83 426 0.573 5.4e-19 <0.001 0050789: regulation of biological 
process/regulation 
8 29 62 1.095 6e-18 <0.001 0016251: general RNA polymerase II 
transcription factor activity 
9 87 516 0.494 9.3e-16 <0.001 0007049: cell cycle/cell-division 
cycle 
10 60 283 0.602 1.4e-15 <0.001 0005654: nucleoplasm 
Table 9 Functional groups among Y2H activators. GO terms in the set of Y2H 
activators were compared to the whole yeast genome using the program FuncAssociate 
(Berriz et al. 2003). GO terms are ranked according to the significance of their 
overrepresentation in this dataset. See http://llama.med.harvard.edu/ 
cgi/func/funcassociate for technical details. Rank = position in the attribute list ranked 
by significance of association, N= number of genes in your query with this attribute, X = 
number of genes overall with this attribute, LOD = the natural log of the odds ratio; 
positive and negative values indicate over- and under representation, respectively, P = 
single hypothesis one-sided P-value of the association between attribute and query (based 
on Fisher's Exact Test), P-adj = adjusted P-value: fraction (as a %) of 1000 null-
hypothesis simulations having attributes with this single-hypothesis P value or smaller. 
Transcription activity was significantly correlated with activation strength: 27% of all strong 
activators are annotated to have “transcription regulatory activity” (Fig. 16 A) whereas this 
annotation drops to 21% and 7% of the medium and weak activators, respectively. These 
numbers are significantly higher than for the Y2H non-activators (~ 3%). As an additional 
reference set, we selected 138 proteins annotated to possess “transcriptional activator 
activity” in the YPD database. Only 55 (or 12%) of the Y2H activators were annotated as 
transcriptional activators in YPD. This annotation correlated with the activational strength: 
19% of strong, 16% of medium, and 4% of weak activators were annotated with this term. 
This suggests that many more proteins may act as transcriptional activators than currently 
known. 
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The intracellular localization of activators was analyzed using the large-scale localization study 
by Huh et al. (Huh et al. 2003). Compared to 22% of nuclear localized non-activators, 
nuclear proteins were highly over-represented in the activator set (41%) (Fig. 16 B). The 
activation strength correlated with nuclear localization, for example, the percentage of 
nuclear localization increased by 12% when the weak LTH activators were compared with 
the strong ones. The percentage of strong activators in the nucleus was lower than the value 
of 67% found for known transcriptional activators (GO annotation “transcription regulator 
activity”). However, even when the known transcription regulators were excluded from the 
analysis, nuclear proteins were still over-represented in the activator set (33% vs. 20%) (not 
shown in figure). As certain properties of proteins, e.g. the isoelectric point depend on the 
localization, the protein sets of nuclear localized activators and the nuclear non-activators was 
commonly included as references in further analyses. 
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Fig. 16 Function, localization and abundance of yeast activators. (a) Percentage of 
proteins annotated to have „transcriptional regulator activity“ (GO term, see also 
Supplementary Table 1). (b) Percentage of protein localized to the nucleus as analyzed by 
Huh et al. 2003. (c) Abundance of proteins as analyzed by Ghaemmaghami et al. 2003. 
(d) The percentage of proteins annotated as transcriptional regulators (F-GO term 
„transcription regulator activity) in different cellular compartments is compared. These 
sets are: non activators (non) and activators (act) localized only to the nucleus (nucleus), 
only to the cytoplasm (cytop.) or to both the nucleus and the cytoplasm (N/C). Figures 
published as “Transcriptional activators in yeast” in Nucleic Acids Research (Titz et al. 
2006b). 
Combining GO function and localization revealed a significant overrepresentation of known 
transcriptional regulators in the sets of activators in the nucleus as well as in the set of nuclear 
and cytoplasmatic localized proteins, but not in the set of only cytoplasmaticaly-localized 
proteins (Fig. 16 D). Strikingly, 47% of nuclear Y2H activators were known transcriptional 
regulators. This number points to the fact that an overwhelming fraction of these activators 
carries the biological function of transcriptional regulation. As a large fraction of activator 
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proteins have no assigned function (~35%) this finding can be used for functional annotation 
of these proteins (see below). 
Ghaemmaghami et al. (Ghaemmaghami et al. 2003) measured the protein abundance in yeast 
at a genome-wide scale. A comparison of protein copy numbers revealed a significant lower 
concentration of activators (Fig. 16 C). Interestingly, known transcription regulators were 
also expressed at lower levels, once more, indicating similar properties of known 
transcriptional regulators and Y2H activators. 
Taken together, yeast-two-hybrid activators tend to be proteins with a described function in 
transcription, a nuclear localization, and less abundance. Interestingly, similar trends are 
observed for known transcription regulators. 
Physicochemical Properties of Y2H Activators 
Although characteristics such as abundance and localization allow us to classify activators, 
they do not explain their behavior. In fact, it has been unclear which properties turn a protein 
into a transcriptional activator even though certain physicochemical properties such as acidic 
stretches have been identified (Sadowski et al. 1988). We therefore revisited the influence of 
physicochemical properties on the propensity of a protein to activate transcription. 
Well defined general properties were analyzed first (Fig. 17). These were the isoelectric point 
(Fig. 17 A), molecular mass (Fig. 17 B), overall hydrophobicity (GRAVY score) (Fig. 17 C), 
and aromaticity (Fig. 17 D). The most pronounced effect was found for the isoelectic point: 
the mean pI for activators was ~1.5 pH units below the value for non activators. This effect 
was also observed for activators in the nucleus, although with ~0.5 pH units the difference 
between nuclear localized activators and nuclear proteins in general was lower. Interestingly, 
known transcriptional regulators had only a slightly reduced mean pI, which was even higher 
than for nuclear proteins in general. The influence of activation strength onto the mean pI 
was not significant (judged by Student’s t-test). 
The mean molecular weight of activators was ~9 kDa higher than for non-activators. This 
tendency is also reflected by the higher mean molecular weight of known transcriptional 
regulators. Activators in the nucleus showed a slightly higher mean molecular weight 
compared to nuclear localized proteins and the mean molecular weight increased with 
activation strength. 
The overall hydrophobicity (GRAVY score) and the aromaticity showed the same pattern. 
Both properties were reduced in activators as well as in known transcriptional regulators. The 
effect was much smaller but at least for the GRAVY score highly significant (Student’s t-test 
p=2.4e-5) for nuclear localized proteins and activators. 
In addition, the codon adaptation index (CAI) was analyzed. As lower codon scores are 
associated with lower protein expression levels (Ghaemmaghami et al. 2003), the lower CAI 
for activators as well as for known transcriptional regulators underlines the previous finding 
of lower protein levels for these two protein sets (Fig. 17 E).  
Interestingly, known transcriptional regulators showed the same tendency for all properties 
except for the isoelectric point. 
For a further refinement, we analyzed more specific physicochemical properties. These 
included the overrepresentation of certain amino-acids or amino-acid classes, the occurrence 
of stretches of charged, acidic and basic residues and clusters of certain amino-acids. As 
many of these properties are highly influenced by the localization, we only took activators in 
the nucleus into account and compared them to the remaining nuclear proteins. After 
correction for multiple testing using Holm’s procedure (Holm 1979), 15 parameters remained 
highly significant. These included the minimum pI in a 20 aa window, the overall percentage 
of several amino-acids (Ala, Gly, Ser, Val, Lys, Asn, Gln) and amino-acid clusters (Ser, Asp, 
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Pro, Asn, Gln). An in detail analysis of the amino-acid clusters and the minimum pI is shown 
in Fig. 17. 
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Fig. 17 Physicochemical properties of activators. Mean and SEM of physicochemical 
properties is shown for several protein sets. (a) isoelectric point (pI), (b) molecular mass 
(Mr), (c) GRAVY score (overall hydrophobicity), (d) aromaticity and (e) codon 
adaptation index (CAI). (f,g,h,i,j) amino-acid clusters indicating the maximum number of 
the respective amino-acid in a window of 20 amino-acids of the protein. (k) Minimum 
isoelectric point (pI) of a protein in 20 amino-acids window. Figures published in the 
paper “Transcriptional activators in yeast” in Nucleic 
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Taken together, the analysis of physicochemical properties showed that activators tend to 
possess a lower isoelectric point, have a lower hydrophobicity, higher molecular weight, 
lower codon adaptation index and show specific properties like enrichment of asparagine 
clusters. 
Protein Domains 
Transcriptional activation domains are still not well defined structurally. This is also reflected 
in specialized domain databases such as SMART (Letunic et al. 2004) or Interpro (Mulder et 
al. 2005) which have hardly any defined entries for transcriptional activation domains. 
Therefore, we have analyzed the Y2H activators for enrichment of known domains. As 
expected, certain DNA-binding domains such as helix-loop-helix motifs or zinc fingers are 
indeed significantly overrepresented among the activators (Table 10). 
Certain domains are also significantly underrepresented such as the AAA domain. However, 
these domains are not considered here. 
 
 
Domain Description # enrich-
ment 
significance 
level 
HLH helix loop helix domain 6 6,64 ** 
ZnF_C2C2 C2C2 Zinc finger 4 8,85 ** 
GAL4 
GAL4-like Zn(II)2Cys6 (or C6 zinc) binuclear 
cluster DNA-binding domain 16 2,53 
* 
RPOL9 RNA polymerase subunit 9 3 8,85 * 
ZnF_C2H2 zinc finger 13 2,30 * 
ZnF_C2HC zinc finger 5 4,02 * 
IBR In Between Ring fingers 2 8,85 * 
BRLZ basic region leucine zipper 5 2,95 * 
ArfGap 
Putative GTP-ase activating proteins for the 
small GTPase, ARF 3 4,43 
* 
PP2C_SIG Sigma factor PP2C-like phosphatases 3 4,43 * 
STYKc Protein kinase; unclassified specificity. 10 2,06 * 
CNH 
Domain found in NIK1-like kinases, mouse citron 
and yeast ROM1, ROM2 2 5,90 
* 
Cu_FIST Copper-Fist 2 5,90 * 
S_TK_X Extension to Ser/Thr-type protein kinases 4 2,95 * 
PP2Ac 
Protein phosphatase 2A homologues, catalytic 
domain. 4 2,95 
* 
Table 10 Domains of Y2H activators. Domains over-represented in the Y2H activator 
set ranked by their significance are shown. The number of Y2H activators containing the 
domain (#) and enrichment of this domain in the set of Y2H activators compared to the 
whole genome are shown. The significance level indicates significant over-representation 
using Fisher’s exact test only (P<0.05, *) or also after correction for multiple testing 
using Holm’s procedure (P<0.05, **). 
Specific Transcriptional Activation by Interaction with the Transcription Machinery 
Specific transcription activation is mediated by physical contact with the transcriptional 
machinery or other factors necessary for transcription, like chromatin remodeling proteins 
(Stringer et al. 1990; Ingles et al. 1991; Goodrich et al. 1993; Ptashne and Gann 1997; Koh et 
al. 1998; Neely et al. 1999).  
Activators form a tightly connected protein interaction network (Fig. 18 A). Therefore, we 
identified proteins with direct physical contact to the transcription machinery employing the 
MIPS (Mewes et al. 2004) physical protein-protein interaction dataset (Fig. 18 B). 
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ORF % % 
ratio 
Definition Description P Padj 
YDL140C 17,7 3,8 RNA polymerase II 
core subunit 
RNA polymerase II large subunit 4,95E-09 1,02E-05 
YOL086C 17,7 2,9 alcohol dehydrogenase Adh protein catalyzes activities for the 
production of certain carboxylate esters. 
1,29E-06 2,63E-03 
YGL112C 16,0 4,5 TATA-binding protein-
associated-factor 
Subunit (60 kDa) of TFIID and SAGA 
complexes, involved in transcription initiation 
of RNA polymerase II and in chromatin 
modification, similar to histone H4 
1,53E-09 3,17E-06 
YBR081C 15,5 4,7 histone 
acetyltransferase SAGA 
complex 
member|transcription 
factor 
Subunit of the SAGA transcriptional 
regulatory complex, involved in proper 
assembly of the complex; also present as a C-
terminally truncated form in the 
SLIK/SALSA transcriptional regulatory 
complex 
1,75E-09 3,61E-06 
YML007W 14,4 8,0 jun-like transcription 
factor 
bZip transcription factor required for 
oxidative stress tolerance and localized to the 
nucleus in response to the presence of 
oxidants. 
2,52E-12 5,22E-09 
YGR252W 14,4 6,5 histone 
acetyltransferase 
functions in the Ada and SAGA (Spt/Ada) 
complexes to acetylate nucleosomal histones 
4,63E-11 9,60E-08 
YDR448W 13,8 6,1 transcription factor transcription factor, member of ADA and 
SAGA, two transcriptional adaptor/HAT 
(histone acetyltransferase)complexes 
3,36E-10 6,95E-07 
YNL236W 13,8 5,7 RNA polymerase II 
holoenzyme/mediator 
subunit 
involved in positive and negative regulation of 
transcription, possibly via changes in 
chromatin structure; regulation of YGP1 
expression 
8,88E-10 1,84E-06 
YOR174W 13,8 3,4 RNA polymerase II 
holoenzyme/mediator 
subunit 
Member of RNA Polymerase II 
transcriptional regulation mediator 
1,72E-06 3,51E-03 
YHR174W 10,5 3,9 enolase Enolase II, catalyzes the first common step of 
glycolysis and gluconeogenesis; expression is 
induced in response to glucose 
6,61E-06 1,35E-02 
YHR147C 9,4 8,0  Mitochondrial ribosomal protein of the large 
subunit 
2,11E-08 4,36E-05 
YNL025C 9,4 4,0 C-type 
cyclin|associates with 
the Ssn3p cyclin-
dependent kinase 
Component of RNA polymerase II 
holoenzyme, involved in RNA pol II carboxy-
terminal domain phosphorylation. Activity of 
the kinase (SSN3)/cyclin (SSN8) pair required, 
along with SSN6 & TUP1, for transcriptional 
repression of a-specific genes 
1,84E-05 3,73E-02 
YBR198C 8,8 4,3  Subunit (90 kDa) of TFIID and SAGA 
complexes, involved in RNA polymerase II 
transcription initiation and in chromatin 
modification 
1,53E-05 3,12E-02 
YKL060C 8,8 4,3 aldolase Fructose 1,6-bisphosphate adolase, required 
for glycolysis and gluconeogenesis 
1,53E-05 3,12E-02 
YGL025C 8,3 9,6  Probable transcription factor, polyglutamine 
domain protein 
3,43E-08 7,09E-05 
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YBR253W 8,3 9,6 part of Srb/Mediator 
complex|transcription 
factor 
involved in transcription as part of 
Srb/Mediator complex 
3,43E-08 7,09E-05 
YHR058C 8,3 9,6  RNA polymerase II transcriptional regulation 
mediator 
3,43E-08 7,09E-05 
YER022W 8,3 9,6 RNA polymerase II 
holoenzyme/mediator 
subunit 
subunit of RNA polymerase II 
holoenzyme/mediator complex 
3,43E-08 7,09E-05 
YPL042C 8,3 8,8 cyclin (SSN8)-
dependent 
serine/threonine 
protein kinase 
Component of RNA polymerase II 
holoenzyme, involved in RNA pol II carboxy-
terminal domain phosphorylation. Activity of 
the kinase (SSN3)/cyclin (SSN8) pair required, 
along with SSN6 & TUP1, for transcriptional 
repression of a-specific genes 
6,89E-08 1,42E-04 
YCR081W 8,3 8,8  activation mediator subcomplex of RNA 
polymerase I holoenzyme 
6,89E-08 1,42E-04 
Table 11 Proteins co-occurring in protein complexes with nuclear activators. 
Proteins significantly overrepresented in protein complexes with nuclear Y2H activators 
(N=181) are shown. The list is sorted by the percentage of nuclear Y2H activators found 
to be in at least one protein complex with the respective ORF. For example, the large 
subunit of RNA polymerase II, YDL140C, was found in a complex with 17.7% of all 
nuclear Y2H activators. The percent % ratio is the previous percentage divided by the 
percentage of nuclear non-activators (in other words: the % ratio is the enrichment 
compared to nuclear non-activators). A significant co-occurrence was assessed using 
Fisher’s exact test comparing the set of nuclear Y2H activators with nuclear non-
activators (P). The P value was adjusted (Padj) for multiple testing using Holm’s 
procedure (Holm 1979). Only the top 20 significance list ranked by percentage is shown. 
Significantly more nuclear Y2H activators (~36%) interacted with components of the 
transcription machinery compared to other nuclear proteins (~23%). The same is true for 
known transcription activators, which show an even higher fraction of proteins interacting 
with the transcription machinery (~46%). Considering bridging proteins (looking for 
transcription proteins that can be reached over two protein-interaction edges), even increases 
the number of interacting transcription proteins to ~57% (nuclear activators) and ~64% 
(transcription regulators), respectively. The activation strength showed no effect on the 
number of proteins interacting with the transcription machinery. However, one needs to 
point out that the overall false negative rate of protein-protein interactions is still quite high. 
Therefore, it cannot be excluded that many explanatory protein links are still missing. In 
addition, one needs to take into account that the MIPS dataset is biased towards well 
characterized proteins probably leading to an overrepresentation of known links between 
described transcriptional regulators and the transcription machinery. 
To analyze a less biased dataset, we considered the interactions found in large scale MS 
studies (Gavin et al. 2002; Ho et al. 2002; Mewes et al. 2004). For each protein set, we 
checked how many proteins interacted with a protein complex involved in transcription (at 
least 50% proteins annotated as transcription) (Fig. 18 C). 19% of nuclear activators 
interacted with transcription complexes compared to 8% of nuclear proteins. An even higher 
fraction (27%) if known transcriptional regulators interacted with complexes involved in 
transcription. Strikingly, activators in the nucleus that were not annotated as transcriptional 
regulators showed a significant higher number of interactions with the transcription 
machinery compared to other nuclear non transcriptional regulator proteins. This might 
indicate that many of these proteins are also biological relevant transcriptional regulators (see 
below). Once more, the high false negative rate of interaction studies is, most probably, the 
reason for the overall low percentages. Assuming that all known transcriptional regulators 
should interact with the transcription machinery gives a false negative rate of 73%. Applying 
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this rate to the interactions of nuclear activators, we would expect that ~70% of them could 
interact with the transcription machinery. 
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Fig. 18 Interactions of transcription activators. (a) This protein interaction network 
shows the activators (red) and the proteins interacting with at least two activators. 
Proteins involved in transcription are indicated by a diamond shape and the activation 
strength (bGal and LTH combined) is reflected by the node size. (b) For indicated 
protein sets (table 1) the percentage of proteins interacting with a protein involved in 
transcription (P-GO term „transcription“) is shown. Physical, binary protein interaction 
data from the MIPS database (Mewes et al. 2004) was used. Direct interactions or 
interactions involving a bridging protein (indicated by „+1“ interaction) were taken into 
account. (c) Percentage of proteins from a given protein set (table 1) interacting with a 
protein complex involved in transcription is shown. Only high-throughput derived 
protein complex data from the MIPS database (Mewes et al. 2004) was considered. 
Figures published in the paper “Transcriptional activators in yeast” in Nucleic Acids 
Research (Titz et al. 2006b). 
To reveal the nature of proteins interacting with transcriptional activators we ranked each 
interacting protein according to the number of interacting proteins in the query set. Proteins 
showing the highest number of interactions with nuclear transcription activators are shown 
in Table 11. This analysis reveals that a high percentage of activators, as well as known 
transcriptional regulators interact with components required for transcription. These were 
components of the RNA-Polymerase II holoenzyme and proteins involved in chromosome 
remodeling, like the SAGA complex. In contrast, nuclear proteins in general do not show 
this clear tendency whereas even 19% of the nuclear activators not known to be 
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transcriptional regulators interacted with RNA polymerase II. Interestingly, both nuclear 
activators and transcription regulators interacted with the metabolic enzyme alcohol 
dehydrogenase. With 17.7% and 19%, respectively, the fractions were much higher than in 
the set of nuclear proteins (~10%, not shown). However, the relevance of the interactions 
needs to be further evaluated. 
All in all, activators and known transcriptional regulators tend to specifically interact with 
components of the transcription machinery. 
 
Y2H Activators as Genuine Transcriptional Regulators 
Many of the Y2H activators described here may be bona fide transcriptional regulators even 
if they have not been annotated as such. We therefore may have identified Y2H activators of 
yet unknown function given their ability to activate transcription efficiently, their nuclear 
localization, and their protein-interaction pattern with other components of the transcription 
machinery. The following Y2H activators of yet unknown function are predicted to be 
physiological activators. 
YFL049W, a protein with no assigned function, was co–purified with Rtt102p, Snf2p, and 
Snf5p indicating that it is a real Swi/Snf component (Defeu Soufo and Graumann 2005). The 
yeast SWI/SNF complex is required for transcription of several yeast genes and has been 
shown to alter nucleosome structure in an ATP-dependent reaction. Transcription 
stimulation by SWI/SNF requires an activation domain with which it directly interacts. 
Strikingly, the acidic activation domains of VP16, Gcn4, Swi5, and Hap4 interacted directly 
with the purified SWI/SNF complex and with the SWI/SNF complex in whole-cell extracts 
(Neely et al. 1999). A physical interaction of YFL049W with the SWI/SNF complex together 
with the strong transcription activation properties (strong Y2H activator) strongly supports 
the possible transcription stimulation function involving the SWI/SNF complex. 
YJR070C is both localized to the nucleus and the cytoplasm. Nucleic acid binding proteins 
are overrepresented in its set of genetic and physical interaction partners. As it is known to 
bind eIF5 (Krogan et al. 2006) it might have regulatory functions involving translation in the 
cytoplasm and transcription in the nucleus. 
YDR520C, also localized to the cytoplasm and the nucleus, was shown to bind a zinc finger-
containing transcriptional repressor, Dal80 (Ito et al. 2001), suggesting the interesting 
hypothesis that Dal80 is repressing the activator properties of YDR520C. 
YGL066W/SGF73, a protein with unknown molecular function, was identified as a novel 
subunit of the SAGA (Spt/Ada/Gcn5 acetylase) multisubunit complex (Sanders et al. 2002). 
Ataxin-7 is the human ortholog of the yeast SAGA SGF73 subunit and is a bona fide subunit 
of the human TFTC-like transcriptional complexes (TATA-binding protein-free TAF-
containing complex) (Helmlinger et al. 2004). The physical association of YGL0066W with 
the TFTC transcription complex and its activation properties supports a role in 
transcriptional regulation function.  
A profiles/patterns analysis of YKR064W revealed the presence of a Zn[2]-Cys[6] fungal-
type binuclear cluster domain in the N-terminal region. This domain binds to DNA and is 
also found in ArgR2p, a component of the ARGR transcription regulatory complex 
(ArgR1p, ArgR2p, ArgR3p, Mcm1p) (This domain already leads to the annotation as 
transcription factor in the YPD database) (Amar et al. 2000). A search in the eMOTIF 
database (Huang and Brutlag 2001) reveals a “fungal transcriptional regulatory protein” motif 
(the eMotif search tool is also available in SGD). Together with the strong transcriptional 
activation properties of YKR064W, this finding indicates a true transcriptional regulation and 
activator function of YKR064W relying on its DNA-binding as well as its activation domain, 
probably involving the ARGR transcription regulatory complex. 
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YCR082w (= Ahc2) is a protein localized in the nucleus as well as in the cytoplasm without 
known function. It was identified as a strong activator in this study and is known to interact 
with chromatin reorganization components like a histone acetyltransferase complex (Ahc1) 
(Uetz et al. 2000) and Abf1, a DNA binding protein involved in chromatin-reorganisation 
(Venditti et al. 1994). In addition, YCR082w interacts with a transcription factor, Srb4, a 
subunit of the RNA polymerase II mediator complex (Ito et al. 2001). 
 
 
ORF Name LTH  
Class 
Biological 
Process (GO) 
Localization Interaction 
with 
transcription 
machinery 
Additional 
evidence 
YFL049W YFL049W Medium unknown Nucleus Yes Yes 
YJR070C YJR070C Medium unknown  Cytoplasm, 
Nucleus  
No Yes 
YDR520C YDR520C Strong unknown Cytoplasm, 
Nucleus 
Yes Yes 
YGL066W  SGF73 Medium Protein 
modification 
Nucleus Yes No 
YKR064W YKR064W Medium unknown Cytoplasm, 
Nucleus 
No Yes 
YCR082W YCR082W Medium unknown Cytoplasm, 
Nucleus 
Yes No 
Table 12 Potential physiological transcription activators. 
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3.3. The Protein-Interaction Map of Treponema pallidum 
This section contains the main topic of this thesis, the analysis of the whole T. pallidum 
protein-interaction network. For this, almost all possible pair-wise combinations of proteins 
of the proteome of T. pallidum are tested for a protein interaction. This map reveals biological 
insights on different levels ranging from topological properties, over functional 
classes/complexes, to individual proteins. Finally, detailed studies shed light on the molecular 
function of two proteins. 
Protein Interactions of Bacteria 
Several large-scale protein-interaction studies have been conducted mainly for eukaryotes (see 
introduction), but bacteria only recently became a focus for the comprehensive analysis of 
protein-protein interactions. To assess the number and characteristics of known bacterial 
protein-protein interactions, the BIND database (Bader et al. 2001) was employed. BIND is a 
comprehensive source for known protein-protein interactions: curators of BIND enter data 
from low throughput studies, all major high throughput studies are incorporated, and data 
from other interaction databases such as DIP (Salwinski et al. 2004) is imported. 
In August 2006, the BIND database contained ~11,000 records for bacterial proteins 
representing 8066 non-redundant interactions (Table 13). 
An overview of the used methods, the analyzed proteins, and the species in the BIND 
database is shown in Table 14. Most of the interactions stored in the BIND database are 
based on the determination of the three-dimensional structure of a co-crystal. The method 
ranking second is the yeast-two-hybrid system, but this number is mainly based on a single 
large-scale study conducted by Rain et al (Rain et al. 2001). The top ranking protein is VirB10, 
a component of the type-IV-secretion system, which was focus of recent protein-interaction 
studies. Escherichia coli, the bacterial model organism, is still on the top rank, but due to one 
large-scale study H. pylori is already found on the second position. Please note that co-affinity-
purification/mass spectrometry (coAP/MS) studies are not considered. 
 
 
 Bacteria E. coli B. subtilis H. pylori 
# non redundant 
interactions 
8066 1637 226 1479 
Homodimers 1262 392 55 68 
# distinct proteins 8014 1991 299 761 
LTP 178 121 2 - 
Y2H 1747 52 - 1456 
m
et
ho
ds
1 
3D prediction 5625 1477 209 21 
Table 13 BIND Database - known protein-interactions for bacteria. LTP identifies 
interactions found by classical small-scale (low-throughput, less than 40 interaction per 
paper) experiments, Y2H the number of yeast-two-hybrid interactions, and „3D 
prediction“ denotes interactions derived from three-dimensional structures of proteins. 
The dataset was downloaded in August 2006. 1Note: The sum over all methods and the 
total number of non redundant interactions is not comparable due to redundancy and 
missing values in used methods. 
To identify tightly connected clusters in the set of known bacterial interactions, the MCODE 
algorithm was employed (Bader and Hogue 2003): 127 protein complexes were identified. 
These complexes include the well-characterized DNA polymerase and the ribosome, the 
RNA polymerase, and metabolic enzyme complexes like histidine decarboxylase. 
However, the most striking point is the low number of protein-interactions derived from 
small-scale studies in the BIND database (178 interactions). Only a small fraction of the 
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original literature on protein-interactions in bacteria is included. Thus, a comparison of the 
interactions presented in this study with published protein-interactions needs to wait for a 
more comprehensive protein-interaction dataset. However, manual curation of bacterial 
protein interactions is in process now. 
 
Proteins Methods Species 
# name (gi) #  #  
65 VirB10 
28262059 
5625 three-dimensional-
structure 
1637 Escherichia coli 
55 HP1409 
15645054 
1747 two-hybrid-test 1479 Helicobacter pylori 
51 HP0336 
15644964 
56 other 436 Thermus 
thermophilus 
46 flgB 
15646166 
47 affinity-
chromatography 
227 Thermotoga 
maritima 
43 HP0849 
15645468 
16 gel-retardation-assays 226 Bacillus subtilis 
33 HP0879 
15645498 
12 gel-filtration-
chromatography 
207 Mycobacterium 
tuberculosis 
32 rpoB 
15645812 
11 immunoprecipitation 154 Haemophilus 
influenzae 
30 Photosynthetic 
Reaction Center 
Protein H Chain 
46447 
11 cross-linking 144 Pseudomonas 
aeruginosa 
28 HP1259 
15645873 
8 far-western 125 Salmonella 
typhimurium 
27 VirD4 
28262057 
5 elisa 116 Rickettsia sibirica 
Table 14 Top 10 lists for known bacterial interactions from the BIND database 
Setup of the Y2H Procedure 
The analysis of the T. pallidum protein-interaction network relied on an array-based Y2H 
system. All ORFs of the genome need to be cloned, preferentially, into a versatile vector 
system. The set of cloned ORFs is the so-called ORFeome. Baits (DNA-binding domain 
fusions) and preys (activation domain fusions) of these ORFs are prepared, transformed into 
yeast cells, and all bait/prey combinations are systematically tested for a protein interaction. 
Bait Strain Construction 
The baits were cloned by Cre-recombinase mediated recombination of the Treponema pallidum 
ORFeome into the selected bait vector.  
Bait vector selection is a crucial issue in Y2H studies as slight modifications of the vector can 
lead to differences in the obtained results. For example, for construction of the pAS2.1 
vector, Clontech (USA) removed the HA-tag of pAS2 and exchanged a single glutamine to 
valine. These slight modifications eliminated the autonomous activation activity of pAS2 
(assayed in Y187 strain using the lacZ reporter).  
As no experience with bait vectors for the employed Cre-mediated cloning system (UPS) was 
at hand in our lab, two possible bait vectors were compared before starting large-scale 
cloning: the pAS1-loxP vector, which is based on pAS2.1 (Clontech) (vector “pAS1”) and the 
pLP-GBK-Amp vector (vector “pGBK”). 
The pLP-GBK-Amp vector was created by exchanging KanR by AmpR in pLP-GBKT7 
(Clontech) (see Material & Methods). The reason for selection of a 2nd bait vector was a) that 
this type of vector was established to work with the employed prey vector, pLP-GADT7 
(Clontech), and b) that this bait/prey vector combination has proven to work well in a screen 
of Gateway-system cloned ORFs (Uetz et al. 2006).  
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To test and compare these bait vectors, a set of 57 genes mainly belonging to the flagellum 
subset (see below) were cloned into both vectors and compared. With the “pAS1” vector, 
191 interactions were recovered after specificity filtering (see below or Materials & Methods); 
the “pGBK” vector recovered only 99 filtered interactions (Fig. 19). For both sets the 
percentage of interactions supported by the String database (von Mering et al. 2005)– a 
database storing predicted associations between genes – was calculated. With 10% and 8% 
for the pAS1 and pGBK vector, respectively, the support was similar indicating a similar 
interaction quality for both vectors. 
For baits with interactions for both vectors (filtered set), ~50% (15 out of 31) had 
overlapping interactions with both vectors. The number of overlapping interactions ranged 
from one to five and covered a percentage range from 5-100%. For baits without 
overlapping interactions in nearly all cases (15 out of 16) at least one of the bait vectors 
recovered only a single interaction. This clearly implies, that the high false-negative rate in the 
Y2H system (see introduction) is the main reason for the observed limited overlap. Table 15 
shows interactions recovered with both bait vectors. 
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Fig. 19 Comparison of pAS1 and pGBK. Number of interactions identified with each 
bait vector. The number of bait constructs yielding a certain number of interactions is 
given (counts). 
 
bait description prey description 
TP0058 replicative DNA helicase (dnaB)  TP0001 chromosomal replication initiator protein (dnaA)  
TP0058 replicative DNA helicase (dnaB)  TP0005 DNA gyrase, subunit A (gyrA)  
TP0058 replicative DNA helicase (dnaB)  TP0046 hypothetical protein  
TP0058 replicative DNA helicase (dnaB)  TP0066 hypothetical protein 
TP0058 replicative DNA helicase (dnaB)  TP0896 hypothetical protein 
TP0100 thioredoxin, putative  TP0832 hypothetical protein 
TP0271 chromosome partitioning protein 
(parB)  
TP0586 leucyl-tRNA synthetase (leuS)  
TP0387 cell division protein (ftsW)  TP0561 conserved hypothetical protein  
TP0387 cell division protein (ftsW)  TP0917 Mg2+ transport protein (mgtE)  
TP0400 flagellar motor switch protein (fliG)  TP0014 hypothetical protein 
TP0400 flagellar motor switch protein (fliG)  TP0066 hypothetical protein 
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TP0400 flagellar motor switch protein (fliG)  TP0209 ribosomal protein L36 (rpmJ)  
TP0492 DNA primase (dnaE)  TP0197 ribosomal protein L29 (rpmC) 
TP0567 conserved hypothetical protein  TP0421 conserved hypothetical protein  
TP0567 conserved hypothetical protein  TP0917 Mg2+ transport protein (mgtE)  
TP0631 protein-glutamate methylesterase 
(cheB)  
TP0832 hypothetical protein 
TP0716 flagellar biosynthetic protein (fliR)  TP0917 Mg2+ transport protein (mgtE)  
TP0717 flagellar biosynthetic protein (fliQ)  TP0561 conserved hypothetical protein  
TP0717 flagellar biosynthetic protein (fliQ)  TP0917 Mg2+ transport protein (mgtE)  
TP0725 flagellar motor rotation protein 
(motA)  
TP0917 Mg2+ transport protein (mgtE)  
TP0763 hypothetical protein TP0917 Mg2+ transport protein (mgtE)  
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
TP0396 flagellar basal-body rod protein (flgB)  
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
TP0658 transmembrane protein, putative  
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
TP0832 hypothetical protein 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
TP0873 hypothetical protein 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
TP0943 flagellar protein (fliS)  
TP0959 hypothetical protein TP0260 hypothetical protein 
TP0959 hypothetical protein TP0832 hypothetical protein 
TP0981 sensory transduction histidine 
kinase, putative  
TP0396 flagellar basal-body rod protein (flgB)  
TP0981 sensory transduction histidine 
kinase, putative  
TP0832 hypothetical protein 
TP0981 sensory transduction histidine 
kinase, putative  
TP1005 DNA polymerase III, subunits gamma and tau 
(dnaH)  
Table 15 Interactions from filtered T. pallidum set identified with pAS1-loxP 
and pLP-GBK-Amp bait constructs. 
Judged by the support by the String database, both vectors showed a similar interaction 
quality, but the pAS1 vector recovered a larger number of interactions. Since the false-
negative rate is a major concern in Y2H studies, the pAS1 vector was selected for bait 
constructs of the remaining ORFs. 
Prey Library Construction 
The prey library was created by Cre-mediated recombination of the T. pallidum ORFeome 
(McKevitt et al. 2003) with the Y2H prey vector, pLP-GADT7 (Clontech). The prey strains 
(prey constructs transformed into Y187 yeast cells) were arranged onto eleven 96-well plates. 
Either these plates were quadruplicated onto 384-well plates, or two of these 96-well plates 
were duplicated and combined on one 384-well plate (6 plates for whole prey array). About 
20% of the screenings were done with the quadruplicated prey array (11 plates); the 
remaining baits were screened against the duplicated array (6 plates) with the purpose to 
increase throughput. 
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LIMS 
High-throughput studies heavily rely on the informatics infrastructure. Several thousand 
cloning events need to be tracked, verification experiments linked to gene constructs, storage 
positions remembered, yeast-two-hybrid experiments scheduled, and finally raw results 
entered and evaluated. 
Software systems handling these diverse data types and supporting experimental procedures 
in the lab are so-called laboratory-information-management-systems (LIMS). Several 
commercial LIMS exist including Starlims (Starlims Corporation, USA) and SQL*LIMS 
(Applied Biosystems, USA). These powerful systems support workflows on the industrial 
scale. 
On the other hand, more and more freely available LIMS for specific scientific procedures 
become available. These include systems for genotyping, structure determination, and 
microarray analysis (Maurer et al. 2005; Monnier et al. 2005; Amin et al. 2006; Baran et al. 
2006; Jayashree et al. 2006). 
No particular system for the Y2H workflow is freely available. Thus, a LIMS was set up, 
which supports all steps of the Y2H-procedure including the cloning process and the storage 
of Y2H results (Fig. 20). This system was based on a database management system (DBMS), 
the FileMaker software (FileMaker, USA), which provides a relational database framework 
and tools to set up specific database schemes and programmable user-interfaces. The 
programming language perl (www.perl.org) extended the functionality of this system. 
A relational database scheme for this LIMS was developed following standard guidelines 
(Kandzia and Klein 1993). Fig. 20 A shows the database scheme. The database can be 
divided into a section storing information about ORFs (general gene properties, sequences, 
structural features), a section storing information for gene constructs (vectors data, 
verification experiments, storage information), and a section storing the Y2H results. Each of 
these sections consists of several tables, which are connected to each other. The table “gene 
construct” is the central element of the database and can exemplify the connectivity of this 
relational database scheme. Each record of this table represents an individual gene construct, 
e.g. protein TP0658 cloned into bait vector pLP-GBKT7-Amp. It stores the name of the 
construct, information about the cloning procedure, and information about the author and 
the creation date. Each record is linked to one vector and one ORF, which unambiguously 
defines the cloned construct (for fragments, start and end positions can be defined or ORF 
fragments can be added to the database). In addition, a gene construct has been verified using 
one or more verification experiments such as restriction digests, PCR reactions and 
sequencing runs (“verification” table). A gene construct is stored at a specific position, e.g. in 
“bait plate 1” at position A1, which is stored in the linked “storage position” table. Finally, 
bait and prey constructs are transformed into yeast and tested for interactions, which is 
captured by the link to the interaction section of the scheme.  
The graphical user interface supports data look-up and data entry (Fig. 20 B) and perl scripts 
have been developed to support more extended data handling, e.g. prediction of restriction 
patterns, cloning a whole plate to a new vector, and extracting the overall status for a list of 
genes. 
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Fig. 20 LIMS for the T. pallidum interaction project. (A) Database scheme with 
tables dedicated to ORFs (blue), gene constructs (yellow), and interactions (purple). 
(continued…) 
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B
 
(…continued) (B) Examples for the graphical user interface (GUI). Several information 
for an individual gene construct are stored (left upper panel), verification experiments are 
linked to the gene constructs (right upper panel), interactions are entered via a special 
entry form (left lower panel), and a list of all interactions is stored (right lower panel). 
Refer to PDF version for details. 
During the course of this project, the established LIMS proved to be well suited to store all 
relevant information including the links between different types of data. The graphical user 
interface, however, has room for improvements. The main disadvantage in this respect is the 
heterologous setup integrating external perl scripts for large-scale data manipulation. For 
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future projects, we plan to migrate the LIMS to the most recent version of the FileMaker 
DBMS. 
Establishment of a Pooling Strategy 
The array-based Y2H system has a quadratic dependency of hand-on time and the amount of 
resources – plates, media and incubator space- on the number of tested proteins;  the 
screening of a small bacterial genome like T. pallidum with ~1,000 ORFs requires 100 times 
more time and resources than a viral genome, e.g. KSHV with ~100 ORFs (Uetz et al. 2006). 
The actual time heavily depends on the robotic equipment, e.g., in our laboratory a single 
Biomek 2000 (Beckman Coulter) robot is sufficient for testing about 50 baits per week 
against a bacterial genome of 1000 ORFs or all 100 proteins of a viral genome against each 
other. The screening effort can be reduced by lowering the number of repetitions: testing of 
each interaction pair in quadruplicates is preferred, however, for larger projects (>200 
proteins) testing in duplicates is advisable. Alternatively, an increase of the array’s colony 
density, e.g., from 384 to 768 colonies per plate, is an option, although, this approach 
requires a higher precision of the robot and can reduce the number of detected interactions, 
e.g. due to a smaller number of transferred cells.  
A completely different screening strategy, the pooling strategy, has the potential to accelerate 
screening significantly, but might also have the disadvantage to increase the number of false 
negatives. In the first step, sets of proteins (pools, rather than single proteins) are tested for 
interactions against each other. In the second step, these interacting protein sets are selected 
and the proteins in this set are individually tested for their binary interactions (as in the 
classical array based Y2H strategy). Depending on the pool size, the first level of screening is 
very fast and, as only a few interactions are expected for each protein, only a few pools need 
to be tested for binary interactions in the second step. Such a pooling strategy was established 
by Zhong et al. (Zhong et al. 2003). Pools of prey proteins were tested against single bait 
proteins and it was shown that the pools can contain 96 or even more proteins. The authors 
calculate that the Y2H array screening of the whole yeast genome (~6,000 proteins) requires 
only 1/24 of time and effort when using the proposed pooling strategy. 
In this thesis, initial results and the crucial steps for adapting a pooling strategy for the 
specific Y2H procedure used in our lab are presented. 
For establishing of the pooling strategy, baits with a known interaction pattern were tested 
and the mating and transfer of cells were controlled by colony counting. Pools of several prey 
strains rather than bait strains were created. Bait strains commonly show different levels of 
autonomous activation of the reporter constructs, which hampers the combination of 
different baits in one screen. A small subset of preys is commonly found to undergo 
unspecific interactions with many bait strains (“sticky-preys”); these were removed from the 
prey array before pooling.  
The following procedure was established. Prey strains were grown in individual wells of 96-
well plates until saturation. Preys from corresponding positions, e.g. A03, of all T. pallidum 
prey plates (11 plates) were mixed and 100µl aliquots were transferred to fresh 96-well plates 
(“prey pooling plates”); glycerol was added to these plates with 96 pools of 11 prey strains 
(whole T. pallidum prey array) and the plates were stored at -80°C. Freezing did not affect the 
number of living prey cells at the day of mating. A day before mating, one prey-pooling plate 
was thawed, 100µl YEPD added and incubated overnight. For mating, the saturated prey-
pooling plate was quadruplicated onto a solid-agar YEPD plate with thick replication pins. 
The number of transferred prey cells was found to be crucial for mating efficiency. A single 
bait strain from a saturated culture was pinned on top of the preys employing a thick-pin 
384-well replication tool. For mating the plates were incubated for one day at 30°C; 
increasing the incubation time to two days did not increase the number of diploid cells. 
Transfer of a sufficient number of diploids to –LT plates was found to be crucial: only ~150 
diploids were transferred with the standard replication procedure with thick pins; a higher 
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number of transferred cells (~500, ~3x more) could be obtained by changing the pinning 
procedure: a swirling step on the source and the destination plate was included. This 
procedure was also employed for the transfer to –LTH plates. 
Based on the tested baits, this procedure proved to work in principle. Strong interactions 
such as the interaction between TP0974 and TP0709 (see below) were reproduced in every 
attempt. However, in total only about 20-50% of the interactions found in the individual tests 
were reproduced with the pooling scheme. This seems to be in agreement with observations 
from another project: Parish et al. (pers. comm.) retested interactions found in the T. pallidum 
screen and found that ~50 out of ~170 interactions were reproduced that were not detected 
by their pooling protocol. 
Due to the high number of undetected interactions in the pooling strategy, the T. pallidum 
network was generated without pooling. However, for larger genomes the use of a pooling 
strategy will be essential. In this thesis, the crucial steps for such a pooling scheme have been 
identified. Note that one reason for the low number of reproduced interactions might be the 
overall low activation level seen with the UPS yeast-two-hybrid vectors (or the T. pallidum 
ORFs compared with results from viral screens (Uetz et al. 2006)). Thus, for a project based 
on Gateway-based Y2H vectors, pGBKT7-DEST and pGADT7-DEST, the presented 
pooling scheme can yield a sufficient number of detected interactions. 
Screening Results – General 
For analyzing the protein-protein interaction network of T. pallidum, individual bait fusions 
were tested in an array-based Y2H test against the whole T. pallidum prey array. 920 out of 
1039 proteins were tested as baits (~90%). The remaining baits could not be tested, mainly 
due to lack of correct entry clones; a summary of tested baits is given in Table 16. 
 
category number of baits 
possible baits 1039 
correct bait constructs ~920 
screened baits 920 
baits with interactions 606 
baits with reliable 
interactions1 
423 
Table 16 Bait Summary. 1Interactions retained in a 
filtered interaction set. 
category number of preys 
possible preys 1039 
correct prey constructs ~1000 
prey with interactions 357 
preys with reliable 
interactions1 
338 
Table 17 Prey Summary. 1Interactions retained in a 
filtered interaction set. 
For most of the baits the screening was done in duplicates; each prey was arrayed twice on 
the prey array to check for reproducibility of the interactions. Interactions only detected in a 
single test were retested (the corresponding bait and prey were selected and individually 
tested for an interaction). Interactions reproduced either directly on the prey array or by the 
retest were considered.  
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A common source for false positive interactions are “sticky” preys, which unspecifically 
interact with a large number of bait fusions. The array-based Y2H-system allows for 
removing these potential false positive interactions by selecting a certain “prey count” cut-off 
– the “prey count” is defined as the number of distinct baits a given prey is interacting with. 
The distribution of “prey counts” is shown in Fig. 27. To define the prey count cut-off, the 
percentage of interactions supported by the String database – a database of bioinformatical 
associations between genes – and the percentage of interactions with identical functional 
classes were calculated for each cut-off value (Fig. 21). For further analysis, a “prey count” 
cut-off of 50 was selected. This cut-off is far beyond the maximum of 285 and corresponds 
to a reasonable percentage of 5% of the proteome (and tested baits). In addition, the selected 
subset of interactions incorporates the major fraction of interactions supported by the 
comparisons in Fig. 21. However, several interactions with high support are excluded by this 
cut-off, e.g. 14 interactions with TP0961 as a prey, which are supported by a high String 
database score (peak at interaction 2263 in Fig. 21). Thus, the interested reader is free to 
choose an own cut-off when analyzing the reported data. 
In total, 3,649 reproducible protein interactions were detected (Table 18). The selected cut-
off yielded 1,633 reliable interactions linking 601 (~60% of genome) proteins in the whole 
proteome T. pallidum screen (Table 18). 
  
category number of 
interactions 
number of linked 
proteins 
total 3649 726 
with prey count <51 1633 601 
with prey count <41 1451 570 
with prey count <21 970 515 
Table 18 Summary Y2H interactions 
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Fig. 21 Selection of prey count cut-off. All interactions below a given 
prey count (prey degree) were selected and the percentage of interactions 
supported by the String database (von Mering et al. 2005) (with medium 
confidence, String score >=0.4) or for which both interacting proteins 
showed the same main role (TIGR classification) was calculated. 
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Fig. 22 Whole interaction network of T. pallidum. Proteins are 
represented as nodes and their interactions as edges of a graph. The 
nodes/proteins are colored according to their functional role (TIGR main 
role), the color of the edges designates the interaction subset (filtered or 
whole set). 
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Fig. 23 Filtered protein-interaction network for T. pallidum. Proteins are 
represented as nodes and their interactions as edges of a graph. The nodes/proteins are 
colored according to their functional role, the color of the edges designates the prey 
count (specificity) of the interactions. 
Features of “sticky” Preys 
“Sticky” preys, i.e. preys unspecifically interacting with a large number of bait fusions, are a 
common annoyance in Y2H tests. The features that lead to this property, however, have not 
been analyzed in detail. One hypothesis is that these proteins expose hydrophobic patches 
that have the propensity to stick to many protein surfaces. 
The prey with the highest number of interactions is TP0993 (“rare lipoprotein A, putative”) 
with 285 distinct interacting baits. A Top 10 list of “sticky” preys is shown in Table 19. In 
addition to the lipoprotein, another putative surface protein (P26), several hypothetical 
proteins, and two flagellar proteins are in this list. 
Interestingly, each of these sticky preys shows a different interaction profile (Fig. 24). Thus, a 
certain level of specificity is retained even in the subset of “unspecifically” interacting preys. 
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prey # interactions description 
TP0993 285 rare lipoprotein A, putative 
TP0989 180 P26 
TP0258 173 conserved hypothetical protein 
TP0764 139 conserved hypothetical protein 
TP0788 132 hypothetical protein 
TP0661 117 hypothetical protein 
TP0398 114 fliE 
TP0907 110 conserved hypothetical 
TP0563 93 hypothetical protein 
TP0961 84 flgG 
Table 19 Top 10 list. Preys with the highest number of interacting baits. 
Only TP0989 has a predicted membrane localization. Thus, the propensity to undergo 
unspecific interactions is not generally due to exposed membrane regions of transmembrane 
proteins. 
The flagellar proteins, the only proteins with well-characterized functions in this list, are 
known to form polymeric complexes in the bacterial cell. In the non-natural environment of 
the yeast’s nucleus, interaction partners might be lacking, which might lead to the exposure 
of unbound hydrophobic interaction epitops. 
TP0907
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TP0961
TP0989
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TP0788
TP0661
TP0398
TP0764
TP0993
interacting baits
 
Fig. 24 Interaction profiles of "sticky" preys. Each row reflects one prey and each 
column one bait. Interactions are marked in grey. The arrangement of the columns (baits) 
results from clustering.  
The protein TP0563 is a specific case. It carries a DnaJ domain, a chaperone domain. Thus, 
its unspecific interaction pattern might be explained by unspecific interactions formed by this 
chaperone, e.g. with exposed hydrophobic patches. 
The “stickiness” of a protein has various reasons. These include specific protein features 
such as chaperone domains, exposed transmembrane regions, and presumably exposed 
binding epitopes of protein complexes. This diversity is nicely reflected by the variability of 
the interaction profiles of these proteins. It will be interesting to learn more about the nature 
of these distinct interaction patterns by performing comparative analyses of several datasets. 
Comparison with bioinformatical predictions 
The large number of sequenced prokaryotic genomes forms the basis for a number of 
bioinformatical methods, which predict associations between pairs of genes or pairs of 
orthologous gene groups. The String database (von Mering et al. 2005) was designed to 
compute and store associations derived from several bioinformatical prediction methods 
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including gene-neighborhood, gene-fusion, phylogenetic profiling, and simple text- and 
database-mining.  
In this paragraph, the Y2H dataset is compared with these bioinformatical predictions. 
Protein interactions supported by bioinformatical predictions were found to be enriched 
(compared to randomized networks) on all levels of significance (Fig. 25). Enrichment was 
found for both the genomic context and the combined score of the String database. The 
genomic context score integrates the genomic neighborhood, gene-fusion, and phylogenetic 
profiling, whereas the combined score additionally includes predictions based on text- and 
database-mining. In general, a higher enrichment for interactions in the filtered interaction set 
was observed.  
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Fig. 25 String database comparison (enrichment over random). The number of 
Y2H interactions supported by the String database (overall score and genomic context 
score) for different significance levels compared to numbers from random networks is 
shown. The Z-value indicates times standard deviation enrichment compared to the 
average of 1000 randomized networks. The “combined score” encorporates all 
bioinformatical prediction methods, whereas the “context score” includes genomic 
neighbourhood, gene fusion, and co-occurrence.  The confidence levels are as defined by 
the String database: low (score ≥ 0.15), medium (score ≥ 0.40), high (score ≥ 0.70), and 
highest (score ≥ 0.90). 
A more detailed analysis of different significance levels and bioinformatical prediction 
methods is presented in Fig. 26. An overall enrichment compared to randomized networks is 
generally observed. At different significance levels, different bioinformatical methods have 
the major contribution to the enrichment score. In a low significance bin (combined string 
score 0.2-0.3), for example, interactions supported by the “experiment score” are highly 
enriched compared to randomized networks. This analysis can only give an impression on 
the contribution of different methods, however, the small sample sizes in each bin leads to an 
unstable statistics. Thus, for the evaluation the data from Fig. 25 should be preferred. 
This analysis can also be employed for filtering of the interaction set. Supplementary Table 7 
lists Y2H interactions supported by the StringDB at a medium confidence level (combined 
score > 0.4). This list of overlapping interactions represents a higher confidence set, which 
could be the basis of selections for initial follow-up studies. 
In summary, the T. pallidum interaction set is well supported by bioinformatical predictions. 
 
RESULTS 
 99 
-3
-2
-1
0
1
2
3
4
5
6
7
8
0.1<0.2 0.2<0.3 0.3<0.4 0.4<0.5 0.5<0.6 0.6<0.7 0.7<0.8 0.8<0.9 0.9<1.0
Z-
Va
lu
es
combined neighbourhood fusion phylogenetic profile co-expression experiments database text mining
 
Fig. 26 The set of filtered Y2H interactions is supported by bioinformatical 
predictions.  The number of interactions supported by the bioinformatical predictions 
by the String database was computed for bins of the significance score. This number of 
found associations was compared to a distribution of 1000 random networks. The z-
scores (see Materials & Methods) for different bioinformatical methods are shown: 
combined (overall score), gene neighbourhood, gene fusion, phylogenetic profile, co-
expression, experiments, database, and text mining. 
General Topological Properties 
Biological networks are commonly characterized by a certain set of topological network 
properties (Uetz et al. 2006). In this section, topological properties of the T. pallidum network 
and networks of other species are compared (Table 20). 
 
 
 T. pallidum H. pylori C. jejuni KSHV Yeast 
 filtered all  HCF all   
Number of 
Proteins (% 
genome) 
601 
(58%) 
726 
(70%) 
732 
(47%) 
1108 
(69%) 
1332 
(83%) 
50 
(56%) 
1004 
(17%) 
Number of 
Interactions 
1634 3684 1465 3209 12012 123 948 
Number of 
Edges (w/o 
reciprocal int.) 
1633 3649 1465 3152 11871 115 948 
avg. node degree 5.4 10.0 3.8 5.3 17.5 4.6 1.8 
avg cluster 
coefficient 
0.064 0.232 0.015 0.039 0.095 0.146 0.021 
Diameter 10 7 9 9 6 7 20 
Avg. shortest 
path length 
3.88 3.0 4.15 3.80 2.91 2.84 7.49 
Power 
coefficient 
1.47 1.15 1.68 1.51 1.27 0.95 2.43 
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R2 0.91 0.85 0.91 0.89 0.90 - 0.95 
largest 
connected 
component 
nodes (edges) 
586 
(1609) 
724 
(3648) 
710 
(1450) 
1081 
(2961) 
1329 
(11869) 
- 474 
(559) 
distinct 
baits 
423 606 244 604 650 - 505 
distinct 
preys 
338 357 615 971 1259 - 630 
Table 20 General topological properties. Network properties were calculated with 
NetworkAnalyzer 2.0 (Max Planck Institut für Informatik, Mario Albrecht). The H. 
pylori dataset was generated by Rain et al.. (Rain et al. 2001), the C. jejuni dataset was 
shared prior to publication by the Finley laboratory (Parish et al.), features of the KSHV 
network work taken from Uetz et al. (Uetz et al. 2006), the yeast dataset (Uetz et al. 2000) 
was downloaded from the homepage of the Fields lab (http://depts. washington.edu 
/sfields). 
In agreement with previous observations, the majority of protein-protein interactions were 
only found in one direction (with specific bait/prey direction). Table 21 contains interactions 
identified in both directions (with bait and prey reversed) in the complete T. pallidum dataset. 
The observation of an interaction in both directions can increase their reliability, but note 
that several interacting proteins in this list show a high prey count (node degree as prey). 
 
protein A description prey  
count 
protein B description prey  
count 
TP0046 hypothetical protein  18 TP0398 flagellar hook-basal body 
complex protein (fliE)  
114 
TP0050 conserved hypothetical protein  10 TP0398 flagellar hook-basal body 
complex protein (fliE)  
114 
TP0050 conserved hypothetical protein  10 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0059 hypothetical protein 21 TP0258 conserved hypothetical protein  173 
TP0059 hypothetical protein 21 TP0661 hypothetical protein 117 
TP0121 conserved hypothetical protein  7 TP0661 hypothetical protein 117 
TP0188 ribosomal protein S10 (rpsJ)  2 TP0661 hypothetical protein 117 
TP0258 conserved hypothetical protein  173 TP0398 flagellar hook-basal body co 
mplex protein (fliE)  
114 
TP0258 conserved hypothetical protein  173 TP0563 hypothetical protein 93 
TP0258 conserved hypothetical protein  173 TP0661 hypothetical protein 117 
TP0258 conserved hypothetical protein  173 TP0664 flagellar filament outer layer 
protein (flaA)  
34 
TP0258 conserved hypothetical protein  173 TP0673 glutamyl-tRNA synthetase (gltX)  1 
TP0258 conserved hypothetical protein  173 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0359 hypothetical protein 2 TP0661 hypothetical protein 117 
TP0398 flagellar hook-basal body complex 
protein (fliE)  
114 TP0530 V-type ATPase, subunit E, 
putative  
19 
TP0398 flagellar hook-basal body complex 
protein (fliE)  
114 TP0661 hypothetical protein 117 
TP0398 flagellar hook-basal body complex 
protein (fliE)  
114 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0398 flagellar hook-basal body complex 
protein (fliE)  
114 TP0989 P26  180 
TP0530 V-type ATPase, subunit E, 
putative  
19 TP0661 hypothetical protein 117 
TP0561 conserved hypothetical protein  44 TP0985 aspartyl-tRNA synthetase (aspS)  2 
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TP0563 hypothetical protein 93 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0563 hypothetical protein 93 TP0981 sensory transduction histidine 
kinase, putative  
5 
TP0563 hypothetical protein 93 TP1023 recX protein (recX)  13 
TP0587 hypothetical protein 23 TP0661 hypothetical protein 117 
TP0626 exonuclease, putative  12 TP0661 hypothetical protein 117 
TP0630 chemotaxis protein 
methyltransferase (cheR)  
1 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0660 flagellar hook-associated protein 1 
(flgK)  
4 TP0661 hypothetical protein 117 
TP0661 hypothetical protein 117 TP0803 hypothetical protein 2 
TP0661 hypothetical protein 117 TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 
TP0661 hypothetical protein 117 TP0946 glucose-inhibited division 
protein B (gidB)  
19 
TP0664 flagellar filament outer layer 
protein (flaA)  
34 TP0961 flagellar basal-body rod protein 
(flgG)  
84 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 TP0873 hypothetical protein 1 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 TP0943 flagellar protein (fliS)  15 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 TP0961 flagellar basal-body rod protein 
(flgG)  
84 
TP0870 flagellar filament 31 kDa core 
protein (flaB3)    
79 TP0981 sensory transduction histidine 
kinase, putative  
5 
Table 21 Y2H interactions found in both (bait - prey) directions. 
One advantage of the Y2H system compared to coAP/MS studies is that homodimers can 
be identified. Homodimers found in the T. pallidum dataset are shown in Table 22. 22 
homodimers were observed in total. In 1000 randomized networks only 6.7 +/- 1.9 
homodimers were found. Thus, the observation of 22 homodimers is highly significant and is 
only expected with p = 2.22 10-16 by chance. 
 
Protein Description Prey 
Count 
TP0330 cell division protein (ftsH)  2 
TP0725 flagellar motor rotation protein (motA)  2 
TP0121 conserved hypothetical protein  7 
TP0088 conserved hypothetical protein  8 
TP0641 histidyl-tRNA synthetase (hisS)  9 
TP0708 hypothetical protein 13 
TP0943 flagellar protein (fliS)  15 
TP0530 V-type ATPase, subunit E, putative  19 
TP0059 hypothetical protein 21 
TP0587 hypothetical protein 23 
TP0559 conserved hypothetical protein  26 
TP0519 response regulatory protein (atoC)  30 
TP0833 hypothetical protein 34 
TP0561 conserved hypothetical protein  44 
TP1005 DNA polymerase III, subunits gamma and tau (dnaH) 44 
TP0383 conserved hypothetical protein  65 
TP0870 flagellar filament 31 kDa core protein (flaB3)  79 
TP0961 flagellar basal-body rod protein (flgG)  84 
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TP0563 hypothetical protein 93 
TP0398 flagellar hook-basal body co mplex protein (fliE) 114 
TP0661 hypothetical protein 117 
TP0258 conserved hypothetical protein  173 
Table 22 Homodimers in the T. pallidum PIM. 
Biological networks were described to exhibit scale-free properties such as scale-free degree 
distributions. For these networks their degree distribution can be described by a power-law – 
P(k) ~ k-γ with node degree k, frequency of a certain node degree P(k), and power coefficient 
γ. As shown in Fig. 27 the degree distribution of the PIM of T. pallidum can be approximated 
by a power law. 
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Fig. 27 Frequency-degree plot showing node degree distributions of T. pallidum 
networks (TPA), C. jejuni networks (CJE), and a yeast network. The insert shows a plain 
histogram of the node-degree distribution for the filtered T. pallidum network. 
However, Tanaka et al. (Tanaka et al. 2005) found that some experimental networks were 
wrongly labeled as scale-free, although their node degree distribution is better described by an 
exponential function. The problem with these analyses was the use of frequency-degree plots 
rather than rank-degree plots, which are standard in statistics. 
For T. pallidum these rank-degree plot show, that the whole network can be approximated by 
a power-law, whereas the distribution of the filtered network is better described by an 
exponential law.  
To gain biological insight into the “sticky” preys, I investigated whether the prey count of a 
protein was dependent on its functional class Fig. 29. However, no specific trend was 
observed. 
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Fig. 28 Rank-degree plots. The plot for the whole T. pallidum network is shown left; 
the filtered network is shown right. Note that the whole network is drawn on logarithmic 
scales (power-law); the filtered network is drawn on semi-logarithmic scales (for 
exponentials). 
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Fig. 29 Prey counts vs. functional classes. Preys were logarithmical binned (two bins 
per decade) according to their prey count and the percentage of preys with a certain 
TIGR main role was calculated. 
Identification of Tightly Connected Clusters 
Protein clusters form functional modules in protein-interaction networks. Examples for 
protein clusters found in bacterial networks are the DNA polymerase, the ribosome, and the 
RNA polymerase. Several algorithms for the identification of clusters in protein-interaction 
networks have been devised among them a set of algorithms by Spirin and Mirny (Spirin and 
Mirny 2003) and MCODE by Bader and Hogue (Bader and Hogue 2003). MCODE is used 
for cluster identification in this study due to its availability as a Cytoscape plug-in (Shannon et 
al. 2003). Using the default parameters (node score cutoff = 0.2; haircut on; fluff off; max. 
depth = 100) six clusters were identified (Table 23, Fig. 30). 
 
 
 
RESULTS 
 104 
Complex Score 
(Density* 
#Proteins) 
# 
Proteins 
# 
Interactions 
Proteins 
1 1,56 25 44 TP0751, TP0344, TP0345, TP0492, TP0389, TP0559, 
TP0237, TP0773, TP0409, TP0197, TP0873, TP0870, 
TP0630, TP0497, TP0209, TP0530, TP0455, TP0554, 
TP0833, TP0720, TP0832, TP0567, TP0708, TP0561, 
TP0668 
2 1,2 5 7 TP0084, TP0587, TP0333, TP0268, TP0664 
3 1,167 6 8 TP0514, TP0648, TP0965, TP0341, TP0519, TP0634 
4 1 3 4 TP0711, TP0059, TP0661 
5 1 3 3 TP0716, TP0042, TP0917 
6 1 3 4 TP0945, TP0943, TP0048 
Table 23 MCODE clusters. Tightly connected clusters in the filtered T. pallidum PIM 
identified by MCODE (Bader and Hogue 2003). 
Since all these clusters contain proteins with diverse functions, a classification into functional 
categories was not possible. Cluster 3, for example, contains two interacting DNA repair 
enzymes (DNA ligase (TP0634) and an exonuclease (TP0514)), but also two proteins 
belonging to the cell envelope category, MurC (TP0341) and a membrane fusion protein 
(TP0965).   
These clusters were also tested for support by genomic context methods as provided by the 
String database (von Mering et al. 2005). In cluster 1, genomic neighbourhood and co-
occurrence at a medium confidence level (score > 0.4) support the association between 
TP0389, TP0345, and TP0344. In cluster 3, the COGs of TP0648, TP0965, and TP0516 are 
associated at medium confidence level; the remaining COGs except for TP0514’s COG are 
associated at the low confidence level (Fig. 30 B) Thus, cluster 3 is well supported not only 
by Y2H interactions, but also by genomic context methods. 
Cluster 6 represents a special case. This cluster is formed by homodimerisation of TP0943 
(FliS) and its interaction with a neighboring gene, TP0945, a pentose-phosphate pathway 
enzyme. In addition, both proteins are interacting with the conserved hypothetical protein 
TP0048. These interactions are only two out of six interactions constituting a genomic link 
between the regions surrounding TP0943/TP0945 and TP0048, respectively (see below). 
These clusters indicate previously unidentified tight functional associations between protein 
sets. The functional implication of cluster 6 (motility involvement) is discussed below. Cluster 
3 is strongly supported by genomic context methods and might represent a link between 
DNA metabolism and the cell envelope. 
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Fig. 30 Tightly connected protein complexes in the filtered T. pallidum network 
identified by MCODE algorithm. (A) Protein complexes colored according to TIGR 
main roles; see main network for color key. (B) Bioinformatical associations between 
proteins of complex 3 obtained from the String database (von Mering et al. 2005). The 
edge labels represent associations scores, the edge color indicates the underlying genomic 
context methods: neighborhood (green), co-occurrence (blue), and co-expression (black). 
Interactions of Paralogs 
Paralogous proteins are homologous proteins, which are present in one species and 
developed by gene duplication events. Since they originated from one ancestral gene, a 
related, but distinct function can be hypothesized. Therefore, paralogous proteins can be 
assumed to have overlapping, but different interaction profiles. To test this hypothesis, 
paralogous proteins of T. pallidum were collected and their interaction patterns compared. 
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Paralogs of T. pallidum were downloaded from the TIGR-CMR database (August 2006) 
(Peterson et al. 2001); their assignments are based on sequence comparisons combined with 
manual inspection of the alignments. Please note that a new release of the CMR database 
appeared in October 2006, which contains a differently defined set of paralogous genes for T. 
pallidum (discussed below). 
42 paralogous gene families containing 127 genes (more than 10% of the genome) are 
present in the genome of T. pallidum. These include conserved hypothetical protein families, 
transporter families, and families of special interest for T. pallidum such as the flagellin family 
(paralogous family 39) and the tpr protein family (paralogous family 2). 
Each of these paralogous families was checked for overlapping interactions (Table 24). For 
summary of the number of interactions and the number of overlapping interactions for each 
paralogous gene family, refer to Supplementary Table 13. 
 
paralogous 
family  
(gtp family #) 
(annotation) 
interacting 
ORF 
annotation # interactions 
02 
(tpr proteins) 
TP0209 ribosomal 
protein L36 
2 TP0117-TP0209 
TP0610-TP0209 
04 
(fliG) 
TP0399 fliF 2 TP0400-TP0399 
TP0399-TP0026 
23 
(ftsW, rodA) 
TP0561 conserved 
hypothetical 
2 TP0501-TP0561 
TP0387-TP0561 
23 
(ftsW, rodA) 
TP0917 Mg2+ 
transport 
protein 
2 TP0501-TP0917 
TP0387-TP0917 
39 
(flagellin) 
TP0050 conserved 
hypothetical 
2 TP0868-TP0050 
TP0870-TP0050 
39 
(flagellin) 
TP0658 conserved 
hypothetical 
3 TP0792-TP0658 
TP0868-TP0658 
TP0870-TP0658 
39 
(flagellin) 
TP0832 hypothetical 3 TP0792-TP0832 
TP0868-TP0832 
TP0870-TP0832 
40 
(flgG) 
TP0832 hypothetical 2 TP0960-TP0832 
TP0961-TP0832 
Table 24 Overlapping interactions of paralogs (status August 2006). Paralogous 
gene families (paralog family), for which different members interacted with the same 
protein (interacting ORF), are shown. The number of distinct interactions with this ORF 
is given (#) and the individual interactions are shown (paralog in normal case, interacting 
ORF in bold case).  
As mentioned a new release of the TIGR-CMR database contained a different list of 
paralogous gene families. Presumably, the computation of these families was based on an 
algorithm developed for the reannotation of the Arabidopsis genome (Tanja Davidsen, pers. 
comm.) (Haas et al. 2005). In this algorithm, Pfam and TIGRfam profiles are assigned using 
HMMER2; the unassigned sequence space is clustered based on sequence identity (BlastP) 
and protein domains are defined on basis of these clusters. Thus, the current “paralogous 
gene family” set from the TIGR-CMR database contains domains rather than real paralogous 
gene families. However, a corresponding analysis of these families is presented in 
Supplementary Table 14.  
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The protein TP0658 interacts with all flagellin proteins indicating a close functional 
association of TP0658 with this gene family; flagellin proteins form the propeller-like 
structure of the bacterial filament. This served as one criterion to select TP0658 for a more 
detailed analysis, which revealed that TP0658 functions as an conserved assembly factor of 
the bacterial filament  (see section 3.5) (Titz et al. 2006a).  
Unlike other bacteria, T. pallidum has a flagellum with two copies of the basal body protein 
fliG, fliG-1 and fliG-2 (Charon and Goldstein 2002). It was hypothesized that this 
redundancy is the basis for the polarized rotation of the flagellum. Since both paralogs still 
show the previously described interaction with FliF (MS ring complex) (Oosawa et al. 1994), 
their general function in the basal body seems to be retained. However, their distinct 
interaction pattern with other proteins indicates a modulation of this function (Rajagopala 
2006). 
Because of its association to both members of the “gtp family_23”, whose members are 
involved in cell division, TP0561 can be hypothesized to have a function in cell division as 
well. Orthologs of TP0561 are widely distributed among bacteria including ygcG (B2778) in 
E. coli and ydjH (BSU06200) in B. subtilis. 
Two interacting paralogous protein families could also have co-evolved in a way that 
different paralogs of one family interact with different paralogs in another family. However, 
in the T. pallidum interaction set such cases could not be identified, although 19 interactions 
between members of paralogous protein families were identified. 
Most paralogs show a different set of interactions. Nevertheless, the cases with overlapping 
and distinct interactions can serve as the basis for further investigations. Detailed epitope 
mappings of these can provide insights into the evolution of different interaction specificities.  
Functional Classes present in Interaction Networks 
Functional classes present in the whole and the filtered T. pallidum network were analyzed 
and compared to the whole genome (Supplementary Table 8, Supplementary Table 9). Based 
on an exact Fisher’s test with Bonferroni’s and Holm’s correction for multiple testing, none 
of the functional classes tested was significant enriched or depleted in the protein interaction 
networks. The main functional classes in the filtered network were conserved hypothetical 
proteins (27%), chemotaxis and motility (7%), DNA metabolism (6%), and ribosomal 
proteins (4%). This corresponds to the distribution of functional classes in the genome. 
Connections between Functional Classes 
To assess a higher organization level of the bacterial cell, proteins can be functionally 
classified. Several classification schemes are applied to bacterial proteins. The TIGR role 
categories (main role and sub role, www.tigr.org/CMR) capture the general function of a 
protein, e.g. an involvement in DNA replication (Peterson et al. 2001). The TIGR categories 
are forming a rather flat classification scheme (with two levels). In contrast, the gene 
ontology (GO) classification scheme is based on three “directed acyclic graphs (DAG)” 
(Lewis 2005). Each protein can be associated to a number of functional terms from each of 
these ontologies: biological process, molecular function, and cellular component.  
Here, the connections of TIGR roles and GO terms based on the identified Y2H links are 
analyzed. For this, the number of Y2H interactions between proteins of all pair-wise 
functional term combinations was counted and compared to the distribution from 1000 
randomized networks. The GO terms were taken from a GO slim mapping (GO slim and 
prokaryotic subset) from the GOA@EBI project, which employs automated algorithms for 
GO term classifications (Camon et al. 2003). The results are shown in Fig. 31 and 
Supplementary Table 10-Supplementary Table 12.  
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GO SLIM MAPPING Z>3.0
Membrane-related processes
DNA metabolism related
Motility-related processes
Protein metabolism
Metabolism
 
 
Fig. 31 Functional associations. The connections between functional categories in the 
filtered T. pallidum dataset are shown. The width of edges between functional categories 
are scaled according  to the number of Y2H interactions connecting them, the number of 
interactions is given as edge label, and the darkness of the edge indicates the statistical 
significance (Z-value, see supplementary tables). Only connections with Z>2.0 for TIGR 
roles and Z>3.0 for GO terms are shown. (continued…) 
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TIGR SUBROLES TIGR MAIN ROLES
 
Fig. 31 (…continued)  
Considering TIGR roles, a significant self-association is observed for “chemotaxis and 
motility” (31 interactions), “DNA replication, recombination, and repair” (16 interactions), 
and “cell division” (2 interactions). 
Interactions of motility proteins are discussed below. Interactions between proteins involved 
in “DNA metabolism” constitute an interesting subset (Table 25). 
 
bait description prey description 
TP0058 replicative DNA helicase (dnaB)  TP0001 chromosomal replication initiator protein 
(dnaA)  
TP0058 replicative DNA helicase (dnaB)  TP0005 DNA gyrase, subunit A (gyrA)  
TP0058 replicative DNA helicase (dnaB)  TP0102 rep helicase, single-stranded DNA-dependent 
ATPase (rep)  
TP0058 replicative DNA helicase (dnaB)  TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH)  
TP0162 Holliday junction DNA helicase (ruvB)  TP0543 Holliday junction DNA helicase (ruvA)  
TP0328 DNA mismatch repair protein (mutS)  TP0946 glucose-inhibited division protein B (gidB)  
TP0344 transcription-repair coupling factor (trcF)  TP0514 excinuclease ABC, subunit A (uvrA)  
TP0380 DNA repair helicase, putative  TP0704 single-stranded-DNA-specific exonuclease 
(recJ)  
TP0380 DNA repair helicase, putative  TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH)  
TP0492 DNA primase (dnaE)  TP0380 DNA repair helicase, putative  
TP0492 DNA primase (dnaE)  TP1006 DNA gyrase, subunit B (gyrB)  
TP0517 Holliday junction nuclease (ruvC)  TP0704 single-stranded-DNA-specific exonuclease 
(recJ)  
TP0526 ATP-dependent helicase (hrpA)  TP1023 recX protein (recX)  
TP0634 DNA ligase (lig)  TP0514 excinuclease ABC, subunit A (uvrA)  
TP0946 glucose-inhibited division protein B (gidB)  TP0514 excinuclease ABC, subunit A (uvrA)  
TP1005 DNA polymerase III, subunits gamma 
and tau (dnaH)  
TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH)  
Table 25 Y2H interactions linking two proteins involved in DNA metabolism 
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“Protein synthesis” and “protein fate” (TIGR main roles) are linked by 19 interactions. These 
include interactions between ribosomal proteins and proteases, between the trigger factor 
(TP0506) and translation elongation factor TS (TP0605), and between methionyl-tRNA 
formyltransferase (fmt, TP0756) and polypeptide deformylase (def, TP0757) (Table 26). 
 
bait description role prey description role 
TP0030 heat shock protein (groEL)  F TP0160 prolyl-tRNA synthetase (proS)  S 
TP0063 ribosomal protein S6 (rpsF)  S TP0757 polypeptide deformylase (def)  F 
TP0063 ribosomal protein S6 (rpsF)  S TP0997 protease IV (sppA)  F 
TP0097 translation initiation factor 1 (infA)  S TP0757 polypeptide deformylase (def)  F 
TP0097 translation initiation factor 1 (infA)  S TP0773 periplasmic serine protease DO 
(htrA)  
F 
TP0097 translation initiation factor 1 (infA)  S TP0997 protease IV (sppA)  F 
TP0185 signal peptidase I (sip)  F TP0644 lysyl-tRNA synthetase  S 
TP0237 ribosomal protein L11 (rplK)  S TP0773 periplasmic serine protease DO 
(htrA)  
F 
TP0255 ribosomal protein L31 (rpmE)  S TP0757 polypeptide deformylase (def)  F 
TP0452 isoleucyl-tRNA synthetase (ileS)  S TP0185 signal peptidase I (sip)  F 
TP0506 trigger factor (tig)  F TP0605 translation elongation factor TS 
(tsf)  
S 
TP0507 ATP-dependent Clp protease proteolytic 
component (clpP)  
F TP0362 ribosomal protein L28 (rpmB)  S 
TP0578 cell division protein (ftsY)  F TP0160 prolyl-tRNA synthetase (proS)  S 
TP0756 methionyl-tRNA formyltransferase (fmt)  S TP0757 polypeptide deformylase (def)  F 
TP0756 methionyl-tRNA formyltransferase (fmt)  S TP1013 chaperonin (groES)  F 
TP0807 ribosomal protein L32 (rpmF)  S TP0773 periplasmic serine protease DO 
(htrA)  
F 
TP0926 signal peptidase I, putative  F TP0209 ribosomal protein L36 (rpmJ)  S 
TP0985 aspartyl-tRNA synthetase (aspS)  S TP0757 polypeptide deformylase (def)  F 
TP0985 aspartyl-tRNA synthetase (aspS)  S TP0773 periplasmic serine protease DO 
(htrA)  
F 
Table 26 Interactions between protein synthesis (S) and protein fate (F). 
 “Chemotaxis and motility” and “tRNA aminoacylation” are linked by 14 interactions. This 
might indicate a regulatory link between motility and the tRNA/aminoacid status of the cell. 
Interestingly, the network of interconnected GO terms is subdivided into several functional 
clusters: DNA metabolism, membrane-process related, intracellular, protein metabolism, and 
motility-related processes. An example for an internal connection is the link between ion 
transporters (“ion transport” and “ion transporter activity”) and other membrane proteins.   
An analysis of connections between KEGG pathways (www.genome.jp/kegg) did not reveal 
further insights (not shown). 
A significant number of interactions within the same functional category allow further 
insights into its molecular details. On the other hand, interesting functional links between 
categories are discovered, e.g. between motility and tRNA metabolism. 
 
A Domain Centered View 
Proteins are composed of individual domains, which form the “building blocks” in evolution 
(Bornberg-Bauer et al. 2005). The Pfam database (Bateman et al. 2004) identifies and stores 
information about the domain content of each protein. Table 27 shows the 15 most 
abundant protein domains in the genome of T. pallidum (Pfam families). The TPR_1 domain 
is found in 17 proteins with as many as 50 copies in total. TPR domains are described as 
versatile protein-protein interaction domains (D'Andrea and Regan 2003). 
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Pfam family Description Number of 
proteins 
Number of 
regions 
TPR_1 (PF00515) Tetratricopeptide repeat 17 50 
Ank (PF00023) Ankyrin repeat 2 27 
TPR_2 (PF07719) Tetratricopeptide repeat 12 21 
ABC_tran (PF00005) ABC transporter 17 20 
LysM (PF01476) LysM domain 7 11 
MOSP_N (PF02707) Major Outer Sheath Protein 
N-terminal region 
9 9 
MOSP_C (PF02722) Major Outer Sheath Protein 
C-terminal region 
9 9 
Helicase_C (PF00271) Helicase conserved C-
terminal domain 
8 8 
AAA (PF00004) ATPase family associated 
with various cellular 
activities (AAA) 
8 8 
S1 (PF00575) S1 RNA binding domain 3 7 
MMR_HSR1 
(PF01926) 
GTPase of unknown 
function 
5 6 
DNA_gyraseA_C 
(PF03989) 
DNA gyrase C-terminal 
domain, beta-propeller 
1 6 
Table 27 Top 15 Pfam families in the T. pallidum genome. Data was taken from 
the Pfam database. 
The filtered T. pallidum PIM was taken as a basis to construct a network of interacting 
domains (Fig. 32, Supplementary Table 15).  
Several significant links between protein domains are present in the T. pallidum protein 
network. Striking examples such as the wide range of TPR domain links and the interaction 
of flagella protein domains with peptidoglycan enzyme domains are discussed below. 
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Fig. 32 A Domain-centered PIM for T. pallidum. Domains for proteins embedded in 
the filtered PIM of T. pallidum were extracted from the Pfam database. The number of 
Y2H links between two domains (Ni) was calculated (shown as edge labels) and 
compared to a distribution of randomized networks. A Z-value for each domain 
interaction was calculated (enrichment), only links with Z>2 are shown, and the edge line 
width is scaled proportional to the Z-value. In addition to links based on Y2H 
interactions (red lines), the fusion of domains in a single T. pallidum protein is indicated 
(black lines; e.g., the fusion of Flagellin_N and Flagellin_C domains compose the 
flagellin proteins), and putative domain-interactions from the InterDom database (Ng et 
al. 2003) are shown (yellow lines). 
Links between Genomic Locations 
Neighboring genes in the genome, e.g. genes in one operon, tend to have a related function 
(Overbeek et al. 1999).  
In this paragraph, links between two genomic locations, which can be far apart in the 
genome, are analyzed. For this, the number of Y2H links between genomic locations is 
counted and compared to a distribution obtained from 1000 randomizations of the Y2H 
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network. Links formed by more Y2H interactions than expected by chance are displayed in 
Fig. 33.  
Indeed, significant links between genomic locations are identified. Examples for different 
underlying interaction patterns are given in the following.  
First, at the diagonal of the matrix homodimerisations and interactions with neighboring 
genes are observed: the conserved hypothetical protein TP0561 forms a homodimer and 
interacts with neighboring genes (Fig. 33, lower left zoom-out); TP0559 (ThiI) also forms a 
homodimer and interacts with a neighboring gene of unknown function, TP0552.  
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Fig. 33 Links between genomic locations. A matrix showing the number of Y2H 
links between genomic locations is shown. Genomic locations with 20 neighboring genes 
were selected (neighboring locations are shifted by 5 amino acids) and the number of 
Y2H interactions between all pair-wise combinations of these locations was counted. For 
estimation of statistical significance, only genomic links between two locations with Z-
value > 2 (based on comparison with 1000 randomized networks) and at least three Y2H 
interactions were selected. Zoom-outs show examples for individual interactions forming 
a link between two genomic locations.  
Second, a genomic link can be also based on one protein interacting with several neighboring 
genes: TP0832, a hypothetical protein, (Fig. 33, lower right zoom-out) interacts with several 
flagellar proteins. Interestingly, TP0833 the neighbor of TP0832 and annotated as 
hypothetical protein, as well, shows an overlapping interaction with TP0720 (FliY). This 
might indicate that both hypothetical proteins, TP0832 and TP0833, have a function related 
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to bacterial motility. TP0832 is located in a COG with the B. subtilis protein gerM, a 
germination protein. GerM was speculated to be involved in peptidoglycan synthesis (Slynn 
et al. 1994). Taken together, TP0832 (and TP0833) might be implicated in reorganization of 
peptidoglycan to accommodate the flagellum.  
Third and most interesting, a link between two loci potentially implicated in bacterial motility 
was identified (Fig. 33, upper right zoom-out). A region flanking TP0943 (FliS), the FliC 
chaperone, is linked to a gene cluster including TP0046-TP0048. TP0046 and TP0048 were 
found to have reduced motility in B. subtilis (see below). TP0945 (R5P3E) and TP0946 (gidB), 
two proteins related to sugar metabolism, are linked to this cluster. Interestingly, this genomic 
location link is additionally supported by the identification of a network cluster (Fig. 30). 
Protein interaction links between genomic locations are present in the interactome of T. 
pallidum. This finding reveals another level of organization of the genome/interactome space. 
Links between Subcellular Locations 
Compared to eukaryotic cells, only a small number of separated compartments exist in 
prokaryotic cells: the cytoplasm, the periplasmic space, and the membranes. In addition, 
bacteria secrete proteins into their environment. The PSORT2.0 algorithm (Gardy et al. 
2005) was used to predict subcellular locations for all T. pallidum proteins (Table 28). This 
algorithm employs a multiple classification approach and evaluates features such as signal 
peptides, transmembrane helices, homologies, and motifs. 
 
predicted location count percent 
Cytoplasmic 408 39 
Unknown 395 38 
CytoplasmicMembrane 177 17 
Unknown (This protein may have multiple localization 
sites.) 
20 2 
OuterMembrane 18 2 
Periplasmic 15 1 
Extracellular 3 <1 
Table 28 Subcellular locations of T. pallidum proteins predicted by PSORT 2.0 
 
 
Fig. 34 Location links. Enrichment of protein-interaction based links between bacterial 
compartments (based on predicted localizations). Number of linking interactions is given 
in the matrix. The color code indicates the statistical significance of an observed link 
compared to randomized protein networks: the color encodes a Z-score. 
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As expected, most of the proteins (~39%) were predicted to be localized in the cytoplasm. 
For a large fraction, a prediction was impossible (“unknown”, 38%) and only a minority of 
proteins was predicted to be localized to other compartments. 
The analysis of protein-interaction links between these compartments revealed only two 
significant (Z-value > 2.0) links: between pairs of cytoplasmic proteins and between pairs of 
cytoplasmic membrane proteins (Fig. 34, Supplementary Table 3). A significant association of 
two different subcellular locations could not be identified. However, a highly significant 
under-representation of interactions between cytoplasmic and cytoplasmic-membrane 
proteins was observed. In addition, a slight overrepresentation of links between proteins of 
unknown localization and proteins with periplasmic (38 interactions) and outer membrane 
localization (13 interactions) was observed. 
Functional Predictions – Guilt by Association 
One main objective in the analysis of protein-protein interactions is the annotation of protein 
functions, especially for hypothetical and conserved hypothetical proteins, which completely 
lack a functional annotation. The basis for these annotations is that proteins rarely function 
alone but in nearly all cases work in the context of other proteins. Thus, the molecular 
environment can provide clues about the respective protein’s function. This approach is 
commonly called “guilt-by-association” (Oliver 2000) approach and will be applied to 
hypothetical proteins and conserved hypothetical proteins in this thesis. 
The strength of this approach for functional annotation can be exemplified with the 
conserved hypothetical protein TP0658. TP0658 was found to specifically interact with all 
three flagellin proteins (FlaB1-3), the proteins forming the filament of the bacterial flagellum. 
These interactions clearly point to a role of TP0658 related to flagellin protein metabolism. 
Indeed, an in detail characterization (see below) (Titz et al. 2006a) definitely showed a 
function of TP0658 as a conserved assembly factor of the bacterial flagellum. 
However, in a functional genomics study not all interesting candidate genes can be followed 
up in detail. This section will provide a statistically filtered list of proteins without known 
function and their associations with functional categories based on their protein interactions. 
Nevertheless, one should keep in mind that these links not necessarily reveal a direct protein 
function, but, for example, can be based on regulatory links between functional categories in 
the cell (see paragraph on functional associations on page 107). 
The procedure was as follows. The number of interactions linking a protein of interest to a 
functional category (GO slim terms or TIGR sub roles) was counted. To remove unspecific 
associations, e.g. associations to highly abundant categories, a comparison with 1000 
randomized networks was done. Only functional links enriched compared to the randomized 
networks (Z-value > 2.0) and present in at least 50% (30% for TIGR sub role) of the 
interactions were selected (Table 29, Table 30). 
 
TPA defline GO term Z- 
Value 
# ints  
to GO 
# ints  
total 
ratio 
TP0004 H nucleotide binding (GO:0000166) 4.10 2 2 1.00 
TP0087 CH hydrolase activity (GO:0016787) 2.80 3 5 0.60 
TP0110 H membrane (GO:0016020) 2.38 2 3 0.67 
TP0150 H hydrolase activity (GO:0016787) 2.62 3 5 0.60 
TP0296 CH nucleotide binding (GO:0000166) 2.52 2 3 0.67 
TP0338 H membrane (GO:0016020) 3.17 2 3 0.67 
TP0432 H nucleotide binding (GO:0000166) 3.29 2 3 0.67 
TP0467 H membrane (GO:0016020) 2.38 2 4 0.50 
TP0496 CH nucleotide binding (GO:0000166) 2.56 3 6 0.50 
TP0496 CH protein biosynthesis (GO:0006412) 2.54 3 6 0.50 
TP0496 CH RNA metabolism (GO:0016070) 5.17 3 6 0.50 
TP0561 CH membrane (GO:0016020) 11.00 33 47 0.70 
TP0582 CH nucleotide binding (GO:0000166) 3.10 5 10 0.50 
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TP0629 H cell motility (GO:0006928) 3.72 3 6 0.50 
TP0650 CH protein biosynthesis (GO:0006412) 3.14 2 3 0.67 
TP0702 CH catalytic activity (GO:0003824) 7.53 2 3 0.67 
TP0702 CH molecular function unknown (GO:0005554) 4.85 2 3 0.67 
TP0708 H membrane (GO:0016020) 4.97 9 16 0.56 
TP0744 CH hydrolase activity (GO:0016787) 2.30 2 3 0.67 
TP0771 CH protein biosynthesis (GO:0006412) 4.71 2 3 0.67 
TP0802 H hydrolase activity (GO:0016787) 2.65 5 10 0.50 
TP0813 H RNA binding (GO:0003723) 5.53 2 3 0.67 
TP0826 CH hydrolase activity (GO:0016787) 2.76 2 3 0.67 
TP0873 H structural molecule activity (GO:0005198) 4.92 3 6 0.50 
TP0937 CH binding (GO:0005488) 6.30 2 2 1.00 
TP1002 CH metal ion binding (GO:0046872) 7.04 2 2 1.00 
TP1002 CH cation binding (GO:0043169) 7.53 2 2 1.00 
TP1002 CH hydrolase activity (GO:0016787) 3.95 2 2 1.00 
Table 29 Guilt-by-association via GO slim mapping. Each row represents the 
association of an uncharacterized protein (H for “hypothetical”, CH for “conserved 
hypothetical”) with a functional category via its protein interactions. The number of 
interactions to this category (# ints to GO) and the number of total interactions (#ints 
total) are given. The ratio defines the fraction of its interactions linking a protein to a 
function category. The Z-value indicates an enrichment of this link compared to 1000 
randomized networks (see Materials & Methods section) 
TPA defline TIGR sub role Z-Value # ints 
to role 
# ints 
total 
ratio 
TP0302 CH Cations and iron carrying compounds 11.49 2 2 1.00 
TP0629 CH Chemotaxis and motility 4.88 4 6 0.67 
TP0050 CH Chemotaxis and motility 4.17 5 10 0.50 
TP0579 CH Chemotaxis and motility 2.71 3 6 0.50 
TP0066 CH Chemotaxis and motility 3.68 5 11 0.45 
TP0064 H Chemotaxis and motility 3.16 4 9 0.44 
TP0877 CH Chemotaxis and motility 2.42 2 5 0.40 
TP0832 CH Chemotaxis and motility 6.12 14 37 0.38 
TP0183 CH DNA replication, recombination, and repair 4.56 6 16 0.38 
TP0873 CH Ribosomal proteins: synthesis and modification 4.54 2 6 0.33 
TP0496 CH tRNA aminoacylation 3.30 2 6 0.33 
TP0772 CH Chemotaxis and motility 2.75 3 9 0.33 
TP0583 CH Chemotaxis and motility 2.70 3 9 0.33 
TP0658 CH Chemotaxis and motility 2.38 3 10 0.30 
TP0782 H Chemotaxis and motility 2.17 2 6 0.33 
Table 30 Guilt-by-association via TIGR sub roles. See previous table for details. 
 
  
Here, the focus will be on proteins not associated to bacterial motility; proteins presumably 
involved in bacterial motility are discussed in the thesis of Rajagopala SV (Rajagopala 2006).  
TP0302 is a conserved hypothetical integral membrane protein associated to proteins 
“carrying cations”. TP0302 interacts with TP0917, a Mg2+ transport protein, and TP1038, 
bacterioferrin – an iron binding protein with unclear function. TP0302 has a “Branched-
chain amino acid transport system / permease component” domain (PF02653) which implies 
that TP0302 is involved in transport of either amino acids or sugars. A genomic 
neighbourhood (and homology) link to TP0301 in the String database indicates that these 
two integral membrane proteins might form a transporter complex in the membrane. The 
found interactions imply a functional link to cation transport. 
TP0183, a hypothetical protein only conserved in Treponema species, is linked to the process 
of “DNA replication, recombination, and repair” via six interactions. The interaction 
partners include DnaA, a DNA repair helicase (TP0380), UvrA, an exonuclease (TP0626), 
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ParB, and RecX. Strikingly, TP0183 is associated to the SsrA-binding protein (TP0184) by 
the genomic neighbourhood method in the String database (combined score 0.418).  SsrA-
binding protein (SmpB) binds and regulates ssrA’s  (tmRNA) function, a small RNA that 
interacts with selected ribosomes to target the nascent polypeptides for degradation. SsrA is 
required for correct timing of DNA replication (Keiler and Shapiro 2003) and the SmpB-
SsrA complex was, for example, found to be required for Yersinia pseudotubercolosis 
pathogenicity (Okan et al. 2006). In this context, TP0183 might be a specific factor present in 
T. pallidum and T. denticola, which functions as a regulatory protein in DNA replication and 
other processes via an unknown mechanism, potentially involving the SsrA-SmpB pair. 
The hypothetical protein TP0873 associates with several ribosomal proteins. On the 
contrary, it was also found to interact with TP0870 in a reciprocal manner and an association 
with flagellar genes is supported by the gene neighbourhood method as provided by the 
String database (combined String score of 0.383 to FliD). Thus, TP0873 might link flagellum 
related processes to the translational machinery. 
The interactions of TP0496, a protein conserved in Treponema and Borrelia species, include 
several proteins involved in protein biosynthesis/tRNA metabolism. A link to DNA 
replication is formed by the interaction with DNA primase (DnaE). TP0496 is located in an 
operon with ROD shape-determining proteins MreB/C (von Mering et al. 2005).  The 
interaction with the DNA replication protein DnaE is in concordance with the known link 
between MreB and DNA replication (Defeu Soufo and Graumann 2005). Therefore, TP0496 
might function as a link between tRNA metabolism (amino acid or translational status) and 
DNA replication. 
 
Comparison with protein networks of other species 
Binary comparison with datasets from other species 
The T. pallidum network was compared with protein interaction networks of other species. 
This comparative interactomics analysis is based on orthologous relationships between genes 
from different species. The common assumption is that orthologous proteins share a similar 
function, and thus show a similar interaction pattern. However, this hypothesis does not 
need to hold for all orthologs considered. 
Interaction datasets from three different bacterial species were considered. Rain et al. 
generated a partial Y2H-based protein-interaction map for H. pylori (HPY); Parish et al. 
analyzed the whole proteome of C. jejuni for binary protein-interaction with the Y2H system 
(unpublished data, kindly provided by R. Finley’s group) (CJE); Butland et al. and 
Ariffuzaman conducted two large-scale complex purification for E. coli (ECO I&II) (Rain et 
al. 2001; Butland et al. 2005; Arifuzzaman et al. 2006; Baba et al. 2006). 
The comparison were based on two different definitions of orthologous gene relationships: 
by the COG algorithm as provided by the String database (von Mering et al. 2005) and by the 
MBGD database (Uchiyama 2003). MBGD provides a more stringent definition of 
orthology; for this thesis, the alignment was demanded to cover at least 50% of the smaller 
protein’s sequence. 
The results of this comparison with the number of interactions identified in another species’ 
set are shown in Table 31. 
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  HPY CJE 
all 
CJE 
HCF 
ECO 
SPK I 
ECO 
SAI I 
ECO 
SPK II 
ECO 
SAI II 
MBGD 6/132 
=4.5% 
10/1016 
=1.0% 
6/318= 
=1.9% 
9/2037 
=0.4% 
4/455 
=0.9% 
6/1268 
=0.5% 
8/546 
=1.5% 
TPA 
all 
COG 10/196 
=5.1% 
25/1314 
=1.9% 
15/428 
=3.5% 
12/2381 
=0.5% 
7/588 
=1.2% 
10/1549 
=0.6% 
12/685 
=1.8% 
MBGD 5/132 
=3.8% 
8/1016 
=0.9% 
6/318 
=1.9% 
8/2037 
=0.4% 
4/455 
=0.9% 
5/1268 
=0.4% 
7/546 
=1.3% 
TPA 
filtered 
COG 9/196 
=4.6% 
18/1314 
=1.4% 
11/428 
=2.6% 
10/2381 
=0.4% 
7/588 
=1.2% 
9/1549 
=0.6% 
11/685 
=1.6% 
Table 31 Overlap between interaction datasets.  T. pallidum interactions were 
compared with other datasets: HPY (H. pylori, (Rain et al. 2001)), ECO SPK I (E. coli 
spoke, (Butland et al. 2005)), ECO SAI I (E.coli SAI, socio-affinity-index (Gavin et al. 
2006), (Butland et al. 2005)), ECO SPK II (E. coli spoke, (Arifuzzaman et al. 2006)), ECO 
SAI II (E. coli SAI, (Arifuzzaman et al. 2006)). Interolog predictions were based on 
orthologous relationships as defined by the MBGD database or the COG database 
(taken from StringDB). Interologs were predicted for T. pallidum and the number of T. 
pallidum interactions overlapping with these predicted interactions was counted. Overlap 
is given as: X/Y=Z%, with X being the number of interactions in T. pallidum overlapping 
with predicted interologs from reference set; Y being the total number of predicted 
interologs only counting a maximum of one interolog per identified interaction; z 
percentage of overlap. Please note: Butland et al. include homodimers in their interaction 
set. 
In addition, the data was compared to an intermediate-scale Y2H study focusing on bacterial 
DNA replication in B. subtilis (Noirot-Gros et al. 2002). The dataset obtained from the SpiD 
database (genome.jouy.inra.fr/spid) contains interactions identified in the library screens, by 
additional matrix screens (directly testing for known interactions), and a few literature derived 
interactions. In total, 110 entries with mapped systematic B. subtilis genes were present. Only 
27 interologs could be predicted for T. pallidum based on MBGD orthology, and of these 
only two were reproduced in our Y2H screen: TP0058 (DnaB)-TP1005 (DnaH) and 
TP1005-TP1005 (7.4%).  
The identity of overlapping T. pallidum interactions with predicted interologs is shown in 
Supplementary Table 4. 
 
Overlap with (predicted) Protein Complexes 
In the previous section, the direct, binary overlap of interactions was calculated. Here, the 
interactions will be compared with predicted complexes from complex purification studies. 
The raw results of complex purification studies show co-purified proteins, not distinct 
protein complexes. To identify defined protein complexes the specific affinity between 
protein pairs in an E. coli complex purification study was defined (Arifuzzaman et al. 2006) – 
the limited coAP/MS study (Butland et al. 2005) was not considered. For this, the socio-
affinity model (SAI) as defined by Gavin et al. (Gavin et al. 2006) was used (the SAI 
calculation was done by J. Goll). SAI combines the spoke and matrix model of co-
purifications into one statistical framework. The SAI score indicates the propensity of two 
proteins to co-purify specifically in the whole dataset. A SAI score cutoff of 5 (as judged 
from the SAI score distribution and similar to the cutoff defined by Gavin et al. (Gavin et al. 
2006)) was chosen and the clustering algorithm MCODE (Bader and Hogue 2003) was 
applied to this network to identify protein complexes (Supplementary Table 6). Table 32 
shows a summary of these complexes with more than 5 orthologous components in T. 
pallidum (as defined by the MBGD database) and T. pallidum interologs connecting the 
homologous components of these complexes. Complex 8 is the complex with the highest 
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number of internal Y2H connections. However, these internal interactions were only found 
for a huge complex covering ~5% of the genome of E. coli. 
  
# 
components 
# Hom. 
components 
interactions in complex # internal 
interactions 
344 74 TP0757-TP0947 TP0757-TP0459 TP0757-TP0255 
TP0519-TP0519 TP0519-TP0234 TP0519-TP0094 
TP0519-TP0237 TP0519-TP0067 TP0124-TP0067 
TP0498-TP0397 TP0586-TP0397 TP0586-TP0648 
TP0586-TP0067 TP0643-TP0397 TP0459-TP0067 
TP0773-TP0237 TP0660-TP0067 TP0094-TP0067 
TP0162-TP0959 TP0034-TP0469  
20 
118 32 TP0554-TP0985 TP0554-TP0097 TP0097-TP0684  3 
113 25   0 
71 23 TP0519-TP0519 1 
83 19 TP0071-TP0519 TP0632-TP0339 TP0188-TP0519 
TP0094-TP0519 TP0519-TP0519  
5 
32 12 TP0870-TP0760 TP0870-TP0640  2 
36 12   0 
22 9   0 
37 6 TP0121-TP0121  1 
35 6   0 
17 6   0 
Table 32 E. coli protein complexes (Mori SAI defined by MCODE) and T. 
pallidum interologs. Only complexes with more than five orthologous components (as 
defined by MBGD) are shown. 
Experimental Overlap 
The overlap with the C. jejuni data from Parish et al. is small (~3%). Interestingly, Parish et al. 
retested 173 interactions from the T. pallidum dataset with their system and classified ~28% as 
positive (pers. comm.). Thus, the actual number of reproducible interactions between two 
species and two different Y2H systems seems to be bigger than one would conclude from 
the direct comparison of large-scale datasets. 
However, only a limited reproducibility rate was observed when testing T. pallidum derived 
interologs in an Y2H system of H. pylori proteins. 71 H. pylori interologs were selected 
(Supplementary Table 5) and the corresponding Gateway-based entry clones (pDONR221 
vector) were obtained from the “Pathogen Functional Genomics Resource Center” (TIGR, 
Rockville, U.S.A.). The ORFs were transferred into a bait (pBD-ccdB, Satoko Yoshida, LMU 
München) and prey vector (pGADT7-DEST), transformed into yeast, and re-tested for Y2H 
interactions; as a control, the activation level on –LTH (without 3-AT) of the bait-prey 
combination was compared with the combination of bait and empty prey vector (pGADT7-
DEST). 
The results are presented in Table 33 and Supplementary Table 5. In total, only 5 out of 71 
tested interologs were reproduced (~7%). This percentage is in the same range as the overlap 
between the whole networks. However, it demonstrates that additional interologs can be still 
identified, especially for H. pylori, for which only 261 baits were tested in the large-scale 
screen (Rain et al. 2001). 
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bait HP0238 
(TP0160) 
HP0238 
(TP0160) 
HP0238 
(TP0160) 
HP0238 
(TP0160) 
HP0717 
(TP1005) 
HP1111 
(TP0939) 
HP0772 
(TP0247) 
HP1547 
(TP0586) 
prey HP0787 
(TP0582) 
HP0763 
(TP0578) 
HP1063 
(TP0946) 
HP1030 
(TP0720) 
HP0269 
(TP0754) 
HP1154 
(TP0658) 
HP1139 
(TP0272) 
HP1138 
(TP0271) 
Y2H 
        
control 
        
result + + (+) + + (+) + (+) 
Table 33 Y2H test of H. pylori interologs. Only tested interologs which showed 
higher activation (Y2H) compared to the background (control, empty prey vector) are 
shown. 5 interactions were marked as positive “+”; three showed too much background 
activation and were not considered (in parenthesis). 
In addition, it should be mentioned that the high false negative rate of the Y2H system 
prevents conclusions on the absence or non conservation of an interaction. For a large-scale 
Y2H study on herpesviral interactions only ~10% of a set of predicted interologs could be 
verified by Y2H using orthologs of another herpes virus, whereas up to 90% could be 
verified by co-immunoprecipitations (groups of P. Uetz and J. Haas, manuscript in preparation). 
Essential and Pathogenicity-related Genes 
Pathogenicity related genes are of special interest as insights on these proteins could be the 
basis for further understanding of the Syphilis disease and potentially be used as targets for 
antibiotic interference. Essential genes are required for survival, and thus for pathogenicity. 
In addition, specific pathogenicity associated genes can be identified. 
Prediction of Essential Genes for T. pallidum 
The literature about gene essentiality and their protein interaction properties is ambiguous. 
Essential genes were suggested to show a higher number of interactions than other gene 
classes (Jeong et al. 2001), but this finding has been questioned (Coulomb et al. 2005) (see 
introduction). 
 
 method essential genes 
(% of genome) 
predicted for T. 
pallidum 
(MBGD) 
(% of genome) 
B. subtilis 
(Kobayashi et 
al.) 
systematic gene 
inactivation & 
integration of 
previous studies 
271 
(6.6%) 
181 
(17.4%) 
 
E. coli  
(Baba et al.) 
systematic gene 
inactivation & 
integration of 
previous studies 
303 
(6.8%) 
179 
(17.2%) 
M. genitalium 
(Glass et al.) 
Saturated 
transposon 
screen 
382 
(79.2%) 
204 
(19.6%) 
Table 34 Overview of datasets and results for the prediction of essential 
genes in T. pallidum. 
Gene essentiality is always dependent on the selected growth conditions and there are large 
variations between datasets. Since T. pallidum cannot be cultured continuously in vitro and 
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genetic manipulation methods are not established, no dataset on gene essentially for T. 
pallidum itself is available. However, essential genes can be predicted based on orthologous 
gene relationships. Still, many essential genes seem to be essential only in a specific species, 
for example, due to the differential presence of paralogous proteins. 
In this thesis, three species with corresponding essential gene datasets were selected for the 
prediction of essential genes in T. pallidum: E. coli (Baba et al. 2006), B. subtilis (Kobayashi et 
al. 2003), and M. genitalium (Glass et al. 2006). The union of these sets can be assumed to 
cover most of the bacterial essential genes, which are conserved in several species. Orthology 
relationships were obtained from the MBGD database (Uchiyama 2003). 
An overview of the predictions is given in Table 34, a list of these predictions can be found 
in Supplementary Table 17. 
In total, 282 genes of T. pallidum were predicted to be essential. Only 99 of these genes were 
found to be essential in all three species, on which the prediction was based (Fig. 35). 
ECO
BSUMGE
99
32
2761 24
17 31
 
Fig. 35 Overlap of predicted essential genes for T. pallidum. Venn diagram shows 
the overlap between the essential gene predictions from three different datasets 
(ECO=E. coli, BSU=B. subtilis, MGE=M. genitalium) 
Pathogenicity Associated Genes 
Possible virulence factors (pathogenicity associated genes) were defined by Weinstock et al. 
(Weinstock et al. 1998) and divided into six groups: Tpr proteins, hemolysins, regulators, 
polysaccharide biosynthesis, potential membrane or surface-exposed proteins, and proteins 
with miscellaneous functions. Several protein interactions were identified for these proteins 
(Supplementary Table 18). Examples of these interactions are discussed next.  
The capsular polysaccharide biosynthesis protein (Cap5D, TP0077) interacts with TP0297, a 
conserved hypothetical protein without known function. TP0297 contains a “SPOR” domain 
(Interpro: IPR007730). This 35 residue repeat is found in bacterial proteins involved in 
sporulation and cell division and might be involved in binding peptidoglycan (Mulder et al. 
2005). The interaction supports a function for TP0297 in cell wall metabolism and puts this 
gene into a pathogenicity context. 
TP0038, the regulatory protein PfoS/R, interacts with the hypothetical protein TP0708. 
TP0708 is the gene neighbor of TP0709, a RNA polymerase sigma factor. This might 
indicate a role of TP0708 in transcriptional regulation in association with TP0038. 
Two binary pathogenicity-related complexes were identified. The virulence factor (MviN), 
TP0516, interacts with TP0171 (Tpp15), another virulence factor. The membrane antigen 
tpd, TP0971, interacts with another virulence gene, TP0171 indicating a functional link of 
these proteins. 
Due to the presence of the “HD_hydro” (Interpro: IPR006674) domain, the conserved 
hypothetical protein TP0877 can be predicted to function as a metal-dependent HD-GYP 
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hydrolase involved in signal transduction. Its interactions points to a signal integration 
function. It interacts with TP0492 (DNA primase), TP0630 (CheR, chemotaxis 
methyltransferase), TP0461 (hypothetical protein with DNA binding domain), and TP0981 
(signal transduction histidine kinase). 
In addition to TP0877, the interactors of the signal transduction protein TP0981 include 
TP0089 (cyclic nucleotide binding protein) and TP0092 (RNA polymerase sigma factor). 
The conserved hypothetical protein TP0819 has a “Blactmase-like” domain (Interpro: 
IPR001279) and shows three interactions with cell wall enzymes: TP0247 (AmiA), TP0341 
(MurC), and TP0670 (D-ala-D-ala-ligase). Thus, this enzyme is most probably involved in 
cell wall metabolism. However, a certain sequence similarity to ribonucleases needs to be 
functionally tested. 
These individual examples provide starting points for a detailed investigation of the 
mechanisms of virulence. 
A second set of putative pathogenicity associated genes is provided by a microarray study. 
Gene expression levels during experimental rabbit infection with T. pallidum were measured 
by Smajs et al. (Smajs et al. 2005). In this microarray study, the cDNA/DNA signal ratio was 
calculated giving relative expression levels of all T. pallidum proteins. Several flagellar, but also 
ribosomal proteins were found among the genes with highest expression levels. This study 
gives an impression on the genes that are highly expressed during infection, but does not 
report specific virulence factors (due to lack of differential expression profiles). 
 
Topological Properties 
Different protein classes can be assessed in respect to several topological properties. Here, 
only the node degree and the centroid values are analyzed.  
The centroid value indicates the localization of a protein towards the center of the network 
and is defined as 
 
 
 
Where f (v,w) := γv(w)- γw(v) and γv(w) denotes the number of vertices that are closer to v 
than to w (Junker et al. 2006).  The centralities were computed with CentriBin (Junker et al. 
2006). 
However, no significant difference of the analyzed distributions was observed except for the 
distribution of centroid values for the pathogenicity related gene classes (Fig. 36). Regulatory 
proteins, which are classified as pathogenicity related proteins, had significantly higher 
centroid values compared to other proteins. Since the centroid value of a protein indicates its 
location in the center of the PIM, regulatory proteins can be thought to be well embedded in 
the network, and thus capable to measure the status of the network. 
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Fig. 36 Centralities. (A) Boxplot of node degrees comparing predicted essential vs. 
remaining proteins. Proteins with node degree of zero were not considered. The whole T. 
pallidum network was used. (B) Cumulative probability for node degrees comparing 
predicted essential vs. remaining proteins. Proteins with node degree of zero were 
considered and the computation was based on the filtered T. pallidum network. (C) 
Boxplot of centroid values comparing predicted essential vs. remaining proteins. The 
filtered T. pallidum network was used. (D) Boxplot of node degrees comparing different 
classes of pathogenicity related genes and remaining proteins (-). The filtered T. pallidum 
network was used.  (E) Boxplot of centroid values comparing different classes of 
pathogenicity related genes and remaining proteins. The filtered T. pallidum network was 
used. (*) Statistically significant difference (p<0.05) based on Kruskal-Wallis rank sum 
test. 
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Functional Associations 
Functional associations of pathogenicity related genes and predicted essential genes were 
analyzed analogously to the functional class connections in the whole network (see above). 
Only connections between gene classes with at least two interactions and a Z-value > 2 
(statistical significance) were considered (Fig. 37, Supplementary Table 19, Supplementary 
Table 20). 
A
B
 
 
Fig. 37 Functional associations of pathogenicity related and essential genes. The 
connections between pathogenicity related and predicted essential genes and functional 
categories in the filtered T. pallidum dataset are shown. Connections to GO terms are 
shown in (A) and connections to TIGR main roles are shown in (B). The width of edges 
between functional categories are scaled according  to the number of Y2H interactions 
connecting them, the number of interactions is given as edge label, and the darkness of 
the edge indicates the statistical significance (Z-value, see supplementary tables). Only 
connections with Z>2.0 are shown. 
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Surface localized pathogenicity proteins (“PATH_SURFACE”) were linked to proteins with 
the highest expression during experimental rabbit infection (“TOP50_EXPRESSION”) 
(Table 35). The linking interactions include, for example, the heterodimer of pathogen-
specific membrane antigen (Tpd, TP0971) and 15kDa lipoprotein (Tpp15, TP0171). Both 
proteins are highly expressed and classified as pathogenicity-related genes indicating the 
formation of a pathogenicity-related binary complex. The hypothetical protein TP0869 
interacts with the leucine-rich repeat protein TpLRR (TP0225) indicating a pathogenicity-
related function for TP0869, as well. 
 
Bait Description Class Prey Description Class 
TP0006 Tp75 protein  S TP1013 chaperonin (groES)  E 
TP0163 ABC transporter, periplasmic binding 
protein (troA)  
S TP1013 chaperonin (groES)  E 
TP0228 biotin synthase, putative (bioY)  E TP0034 ABC transporter, periplasmic 
binding protein  
S 
TP0869 hypothetical protein E TP0225 leucine-rich repeat protein 
TpLRR  
S 
TP0870 flagellar filament 31 kDa core protein 
(flaB3)    
E TP0702 conserved hypothetical protein  S 
TP0971 membrane antigen, pathogen-specific 
(tpd)  
E, S TP0171 lipoprotein, 15 kDa (tpp15)  E, S 
TP1038 bacterioferrin (TpF1)  S TP0171 lipoprotein, 15 kDa (tpp15)  E 
Table 35 Interactions linking PATH_SURFACE (S) and TOP50_EXPRESSION (E) 
Genes essential in E. coli, B. subtilis, and M. genitalium were, for example, linked to genes 
possessing helicase activity (Table 36). 
  
Bait Description Class Prey Description Class 
TP0058 replicative DNA helicase 
(dnaB)  
H TP0001 chromosomal replication initiator protein 
(dnaA)  
E 
TP0058 replicative DNA helicase 
(dnaB)  
H TP0005 DNA gyrase, subunit A (gyrA)  E 
TP0058 replicative DNA helicase 
(dnaB)  
E TP0102 rep helicase, single-stranded DNA-
dependent ATPase (rep)  
H 
TP0526 ATP-dependent helicase 
(hrpA)  
H TP0192 ribosomal protein L2 (rplB)  E 
TP0526 ATP-dependent helicase 
(hrpA)  
H TP0892 N utilization substance protein A (nusA)  E 
TP0578 cell division protein (ftsY)  E TP0380 DNA repair helicase, putative  H 
TP0687 DNA recombinase 
(recG)  
H TP1013 chaperonin (groES)  E 
Table 36 Interactions linking "essential in all" (E) and "helicase activity GO:0004386" (H) 
Another interesting interaction class, although not over-represented, links genes essential in 
all three considered bacteria to other essential genes (Table 37). These interactions are 
attractive targets for antibiotics directed against protein interaction epitopes.  
 
Bait Description Prey Description 
TP0058 replicative DNA helicase (dnaB)  TP0001 chromosomal replication initiator protein 
(dnaA)  
TP0058 replicative DNA helicase (dnaB)  TP0005 DNA gyrase, subunit A (gyrA)  
TP0192 ribosomal protein L2 (rplB)  TP0756 methionyl-tRNA formyltransferase (fmt)  
TP0354 thymidylate kinase (tmk)  TP0097 translation initiation factor 1 (infA)  
TP0394 DNA topoisomerase I (topA)  TP0208 preprotein translocase subunit (secY)  
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TP0641 histidyl-tRNA synthetase (hisS)  TP0641 histidyl-tRNA synthetase (hisS)  
TP0756 methionyl-tRNA formyltransferase 
(fmt)  
TP1013 chaperonin (groES)  
TP0794 S-adenosylmethionine synthetase 
(metK)  
TP0002 DNA polymerase III, subunit beta (dnaN)  
TP0842 methionine aminopeptidase (map)  TP0294 phosphoribosyl pyrophosphate synthetase 
(prs)  
TP0842 methionine aminopeptidase (map)  TP0354 thymidylate kinase (tmk)  
TP1024 ribosomal protein S9 (rpsI)  TP0743 ribosomal protein L27 (rpl27)  
Table 37 Interactions between genes essential in all considered bacteria (E. coli, B. 
subtilis, and M. genitalium). 
Protein interactions of essential and pathogenicity related proteins provide interesting clues 
on the function and functional links of these proteins. However, these clues need to be taken 
as a basis for functional and pathogenicity related tests. 
Set of Interactions Supported by Additional Evidences & Evolutionary Conservation 
In this paragraph, a subset of protein interactions identified by Y2H and supported by 
additional evidences is defined and analyzed with respect to evolutionary conservation. 
Interactions supported by the String database at a medium confidence level (score > 0.4) or 
reproduced by any other dataset considered in this study were selected. In total, 155 
interactions were compiled in this subset with the majority (106) supported by the String 
database. 
The network of these selected interactions is shown in Fig. 38 A. Conservation of these 
protein interactions through evolution is visualized in Fig. 38 B and individual interactions 
can be found in Supplementary Table 16. 
Conserved interactions fall into different conservation classes: the protein-interaction 
partners might be overall conserved (class II, IV), always present and absent together (class 
I), or one interacting protein might be abundantly expressed whereas the other is optional 
(class III). 
These conservation classes are based on different distributions of functional categories. Class 
I consists mainly of “chemotaxis and motility proteins” (~65% of the interacting proteins). 
These motility-related interaction pairs are present in motile bacteria and absent in non-
motile bacteria. Class II contains several DNA metabolism-related (27%) and protein 
translation (24%) proteins. These interaction pairs are highly conserved in prokaryotes. Class 
III contains conserved hypothetical proteins (20%), DNA metabolism (17%), and 
“chemotaxis and motility” (13%) proteins. These interactions are formed between one 
constitutive and on optional interaction partner. For example, the constitutive protein 
ribonucleoside-diphosphate reductase (NrdB) interacts with a flagellar filament protein 
(FlaB3) in motile bacteria. This link is probably involved in regulation and is supported by the 
discovery of a regulationary link between NrdB and motility by Nishimura & Hirota 
(Nishimura and Hirota 1989). Another example is the constitutive excinuclease uvrC, which 
is co-conserved with the interacting conserved hypothetical protein TP0894 in a subset of 
bacterial species. TP0894 carries a DNA binding domain (OB-fold nucleic acid-binding 
domain), which is also present in DNA repair proteins such as RecG and BRCA2. Thus, the 
orthologous group of TP0894 appears to contain novel DNA repair proteins, whose 
function involves the binding to uvrC. Class IV contains an even higher number of 
conserved proteins (45%) and DNA metabolism proteins (18%). 
In addition, note that the protein interaction network of T. pallidum serve as a reliable basis to 
predict protein interactions for other sequenced species (Fig. 38). 
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Fig. 38 Subset of interactions supported by additional evidences. Y2H interactions 
from the whole T. pallidum dataset, which are supported either by the String database 
(medium confidence level) or by an overlap with any other protein-interaction study, are 
selected. (A) Network of these interactions colored according to TIGR main roles. (B) 
Conservation of protein interactions through evolution. Phylogenetic profiles of selected 
protein interactions (only from filtered dataset) are shown: each column reflects one 
species, each row one protein interaction. The color indicates the conservation of each 
protein interaction (on proteins’ level) in each species ranging from white (both 
interacting proteins are absent) to dark green (both proteins are present) (see color key). 
The species are arranged according to their taxonomic relationships (String database). 
The phylogenetic profiles are based on predicted orthology relationships taken from the 
String database (von Mering et al. 2005). Orthology can be used for predicting protein 
interactions in other species. Predictions were based on the filtered interaction set of T. 
pallidum. The maximal number of protein interactions depends on the number of proteins 
of the organism. The bar diagram below the conservation diagram shows the percentage 
of predicted interactions for each species taking the maximal number of interactions as 
the basis. 
Establishing of Co-Immunoprecipitation Strategy and Initial Results (coEXcoIP method) 
The yeast-two-hybrid system employed in this study is designed to reduce the number of 
false positive interactions. Nevertheless, verification of the identified protein-interactions is 
usually the first step before focusing on functional details of a protein-interaction. 
In this paragraph, a method that allows for intermediate-throughput verification of protein-
interactions is presented. This method relies on the co-immunoprecipitation (coIP) of 
proteins co-expressed in E. coli cells. 
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Fig. 39 coExCoIP method. Verification of protein-interactions by co-
immunoprecipitation of co-expressed proteins. (A) Vectors designed for co-expression in 
E. coli. (B) Co-immunoprecipitation done for T. pallidum interactome. (*) Myc-fusion not 
expressed in soluble form. 
The selection of the expression systems is most crucial; a non-physiological high expression 
level can, for example, lead to aggregation and precipitation of the proteins. The co-
expression vectors were designed on basis of the pBad-vector series (Fig. 39 A) (Guzman et 
al. 1995). A Myc-tag fused to a loxP-site was inserted into the multiple cloning site (MCS) of 
pBad24 and a HA-tag fused to a loxP-site was inserted into the MCS of pBad33. Co-
transformation of a single E. coli cell with these vectors is feasible due to compatible origins, 
pBR322 origin and pACYC184 origin, and complementary resistance genes, AmpR 
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(ampicillin) and Cmr (chloramphenicol). Entry clones from the UPS-cloning system can easily 
be recombined with these vectors, co-transformed into E. coli DE3 cells, and used for co-
immunoprecipitation. Because the anti-Myc antibody (Santa Cruz) proved to work well for 
co-immunoprecipitation, coIPs were done with this antibody. 
A small subset of protein-interactions from the Y2H screen was tested with this method (Fig. 
39 B). The following interactions could be confirmed: TP0974 (newly identified FlgM 
protein)-TP0709 (sigma factor), TP0247 (AmiA)-TP0443 (hypothetical protein), TP0121 
(hypothetical, lysine aminomutase) -TP0121, TP0212 (RNA polymerase alpha chain) -
TP0383 (conserved hypothetical protein), TP0058 (DNA helicase)-TP0092 (sigma factor), 
and TP0058-TP1005 (DNA polymerase III, subunits gamma and tau). 
Thus, the system works as a verification method for protein-interactions detected by the 
Y2H system. In addition, a higher solubility of proteins is observed in this system compared 
to expression from a GST-vector, pMM110. However, this system should be adapted for 
higher throughput in the future. This can be done performing the co-expression in 96-well 
plates and optimizing the coIP-method for the same plate format. 
 
An Individual Gene Truncation Study – TP0981 
TP0981 is a putative sensory transduction enzyme, which carries a GAF and a 
DUF1/GGDEF domain. The GAF domain probably functions as a signal input domain, 
whereas the output is mediated through cyclic-di-GMP produced by the GGDEF domain 
(Jenal and Malone 2006). 
Due to its signalling function TP0981 is of special interest. It was found to interact with 
several proteins including DNA metabolism and tRNA metabolism proteins (Supplementary 
Table 2). 
TP0981 was split into its domains and these fragments were tested for interactions in the 
Y2H assay (Fig. 40). 
 
 
Fig. 40 Interactions of TP0981's fragments. Four fragments of TP0981 (T1-T4, see B) 
were prepared and tested for interactions in the Y2H assay (A). Only tests which yielded 
a positive interaction are shown. In the upper panel TP0981 and its fragments are tested 
as baits, in the lower panel as preys. GAD is the mating with the empty prey vector (pLP-
GADT7) and serves as a negative control. (B) Summary of TP0981 fragments and 
interacting regions. TP0981 consists of a GAF and a DUF1 (GGDEF) domain. The 
rows T1-T4 show the region of the individual fragments of TP0981. For the interactors 
of TP0981 (TP0870-TP1019), the interacting regions of TP0981 is shown. 
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The DUF1/GGDEF domain alone (fragment T4) showed unspecific interactions (self-
activator). Even at higher concentrations of 3-AT (competitive inhibitor of His3p) no 
specific interactions were identified. Thus, results involving interactions with this fragment 
could not be evaluated. 
TP0661 interacts unspecifically with all fragments indicating that its interactions are false 
positives (interaction is not contained in filtered interaction map). 
TP0530, TP1004, and TP1005 appear to bind to the N-terminal part, which also includes the 
GAF domain. TP1019 interacts only with fragment T3, thus it might interact with the 
GGDEF domain. 
TP1004 (RecR) and TP1005 (DnaA) are both involved in DNA metabolism indicating a link 
of the input domain to DNA metabolism. TP1019 is involved in tRNA metabolism and 
might constitute another regulatory link. 
Thus, it can be concluded that the interacting domains of TP0981 could be narrowed down 
for a few interacting proteins. The results indicate a link between the input domain and DNA 
metabolism. However, the biological significance of this link is still not clear. 
 
3.4. A Functional Complex – Proteins Involved in Bacterial Motility 
A special type of motility, e.g. involving periplasmic flagella, characterizes T. pallidum. 
However, understanding of its motility is still at its infancy. What can large-scale studies 
contribute to the characterization of bacterial motility? 
Several interactions involving known motility proteins were discovered by Y2H screening. 
These include intra motility interactions and interactions with other functional classes (see 
Fig. 31). Among them, several uncharacterized proteins showed an interaction with known 
motility proteins (see Table 30). These are candidates for bona fide motility proteins. In 
chapter 3.5 the in detail characterization of a newly identified assembly factor for the bacterial 
flagellum is presented. 
This section is limited to two aspects. First, a genome-wide motility screen for E. coli is 
presented. Secondly, connections of motility proteins to other functional categories in several 
datasets are compared. These results are part of a broader analysis of bacterial motility, which 
will be published separately. An in detail analysis of T. pallidum’s motility proteins can be 
found in the PhD thesis of SV Rajagopala (Rajagopala 2006).  
Genes Essential for Bacterial Motility 
Although, interaction datasets provide evidence for 
physical links of proteins with the motility complex, they 
do not offer insights into the functional relevance of the 
found interactions. Thus, the interaction sets need to be 
complemented with functional data.  
For B. subtilis, a genome-wide analysis of genes affecting 
motility is available (Schumann et al. 2000). Additional 
mutants were added to this set (Rajagopala 2006; Titz et al. 
2006a). 
For E. coli such a systematic analysis of motility 
phenotypes has not been undertaken. Therefore, a 
systematic knockout library comprising of 3985 individual 
mutant strains (Baba et al. 2006) was tested for a reduction 
of motility using an automated robotic procedure 
(Supplementary Table 22). 
Both large-scale motility datasets contain a similar number 
of affected mutants: 146 for B. subtilis and 159 for E. coli (Table 38). About 4% of genes in 
both species show an effect on motility under the conditions tested. Among them are 45 
Fig. 41 Example plates of 
genome-wide motility 
phenotyping for E. coli. Two 
"swarming plates" with 24 tested 
mutant strains on each plate are 
shown. 
azoR
purC
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(30%) and 43 (27%) known motility genes, respectively. The others belong to several 
functional classes (Fig. 42): Both datasets are, for example, significantly enriched for proteins 
involved in “Energy metabolism” and “Biosynthesis and degradation of surface 
polysaccharides and lipopolysaccharides”.  
Both motility datasets show a high fraction (~30%) of known motility proteins supporting 
the quality of both datasets. The overlap between both datasets, however, is small with 37% 
and 50% of the orthologs present in the other species showing a motility phenotype. 
 
 
 E. coli B. subtilis 
motility mutants 
(% genome) 
159 
(3.7%) 
146 
(3.5%) 
orthologs (MBGD) 
in other species 
81 
(51%) 
68 
(47%) 
orthologs with reduced motility 
(% overlap of orthologs) 
30 
(37%) 
34 
(50%) 
Table 38 Comparison of E. coli and B. subtilis motility mutant data. 
The number of mutant strains (genes) with reduced motility in B. subtilis 
and E. coli is given. For each motility mutant set, the number of orthologs 
in the other species is shown, e.g. 81 motility mutant genes of E. coli are 
present in the genome of B. subtilis as orthologous proteins. Orthology was 
defined by the MBGD database (Uchiyama 2003). For these orthologous 
mutant genes the number showing a motility phenotype in the other 
species is given. 
The overlap between both motility datasets is mainly based on known motility proteins 
(Table 39). Apart from these, only a single peptidoglycan enzyme, AmiA, was reproducibly 
found in both species. On can conclude, that most (if not all) bona fide core motility proteins, 
which are conserved throughout evolution, have already been identified. On the other hand, 
it is clear that a large number of additional genes show an effect on motility. This can be 
explained by different levels of essentiality of certain metabolic or peptidoglycan enzymes 
(for general processes required for motility) in these species. Strikingly, only about 50% of 
genes affecting motility in one species are conserved in the other. A certain subset of these 
genes might be species-specific genuine motility genes. Examples of species-specific motility 
proteins are given by Pallen et al. (Pallen et al. 2005) and another example is presented in 
chapter 3.5. 
 
 Gene Description 
 B1073  flgB (flagellar component of cell-proximal portion of basal-body rod) 
 B1074  flgC (flagellar component of cell-proximal portion of basal-body rod) 
 B1078  flgG (flagellar component of cell-distal portion of basal-body rod) 
 B1081  flgJ (muramidase) 
 B1082  flgK (flagellar hook-filament junction protein 1) 
 B1083  flgL (flagellar hook-filament junction protein) 
 B1879  flhA (predicted flagellar export pore protein) 
 B1880  flhB (predicted flagellar export pore protein) 
 B1883  cheB (fused chemotaxis regulator) 
 B1884  cheR (chemotaxis regulator, protein-glutamate methyltransferase) 
 B1885*  tap (methyl-accepting protein IV) 
 B1887  cheW (purine-binding chemotaxis protein) 
 B1888  cheA (fused chemotactic sensory histidine kinase) 
 B1889  motB (protein that enables flagellar motor rotation) 
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 B1890  motA (proton conductor component of flagella motor) 
 B1922  fliA (RNA polymerase, sigma 28 (sigma F) factor) 
 B1923*  fliC (flagellar filament structural protein (flagellin)) 
 B1924  fliD (flagellar filament capping protein) 
 B1925  fliS (flagellar protein potentiates polymerization) 
 B1938  fliF (flagellar basal-body MS-ring and collar protein) 
 B1939  fliG (flagellar motor switching and energizing component) 
 B1941  fliI (flagellum-specific ATP synthase) 
 B1942  fliJ (flagellar protein) 
 B1945  fliM (flagellar motor switching and energizing component) 
 B1946  fliN (flagellar motor switching and energizing component) 
 B1948  fliP (flagellar biosynthesis protein) 
 B1949  fliQ (flagellar biosynthesis protein) 
 B1950  fliR (flagellar export pore protein) 
 B2435  amiA (N-acetylmuramoyl-l-alanine amidase I) 
 B4355*  tsr (methyl-accepting chemotaxis protein I, serine sensor receptor) 
Table 39 Mutated E. coli genes with motility phenotype in E. coli and B. subtilis. 
* more than one paralog with reduced motility in B. subtilis. 
TPA  
protein 
…interacts 
with 
description …has 
motility 
Phenotype 
TP0738  FlgC, FlaA, FliS conserved hypothetical protein  B0637 
TP0247  FlaA N-acetylmuramoyl-L-alanine amidase (amiA)  B2435 
TP0255  FlaA ribosomal protein L31 (rpmE)  B3936 
TP0339  FlgD conserved hypothetical protein  B2594 
TP0773  FlgG periplasmic serine protease DO (htrA)  B0161 
TP0209  FliG, CheR, FliY, 
FlgE, FliS 
ribosomal protein L36 (rpmJ)  B3299 
TP0945  FliS ribulose-phosphate 3-epimerase (cfxE)  B3386 
Table 40 Orthologous proteins interacting with motility proteins and showing motility 
phenotype in E. coli. 
TPA  
protein 
…interacts 
with 
description …has 
motility 
Phenotype 
TP0247  FlaA N-acetylmuramoyl-L-alanine amidase (amiA)  BSU35620 
TP0046 CheR, FlgD, 
FlaB3, FliE 
hypothetical protein  BSU00320 
TP0048* FliY, FlgC, FlaA, 
FliS 
conserved hypothetical protein  BSU08950 
BSU08960 
TP0658*  FlaB1, FlaB2, 
FlaB3 
transmembrane protein, putative  BSU35380 
Table 41  Orthologous proteins interacting with motility proteins and showing 
motility phenotype in B. subtilis. * mutants from (Rajagopala 2006; Titz et al. 2006a). 
A large fraction of the proteome (143 proteins) of T. pallidum had at least a single interaction 
with a known motility protein (TIGR sub role). 65 and 68 of these have orthologs in E. coli 
and B. subtilis, respectively. Only seven and four of these orthologs showed a motility 
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phenotype (Table 40, Table 41). The hypothetical proteins among these are candidates for 
bona fide motility proteins. 
 
Connections of Motility Genes with other Functional Classes 
To get a broader overview of the connections of known motility proteins, several motility 
related datasets were compared. These included interactions from the motility subset of T. 
pallidum (Rajagopala 2006), C. jejuni (Parish et al. unpublished), H. pylori (Rain et al. 2001), and 
E. coli (Arifuzzaman et al. 2006). In addition, both motility phenotyping sets were included 
(see previous chapter). A set of genes regulated by the master regulator of the flagellum, 
FlhD, was obtained from Prüß et al. (Pruss et al. 2003). 
These datasets were analyzed for a significant enrichment of functional categories (TIGR sub 
roles). For interaction sets, the enrichment in the set of proteins interacting with known 
motility proteins was analyzed by comparison to randomized networks (see materials and 
methods). For the individual datasets, an enrichment compared to the distribution in the 
genome was assessed. 
The results are visualized in Fig. 42; details can be found in Supplementary Table 23-
Supplementary Table 31. 
Strikingly, nearly all sets showed a clear overrepresentation of known motility proteins (top 
row in Fig. 42) supporting the overall quality of the data. An interesting finding is the high 
number of interactions with proteins of unknown function in the T. pallidum set (44 
interactions); many motility-related proteins required in a subset of bacterial species might be 
still undiscovered. 
Although statistical overrepresentation of functional associations can be calculated and is 
given in Fig. 42, one needs to keep in mind that individual links might be sufficient to 
mediate a biological function.  
The T. pallidum motility set is significantly associated to enzymes involved in tRNA 
aminoacylation (11 interactions). However, only in the E. coli motility dataset a somewhat 
similar association to proteins involved in “tRNA and rRNA base modification” is observed. 
Four interactions to the “DNA-dependent RNA polymerase” category are found; these 
include interactions of a sigma factor with components of the basal-body complex of the 
flagellum. Albeit not statistically significant, the link is enriched compared to the genome and 
might constitute a regulatory control system. An especially interesting interaction, which falls 
into this category (although not classified yet), is formed between a sigma factor, TP0709, 
and a hypothetical protein, TP0974. This interaction was also verified by co-
immunoprecipitation (see page 127). TP0974 was found to have remote homology to FlgM, 
an anti-sigma factor controlling the timing of flagellar gene expression during assembly (Pons 
et al. 2006). This exemplifies that in cases with limited sequence similarity only the 
combination of bioinformatics and experimental verification can prove orthologous 
relationships between proteins. 
A link between motility and energy metabolism is both found in the set of FlhD-regulated 
genes and the high-confidence C. jejuni interaction set; this indicates that these processes are 
not only linked in the metabolic network (energy requirement), but also on the regulatory and 
protein-interaction level. 
Both motility phenotyping datasets show an enrichment of enzymes involved in the 
“biosynthesis and degradation of polysaccharides”, which demonstrates the dependency of 
motility on the proper structuring of the cell wall. 
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Fig. 42 Enriched TIGR sub roles in several motility related datasets. The 
associations of known motility proteins with several functional classes are shown for the 
interaction datasets (TPA=T. pallidum, CJE=C. jejuni, ECO=E. coli), motility phenotyping 
sets (BSU MOT=B. subtilis phenotypes, ECO MOT=E. coli phenotypes), and for the set 
regulated by the master regulator of the flagellum, FlhD, (ECO FlhD). 
Overrepresentation of a specific category in a certain dataset is color coded according to 
the shown color key – the color encodes the z-value of the respective association, which 
corresponds to the times standard deviation distance of the found association to a 
random set (1000x). Statistical significance of each association is indicated by “*” and is 
calculated by a ranking statistic for the interaction sets and by a hypergeometric 
distribution for the others. Please, refer to PDF version or supplementary table to 
identify the identity of individual functional categories. 
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3.5. Towards a Membrane Protein Interaction Map 
Membrane proteins mediate interesting biological functions like metabolite transport, 
signalling or cell division regulation. Protein-interactions play a role in many of these 
functions, e.g. interactions of periplasmatic binding proteins with ABC-transporters, 
signalling molecule interactions (chemoreceptors), or regulation of transport processes.  
Unfortunately, protein interactions of membrane proteins are difficult to analyze using the 
Y2H system as they do not localize to the nucleus or undergo unspecific hydrophobic 
interactions. Interestingly, in the analysis of membrane protein connections an enriched 
number of interactions to other membrane proteins, but a lower number of interactions to 
cytoplasmic proteins was found (Fig. 34). One solution is to fragment these proteins into 
their intracellular and periplasmic parts and test these fragments individually (against each 
other and the whole prey array by Y2H).  
First, the topology of membrane proteins was predicted. 99 fragments, which are mainly 
located at the cytoplasmic face of the membrane, were selected. These are cloned and tested 
for protein interactions against the whole T. pallidum prey array. 
Prediction of Membrane Protein Topology and Selection 
Prediction of transmembrane segments for the whole proteome of T. pallidum was conducted 
with TMHMM v. 2.0 (Krogh et al. 2001). The predictions are based on a Hidden Markov 
Model and TMHMM has been rated as the best performing transmembrane prediction 
program (Moller et al. 2001). 243 proteins with at least one transmembrane region were 
identified; this corresponds to ~24% of the whole proteome and is in concordance with data 
for other genomes (Krogh et al. 2001). The distribution of predicted membrane segments is 
shown in Fig. 43: most of the membrane proteins carry only a single predicted 
transmembrane region (97 proteins); a slight over-representation of an even number of 
segments is observed (for proteins with at least two segments); note that signal peptides can 
not unambiguously be separated from membrane segments. 
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Fig. 43 Predicted membrane proteins in the T. pallidum proteome. The number of 
proteins with a given number of predicted transmembrane segments is shown. 
Most of the transmembrane protein fragments (TMPFs) – protein at N- or C-terminus or 
between predicted transmembrane regions – are shorter than 30 amino-acids (Fig. 44). The 
C-terminal regions have a length distribution shifted to bigger sizes. 
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Fig. 44 Length distribution of inter-transmembrane segments. The length of inter-
transmembrane segments were binned (30 amino-acid bins). The number of segments 
with a length falling into these bins is shown. The length distribution for all segments 
(total), for N-terminal regions (N-terminus), for C-terminal regions (C-terminus), and for 
regions in between are shown. 
A subset of these TMPFs was selected for cloning and, eventually, testing of their protein 
interactions. Fragments comprising of at least 30 amino acids, which were predicted to be 
located at the cytoplasmic face of the membrane, were selected. A number of fragments, for 
which cloning of the full-length construct failed, were omitted. A few fragments with a 
predicted periplasmic localisation were selected in addition. The full list of selected TMPFs 
can be found in Supplementary Table 32 and the length distribution of this set is shown in 
Fig. 45. 
Primers for cloning of these fragments were designed with high-throughput primer design 
software (Express Primer Tool, F. Collart, Argonne National Laboratory). The cloning was 
done by BP clonase mediated recombinations of PCR products into the pDONR207 vector. 
For Y2H analysis the cloned segments were transferred to pGBKT7-DEST (bait vector) and 
pGADT7-DEST (prey vector) and transformed into yeast cells. At present ~80% of the 
selected fragments have been cloned. 
 
RESULTS 
 137 
0
10
20
30
40
50
60
0 30 60 90 12
0
15
0
18
0
21
0
24
0
27
0
30
0
33
0
36
0
39
0
42
0
45
0
48
0
length >= (30aa bins)
# 
se
le
ct
ed
 
se
gm
en
ts
 
Fig. 45 Length distribution of selected inter-transmembrane segments. Ranges of 
30 amino-acids were binned. 
Initial Protein Interaction Mapping of Transmembrane Protein Fragments (TMPFs) 
In this thesis only an initial protein interaction map of the TMPFs is presented. 59 out of 99 
fragments were screened as baits against the whole T. pallidum Y2H prey library and against 
each other. Thus, only a broad overview of the features and expected outcome of this screen 
is given. 
In the screen against the whole prey array, 229 reproducible interactions were detected in 
total, of these only 107 were retained in a specificity filtered set (prey count < 51, “filtered 
set”). 84 additional interactions with prey constructs of the TMPFs were detected; a 
specificity filtered subset contains 45 interactions (prey count less than 6). 
Thus, 152 specific interactions were detected for this set of membrane protein fragments 
(Supplementary Table 33). 
Only a small number of these were supported by the String database (Table 42) (von Mering 
et al. 2005). However, note that a bioinformatical association can only support an interaction, 
but lack of an association does not exclude it. The interaction with the highest 
bioinformatical score is formed between FtsH (TP0765) and SecY (TP0208). Interestingly, 
FtsH is known to degrade SecY (Kihara et al. 1995). Topology mapping of the FtsH ortholog 
in E. coli indicated that the N-terminal part is located in the periplasm (the E. coli ortholog 
was suggested to carry an additional N-terminal transmembrane segment) (Tomoyasu et al. 
1993).  In contrast, the interacting C-terminal part of SecY is localized to the cytoplasm 
(Kaufmann et al. 1999) (Fig. 46). This might indicate an involvement of mislocalized protein 
regions in the recognition of substrates by FtsH.   
 
 
bait description prey description combined 
String 
score 
TP0765_1-83 cell division protein 
(ftsH)  
TP0208-409_450 preprotein translocase subunit 
(secY)  
960 
TP0392_94-319 conserved 
hypothetical protein  
TP0995 cyclic nucleotide binding 
protein  
830 
TP1036-235_389 cation-transporting TP0995 cyclic nucleotide binding 591 
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ATPase, P-type  protein  
TP1036-1_102 cation-transporting 
ATPase, P-type  
TP0995 cyclic nucleotide binding 
protein  
591 
TP0730-1_86 conserved 
hypothetical protein  
TP0392-94_319 conserved hypothetical protein  501 
TP1036-1_102 cation-transporting 
ATPase, P-type  
TP0519 response regulatory protein 
(atoC)  
394 
TP0471-38_469 hypothetical protein TP0519 response regulatory protein 
(atoC)  
345 
TP0392_94-319 conserved 
hypothetical protein  
TP0445 4-methyl-5(b-hydroxyethyl)-
thiazole monophosphate 
biosynthesis enzyme (thiJ)  
274 
TP0392_94-319 conserved 
hypothetical protein  
TP0917 Mg2+ transport protein (mgtE)  253 
TP0771-1_33 conserved 
hypothetical integral 
membrane protein  _ 
TP0995 cyclic nucleotide binding 
protein  
245 
TP0765-1_83 cell division protein 
(ftsH)  
TP0995 cyclic nucleotide binding 
protein  
196 
Table 42 TMPF interactions with supporting String score. 
Another noteworthy interaction is the homodimerisation of the flagellar protein FliL 
(fragment TP0722_58-182) (Fig. 46).  
 
 
Fig. 46 Examples for TMPF interactions. Proteins drawn with TOPO2 
(http://www.sacs.ucsf.edu/TOPO2) 
First Comparison and Outlook 
The results obtained with the inter-transmembrane segments and with the full-length 
constructs were compared. When we consider the filtered dataset, we find the following: out 
of 47 distinct proteins tested, 11 did not show interactions in both approaches, 6 showed 
interactions only with the full-length proteins, and 14 showed interactions only with a 
fragment; out of 16 proteins with interaction from both approaches, only 3 showed 
overlapping interactions (5 interactions in total). 
Thus, the datasets obtained from full-length and from fragment screens are rather 
complementary. 
However, the screening yields additional interactions and further investigations are necessary 
to evaluate their biological relevance. 
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3.6. Individual Gene I: TP0658 – A Novell Conserved Assembly Factor for the 
Bacterial Flagellum 
Results in this section have been published in the Journal of 
Bacteriology (Titz et al. 2006a). The text is modified 
compared to the published manuscript. 
 
Protein interactions networks can support the annotation of previously uncharacterized gene 
products. The molecular environment of a protein provides clues about the function of a 
protein (“guilt-by-association approach”, see above). This section should exemplify, how 
results from protein interaction network can be the starting point for an in detail 
characterization of a previously unknown motility protein. 
Motility of most bacterial species depends on the proper function of the flagellar apparatus. 
Embedded in the membrane its motor transmits torque via parts of the basal body and the 
hook structure to the filament, a long helical protein assembly rotating as a propeller. In 
Salmonella typhimurium, for example, the filament consists of a homopolymer of ~20,000 
flagellin (FliC) proteins (O'Brien and Bennett 1972). In other species, such as Treponema 
pallidum, three flagellin proteins, FlaB1-3, are thought to form a heteropolymeric filament 
(Charon and Goldstein 2002). The assembly of the flagellum proceeds in a stepwise, well-
regulated manner. Only after the assembly of the basal body complex, similar to a type III 
secretion system, the outer parts of the flagellum are secreted: first the proximal parts, the 
rod proteins, then the hook proteins, and finally the distal parts including the flagellin 
proteins. The new components are secreted through a hollow tube and polymerize on the 
distant tip of the structure (Macnab 2003). Additional assembly factors are required, most 
prominently chaperones that prevent premature polymerization of flagellum proteins in the 
cytosol. Several substrate-specific export chaperones have been identified: The chaperone 
FlgN for the hook-filament junction proteins FlgK and FlgL, FliT for the filament capping 
protein FliD, and FliS for flagellin proteins (Yokoseki et al. 1995; Fraser et al. 1999; Auvray et 
al. 2001; Bennett et al. 2001). FliS binds to the C-terminal part of flagellin, most likely 
preventing premature polymerization in the cytosol (Auvray et al. 2001). 
The Y2H network provided evidence that a protein of unknown function, TP0658, is an 
additional factor required for assembly of the flagellum. 
TP0658 Interacts with Flagellin Proteins 
Surprisingly, a screen with the Treponema FliC homolog, FlaB3 (= TP0870) resulted in an 
unusually large number of 20 positives while the other FliC homologs yielded only four 
(FlaB1 = TP0868) and five positives (FlaB2 = TP0792), respectively (Supplementary Table 
2). Strikingly, all three flagellin proteins of T. pallidum reproducibly interacted with TP0658, 
an uncharacterized protein of unknown function. This specific interaction with all three 
paralogs clearly pointed to a role of TP0658 linked to flagellin metabolism (see “guilt-by-
association” list, Table 30). Therefore, TP0658 was selected for further investigations starting 
with a biochemical verification of these interactions. 
Indeed, all three flagellin interactions of TP0658 could be verified in vitro using an overlay 
assay (Fig. 47 A). 
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Fig. 47 T. pallidum protein TP0658 and its B. subtilis ortholog yviF interact with 
flagellin proteins. (A) HA-tagged flagellin proteins of T. pallidum - TP0868 (FlaB1), 
TP0792 (FlaB2), and TP0870 (FlaB3) - were expressed in E. coli BL21/DE3 cells and the 
total lysate was separated by SDS-PAGE and transferred onto a PVDF membrane. The 
membrane was blocked and then incubated with 25nM purified GST-TP0658 fusion 
protein (left panel) or 25nM GST control protein (right panel). Detection of bound GST-
protein (anti-GST antibody G1160, Sigma-Aldrich, Germany) and HA-tagged proteins 
(anti-HA antibody HA.11, Covance Research Products, CA, USA) were done using 
standard Western Blotting procedures. The proteins TP0567 and TP0711 are randomly 
chosen negative controls to exclude unspecific binding of TP0658. Probing with anti-HA 
(middle panel) and anti-GST antibodies (right panel) served as controls for expression 
levels and unspecific binding, respectively. (B) HA-tagged flagellin proteins of T. pallidum 
(TP0792, TP0868, and TP0870) and B. subtilis (hag and yvzB) were expressed in E. coli 
and tested for protein interactions with GST-tagged yviF (GST-yviF) in an overlay assay. 
The protein TP0567 was included as negative control. Probing with anti-HA and GST 
alone served as controls for expression levels and unspecific binding, respectively. (C) 
Lysates of a B. subtilis wild type strain (168) and of hag, motA and flgM mutants (Table 2) 
were tested for proteins interacting with GST-yviF in an overlay assay. The molecular 
mass of the bands shown corresponds to hag (~ 31 kDa); total (t) and soluble (s) extracts 
are shown. Done in collaboration with Rajagopala SV. Figures as published in (Titz et al. 
2006a). 
The Interaction is conserved in B. subtilis 
Sequence orthologs of TP0658 were identified in the MBGD database (Uchiyama 2003). 
TP0658 is conserved in a variety of bacteria including Spirochetes, Bacillales, and delta/epsilon 
Proteobacteria. To test whether the protein interactions of TP0658 are conserved as well, the 
interaction of its ortholog in B. subtilis, YviF, with the two flagellin proteins of B. subtilis, Hag 
and YvzB, was tested: hag is the full-length flagellin protein of B. subtilis while yvzB 
represents an N-terminally truncated form of unknown function. The overlay assay clearly 
showed that YviF interacts with both B. subtilis flagellin proteins (Fig. 47 B). In addition, YviF 
bound to all three flagellin proteins of T. pallidum, suggesting that the interaction epitope is 
highly conserved even among distantly related species. In addition, the interaction between 
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YviF and Hag could be confirmed in an overlay assay using different B. subtilis deletion 
strains (Fig. 47 C). The truncated flagellin protein, YvzB, could not be detected in this 
Western Blot (not shown), probably due to insufficient YvzB expression under the 
conditions used.  
 
792     868     870
Control
868-Pep
mM 868-Pep
GST-658
GST
V  G  L   D   I..E  N   L  Q..E   S  R   I   R  D
T1
T2
T3
 F  T1 T2  T3 T4 T5  T6  T7 T8 F  T1  T2  T3 T4 T5 T6 T7 T8
A
B
D
VGL D231 247I NAAE LQAAESRIRD
C-term
N- -C
T4
T5
T6
T7
T8
L59
A43 I149 D247
N60
N60
N60
V118
V118
I200
L231
S141
S141
S!99
C
GST-658 anti-HA
GST-658
GST
0 1 10 100 C
45
kDa
35
25
15
FlaBs E
TP0792   AGIN AAE LQAAESRIRD
TP0868   VGLD AAE LQAAESRIRD
TP0870   QGIA AAE LQAAESRIRD
HP0115   NNIS TQV VKAAESQIRD
HP0601   NNIS TQV VKAAESQIRD
CJ1338   NNIT TQV VKAAESTIRD
BSU35360 NNLS SGE LTAAESRIRD
BSU35150 NNLG SSE LTAAESRIRD
V N
I N
I N
V N
I N
V N
A N
A N
WT     HA     N2A
GST-yviF
hagF
GST
anti-HA
L D I A A E N L Q A A E S R I R D A N I A K Q M V E Y T K N Q V L T Q S G T A M L A
231
...
R286
L117yvzB
272
probe
 
Fig. 48 TP0658/YviF binds to the C-terminal loop region of flagellin. (A) 
Schematic representation of TP0868 (FlaB1) fragments and results of interaction epitope 
mapping. The S. typhimurium flagellin structure is shown (19); the primary sequence of 
TP0868 is color-coded accordingly (not drawn to scale). (B) Eight fragments of TP0868 
(T1-T8) were tested for interactions with GST-658 in an overlay assay; positive and 
negative results for the fragments are indicated by ticks and crosses in (A). The 
interaction region is indicated by a shaded box in (A). (C) The corresponding sequence 
(L231-C-terminus) as tested by peptide spotting: the sequence was synthesized as 
overlapping peptides of 15 amino acids with one amino acid shifts directly onto a 
cellulose membrane. These peptides were tested for interactions with GST-658 or GST 
as a control. The first amino acid of each 15-mer peptide is shown above its spot; the last 
peptide is a positive control recognized by the anti-GST antibody. Only the first three 
peptides starting from L231 interacted, indicating an interaction epitope between L231 to 
D247. (D) 100 mM synthetic peptide of this epitope region (868-Pep) but not a control 
peptide (DRRLADHFCGKIHCG) was able to inhibit the binding of GST-658 to all 
three flagellin proteins, FlaB1 (TP0868), FlaB2 (TP0792), and FlaB3 (TP0870) in an 
overlay assay. Lower panel: The inhibitory effect of 868-Pep was concentration-
dependent (shown for TP0868, FlaB1). (E) An extended interaction peptide (V229-
D247) was tested in an alanine-scan showing that I233 and N237 are crucial for binding. 
The first and the last spot of the row comprise of the wild type and an antibody control 
sequence, respectively. The remaining peptide spots have the indicated amino acid 
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replaced by alanine. Double dots (“...”) indicate positions not synthesized, because of 
naturally occurring alanine residues at these positions (these peptides correspond to the 
wild type sequence in position 1). (F) Mutants of the B. subtilis hag binding epitope (i.e. B. 
subtilis flagellin) were tested for binding to yviF in an overlay assay. The construct hag-
HA has the interaction epitope replaced by a HA-tag, hag-N255A (N2A) has the crucial 
Asn255 residue (Asn237 in FlaB1/TP0868) replaced by alanine. Probing with GST 
protein and anti-HA antibodies served as controls. The interacting region in different 
flagellin orthologs is shown in the alignment in (A), right panel: Treponema pallidum 
flagellins TP0792 (FlaB2), TP0868 (FlaB1), and TP0870 (FlaB3); Helicobacter pylori 
flagellins HP0115 (flagellin B) and HP0601 (flagellin A); Campylobacter jejuni flagellin 
CJ1338 (flagellin B); and Bacillus subtilis flagellins BSU35360 (hag) and BSU35150 (yvzB). 
Peptide spotting was done in collaboration with Claudia Ester. Figures as published in 
(Titz et al. 2006a). 
TP0658 and FliS Bind to Similar Epitopes of Flagellin 
As the structure of flagellin is known (Samatey et al. 2001) the interaction epitope of the 
flagellin protein was mapped to get structural insight into the function of this interaction. A 
combination of systematic truncations of TP0868 (FlaB1) with an overlay assay showed that 
TP0658 interacts with an epitope within the C-terminal 55 amino acids of TP0868 (L231 – C-
terminus) (Fig. 48 A, B). An interaction with the C-terminal half of flagellin is also supported 
by the interaction of YviF with the N-terminally truncated flagellin, YvzB (Fig. 48 A), which 
is naturally lacking the region homologous to the first 110 amino acids of TP0868 (Fig. 48 A). 
Strikingly, the TP0658 interaction epitope of FlaB1 is similar to the FliS-binding site in FliC: 
FliS binds to the C-terminal 40 amino acids of S. typhimurium flagellin (Ozin et al. 2003). For a 
more detailed characterization of the interaction epitope the SPOT peptide synthesis 
technology was employed (SPOT synthesis was conducted by Claudia Ester) (Rual et al. 
2005). The amino-acid sequence of the binding domain was synthesized as overlapping 15-
mer peptides on a cellulose membrane and then probed with a GST-fusion protein to 
identify interacting peptides. TP0658 interacted with peptides that correspond to the 
sequence between L231 and D247 of TP0868 (Fig. 48 A, C). The relevance of the interacting 
peptide was further demonstrated by a competition experiment. A peptide comprising the 
interaction epitope sequence (VGL231DIAAENLQAAESRIRD247) (synthesized by Olaf 
Zwernemann) was able to inhibit the binding of TP0658 to all three T. pallidum flagellin 
proteins (Fig. 48 D). Inhibition strength also depended on peptide concentration (Fig. 48 D, 
lower panel). An alanine scan was then used to identify amino acids crucial for binding: each 
position of the previously identified peptide (VGLDIAAENLQAAESRIRD) was 
systematically replaced by alanine and then tested for binding, showing that I233 and N237 of 
the previously identified interaction epitope are crucial for binding (Fig. 48 E). For additional 
verification and testing of evolutionary conservation of this interaction epitope in B. subtilis 
two targeted mutations of Hag (flagellin protein of B. subtilis) were created. First, in the 
construct hag-HA the homologous interaction epitope (Fig. 48 A), 
N247NLSASGENLTAAESRIRD265 in hag, was replaced by a HA-tag sequence. Second, in 
the construct hag-N255A only the Asparagine residue at position 255 of hag was replaced by 
Alanine. This residue corresponds to N237 found to be crucial for TP0658 binding to TP0868 
in the T. pallidum SPOT analysis. Strikingly, an overlay with GST-yviF showed complete loss 
of binding to these mutated forms of Hag (even when probing a large surplus of the 
mutants) (Fig. 48 F) – verifying the essentiality of Asn255 (Asn237 in TP0868) and 
demonstrating the evolutionary conservation of the interaction epitope identified for T. 
pallidum proteins.  
These findings are summarized in Fig. 48 A: TP0658/YviF bind to an evolutionary 
conserved interaction region of flagellin proteins, which is localized to the so-called cs-loop of 
flagellin. A conserved Asparagine (position 237 of TP0868) is crucial for binding. 
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YviF is required for Motility 
A functional involvement of YviF in bacterial motility was tested using a B. subtilis deletion 
mutant of yviF. The ∆yviF strain was created by specific integration of a phleomycin-upp 
cassette into the yviF locus as described by Fabret et al. (Fabret et al. 2002). Despite several 
attempts, the cassette could not be removed from the genome by the suggested counter-
selection procedure. As an additional control, the rescue of the phenotype by over-expression 
of YviF was conducted. The ∆yviF mutant showed a strong reduction of motility in a 
swarming assay (Fig. 49 A). As expected, only IPTG-induced expression of YviF from a 
plasmid (Pspac promoter) could rescue the motility phenotype, clearly proving that the reduced 
motility is due to the lack of the yviF gene in the ∆yviF mutant. 
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Fig. 49 (a) YviF deletion mutant shows impaired motility. The B. subtilis ∆yviF 
mutant was tested in a swarming assay without (-IPTG) and with (+IPTG) induction of 
YviF expression from a plasmid (+yviF). B. subtilis cells transformed with the empty 
vector, pDG148-Stu, served as controls (+V). The ∆yviF mutant has a clear swarming 
defect that can be rescued by yviF expression. (b) TP0658 and yviF stabilize flagellin. B. 
subtilis strains were tested for flagellin (hag) and yviF expression from a plasmid. Hag and 
HA-yviF were detected by a GST-yviF overlay and anti-HA antibodies, respectively. Wild 
type (WT) and ∆yviF cells carrying an empty plasmid, pDG148-Stu (+V), or the YviF 
expression plasmid, pDG-yviF (+yviF), are compared. Flagellin can only be detected 
when yviF is present. (c) His-tagged TP0868 (FlaB1) and GST-tagged TP0658 (or GST) 
were co-expressed in E. coli. The expression was done overnight relying on the basal 
expression levels of both constructs to obtain physiological more relevant expression 
levels. Total (t) and soluble (s) lysates were tested for the presence of protein. TP0868 
(FlaB1) can only be detected when TP0658 is present; co-expression of TP0658 thus 
leads to TP0868 stabilization. Please note that stabilized TP0868 is not found in the 
soluble fraction, e.g. supporting stabilization at the membrane (see text). Figures as 
published in (Titz et al. 2006a). 
TP0658 and its Orthologs are New Assembly Factors of the Flagellum 
Based on the similar interaction pattern of FliS and TP0658/YviF (with flagellin), I 
hypothesized that TP0658/YviF might be a novel assembly factor or chaperone for flagellin 
proteins. Deletion of yviF leads to a strong reduction of the amount of flagellin protein 
detected in B. subtilis cells (Fig. 49 B), probably due to an inhibition of flagellin incorporation 
into the nascent filament. Strikingly, a similar stabilization was found when TP0658 and 
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TP0868 were co-expressed in E. coli, supporting a direct stabilization effect of TP0658 
mediated by an interaction between the two proteins (Fig. 49 C). 
 
3.7. Individual Gene II: YjjG – An in vivo House-Cleaning Nucleotidase 
Results of this section have been submitted for 
publication. 
Despite the power of interaction mapping demonstrated in the previous paragraphs, the 
thorough understanding of gene function can only be accomplished by the combination of 
several approaches. A promising strategy is to start with high-throughput methods to collect 
new ideas and to follow up these ideas employing classical in detail experiments. Here, a 
screening for gene mutants affected in detoxification of nucleotide compounds is combined 
with several individual experiments. 
Bacteria are constantly exposed to innumerable toxic compounds, both substances from their 
environment, as well as by-products of their own metabolism (Galperin et al. 2006). Several 
protection mechanisms evolved to cope with this challenge and range from blocking the 
uptake (e.g., by the outer membrane of gram-negative bacteria), over export by specific 
transporters (e.g., ABC transporters), to specific inactivation of these compounds by 
dedicated enzymes. An especially noteworthy class of toxic compounds are non-canonical 
nucleobase compounds as these can either inhibit DNA replication directly or lead to an 
elevated mutation rate (Kamiya 2003). Enzymes recognizing these non-canonical nucleobase 
derivatives are so-called “house-cleaning nucleotidases” which dephosphorylate non-
canonical nucleotides and, in so doing, prevent their incorporation into the classical 
nucleotide metabolism (Galperin et al. 2006). The most extensively studied of these enzymes 
is the Escherichia coli protein MutT, which specifically dephosphorylates 8-oxo-GTP and 
thereby reduces the mutation rate ~100 – 3200-fold (Treffers et al. 1954; Bacon and Treffers 
1961; Cox and Yanofsky 1969). Several nucleotidases have been identified that show activity 
against canonical nucleotides with a Km (Michaelis-Menten constant) in the millimolar range. 
These Km values are higher than expected for an in vivo function in canonical nucleotide 
metabolism. In addition, these nucleotidases do not show an obvious knock-out phenotype 
under normal laboratory conditions except for elevated mutation rates – these can be as 
highly elevated as for the mutT deletion (~100 to 3200-fold) or only slightly elevated (~ 2-
fold) like for the mazG mutant (Galperin et al. 2006).  Galperin et al. (Galperin et al. 2006) 
hypothesized that many of these nucleotidases function as house-cleaning nucleotidases in 
vivo. However, the identification of their house-cleaning substrates remains a challenge, which 
can only be solved by extensive screening. 
Here, a screen of conserved hypothetical gene deletion mutants with the toxic non-canonical 
nucleoside 5-fluoro-2‘-deoxyuridine is presented. 
YjjG Mutant Shows High Sensitivity towards 5-fluoro-2’-deoxyuridine 
A screen for mutants ((Baba et al. 2006), Supplementary Table 21) with altered sensitivity 
towards 5-fluoro-2’-deoxyuridine, a toxic non-canonical nucleotide, yielded one highly 
sensitive mutant, ∆yjjG (B4374, JW4336) (Fig. 50 A). Growth of ∆yjjG was already completely 
blocked at a concentration of 1µM 5-fluoro-2’-deoxyuridine in the agar-plate based assay, 
whereas the wild type and the remaining mutants were not affected. As the mutant strains of 
the systematic knockout library used for the screen retain the gene-inactivation cassette, this 
cassette was removed for the following assays by the procedure suggested by Datsenko and 
Wanner (Datsenko and Wanner 2000). The observed sensitivity towards 5-fluoro-2’-
deoxyuridine was clearly reproduced in a growth assay with a striking effect even at 1µM 5-
fluoro-2’-deoxyuridine (Fig. 50 B). Additionally, the phenotype was considerably rescued by 
expressing yjjG from a plasmid.  
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Recently, YjjG was found in an in vitro screen for proteins with phosphatase activity and 
shown to have activity against thymidine monophosphate (dTMP), uridine monophosphate 
(UMP), and deoxyuridine monophosphate (dUMP) (Proudfoot et al. 2004). Based on this 
observation, a function of YjjG in canonical nucleotide metabolism was suggested, probably 
with involvement in regulatory pyrimidine nucleotide substrate cycles. However, Galperin et 
al. (Galperin et al. 2006) hypothesized in a recent review that many nucleotide phosphatases 
identified to act on canonical nucleotides are indeed “house-cleaning” phosphatases. These 
enzymes prevent the incorporation of non-canonical nucleotides into the metabolism and 
thus protect the cell from toxic side effects and mutations. The most extensively studied of 
these enzymes is the Escherichia coli protein MutT, which specifically dephosphorylates 8-oxo-
GTP and thereby reduces the mutation rate by ~100 - 3200-fold (Treffers et al. 1954; Bacon 
and Treffers 1961; Cox and Yanofsky 1969). The finding clearly implies that YjjG has a 
“house-cleaning” function in vivo rather than a regulatory function in canonical nucleotide 
metabolism: the assays clearly show a protection against toxic 5-fluoro-2’-deoxyuridine even 
at a concentration of 1µM; no growth inhibition of the mutant could be observed under 
standard conditions pointing to a non-essential role of YjjG in canonical nucleotide 
metabolism. 
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Fig. 50 YjjG mediates resistance against 5-fluoro-2’-deoxyuridine. (a) An array of 
conserved hypothetical gene mutants of E. coli was tested for sensitivity towards 5-
fluoro-2’-deoxyuridine; the yjjG mutant (two independent mutant strains: white box) was 
found to be highly sensitive towards 5-fluoro-2’-deoxyuridine even at a concentration of 
1µM 5-fluoro-2’-deoxyuridine. (b)  The yjjG mutant phenotype could be verified after 
flipout of the resistance gene and rescued by YjjG expression in a growth curve assay. 
Tested conditions are indicated in the diagram legend as follows: wild type (WT, solid 
line) or yjjG mutant (yjjG, dashed line), transformed with empty vector (V) or YjjG 
expression vector (yjjG), grown in LB medium without (0 µM) or with 1µM 5-fluoro-2’-
deoxyuridine (1 µM). Phenotyping was done in collaboration with Roman Häuser. 
YjjG Shows in vivo Activity against Pyrimidine Derivatives 
To assess the activity of YjjG to a further extend, several related nucleobase/nucleoside 
compounds were tested in an in vivo assay (Fig. 51). YjjG protects the cell from all 5-
fluoropyrimidine derivatives tested: 5-fluorouracil (5-FU) is metabolized by the pyrimidine 
salvage pathway, 5-fluoroorotate (5-FOA) is an intermediate of the de novo synthesis of 
pyrimidines, and 5-fluorouridine is the ribonucleoside analog of 5-fluoro-2’-deoxyuridine. 
The protective effect of YjjG towards these fluorinated compounds is found regardless of 
the way the derivatives are channeled into nucleotide metabolism, indicating a general 
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function of YjjG that is not focused on either the salvage pathway or de novo synthesis. 
Interestingly, YjjG not only mediated resistance against these uridine derivatives, but also 
against the cytidine nucleoside analog, 5-aza-2’-deoxycytidine. 
Finally, 5-bromo-2’-deoxyuridine (BrdU) and 5-iodo-2’-deoxyuridine at concentrations as 
high as 1mM were not toxic for the cell, preventing the estimation of an effect of YjjG in this 
assay. Nevertheless, activity of YjjG towards BrdU was shown in an in vivo DNA 
incorporation experiment (see below). 
Taken together, YjjG shows a “house-cleaning” function for non-canonical pyrimidine 
nucleotides but is not specific for a single nucleotide species. 
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Fig. 51 YjjG shows activity against several non-canonical pyrimidine derivatives. 
(a) Several non-canonical nucleosides were tested for toxicity in growth curve assays. 
Tested conditions are indicated in the diagram legend as follows: wild type (WT, solid 
line) or yjjG mutant (yjjG, dashed line) grown in LB medium with varying concentrations 
(µM) of a non-canonical nucleoside analog or nucleobase (as given in the title of the 
diagrams). (b) Summary of structures and effects of tested non-canonical nucleosides. 
Strong (***), intermediate (**), and no effect (*) on the YjjG mutant. For comparison 
pyrimidine derivative concentrations inhibiting growth by 50 percent (at 8h time point) 
are given in parentheses (∆ yjjG/WT). Phenotyping was done in collaboration with 
Roman Häuser. 
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YjjG Prevents Incorporation of Non-canonical Nucleotides into DNA 
House-cleaning phosphatases are expected to eventually prevent the incorporation of non-
canonical nucleotides into DNA, and thus avoid a detrimental increase of the mutation rate. 
To test a direct effect of YjjG on the incorporation of these nucleotide analogs into DNA, 
we conducted a BrdU incorporation assay (Fig. 52 A). Whereas BrdU is readily incorporated 
into DNA of yjjG mutants, no incorporation could be seen in the wild type background. 
Additionally, an overexpression of YjjG in the yjjG mutant was able to rescue the phenotype 
to a large extent. 
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Fig. 52 YjjG is a nucleotide house-cleaning phosphatase. (a) Incorporation of 
bromo-2’-deoxyuridine (BrdU) is prevented by YjjG. The yjjG mutant and wild type 
(WT) strain were incubated with BrdU and incorporation into DNA was tested by a 
genomic DNA dot-blot procedure (probing with anti-BrdU antibody, Roche); with 
untransformed strains (left panel) or transformed with empty vector (V) and YjjG 
expression vector (+yjjG) (right panel). (b) Kinetic measurement with purified YjjG 
shows higher activity (release of Pi in µmol/min) against non-canonical 5-fluoro-2’-
deoxyuridine monophosphate (5-FdUMP) compared to canonical thymidine 
monophosphate (TMP). (c) The closest human homolog of YjjG, HDHD4, was tested 
for complementation of the yjjG mutant’s sensitivity towards 5-fluoro-2’-deoxyuridine; 
no complementation was observed. 
YjjG shows in vitro Selectivity towards Non-canonical 5-FdUMP 
Galperin et al. (Galperin et al. 2006) proposed that house cleaning phosphatases show at least 
a ten-fold higher affinity (Km) against their physiological “house-cleaning” substrates in 
contrast to canonical nucleotides. We compared the in vitro activity of YjjG against thymidine 
monophosphate (dTMP) and 5-fluoro-2’-deoxyuridine monophosphate (5-FdUMP) (Fig. 52 
B). YjjG showed a Km of 2.14 +/-0.49 mM towards dTMP and of 0.237 +/- 0.074 mM 
towards 5-FdUMP. The apparent difference of the Km observed for dTMP compared to the 
value given by Proudfoot et al. (Proudfoot et al. 2004) is probably due to the different 
conditions used. In this assay, YjjG showed an approximately ten-fold higher activity towards 
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the non-canonical nucleotide, explaining the biochemical basis for the observed in vivo 
phenotypes. 
House-cleaning Functions of YjjG’s Homologs 
Most of the tested substrates are employed as chemotherapeutic drugs in cancer therapy. 
Therefore, human orthologs of YjjG could in principle interfere with cancer therapy. The 
closest homolog of YjjG in human is HDHD4, which can be classified as a sequence 
ortholog due to a best-best blast-hit (30% sequence identity, 42% sequence similarity) and the 
occurrence in the same phylogenetic branch in the Pfam database (Bateman et al. 2004). 
HDHD4, although recently identified as a phosphatase involved in neuraminidase 
metabolism (Maliekal et al. 2006), was hypothesized to possess in addition a moonlighting 
house-cleaning function. We tested whether HDHD4 has the propensity to replace YjjG in 
the yjjG mutant functionally (Fig. 52 C). However, no phenotypic complementation by 
HDHD4 was observed. This clearly indicates that YjjG and HDHD4 despite their close 
sequence similarity have evolved different specificities. This finding makes interference of 
HDHD4 with non-canonical pyrimidine nucleoside based cancer therapy unlikely. 
The closest sequence homolog of YjjG in yeast is SDT1 (24% sequence identity, 44% 
sequence similarity); however, SDT1 is not classified as a sequence ortholog by the MBGD 
database (Uchiyama 2003). Interestingly, Nakanishi et al. discovered a nucleotidase activity for 
SDT1 directed against UMP and CMP (Nakanishi and Sekimizu 2002). Additionally, 
overexpression of SDT1 in yeast cells leads to hyposensitivity towards 6-azauracil, 5-
fluorouracil, and 5-fluorocytosine implying a physiological role of SDT1 as a house-cleaning 
nucleotidase. 
These two homologs of YjjG, HDHD4 and SDT1, show different physiological functions 
despite comparable sequence similarity. Both enzymes are classified by the Pfam database as 
“haloacid dehalogenase-like hydrolases (PF00702)” (Bateman et al. 2004), a large group of 
hydrolytic enzyme with more than 6500 members. This group shows diverse hydrolytic 
specificities (Koonin and Tatusov 1994). Our data suggests that sequence similarity alone is 
not sufficient to identify specific functions; the identification of true functional orthologs of 
YjjG in other species should therefore not rely solely on sequence similarity but should also 
be supported by experimental data. 
DISCUSSION 
4. Discussion 
The individual parts of this thesis are discussed separately: first, properties of transcriptional 
activators in yeast, which were unraveled by an detailed analysis of self-activating proteins in 
the Y2H assay; secondly, the major topic of this thesis, the protein-interaction network of T. 
pallidum; and finally, the detailed analysis of two individual proteins employing low-scale 
experiments. 
 
4.1. Transcriptional Activators in Yeast 
Transcriptional activation is the basis of the yeast two-hybrid system. However, some bait 
proteins activate transcription without requiring an interacting protein that bears a separate 
activation domain. In fact, this property prevents the study of many transcriptional regulators 
by means of the two-hybrid system. Nevertheless, this observation can help to extend our 
knowledge about the properties of transcriptional activation domains. 
In this thesis, previously identified (but mostly unpublished) activators from several Y2H 
screens (Uetz et al. 2000; Ito et al. 2001) were selected and their activation strength was 
measured. Properties distinguishing this set from non-activator proteins were analyzed. 
Although many well-characterized transcriptional regulators and nuclear proteins are highly 
over-represented in the set of Y2H activators, many proteins that have not been associated 
with transcription previously were identified. Irrespective of their physiological role, these 
activators must be able to interact with and recruit the transcriptional machinery. 
Similar assays have been used previously by Wiesner et al. (Wiesner et al. 2002) and Ma et al. 
(Ma and Ptashne 1987) for screening human and E. coli proteins/peptides for their 
transcriptional activation properties. 
Which features or sequences mediate the recruitment of the general transcriptional 
machinery to the activator? Although there is no single feature, several rather general 
properties of transcription activators have been defined previously. These included the 
protein sequence composition as in acidic activators (Ma and Ptashne 1987) or more specific 
features such as defined interactions between activators and the basal transcription machinery 
(Neely et al. 1999; Bhaumik et al. 2004).  
Acidic activators, i.e. activators with stretches of acidic amino-acids, were the first class to be 
identified in yeast and the ones studied most extensively (Sadowski et al. 1988; Ptashne and 
Gann 1990). Their importance was emphasized by screens for random activating fragments 
of the E. coli genome or activating peptides, both of which mainly identified acidic activators 
(Ruden et al. 1991). The finding was confirmed in this thesis by the lower isoelectric point of 
activators, more acidic stretches and by the increased clustering of aspartate (Fig. 16 & Fig. 
17). 
Other previously defined activator classes were also found by this study: glutamine-rich 
activators (Courey et al. 1989), proline-rich activators (Mermod et al. 1989), and serine-rich 
activators (van de Wetering et al. 1993). Elevated asparagine levels and cluster values of 
activators may indicate a role of an additional amino acid in transcription activation, possibly 
similar to the closely related amino-acid glutamine in glutamine-rich activators. 
It is generally accepted that activation domains mediate their function by specific interactions 
with the basal transcription machinery (Ptashne and Gann 1997) or additional factors 
involved in transcription, like chromosome remodeling complexes (Utley et al. 1998). 
Transcription activators analyzed in this study form a highly interconnected protein 
interaction network involving transcription related proteins (Fig. 18). Protein interactions 
with transcription-related proteins are highly over-represented, even in the set of activators 
that have not been described as transcriptional regulators. 
A significant fraction of nuclear Y2H activators as well as known transcriptional regulators 
interact with the basal transcription machinery (like RNA polymerase II) and chromosome 
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remodeling complexes (like the SAGA complex) (Table 11). These interactions possibly 
explain their activation properties. Strikingly, the top ranking interaction partner of nuclear 
activators not previously known to regulate transcription was also RNA polymerase II. This 
indicates that genuine transcription regulators are contained in this set and form the basis for 
annotating them as transcriptional regulators (see results). However, for a large fraction of 
the Y2H activators, no interactions are known and thus their mode of action remains unclear. 
A surprising finding is the frequent interaction of activators with alcohol dehydrogenase. This 
enzyme is found with ~10% of nuclear proteins (not shown) but with ~20% in both the 
nuclear activator and known transcription regulator dataset. Thus, alcohol dehydrogenase 
might be more a specific component of activation complexes than an unspecific 
contamination. Such moonlighting functions (Jeffery 1999) have been found in other 
components of various transcription factor complexes but also among other proteins such as 
actin which acts both as a cytoskeletal protein and a transcription factor (Hofmann et al. 
2004). 
Screening of protein fragments fused to the DNA binding domain of Gal4 has been used 
before to identify transcriptional activators. Ruden et al. (Ruden et al. 1991) screened 
fragments of the E. coli genome and mainly identified acidic stretches that activate 
transcription in yeast. Wiesner et al. established a screening system based on a GFP reporter 
gene in a murine cell line and identified human transcription factors using a cDNA library 
(Wiesner et al. 2002). In contrast to this study I could make use of extensive large-scale 
studies which not only identified a set of transcription activators (Uetz et al. 2000; Ito et al. 
2001), but also localized proteins (Huh et al. 2003), measured protein concentrations 
(Ghaemmaghami et al. 2003) and protein interactions (Uetz et al. 2000; Ito et al. 2001; Gavin 
et al. 2002; Ho et al. 2002). The measurement of the activation strength allowed focusing on 
sets of proteins highly enriched in known transcriptional regulators. Combining several data 
sources, for six uncharacterized yeast proteins additional evidence for their genuine role in 
transcriptional regulation could be identified. 
Still, a number of activators has been missed by this strategy: of 138 proteins annotated with 
the GO-term “transcriptional activator activity” in the YPD database, 55 (40%) were 
detected as activators in this study (Supplementary Table 1), suggesting a false negative rate 
of about 60%. This discrepancy may be explained by the fact that some transcriptional 
regulators are annotated as activators although they do not act as such in our assay.  Other 
proteins may require specific promoters, cofactors, or conditions to exhibit activating activity. 
For example, several activators are only active when yeast is grown in glucose-free media. 
Interestingly, Gal4 itself becomes a very weak activator when fused to another Gal4-DBD, 
i.e. the DBD domain appears to inhibit the activating properties of some proteins. Thus, our 
studies need to be extended in order to get a more complete picture of all transcriptional 
activators in yeast, e.g. by using different conditions or fusing the DBD C-terminally. 
Although a large number of transcriptional activators in yeast were identified and their 
activation strength was semi-quantitatively measured, this measurement was not truly 
quantitative. New reporter strains with luciferase or some other enzyme need to be used in 
the future for more precise measurements. 
In addition, by this study the actual activation domains were not determined. Given the poor 
definition of activation domains, it remains an important challenge to map these domains by 
fragmenting the proteins described here. As activation domains do not appear to be well-
defined structural domains it appears to be likely that they do not require a defined three-
dimensional structure. Instead, short linear peptides may contain the activation activity 
proper. 
Once the activation domains have been mapped, their interactions with the transcriptional 
machinery have to be identified. Unfortunately, the classical two-hybrid system cannot be 
used for this purpose. Thus either classical biochemistry or alternative systems have to be 
used such as the split-Ubiquitin system (Johnsson and Varshavsky 1994). 
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Finally, activators can differ in their ability to activate transcription dependent on the 
promoters to which they are bound (Harbury and Struhl 1989). Hence, all activators need to 
be tested in different promoter contexts and their transcriptional activity quantitated. 
Once their interactions have been mapped on a proteome-wide scale and their promoter 
context evaluated, it may be possible to generalize these findings and predict the 
transcriptional activity of every protein, including their activation strength. This would be a 
major step towards quantitative and thus systems biology. 
 
4.2. A Protein Interaction Map of T. pallidum 
In this thesis the binary protein-interaction map of T. pallidum, the Syphilis spirochete, is 
presented. The aim was to test all pair-wise protein combinations of T. pallidum for a protein 
interaction in the yeast-two-hybrid assay. These up to 1,000,000 individual tests revealed 3684 
interactions, from which a specificity-filtered set of 1634 interactions was selected for the 
analysis. 726 (70% of the proteome) and 601 (58% of the proteome) distinct proteins were 
incorporated in the complete and filtered network, respectively. However, only 0.3-0.7% of 
the total number of possible interactions (540,280) was tested positive, which supports the 
common notion that protein interaction graphs are sparse (Uetz et al. 2006). 
Protein-interaction mapping – both by Y2H and by coAP/MS (co-affinity purification & 
mass-spectrometry) – is one of the favorite functional genomics approaches to elucidate the 
functions and connections of the gigantic number of gene-products catalogued by whole 
genome sequencing. Several large-scale interaction studies have been published – ranging 
from virus, over yeast, to human (Table 3). Despite their large number, the published 
interactome studies are far from being complete; still, most of interaction space is terra 
incognita: a) classical individual protein studies can never cope with the number of gene-
products, b) most published Y2H studies tested only a fraction of the interactome or did not 
systematically test all pair-wise interactions, c) interaction mapping approaches suffer from a 
high percentage (up to 90% in Y2H) of false negatives, d) post-translational modification 
dependent interactions are not covered by Y2H, and e) interactions only taking place in 
specific cell states, e.g. activation of a signaling pathway, are not detected by common 
coAP/MS studies. 
In parallel to this study, the Y2H interaction map of C. jejuni was analyzed by the group of R. 
Finley (Parish et al., pers. comm.). With respect to interactome coverage, the T. pallidum and the 
C. jejuni networks are currently the most comprehensive available Y2H maps. They 
incorporate, for example, 70% and 83% of the proteome, respectively, compared to up to 
55% in yeast ((Ito et al. 2001), Table 3, Table 20). Please note that the tested interaction space 
can be even smaller: for H. pylori only 261 out of 1552 (17%) possible baits were tested, 
although already 47% of the proteome is incorporated. This compares to ~90% tested baits 
in this study (Table 16). 
The majority of large-scale interaction mapping studies targeted eukaryotic proteomes; 
prokaryotic interactions were only analyzed in three studies. However, only a single study 
tried to achieve whole proteome coverage for a bacterium: Arifuzzaman et al. recently 
conducted a coAP/MS study and tried to identify co-purified proteins for all E. coli proteins 
(Arifuzzaman et al. 2006). Another coAP/MS study for E. coli was published before (Butland 
et al. 2005). In this study, the expression conditions were closer to physiological levels, but 
only ~900 proteins (out of ~4,300) were analyzed. Only a single incomplete Y2H interaction 
map for a bacterium was published: Rain et al. tested 261 baits (17% of proteome) against the 
whole proteome of H. pylori (Rain et al. 2001). In addition, a few small-scale Y2H studies 
(testing only 5-20 baits) for bacteria were published including interactions involved in DNA 
replication in B. subtilis (Noirot-Gros et al. 2002) and several studies analyzing the Type-IV-
secretion-system of bacteria (Alegria et al. 2005). 
Thus, the interaction maps presented for T. pallidum and C. jejuni (Parish et al., pers. comm.) 
constitute the first comprehensive binary interaction maps for bacteria. They form the 
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basis for comparative interactomics studies with the ultimate goal to understand the 
evolution of protein interactions. However, comprehensive interaction maps for several 
other bacterial species (out of >300 genomes at present) need to be analyzed until this goal 
can be achieved (discussed below). Moreover, they will constitute the basis for systems 
biology approaches to understand the biology of bacteria at the system’s level. 
With 3684 interactions between 726 proteins for T. pallidum the key question is: What can we 
learn (for biology) from this comprehensive dataset? A few answers to this question are given 
below. 
 
Special Topic: Interaction Map of a Minimal Proteome? 
With 1039 genes the genome of Treponema pallidum can be considered as small.  
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The common model bacteria, Escherichia coli and Bacillus subtilis, carry with ~4500 
a considerable larger number of genes. However, recent genome sequencing 
projects revealed much smaller genome sizes: the bacterial endosymbiont 
Carsonella has only 182 ORFs (Nakabachi et al. 2006) and the endosymbiont 
Buchnera aphidicola BCc carries only 362 ORFs (Perez-Brocal et al. 2006). Both 
bacteria follow an intracellular life style in uttermost close association to its host, 
which allowed for a significant genome reduction. T. pallidum also strictly 
depends on its host, but due to its extracellular life style is less closely associated 
to its host. Thus, a larger number of genes are required, e.g. additional genes 
involved in transport and metabolism. A reduced proteome was selected for this 
study to reduce the time required for screening, while focusing on the crucial 
processes of a bacterial cell. T. pallidum represents a good tradeoff, since it carries 
a reduced genome sufficient for extracellular living. The diagram shows the size 
distribution of bacterial genomes available, today (TIGR-CMR database). All 
bacteria with smaller genomes than T. pallidum show an intracellular life style. 
 
Generation of the Interaction Map 
Before discussing the biological insights gained from the interaction network, a few technical 
issues should be discussed. 
Large-scale functional genomics studies (except for the majority of microarray studies) are 
enabled by versatile vector systems, which allow for convenient transfer of ORFs from one 
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vector to the other. These systems employ site-specific DNA recombinases to engineer 
DNA. The most commonly used system is the lambda-phage recombinase based Gateway 
system (Invitrogen). Another system, the univector plasmid-fusion system (UPS), relies on a 
Cre-recombinase mediated reaction between loxP-recognition sites (Liu et al. 1998; Liu et al. 
2000). The main advantage of the latter system is its cost efficiency; the main disadvantages 
are that C-terminal fusions are not possible, cloning of PCR products is not directly 
supported, and most importantly the availability of many more cloned genes and vectors for 
the Gateway system only. A prerequisite of functional genomics projects is the availability of 
all cloned genes in such a versatile vector system (called the ORFeome). The reason for 
selecting the UPS system for the T. pallidum interaction map was the availability of an 
ORFeome in this system (McKevitt et al. 2003).  However, no experience with this system 
was present in our lab and high-throughput cloning strategies had to be established. In 
addition, a commonly used bait vector (pGBKT7, Clontech) was adapted for this system 
(Fig. 12).  
An observation when working with the Y2H system for T. pallidum was that the reporter gene 
activation level was generally lower than for several viral interactomes tested at the same time 
in our laboratory ((Uetz et al. 2006) and unpublished data). The ORFs of these viruses were 
cloned into the well tested pGBKT7-DEST (bait vector) and pGADT7-DEST (prey vector) 
combination employing the Gateway system. This difference may be due to properties of the 
ORFs or the vectors. Because of its versatility, future projects should be based on the more 
commonly used Gateway system. 
The array-based Y2H system has a quadratic dependency of time and resources on the 
number of tested proteins, meaning that a genome twice as big as T. pallidum would require 
four times more effort; the interactome of E. coli would take 19 times longer than that of T. 
pallidum. One can only escape from this quadratic dependency by changing the strategy: 
several proteins need to be combined and tested in pools for their interactions; in a second 
step these pools need to be deconvoluted by individual retests. Such a strategy was proposed 
by Zhong et al. (Zhong et al. 2003). In this thesis a pooling scheme for the sytem used in 
our laboratory is presented and crucial steps were identified (chapter 3.3). However, a certain 
fraction of interactions get lost with this system. Therefore, it was not used for the study 
presented in this thesis, but should be reconsidered for the next large-scale project, especially 
when a higher activation level of the reporter genes is observed. 
Probably, the most crucial issue for high-throughput projects is the proper storing of data, 
both for the setup step (e.g., information on cloned gene constructs) and of the obtained 
results. For this thesis, a laboratory information management system (LIMS) based on the 
FileMaker system was developed (page 89). This LIMS is especially designed for the needs of 
a large-scale Y2H study and tracks all steps of this functional genomics study – ranging from 
the cloning steps to entering of Y2H results. This system proved to be well suited for this 
purpose. However, for future projects the user interface needs to be optimized to allow for 
more convenient data entry. 
Co-immunoprecipitation of genes co-expressed in tissue culture is used as a second-level 
protein-interaction test for interactions from the eukaryotic system (Rual et al. 2004; Uetz et 
al. 2006). No such system was available for bacterial proteins. Thus, the coEXcoIP-method 
was established, which involved co-immunoprecipitation of proteins co-expressed in E. coli 
(page 127). For this, a special vector combination was adapted for the UPS system. The 
combination allows for better-controlled expression conditions and higher yields of soluble 
protein pairs. To test this system, a few interaction pairs were tested and verified with this 
system. This system can still be optimized for higher-throughput and an adaptation for the 
Gateway system should be possible. 
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The Quality of the Network 
The quality of a protein interaction network is hard to evaluate. One main problem is that all 
employed reference sets are more or less incomplete and biased (see introduction). In other 
studies, 50%-80% of the Y2H interaction could be verified by an independent method (Rual 
et al. 2004; Uetz et al. 2006). However, due to this finding a large-scale verification was not 
attempted here; only a small subset of interaction was verified with another method (Fig. 39 
& Fig. 47). 
Evidences for the quality of the dataset can be obtained from bioinformatical analyses. 
Microbial functional genomics studies can make use of the large number of sequenced 
genomes: evolutionary patterns such as operons and phyologenetic profiles indicate 
conserved associations between genes (or orthologous gene groups). The String database 
computes and stores these bioinformatical associations between genes (von Mering et al. 
2005); a statistically significant fraction of Y2H interactions was found to be associated by the 
String database supporting the overall significance of the data (page 97). Interactions 
supported by the String database can also be used as a pre-filtered set for further 
investigations (Supplementary Table 7). However, protein interactions are also formed 
between proteins without leaving significant traces for bioinformatical prediction methods; 
possible examples are regulatory links between pathways and the noteworthy class of 
hypothetical proteins, which are only conserved in Treponemes or Spirochetes. 
Another interesting observation is the high enrichment of homodimeric interactions, 
which would not be expected by chance (p = 2.22 10-16) (Table 22). 
Several other properties of the network strongly deviate from observations in randomized 
networks, e.g. the topology (see below), clearly indicating a biological structuring of the 
observed network. 
However, interactions might be biologically meaningful or just occurring without detrimental 
effects for the cell. Thus, the biological relevance of the observed interactions can only be 
found on a case-by-case basis (like TP0658; see chapter 3.5), but the bioinformatical analysis 
presented here can identify the most interesting candidates, which can then be prioritized. 
Topological Features 
Biological insights can be obtained at all levels of a protein interaction network (see 
introduction). At the topmost level topological features of the network are analyzed (Table 
20). 
On average 5.4 interactions were found for each protein, which is in agreement with other 
protein interaction studies, e.g. for C. jejuni and KSHV. On average each protein can be 
reached from each other protein through 3.9 protein interactions (average shortest path 
length) which also corresponds to values observed in other interactions networks (Table 20). 
This exemplifies that all proteins of a cell are closely connected. One might consider this 
principle, for example, when signalling pathways are analyzed: a relatively close link between 
every given pair of signalling molecules must be anticipated and only the status of the whole 
network can eventually explain the observed output (rather than considering linear 
pathways). This “small world phenomenon” was first observed for social networks, for 
which an average distance of 6 between two people has been found (Milgram 1967). Later 
this concept was called “six degrees of separation” (Guare 1990).  
Another topological property that often deviates from random graphs is the clustering 
coefficient, which is proportional to the number of interactions between direct neighbours of 
a protein. The clustering coefficient of the T. pallidum networks is relatively high compared 
to other protein interaction networks (Table 20). Interestingly, especially the clustering 
coefficient of the unfiltered network has a high value of 0.23; apparently, proteins interacting 
with highly connected proteins (hubs) tend to interact with each other. This might be 
explained by the existence of certain general properties leading to unspecific interactions, e.g. 
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exposed hydrophobic patches that make a protein to interact with other proteins showing the 
same property. 
Biological networks show a few proteins with many interactions (hubs) and many proteins 
with few interactions (Jeong et al. 2000). The same is found for the T. pallidum network (Fig. 
27). Moreover, in many biological network the node-degree distribution follows a power-law 
(P(k)~k-γ  with node degree k, frequency of a node degree P(k), and power-coefficient γ); 
these networks are often called “scale-free”.  The node degree distributions of both T. 
pallidum networks approximate a power-law in frequency-degree plots. However, Tanaka et al. 
(Tanaka et al. 2005) insisted to base this analysis on rank-degree plots to circumvent statistical 
problems posed by the underlying distribution (many data points in the lower degree range, 
only few data points in the higher degree range). In rank-degree plots only the whole T. 
pallidum network appears to be scale-free, whereas the distribution of the filtered network 
follows an exponential law (P(k)~e-k) (Fig. 28). Since the result of this classification heavily 
depends on the data source, one cannot unambiguously conclude for one or the other model. 
Probably, a final conclusion on the topological building principle of bacterial networks (and 
for other organisms) can only be made once much more sophisticated networks also 
encoding the biological relevance of each interaction become available. 
The same is probably true for biological features of hubs. Hubs were, for example, found 
to have a higher probability to be essential proteins for the cell ((Jeong et al. 2001), page 27). 
However, this finding has been questioned and suggested to rely on the underlying biased 
data (Coulomb et al. 2005). For T. pallidum no difference in the node degree distribution of 
essential vs. non essential genes was observed (Fig. 36); the same observation was made for 
C. jejuni (Parish et al., pers. comm.). Thus, at least from single networks no reliable conclusions 
on the biological properties of hub proteins can be drawn; large-scale protein interaction 
networks also encoding the biological meaning of interactions need to be integrated with 
other important networks such as gene regulatory networks and the metabolic network until 
biological meaningful conclusions on the underlying building principles can be derived. 
However, an interesting topological finding concerning regulator proteins was made: these 
proteins appear to have a higher centroid value (Fig. 36), which means that they are located 
towards the centre of the protein-interaction network. This would be expected for a family of 
proteins that integrates input signals from several different sources. 
Links Mediated by Y2H Interactions 
The Y2H interactions were analyzed with respect to their function to link different biological 
categories ranging form genomic locations, over sub-cellular localizations, to domains and 
functions. 
Bacterial genomes are known to be functionally structured. Operons often contain 
functionally related genes and genes located in a conserved neighbourhood in several 
genomes tend to show a functional association (Overbeek et al. 1999). The association 
between different genomic locations has not been considered, yet. In this thesis, protein 
interaction based links between different genomic locations were analyzed (Fig. 33). 
Strikingly, several overrepresented links compared to randomized networks were identified. 
These are based on different underlying interaction patterns: clusters of interactions between 
neighboring genes (including homodimers), a single gene interacting with several neighboring 
genes at a different genomic location, or most interestingly several interactions involving 
various genes at two genomic locations. The most interesting link was observed between a 
location flanking TP0943 and a region flanking TP0046. These locations were linked by six 
interactions involving six distinct proteins at these two locations. TP0943, FliS, is a well-
known flagellar chaperone. Interestingly, the ortholog of the neighboring gene TP0945, 
ribulose-5P-epimerase, which is also involved in this link, shows a motility phenotype in E. 
coli (Table 40). The orthologs of the linking genes at the location, TP0046 and TP0048, both 
showed a motility phenotype in B. subtilis (Table 41). Thus, the observed link between these 
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locations connects two gene clusters involved in motility. Further studies need to clarify the 
molecular function of this link. In summary, functional relevant links between genomic 
locations in bacteria can be identified. This should set the basis for the identification of such 
links in other bacteria, and moreover for the analysis of these links down to molecular detail. 
It is generally assumed (and biologically meaningful) that protein should preferentially attach 
to proteins in the same compartment (von Mering et al. 2002). For T. pallidum, such an 
analysis is hampered by the lower number of distinct compartments in bacteria and by the 
unavailability of experimental localization data – a genome-wide localization study for E. coli 
has been conducted, but is unpublished (Prof. Mori, pers. comm.). Thus, the analysis presented 
in this thesis had to rely on bioinformatical predictions, for which the PSORT 2.0 algorithm 
was employed (Gardy et al. 2005). Most of the proteins were localized to the cytoplasm 
(39%), a similar percentage had an unknown localization (38%), and 17% were localized to 
the cytoplasmic membrane (Table 28). Cytoplasmic proteins were found to attach 
preferentially to other cytoplasmic proteins and membrane proteins to other membrane 
proteins (Fig. 34). In addition, an underrepresentation of interactions between cytoplasmic 
and membrane proteins was found. The anticipated over-representation of links between the 
same localization was found in the T. pallidum network, however, the limited number of 
localization compartments should be kept in mind. 
Protein interaction networks are based on the interactions of individual domains. The T. 
pallidum network was decomposed into a domain network filtered for unspecifically 
interacting domains (Fig. 32). This is the first domain-centered network for a prokaryotic 
species and for the first time provides insights into prokaryotic domain interactions at a 
genome-wide scale. However, it should be noted that follow-up experiments are required to 
unambiguously identify some interacting domain pairs, e.g. the DUF180 domain (protein 
TP0658) was found to interact with proteins consisting of a Flagellin_C and Flagellin_N 
domain. Further experiments showed that only the Flagellin_C part interacts with TP0658, 
and thus with the DUF180 domain (chapter 3.5). The most frequent domain in the genome 
of T. pallidum is the Tpr domain (Table 27).  This domain is known as a protein-interaction 
domain and members of a paralogous gene family carrying this domain are described as 
virulence factors (see introduction). As expected, this domain showed several interactions to 
a diverse array of domains also including self-associations. Links not discovered in the whole 
network can be identified in the domain network: two links between Mur_ligase and 
Flg_bb_rod domains are observed (Fig. 32). These links are constituted by the interactions 
TP0961 (FlgG-2) - TP0341 (MurC) and TP0903 (MurD) - TP0396 (FlgB). The flagellum is in 
principle known to associate with peptidoglycane processing enzymes, e.g. FlgJ consists of a 
domain involved in rod assembly and a domain involved in hydrolyzing peptidoglycan in E. 
coli and S. enterica (Pallen et al. 2005). The observed interactions might form a similar 
functional link in T. pallidum, which has a FlgJ ortholog only consisting of the rod assembly 
domain. However, it should be noted that MurC and MurD are commonly believed to 
localize to the cytoplasm. 
To assess the higher-level organization of the bacterial cell, links between function categories 
were considered (Fig. 31). Such an analysis was first conducted for the yeast network 
(Schwikowski et al. 2000). Self-associations of functional categories are expected (von 
Mering et al. 2002). These are found for motility related proteins, proteins involved in DNA 
metabolism, and for cell division proteins. Especially, the links of the former to categories 
can be the basis for analyzing these categories in more detail. An in detail discussion of 
motility related proteins was presented by Rajagopala SV (Rajagopala 2006). Other interesting 
links such as the link between “protein synthesis” and “protein fate” and the potential 
regulatory link between motility genes and tRNA aminoacylation links open the route for 
further in detail investigations. 
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Comparison, Integration & Conservation 
One major aim of protein interaction studies is the comparison with other data sets. The idea 
is to identify common patterns in different interaction sets, and finally devise a theory on the 
evolution of protein-protein interactions. However, these comparisons are (at the moment) 
hampered by the little overlap between data sets. Already, within the same species and with a 
similar method only a small overlap is observed, e.g. only 28% of the core complexes are 
conserved between to recently published coAP/MS data sets for yeast (Goll and Uetz 2006) 
and two yeast-two-hybrid studies for yeast showed an overlap of ~17% (Ito et al. 2001). 
Comparisons between different species, which are based on orthologous gene relationships, 
show an even smaller overlap: Suthram et al. found an overlap between 5% and 13% when 
comparing interaction networks from four eukaryotic species (yeast, fly, worm, and 
Plasmodium). 
The overlap observed between the T. pallidum network and other networks from other 
species was also very small (Table 31) ranging from 0.4% (E. coli coAP/MS) to 5.1% (H. 
pylori yeast-two-hybrid). The smaller overlap with coAP/MS data is expected due to the 
methodological differences. The overlap with H. pylori is in a reasonable range compared to 
the results for eukaryotic data. Nevertheless, a larger absolute number could be expected if 
the whole proteome of H. pylori had been screened (only a partial interaction map with 261 
tested baits has been generated). The overlap with the C. jejuni data from Parish et al. is small 
(~3%). Interestingly, Parish et al. retested 173 interactions from the T. pallidum dataset with 
their system and classified ~28% as positive (pers. comm.). Thus, the actual number of 
reproducible interactions between species and two different Y2H systems seems to be bigger 
than one would conclude from the direct comparison of data sets. 
However, in addition to methodological differences and the observed high number of false 
negative interactions in the Y2H system, the lower overlap of inter-species comparisons is 
probably due to real differences between species. For understanding the evolution of protein 
interactions, it will be crucial to sort out these interactions; this can be done by making use of 
additional protein-interaction verification methods. 
Here I looked at the conservation of interacting proteins throughout evolution (Fig. 38). This 
analysis was based on the subset of Y2H interactions supported either by bioinformatical 
predictions or by an overlap with any other protein-interaction dataset. Interestingly, the 
interaction set could be divided into different conservation classes including overall 
conserved interactions and interactions with one constitutive and one optional interaction 
partner. This analysis allows a glimpse of the variability of protein-interaction networks and 
arouses interest in looking at the variability of interactions for cases where both interacting 
partners are conserved. 
Motility and Genome-wide Motility Phenotyping of E. coli 
As seen in the last paragraphs, protein interactions themselves can already provide a wealth 
of ideas on the biology of organisms. However, the common goal is to relate these molecular 
properties to phenotypic effects on the organismal level, and thus, try to explain the latter by 
the former. 
Following a top-down strategy, the first step to achieve this objective is the integration of 
several functional genomic datasets including molecular properties and phenotypic effects – 
such approaches can be termed “integrative systems biology”.  
For yeast, several of these datasets are available ranging from protein abundance 
measurements, over protein localization studies, to quantitative phenotypic profiling 
(http://www.yeastgenome.org/cache/genome-wide-analysis.html). 
For bacteria, only a few systematic large-scale datasets are available. The most comprehensive 
phenotyping study was done by the “Bacillus subtilis Functional Analysis Consortium” 
including specific phenotyping assays for a large array of functional processes (Schumann et 
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al. 2000). Recently, Baba et al. established a systematic single gene deletion library for E. coli 
(Baba et al. 2006) which provides a basis for large scale phenotyping assays in E. coli.  
The bacterial flagellum is probably the best studied protein complex of bacteria, motility 
plays a crucial role in the pathogenesis of Syphilis and many other infectious diseases (see 
introduction). Bacterial motility was selected and genome-wide motility phenotyping for E. 
coli based on the afore mentioned library was conducted. The intention was to find out what 
we can learn – even about a well-characterized functional complex –when genome-scale 
approaches are applied. 159 gene-deletion mutants with reduced motility were identified 
(page 130). These included the majority of known motility genes, which supports the 
reliability of the method. The intersection of the E. coli and the B. subtilis (Schumann et al. 
2000) motility phenotyping sets mainly contained known motility genes. From this, we can 
conclude that most of the essential conserved motility genes are already known. However, 
several additional genes influencing motility have been identified. These genes can have an 
indirect role for motility such as by synthesis of required cofactors or restructuring of 
peptidoglycan (Supplementary Table 29) or they might play a species-specific role in motility. 
An assembly factor for the bacterial flagellum, which is only present in a certain subset of 
bacterial species has been, for example, identified to be required for motility in B. subtilis 
(chapter 3.5). 
A number of proteins were both found to interact with motility-related proteins in T. pallidum 
and have an ortholog with reduced motility in E. coli (Table 40). These proteins can be 
assumed to have a direct role in motility and include a protein involved in restructuring of 
peptidoglycan (AmiA), an enzyme showing a genomic location link to motility, TP0945, and 
conserved hypothetical proteins. 
A further discussion of the implications for bacterial motility from interaction mapping is 
provided by Rajagopala (Rajagopala 2006). 
 
Pathogenicity-related Genes 
T. pallidum is the causative agent of Syphilis, but the molecular details of this disease are only 
poorly understood (see introduction) – mainly due to the impossibility to culture this 
spirochete. However, a set of possible virulence factors has been identified (Weinstock et al. 
1998) and a set of genes with highest expression levels during an experimental rabbit 
infection has been characterized (Smajs et al. 2005). These genes were analyzed with respect 
to their interaction properties (page 120). 
On the individual gene level the identified interactions can provide routes for further 
investigations, e.g. a functional link between a virulence associated capsular polysaccharide 
biosynthesis protein, TP0077, and a protein potentially binding to peptidoglycan, TP0297, 
was found. This puts the later into a virulence context and could evoke further studies on the 
role of this link in cell-wall metabolism. Another example is the interaction between two 
membrane located virulence factors, TP0971 and TP0171, which indicates also a functional 
link between these proteins. 
On the topological level, no differences between virulence-related genes and the remaining 
gene were found except for a higher centroid value of regulator proteins which form a 
virulence associated gene class (see above). 
Several functional associations of these virulence classes could be observed (Fig. 37). The 
biological relevance of these links, however, needs to be elucidated by further studies. An 
interesting link is formed between virulence proteins exposed on the surface and proteins 
highly expressed during experimental rabbit infection (Table 35). A subset of these protein 
pairs might provide candidates for medical intervention, e.g. by selecting pairs of proteins for 
combination vaccines. 
Although, no definite consequences for therapeutic intervention or vaccination can be drawn 
from these results, they deliver further insight into the molecular details of virulence genes. 
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They can provide first ideas for further investigations, which is especially crucial for an 
organism such as T. pallidum, which can not be cultured or genetically manipulated. 
Guilt-by-association – Functional Predictions 
Another major objective of interactome studies is to derive hypotheses on the functions of 
previously uncharacterized proteins. The basis is that proteins rarely function alone, but 
nearly in all cases function in the context of other proteins. By looking at the interacting 
partners of a given protein certain predictions about its function can be made (“guilt-by-
association” approach).  
Schwikowski et al. (Schwikowski et al. 2000) derived predictions for the function of 29 
proteins by considering their interactions in the interaction network of yeast; predictions 
were only made for proteins with at least two interacting proteins with at least one function 
in common. Another approach taken by Vazquez et al. minimizes the number of protein 
interactions among different functional categories (Vazquez et al. 2003). 
In this thesis, the interaction partners of each protein of unknown function were analyzed 
with respect to their functional categories. To reduce the influence of unspecifically 
interacting protein categories (or categories with a large number of members), only functional 
links that were enriched compared to randomized networks were considered. In addition, at 
least 30% (TIGR classification) or 50% (GO terms) of the total number of interactions 
should be involved in the observed link. This filtering provided lists of genes with their 
associated potential functions (Table 29 & Table 30). 
The hypothetical protein TP0183, for example, seems to function in regulation of “DNA 
replication, recombination, and repair”, probably involving a small RNA, tmRNA, mediated 
regulatory mechanism (Keiler and Shapiro 2003). 
The interactions of TP0496, a protein conserved in Treponema and Borrelia species, include 
several proteins involved in protein biosynthesis/tRNA metabolism. A link to DNA 
replication is provided by the interaction with DNA primase (DnaE). TP0496 is located in an 
operon with ROD shape-determining proteins MreB/C (von Mering et al. 2005).  The 
interaction with the DNA replication protein DnaE is in concordance with the known link 
between MreB and DNA replication (Defeu Soufo and Graumann 2005). Therefore, TP0496 
might function as a link between tRNA metabolism (amino acid or translational status) and 
DNA replication. 
However, these potential functional links of these proteins need to be verified by further 
investigations. An example for such an investigation is given in the next chapter: the protein 
TP0658 was found to be associated to bacterial motility in the interactions dataset, which 
motivated an in detail characterization of its function. 
 
4.3. Individual Protein I – TP0658, a Conserved Assembly Factor for the Bacterial 
Flagellum 
In the T. pallidum Y2H screen, TP0658 was the only widely conserved protein of unknown 
function which interacted with all three flagellin proteins of T. pallidum (FlaB1 = TP0868, 
FlaB2 = TP0792, and FlaB3 = TP0870) in a specific manner. Thus, TP0658 was selected for 
an in detail characterization (Titz et al. 2006a). 
The Interaction between TP0658 and Flagellins is widely conserved 
TP0658 is conserved in several bacterial species including spirochetes, clostridia, bacillales 
and delta/epsilon proteobacteria. The interaction between TP0658 and flagellin was verified 
biochemically for T. pallidum and B. subtilis (yviF-flagellin) (Fig. 47). In addition, an interaction 
between flagellin and two TP0658 orthologs in H. pylori, HP1377 and HP1154, was found in 
another large scale Y2H study (Rain et al. 2001). Here it is demonstrated that the TP0658 
ortholog in B. subtilis, yviF, is crucial for bacterial motility (Fig. 49). This confirms an earlier 
observation by Golden et al. (Golden and Acheson 2002) who identified the Campylobacter 
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jejuni ortholog of TP0658, CJ1075, in a motility mutagenesis screen. Taken together, these 
findings demonstrate that TP0658 as well as its interaction with flagellin proteins, is essential 
for motility in many divergent bacterial species. Finally, J. Parish and R. Finley (pers. comm.) 
found the Campylobacter jejuni homologs of FliC and TP0658 to interact in a two-hybrid assay. 
Bioinformatical analysis of flagella proteins present in species other than the classical model 
bacteria, S. typhimurium and E. coli, shows a divergence, for example, in respect to export 
chaperones (Pallen et al. 2005): FlgN (the chaperone for FlgK) is absent, for example, in 
spirochetes, FliT (the chaperone for FliD) is restricted to proteobacteria, and despite its six 
flagellin proteins, no FliS gene is present in the genome of Caulobacter crescendus. There is also 
no obvious similarity between TP0658 and FliS, so it is unlikely that their function is very 
similar either. 
What is the molecular mechanism of TP0658’s function? 
In several databases, TP0658 and its orthologs are still annotated as “putative membrane 
protein”. Although the sequence indicates a hydrophobic stretch near the middle of the 
protein, the presented experiments show clearly that the protein is highly soluble. Moreover, 
several (~45) GST-fusions of T. pallidum were tested for soluble expression. Of these, the 
TP0658 was the protein with the highest solubility (not shown). Interestingly, at least some 
chaperones exhibit such hydrophobic stretches as well (Deuerling and Bukau, 2004). 
In particular, several observations are reminiscent of the export chaperone FliS in S. 
typhimurium (Auvray et al. 2001; Ozin et al. 2003). First, the direct interaction between flagellin 
and TP0658 supports physical cooperation of TP0658 and flagellin. Second, lack of TP0658 
leads to impairment of motility due to loss of flagellin supporting a role of TP0658 in 
filament assembly and/or stabilization of flagellin in the cytosol. In fact, Golden & Acheson 
(Golden and Acheson 2002) showed that a mutant of Campylobacter CJ1075 was not only 
completely immotile but also had no detectable flagellin (FlaA). A direct effect on flagellin 
stability is also supported by artificially co-expression of TP0658 and flagellin (Fig. 49). Third, 
both TP0658 and FliS bind to the c-terminal part of flagellin which is implicated in 
polymerization (Auvray et al. 2001). However, the detailed molecular mechanism of TP0658 
and FliS function remain unclear. They may act in parallel or subsequently and it cannot be 
excluded that TP0658 might, for example, add a further layer of regulation to the process. 
Finally, type III secretion chaperones (TTSCs) have been shown to prevent degradation and 
aggregation of their cognate substrates prior to secretion (Bennett and Hughes 2000), just as 
TP0658 appears to do (Fig. 49). Once secretion of the bound substrate is initiated, the 
TTSCs are thought to donate the substrates to the secretion apparatus. Unlike chaperones 
associated with virulent TTSSs, all flagella-associated TTSCs bind the carboxyterminal region 
of their partners (Bennett and Hughes 2000). 
To unravel these distinct functions of FliS and TP0658 it will be necessary to characterize the 
molecular function of TP0658 in more detail and analyze to which extent both proteins can 
compensate for each other. 
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4.4. Individual Protein II – yjjG, a House-cleaning Nucleotidase in vivo 
YjjG was found to function as an in vivo house cleaning phosphatase for non-canonical 
pyrimidine nucleotides. YjjG recognizes a range of substrates in vivo, prevents their 
incorporation into DNA and has a higher enzymatic activity towards non-canonical 
nucleotides than towards canonical nucleotides in vitro. An overview of YjjG’s function in the 
nucleotide metabolism is shown 
in Fig. 53. However, the in vivo 
relevance of the substrates tested 
is not clear. Reactive 
oxygen/nitrogen species are 
thought to be the main sources 
of damage to DNA and DNA 
precursors (Kamiya 2003): 
oxidation products of 
pyrimidine DNA precursors 
include 5-formyluracil, 5-
hydroxyuracil, and thymine 
glycol. Although their evaluation 
in the in vivo assay used in this 
thesis was not feasible (5-
formyluracil and 5-hydroxyuracil 
did not show a toxic effect even 
at a concentration of 1mM; data 
not shown), 
monophosphorylated derivatives 
of these compounds are 
potential substrates of YjjG. A 
higher sensitivity towards H2O2, 
however, was not observed for 
the yjjG mutant either (data not 
shown). Apart from oxidative 
damage, YjjG could also directly 
protect bacteria from modified 
pyrimidine nucleotides acquired 
from environmental sources. 
Bacteria of the gut might have 
the propensity to modify the 
pharmacokinetics of 
chemotherapeutic drugs based 
on modified pyrimidine 
compounds. In summary, our 
findings imply that YjjG with its 
broad pyrimidine nucleotide 
activity spectrum is a house-
cleaning candidate for newly 
identified non-canonical pyrimidine nucleotides found in the environment or as by-products 
of metabolism. 
An especially noteworthy feature of YjjG and its yeast homolog SDT1 is their activity against 
nucleotide monophosphates. All previously described house-cleaning phophatases act on 
nucleoside triphosphates (Galperin et al. 2006). Thus, YjjG and SDT1 do not only constitute 
a new homology, but also a new functional group of house-cleaning phosphatases. This 
clearly supports the hypothesis by Galperin et al. that the importance of the house-cleaning 
Fig. 53 Overview of nucleotide metabolism and YjjG’s function. 
The main enzymatic reactions of pyrimidine metabolism, entry points of 
non canonical pyrimidine derivatives, and reactions controlled by YjjG’s 
house-cleaning function are shown. Circles represent canonical 
compounds; triangles represent non-canonical compounds, and octagons 
DNA and RNA. Enzymatic reactions are shown by arrows. Only a 
selection of E. coli enzymes is given. Entry points of non-canonical 
nucleobase compounds are indicated by dashed arrows. Reactions 
controlled by YjjG are marked with thick lines. 
DISCUSSION 
 162 
function suggests that many undiscovered house-cleaning enzymes are “lurking among the 
unannotated ‘conserved hypothetical’ open reading frames found in microbial genomes” 
(Galperin et al. 2006). 
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4.5. Final Conclusions & Outlook 
The protein-interaction map for T. pallidum presented in this thesis represents one of the first 
and most comprehensive interaction maps for bacteria. 
 
Several analyses on different levels of the network revealed biological insights for this 
spirochete, and moreover form the basis for further investigations by “integrative systems 
biology” approaches. An outstanding example is the identification of protein interaction 
mediated links between different genomic locations, which has not been attempted and 
shown before. 
 
Several insights for individual proteins have been obtained, e.g. functional predictions and 
associations to virulence related genes. However, in a functional proteomics study only a 
limited number of follow-up experiments can be conducted. The power of this approach is 
exemplified by the identification of a conserved assembly factor of the flagellum, TP0658. In 
addition, the complementary nature of phenotyping datasets is shown by the characterization 
of YjjG, which functions as an in vivo house-cleaning nucleotidase in E. coli. 
 
The idea of integrating datasets of different types – to eventually reach a functional 
understanding of the observed molecular details – is exemplified by a whole-genome motility 
phenotyping study of E. coli. 
 
Finally, the analysis of transcriptional activator properties demonstrates that high-throughput 
datasets provide a wealth of information that needs to be integrated with several other data 
types to draw conclusions that are not possible to reach by classical approaches. 
 
However, functional proteomics studies raise more questions than they can answer – they 
generate hypotheses rather than testing them. Thus, several further investigations are needed, 
for example to check for functional prediction or look for the biological relevance of the 
identified genomic location links. 
 
The major challenge will be to transform the presented static interaction network into a 
dynamic network of functional associations. The questions are: “When/under which 
conditions are these interactions formed?”, “What are the molecular functions of these 
interactions?” and “How do we capture this biological knowledge in computational models?” 
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Supplementary Table 1 Identified Y2H activators for Yeast. The original Y2H study from 
which they were extracted (Uetz = (Ito et al. 2001) or Ito = (Uetz et al. 2000)) and the 
measured activation strengths are given. LTH is the minimal concentration of 3-AT (in 
mM) that is required to suppress activator activity and thus a direct measure of activation 
strength. bGAL is the beta-Galactosidase activity measured as described in Materials and 
Methods, including the Standard Error Mean (SEM) resulting from 3 measurements. 
Proteins annotated to have the F-GO term “transcriptional activator activity” in the YPD 
database (Biobase) are indicated (YPD). See also (Titz et al. 2006b). 
ORF name source LTH  
(3-AT) 
bGAL (+/- 
SEM) 
YPD 
YAL014C YAL014C Ito >200 0.8685+/-
0.0990 
 
YAL040C CLN3 Ito 50 -0.029+/-
0.0399 
 
YAR003W YAR003W Ito 100 0.1138+/-
0.1060 
 
YAR014C YAR014C Ito & 
Uetz 
50 NA  
YAR042W SWH1 Ito 25 -0.073+/-
0.0191 
 
YAR062W YAR062W Ito 50 0.2152+/-
0.0601 
 
YAR074C  Ito NA NA  
YBL005W-A  Ito NA NA  
YBL007C SLA1 Ito >200 0.8809+/-
0.0605 
 
YBL010C YBL010C Ito 100 NA  
YBL025W RRN10 Ito NA NA  
YBL032W  Uetz NA NA  
YBL046W YBL046W Ito 10 NA  
YBL049W YBL049W Ito NA NA  
YBL051C YBL051C Ito 100 0.4275+/-
0.1067 
 
YBL056W PTC3 Ito 3 NA  
YBL074C AAR2 Ito NA NA  
YBL079W NUP170 Ito 100 0.2055+/-
0.0769 
 
YBL081W YBL081W Ito >200 0.8972+/-
0.0431 
 
YBL093C ROX3 Ito >200 0.5879+/-
0.0490 
y 
YBL097W BRN1 Ito 10 NA  
YBR012C YBR012C Ito NA NA  
YBR028C  Uetz  10 NA  
YBR030W YBR030W Ito 100 0.5805+/-
0.1252 
 
YBR045C GIP1 Ito NA NA  
YBR050C REG2 Ito & 
Uetz  
NA NA  
YBR057C MUM2 Ito NA NA  
YBR058C UBP14 Ito 50 0.6862+/-
0.0742 
 
YBR061C YBR061C Ito 200 NA  
YBR062C YBR062C Ito NA NA  
YBR072W HSP26 Ito 50 0.6162+/-
0.1196 
 
YBR098W YBR098W Ito 100 0.0312+/-
0.0478 
y 
YBR105C VID24 Ito NA NA  
YBR125C  Uetz 3 NA  
YBR138C YBR138C Ito 100 0.5158+/-
0.0970 
 
YBR156C  Uetz NA NA  
YBR193C MED8 Ito >200 0.8372+/-
0.1316 
y 
YBR211C  Uetz NA NA  
YBR212W NGR1 Ito 100 NA  
YBR239C  Uetz 3 NA  
YBR240C THI2 Ito 50 NA  
YBR250W  Uetz 3 NA  
YBR271W YBR271W Ito 200 0.7195+/-
0.1125 
 
YBR284W YBR284W Ito 50 -0.000+/-
0.0249 
 
YBR289W SNF5 Ito 100 NA y 
YCL012W  Ito NA NA  
YCL017C NFS1 Ito 50 -0.137+/-
0.0089 
 
YCL032W  Uetz 3 NA  
YCL043C  Uetz NA NA  
YCR065W HCM1 Ito 100 0.1958+/-
0.0279 
y 
YCR077C PAT1 Ito >200 0.5859+/-
0.0760 
 
YCR082W YCR082W Ito 200 0.5496+/-
0.0552 
 
YDL005C MED2 Ito NA NA  
YDL017W CDC7 Ito 100 0.2612+/-
0.0748 
 
YDL020C RPN4 Ito 25 NA y 
YDL028C  Uetz 3 NA  
YDL037C YDL037c Ito NA NA  
YDL065C PEX19 Ito 200 0.1532+/-
0.0317 
 
YDL081C RPP1A Ito 200 0.1932+/-
0.0225 
 
YDL088C ASM4 Ito >200 0.0355+/-
0.0473 
 
YDL106C GRF10 Ito NA NA  
YDL115C YDL115c Ito NA NA  
YDL125C  Uetz NA NA  
YDL130W RPP1B Ito 100 0.1822+/-
0.0318 
 
YDL134C PPH21 Ito & 
Uetz 
100 0.1252+/-
0.0366 
 
YDL154W MSH5 Ito 100 -0.080+/-
0.0233 
 
YDL161W YDL161w Ito >200 0.7565+/-
0.1249 
 
YDL165W CDC36 Ito 50 0.3929+/-
0.1141 
y 
YDL188C PPH22 Ito 25 -0.003+/-
0.0198 
 
YDL215C GDH2 Ito 3 NA  
YDL223C  Uetz 3 NA  
YDR016C YDR016c Ito 100 NA  
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YDR022C CIS1 Ito 100 0.0735+/-
0.0341 
 
YDR031W YDR031w Ito 200 0.4646+/-
0.0889 
 
YDR045C YDR045C Ito 10 0.0372+/-
0.0526 
 
YDR073W SNF11 Ito 100 0.3912+/-
0.0466 
y 
YDR075W YDR075W Ito & 
Uetz 
NA NA  
YDR081C PDC2 Ito >200 0.0566+/-
0.0424 
 
YDR082W STN1 Ito 50 0.3036+/-
0.0682 
 
YDR098C YDR098C Ito 3 0.0172+/-
0.0266 
 
YDR103W STE5 Ito 200 NA  
YDR111C  Uetz 3 NA  
YDR118W APC4 Ito >200 0.2609+/-
0.0465 
 
YDR123C YDR123C Ito NA NA y 
YDR124W YDR124W Ito NA NA  
YDR132C  Uetz 10 NA  
YDR145W YDR145W Ito NA NA y 
YDR146C SWI5 Ito >200 0.5196+/-
0.1306 
y 
YDR151C YDR151C Ito NA NA  
YDR162C YDR162C Ito NA NA  
YDR164C  Uetz NA NA  
YDR165W  Uetz 3 NA  
YDR167W YDR167W Ito NA NA y 
YDR183W YDR183W Ito NA NA  
YDR184C ATC1 Ito >200 0.5882+/-
0.0313 
 
YDR189W  Uetz 3 NA  
YDR210W YDR210W Ito 100 NA  
YDR213W YDR213W Ito >200 0.5049+/-
0.1203 
y 
YDR216W ADR1 Ito >200 0.4752+/-
0.2174 
y 
YDR221W YDR221W Ito 3 NA  
YDR223W YDR223W Ito >200 0.5482+/-
0.0435 
 
YDR253C MET32 Ito 50 0.3632+/-
0.0988 
 
YDR260C YDR260C Ito 200 -0.010+/-
0.0371 
 
YDR273W YDR273W Ito 100 0.5725+/-
0.0730 
 
YDR277C MTH1 Ito NA NA  
YDR291W YDR291W Ito >200 0.0675+/-
0.0683 
 
YDR299W BFR2 Ito >200 0.5766+/-
0.0529 
 
YDR308C SRB7 Ito 25 0.0699+/-
0.0375 
 
YDR318W YDR318W Ito NA NA  
YDR320C YDR320C Ito >200 0.8629+/-
0.0902 
 
YDR328C SKP1 Ito 3 0.0399+/-
0.0280 
 
YDR330W YDR330W Ito 200 0.2609+/-
0.0773 
 
YDR373W  Uetz 3 NA  
YDR392W SPT3 Ito 50 0.2372+/-
0.1230 
y 
YDR423C CAD1 Ito 100 0.0096+/-
0.0185 
y 
YDR443C SSN2 Ito >200 0.7916+/-
0.0357 
 
YDR448W ADA2 Ito NA NA y 
YDR464W SPP41 Ito 3 0.1369+/-
0.0537 
 
YDR484W  Uetz NA NA  
YDR489W YDR489W Ito >200 NA  
YDR518W  Uetz NA NA  
YDR520C YDR520C Ito >200 0.8299+/-
0.0179 
 
YDR527W YDR527W Ito NA NA  
YDR532C YDR532C Ito 100 0.2726+/-
0.0802 
 
YEL053C MAK10 Ito 3 NA  
YER008C SEC3 Ito 50 0.0352+/-
0.0300 
 
YER021W RPN3 Ito 50 0.3698+/-
0.2191 
 
YER027C GAL83 Ito 100 0.0962+/-
0.0576 
 
YER033C YER033c Ito 100 NA  
YER040W GLN3 Ito >200 NA  
YER045C YER045c Ito >200 0.9192+/-
0.0479 
y 
YER051W  Uetz 200 NA  
YER059W PCL6 Ito 200 0.0992+/-
0.1759 
 
YER089C  Uetz 3 NA  
YER096W YER096w Ito 100 0.4195+/-
0.0440 
 
YER108C  Ito NA NA  
YER111C SWI4 Ito 100 0.2982+/-
0.1524 
y 
YER118C YER118c Ito 100 0.7692+/-
0.0578 
 
YER122C  Uetz 3 NA  
YER125W RSP5 Ito >200 0.9515+/-
0.0602 
 
YER130C YER130c Ito 10 NA  
YER149C PEA2 Ito 25 NA  
YER151C UBP3 Ito >200 0.8425+/-
0.0947 
 
YER167W BCK2 Ito >200 0.6002+/-
0.2382 
 
YFL029C CAK1 Ito 200 0.5335+/-
0.0385 
 
YFL033C RIM15 Ito >200 0.4306+/-
0.0764 
 
YFL049W YFL049W Ito 100 0.6852+/-
0.1114 
 
YFR033C QCR6 Ito 25 0.0139+/-
0.0445 
 
YFR034C PHO4 Ito 200 0.5952+/-
0.0681 
y 
YFR043C YFR043C Ito 100 -0.101+/-
0.0157 
 
YFR046C YFR046C Ito NA NA  
YGL003C CDH1 Ito 100 NA  
YGL015C YGL015C Ito 100 0.0675+/-
0.0458 
 
YGL019W CKB1 Ito 50 0.2105+/-
0.1388 
 
YGL036W YGL036W Ito >200 0.5912+/-
0.1001 
 
YGL043W DST1 Ito 100 0.1785+/-
0.1442 
 
YGL066W YGL066W Ito & 
Uetz 
50 (3 Uetz) 0.7785+/-
0.1077 
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YGL070C RPB9 Ito 100 0.0272+/-
0.0506 
 
YGL073W HSF1 Ito >200 NA  
YGL079W YGL079W Ito 200 0.2138+/-
0.0565 
 
YGL127C SOH1 Ito 50 0.0412+/-
0.0288 
 
YGL134W PCL10 Ito 25 -0.054+/-
0.0140 
 
YGL151W YGL151W Ito NA NA  
YGL154C LYS5 Ito 10 0.3445+/-
0.1086 
 
YGL161C  Uetz NA NA  
YGL166W CUP2 Ito >200 0.8069+/-
0.1406 
y 
YGL170C YGL170C Ito 100 0.2252+/-
0.1502 
 
YGL172W NUP49 Ito 100 0.5799+/-
0.0877 
 
YGL175C SAE2 Ito NA NA  
YGL181W  Uetz 3 NA y 
YGL223C YGL223C Ito 200 NA  
YGL227W YGL227W Ito NA NA  
YGL229C SAP4 Ito 100 NA  
YGR052W  Uetz 3 NA  
YGR070W  Uetz NA NA  
YGR077C PEX8 Ito 25 0.0188+/-
0.0190 
 
YGR120C YGR120C Ito >200 NA  
YGR130C YGR130C Ito >200 0.4559+/-
0.0909 
 
YGR160W  Uetz 25 NA  
YGR163W YGR163W Ito NA NA  
YGR188C  Uetz 3 NA  
YGR241C YAP1802 Ito >200 0.2015+/-
0.0863 
 
YGR251W YGR251W Ito 50 NA  
YGR253C PUP2 Ito 200 0.1598+/-
0.0615 
 
YGR256W  Uetz 3 NA  
YGR269W YGR269W Ito 25 NA  
YGR274C YGR274C Ito NA NA y 
YGR288W YGR288W Ito 25 NA y 
YHL009C YAP3 Ito NA NA  
YHL012W YHL012W Ito 200 NA  
YHL018W YHL018W Ito 3 NA  
YHR030C SLT2 Ito 100 0.5042+/-
0.0686 
 
YHR056C YHR056C Ito 25 NA  
YHR086W NAM8 Ito 3 NA  
YHR124W NDT80 Ito 3 0.0272+/-
0.0281 
 
YHR135C  Uetz 3 NA  
YHR149C YHR149C Ito 10 NA  
YHR160C YHR160C Ito >200 1.0002+/-
0.0941 
 
YHR167W  Uetz 3 NA  
YHR170W NMD3 Ito 3 NA  
YHR183W  Uetz 10 NA  
YHR184W SSP1 Ito 25 NA  
YHR185C YHR185C Ito 25 NA  
YHR187W IKI1 Ito 200 0.8495+/-
0.0858 
 
YHR205W SCH9 Ito 200 0.1552+/-
0.0475 
 
YIL007C  Uetz 50 NA  
YIL019W YIL019W Ito 200 0.2692+/-
0.0706 
 
YIL021W RPB3 Ito >200 0.6482+/-
0.0357 
 
YIL034C CAP2 Ito 100 0.2682+/-
0.0399 
 
YIL036W YIL036W Ito 100 0.2162+/-
0.0778 
y 
YIL046W  Uetz NA NA  
YIL062C ARC15 Ito 100 -0.047+/-
0.0183 
 
YIL071W  Ito NA NA  
YIL079C YIL079C Ito >200 0.9892+/-
0.0207 
 
YIL093C YIL093C Ito 3 -0.042+/-
0.0378 
 
YIL119C RPI1 Ito >200 0.9349+/-
0.0426 
y 
YIL123W SIM1 Ito 3 NA  
YIL135C YIL135C Ito 3 NA  
YIL151C YIL151C Ito NA NA  
YIR010W YIR010W Ito 100 0.0122+/-
0.0233 
 
YIR025W YIR025W Ito 3 -0.092+/-
0.0238 
 
YJL029C YJL029C Ito >200 NA  
YJL058C YJL058C Ito 50 0.0046+/-
0.0229 
 
YJL069C YJL069C Ito 100 -0.019+/-
0.0421 
 
YJL070C YJL070C Ito NA NA  
YJL084C YJL084C Ito 50 NA  
YJL098W YJL098W Ito 10 NA  
YJL100W  Uetz 100 NA  
YJL103C YJL103C Ito 50 -0.056+/-
0.0198 
 
YJL106W IME2 Ito 10 NA  
YJL116C NCA3 Ito 200 0.6629+/-
0.1065 
 
YJL126W  Uetz 3 NA  
YJL127C SPT10 Ito 25 -0.076+/-
0.0166 
y 
YJL146W IDS2 Ito >200 0.2022+/-
0.1395 
 
YJL147C YJL147C Ito 3 NA  
YJL159W HSP150 Ito NA NA  
YJL176C SWI3 Ito 200 0.0189+/-
0.0175 
 
YJL181W YJL181W Ito >200 0.1689+/-
0.0668 
 
YJL185C YJL185C Ito 50 0.0228+/-
0.0163 
 
YJL187C SWE1 Ito 25 0.0969+/-
0.0519 
 
YJL204C  Uetz 3 NA  
YJL218W YJL218W Ito 100 NA  
YJR002W MPP10 Ito 25 -0.006+/-
0.0353 
 
YJR042W YJR042W Ito NA NA  
YJR056C  Uetz 3 NA  
YJR063W RPA12 Ito 200 -0.011+/-
0.0032 
 
YJR067C YAE1 Ito 3 NA  
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YJR070C YJR070C Ito & 
Uetz 
200 (3 Uetz) NA  
YJR082C YJR082C Ito 3 0.0038+/-
0.0197 
 
YJR093C FIP1 Ito 100 -0.134+/-
0.0214 
 
YJR094C IME1 Ito 200 NA  
YJR112W NNF1 Ito 10 NA  
YJR119C YJR119C Ito 200 0.2019+/-
0.1009 
 
YJR125C YJR125C Ito 3 NA  
YJR141W  Uetz 10 NA  
YKL002W YKL002W Ito 100 NA  
YKL015W PUT3 Ito 200 0.3072+/-
0.0846 
y 
YKL025C PAN3 Ito 100 0.2319+/-
0.0485 
 
YKL028W TFA1 Ito 100 0.3572+/-
0.1658 
 
YKL038W YKL038W Ito NA NA y 
YKL048C  Uetz 10 NA  
YKL059C YKL059C Ito 200 0.1292+/-
0.0985 
 
YKL061W YKL061W Ito 100 0.3545+/-
0.1920 
 
YKL062W MSN4 Ito 100 0.7522+/-
0.0354 
y 
YKL068W NUP100 Ito 200 0.3679+/-
0.0517 
 
YKL093W MBR1 Ito 200 -0.132+/-
0.0142 
 
YKL109W HAP4 Ito 200 0.6056+/-
0.0597 
y 
YKL135C APL2 Ito >200 0.1112+/-
0.0662 
 
YKL143W LTV1 Ito 200 0.5272+/-
0.0376 
 
YKL161C YKL161C Ito 3 0.0465+/-
0.0765 
 
YKL165C MCD4 Ito >200 0.3156+/-
0.0892 
 
YKL171W YKL171W Ito 200 NA  
YKL173W SNU114 Ito 100 0.1232+/-
0.0124 
 
YKL190W  Uetz 25 NA  
YKR017C YKR017C Ito 50 0.0619+/-
0.0165 
 
YKR021W YKR021W Ito 50 0.3116+/-
0.0905 
 
YKR022C  Uetz 100 NA  
YKR027W YKR027W Ito 50 0.2616+/-
0.0432 
 
YKR048C NAP1 Ito 200 0.6022+/-
0.0544 
 
YKR060W YKR060W Ito >200 NA  
YKR064W YKR064W Ito 200 -0.024+/-
0.0423 
 
YKR077W YKR077W Ito >200 0.9899+/-
0.0390 
 
YLL013C YLL013C Ito >200 0.7076+/-
0.0934 
 
YLR016C  Uetz 50 NA  
YLR019W YLR019W Ito 100 NA  
YLR024C YLR024C Ito 100 0.1615+/-
0.0752 
 
YLR038C COX12 Ito 3 NA  
YLR053C YLR053C Ito 3 NA  
YLR071C RGR1 Ito 50 NA y 
YLR085C ARP6 Ito 25 NA  
YLR095C YLR095C Ito 100 0.2445+/-
0.0776 
 
YLR098C CHA4 Ito 200 0.6499+/-
0.0856 
y 
YLR102C APC9 Ito 100 NA  
YLR113W HOG1 Ito 100 0.1389+/-
0.0362 
 
YLR119W SRN2 Ito 3 NA  
YLR131C ACE2 Ito >200 NA y 
YLR135W YLR135W Ito >200 0.7172+/-
0.1206 
 
YLR144C ACF2 Ito >200 NA  
YLR154C YLR154C Ito 3 -0.099+/-
0.0144 
 
YLR182W SWI6 Ito 100 NA y 
YLR192C YLR192C Ito >200 0.8849+/-
0.0641 
 
YLR212C TUB4 Ito 100 0.2939+/-
0.0491 
 
YLR215C  Uetz 100 NA  
YLR226W  Uetz NA NA  
YLR228C ECM22 Ito >200 0.7762+/-
0.1344 
y 
YLR273C PIG1 Ito 100 NA  
YLR285W YLR285W Ito >200 0.9469+/-
0.0781 
 
YLR288C MEC3 Ito 25 NA  
YLR300W EXG1 Ito 25 NA  
YLR321C SFH1 Ito 100 0.2722+/-
0.0064 
 
YLR331C YLR331C Ito 100 1.0302+/-
0.0364 
 
YLR371W  Uetz 3 NA  
YLR403W SFP1 Ito 3 0.0022+/-
0.0089 
 
YLR417W VPS36 Ito 25 0.0082+/-
0.0187 
 
YLR424W YLR424W Ito 100 -0.011+/-
0.0300 
 
YLR435W YLR435W Ito 10 -0.028+/-
0.0141 
 
YLR445W YLR445W Ito 200 0.1456+/-
0.0112 
 
YLR451W LEU3 Ito 100 0.3956+/-
0.1238 
y 
YML037C YML037C Ito 200  0.0382+/-
0.0207 
 
YML058W SML1 Ito 3 NA  
YML068W YML068W Ito 3 -0.098+/-
0.0059 
 
YML081W YML081W Ito 3 -0.061+/-
0.0332 
 
YML091C YML091C Ito NA NA  
YML099C ARG81 Ito 100 NA y 
YML128C YML128C Ito 100 0.3646+/-
0.0531 
 
YMR004W MVP1 Ito >200 0.3639+/-
0.0600 
 
YMR022W  Uetz 3 NA  
YMR030W YMR030W Ito >200 0.0425+/-
0.0698 
y 
YMR037C MSN2 Ito >200 1.1689+/-
0.1381 
y 
YMR048W YMR048W Ito >200 0.1739+/-
0.0609 
 
YMR080C NAM7 Ito 200 0.0282+/-
0.0298 
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YMR081C ISF1 Ito 200 0.2389+/-
0.0471 
 
YMR091C NPL6 Ito 25 NA  
YMR112C YMR112C Ito 100 0.2012+/-
0.0585 
 
YMR133W REC114 Ito 200 -0.035+/-
0.0319 
 
YMR179W SPT21 Ito >200 -0.009+/-
0.0390 
 
YMR181C YMR181C Ito >200 0.8592+/-
0.0775 
 
YMR195W YMR195W Ito >200 0.3746+/-
0.0845 
 
YMR223W UBP8 Ito 50 0.6462+/-
0.1722 
 
YMR227C YMR227C Ito NA NA  
YMR236W YMR236W Ito NA NA y 
YMR270C RRN9 Ito 100 NA  
YMR277W FCP1 Ito 200 0.1342+/-
0.0405 
 
YMR295C YMR295C Ito >200 NA  
YMR297W PRC1 Ito 25 NA  
YMR299C YMR299C Ito 200 0.0979+/-
0.0148 
 
YMR323W YMR323W Ito 3 -0.014+/-
0.0122 
 
YNL004W HRB1 Ito 3 -0.062+/-
0.0235 
 
YNL025C SSN8 Ito 100 0.2122+/-
0.0517 
 
YNL027W CRZ1 Ito >200 0.8595+/-
0.0728 
 
YNL032W SIW14 Ito 200 0.7252+/-
0.1191 
 
YNL074C YNL074C Ito NA NA  
YNL075W  Uetz 25 NA  
YNL091W YNL091W Ito 50 -0.014+/-
0.0416 
 
YNL092W YNL092W Ito 3 -0.045+/-
0.0169 
 
YNL103W MET4 Ito >200 0.7636+/-
0.0770 
y 
YNL127W YNL127W Ito 3 0.0485+/-
0.0240 
 
YNL151C RPC31 Ito 50 -0.026+/-
0.0369 
 
YNL161W CBK1 Ito 100 0.3809+/-
0.1267 
 
YNL164C YNL164C Ito 3 0.0162+/-
0.0497 
 
YNL192W YNL192W Ito NA NA  
YNL199C GCR2 Ito 100 0.5216+/-
0.0662 
y 
YNL204C SPS18 Ito 100 0.0242+/-
0.0378 
 
YNL223W YNL223W Ito NA NA  
YNL225C CNM67 Ito 100 0.1709+/-
0.0875 
 
YNL236W SIN4 Ito >200 0.1229+/-
0.0694 
 
YNL245C  Uetz NA NA  
YNL308C  Uetz 3 NA  
YNL309W STB1 Ito 100 NA y 
YNL314W DAL82 Ito 100 -0.047+/-
0.0655 
y 
YNL330C RPD3 Ito 10 NA  
YNR003C RPC34 Ito 3 NA  
YNR004W YNR004W Ito 10 0.0165+/-
0.0629 
 
YNR010W CSE2 Ito 200 0.3445+/-
0.0819 
 
YNR017W MAS6 Ito 200 0.5209+/-
0.1233 
 
YNR023W SNF12 Ito NA NA  
YNR032W PPG1 Ito 200 NA  
YNR063W YNR063W Ito 100 0.0312+/-
0.0368 
 
YNR069C YNR069C Ito >200 0.9416+/-
0.3435 
 
YOL044W  Uetz 3 NA  
YOL051W GAL11 Ito 200 0.9772+/-
0.0244 
y 
YOL067C RTG1 Ito >200 0.5925+/-
0.0651 
y 
YOL082W YOL082W Ito NA NA  
YOL083W YOL083W Ito NA NA  
YOL108C INO4 Ito 100 NA y 
YOL112W MSB4 Ito 200 0.4759+/-
0.1309 
 
YOL135C MED7 Ito 50 0.0815+/-
0.0151 
 
YOL136C PFK27 Ito 200 0.3526+/-
0.0579 
 
YOL148C SPT20 Ito 100 0.4402+/-
0.1069 
y 
YOR032C HMS1 Ito NA NA  
YOR066W YOR066W Ito >200 0.5309+/-
0.1226 
 
YOR069W  Uetz NA NA  
YOR070C GYP1 Ito >200 -0.070+/-
0.0176 
 
YOR113W  Uetz NA NA y 
YOR128C ADE2 Ito NA NA  
YOR151C YOR151C Ito & 
Uetz 
NA NA  
YOR162C YRR1 Ito 100 0.0812+/-
0.0411 
y 
YOR166C YOR166C Ito 200 0.0519+/-
0.0395 
 
YOR174W MED4 Ito >200 0.1035+/-
0.0747 
 
YOR177C  Uetz 3 NA  
YOR178C GAC1 Ito >200 0.5292+/-
0.0982 
 
YOR194C TOA1 Ito >200 NA  
YOR197W YOR197W Ito 100 0.1565+/-
0.0919 
 
YOR212W STE4 Ito NA NA  
YOR262W YOR262W Ito 200 0.5596+/-
0.0335 
 
YOR281C YOR281C Ito 100 NA  
YOR290C SNF2 Ito 200 0.7139+/-
0.1587 
 
YOR299W BUD7 Ito 50 0.1079+/-
0.0420 
 
YOR329C SCD5 Ito >200 0.2706+/-
0.0516 
 
YOR339C  Uetz NA NA  
YOR344C TYE7 Ito 100 0.3559+/-
0.1249 
y 
YOR352W YOR352W Ito 100 0.2375+/-
0.0558 
 
YOR355W GDS1 Ito 100 0.2076+/-
0.0304 
 
YOR370C MRS6 Ito >200 0.5295+/-
0.1343 
 
YOR382W YOR382W Ito 3 -0.023+/-
0.0297 
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YPL011C YPL011C Ito NA NA  
YPL014W YPL014W Ito 3 0.0819+/-
0.0381 
 
YPL026C SKS1 Ito 50 -0.025+/-
0.0102 
 
YPL038W MET31 Ito 50 0.0242+/-
0.0316 
 
YPL042C SSN3 Ito NA NA  
YPL054W LEE1 Ito 50 -0.041+/-
0.0251 
 
YPL055C YPL055C Ito 3 -0.047+/-
0.0301 
 
YPL075W GCR1 Ito 50 0.0769+/-
0.0356 
y 
YPL089C RLM1 Ito 200 NA  
YPL105C YPL105C Ito 200 0.0619+/-
0.0482 
 
YPL124W YPL124W Ito NA NA  
YPL174C NIP100 Ito 100 -0.056+/-
0.0151 
 
YPL184C YPL184C Ito 100 0.5069+/-
0.1525 
 
YPL202C YPL202C Ito NA NA y 
YPL229W YPL229W Ito & 
Uetz 
200 0.0929+/-
0.0316 
 
YPL233W YPL233W Ito 200 NA  
YPL250C YPL250C Ito >200 0.5319+/-
0.1199 
 
YPL254W HFI1 Ito 100 0.2372+/-
0.1030 
y 
YPL256C CLN2 Ito NA NA  
YPL278C YPL278C Ito 100 0.3419+/-
0.0477 
 
YPR007C YPR007C Ito 3 -0.013+/-
0.0290 
 
YPR008W YPR008W Ito >200 0.8622+/-
0.1090 
 
YPR040W  Uetz 3 NA  
YPR046W MCM16 Ito 50 0.0815+/-
0.0187 
 
YPR066W YPR066W Ito NA NA  
YPR070W YPR070W Ito NA NA  
YPR076W YPR076W Ito 100 0.4306+/-
0.0696 
 
YPR103W PRE2 Ito 100 0.0619+/-
0.0151 
 
YPR105C  Uetz 3 NA  
YPR119W  Uetz 3 NA  
YPR144C YPR144C Ito & 
Uetz 
50 NA  
YPR168W NUT2 Ito 100 0.0442+/-
0.0305 
 
YPR179C YPR179C Ito >200 0.8885+/-
0.0251 
 
YPR180W AOS1 Ito >200 -0.048+/-
0.1139 
 
YPR187W RPO26 Ito 100 0.0695+/-
0.0532 
 
YPR192W YPR192W Ito NA NA  
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Supplementary Table 2 Protein interactions of T. pallidum. All protein interactions 
detected for T. pallidum are shown. The definition lines are shortened and the prey count 
and subset (W=whole set; F=filtered set) is given in parenthesis. 
TP0001 [chromosomal replicat...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0004 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0004 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0006 [Tp75 protein {Trepon...] - TP0281 [hypothetical protein...] (64,W) 
TP0006 [Tp75 protein {Trepon...] - TP0518 [conserved hypothetic...] (70,W) 
TP0006 [Tp75 protein {Trepon...] - TP0563 [hypothetical protein...] (93,W) 
TP0006 [Tp75 protein {Trepon...] - TP0587 [hypothetical protein...] (23,F) 
TP0006 [Tp75 protein {Trepon...] - TP0618 [hypothetical protein...] (24,F) 
TP0006 [Tp75 protein {Trepon...] - TP0664 [flagellar filament o...] (34,F) 
TP0006 [Tp75 protein {Trepon...] - TP0764 [conserved hypothetic...] (139,W) 
TP0006 [Tp75 protein {Trepon...] - TP0788 [hypothetical protein...] (132,W) 
TP0006 [Tp75 protein {Trepon...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0006 [Tp75 protein {Trepon...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0006 [Tp75 protein {Trepon...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0006 [Tp75 protein {Trepon...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0006 [Tp75 protein {Trepon...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0007 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0007 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0007 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0007 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0007 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0007 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0007 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0007 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0011 [tpr protein B (tprB)...] - TP0563 [hypothetical protein...] (93,W) 
TP0011 [tpr protein B (tprB)...] - TP0661 [hypothetical protein...] (117,W) 
TP0012 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0012 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0012 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0012 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0012 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0012 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0012 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0012 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0012 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0012 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0012 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0012 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0012 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0012 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0012 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0012 [hypothetical protein...] - TP0894 [conserved hypothetic...] (13,F) 
TP0012 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0012 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0012 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0012 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0012 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0013 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0013 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0013 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0013 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0015 [phenylalanyl-tRNA sy...] - TP0258 [conserved hypothetic...] (173,W) 
TP0015 [phenylalanyl-tRNA sy...] - TP0383 [conserved hypothetic...] (65,W) 
TP0015 [phenylalanyl-tRNA sy...] - TP0563 [hypothetical protein...] (93,W) 
TP0015 [phenylalanyl-tRNA sy...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0015 [phenylalanyl-tRNA sy...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0017 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0017 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0017 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0017 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0017 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0018 [transcription elonga...] - TP0677 [hypothetical protein...] (2,F) 
TP0018 [transcription elonga...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0018 [transcription elonga...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0019 [transcription elonga...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0019 [transcription elonga...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0019 [transcription elonga...] - TP0281 [hypothetical protein...] (64,W) 
TP0019 [transcription elonga...] - TP0563 [hypothetical protein...] (93,W) 
TP0019 [transcription elonga...] - TP0741 [conserved hypothetic...] (8,F) 
TP0019 [transcription elonga...] - TP0788 [hypothetical protein...] (132,W) 
TP0019 [transcription elonga...] - TP0907 [conserved hypothetic...] (110,W) 
TP0019 [transcription elonga...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0019 [transcription elonga...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0021 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0025 [conserved hypothetic...] - TP0928 [hypothetical protein...] (1,F) 
TP0025 [conserved hypothetic...] - TP1040 [lysyl-tRNA synthetas...] (2,F) 
TP0026 [flagellar motor swit...] - TP0563 [hypothetical protein...] (93,W) 
TP0027 [hemolysin, putative ...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0027 [hemolysin, putative ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0029 [UDP-N-acetylglucosam...] - TP0713 [flagellar-associated...] (1,F) 
TP0029 [UDP-N-acetylglucosam...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0030 [heat shock protein (...] - TP0050 [conserved hypothetic...] (10,F) 
TP0030 [heat shock protein (...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0030 [heat shock protein (...] - TP0726 [flagellar protein (f...] (7,F) 
TP0030 [heat shock protein (...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0030 [heat shock protein (...] - TP0987 [hypothetical protein...] (2,F) 
TP0031 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0031 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0031 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0031 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0032 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0033 [conserved hypothetic...] - TP0227 [cobalt ABC transport...] (1,F) 
TP0034 [ABC transporter, per...] - TP0469 [hypothetical protein...] (1,F) 
TP0034 [ABC transporter, per...] - TP0788 [hypothetical protein...] (132,W) 
TP0034 [ABC transporter, per...] - TP0799 [hypothetical protein...] (2,F) 
TP0035 [ABC transporter, ATP...] - TP0383 [conserved hypothetic...] (65,W) 
TP0035 [ABC transporter, ATP...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0035 [ABC transporter, ATP...] - TP0519 [response regulatory ...] (30,F) 
TP0035 [ABC transporter, ATP...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0035 [ABC transporter, ATP...] - TP0563 [hypothetical protein...] (93,W) 
TP0035 [ABC transporter, ATP...] - TP0788 [hypothetical protein...] (132,W) 
TP0035 [ABC transporter, ATP...] - TP0872 [flagellar filament c...] (1,F) 
TP0035 [ABC transporter, ATP...] - TP0907 [conserved hypothetic...] (110,W) 
TP0035 [ABC transporter, ATP...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0035 [ABC transporter, ATP...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0035 [ABC transporter, ATP...] - TP1004 [recombination protei...] (74,W) 
TP0035 [ABC transporter, ATP...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0036 [ABC transporter, per...] - TP0561 [conserved hypothetic...] (44,F) 
TP0037 [D-specific D-2-hydro...] - TP0764 [conserved hypothetic...] (139,W) 
TP0038 [regulatory protein (...] - TP0377 [conserved hypothetic...] (11,F) 
TP0038 [regulatory protein (...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0038 [regulatory protein (...] - TP0561 [conserved hypothetic...] (44,F) 
TP0038 [regulatory protein (...] - TP0708 [hypothetical protein...] (13,F) 
TP0038 [regulatory protein (...] - TP0764 [conserved hypothetic...] (139,W) 
TP0038 [regulatory protein (...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0039 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0039 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0039 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0039 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0039 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0041 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0041 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0041 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0041 [hypothetical protein...] - TP0727 [flagellar hook prote...] (5,F) 
TP0041 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0042 [hypothetical protein...] - TP0334 [conserved hypothetic...] (5,F) 
TP0042 [hypothetical protein...] - TP0377 [conserved hypothetic...] (11,F) 
TP0042 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0042 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0042 [hypothetical protein...] - TP0716 [flagellar biosynthet...] (2,F) 
TP0042 [hypothetical protein...] - TP0826 [conserved hypothetic...] (1,F) 
TP0042 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0043 [soluble lytic transg...] - TP0764 [conserved hypothetic...] (139,W) 
TP0044 [glucose inhibited di...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0044 [glucose inhibited di...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0044 [glucose inhibited di...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0045 [adenosine deaminase,...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0045 [adenosine deaminase,...] - TP0258 [conserved hypothetic...] (173,W) 
TP0045 [adenosine deaminase,...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0045 [adenosine deaminase,...] - TP0661 [hypothetical protein...] (117,W) 
TP0045 [adenosine deaminase,...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0045 [adenosine deaminase,...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0046 [hypothetical protein...] - TP0099 [uridylate kinase (sm...] (3,F) 
TP0046 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0046 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0046 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0046 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0046 [hypothetical protein...] - TP0797 [1-pyrroline-5-carbox...] (5,F) 
TP0046 [hypothetical protein...] - TP0894 [conserved hypothetic...] (13,F) 
TP0046 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0046 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0046 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0046 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0046 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0046 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0046 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0047 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0047 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0047 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0047 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0047 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0047 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0047 [conserved hypothetic...] - TP0618 [hypothetical protein...] (24,F) 
TP0047 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0047 [conserved hypothetic...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0047 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
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TP0047 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0047 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0047 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0047 [conserved hypothetic...] - TP0797 [1-pyrroline-5-carbox...] (5,F) 
TP0047 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0047 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0047 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0047 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0047 [conserved hypothetic...] - TP0974 [hypothetical protein...] (23,F) 
TP0047 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0047 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0047 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0047 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0047 [conserved hypothetic...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0048 [conserved hypothetic...] - TP0059 [hypothetical protein...] (21,F) 
TP0048 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0048 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0048 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0048 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0048 [conserved hypothetic...] - TP0287 [conserved hypothetic...] (27,F) 
TP0048 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0048 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0048 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0048 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0048 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0048 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0048 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0048 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0048 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0048 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0048 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0048 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0048 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0048 [conserved hypothetic...] - TP0618 [hypothetical protein...] (24,F) 
TP0048 [conserved hypothetic...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0048 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0048 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0048 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0048 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0048 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0048 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0048 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0048 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0048 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0048 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0048 [conserved hypothetic...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0048 [conserved hypothetic...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0048 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0048 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0048 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0048 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0048 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0048 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0048 [conserved hypothetic...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0050 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0050 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0050 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0050 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0050 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0050 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0051 [peptide chain releas...] - TP0067 [conserved hypothetic...] (19,F) 
TP0051 [peptide chain releas...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0051 [peptide chain releas...] - TP0210 [ribosomal protein S1...] (1,F) 
TP0052 [protoporphyrinogen o...] - TP0764 [conserved hypothetic...] (139,W) 
TP0053 [ribonucleoside-dipho...] - TP0832 [hypothetical protein...] (37,F) 
TP0053 [ribonucleoside-dipho...] - TP0961 [flagellar basal-body...] (84,W) 
TP0054 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0054 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0054 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0054 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0054 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0054 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0054 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0054 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0054 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0055 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0055 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0057 [oxaloacetate decarbo...] - TP0377 [conserved hypothetic...] (11,F) 
TP0057 [oxaloacetate decarbo...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0058 [replicative DNA heli...] - TP0001 [chromosomal replicat...] (3,F) 
TP0058 [replicative DNA heli...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0058 [replicative DNA heli...] - TP0046 [hypothetical protein...] (18,F) 
TP0058 [replicative DNA heli...] - TP0050 [conserved hypothetic...] (10,F) 
TP0058 [replicative DNA heli...] - TP0064 [hypothetical, protei...] (8,F) 
TP0058 [replicative DNA heli...] - TP0066 [hypothetical protein...] (11,F) 
TP0058 [replicative DNA heli...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0058 [replicative DNA heli...] - TP0102 [rep helicase, single...] (1,F) 
TP0058 [replicative DNA heli...] - TP0258 [conserved hypothetic...] (173,W) 
TP0058 [replicative DNA heli...] - TP0288 [spore coat polysacch...] (77,W) 
TP0058 [replicative DNA heli...] - TP0563 [hypothetical protein...] (93,W) 
TP0058 [replicative DNA heli...] - TP0832 [hypothetical protein...] (37,F) 
TP0058 [replicative DNA heli...] - TP0896 [hypothetical protein...] (1,F) 
TP0058 [replicative DNA heli...] - TP0897 [tpr protein K (tprK)...] (1,F) 
TP0058 [replicative DNA heli...] - TP0907 [conserved hypothetic...] (110,W) 
TP0058 [replicative DNA heli...] - TP0961 [flagellar basal-body...] (84,W) 
TP0058 [replicative DNA heli...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0058 [replicative DNA heli...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0058 [replicative DNA heli...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0059 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0059 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0059 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0059 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0059 [hypothetical protein...] - TP0286 [conserved hypothetic...] (9,F) 
TP0059 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0059 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0059 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0059 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0059 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0059 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0059 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0059 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0059 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0059 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0059 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0059 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0059 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0059 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0059 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0059 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0059 [hypothetical protein...] - TP0995 [cyclic nucleotide bi...] (5,F) 
TP0060 [ribosomal protein L9...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0060 [ribosomal protein L9...] - TP0907 [conserved hypothetic...] (110,W) 
TP0060 [ribosomal protein L9...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0060 [ribosomal protein L9...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0061 [ribosomal protein S1...] - TP0258 [conserved hypothetic...] (173,W) 
TP0061 [ribosomal protein S1...] - TP0287 [conserved hypothetic...] (27,F) 
TP0061 [ribosomal protein S1...] - TP0288 [spore coat polysacch...] (77,W) 
TP0061 [ribosomal protein S1...] - TP0383 [conserved hypothetic...] (65,W) 
TP0061 [ribosomal protein S1...] - TP0711 [conserved hypothetic...] (46,F) 
TP0061 [ribosomal protein S1...] - TP0788 [hypothetical protein...] (132,W) 
TP0061 [ribosomal protein S1...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0061 [ribosomal protein S1...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0061 [ribosomal protein S1...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0062 [single-strand DNA bi...] - TP0288 [spore coat polysacch...] (77,W) 
TP0063 [ribosomal protein S6...] - TP0258 [conserved hypothetic...] (173,W) 
TP0063 [ribosomal protein S6...] - TP0383 [conserved hypothetic...] (65,W) 
TP0063 [ribosomal protein S6...] - TP0518 [conserved hypothetic...] (70,W) 
TP0063 [ribosomal protein S6...] - TP0661 [hypothetical protein...] (117,W) 
TP0063 [ribosomal protein S6...] - TP0711 [conserved hypothetic...] (46,F) 
TP0063 [ribosomal protein S6...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0063 [ribosomal protein S6...] - TP0788 [hypothetical protein...] (132,W) 
TP0063 [ribosomal protein S6...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0063 [ribosomal protein S6...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0063 [ribosomal protein S6...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0063 [ribosomal protein S6...] - TP1004 [recombination protei...] (74,W) 
TP0064 [hypothetical, protei...] - TP0281 [hypothetical protein...] (64,W) 
TP0064 [hypothetical, protei...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0064 [hypothetical, protei...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0066 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0067 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0067 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0067 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0067 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0067 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0067 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0067 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0067 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0067 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0068 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0068 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0068 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0068 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0068 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0068 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0070 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0070 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0070 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0071 [ATP-dependent Clp pr...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0071 [ATP-dependent Clp pr...] - TP0465 [hypothetical protein...] (7,F) 
TP0071 [ATP-dependent Clp pr...] - TP0519 [response regulatory ...] (30,F) 
TP0071 [ATP-dependent Clp pr...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0071 [ATP-dependent Clp pr...] - TP1004 [recombination protei...] (74,W) 
TP0072 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0072 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0072 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0073 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0073 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0074 [sugar ABC transporte...] - TP0067 [conserved hypothetic...] (19,F) 
TP0074 [sugar ABC transporte...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0074 [sugar ABC transporte...] - TP0258 [conserved hypothetic...] (173,W) 
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TP0074 [sugar ABC transporte...] - TP0281 [hypothetical protein...] (64,W) 
TP0074 [sugar ABC transporte...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0074 [sugar ABC transporte...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0074 [sugar ABC transporte...] - TP0519 [response regulatory ...] (30,F) 
TP0074 [sugar ABC transporte...] - TP0587 [hypothetical protein...] (23,F) 
TP0074 [sugar ABC transporte...] - TP0764 [conserved hypothetic...] (139,W) 
TP0074 [sugar ABC transporte...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0074 [sugar ABC transporte...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0074 [sugar ABC transporte...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0074 [sugar ABC transporte...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0077 [capsular polysacchar...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0077 [capsular polysacchar...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0079 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0079 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0079 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0079 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0079 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0079 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0080 [quinoline 2-oxidored...] - TP0518 [conserved hypothetic...] (70,W) 
TP0080 [quinoline 2-oxidored...] - TP0559 [conserved hypothetic...] (26,F) 
TP0080 [quinoline 2-oxidored...] - TP0788 [hypothetical protein...] (132,W) 
TP0080 [quinoline 2-oxidored...] - TP0907 [conserved hypothetic...] (110,W) 
TP0080 [quinoline 2-oxidored...] - TP0920 [hypothetical protein...] (7,F) 
TP0080 [quinoline 2-oxidored...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0080 [quinoline 2-oxidored...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0080 [quinoline 2-oxidored...] - TP1004 [recombination protei...] (74,W) 
TP0081 [conserved hypothetic...] - TP0414 [D-alanine glycine pe...] (1,F) 
TP0083 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0083 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0083 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0083 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0083 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0083 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0084 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0084 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0084 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0084 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0084 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0084 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0084 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0084 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0084 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0084 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0084 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0084 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0084 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0084 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0084 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0085 [PTS system, nitrogen...] - TP0059 [hypothetical protein...] (21,F) 
TP0085 [PTS system, nitrogen...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0085 [PTS system, nitrogen...] - TP0258 [conserved hypothetic...] (173,W) 
TP0085 [PTS system, nitrogen...] - TP0281 [hypothetical protein...] (64,W) 
TP0085 [PTS system, nitrogen...] - TP0287 [conserved hypothetic...] (27,F) 
TP0085 [PTS system, nitrogen...] - TP0383 [conserved hypothetic...] (65,W) 
TP0085 [PTS system, nitrogen...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0085 [PTS system, nitrogen...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0085 [PTS system, nitrogen...] - TP0518 [conserved hypothetic...] (70,W) 
TP0085 [PTS system, nitrogen...] - TP0519 [response regulatory ...] (30,F) 
TP0085 [PTS system, nitrogen...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0085 [PTS system, nitrogen...] - TP0559 [conserved hypothetic...] (26,F) 
TP0085 [PTS system, nitrogen...] - TP0711 [conserved hypothetic...] (46,F) 
TP0085 [PTS system, nitrogen...] - TP0764 [conserved hypothetic...] (139,W) 
TP0085 [PTS system, nitrogen...] - TP0773 [periplasmic serine p...] (30,F) 
TP0085 [PTS system, nitrogen...] - TP0788 [hypothetical protein...] (132,W) 
TP0085 [PTS system, nitrogen...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0085 [PTS system, nitrogen...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0085 [PTS system, nitrogen...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0086 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0086 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0086 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0086 [conserved hypothetic...] - TP0167 [cation-activated rep...] (1,F) 
TP0086 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0086 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0086 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0086 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0086 [conserved hypothetic...] - TP0412 [conserved hypothetic...] (4,F) 
TP0086 [conserved hypothetic...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0086 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0086 [conserved hypothetic...] - TP0513 [K+ transport protein...] (4,F) 
TP0086 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0086 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0086 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0086 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0086 [conserved hypothetic...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0086 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0086 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0086 [conserved hypothetic...] - TP0797 [1-pyrroline-5-carbox...] (5,F) 
TP0086 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0086 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0086 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0086 [conserved hypothetic...] - TP0895 [hypothetical protein...] (3,F) 
TP0086 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0086 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0086 [conserved hypothetic...] - TP0974 [hypothetical protein...] (23,F) 
TP0086 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0086 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0086 [conserved hypothetic...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0086 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0086 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0087 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0087 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0087 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0087 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0087 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0087 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0087 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0087 [conserved hypothetic...] - TP0688 [immunity protein (mc...] (1,F) 
TP0087 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0087 [conserved hypothetic...] - TP0974 [hypothetical protein...] (23,F) 
TP0087 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0088 [conserved hypothetic...] - TP0088 [conserved hypothetic...] (8,F) 
TP0088 [conserved hypothetic...] - TP0832 [hypothetical protein...] (37,F) 
TP0089 [cyclic nucleotide bi...] - TP0258 [conserved hypothetic...] (173,W) 
TP0089 [cyclic nucleotide bi...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0089 [cyclic nucleotide bi...] - TP0898 [ATP-dependent nuclea...] (1,F) 
TP0089 [cyclic nucleotide bi...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0089 [cyclic nucleotide bi...] - TP1004 [recombination protei...] (74,W) 
TP0092 [RNA polymerase sigma...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0092 [RNA polymerase sigma...] - TP0258 [conserved hypothetic...] (173,W) 
TP0092 [RNA polymerase sigma...] - TP0288 [spore coat polysacch...] (77,W) 
TP0092 [RNA polymerase sigma...] - TP0518 [conserved hypothetic...] (70,W) 
TP0092 [RNA polymerase sigma...] - TP0661 [hypothetical protein...] (117,W) 
TP0092 [RNA polymerase sigma...] - TP0764 [conserved hypothetic...] (139,W) 
TP0092 [RNA polymerase sigma...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0094 [phosphate acetyltran...] - TP0059 [hypothetical protein...] (21,F) 
TP0094 [phosphate acetyltran...] - TP0067 [conserved hypothetic...] (19,F) 
TP0094 [phosphate acetyltran...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0094 [phosphate acetyltran...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0094 [phosphate acetyltran...] - TP0258 [conserved hypothetic...] (173,W) 
TP0094 [phosphate acetyltran...] - TP0281 [hypothetical protein...] (64,W) 
TP0094 [phosphate acetyltran...] - TP0286 [conserved hypothetic...] (9,F) 
TP0094 [phosphate acetyltran...] - TP0287 [conserved hypothetic...] (27,F) 
TP0094 [phosphate acetyltran...] - TP0383 [conserved hypothetic...] (65,W) 
TP0094 [phosphate acetyltran...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0094 [phosphate acetyltran...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0094 [phosphate acetyltran...] - TP0465 [hypothetical protein...] (7,F) 
TP0094 [phosphate acetyltran...] - TP0519 [response regulatory ...] (30,F) 
TP0094 [phosphate acetyltran...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0094 [phosphate acetyltran...] - TP0563 [hypothetical protein...] (93,W) 
TP0094 [phosphate acetyltran...] - TP0664 [flagellar filament o...] (34,F) 
TP0094 [phosphate acetyltran...] - TP0907 [conserved hypothetic...] (110,W) 
TP0094 [phosphate acetyltran...] - TP0920 [hypothetical protein...] (7,F) 
TP0094 [phosphate acetyltran...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0094 [phosphate acetyltran...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0094 [phosphate acetyltran...] - TP1004 [recombination protei...] (74,W) 
TP0094 [phosphate acetyltran...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0095 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0097 [translation initiati...] - TP0059 [hypothetical protein...] (21,F) 
TP0097 [translation initiati...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0097 [translation initiati...] - TP0078 [spore coat polysacch...] (2,F) 
TP0097 [translation initiati...] - TP0177 [hypothetical protein...] (1,F) 
TP0097 [translation initiati...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0097 [translation initiati...] - TP0258 [conserved hypothetic...] (173,W) 
TP0097 [translation initiati...] - TP0281 [hypothetical protein...] (64,W) 
TP0097 [translation initiati...] - TP0286 [conserved hypothetic...] (9,F) 
TP0097 [translation initiati...] - TP0287 [conserved hypothetic...] (27,F) 
TP0097 [translation initiati...] - TP0383 [conserved hypothetic...] (65,W) 
TP0097 [translation initiati...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0097 [translation initiati...] - TP0412 [conserved hypothetic...] (4,F) 
TP0097 [translation initiati...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0097 [translation initiati...] - TP0518 [conserved hypothetic...] (70,W) 
TP0097 [translation initiati...] - TP0519 [response regulatory ...] (30,F) 
TP0097 [translation initiati...] - TP0552 [hypothetical protein...] (3,F) 
TP0097 [translation initiati...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0097 [translation initiati...] - TP0563 [hypothetical protein...] (93,W) 
TP0097 [translation initiati...] - TP0587 [hypothetical protein...] (23,F) 
TP0097 [translation initiati...] - TP0618 [hypothetical protein...] (24,F) 
TP0097 [translation initiati...] - TP0661 [hypothetical protein...] (117,W) 
TP0097 [translation initiati...] - TP0664 [flagellar filament o...] (34,F) 
TP0097 [translation initiati...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0097 [translation initiati...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0097 [translation initiati...] - TP0711 [conserved hypothetic...] (46,F) 
TP0097 [translation initiati...] - TP0751 [hypothetical protein...] (7,F) 
TP0097 [translation initiati...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0097 [translation initiati...] - TP0764 [conserved hypothetic...] (139,W) 
TP0097 [translation initiati...] - TP0773 [periplasmic serine p...] (30,F) 
TP0097 [translation initiati...] - TP0788 [hypothetical protein...] (132,W) 
TP0097 [translation initiati...] - TP0833 [hypothetical protein...] (34,F) 
TP0097 [translation initiati...] - TP0907 [conserved hypothetic...] (110,W) 
TP0097 [translation initiati...] - TP0945 [ribulose-phosphate 3...] (21,F) 
SUPPLEMENTARY INFORMATION 
 187 
TP0097 [translation initiati...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0097 [translation initiati...] - TP0974 [hypothetical protein...] (23,F) 
TP0097 [translation initiati...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0097 [translation initiati...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0097 [translation initiati...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0097 [translation initiati...] - TP1004 [recombination protei...] (74,W) 
TP0097 [translation initiati...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0099 [uridylate kinase (sm...] - TP0281 [hypothetical protein...] (64,W) 
TP0099 [uridylate kinase (sm...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0099 [uridylate kinase (sm...] - TP0518 [conserved hypothetic...] (70,W) 
TP0099 [uridylate kinase (sm...] - TP0764 [conserved hypothetic...] (139,W) 
TP0099 [uridylate kinase (sm...] - TP0788 [hypothetical protein...] (132,W) 
TP0100 [thioredoxin, putativ...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0100 [thioredoxin, putativ...] - TP0088 [conserved hypothetic...] (8,F) 
TP0100 [thioredoxin, putativ...] - TP0832 [hypothetical protein...] (37,F) 
TP0100 [thioredoxin, putativ...] - TP0961 [flagellar basal-body...] (84,W) 
TP0100 [thioredoxin, putativ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0101 [cytochrome c biogene...] - TP0561 [conserved hypothetic...] (44,F) 
TP0101 [cytochrome c biogene...] - TP0708 [hypothetical protein...] (13,F) 
TP0101 [cytochrome c biogene...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0103 [ATP-dependent DNA he...] - TP0559 [conserved hypothetic...] (26,F) 
TP0103 [ATP-dependent DNA he...] - TP0661 [hypothetical protein...] 
(117,W) 
TP0103 [ATP-dependent DNA he...] - TP0764 [conserved hypothetic...] 
(139,W) 
TP0103 [ATP-dependent DNA he...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0103 [ATP-dependent DNA he...] - TP1004 [recombination protei...] 
(74,W) 
TP0104 [5'-nucleotidase (ush...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0104 [5'-nucleotidase (ush...] - TP0281 [hypothetical protein...] (64,W) 
TP0104 [5'-nucleotidase (ush...] - TP0287 [conserved hypothetic...] (27,F) 
TP0104 [5'-nucleotidase (ush...] - TP0518 [conserved hypothetic...] (70,W) 
TP0104 [5'-nucleotidase (ush...] - TP0561 [conserved hypothetic...] (44,F) 
TP0104 [5'-nucleotidase (ush...] - TP0764 [conserved hypothetic...] (139,W) 
TP0104 [5'-nucleotidase (ush...] - TP0907 [conserved hypothetic...] (110,W) 
TP0104 [5'-nucleotidase (ush...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0104 [5'-nucleotidase (ush...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0104 [5'-nucleotidase (ush...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0104 [5'-nucleotidase (ush...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0106 [carnitine transporte...] - TP0377 [conserved hypothetic...] (11,F) 
TP0106 [carnitine transporte...] - TP0561 [conserved hypothetic...] (44,F) 
TP0106 [carnitine transporte...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0107 [licC protein (licC) ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0107 [licC protein (licC) ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0109 [rRNA methylase, puta...] - TP0764 [conserved hypothetic...] (139,W) 
TP0110 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0110 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0110 [hypothetical protein...] - TP0774 [Mg2+ transport prote...] (2,F) 
TP0111 [RNA polymerase sigma...] - TP0764 [conserved hypothetic...] (139,W) 
TP0112 [aminopeptidase C (pe...] - TP0818 [hypothetical protein...] (2,F) 
TP0113 [Lambda CII stability...] - TP0661 [hypothetical protein...] (117,W) 
TP0113 [Lambda CII stability...] - TP0764 [conserved hypothetic...] (139,W) 
TP0113 [Lambda CII stability...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0114 [Lambda CII stability...] - TP0764 [conserved hypothetic...] (139,W) 
TP0115 [phosphomethypyrimidi...] - TP0258 [conserved hypothetic...] (173,W) 
TP0115 [phosphomethypyrimidi...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0117 [tpr protein C (tprC)...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0117 [tpr protein C (tprC)...] - TP0788 [hypothetical protein...] (132,W) 
TP0119 [amino acid ABC trans...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0121 [conserved hypothetic...] - TP0121 [conserved hypothetic...] (7,F) 
TP0121 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0121 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0121 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0121 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0121 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0124 [conserved hypothetic...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0124 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0124 [conserved hypothetic...] - TP0067 [conserved hypothetic...] (19,F) 
TP0124 [conserved hypothetic...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0124 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0124 [conserved hypothetic...] - TP0432 [hypothetical protein...] (2,F) 
TP0124 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0124 [conserved hypothetic...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0124 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0124 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0124 [conserved hypothetic...] - TP0795 [hypothetical protein...] (4,F) 
TP0124 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0126 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0128 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0128 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0128 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0128 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0128 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0128 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0128 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0128 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0128 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0128 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0128 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0129 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0130 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0130 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0130 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0130 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0130 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0130 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0131 [tpr protein D (tprD)...] - TP0853 [ATP-binding protein ...] (1,F) 
TP0132 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0132 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0132 [hypothetical protein...] - TP0095 [hypothetical protein...] (15,F) 
TP0132 [hypothetical protein...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0132 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0132 [hypothetical protein...] - TP0255 [ribosomal protein L3...] (2,F) 
TP0132 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0132 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0132 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0132 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0132 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0132 [hypothetical protein...] - TP0465 [hypothetical protein...] (7,F) 
TP0132 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0132 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0132 [hypothetical protein...] - TP0552 [hypothetical protein...] (3,F) 
TP0132 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0132 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0132 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0132 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0132 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0132 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0132 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0132 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0132 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0132 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0132 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0132 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0132 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0132 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0132 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0132 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0132 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0132 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0132 [hypothetical protein...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0132 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0132 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0133 [hypothetical protein...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0133 [hypothetical protein...] - TP0640 [methyl-accepting che...] (5,F) 
TP0133 [hypothetical protein...] - TP0832 [hypothetical protein...] (37,F) 
TP0134 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0134 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0135 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0135 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0135 [hypothetical protein...] - TP0965 [membrane fusion prot...] (14,F) 
TP0135 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0136 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0136 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0136 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0140 [K+ transport protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0140 [K+ transport protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0140 [K+ transport protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0140 [K+ transport protein...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0140 [K+ transport protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0140 [K+ transport protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0140 [K+ transport protein...] - TP1004 [recombination protei...] (74,W) 
TP0142 [thiamine ABC transpo...] - TP0281 [hypothetical protein...] (64,W) 
TP0142 [thiamine ABC transpo...] - TP0518 [conserved hypothetic...] (70,W) 
TP0142 [thiamine ABC transpo...] - TP0764 [conserved hypothetic...] (139,W) 
TP0142 [thiamine ABC transpo...] - TP0907 [conserved hypothetic...] (110,W) 
TP0142 [thiamine ABC transpo...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0142 [thiamine ABC transpo...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0142 [thiamine ABC transpo...] - TP1004 [recombination protei...] (74,W) 
TP0142 [thiamine ABC transpo...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0148 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0149 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0149 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0150 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0150 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0150 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0150 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0150 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0150 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0150 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0150 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0150 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0150 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0150 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0150 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0151 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0151 [conserved hypothetic...] - TP0658 [transmembrane protei...] (5,F) 
TP0151 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0153 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0153 [conserved hypothetic...] - TP0610 [tpr protein H (tprH)...] (1,F) 
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TP0154 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0154 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0154 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0154 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0154 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0155 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0157 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0157 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0157 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0157 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0157 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0157 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0157 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0157 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0157 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0157 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0157 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0157 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0157 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0158 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0158 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0158 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0158 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0158 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0158 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0158 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0158 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0158 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0158 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0158 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0158 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0162 [Holliday junction DN...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0162 [Holliday junction DN...] - TP0543 [Holliday junction DN...] (1,F) 
TP0163 [ABC transporter, per...] - TP0206 [ribosomal protein S5...] (1,F) 
TP0163 [ABC transporter, per...] - TP0550 [thiophene and furan ...] (1,F) 
TP0163 [ABC transporter, per...] - TP0832 [hypothetical protein...] (37,F) 
TP0163 [ABC transporter, per...] - TP0833 [hypothetical protein...] (34,F) 
TP0163 [ABC transporter, per...] - TP0907 [conserved hypothetic...] (110,W) 
TP0163 [ABC transporter, per...] - TP0961 [flagellar basal-body...] (84,W) 
TP0163 [ABC transporter, per...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0163 [ABC transporter, per...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0164 [ABC transporter, ATP...] - TP0504 [hypothetical protein...] (1,F) 
TP0164 [ABC transporter, ATP...] - TP0764 [conserved hypothetic...] (139,W) 
TP0164 [ABC transporter, ATP...] - TP0842 [methionine aminopept...] (3,F) 
TP0164 [ABC transporter, ATP...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0165 [ABC transporter, per...] - TP0249 [flagellar filament o...] (1,F) 
TP0165 [ABC transporter, per...] - TP0880 [membrane spanning pr...] (1,F) 
TP0165 [ABC transporter, per...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0167 [cation-activated rep...] - TP0046 [hypothetical protein...] (18,F) 
TP0167 [cation-activated rep...] - TP0288 [spore coat polysacch...] (77,W) 
TP0167 [cation-activated rep...] - TP0661 [hypothetical protein...] (117,W) 
TP0167 [cation-activated rep...] - TP0832 [hypothetical protein...] (37,F) 
TP0167 [cation-activated rep...] - TP0961 [flagellar basal-body...] (84,W) 
TP0167 [cation-activated rep...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0170 [pfs protein (pfs) {T...] - TP0661 [hypothetical protein...] (117,W) 
TP0170 [pfs protein (pfs) {T...] - TP0764 [conserved hypothetic...] (139,W) 
TP0170 [pfs protein (pfs) {T...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0177 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0183 [hypothetical protein...] - TP0001 [chromosomal replicat...] (3,F) 
TP0183 [hypothetical protein...] - TP0024 [conserved hypothetic...] (16,F) 
TP0183 [hypothetical protein...] - TP0066 [hypothetical protein...] (11,F) 
TP0183 [hypothetical protein...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0183 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0183 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0183 [hypothetical protein...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0183 [hypothetical protein...] - TP0380 [DNA repair helicase,...] (5,F) 
TP0183 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0183 [hypothetical protein...] - TP0421 [conserved hypothetic...] (4,F) 
TP0183 [hypothetical protein...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0183 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0183 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0183 [hypothetical protein...] - TP0648 [conserved hypothetic...] (3,F) 
TP0183 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0183 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0183 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0183 [hypothetical protein...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0183 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0183 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0183 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0183 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0183 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0184 [small protein (smpB)...] - TP0764 [conserved hypothetic...] (139,W) 
TP0185 [signal peptidase I (...] - TP0644 [lysyl-tRNA synthetas...] (1,F) 
TP0185 [signal peptidase I (...] - TP0661 [hypothetical protein...] (117,W) 
TP0185 [signal peptidase I (...] - TP0764 [conserved hypothetic...] (139,W) 
TP0185 [signal peptidase I (...] - TP0788 [hypothetical protein...] (132,W) 
TP0187 [translation elongati...] - TP0067 [conserved hypothetic...] (19,F) 
TP0187 [translation elongati...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0188 [ribosomal protein S1...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0188 [ribosomal protein S1...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0188 [ribosomal protein S1...] - TP0519 [response regulatory ...] (30,F) 
TP0188 [ribosomal protein S1...] - TP0661 [hypothetical protein...] (117,W) 
TP0192 [ribosomal protein L2...] - TP0756 [methionyl-tRNA formy...] (1,F) 
TP0193 [ribosomal protein S1...] - TP0764 [conserved hypothetic...] (139,W) 
TP0194 [ribosomal protein L2...] - TP0258 [conserved hypothetic...] (173,W) 
TP0194 [ribosomal protein L2...] - TP0288 [spore coat polysacch...] (77,W) 
TP0194 [ribosomal protein L2...] - TP0661 [hypothetical protein...] (117,W) 
TP0194 [ribosomal protein L2...] - TP0764 [conserved hypothetic...] (139,W) 
TP0194 [ribosomal protein L2...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0195 [ribosomal protein S3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0195 [ribosomal protein S3...] - TP0559 [conserved hypothetic...] (26,F) 
TP0195 [ribosomal protein S3...] - TP0764 [conserved hypothetic...] (139,W) 
TP0197 [ribosomal protein L2...] - TP0661 [hypothetical protein...] (117,W) 
TP0197 [ribosomal protein L2...] - TP0711 [conserved hypothetic...] (46,F) 
TP0202 [ribosomal protein S1...] - TP0661 [hypothetical protein...] (117,W) 
TP0202 [ribosomal protein S1...] - TP0711 [conserved hypothetic...] (46,F) 
TP0202 [ribosomal protein S1...] - TP0788 [hypothetical protein...] (132,W) 
TP0202 [ribosomal protein S1...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0207 [ribosomal protein L1...] - TP0258 [conserved hypothetic...] (173,W) 
TP0208 [preprotein transloca...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0209 [ribosomal protein L3...] - TP0258 [conserved hypothetic...] (173,W) 
TP0209 [ribosomal protein L3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0209 [ribosomal protein L3...] - TP0518 [conserved hypothetic...] (70,W) 
TP0209 [ribosomal protein L3...] - TP0519 [response regulatory ...] (30,F) 
TP0209 [ribosomal protein L3...] - TP0974 [hypothetical protein...] (23,F) 
TP0209 [ribosomal protein L3...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0210 [ribosomal protein S1...] - TP0258 [conserved hypothetic...] (173,W) 
TP0210 [ribosomal protein S1...] - TP0383 [conserved hypothetic...] (65,W) 
TP0211 [ribosomal protein S1...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0212 [DNA-directed RNA pol...] - TP0059 [hypothetical protein...] (21,F) 
TP0212 [DNA-directed RNA pol...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0212 [DNA-directed RNA pol...] - TP0383 [conserved hypothetic...] (65,W) 
TP0213 [ribosomal protein L1...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0214 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0214 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0216 [heat shock protein 7...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0216 [heat shock protein 7...] - TP1004 [recombination protei...] (74,W) 
TP0218 [sigma factor SigG re...] - TP0269 [conserved hypothetic...] (3,F) 
TP0218 [sigma factor SigG re...] - TP0377 [conserved hypothetic...] (11,F) 
TP0218 [sigma factor SigG re...] - TP0561 [conserved hypothetic...] (44,F) 
TP0218 [sigma factor SigG re...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0222 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0222 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0222 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0223 [aspartate aminotrans...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0224 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0224 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0224 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0224 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0225 [leucine-rich repeat ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0225 [leucine-rich repeat ...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0225 [leucine-rich repeat ...] - TP0788 [hypothetical protein...] (132,W) 
TP0227 [cobalt ABC transport...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0227 [cobalt ABC transport...] - TP0404 [hypothetical protein...] (1,F) 
TP0227 [cobalt ABC transport...] - TP0894 [conserved hypothetic...] (13,F) 
TP0227 [cobalt ABC transport...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0227 [cobalt ABC transport...] - TP1004 [recombination protei...] (74,W) 
TP0228 [biotin synthase, put...] - TP0034 [ABC transporter, per...] (1,F) 
TP0229 [DNA polymerase, bact...] - TP0258 [conserved hypothetic...] (173,W) 
TP0229 [DNA polymerase, bact...] - TP0764 [conserved hypothetic...] (139,W) 
TP0229 [DNA polymerase, bact...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0229 [DNA polymerase, bact...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0232 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0232 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0232 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0232 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0232 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0232 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0232 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0233 [anti-sigma F factor ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0233 [anti-sigma F factor ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0233 [anti-sigma F factor ...] - TP0966 [hypothetical protein...] (1,F) 
TP0233 [anti-sigma F factor ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0233 [anti-sigma F factor ...] - TP1003 [hypothetical protein...] (1,F) 
TP0234 [ribosomal protein L3...] - TP0258 [conserved hypothetic...] (173,W) 
TP0234 [ribosomal protein L3...] - TP0281 [hypothetical protein...] (64,W) 
TP0234 [ribosomal protein L3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0234 [ribosomal protein L3...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0234 [ribosomal protein L3...] - TP0518 [conserved hypothetic...] (70,W) 
TP0234 [ribosomal protein L3...] - TP0519 [response regulatory ...] (30,F) 
TP0234 [ribosomal protein L3...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0234 [ribosomal protein L3...] - TP0587 [hypothetical protein...] (23,F) 
TP0234 [ribosomal protein L3...] - TP0661 [hypothetical protein...] (117,W) 
TP0234 [ribosomal protein L3...] - TP0664 [flagellar filament o...] (34,F) 
TP0234 [ribosomal protein L3...] - TP0711 [conserved hypothetic...] (46,F) 
TP0234 [ribosomal protein L3...] - TP0764 [conserved hypothetic...] (139,W) 
TP0234 [ribosomal protein L3...] - TP0788 [hypothetical protein...] (132,W) 
TP0234 [ribosomal protein L3...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0234 [ribosomal protein L3...] - TP0974 [hypothetical protein...] (23,F) 
TP0234 [ribosomal protein L3...] - TP0993 [rare lipoprotein A, ...] (285,W) 
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TP0234 [ribosomal protein L3...] - TP1004 [recombination protei...] (74,W) 
TP0234 [ribosomal protein L3...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0234 [ribosomal protein L3...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0235 [preprotein transloca...] - TP0561 [conserved hypothetic...] (44,F) 
TP0236 [transcription antite...] - TP0258 [conserved hypothetic...] (173,W) 
TP0237 [ribosomal protein L1...] - TP0258 [conserved hypothetic...] (173,W) 
TP0237 [ribosomal protein L1...] - TP0288 [spore coat polysacch...] (77,W) 
TP0237 [ribosomal protein L1...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0237 [ribosomal protein L1...] - TP0518 [conserved hypothetic...] (70,W) 
TP0237 [ribosomal protein L1...] - TP0519 [response regulatory ...] (30,F) 
TP0237 [ribosomal protein L1...] - TP0559 [conserved hypothetic...] (26,F) 
TP0237 [ribosomal protein L1...] - TP0661 [hypothetical protein...] (117,W) 
TP0237 [ribosomal protein L1...] - TP0664 [flagellar filament o...] (34,F) 
TP0237 [ribosomal protein L1...] - TP0711 [conserved hypothetic...] (46,F) 
TP0237 [ribosomal protein L1...] - TP0764 [conserved hypothetic...] (139,W) 
TP0237 [ribosomal protein L1...] - TP0773 [periplasmic serine p...] (30,F) 
TP0237 [ribosomal protein L1...] - TP0788 [hypothetical protein...] (132,W) 
TP0237 [ribosomal protein L1...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0247 [N-acetylmuramoyl-L-a...] - TP0067 [conserved hypothetic...] (19,F) 
TP0247 [N-acetylmuramoyl-L-a...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0247 [N-acetylmuramoyl-L-a...] - TP0150 [hypothetical protein...] (1,F) 
TP0247 [N-acetylmuramoyl-L-a...] - TP0382 [hypothetical protein...] (1,F) 
TP0248 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0248 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0251 [DNA-binding protein ...] - TP0974 [hypothetical protein...] (23,F) 
TP0252 [apolipoprotein N-acy...] - TP0258 [conserved hypothetic...] (173,W) 
TP0252 [apolipoprotein N-acy...] - TP0281 [hypothetical protein...] (64,W) 
TP0252 [apolipoprotein N-acy...] - TP0287 [conserved hypothetic...] (27,F) 
TP0252 [apolipoprotein N-acy...] - TP0383 [conserved hypothetic...] (65,W) 
TP0252 [apolipoprotein N-acy...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0252 [apolipoprotein N-acy...] - TP0518 [conserved hypothetic...] (70,W) 
TP0252 [apolipoprotein N-acy...] - TP0764 [conserved hypothetic...] (139,W) 
TP0252 [apolipoprotein N-acy...] - TP0788 [hypothetical protein...] (132,W) 
TP0252 [apolipoprotein N-acy...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0252 [apolipoprotein N-acy...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0252 [apolipoprotein N-acy...] - TP1004 [recombination protei...] (74,W) 
TP0252 [apolipoprotein N-acy...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0255 [ribosomal protein L3...] - TP0281 [hypothetical protein...] (64,W) 
TP0255 [ribosomal protein L3...] - TP0383 [conserved hypothetic...] (65,W) 
TP0255 [ribosomal protein L3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0255 [ribosomal protein L3...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0255 [ribosomal protein L3...] - TP0661 [hypothetical protein...] (117,W) 
TP0255 [ribosomal protein L3...] - TP0664 [flagellar filament o...] (34,F) 
TP0255 [ribosomal protein L3...] - TP0711 [conserved hypothetic...] (46,F) 
TP0255 [ribosomal protein L3...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0255 [ribosomal protein L3...] - TP0764 [conserved hypothetic...] (139,W) 
TP0255 [ribosomal protein L3...] - TP0907 [conserved hypothetic...] (110,W) 
TP0255 [ribosomal protein L3...] - TP1004 [recombination protei...] (74,W) 
TP0256 [CDP-diacylglycerol--...] - TP0708 [hypothetical protein...] (13,F) 
TP0256 [CDP-diacylglycerol--...] - TP0765 [cell division protei...] (2,F) 
TP0256 [CDP-diacylglycerol--...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0258 [conserved hypothetic...] - TP0059 [hypothetical protein...] (21,F) 
TP0258 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0258 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0258 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0258 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0258 [conserved hypothetic...] - TP0329 [serine hydroxymethyl...] (1,F) 
TP0258 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0258 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0258 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0258 [conserved hypothetic...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0258 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0258 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0258 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0258 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0258 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0258 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0258 [conserved hypothetic...] - TP0673 [glutamyl-tRNA synthe...] (1,F) 
TP0258 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0258 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0258 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0258 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0258 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0258 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0258 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0258 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0258 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0258 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0260 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0260 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0260 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0260 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0260 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0260 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0266 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0267 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0268 [conserved hypothetic...] - TP0059 [hypothetical protein...] (21,F) 
TP0268 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0268 [conserved hypothetic...] - TP0334 [conserved hypothetic...] (5,F) 
TP0268 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0268 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0268 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0268 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0268 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0268 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0268 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0268 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0268 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0268 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0268 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0268 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0270 [polynucleotide adeny...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0270 [polynucleotide adeny...] - TP0661 [hypothetical protein...] (117,W) 
TP0270 [polynucleotide adeny...] - TP0813 [hypothetical protein...] (3,F) 
TP0271 [chromosome partition...] - TP0046 [hypothetical protein...] (18,F) 
TP0271 [chromosome partition...] - TP0183 [hypothetical protein...] (1,F) 
TP0271 [chromosome partition...] - TP0198 [ribosomal protein S1...] (1,F) 
TP0271 [chromosome partition...] - TP0305 [CTP synthase (pyrG) ...] (4,F) 
TP0271 [chromosome partition...] - TP0463 [hypothetical protein...] (8,F) 
TP0271 [chromosome partition...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0271 [chromosome partition...] - TP0764 [conserved hypothetic...] (139,W) 
TP0271 [chromosome partition...] - TP0832 [hypothetical protein...] (37,F) 
TP0271 [chromosome partition...] - TP0961 [flagellar basal-body...] (84,W) 
TP0271 [chromosome partition...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0272 [SpoOJ regulator (soj...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0272 [SpoOJ regulator (soj...] - TP0188 [ribosomal protein S1...] (2,F) 
TP0272 [SpoOJ regulator (soj...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0272 [SpoOJ regulator (soj...] - TP0833 [hypothetical protein...] (34,F) 
TP0272 [SpoOJ regulator (soj...] - TP0843 [heat shock protein, ...] (3,F) 
TP0273 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0273 [hypothetical protein...] - TP0972 [conserved hypothetic...] (1,F) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0059 [hypothetical protein...] (21,F) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0258 [conserved hypothetic...] 
(173,W) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0281 [hypothetical protein...] (64,W) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0275 [UDP-N-acetyl-D-manno...] - TP0587 [hypothetical protein...] (23,F) 
TP0276 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0276 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0280 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0280 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0280 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0280 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0280 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0280 [hypothetical protein...] - TP0995 [cyclic nucleotide bi...] (5,F) 
TP0280 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0282 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0282 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0282 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0282 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0282 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0282 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0282 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0283 [lipopolysaccharide c...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0284 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0284 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0284 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0284 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0284 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0284 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0284 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0287 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0287 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0287 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0287 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0287 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0287 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0287 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0287 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0287 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0290 [conserved hypothetic...] - TP0040 [methyl-accepting che...] (1,F) 
TP0290 [conserved hypothetic...] - TP0044 [glucose inhibited di...] (3,F) 
TP0290 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0295 [xylulokinase (xylB) ...] - TP0640 [methyl-accepting che...] (5,F) 
TP0295 [xylulokinase (xylB) ...] - TP0723 [hypothetical protein...] (1,F) 
TP0296 [conserved hypothetic...] - TP0557 [conserved hypothetic...] (1,F) 
TP0296 [conserved hypothetic...] - TP0578 [cell division protei...] (1,F) 
TP0296 [conserved hypothetic...] - TP0591 [HPr kinase (ptsK) {B...] (1,F) 
TP0296 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0297 [conserved hypothetic...] - TP0077 [capsular polysacchar...] (1,F) 
TP0297 [conserved hypothetic...] - TP0236 [transcription antite...] (5,F) 
TP0297 [conserved hypothetic...] - TP0738 [conserved hypothetic...] (1,F) 
TP0298 [exported protein (tp...] - TP0258 [conserved hypothetic...] (173,W) 
TP0298 [exported protein (tp...] - TP0287 [conserved hypothetic...] (27,F) 
TP0298 [exported protein (tp...] - TP0288 [spore coat polysacch...] (77,W) 
TP0298 [exported protein (tp...] - TP0383 [conserved hypothetic...] (65,W) 
TP0298 [exported protein (tp...] - TP0518 [conserved hypothetic...] (70,W) 
TP0298 [exported protein (tp...] - TP0563 [hypothetical protein...] (93,W) 
TP0298 [exported protein (tp...] - TP0661 [hypothetical protein...] (117,W) 
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TP0298 [exported protein (tp...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0298 [exported protein (tp...] - TP0788 [hypothetical protein...] (132,W) 
TP0301 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0301 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0302 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0303 [DNA mismatch repair ...] - TP0661 [hypothetical protein...] (117,W) 
TP0307 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0307 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0307 [conserved hypothetic...] - TP0396 [flagellar basal-body...] (15,F) 
TP0307 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0307 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0307 [conserved hypothetic...] - TP0741 [conserved hypothetic...] (8,F) 
TP0307 [conserved hypothetic...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0308 [amino acid ABC trans...] - TP0961 [flagellar basal-body...] (84,W) 
TP0308 [amino acid ABC trans...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0308 [amino acid ABC trans...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0312 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0313 [tpr protein E (tprE)...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0314 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0320 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0320 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0320 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0320 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0320 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0320 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0320 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0320 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0320 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0320 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0322 [ribose/galactose ABC...] - TP0561 [conserved hypothetic...] (44,F) 
TP0328 [DNA mismatch repair ...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0328 [DNA mismatch repair ...] - TP0095 [hypothetical protein...] (15,F) 
TP0328 [DNA mismatch repair ...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0328 [DNA mismatch repair ...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0328 [DNA mismatch repair ...] - TP0661 [hypothetical protein...] (117,W) 
TP0328 [DNA mismatch repair ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0328 [DNA mismatch repair ...] - TP0907 [conserved hypothetic...] (110,W) 
TP0328 [DNA mismatch repair ...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0328 [DNA mismatch repair ...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0328 [DNA mismatch repair ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0329 [serine hydroxymethyl...] - TP0788 [hypothetical protein...] (132,W) 
TP0330 [cell division protei...] - TP0127 [hypothetical protein...] (1,F) 
TP0330 [cell division protei...] - TP0330 [cell division protei...] (2,F) 
TP0330 [cell division protei...] - TP0387 [cell division protei...] (1,F) 
TP0330 [cell division protei...] - TP0499 [rod shape-determinin...] (1,F) 
TP0330 [cell division protei...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0330 [cell division protei...] - TP0870 [flagellar filament 3...] (79,W) 
TP0330 [cell division protei...] - TP0891 [translation initiati...] (1,F) 
TP0330 [cell division protei...] - TP0961 [flagellar basal-body...] (84,W) 
TP0333 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0333 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0333 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0333 [conserved hypothetic...] - TP0465 [hypothetical protein...] (7,F) 
TP0333 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0333 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0333 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0333 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0333 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0333 [conserved hypothetic...] - TP0618 [hypothetical protein...] (24,F) 
TP0333 [conserved hypothetic...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0333 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0333 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0333 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0333 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0333 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0333 [conserved hypothetic...] - TP0834 [tyrosyl-tRNA synthet...] (1,F) 
TP0333 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0333 [conserved hypothetic...] - TP0940 [hypothetical protein...] (1,F) 
TP0333 [conserved hypothetic...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0333 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0333 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0333 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0334 [conserved hypothetic...] - TP0784 [hypothetical protein...] (1,F) 
TP0334 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0338 [hypothetical protein...] - TP0377 [conserved hypothetic...] (11,F) 
TP0338 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0338 [hypothetical protein...] - TP0716 [flagellar biosynthet...] (2,F) 
TP0339 [conserved hypothetic...] - TP0632 [tryptophanyl-tRNA sy...] (1,F) 
TP0339 [conserved hypothetic...] - TP0687 [DNA recombinase (rec...] (2,F) 
TP0339 [conserved hypothetic...] - TP0728 [flagellar hook assem...] (1,F) 
TP0339 [conserved hypothetic...] - TP0869 [hypothetical protein...] (1,F) 
TP0341 [UDP-N-acetylmuramate...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0341 [UDP-N-acetylmuramate...] - TP0288 [spore coat polysacch...] (77,W) 
TP0341 [UDP-N-acetylmuramate...] - TP0761 [hypothetical protein...] (1,F) 
TP0341 [UDP-N-acetylmuramate...] - TP0907 [conserved hypothetic...] 
(110,W) 
TP0341 [UDP-N-acetylmuramate...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0342 [cytidylate kinase (c...] - TP0661 [hypothetical protein...] (117,W) 
TP0343 [A/G-specific adenine...] - TP0470 [conserved hypothetic...] (1,F) 
TP0343 [A/G-specific adenine...] - TP0598 [hypothetical protein...] (1,F) 
TP0343 [A/G-specific adenine...] - TP0661 [hypothetical protein...] (117,W) 
TP0343 [A/G-specific adenine...] - TP0664 [flagellar filament o...] (34,F) 
TP0343 [A/G-specific adenine...] - TP0788 [hypothetical protein...] (132,W) 
TP0343 [A/G-specific adenine...] - TP0870 [flagellar filament 3...] (79,W) 
TP0343 [A/G-specific adenine...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0343 [A/G-specific adenine...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0344 [transcription-repair...] - TP0046 [hypothetical protein...] (18,F) 
TP0344 [transcription-repair...] - TP0505 [hexokinase (hxk) {Sc...] (1,F) 
TP0344 [transcription-repair...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0344 [transcription-repair...] - TP0563 [hypothetical protein...] (93,W) 
TP0344 [transcription-repair...] - TP0832 [hypothetical protein...] (37,F) 
TP0344 [transcription-repair...] - TP0833 [hypothetical protein...] (34,F) 
TP0344 [transcription-repair...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0345 [phospho-N-acetylmura...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0345 [phospho-N-acetylmura...] - TP0420 [hypothetical protein...] (1,F) 
TP0345 [phospho-N-acetylmura...] - TP0561 [conserved hypothetic...] (44,F) 
TP0345 [phospho-N-acetylmura...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0350 [glutamate-5-semialde...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0350 [glutamate-5-semialde...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0351 [glutamate 5-kinase (...] - TP0661 [hypothetical protein...] (117,W) 
TP0351 [glutamate 5-kinase (...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0351 [glutamate 5-kinase (...] - TP0764 [conserved hypothetic...] (139,W) 
TP0351 [glutamate 5-kinase (...] - TP0788 [hypothetical protein...] (132,W) 
TP0351 [glutamate 5-kinase (...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0354 [thymidylate kinase (...] - TP0097 [translation initiati...] (3,F) 
TP0354 [thymidylate kinase (...] - TP0870 [flagellar filament 3...] (79,W) 
TP0354 [thymidylate kinase (...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0356 [RNA-binding protein,...] - TP0850 [translation initiati...] (1,F) 
TP0359 [hypothetical protein...] - TP0024 [conserved hypothetic...] (16,F) 
TP0359 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0359 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0359 [hypothetical protein...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0359 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0359 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0359 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0359 [hypothetical protein...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0359 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0359 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0359 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0359 [hypothetical protein...] - TP0443 [conserved hypothetic...] (6,F) 
TP0359 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0359 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0359 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0359 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0359 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0359 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0359 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0359 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0359 [hypothetical protein...] - TP0726 [flagellar protein (f...] (7,F) 
TP0359 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0359 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0359 [hypothetical protein...] - TP0807 [ribosomal protein L3...] (4,F) 
TP0359 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0359 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0359 [hypothetical protein...] - TP0959 [hypothetical protein...] (1,F) 
TP0359 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0359 [hypothetical protein...] - TP0981 [sensory transduction...] (5,F) 
TP0359 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0359 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0359 [hypothetical protein...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0359 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0359 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0360 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0362 [ribosomal protein L2...] - TP0059 [hypothetical protein...] (21,F) 
TP0362 [ribosomal protein L2...] - TP0518 [conserved hypothetic...] (70,W) 
TP0367 [chromosome segregati...] - TP0050 [conserved hypothetic...] (10,F) 
TP0367 [chromosome segregati...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0367 [chromosome segregati...] - TP0064 [hypothetical, protei...] (8,F) 
TP0367 [chromosome segregati...] - TP0066 [hypothetical protein...] (11,F) 
TP0367 [chromosome segregati...] - TP0764 [conserved hypothetic...] (139,W) 
TP0367 [chromosome segregati...] - TP0772 [hypothetical protein...] (3,F) 
TP0367 [chromosome segregati...] - TP0832 [hypothetical protein...] (37,F) 
TP0367 [chromosome segregati...] - TP0870 [flagellar filament 3...] (79,W) 
TP0367 [chromosome segregati...] - TP0961 [flagellar basal-body...] (84,W) 
TP0368 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0368 [hypothetical protein...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0368 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0368 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0368 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0368 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0368 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0368 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0368 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0368 [hypothetical protein...] - TP0842 [methionine aminopept...] (3,F) 
TP0370 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0370 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0370 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0370 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0370 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0370 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
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TP0371 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0371 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0372 [general stress prote...] - TP0258 [conserved hypothetic...] (173,W) 
TP0372 [general stress prote...] - TP0907 [conserved hypothetic...] (110,W) 
TP0372 [general stress prote...] - TP0961 [flagellar basal-body...] (84,W) 
TP0372 [general stress prote...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0372 [general stress prote...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0373 [conserved hypothetic...] - TP0409 [hypothetical protein...] (1,F) 
TP0373 [conserved hypothetic...] - TP0733 [hypothetical protein...] (1,F) 
TP0374 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0374 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0374 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0374 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0374 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0374 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0374 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0376 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0376 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0376 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0376 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0376 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0376 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0376 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0376 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0377 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0377 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0377 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0378 [flagellar protein, p...] - TP0002 [DNA polymerase III, ...] (4,F) 
TP0378 [flagellar protein, p...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0380 [DNA repair helicase,...] - TP0095 [hypothetical protein...] (15,F) 
TP0380 [DNA repair helicase,...] - TP0121 [conserved hypothetic...] (7,F) 
TP0380 [DNA repair helicase,...] - TP0258 [conserved hypothetic...] (173,W) 
TP0380 [DNA repair helicase,...] - TP0288 [spore coat polysacch...] (77,W) 
TP0380 [DNA repair helicase,...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0380 [DNA repair helicase,...] - TP0421 [conserved hypothetic...] (4,F) 
TP0380 [DNA repair helicase,...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0380 [DNA repair helicase,...] - TP0449 [hypothetical protein...] (51,W) 
TP0380 [DNA repair helicase,...] - TP0487 [hypothetical protein...] (1,F) 
TP0380 [DNA repair helicase,...] - TP0518 [conserved hypothetic...] (70,W) 
TP0380 [DNA repair helicase,...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0380 [DNA repair helicase,...] - TP0559 [conserved hypothetic...] (26,F) 
TP0380 [DNA repair helicase,...] - TP0661 [hypothetical protein...] (117,W) 
TP0380 [DNA repair helicase,...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0380 [DNA repair helicase,...] - TP0764 [conserved hypothetic...] (139,W) 
TP0380 [DNA repair helicase,...] - TP0773 [periplasmic serine p...] (30,F) 
TP0380 [DNA repair helicase,...] - TP0788 [hypothetical protein...] (132,W) 
TP0380 [DNA repair helicase,...] - TP0870 [flagellar filament 3...] (79,W) 
TP0380 [DNA repair helicase,...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0380 [DNA repair helicase,...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0380 [DNA repair helicase,...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0380 [DNA repair helicase,...] - TP1004 [recombination protei...] (74,W) 
TP0380 [DNA repair helicase,...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0381 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0383 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0383 [conserved hypothetic...] - TP0856 [hypothetical protein...] (1,F) 
TP0383 [conserved hypothetic...] - TP0938 [hypothetical protein...] (1,F) 
TP0383 [conserved hypothetic...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0384 [conserved hypothetic...] - TP0068 [conserved hypothetic...] (1,F) 
TP0384 [conserved hypothetic...] - TP0396 [flagellar basal-body...] (15,F) 
TP0384 [conserved hypothetic...] - TP0832 [hypothetical protein...] (37,F) 
TP0386 [UDP-N-acetylmuramoyl...] - TP0383 [conserved hypothetic...] (65,W) 
TP0387 [cell division protei...] - TP0236 [transcription antite...] (5,F) 
TP0387 [cell division protei...] - TP0260 [hypothetical protein...] (5,F) 
TP0387 [cell division protei...] - TP0561 [conserved hypothetic...] (44,F) 
TP0387 [cell division protei...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0387 [cell division protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0387 [cell division protei...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0388 [cell division protei...] - TP0109 [rRNA methylase, puta...] (1,F) 
TP0389 [cell division protei...] - TP0066 [hypothetical protein...] (11,F) 
TP0389 [cell division protei...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0389 [cell division protei...] - TP0260 [hypothetical protein...] (5,F) 
TP0389 [cell division protei...] - TP0380 [DNA repair helicase,...] (5,F) 
TP0389 [cell division protei...] - TP0559 [conserved hypothetic...] (26,F) 
TP0389 [cell division protei...] - TP0563 [hypothetical protein...] (93,W) 
TP0389 [cell division protei...] - TP0579 [hypothetical protein...] (5,F) 
TP0389 [cell division protei...] - TP0764 [conserved hypothetic...] (139,W) 
TP0389 [cell division protei...] - TP0832 [hypothetical protein...] (37,F) 
TP0389 [cell division protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0390 [cell division protei...] - TP0046 [hypothetical protein...] (18,F) 
TP0390 [cell division protei...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0390 [cell division protei...] - TP0288 [spore coat polysacch...] (77,W) 
TP0390 [cell division protei...] - TP0907 [conserved hypothetic...] (110,W) 
TP0390 [cell division protei...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0390 [cell division protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0391 [integrase/recombinas...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0391 [integrase/recombinas...] - TP0788 [hypothetical protein...] (132,W) 
TP0391 [integrase/recombinas...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0394 [DNA topoisomerase I ...] - TP0208 [preprotein transloca...] (2,F) 
TP0394 [DNA topoisomerase I ...] - TP0763 [hypothetical protein...] (2,F) 
TP0395 [integrase/recombinas...] - TP0661 [hypothetical protein...] (117,W) 
TP0398 [flagellar hook-basal...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0398 [flagellar hook-basal...] - TP0026 [flagellar motor swit...] (8,F) 
TP0398 [flagellar hook-basal...] - TP0046 [hypothetical protein...] (18,F) 
TP0398 [flagellar hook-basal...] - TP0050 [conserved hypothetic...] (10,F) 
TP0398 [flagellar hook-basal...] - TP0064 [hypothetical, protei...] (8,F) 
TP0398 [flagellar hook-basal...] - TP0066 [hypothetical protein...] (11,F) 
TP0398 [flagellar hook-basal...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0398 [flagellar hook-basal...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0398 [flagellar hook-basal...] - TP0162 [Holliday junction DN...] (3,F) 
TP0398 [flagellar hook-basal...] - TP0258 [conserved hypothetic...] (173,W) 
TP0398 [flagellar hook-basal...] - TP0288 [spore coat polysacch...] (77,W) 
TP0398 [flagellar hook-basal...] - TP0383 [conserved hypothetic...] (65,W) 
TP0398 [flagellar hook-basal...] - TP0396 [flagellar basal-body...] (15,F) 
TP0398 [flagellar hook-basal...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0398 [flagellar hook-basal...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0398 [flagellar hook-basal...] - TP0563 [hypothetical protein...] (93,W) 
TP0398 [flagellar hook-basal...] - TP0579 [hypothetical protein...] (5,F) 
TP0398 [flagellar hook-basal...] - TP0629 [hypothetical protein...] (6,F) 
TP0398 [flagellar hook-basal...] - TP0661 [hypothetical protein...] (117,W) 
TP0398 [flagellar hook-basal...] - TP0764 [conserved hypothetic...] (139,W) 
TP0398 [flagellar hook-basal...] - TP0788 [hypothetical protein...] (132,W) 
TP0398 [flagellar hook-basal...] - TP0832 [hypothetical protein...] (37,F) 
TP0398 [flagellar hook-basal...] - TP0870 [flagellar filament 3...] (79,W) 
TP0398 [flagellar hook-basal...] - TP0907 [conserved hypothetic...] (110,W) 
TP0398 [flagellar hook-basal...] - TP0961 [flagellar basal-body...] (84,W) 
TP0398 [flagellar hook-basal...] - TP0979 [conserved hypothetic...] (1,F) 
TP0398 [flagellar hook-basal...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0398 [flagellar hook-basal...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0399 [flagellar basal-body...] - TP0026 [flagellar motor swit...] (8,F) 
TP0399 [flagellar basal-body...] - TP0561 [conserved hypothetic...] (44,F) 
TP0399 [flagellar basal-body...] - TP0708 [hypothetical protein...] (13,F) 
TP0399 [flagellar basal-body...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0400 [flagellar motor swit...] - TP0014 [hypothetical protein...] (2,F) 
TP0400 [flagellar motor swit...] - TP0026 [flagellar motor swit...] (8,F) 
TP0400 [flagellar motor swit...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0400 [flagellar motor swit...] - TP0066 [hypothetical protein...] (11,F) 
TP0400 [flagellar motor swit...] - TP0091 [cysteinyl-tRNA synth...] (1,F) 
TP0400 [flagellar motor swit...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0400 [flagellar motor swit...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0400 [flagellar motor swit...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0400 [flagellar motor swit...] - TP0399 [flagellar basal-body...] (2,F) 
TP0400 [flagellar motor swit...] - TP0443 [conserved hypothetic...] (6,F) 
TP0400 [flagellar motor swit...] - TP0563 [hypothetical protein...] (93,W) 
TP0400 [flagellar motor swit...] - TP0648 [conserved hypothetic...] (3,F) 
TP0400 [flagellar motor swit...] - TP0665 [hypothetical protein...] (1,F) 
TP0400 [flagellar motor swit...] - TP0743 [ribosomal protein L2...] (2,F) 
TP0400 [flagellar motor swit...] - TP0764 [conserved hypothetic...] (139,W) 
TP0400 [flagellar motor swit...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0401 [flagellar assembly p...] - TP0026 [flagellar motor swit...] (8,F) 
TP0402 [flagellum-specific A...] - TP0413 [phosphoglucomutase {...] (2,F) 
TP0402 [flagellum-specific A...] - TP0640 [methyl-accepting che...] (5,F) 
TP0402 [flagellum-specific A...] - TP0833 [hypothetical protein...] (34,F) 
TP0402 [flagellum-specific A...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0403 [flagellar protein, p...] - TP0288 [spore coat polysacch...] (77,W) 
TP0403 [flagellar protein, p...] - TP0563 [hypothetical protein...] (93,W) 
TP0403 [flagellar protein, p...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0403 [flagellar protein, p...] - TP0764 [conserved hypothetic...] (139,W) 
TP0403 [flagellar protein, p...] - TP0832 [hypothetical protein...] (37,F) 
TP0403 [flagellar protein, p...] - TP0868 [flagellar filament 3...] (1,F) 
TP0403 [flagellar protein, p...] - TP0961 [flagellar basal-body...] (84,W) 
TP0403 [flagellar protein, p...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0403 [flagellar protein, p...] - TP1004 [recombination protei...] (74,W) 
TP0407 [phosphoglycolate pho...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0407 [phosphoglycolate pho...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0409 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0409 [hypothetical protein...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0409 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0409 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0409 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0409 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0409 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0409 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0409 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0409 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0410 [protein-export membr...] - TP0281 [hypothetical protein...] (64,W) 
TP0410 [protein-export membr...] - TP0287 [conserved hypothetic...] (27,F) 
TP0410 [protein-export membr...] - TP0383 [conserved hypothetic...] (65,W) 
TP0410 [protein-export membr...] - TP0518 [conserved hypothetic...] (70,W) 
TP0410 [protein-export membr...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0410 [protein-export membr...] - TP0587 [hypothetical protein...] (23,F) 
TP0410 [protein-export membr...] - TP0661 [hypothetical protein...] (117,W) 
TP0410 [protein-export membr...] - TP0788 [hypothetical protein...] (132,W) 
TP0410 [protein-export membr...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0411 [protein-export membr...] - TP0561 [conserved hypothetic...] (44,F) 
TP0411 [protein-export membr...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0412 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0412 [conserved hypothetic...] - TP0067 [conserved hypothetic...] (19,F) 
TP0412 [conserved hypothetic...] - TP0121 [conserved hypothetic...] (7,F) 
TP0412 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0412 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
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TP0412 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0412 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0412 [conserved hypothetic...] - TP0287 [conserved hypothetic...] (27,F) 
TP0412 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0412 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0412 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0412 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0412 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0412 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0412 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0412 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0412 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0412 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0412 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0412 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0412 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0412 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0412 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0412 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0412 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0412 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0412 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0412 [conserved hypothetic...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0412 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0412 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0413 [phosphoglucomutase {...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0414 [D-alanine glycine pe...] - TP0561 [conserved hypothetic...] (44,F) 
TP0414 [D-alanine glycine pe...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0418 [galactokinase {Homo ...] - TP0067 [conserved hypothetic...] (19,F) 
TP0418 [galactokinase {Homo ...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0418 [galactokinase {Homo ...] - TP0095 [hypothetical protein...] (15,F) 
TP0418 [galactokinase {Homo ...] - TP0661 [hypothetical protein...] (117,W) 
TP0418 [galactokinase {Homo ...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0418 [galactokinase {Homo ...] - TP0711 [conserved hypothetic...] (46,F) 
TP0418 [galactokinase {Homo ...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0418 [galactokinase {Homo ...] - TP0907 [conserved hypothetic...] (110,W) 
TP0418 [galactokinase {Homo ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0419 [survival protein, pu...] - TP0046 [hypothetical protein...] (18,F) 
TP0421 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0421 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0421 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0421 [conserved hypothetic...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0424 [V-type ATPase, subun...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0427 [V-type ATPase, subun...] - TP0243 [ribosomal protein S1...] (1,F) 
TP0427 [V-type ATPase, subun...] - TP0328 [DNA mismatch repair ...] (1,F) 
TP0430 [V-type ATPase, subun...] - TP0561 [conserved hypothetic...] (44,F) 
TP0432 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0434 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0434 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0434 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0434 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0434 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0434 [hypothetical protein...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0434 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0434 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0434 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0434 [hypothetical protein...] - TP0463 [hypothetical protein...] (8,F) 
TP0434 [hypothetical protein...] - TP0465 [hypothetical protein...] (7,F) 
TP0434 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0434 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0434 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0434 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0434 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0434 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0434 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0434 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0434 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0434 [hypothetical protein...] - TP0727 [flagellar hook prote...] (5,F) 
TP0434 [hypothetical protein...] - TP0741 [conserved hypothetic...] (8,F) 
TP0434 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0434 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0434 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0434 [hypothetical protein...] - TP0807 [ribosomal protein L3...] (4,F) 
TP0434 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0434 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0434 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0434 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0434 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0434 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0434 [hypothetical protein...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0434 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0434 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0046 [hypothetical protein...] (18,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0050 [conserved hypothetic...] (10,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0287 [conserved hypothetic...] (27,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0288 [spore coat polysacch...] (77,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0396 [flagellar basal-body...] (15,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0467 [hypothetical protein...] (2,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0563 [hypothetical protein...] (93,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0629 [hypothetical protein...] (6,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0661 [hypothetical protein...] (117,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0726 [flagellar protein (f...] (7,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0741 [conserved hypothetic...] (8,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0788 [hypothetical protein...] (132,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0832 [hypothetical protein...] (37,F) 
TP0435 [lipoprotein, 17 kDa ...] - TP0907 [conserved hypothetic...] (110,W) 
TP0435 [lipoprotein, 17 kDa ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0437 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0437 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0439 [purine-binding chemo...] - TP0258 [conserved hypothetic...] (173,W) 
TP0439 [purine-binding chemo...] - TP0764 [conserved hypothetic...] (139,W) 
TP0439 [purine-binding chemo...] - TP0788 [hypothetical protein...] (132,W) 
TP0441 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0443 [conserved hypothetic...] - TP0029 [UDP-N-acetylglucosam...] (1,F) 
TP0443 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0443 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0443 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0443 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0443 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0443 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0443 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0443 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0443 [conserved hypothetic...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0443 [conserved hypothetic...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0443 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0443 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0443 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0443 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0443 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0443 [conserved hypothetic...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0446 [gcpE protein (gcpE) ...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0446 [gcpE protein (gcpE) ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0451 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0451 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0451 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0451 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0451 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0451 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0451 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0452 [isoleucyl-tRNA synth...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0452 [isoleucyl-tRNA synth...] - TP0185 [signal peptidase I (...] (1,F) 
TP0452 [isoleucyl-tRNA synth...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0453 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0453 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0453 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0453 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0455 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0455 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0455 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0455 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0455 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0455 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0455 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0455 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0455 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0455 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0455 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0455 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0455 [conserved hypothetic...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0455 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0455 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0455 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0455 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0455 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0455 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0455 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0457 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0457 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0457 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0457 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0457 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0457 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0457 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0457 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0457 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0457 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0457 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0457 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0457 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0457 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0457 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0457 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0457 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0457 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0457 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0458 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0459 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
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TP0459 [conserved hypothetic...] - TP0067 [conserved hypothetic...] (19,F) 
TP0459 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0459 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0459 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0459 [conserved hypothetic...] - TP0336 [comE protein, putati...] (1,F) 
TP0459 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0459 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0459 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0459 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0459 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0459 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0459 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0459 [conserved hypothetic...] - TP0874 [conserved hypothetic...] (1,F) 
TP0459 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0459 [conserved hypothetic...] - TP0982 [glpG protein, putati...] (1,F) 
TP0459 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0459 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0461 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0461 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0461 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0461 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0461 [hypothetical protein...] - TP0443 [conserved hypothetic...] (6,F) 
TP0462 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0462 [hypothetical protein...] - TP0286 [conserved hypothetic...] (9,F) 
TP0462 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0462 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0462 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0462 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0462 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0462 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0462 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0462 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0462 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0462 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0463 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0464 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0464 [conserved hypothetic...] - TP0712 [ATP-binding protein ...] (1,F) 
TP0464 [conserved hypothetic...] - TP0739 [conserved hypothetic...] (1,F) 
TP0464 [conserved hypothetic...] - TP0832 [hypothetical protein...] (37,F) 
TP0465 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0465 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0465 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0466 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0467 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0467 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0467 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0467 [hypothetical protein...] - TP0965 [membrane fusion prot...] (14,F) 
TP0467 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0467 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0467 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0468 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0468 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0468 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0469 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0469 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0471 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0471 [hypothetical protein...] - TP0421 [conserved hypothetic...] (4,F) 
TP0471 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0472 [excinuclease ABC, su...] - TP0258 [conserved hypothetic...] (173,W) 
TP0472 [excinuclease ABC, su...] - TP0661 [hypothetical protein...] (117,W) 
TP0472 [excinuclease ABC, su...] - TP0894 [conserved hypothetic...] (13,F) 
TP0472 [excinuclease ABC, su...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0472 [excinuclease ABC, su...] - TP1004 [recombination protei...] (74,W) 
TP0473 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0474 [conserved hypothetic...] - TP0462 [hypothetical protein...] (1,F) 
TP0474 [conserved hypothetic...] - TP0481 [hypothetical protein...] (1,F) 
TP0474 [conserved hypothetic...] - TP0489 [conserved hypothetic...] (1,F) 
TP0474 [conserved hypothetic...] - TP0510 [GTP-binding membrane...] (1,F) 
TP0474 [conserved hypothetic...] - TP0533 [V-type ATPase, subun...] (1,F) 
TP0474 [conserved hypothetic...] - TP0651 [conserved hypothetic...] (1,F) 
TP0474 [conserved hypothetic...] - TP0794 [S-adenosylmethionine...] (1,F) 
TP0474 [conserved hypothetic...] - TP0798 [methionyl-tRNA synth...] (1,F) 
TP0474 [conserved hypothetic...] - TP0864 [conserved hypothetic...] (1,F) 
TP0474 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0478 [glucose-6-phosphate ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0479 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0481 [hypothetical protein...] - TP0968 [hypothetical protein...] (1,F) 
TP0481 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0481 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0484 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0484 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0484 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0484 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0484 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0485 [adenylate cyclase {A...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0485 [adenylate cyclase {A...] - TP0518 [conserved hypothetic...] (70,W) 
TP0485 [adenylate cyclase {A...] - TP0563 [hypothetical protein...] (93,W) 
TP0485 [adenylate cyclase {A...] - TP0907 [conserved hypothetic...] (110,W) 
TP0485 [adenylate cyclase {A...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0485 [adenylate cyclase {A...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0485 [adenylate cyclase {A...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0490 [conserved hypothetic...] - TP0371 [conserved hypothetic...] (1,F) 
TP0490 [conserved hypothetic...] - TP0920 [hypothetical protein...] (7,F) 
TP0492 [DNA primase (dnaE) {...] - TP0024 [conserved hypothetic...] (16,F) 
TP0492 [DNA primase (dnaE) {...] - TP0066 [hypothetical protein...] (11,F) 
TP0492 [DNA primase (dnaE) {...] - TP0088 [conserved hypothetic...] (8,F) 
TP0492 [DNA primase (dnaE) {...] - TP0092 [RNA polymerase sigma...] 
(10,F) 
TP0492 [DNA primase (dnaE) {...] - TP0095 [hypothetical protein...] (15,F) 
TP0492 [DNA primase (dnaE) {...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0492 [DNA primase (dnaE) {...] - TP0168 [phosphoglycerate mut...] (1,F) 
TP0492 [DNA primase (dnaE) {...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0492 [DNA primase (dnaE) {...] - TP0258 [conserved hypothetic...] (173,W) 
TP0492 [DNA primase (dnaE) {...] - TP0288 [spore coat polysacch...] (77,W) 
TP0492 [DNA primase (dnaE) {...] - TP0305 [CTP synthase (pyrG) ...] (4,F) 
TP0492 [DNA primase (dnaE) {...] - TP0380 [DNA repair helicase,...] (5,F) 
TP0492 [DNA primase (dnaE) {...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0492 [DNA primase (dnaE) {...] - TP0519 [response regulatory ...] (30,F) 
TP0492 [DNA primase (dnaE) {...] - TP0648 [conserved hypothetic...] (3,F) 
TP0492 [DNA primase (dnaE) {...] - TP0661 [hypothetical protein...] (117,W) 
TP0492 [DNA primase (dnaE) {...] - TP0751 [hypothetical protein...] (7,F) 
TP0492 [DNA primase (dnaE) {...] - TP0764 [conserved hypothetic...] (139,W) 
TP0492 [DNA primase (dnaE) {...] - TP0788 [hypothetical protein...] (132,W) 
TP0492 [DNA primase (dnaE) {...] - TP0797 [1-pyrroline-5-carbox...] (5,F) 
TP0492 [DNA primase (dnaE) {...] - TP0832 [hypothetical protein...] (37,F) 
TP0492 [DNA primase (dnaE) {...] - TP0833 [hypothetical protein...] (34,F) 
TP0492 [DNA primase (dnaE) {...] - TP0877 [conserved hypothetic...] (4,F) 
TP0492 [DNA primase (dnaE) {...] - TP0907 [conserved hypothetic...] (110,W) 
TP0492 [DNA primase (dnaE) {...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0492 [DNA primase (dnaE) {...] - TP0942 [hypothetical protein...] (1,F) 
TP0492 [DNA primase (dnaE) {...] - TP0961 [flagellar basal-body...] (84,W) 
TP0492 [DNA primase (dnaE) {...] - TP0989 [P26 {Borrelia burgdo...] 
(180,W) 
TP0492 [DNA primase (dnaE) {...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0492 [DNA primase (dnaE) {...] - TP1006 [DNA gyrase, subunit ...] (1,F) 
TP0495 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0495 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0495 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0496 [conserved hypothetic...] - TP0492 [DNA primase (dnaE) {...] (1,F) 
TP0496 [conserved hypothetic...] - TP0889 [tRNA pseudouridine 5...] (1,F) 
TP0496 [conserved hypothetic...] - TP0909 [ribosomal protein L1...] (1,F) 
TP0496 [conserved hypothetic...] - TP0973 [phenylalanyl-tRNA sy...] (1,F) 
TP0496 [conserved hypothetic...] - TP0985 [aspartyl-tRNA synthe...] (2,F) 
TP0496 [conserved hypothetic...] - TP1008 [ribonucleoside-dipho...] (2,F) 
TP0497 [rod shape-determinin...] - TP0001 [chromosomal replicat...] (3,F) 
TP0497 [rod shape-determinin...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0497 [rod shape-determinin...] - TP0088 [conserved hypothetic...] (8,F) 
TP0497 [rod shape-determinin...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0497 [rod shape-determinin...] - TP0258 [conserved hypothetic...] (173,W) 
TP0497 [rod shape-determinin...] - TP0260 [hypothetical protein...] (5,F) 
TP0497 [rod shape-determinin...] - TP0334 [conserved hypothetic...] (5,F) 
TP0497 [rod shape-determinin...] - TP0629 [hypothetical protein...] (6,F) 
TP0497 [rod shape-determinin...] - TP0764 [conserved hypothetic...] (139,W) 
TP0497 [rod shape-determinin...] - TP0788 [hypothetical protein...] (132,W) 
TP0497 [rod shape-determinin...] - TP0807 [ribosomal protein L3...] (4,F) 
TP0497 [rod shape-determinin...] - TP0832 [hypothetical protein...] (37,F) 
TP0497 [rod shape-determinin...] - TP0907 [conserved hypothetic...] (110,W) 
TP0497 [rod shape-determinin...] - TP0961 [flagellar basal-body...] (84,W) 
TP0497 [rod shape-determinin...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0497 [rod shape-determinin...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0498 [rod shape-determinin...] - TP0258 [conserved hypothetic...] (173,W) 
TP0498 [rod shape-determinin...] - TP0288 [spore coat polysacch...] (77,W) 
TP0498 [rod shape-determinin...] - TP0397 [flagellar basal-body...] (25,F) 
TP0498 [rod shape-determinin...] - TP0473 [hypothetical protein...] (1,F) 
TP0498 [rod shape-determinin...] - TP0870 [flagellar filament 3...] (79,W) 
TP0498 [rod shape-determinin...] - TP0884 [conserved hypothetic...] (1,F) 
TP0498 [rod shape-determinin...] - TP0907 [conserved hypothetic...] (110,W) 
TP0498 [rod shape-determinin...] - TP0961 [flagellar basal-body...] (84,W) 
TP0498 [rod shape-determinin...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0499 [rod shape-determinin...] - TP0561 [conserved hypothetic...] (44,F) 
TP0500 [penicillin-binding p...] - TP0012 [hypothetical protein...] (1,F) 
TP0500 [penicillin-binding p...] - TP0252 [apolipoprotein N-acy...] (1,F) 
TP0500 [penicillin-binding p...] - TP0907 [conserved hypothetic...] (110,W) 
TP0500 [penicillin-binding p...] - TP0961 [flagellar basal-body...] (84,W) 
TP0500 [penicillin-binding p...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0500 [penicillin-binding p...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0500 [penicillin-binding p...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0500 [penicillin-binding p...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0501 [rod shape-determinin...] - TP0113 [Lambda CII stability...] (2,F) 
TP0501 [rod shape-determinin...] - TP0258 [conserved hypothetic...] (173,W) 
TP0501 [rod shape-determinin...] - TP0377 [conserved hypothetic...] (11,F) 
TP0501 [rod shape-determinin...] - TP0561 [conserved hypothetic...] (44,F) 
TP0501 [rod shape-determinin...] - TP0563 [hypothetical protein...] (93,W) 
TP0501 [rod shape-determinin...] - TP0708 [hypothetical protein...] (13,F) 
TP0501 [rod shape-determinin...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0501 [rod shape-determinin...] - TP0961 [flagellar basal-body...] (84,W) 
TP0501 [rod shape-determinin...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0501 [rod shape-determinin...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0501 [rod shape-determinin...] - TP0998 [sodium/proton-depend...] (1,F) 
TP0503 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
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TP0503 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0503 [hypothetical protein...] - TP0396 [flagellar basal-body...] (15,F) 
TP0503 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0503 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0503 [hypothetical protein...] - TP0463 [hypothetical protein...] (8,F) 
TP0503 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0503 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0503 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0503 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0503 [hypothetical protein...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0503 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0503 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0503 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0503 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0503 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0503 [hypothetical protein...] - TP0797 [1-pyrroline-5-carbox...] (5,F) 
TP0503 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0503 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0503 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0503 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0503 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0503 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0504 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0504 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0504 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0504 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0505 [hexokinase (hxk) {Sc...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0506 [trigger factor (tig)...] - TP0086 [conserved hypothetic...] (1,F) 
TP0506 [trigger factor (tig)...] - TP0605 [translation elongati...] (1,F) 
TP0507 [ATP-dependent Clp pr...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0507 [ATP-dependent Clp pr...] - TP0362 [ribosomal protein L2...] (2,F) 
TP0507 [ATP-dependent Clp pr...] - TP0377 [conserved hypothetic...] (11,F) 
TP0507 [ATP-dependent Clp pr...] - TP0563 [hypothetical protein...] (93,W) 
TP0507 [ATP-dependent Clp pr...] - TP0907 [conserved hypothetic...] (110,W) 
TP0507 [ATP-dependent Clp pr...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0507 [ATP-dependent Clp pr...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0508 [ATP-dependent Clp pr...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0508 [ATP-dependent Clp pr...] - TP0961 [flagellar basal-body...] (84,W) 
TP0508 [ATP-dependent Clp pr...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0509 [alkyl hydroperoxide ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0509 [alkyl hydroperoxide ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0511 [transcription factor...] - TP0258 [conserved hypothetic...] (173,W) 
TP0511 [transcription factor...] - TP0788 [hypothetical protein...] (132,W) 
TP0511 [transcription factor...] - TP0907 [conserved hypothetic...] (110,W) 
TP0511 [transcription factor...] - TP0961 [flagellar basal-body...] (84,W) 
TP0511 [transcription factor...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0511 [transcription factor...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0516 [virulence factor (mv...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0516 [virulence factor (mv...] - TP0305 [CTP synthase (pyrG) ...] (4,F) 
TP0517 [Holliday junction nu...] - TP0258 [conserved hypothetic...] (173,W) 
TP0517 [Holliday junction nu...] - TP0288 [spore coat polysacch...] (77,W) 
TP0517 [Holliday junction nu...] - TP0294 [phosphoribosyl pyrop...] (3,F) 
TP0517 [Holliday junction nu...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0517 [Holliday junction nu...] - TP0383 [conserved hypothetic...] (65,W) 
TP0517 [Holliday junction nu...] - TP0397 [flagellar basal-body...] (25,F) 
TP0517 [Holliday junction nu...] - TP0449 [hypothetical protein...] (51,W) 
TP0517 [Holliday junction nu...] - TP0518 [conserved hypothetic...] (70,W) 
TP0517 [Holliday junction nu...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0517 [Holliday junction nu...] - TP0661 [hypothetical protein...] (117,W) 
TP0517 [Holliday junction nu...] - TP0664 [flagellar filament o...] (34,F) 
TP0517 [Holliday junction nu...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0517 [Holliday junction nu...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0517 [Holliday junction nu...] - TP0711 [conserved hypothetic...] (46,F) 
TP0517 [Holliday junction nu...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0517 [Holliday junction nu...] - TP0773 [periplasmic serine p...] (30,F) 
TP0517 [Holliday junction nu...] - TP0788 [hypothetical protein...] (132,W) 
TP0517 [Holliday junction nu...] - TP0870 [flagellar filament 3...] (79,W) 
TP0517 [Holliday junction nu...] - TP0907 [conserved hypothetic...] (110,W) 
TP0517 [Holliday junction nu...] - TP0943 [flagellar protein (f...] (15,F) 
TP0517 [Holliday junction nu...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0519 [response regulatory ...] - TP0352 [hypothetical protein...] (1,F) 
TP0519 [response regulatory ...] - TP0519 [response regulatory ...] (30,F) 
TP0521 [DNA polymerase III, ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0521 [DNA polymerase III, ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0521 [DNA polymerase III, ...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0525 [translation elongati...] - TP0764 [conserved hypothetic...] (139,W) 
TP0526 [ATP-dependent helica...] - TP0067 [conserved hypothetic...] (19,F) 
TP0526 [ATP-dependent helica...] - TP0192 [ribosomal protein L2...] (1,F) 
TP0526 [ATP-dependent helica...] - TP0258 [conserved hypothetic...] (173,W) 
TP0526 [ATP-dependent helica...] - TP0559 [conserved hypothetic...] (26,F) 
TP0526 [ATP-dependent helica...] - TP0764 [conserved hypothetic...] (139,W) 
TP0526 [ATP-dependent helica...] - TP0788 [hypothetical protein...] (132,W) 
TP0526 [ATP-dependent helica...] - TP0892 [N utilization substa...] (1,F) 
TP0526 [ATP-dependent helica...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0526 [ATP-dependent helica...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0526 [ATP-dependent helica...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0527 [V-type ATPase, subun...] - TP0059 [hypothetical protein...] (21,F) 
TP0527 [V-type ATPase, subun...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0527 [V-type ATPase, subun...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0527 [V-type ATPase, subun...] - TP0288 [spore coat polysacch...] (77,W) 
TP0527 [V-type ATPase, subun...] - TP0383 [conserved hypothetic...] (65,W) 
TP0527 [V-type ATPase, subun...] - TP0396 [flagellar basal-body...] (15,F) 
TP0527 [V-type ATPase, subun...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0527 [V-type ATPase, subun...] - TP0449 [hypothetical protein...] (51,W) 
TP0527 [V-type ATPase, subun...] - TP0563 [hypothetical protein...] (93,W) 
TP0527 [V-type ATPase, subun...] - TP0661 [hypothetical protein...] (117,W) 
TP0527 [V-type ATPase, subun...] - TP0764 [conserved hypothetic...] (139,W) 
TP0527 [V-type ATPase, subun...] - TP0870 [flagellar filament 3...] (79,W) 
TP0527 [V-type ATPase, subun...] - TP0907 [conserved hypothetic...] (110,W) 
TP0527 [V-type ATPase, subun...] - TP0961 [flagellar basal-body...] (84,W) 
TP0527 [V-type ATPase, subun...] - TP0965 [membrane fusion prot...] (14,F) 
TP0527 [V-type ATPase, subun...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0527 [V-type ATPase, subun...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0527 [V-type ATPase, subun...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0528 [V-type ATPase, subun...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0528 [V-type ATPase, subun...] - TP0288 [spore coat polysacch...] (77,W) 
TP0528 [V-type ATPase, subun...] - TP0383 [conserved hypothetic...] (65,W) 
TP0528 [V-type ATPase, subun...] - TP0661 [hypothetical protein...] (117,W) 
TP0528 [V-type ATPase, subun...] - TP0961 [flagellar basal-body...] (84,W) 
TP0528 [V-type ATPase, subun...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0528 [V-type ATPase, subun...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0530 [V-type ATPase, subun...] - TP0258 [conserved hypothetic...] (173,W) 
TP0530 [V-type ATPase, subun...] - TP0288 [spore coat polysacch...] (77,W) 
TP0530 [V-type ATPase, subun...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0530 [V-type ATPase, subun...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0530 [V-type ATPase, subun...] - TP0563 [hypothetical protein...] (93,W) 
TP0530 [V-type ATPase, subun...] - TP0661 [hypothetical protein...] (117,W) 
TP0530 [V-type ATPase, subun...] - TP0870 [flagellar filament 3...] (79,W) 
TP0530 [V-type ATPase, subun...] - TP0961 [flagellar basal-body...] (84,W) 
TP0530 [V-type ATPase, subun...] - TP0974 [hypothetical protein...] (23,F) 
TP0530 [V-type ATPase, subun...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0530 [V-type ATPase, subun...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0531 [V-type ATPase, subun...] - TP0258 [conserved hypothetic...] (173,W) 
TP0531 [V-type ATPase, subun...] - TP0383 [conserved hypothetic...] (65,W) 
TP0531 [V-type ATPase, subun...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0531 [V-type ATPase, subun...] - TP0449 [hypothetical protein...] (51,W) 
TP0531 [V-type ATPase, subun...] - TP0518 [conserved hypothetic...] (70,W) 
TP0531 [V-type ATPase, subun...] - TP0563 [hypothetical protein...] (93,W) 
TP0531 [V-type ATPase, subun...] - TP0661 [hypothetical protein...] (117,W) 
TP0531 [V-type ATPase, subun...] - TP0764 [conserved hypothetic...] (139,W) 
TP0531 [V-type ATPase, subun...] - TP0907 [conserved hypothetic...] (110,W) 
TP0531 [V-type ATPase, subun...] - TP0961 [flagellar basal-body...] (84,W) 
TP0531 [V-type ATPase, subun...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0533 [V-type ATPase, subun...] - TP0377 [conserved hypothetic...] (11,F) 
TP0533 [V-type ATPase, subun...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0537 [triosephosphate isom...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0538 [phosphoglycerate kin...] - TP0961 [flagellar basal-body...] (84,W) 
TP0539 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0539 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0539 [hypothetical protein...] - TP0687 [DNA recombinase (rec...] (2,F) 
TP0539 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0539 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0540 [anti-sigma F factor ...] - TP0288 [spore coat polysacch...] (77,W) 
TP0540 [anti-sigma F factor ...] - TP0563 [hypothetical protein...] (93,W) 
TP0540 [anti-sigma F factor ...] - TP0661 [hypothetical protein...] (117,W) 
TP0540 [anti-sigma F factor ...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0540 [anti-sigma F factor ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0540 [anti-sigma F factor ...] - TP0961 [flagellar basal-body...] (84,W) 
TP0541 [GTP-binding protein ...] - TP0658 [transmembrane protei...] (5,F) 
TP0541 [GTP-binding protein ...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0542 [pyrophosphate--fruct...] - TP0258 [conserved hypothetic...] (173,W) 
TP0542 [pyrophosphate--fruct...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0542 [pyrophosphate--fruct...] - TP0788 [hypothetical protein...] (132,W) 
TP0544 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0544 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0544 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0547 [penicillin tolerance...] - TP0287 [conserved hypothetic...] (27,F) 
TP0547 [penicillin tolerance...] - TP0288 [spore coat polysacch...] (77,W) 
TP0547 [penicillin tolerance...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0547 [penicillin tolerance...] - TP0449 [hypothetical protein...] (51,W) 
TP0547 [penicillin tolerance...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0547 [penicillin tolerance...] - TP0764 [conserved hypothetic...] (139,W) 
TP0547 [penicillin tolerance...] - TP0870 [flagellar filament 3...] (79,W) 
TP0547 [penicillin tolerance...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0547 [penicillin tolerance...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0547 [penicillin tolerance...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0551 [phosphatase {Trepone...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0552 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0552 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0552 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0552 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0552 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0552 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0552 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0552 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0552 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0552 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0552 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0552 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0552 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
SUPPLEMENTARY INFORMATION 
 195 
TP0552 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0552 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0552 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0552 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0552 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0555 [glutamate/ aspartate...] - TP0561 [conserved hypothetic...] (44,F) 
TP0557 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0557 [conserved hypothetic...] - TP0655 [spermidine/putrescin...] (1,F) 
TP0557 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0558 [conserved hypothetic...] - TP0234 [ribosomal protein L3...] (1,F) 
TP0558 [conserved hypothetic...] - TP0274 [deoxycytidylate deam...] (1,F) 
TP0558 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0558 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0559 [conserved hypothetic...] - TP0559 [conserved hypothetic...] (26,F) 
TP0561 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0561 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0561 [conserved hypothetic...] - TP0920 [hypothetical protein...] (7,F) 
TP0561 [conserved hypothetic...] - TP0985 [aspartyl-tRNA synthe...] (2,F) 
TP0562 [spore coat polysacch...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0563 [hypothetical protein...] - TP0014 [hypothetical protein...] (2,F) 
TP0563 [hypothetical protein...] - TP0024 [conserved hypothetic...] (16,F) 
TP0563 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0563 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0563 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0563 [hypothetical protein...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0563 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0563 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0563 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0563 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0563 [hypothetical protein...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0563 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0563 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0563 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0563 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0563 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0563 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0563 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0563 [hypothetical protein...] - TP0943 [flagellar protein (f...] (15,F) 
TP0563 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0563 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0563 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0563 [hypothetical protein...] - TP0981 [sensory transduction...] (5,F) 
TP0563 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0563 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0563 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0563 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0564 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0564 [hypothetical protein...] - TP0675 [hypothetical protein...] (2,F) 
TP0564 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0564 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0565 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0565 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0565 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0567 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0567 [conserved hypothetic...] - TP0421 [conserved hypothetic...] (4,F) 
TP0567 [conserved hypothetic...] - TP0675 [hypothetical protein...] (2,F) 
TP0567 [conserved hypothetic...] - TP0708 [hypothetical protein...] (13,F) 
TP0567 [conserved hypothetic...] - TP0832 [hypothetical protein...] (37,F) 
TP0567 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0567 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0567 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0567 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0571 [Tp70 protein {Trepon...] - TP0059 [hypothetical protein...] (21,F) 
TP0571 [Tp70 protein {Trepon...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0571 [Tp70 protein {Trepon...] - TP0281 [hypothetical protein...] (64,W) 
TP0571 [Tp70 protein {Trepon...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0571 [Tp70 protein {Trepon...] - TP0711 [conserved hypothetic...] (46,F) 
TP0573 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0573 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0573 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0578 [cell division protei...] - TP0046 [hypothetical protein...] (18,F) 
TP0578 [cell division protei...] - TP0066 [hypothetical protein...] (11,F) 
TP0578 [cell division protei...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0578 [cell division protei...] - TP0258 [conserved hypothetic...] (173,W) 
TP0578 [cell division protei...] - TP0288 [spore coat polysacch...] (77,W) 
TP0578 [cell division protei...] - TP0380 [DNA repair helicase,...] (5,F) 
TP0578 [cell division protei...] - TP0563 [hypothetical protein...] (93,W) 
TP0578 [cell division protei...] - TP0764 [conserved hypothetic...] (139,W) 
TP0578 [cell division protei...] - TP0788 [hypothetical protein...] (132,W) 
TP0578 [cell division protei...] - TP0832 [hypothetical protein...] (37,F) 
TP0578 [cell division protei...] - TP0870 [flagellar filament 3...] (79,W) 
TP0578 [cell division protei...] - TP0907 [conserved hypothetic...] (110,W) 
TP0578 [cell division protei...] - TP0961 [flagellar basal-body...] (84,W) 
TP0578 [cell division protei...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0578 [cell division protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0579 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0580 [conserved hypothetic...] - TP0099 [uridylate kinase (sm...] (3,F) 
TP0582 [conserved hypothetic...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0582 [conserved hypothetic...] - TP0342 [cytidylate kinase (c...] (1,F) 
TP0582 [conserved hypothetic...] - TP0368 [hypothetical protein...] (1,F) 
TP0582 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0582 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0582 [conserved hypothetic...] - TP0685 [methylgalactoside AB...] (1,F) 
TP0582 [conserved hypothetic...] - TP0698 [hypothetical protein...] (1,F) 
TP0582 [conserved hypothetic...] - TP0765 [cell division protei...] (2,F) 
TP0582 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0582 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0582 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0582 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0582 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0582 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0583 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0583 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0583 [hypothetical protein...] - TP0396 [flagellar basal-body...] (15,F) 
TP0583 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0583 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0583 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0583 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0583 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0583 [hypothetical protein...] - TP0741 [conserved hypothetic...] (8,F) 
TP0583 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0583 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0583 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0258 [conserved hypothetic...] (173,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0281 [hypothetical protein...] (64,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0397 [flagellar basal-body...] (25,F) 
TP0586 [leucyl-tRNA syntheta...] - TP0449 [hypothetical protein...] (51,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0870 [flagellar filament 3...] (79,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0907 [conserved hypothetic...] (110,W) 
TP0586 [leucyl-tRNA syntheta...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0587 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0587 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0587 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0587 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0588 [conserved hypothetic...] - TP0120 [amino acid ABC trans...] (1,F) 
TP0588 [conserved hypothetic...] - TP0134 [hypothetical protein...] (1,F) 
TP0588 [conserved hypothetic...] - TP0148 [hypothetical protein...] (1,F) 
TP0588 [conserved hypothetic...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0588 [conserved hypothetic...] - TP0483 [hypothetical protein...] (1,F) 
TP0588 [conserved hypothetic...] - TP0676 [hypothetical protein...] (2,F) 
TP0588 [conserved hypothetic...] - TP0678 [hypothetical protein...] (1,F) 
TP0588 [conserved hypothetic...] - TP0948 [spoIIIJ-associated p...] (1,F) 
TP0589 [phosphocarrier prote...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0589 [phosphocarrier prote...] - TP0576 [peptide chain releas...] (1,F) 
TP0589 [phosphocarrier prote...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0591 [HPr kinase (ptsK) {B...] - TP0257 [glycerophosphodieste...] (3,F) 
TP0591 [HPr kinase (ptsK) {B...] - TP0286 [conserved hypothetic...] (9,F) 
TP0591 [HPr kinase (ptsK) {B...] - TP0449 [hypothetical protein...] (51,W) 
TP0591 [HPr kinase (ptsK) {B...] - TP0661 [hypothetical protein...] (117,W) 
TP0591 [HPr kinase (ptsK) {B...] - TP0870 [flagellar filament 3...] (79,W) 
TP0591 [HPr kinase (ptsK) {B...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0592 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0592 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0592 [hypothetical protein...] - TP0583 [hypothetical protein...] (1,F) 
TP0593 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0593 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0593 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0593 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0593 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0593 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0593 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0597 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0597 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0597 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0597 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0597 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0597 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0597 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0597 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0597 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0597 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0597 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0598 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0598 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0598 [hypothetical protein...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0600 [zinc protease, putat...] - TP0561 [conserved hypothetic...] (44,F) 
TP0603 [conserved hypothetic...] - TP0111 [RNA polymerase sigma...] (1,F) 
TP0603 [conserved hypothetic...] - TP0284 [hypothetical protein...] (1,F) 
TP0603 [conserved hypothetic...] - TP0424 [V-type ATPase, subun...] (1,F) 
TP0604 [ribosome recycling f...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0604 [ribosome recycling f...] - TP0214 [hypothetical protein...] (2,F) 
TP0604 [ribosome recycling f...] - TP0258 [conserved hypothetic...] (173,W) 
TP0604 [ribosome recycling f...] - TP0288 [spore coat polysacch...] (77,W) 
TP0604 [ribosome recycling f...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0604 [ribosome recycling f...] - TP0449 [hypothetical protein...] (51,W) 
TP0604 [ribosome recycling f...] - TP0563 [hypothetical protein...] (93,W) 
TP0604 [ribosome recycling f...] - TP0771 [conserved hypothetic...] (1,F) 
TP0604 [ribosome recycling f...] - TP0788 [hypothetical protein...] (132,W) 
TP0607 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
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TP0610 [tpr protein H (tprH)...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0611 [ABC transporter, ATP...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0612 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0612 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0615 [nitrogen fixation pr...] - TP0258 [conserved hypothetic...] (173,W) 
TP0615 [nitrogen fixation pr...] - TP0563 [hypothetical protein...] (93,W) 
TP0615 [nitrogen fixation pr...] - TP0661 [hypothetical protein...] (117,W) 
TP0615 [nitrogen fixation pr...] - TP0788 [hypothetical protein...] (132,W) 
TP0615 [nitrogen fixation pr...] - TP0907 [conserved hypothetic...] (110,W) 
TP0615 [nitrogen fixation pr...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0615 [nitrogen fixation pr...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0617 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0621 [tpr protein J (tprJ)...] - TP0258 [conserved hypothetic...] (173,W) 
TP0622 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0622 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0622 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0622 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0622 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0622 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0622 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0622 [hypothetical protein...] - TP0660 [flagellar hook-assoc...] (4,F) 
TP0622 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0622 [hypothetical protein...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0622 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0622 [hypothetical protein...] - TP0751 [hypothetical protein...] (7,F) 
TP0622 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0624 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0625 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0626 [exonuclease, putativ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0626 [exonuclease, putativ...] - TP0661 [hypothetical protein...] (117,W) 
TP0626 [exonuclease, putativ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0627 [exonuclease (sbcC) {...] - TP0561 [conserved hypothetic...] (44,F) 
TP0627 [exonuclease (sbcC) {...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0628 [conserved hypothetic...] - TP0176 [hypothetical protein...] (1,F) 
TP0628 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0628 [conserved hypothetic...] - TP0314 [hypothetical protein...] (2,F) 
TP0628 [conserved hypothetic...] - TP0413 [phosphoglucomutase {...] (2,F) 
TP0628 [conserved hypothetic...] - TP0515 [conserved hypothetic...] (1,F) 
TP0628 [conserved hypothetic...] - TP0677 [hypothetical protein...] (2,F) 
TP0628 [conserved hypothetic...] - TP0735 [glutamate synthase (...] (2,F) 
TP0628 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0628 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0628 [conserved hypothetic...] - TP0987 [hypothetical protein...] (2,F) 
TP0628 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0628 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0628 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0628 [conserved hypothetic...] - TP1039 [adenine phosphoribos...] (1,F) 
TP0630 [chemotaxis protein m...] - TP0026 [flagellar motor swit...] (8,F) 
TP0630 [chemotaxis protein m...] - TP0046 [hypothetical protein...] (18,F) 
TP0630 [chemotaxis protein m...] - TP0064 [hypothetical, protei...] (8,F) 
TP0630 [chemotaxis protein m...] - TP0088 [conserved hypothetic...] (8,F) 
TP0630 [chemotaxis protein m...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0630 [chemotaxis protein m...] - TP0121 [conserved hypothetic...] (7,F) 
TP0630 [chemotaxis protein m...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0630 [chemotaxis protein m...] - TP0162 [Holliday junction DN...] (3,F) 
TP0630 [chemotaxis protein m...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0630 [chemotaxis protein m...] - TP0288 [spore coat polysacch...] (77,W) 
TP0630 [chemotaxis protein m...] - TP0305 [CTP synthase (pyrG) ...] (4,F) 
TP0630 [chemotaxis protein m...] - TP0330 [cell division protei...] (2,F) 
TP0630 [chemotaxis protein m...] - TP0396 [flagellar basal-body...] (15,F) 
TP0630 [chemotaxis protein m...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0630 [chemotaxis protein m...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0630 [chemotaxis protein m...] - TP0764 [conserved hypothetic...] (139,W) 
TP0630 [chemotaxis protein m...] - TP0832 [hypothetical protein...] (37,F) 
TP0630 [chemotaxis protein m...] - TP0851 [hypothetical protein...] (1,F) 
TP0630 [chemotaxis protein m...] - TP0870 [flagellar filament 3...] (79,W) 
TP0630 [chemotaxis protein m...] - TP0877 [conserved hypothetic...] (4,F) 
TP0630 [chemotaxis protein m...] - TP0961 [flagellar basal-body...] (84,W) 
TP0630 [chemotaxis protein m...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0630 [chemotaxis protein m...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0630 [chemotaxis protein m...] - TP1004 [recombination protei...] (74,W) 
TP0630 [chemotaxis protein m...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0631 [protein-glutamate me...] - TP0258 [conserved hypothetic...] (173,W) 
TP0631 [protein-glutamate me...] - TP0288 [spore coat polysacch...] (77,W) 
TP0631 [protein-glutamate me...] - TP0764 [conserved hypothetic...] (139,W) 
TP0631 [protein-glutamate me...] - TP0832 [hypothetical protein...] (37,F) 
TP0631 [protein-glutamate me...] - TP0961 [flagellar basal-body...] (84,W) 
TP0631 [protein-glutamate me...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0632 [tryptophanyl-tRNA sy...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0634 [DNA ligase (lig) {Th...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0634 [DNA ligase (lig) {Th...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0258 [conserved hypothetic...] (173,W) 
TP0634 [DNA ligase (lig) {Th...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0461 [hypothetical protein...] (3,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0519 [response regulatory ...] (30,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0618 [hypothetical protein...] (24,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0661 [hypothetical protein...] (117,W) 
TP0634 [DNA ligase (lig) {Th...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0711 [conserved hypothetic...] (46,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0634 [DNA ligase (lig) {Th...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0636 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0636 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0636 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0637 [tRNA delta(2)-isopen...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0637 [tRNA delta(2)-isopen...] - TP0397 [flagellar basal-body...] (25,F) 
TP0637 [tRNA delta(2)-isopen...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0637 [tRNA delta(2)-isopen...] - TP0870 [flagellar filament 3...] (79,W) 
TP0638 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0640 [methyl-accepting che...] - TP0064 [hypothetical, protei...] (8,F) 
TP0640 [methyl-accepting che...] - TP0088 [conserved hypothetic...] (8,F) 
TP0640 [methyl-accepting che...] - TP0288 [spore coat polysacch...] (77,W) 
TP0640 [methyl-accepting che...] - TP0397 [flagellar basal-body...] (25,F) 
TP0640 [methyl-accepting che...] - TP0764 [conserved hypothetic...] (139,W) 
TP0640 [methyl-accepting che...] - TP0832 [hypothetical protein...] (37,F) 
TP0641 [histidyl-tRNA synthe...] - TP0258 [conserved hypothetic...] (173,W) 
TP0641 [histidyl-tRNA synthe...] - TP0383 [conserved hypothetic...] (65,W) 
TP0641 [histidyl-tRNA synthe...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0641 [histidyl-tRNA synthe...] - TP0518 [conserved hypothetic...] (70,W) 
TP0641 [histidyl-tRNA synthe...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0641 [histidyl-tRNA synthe...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0641 [histidyl-tRNA synthe...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0641 [histidyl-tRNA synthe...] - TP0764 [conserved hypothetic...] (139,W) 
TP0641 [histidyl-tRNA synthe...] - TP0788 [hypothetical protein...] (132,W) 
TP0641 [histidyl-tRNA synthe...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0642 [phosphomannomutase (...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0642 [phosphomannomutase (...] - TP0449 [hypothetical protein...] (51,W) 
TP0643 [DNA polymerase III, ...] - TP0397 [flagellar basal-body...] (25,F) 
TP0644 [lysyl-tRNA synthetas...] - TP0661 [hypothetical protein...] (117,W) 
TP0644 [lysyl-tRNA synthetas...] - TP0664 [flagellar filament o...] (34,F) 
TP0647 [seryl-tRNA synthetas...] - TP0563 [hypothetical protein...] (93,W) 
TP0647 [seryl-tRNA synthetas...] - TP0788 [hypothetical protein...] (132,W) 
TP0648 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0648 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0648 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0648 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0648 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0648 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0648 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0648 [conserved hypothetic...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0648 [conserved hypothetic...] - TP0443 [conserved hypothetic...] (6,F) 
TP0648 [conserved hypothetic...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0648 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0648 [conserved hypothetic...] - TP0461 [hypothetical protein...] (3,F) 
TP0648 [conserved hypothetic...] - TP0513 [K+ transport protein...] (4,F) 
TP0648 [conserved hypothetic...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0648 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0648 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0648 [conserved hypothetic...] - TP0582 [conserved hypothetic...] (1,F) 
TP0648 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0648 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0648 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0648 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0648 [conserved hypothetic...] - TP0895 [hypothetical protein...] (3,F) 
TP0648 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0648 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0648 [conserved hypothetic...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0648 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0648 [conserved hypothetic...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0648 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0648 [conserved hypothetic...] - TP0974 [hypothetical protein...] (23,F) 
TP0648 [conserved hypothetic...] - TP0981 [sensory transduction...] (5,F) 
TP0648 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0648 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0648 [conserved hypothetic...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0648 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0648 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0648 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0649 [hemolysin (tlyC) {Bo...] - TP0258 [conserved hypothetic...] (173,W) 
TP0649 [hemolysin (tlyC) {Bo...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0649 [hemolysin (tlyC) {Bo...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0649 [hemolysin (tlyC) {Bo...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0650 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0650 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0650 [conserved hypothetic...] - TP0681 [alanine racemase (al...] (1,F) 
TP0650 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0650 [conserved hypothetic...] - TP0807 [ribosomal protein L3...] (4,F) 
TP0650 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0651 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0651 [conserved hypothetic...] - TP0156 [conserved hypothetic...] (1,F) 
TP0651 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0651 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0651 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0651 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0651 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0651 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0651 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
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TP0651 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0651 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0651 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0651 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0651 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0651 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0651 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0651 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0651 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0653 [spermidine/putrescin...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0653 [spermidine/putrescin...] - TP0561 [conserved hypothetic...] (44,F) 
TP0653 [spermidine/putrescin...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0654 [spermidine/putrescin...] - TP0397 [flagellar basal-body...] (25,F) 
TP0655 [spermidine/putrescin...] - TP0281 [hypothetical protein...] (64,W) 
TP0655 [spermidine/putrescin...] - TP0397 [flagellar basal-body...] (25,F) 
TP0655 [spermidine/putrescin...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0655 [spermidine/putrescin...] - TP0449 [hypothetical protein...] (51,W) 
TP0655 [spermidine/putrescin...] - TP0661 [hypothetical protein...] (117,W) 
TP0655 [spermidine/putrescin...] - TP0741 [conserved hypothetic...] (8,F) 
TP0655 [spermidine/putrescin...] - TP0870 [flagellar filament 3...] (79,W) 
TP0655 [spermidine/putrescin...] - TP0907 [conserved hypothetic...] (110,W) 
TP0656 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0656 [hypothetical protein...] - TP0067 [conserved hypothetic...] (19,F) 
TP0656 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0656 [hypothetical protein...] - TP0180 [hypothetical protein...] (1,F) 
TP0656 [hypothetical protein...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0656 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0656 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0656 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0656 [hypothetical protein...] - TP0286 [conserved hypothetic...] (9,F) 
TP0656 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0656 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0656 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0656 [hypothetical protein...] - TP0443 [conserved hypothetic...] (6,F) 
TP0656 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0656 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0656 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0656 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0656 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0656 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0656 [hypothetical protein...] - TP0641 [histidyl-tRNA synthe...] (9,F) 
TP0656 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0656 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0656 [hypothetical protein...] - TP0741 [conserved hypothetic...] (8,F) 
TP0656 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0656 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0656 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0656 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0656 [hypothetical protein...] - TP0894 [conserved hypothetic...] (13,F) 
TP0656 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0656 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0656 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0656 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0656 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0656 [hypothetical protein...] - TP0995 [cyclic nucleotide bi...] (5,F) 
TP0656 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0657 [carbon storage regul...] - TP0226 [hypothetical protein...] (1,F) 
TP0657 [carbon storage regul...] - TP0258 [conserved hypothetic...] (173,W) 
TP0657 [carbon storage regul...] - TP0518 [conserved hypothetic...] (70,W) 
TP0658 [transmembrane protei...] - TP0620 [tpr protein I (tprI)...] (1,F) 
TP0658 [transmembrane protei...] - TP0736 [hydrogenase, gamma c...] (1,F) 
TP0658 [transmembrane protei...] - TP0831 [arginyl-tRNA synthet...] (1,F) 
TP0658 [transmembrane protei...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0658 [transmembrane protei...] - TP0941 [hypothetical protein...] (1,F) 
TP0658 [transmembrane protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0659 [flagellar hook-assoc...] - TP0002 [DNA polymerase III, ...] (4,F) 
TP0659 [flagellar hook-assoc...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0659 [flagellar hook-assoc...] - TP0258 [conserved hypothetic...] (173,W) 
TP0659 [flagellar hook-assoc...] - TP0563 [hypothetical protein...] (93,W) 
TP0659 [flagellar hook-assoc...] - TP0726 [flagellar protein (f...] (7,F) 
TP0659 [flagellar hook-assoc...] - TP0764 [conserved hypothetic...] (139,W) 
TP0659 [flagellar hook-assoc...] - TP0788 [hypothetical protein...] (132,W) 
TP0659 [flagellar hook-assoc...] - TP0832 [hypothetical protein...] (37,F) 
TP0659 [flagellar hook-assoc...] - TP0907 [conserved hypothetic...] (110,W) 
TP0659 [flagellar hook-assoc...] - TP0961 [flagellar basal-body...] (84,W) 
TP0659 [flagellar hook-assoc...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0659 [flagellar hook-assoc...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0659 [flagellar hook-assoc...] - TP1004 [recombination protei...] (74,W) 
TP0660 [flagellar hook-assoc...] - TP0024 [conserved hypothetic...] (16,F) 
TP0660 [flagellar hook-assoc...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0660 [flagellar hook-assoc...] - TP0067 [conserved hypothetic...] (19,F) 
TP0660 [flagellar hook-assoc...] - TP0258 [conserved hypothetic...] (173,W) 
TP0660 [flagellar hook-assoc...] - TP0288 [spore coat polysacch...] (77,W) 
TP0660 [flagellar hook-assoc...] - TP0383 [conserved hypothetic...] (65,W) 
TP0660 [flagellar hook-assoc...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0660 [flagellar hook-assoc...] - TP0465 [hypothetical protein...] (7,F) 
TP0660 [flagellar hook-assoc...] - TP0518 [conserved hypothetic...] (70,W) 
TP0660 [flagellar hook-assoc...] - TP0563 [hypothetical protein...] (93,W) 
TP0660 [flagellar hook-assoc...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0660 [flagellar hook-assoc...] - TP0661 [hypothetical protein...] (117,W) 
TP0660 [flagellar hook-assoc...] - TP0788 [hypothetical protein...] (132,W) 
TP0661 [hypothetical protein...] - TP0024 [conserved hypothetic...] (16,F) 
TP0661 [hypothetical protein...] - TP0059 [hypothetical protein...] (21,F) 
TP0661 [hypothetical protein...] - TP0121 [conserved hypothetic...] (7,F) 
TP0661 [hypothetical protein...] - TP0188 [ribosomal protein S1...] (2,F) 
TP0661 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0661 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0661 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0661 [hypothetical protein...] - TP0286 [conserved hypothetic...] (9,F) 
TP0661 [hypothetical protein...] - TP0287 [conserved hypothetic...] (27,F) 
TP0661 [hypothetical protein...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0661 [hypothetical protein...] - TP0359 [hypothetical protein...] (2,F) 
TP0661 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0661 [hypothetical protein...] - TP0397 [flagellar basal-body...] (25,F) 
TP0661 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0661 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0661 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0661 [hypothetical protein...] - TP0513 [K+ transport protein...] (4,F) 
TP0661 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0661 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0661 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0661 [hypothetical protein...] - TP0587 [hypothetical protein...] (23,F) 
TP0661 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0661 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0661 [hypothetical protein...] - TP0660 [flagellar hook-assoc...] (4,F) 
TP0661 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0661 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0661 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0661 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0661 [hypothetical protein...] - TP0741 [conserved hypothetic...] (8,F) 
TP0661 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0661 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0661 [hypothetical protein...] - TP0803 [hypothetical protein...] (2,F) 
TP0661 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0661 [hypothetical protein...] - TP0932 [hypothetical protein...] (1,F) 
TP0661 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0661 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0661 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0661 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0661 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0662 [fructose-bisphosphat...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0662 [fructose-bisphosphat...] - TP0870 [flagellar filament 3...] (79,W) 
TP0662 [fructose-bisphosphat...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0662 [fructose-bisphosphat...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0663 [outer membrane prote...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0664 [flagellar filament o...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0664 [flagellar filament o...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0664 [flagellar filament o...] - TP0258 [conserved hypothetic...] (173,W) 
TP0664 [flagellar filament o...] - TP0764 [conserved hypothetic...] (139,W) 
TP0664 [flagellar filament o...] - TP0961 [flagellar basal-body...] (84,W) 
TP0664 [flagellar filament o...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0666 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0668 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0668 [conserved hypothetic...] - TP0751 [hypothetical protein...] (7,F) 
TP0668 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0669 [DNA polymerase III, ...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0669 [DNA polymerase III, ...] - TP0518 [conserved hypothetic...] (70,W) 
TP0670 [D-alanine--D-alanine...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0671 [sn-1,2-diacylglycero...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0673 [glutamyl-tRNA synthe...] - TP0258 [conserved hypothetic...] (173,W) 
TP0673 [glutamyl-tRNA synthe...] - TP0788 [hypothetical protein...] (132,W) 
TP0676 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0676 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0676 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0676 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0676 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0676 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0676 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0676 [hypothetical protein...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0679 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0679 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0679 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0679 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0679 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0679 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0679 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0679 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0679 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0679 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0686 [methylgalactoside AB...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0686 [methylgalactoside AB...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0687 [DNA recombinase (rec...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0687 [DNA recombinase (rec...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0687 [DNA recombinase (rec...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0688 [immunity protein (mc...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0688 [immunity protein (mc...] - TP0258 [conserved hypothetic...] (173,W) 
TP0688 [immunity protein (mc...] - TP0281 [hypothetical protein...] (64,W) 
TP0688 [immunity protein (mc...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0688 [immunity protein (mc...] - TP0618 [hypothetical protein...] (24,F) 
TP0688 [immunity protein (mc...] - TP0757 [polypeptide deformyl...] (36,F) 
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TP0688 [immunity protein (mc...] - TP0764 [conserved hypothetic...] (139,W) 
TP0688 [immunity protein (mc...] - TP0788 [hypothetical protein...] (132,W) 
TP0688 [immunity protein (mc...] - TP0974 [hypothetical protein...] (23,F) 
TP0688 [immunity protein (mc...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0688 [immunity protein (mc...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0690 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0691 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0691 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0691 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0691 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0691 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0693 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0694 [5,10-methenyltetrahy...] - TP0833 [hypothetical protein...] (34,F) 
TP0694 [5,10-methenyltetrahy...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0695 [phosphoribosylglycin...] - TP0661 [hypothetical protein...] (117,W) 
TP0695 [phosphoribosylglycin...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0696 [nicotinamidase, puta...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0699 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0699 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0699 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0699 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0699 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0700 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0700 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0700 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0700 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0700 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0700 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0700 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0700 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0700 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0702 [conserved hypothetic...] - TP0269 [conserved hypothetic...] (3,F) 
TP0702 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0706 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0706 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0706 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0706 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0708 [hypothetical protein...] - TP0036 [ABC transporter, per...] (1,F) 
TP0708 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0708 [hypothetical protein...] - TP0708 [hypothetical protein...] (13,F) 
TP0708 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0709 [RNA polymerase sigma...] - TP0974 [hypothetical protein...] (23,F) 
TP0711 [conserved hypothetic...] - TP0126 [hypothetical protein...] (1,F) 
TP0713 [flagellar-associated...] - TP0711 [conserved hypothetic...] (46,F) 
TP0713 [flagellar-associated...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0714 [flagellar biosynthes...] - TP0377 [conserved hypothetic...] (11,F) 
TP0714 [flagellar biosynthes...] - TP0708 [hypothetical protein...] (13,F) 
TP0715 [flagellar biosynthet...] - TP0561 [conserved hypothetic...] (44,F) 
TP0715 [flagellar biosynthet...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0716 [flagellar biosynthet...] - TP0561 [conserved hypothetic...] (44,F) 
TP0716 [flagellar biosynthet...] - TP0725 [flagellar motor rota...] (2,F) 
TP0716 [flagellar biosynthet...] - TP0774 [Mg2+ transport prote...] (2,F) 
TP0716 [flagellar biosynthet...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0717 [flagellar biosynthet...] - TP0561 [conserved hypothetic...] (44,F) 
TP0717 [flagellar biosynthet...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0719 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0720 [flagellar motor swit...] - TP0026 [flagellar motor swit...] (8,F) 
TP0720 [flagellar motor swit...] - TP0048 [conserved hypothetic...] (1,F) 
TP0720 [flagellar motor swit...] - TP0066 [hypothetical protein...] (11,F) 
TP0720 [flagellar motor swit...] - TP0088 [conserved hypothetic...] (8,F) 
TP0720 [flagellar motor swit...] - TP0100 [thioredoxin, putativ...] (3,F) 
TP0720 [flagellar motor swit...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0720 [flagellar motor swit...] - TP0193 [ribosomal protein S1...] (1,F) 
TP0720 [flagellar motor swit...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0720 [flagellar motor swit...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0720 [flagellar motor swit...] - TP0258 [conserved hypothetic...] (173,W) 
TP0720 [flagellar motor swit...] - TP0287 [conserved hypothetic...] (27,F) 
TP0720 [flagellar motor swit...] - TP0288 [spore coat polysacch...] (77,W) 
TP0720 [flagellar motor swit...] - TP0397 [flagellar basal-body...] (25,F) 
TP0720 [flagellar motor swit...] - TP0563 [hypothetical protein...] (93,W) 
TP0720 [flagellar motor swit...] - TP0579 [hypothetical protein...] (5,F) 
TP0720 [flagellar motor swit...] - TP0629 [hypothetical protein...] (6,F) 
TP0720 [flagellar motor swit...] - TP0660 [flagellar hook-assoc...] (4,F) 
TP0720 [flagellar motor swit...] - TP0700 [hypothetical protein...] (1,F) 
TP0720 [flagellar motor swit...] - TP0764 [conserved hypothetic...] (139,W) 
TP0720 [flagellar motor swit...] - TP0772 [hypothetical protein...] (3,F) 
TP0720 [flagellar motor swit...] - TP0782 [hypothetical protein...] (2,F) 
TP0720 [flagellar motor swit...] - TP0788 [hypothetical protein...] (132,W) 
TP0720 [flagellar motor swit...] - TP0832 [hypothetical protein...] (37,F) 
TP0720 [flagellar motor swit...] - TP0833 [hypothetical protein...] (34,F) 
TP0720 [flagellar motor swit...] - TP0843 [heat shock protein, ...] (3,F) 
TP0720 [flagellar motor swit...] - TP0870 [flagellar filament 3...] (79,W) 
TP0720 [flagellar motor swit...] - TP0907 [conserved hypothetic...] (110,W) 
TP0720 [flagellar motor swit...] - TP0961 [flagellar basal-body...] (84,W) 
TP0720 [flagellar motor swit...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0720 [flagellar motor swit...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0720 [flagellar motor swit...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0721 [flagellar motor swit...] - TP0026 [flagellar motor swit...] (8,F) 
TP0721 [flagellar motor swit...] - TP0066 [hypothetical protein...] (11,F) 
TP0721 [flagellar motor swit...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0721 [flagellar motor swit...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0722 [flagellar protein (f...] - TP0260 [hypothetical protein...] (5,F) 
TP0722 [flagellar protein (f...] - TP0561 [conserved hypothetic...] (44,F) 
TP0722 [flagellar protein (f...] - TP0832 [hypothetical protein...] (37,F) 
TP0722 [flagellar protein (f...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0724 [flagellar motor rota...] - TP0832 [hypothetical protein...] (37,F) 
TP0724 [flagellar motor rota...] - TP0961 [flagellar basal-body...] (84,W) 
TP0725 [flagellar motor rota...] - TP0725 [flagellar motor rota...] (2,F) 
TP0725 [flagellar motor rota...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0727 [flagellar hook prote...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0727 [flagellar hook prote...] - TP0292 [outer membrane prote...] (1,F) 
TP0728 [flagellar hook assem...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0728 [flagellar hook assem...] - TP0046 [hypothetical protein...] (18,F) 
TP0728 [flagellar hook assem...] - TP0050 [conserved hypothetic...] (10,F) 
TP0728 [flagellar hook assem...] - TP0100 [thioredoxin, putativ...] (3,F) 
TP0728 [flagellar hook assem...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0728 [flagellar hook assem...] - TP0258 [conserved hypothetic...] (173,W) 
TP0728 [flagellar hook assem...] - TP0396 [flagellar basal-body...] (15,F) 
TP0728 [flagellar hook assem...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0728 [flagellar hook assem...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0728 [flagellar hook assem...] - TP0563 [hypothetical protein...] (93,W) 
TP0728 [flagellar hook assem...] - TP0579 [hypothetical protein...] (5,F) 
TP0728 [flagellar hook assem...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0728 [flagellar hook assem...] - TP0629 [hypothetical protein...] (6,F) 
TP0728 [flagellar hook assem...] - TP0661 [hypothetical protein...] (117,W) 
TP0728 [flagellar hook assem...] - TP0726 [flagellar protein (f...] (7,F) 
TP0728 [flagellar hook assem...] - TP0727 [flagellar hook prote...] (5,F) 
TP0728 [flagellar hook assem...] - TP0764 [conserved hypothetic...] (139,W) 
TP0728 [flagellar hook assem...] - TP0788 [hypothetical protein...] (132,W) 
TP0728 [flagellar hook assem...] - TP0832 [hypothetical protein...] (37,F) 
TP0728 [flagellar hook assem...] - TP0870 [flagellar filament 3...] (79,W) 
TP0728 [flagellar hook assem...] - TP0907 [conserved hypothetic...] (110,W) 
TP0728 [flagellar hook assem...] - TP0961 [flagellar basal-body...] (84,W) 
TP0728 [flagellar hook assem...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0728 [flagellar hook assem...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0730 [conserved hypothetic...] - TP0067 [conserved hypothetic...] (19,F) 
TP0733 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0738 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0738 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0738 [conserved hypothetic...] - TP0067 [conserved hypothetic...] (19,F) 
TP0738 [conserved hypothetic...] - TP0078 [spore coat polysacch...] (2,F) 
TP0738 [conserved hypothetic...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0738 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0738 [conserved hypothetic...] - TP0097 [translation initiati...] (3,F) 
TP0738 [conserved hypothetic...] - TP0113 [Lambda CII stability...] (2,F) 
TP0738 [conserved hypothetic...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0738 [conserved hypothetic...] - TP0199 [ribosomal protein L1...] (1,F) 
TP0738 [conserved hypothetic...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0738 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0738 [conserved hypothetic...] - TP0255 [ribosomal protein L3...] (2,F) 
TP0738 [conserved hypothetic...] - TP0257 [glycerophosphodieste...] (3,F) 
TP0738 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0738 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0738 [conserved hypothetic...] - TP0286 [conserved hypothetic...] (9,F) 
TP0738 [conserved hypothetic...] - TP0334 [conserved hypothetic...] (5,F) 
TP0738 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0738 [conserved hypothetic...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0738 [conserved hypothetic...] - TP0359 [hypothetical protein...] (2,F) 
TP0738 [conserved hypothetic...] - TP0375 [hypothetical protein...] (1,F) 
TP0738 [conserved hypothetic...] - TP0393 [smf protein (smf) {B...] (1,F) 
TP0738 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0738 [conserved hypothetic...] - TP0408 [hypothetical protein...] (1,F) 
TP0738 [conserved hypothetic...] - TP0412 [conserved hypothetic...] (4,F) 
TP0738 [conserved hypothetic...] - TP0443 [conserved hypothetic...] (6,F) 
TP0738 [conserved hypothetic...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0738 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0738 [conserved hypothetic...] - TP0465 [hypothetical protein...] (7,F) 
TP0738 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0738 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0738 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0738 [conserved hypothetic...] - TP0552 [hypothetical protein...] (3,F) 
TP0738 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0738 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0738 [conserved hypothetic...] - TP0569 [aminopeptidase P {Ho...] (1,F) 
TP0738 [conserved hypothetic...] - TP0587 [hypothetical protein...] (23,F) 
TP0738 [conserved hypothetic...] - TP0607 [hypothetical protein...] (1,F) 
TP0738 [conserved hypothetic...] - TP0618 [hypothetical protein...] (24,F) 
TP0738 [conserved hypothetic...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0738 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0738 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0738 [conserved hypothetic...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0738 [conserved hypothetic...] - TP0711 [conserved hypothetic...] (46,F) 
TP0738 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0738 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0738 [conserved hypothetic...] - TP0773 [periplasmic serine p...] (30,F) 
TP0738 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0738 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0738 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0738 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0738 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
SUPPLEMENTARY INFORMATION 
 199 
TP0738 [conserved hypothetic...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0738 [conserved hypothetic...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0738 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0738 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0738 [conserved hypothetic...] - TP0981 [sensory transduction...] (5,F) 
TP0738 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0738 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0738 [conserved hypothetic...] - TP0997 [protease IV (sppA) {...] (8,F) 
TP0738 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0738 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0738 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0738 [conserved hypothetic...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0739 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0739 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0740 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0741 [conserved hypothetic...] - TP0046 [hypothetical protein...] (18,F) 
TP0741 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0741 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0741 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0743 [ribosomal protein L2...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0744 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0744 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0744 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0744 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0744 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0744 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0744 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0744 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0744 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0744 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0744 [conserved hypothetic...] - TP1020 [glu-tRNA amidotransf...] (2,F) 
TP0747 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0747 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0747 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0747 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0747 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0748 [cytoplasmic filament...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0751 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0751 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0751 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0751 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0751 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0751 [hypothetical protein...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0751 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0751 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0752 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0752 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0752 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0752 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0752 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0752 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0752 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0752 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0753 [hypothetical protein...] - TP0561 [conserved hypothetic...] (44,F) 
TP0753 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0754 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0754 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0754 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0755 [PTS system, nitrogen...] - TP0619 [hypothetical protein...] (2,F) 
TP0756 [methionyl-tRNA formy...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0756 [methionyl-tRNA formy...] - TP0258 [conserved hypothetic...] (173,W) 
TP0756 [methionyl-tRNA formy...] - TP0383 [conserved hypothetic...] (65,W) 
TP0756 [methionyl-tRNA formy...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0756 [methionyl-tRNA formy...] - TP0657 [carbon storage regul...] (1,F) 
TP0756 [methionyl-tRNA formy...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0756 [methionyl-tRNA formy...] - TP0764 [conserved hypothetic...] (139,W) 
TP0756 [methionyl-tRNA formy...] - TP0788 [hypothetical protein...] (132,W) 
TP0756 [methionyl-tRNA formy...] - TP0833 [hypothetical protein...] (34,F) 
TP0756 [methionyl-tRNA formy...] - TP0974 [hypothetical protein...] (23,F) 
TP0756 [methionyl-tRNA formy...] - TP0989 [P26 {Borrelia burgdo...] 
(180,W) 
TP0756 [methionyl-tRNA formy...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0756 [methionyl-tRNA formy...] - TP0995 [cyclic nucleotide bi...] (5,F) 
TP0756 [methionyl-tRNA formy...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0756 [methionyl-tRNA formy...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0757 [polypeptide deformyl...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0757 [polypeptide deformyl...] - TP0788 [hypothetical protein...] (132,W) 
TP0757 [polypeptide deformyl...] - TP0833 [hypothetical protein...] (34,F) 
TP0757 [polypeptide deformyl...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0759 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0760 [penicillin-binding p...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0761 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0763 [hypothetical protein...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0766 [hypothetical protein...] - TP0619 [hypothetical protein...] (2,F) 
TP0766 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0768 [membrane protein (tm...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0771 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0771 [conserved hypothetic...] - TP0522 [hypothetical protein...] (1,F) 
TP0772 [hypothetical protein...] - TP0017 [conserved hypothetic...] (1,F) 
TP0772 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0772 [hypothetical protein...] - TP0334 [conserved hypothetic...] (5,F) 
TP0772 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0772 [hypothetical protein...] - TP0396 [flagellar basal-body...] (15,F) 
TP0772 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0772 [hypothetical protein...] - TP0701 [DNA-directed RNA pol...] (3,F) 
TP0772 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0772 [hypothetical protein...] - TP0795 [hypothetical protein...] (4,F) 
TP0772 [hypothetical protein...] - TP0818 [hypothetical protein...] (2,F) 
TP0777 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0777 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0778 [beta-lactamase regul...] - TP0258 [conserved hypothetic...] (173,W) 
TP0778 [beta-lactamase regul...] - TP0907 [conserved hypothetic...] (110,W) 
TP0778 [beta-lactamase regul...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0778 [beta-lactamase regul...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0779 [dedA protein (dedA) ...] - TP0050 [conserved hypothetic...] (10,F) 
TP0779 [dedA protein (dedA) ...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0779 [dedA protein (dedA) ...] - TP0380 [DNA repair helicase,...] (5,F) 
TP0779 [dedA protein (dedA) ...] - TP0563 [hypothetical protein...] (93,W) 
TP0779 [dedA protein (dedA) ...] - TP0618 [hypothetical protein...] (24,F) 
TP0779 [dedA protein (dedA) ...] - TP0764 [conserved hypothetic...] (139,W) 
TP0779 [dedA protein (dedA) ...] - TP0832 [hypothetical protein...] (37,F) 
TP0779 [dedA protein (dedA) ...] - TP0833 [hypothetical protein...] (34,F) 
TP0779 [dedA protein (dedA) ...] - TP0907 [conserved hypothetic...] (110,W) 
TP0779 [dedA protein (dedA) ...] - TP0961 [flagellar basal-body...] (84,W) 
TP0782 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0782 [hypothetical protein...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0782 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0782 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0782 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0782 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0782 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0785 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0785 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0785 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0785 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0785 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0786 [ABC transporter, ATP...] - TP0258 [conserved hypothetic...] (173,W) 
TP0786 [ABC transporter, ATP...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0787 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0787 [hypothetical protein...] - TP0920 [hypothetical protein...] (7,F) 
TP0787 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0787 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0788 [hypothetical protein...] - TP0121 [conserved hypothetic...] (7,F) 
TP0789 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0789 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0789 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0790 [antibiotic transport...] - TP0518 [conserved hypothetic...] (70,W) 
TP0790 [antibiotic transport...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0790 [antibiotic transport...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0791 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0791 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0791 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0791 [hypothetical protein...] - TP0995 [cyclic nucleotide bi...] (5,F) 
TP0792 [flagellar filament 3...] - TP0064 [hypothetical, protei...] (8,F) 
TP0792 [flagellar filament 3...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0792 [flagellar filament 3...] - TP0658 [transmembrane protei...] (5,F) 
TP0792 [flagellar filament 3...] - TP0764 [conserved hypothetic...] (139,W) 
TP0792 [flagellar filament 3...] - TP0832 [hypothetical protein...] (37,F) 
TP0792 [flagellar filament 3...] - TP0961 [flagellar basal-body...] (84,W) 
TP0793 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0793 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0793 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0793 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0793 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0793 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0793 [hypothetical protein...] - TP1023 [recX protein (recX) ...] (13,F) 
TP0794 [S-adenosylmethionine...] - TP0002 [DNA polymerase III, ...] (4,F) 
TP0794 [S-adenosylmethionine...] - TP0046 [hypothetical protein...] (18,F) 
TP0794 [S-adenosylmethionine...] - TP0955 [hypothetical protein...] (1,F) 
TP0794 [S-adenosylmethionine...] - TP0961 [flagellar basal-body...] (84,W) 
TP0795 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0795 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0795 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0795 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0795 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0795 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0795 [hypothetical protein...] - TP0727 [flagellar hook prote...] (5,F) 
TP0795 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0795 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0795 [hypothetical protein...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0795 [hypothetical protein...] - TP0946 [glucose-inhibited di...] (19,F) 
TP0795 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0795 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0795 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0798 [methionyl-tRNA synth...] - TP0258 [conserved hypothetic...] (173,W) 
TP0798 [methionyl-tRNA synth...] - TP0281 [hypothetical protein...] (64,W) 
TP0798 [methionyl-tRNA synth...] - TP0288 [spore coat polysacch...] (77,W) 
TP0798 [methionyl-tRNA synth...] - TP0383 [conserved hypothetic...] (65,W) 
TP0798 [methionyl-tRNA synth...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0798 [methionyl-tRNA synth...] - TP0518 [conserved hypothetic...] (70,W) 
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TP0798 [methionyl-tRNA synth...] - TP0764 [conserved hypothetic...] (139,W) 
TP0798 [methionyl-tRNA synth...] - TP0965 [membrane fusion prot...] (14,F) 
TP0798 [methionyl-tRNA synth...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0798 [methionyl-tRNA synth...] - TP0992 [conserved hypothetic...] (1,F) 
TP0798 [methionyl-tRNA synth...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0798 [methionyl-tRNA synth...] - TP1004 [recombination protei...] (74,W) 
TP0800 [serine-type D-Ala-D-...] - TP0258 [conserved hypothetic...] (173,W) 
TP0800 [serine-type D-Ala-D-...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0802 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0802 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0802 [hypothetical protein...] - TP0286 [conserved hypothetic...] (9,F) 
TP0802 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0802 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0802 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0802 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0802 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0802 [hypothetical protein...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0802 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0802 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0802 [hypothetical protein...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0802 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0802 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0802 [hypothetical protein...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0802 [hypothetical protein...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0802 [hypothetical protein...] - TP0773 [periplasmic serine p...] (30,F) 
TP0803 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0803 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0803 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0803 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0803 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0803 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0803 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0803 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0803 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0803 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0804 [sugar ABC transporte...] - TP0044 [glucose inhibited di...] (3,F) 
TP0805 [exoribonuclease II (...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0805 [exoribonuclease II (...] - TP0258 [conserved hypothetic...] (173,W) 
TP0805 [exoribonuclease II (...] - TP0383 [conserved hypothetic...] (65,W) 
TP0805 [exoribonuclease II (...] - TP0518 [conserved hypothetic...] (70,W) 
TP0805 [exoribonuclease II (...] - TP0661 [hypothetical protein...] (117,W) 
TP0805 [exoribonuclease II (...] - TP0751 [hypothetical protein...] (7,F) 
TP0805 [exoribonuclease II (...] - TP0764 [conserved hypothetic...] (139,W) 
TP0805 [exoribonuclease II (...] - TP0788 [hypothetical protein...] (132,W) 
TP0805 [exoribonuclease II (...] - TP0813 [hypothetical protein...] (3,F) 
TP0805 [exoribonuclease II (...] - TP0833 [hypothetical protein...] (34,F) 
TP0805 [exoribonuclease II (...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0805 [exoribonuclease II (...] - TP1004 [recombination protei...] (74,W) 
TP0806 [femA protein, putati...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0806 [femA protein, putati...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0806 [femA protein, putati...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0807 [ribosomal protein L3...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0807 [ribosomal protein L3...] - TP0258 [conserved hypothetic...] (173,W) 
TP0807 [ribosomal protein L3...] - TP0281 [hypothetical protein...] (64,W) 
TP0807 [ribosomal protein L3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0807 [ribosomal protein L3...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0807 [ribosomal protein L3...] - TP0449 [hypothetical protein...] (51,W) 
TP0807 [ribosomal protein L3...] - TP0618 [hypothetical protein...] (24,F) 
TP0807 [ribosomal protein L3...] - TP0661 [hypothetical protein...] (117,W) 
TP0807 [ribosomal protein L3...] - TP0664 [flagellar filament o...] (34,F) 
TP0807 [ribosomal protein L3...] - TP0711 [conserved hypothetic...] (46,F) 
TP0807 [ribosomal protein L3...] - TP0773 [periplasmic serine p...] (30,F) 
TP0807 [ribosomal protein L3...] - TP0788 [hypothetical protein...] (132,W) 
TP0807 [ribosomal protein L3...] - TP0870 [flagellar filament 3...] (79,W) 
TP0807 [ribosomal protein L3...] - TP0907 [conserved hypothetic...] (110,W) 
TP0807 [ribosomal protein L3...] - TP0961 [flagellar basal-body...] (84,W) 
TP0807 [ribosomal protein L3...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0807 [ribosomal protein L3...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0807 [ribosomal protein L3...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0807 [ribosomal protein L3...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0809 [ribonuclease III (rn...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0809 [ribonuclease III (rn...] - TP0661 [hypothetical protein...] (117,W) 
TP0809 [ribonuclease III (rn...] - TP0711 [conserved hypothetic...] (46,F) 
TP0809 [ribonuclease III (rn...] - TP0870 [flagellar filament 3...] (79,W) 
TP0809 [ribonuclease III (rn...] - TP0961 [flagellar basal-body...] (84,W) 
TP0809 [ribonuclease III (rn...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0810 [DNA adenine methyltr...] - TP0258 [conserved hypothetic...] (173,W) 
TP0813 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0814 [thioredoxin reductas...] - TP0294 [phosphoribosyl pyrop...] (3,F) 
TP0814 [thioredoxin reductas...] - TP0362 [ribosomal protein L2...] (2,F) 
TP0814 [thioredoxin reductas...] - TP0661 [hypothetical protein...] (117,W) 
TP0814 [thioredoxin reductas...] - TP0773 [periplasmic serine p...] (30,F) 
TP0814 [thioredoxin reductas...] - TP0813 [hypothetical protein...] (3,F) 
TP0814 [thioredoxin reductas...] - TP0870 [flagellar filament 3...] (79,W) 
TP0814 [thioredoxin reductas...] - TP0961 [flagellar basal-body...] (84,W) 
TP0814 [thioredoxin reductas...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0814 [thioredoxin reductas...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0816 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0816 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0816 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0816 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0816 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0818 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0818 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0818 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0819 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0819 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0819 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0819 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0819 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0819 [conserved hypothetic...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0819 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0819 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0819 [conserved hypothetic...] - TP0399 [flagellar basal-body...] (2,F) 
TP0819 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0819 [conserved hypothetic...] - TP0512 [conserved hypothetic...] (1,F) 
TP0819 [conserved hypothetic...] - TP0513 [K+ transport protein...] (4,F) 
TP0819 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0819 [conserved hypothetic...] - TP0640 [methyl-accepting che...] (5,F) 
TP0819 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0819 [conserved hypothetic...] - TP0664 [flagellar filament o...] (34,F) 
TP0819 [conserved hypothetic...] - TP0670 [D-alanine--D-alanine...] (1,F) 
TP0819 [conserved hypothetic...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0819 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0819 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0819 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0819 [conserved hypothetic...] - TP0920 [hypothetical protein...] (7,F) 
TP0819 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0819 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0819 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0819 [conserved hypothetic...] - TP1002 [conserved hypothetic...] (1,F) 
TP0819 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0820 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0820 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0820 [hypothetical protein...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0820 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0820 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0820 [hypothetical protein...] - TP0463 [hypothetical protein...] (8,F) 
TP0820 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0820 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0823 [desulfoferrodoxin (r...] - TP1037 [hemolysin III (hlyII...] (1,F) 
TP0824 [transketolase B (tkt...] - TP0768 [membrane protein (tm...] (1,F) 
TP0824 [transketolase B (tkt...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0824 [transketolase B (tkt...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0826 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0826 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0826 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0826 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0826 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0826 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0826 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0826 [conserved hypothetic...] - TP1020 [glu-tRNA amidotransf...] (2,F) 
TP0827 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0827 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0827 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0829 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0829 [conserved hypothetic...] - TP0412 [conserved hypothetic...] (4,F) 
TP0829 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0829 [conserved hypothetic...] - TP0518 [conserved hypothetic...] (70,W) 
TP0829 [conserved hypothetic...] - TP0519 [response regulatory ...] (30,F) 
TP0829 [conserved hypothetic...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0829 [conserved hypothetic...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0829 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0829 [conserved hypothetic...] - TP0626 [exonuclease, putativ...] (12,F) 
TP0829 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0829 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0829 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0829 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0829 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0829 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0829 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0829 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0830 [pseudouridylate synt...] - TP0288 [spore coat polysacch...] (77,W) 
TP0830 [pseudouridylate synt...] - TP0907 [conserved hypothetic...] (110,W) 
TP0830 [pseudouridylate synt...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0830 [pseudouridylate synt...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0831 [arginyl-tRNA synthet...] - TP0788 [hypothetical protein...] (132,W) 
TP0831 [arginyl-tRNA synthet...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0831 [arginyl-tRNA synthet...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0833 [hypothetical protein...] - TP0024 [conserved hypothetic...] (16,F) 
TP0833 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0833 [hypothetical protein...] - TP0080 [quinoline 2-oxidored...] (13,F) 
TP0833 [hypothetical protein...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0833 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0833 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0833 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0833 [hypothetical protein...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0833 [hypothetical protein...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0833 [hypothetical protein...] - TP0559 [conserved hypothetic...] (26,F) 
TP0833 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
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TP0833 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP0833 [hypothetical protein...] - TP0664 [flagellar filament o...] (34,F) 
TP0833 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0833 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0833 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0833 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0833 [hypothetical protein...] - TP0943 [flagellar protein (f...] (15,F) 
TP0833 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0836 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0840 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0840 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0840 [conserved hypothetic...] - TP0397 [flagellar basal-body...] (25,F) 
TP0840 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0840 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0840 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0840 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0840 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0840 [conserved hypothetic...] - TP0894 [conserved hypothetic...] (13,F) 
TP0840 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0840 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0840 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0840 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0840 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0840 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0840 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0841 [periplasmic serine p...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0842 [methionine aminopept...] - TP0258 [conserved hypothetic...] (173,W) 
TP0842 [methionine aminopept...] - TP0294 [phosphoribosyl pyrop...] (3,F) 
TP0842 [methionine aminopept...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0842 [methionine aminopept...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0844 [glyceraldehyde 3-pho...] - TP0449 [hypothetical protein...] (51,W) 
TP0844 [glyceraldehyde 3-pho...] - TP0870 [flagellar filament 3...] (79,W) 
TP0845 [P23 protein, putativ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0845 [P23 protein, putativ...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0846 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0847 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0847 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0848 [ribosomal protein L2...] - TP0764 [conserved hypothetic...] (139,W) 
TP0849 [ribosomal protein L3...] - TP0258 [conserved hypothetic...] (173,W) 
TP0849 [ribosomal protein L3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0850 [translation initiati...] - TP0095 [hypothetical protein...] (15,F) 
TP0850 [translation initiati...] - TP0258 [conserved hypothetic...] (173,W) 
TP0850 [translation initiati...] - TP0449 [hypothetical protein...] (51,W) 
TP0850 [translation initiati...] - TP0661 [hypothetical protein...] (117,W) 
TP0850 [translation initiati...] - TP0664 [flagellar filament o...] (34,F) 
TP0850 [translation initiati...] - TP0788 [hypothetical protein...] (132,W) 
TP0850 [translation initiati...] - TP0870 [flagellar filament 3...] (79,W) 
TP0850 [translation initiati...] - TP0906 [conserved hypothetic...] (1,F) 
TP0850 [translation initiati...] - TP0907 [conserved hypothetic...] (110,W) 
TP0850 [translation initiati...] - TP0943 [flagellar protein (f...] (15,F) 
TP0850 [translation initiati...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0856 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0856 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0856 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0856 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0858 [hypothetical protein...] - TP0046 [hypothetical protein...] (18,F) 
TP0858 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0860 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0864 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0864 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0866 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0866 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0866 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0866 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0866 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0866 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0867 [hypothetical protein...] - TP0002 [DNA polymerase III, ...] (4,F) 
TP0868 [flagellar filament 3...] - TP0050 [conserved hypothetic...] (10,F) 
TP0868 [flagellar filament 3...] - TP0658 [transmembrane protei...] (5,F) 
TP0868 [flagellar filament 3...] - TP0832 [hypothetical protein...] (37,F) 
TP0869 [hypothetical protein...] - TP0124 [conserved hypothetic...] (1,F) 
TP0869 [hypothetical protein...] - TP0208 [preprotein transloca...] (2,F) 
TP0869 [hypothetical protein...] - TP0225 [leucine-rich repeat ...] (1,F) 
TP0869 [hypothetical protein...] - TP0701 [DNA-directed RNA pol...] (3,F) 
TP0870 [flagellar filament 3...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0870 [flagellar filament 3...] - TP0046 [hypothetical protein...] (18,F) 
TP0870 [flagellar filament 3...] - TP0050 [conserved hypothetic...] (10,F) 
TP0870 [flagellar filament 3...] - TP0053 [ribonucleoside-dipho...] (1,F) 
TP0870 [flagellar filament 3...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0870 [flagellar filament 3...] - TP0066 [hypothetical protein...] (11,F) 
TP0870 [flagellar filament 3...] - TP0174 [hypothetical protein...] (1,F) 
TP0870 [flagellar filament 3...] - TP0257 [glycerophosphodieste...] (3,F) 
TP0870 [flagellar filament 3...] - TP0258 [conserved hypothetic...] (173,W) 
TP0870 [flagellar filament 3...] - TP0288 [spore coat polysacch...] (77,W) 
TP0870 [flagellar filament 3...] - TP0383 [conserved hypothetic...] (65,W) 
TP0870 [flagellar filament 3...] - TP0396 [flagellar basal-body...] (15,F) 
TP0870 [flagellar filament 3...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0870 [flagellar filament 3...] - TP0518 [conserved hypothetic...] (70,W) 
TP0870 [flagellar filament 3...] - TP0563 [hypothetical protein...] (93,W) 
TP0870 [flagellar filament 3...] - TP0629 [hypothetical protein...] (6,F) 
TP0870 [flagellar filament 3...] - TP0630 [chemotaxis protein m...] (1,F) 
TP0870 [flagellar filament 3...] - TP0640 [methyl-accepting che...] (5,F) 
TP0870 [flagellar filament 3...] - TP0658 [transmembrane protei...] (5,F) 
TP0870 [flagellar filament 3...] - TP0661 [hypothetical protein...] (117,W) 
TP0870 [flagellar filament 3...] - TP0702 [conserved hypothetic...] (2,F) 
TP0870 [flagellar filament 3...] - TP0711 [conserved hypothetic...] (46,F) 
TP0870 [flagellar filament 3...] - TP0760 [penicillin-binding p...] (1,F) 
TP0870 [flagellar filament 3...] - TP0764 [conserved hypothetic...] (139,W) 
TP0870 [flagellar filament 3...] - TP0788 [hypothetical protein...] (132,W) 
TP0870 [flagellar filament 3...] - TP0832 [hypothetical protein...] (37,F) 
TP0870 [flagellar filament 3...] - TP0870 [flagellar filament 3...] (79,W) 
TP0870 [flagellar filament 3...] - TP0873 [hypothetical protein...] (1,F) 
TP0870 [flagellar filament 3...] - TP0907 [conserved hypothetic...] (110,W) 
TP0870 [flagellar filament 3...] - TP0943 [flagellar protein (f...] (15,F) 
TP0870 [flagellar filament 3...] - TP0961 [flagellar basal-body...] (84,W) 
TP0870 [flagellar filament 3...] - TP0981 [sensory transduction...] (5,F) 
TP0870 [flagellar filament 3...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0870 [flagellar filament 3...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0873 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0873 [hypothetical protein...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0873 [hypothetical protein...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0873 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0873 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0873 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0873 [hypothetical protein...] - TP0354 [thymidylate kinase (...] (8,F) 
TP0873 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0873 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0873 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0873 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0874 [conserved hypothetic...] - TP0463 [hypothetical protein...] (8,F) 
TP0874 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0875 [conserved hypothetic...] - TP0046 [hypothetical protein...] (18,F) 
TP0875 [conserved hypothetic...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0875 [conserved hypothetic...] - TP0240 [ribosomal protein L7...] (2,F) 
TP0875 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0875 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0875 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0876 [conserved hypothetic...] - TP0024 [conserved hypothetic...] (16,F) 
TP0876 [conserved hypothetic...] - TP0097 [translation initiati...] (3,F) 
TP0876 [conserved hypothetic...] - TP0121 [conserved hypothetic...] (7,F) 
TP0876 [conserved hypothetic...] - TP0247 [N-acetylmuramoyl-L-a...] (20,F) 
TP0876 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0876 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP0876 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0876 [conserved hypothetic...] - TP0586 [leucyl-tRNA syntheta...] (16,F) 
TP0876 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0876 [conserved hypothetic...] - TP0751 [hypothetical protein...] (7,F) 
TP0876 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0876 [conserved hypothetic...] - TP0803 [hypothetical protein...] (2,F) 
TP0876 [conserved hypothetic...] - TP0895 [hypothetical protein...] (3,F) 
TP0876 [conserved hypothetic...] - TP0943 [flagellar protein (f...] (15,F) 
TP0876 [conserved hypothetic...] - TP0974 [hypothetical protein...] (23,F) 
TP0876 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0876 [conserved hypothetic...] - TP0991 [rubredoxin {Clostrid...] (1,F) 
TP0876 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0876 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0876 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0877 [conserved hypothetic...] - TP0461 [hypothetical protein...] (3,F) 
TP0880 [membrane spanning pr...] - TP0833 [hypothetical protein...] (34,F) 
TP0881 [ABC transporter, ATP...] - TP0383 [conserved hypothetic...] (65,W) 
TP0881 [ABC transporter, ATP...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0881 [ABC transporter, ATP...] - TP0518 [conserved hypothetic...] (70,W) 
TP0881 [ABC transporter, ATP...] - TP0764 [conserved hypothetic...] (139,W) 
TP0881 [ABC transporter, ATP...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0881 [ABC transporter, ATP...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0881 [ABC transporter, ATP...] - TP1004 [recombination protei...] (74,W) 
TP0881 [ABC transporter, ATP...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0884 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0891 [translation initiati...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0893 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0895 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0895 [hypothetical protein...] - TP0236 [transcription antite...] (5,F) 
TP0895 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0895 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0895 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0895 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0895 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0895 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0896 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0896 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0897 [tpr protein K (tprK)...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0902 [carboxylesterase (es...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0064 [hypothetical, protei...] (8,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0092 [RNA polymerase sigma...] 
(10,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0100 [thioredoxin, putativ...] (3,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0288 [spore coat polysacch...] (77,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0396 [flagellar basal-body...] (15,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0563 [hypothetical protein...] (93,W) 
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TP0903 [UDP-N-acetylmuramoyl...] - TP0618 [hypothetical protein...] (24,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0661 [hypothetical protein...] (117,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0711 [conserved hypothetic...] (46,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0788 [hypothetical protein...] (132,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0832 [hypothetical protein...] (37,F) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0870 [flagellar filament 3...] (79,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0907 [conserved hypothetic...] 
(110,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0961 [flagellar basal-body...] (84,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0989 [P26 {Borrelia burgdo...] 
(180,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0903 [UDP-N-acetylmuramoyl...] - TP1019 [glu-tRNA amidotransf...] 
(65,W) 
TP0905 [ribosomal protein S1...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0905 [ribosomal protein S1...] - TP0236 [transcription antite...] (5,F) 
TP0905 [ribosomal protein S1...] - TP0258 [conserved hypothetic...] (173,W) 
TP0905 [ribosomal protein S1...] - TP0281 [hypothetical protein...] (64,W) 
TP0905 [ribosomal protein S1...] - TP0288 [spore coat polysacch...] (77,W) 
TP0905 [ribosomal protein S1...] - TP0518 [conserved hypothetic...] (70,W) 
TP0905 [ribosomal protein S1...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0905 [ribosomal protein S1...] - TP0618 [hypothetical protein...] (24,F) 
TP0905 [ribosomal protein S1...] - TP0961 [flagellar basal-body...] (84,W) 
TP0906 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0907 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0909 [ribosomal protein L1...] - TP0764 [conserved hypothetic...] (139,W) 
TP0909 [ribosomal protein L1...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0911 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0912 [conserved hypothetic...] - TP0704 [single-stranded-DNA-...] (12,F) 
TP0912 [conserved hypothetic...] - TP0833 [hypothetical protein...] (34,F) 
TP0912 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0913 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0913 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0913 [conserved hypothetic...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0914 [conserved hypothetic...] - TP0095 [hypothetical protein...] (15,F) 
TP0914 [conserved hypothetic...] - TP0214 [hypothetical protein...] (2,F) 
TP0914 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0914 [conserved hypothetic...] - TP0291 [hypothetical protein...] (1,F) 
TP0914 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP0914 [conserved hypothetic...] - TP0661 [hypothetical protein...] (117,W) 
TP0914 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0914 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0914 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0914 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0914 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0914 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0915 [conserved hypothetic...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0915 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0915 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0915 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0915 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0916 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0917 [Mg2+ transport prote...] - TP1016 [basic membrane prote...] (1,F) 
TP0918 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0918 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0921 [NADH oxidase {Strept...] - TP0726 [flagellar protein (f...] (7,F) 
TP0921 [NADH oxidase {Strept...] - TP0788 [hypothetical protein...] (132,W) 
TP0924 [tex protein (tex) {B...] - TP0833 [hypothetical protein...] (34,F) 
TP0924 [tex protein (tex) {B...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0925 [flavodoxin {Clostrid...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0926 [signal peptidase I, ...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0928 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0928 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0928 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0929 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0929 [hypothetical protein...] - TP0099 [uridylate kinase (sm...] (3,F) 
TP0929 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0929 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0929 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0929 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0929 [hypothetical protein...] - TP0396 [flagellar basal-body...] (15,F) 
TP0929 [hypothetical protein...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0929 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0929 [hypothetical protein...] - TP0463 [hypothetical protein...] (8,F) 
TP0929 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0929 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0929 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0929 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0929 [hypothetical protein...] - TP0870 [flagellar filament 3...] (79,W) 
TP0929 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0929 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0929 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0929 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0929 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0932 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0932 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0932 [hypothetical protein...] - TP0281 [hypothetical protein...] (64,W) 
TP0932 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0932 [hypothetical protein...] - TP0383 [conserved hypothetic...] (65,W) 
TP0932 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0932 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0932 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0932 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0932 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0932 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0932 [hypothetical protein...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0933 [UDP-N-acetylmuramoyl...] - TP0833 [hypothetical protein...] (34,F) 
TP0935 [N-acetylphosphinothr...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0936 [hemolysin, putative ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0937 [conserved hypothetic...] - TP0920 [hypothetical protein...] (7,F) 
TP0937 [conserved hypothetic...] - TP1009 [glycerol-3-phosphate...] (1,F) 
TP0939 [pyruvate oxidoreduct...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0939 [pyruvate oxidoreduct...] - TP0258 [conserved hypothetic...] (173,W) 
TP0939 [pyruvate oxidoreduct...] - TP0281 [hypothetical protein...] (64,W) 
TP0939 [pyruvate oxidoreduct...] - TP0288 [spore coat polysacch...] (77,W) 
TP0939 [pyruvate oxidoreduct...] - TP0396 [flagellar basal-body...] (15,F) 
TP0939 [pyruvate oxidoreduct...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0939 [pyruvate oxidoreduct...] - TP0449 [hypothetical protein...] (51,W) 
TP0939 [pyruvate oxidoreduct...] - TP0518 [conserved hypothetic...] (70,W) 
TP0939 [pyruvate oxidoreduct...] - TP0563 [hypothetical protein...] (93,W) 
TP0939 [pyruvate oxidoreduct...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0939 [pyruvate oxidoreduct...] - TP0764 [conserved hypothetic...] (139,W) 
TP0939 [pyruvate oxidoreduct...] - TP0907 [conserved hypothetic...] (110,W) 
TP0939 [pyruvate oxidoreduct...] - TP0961 [flagellar basal-body...] (84,W) 
TP0939 [pyruvate oxidoreduct...] - TP0965 [membrane fusion prot...] (14,F) 
TP0939 [pyruvate oxidoreduct...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0939 [pyruvate oxidoreduct...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0939 [pyruvate oxidoreduct...] - TP1004 [recombination protei...] (74,W) 
TP0939 [pyruvate oxidoreduct...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0940 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0940 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0940 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0940 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0940 [hypothetical protein...] - TP0788 [hypothetical protein...] (132,W) 
TP0940 [hypothetical protein...] - TP0833 [hypothetical protein...] (34,F) 
TP0940 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0940 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0940 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0940 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0940 [hypothetical protein...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0940 [hypothetical protein...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0940 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0941 [hypothetical protein...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0941 [hypothetical protein...] - TP0233 [anti-sigma F factor ...] (13,F) 
TP0941 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0941 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0941 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0941 [hypothetical protein...] - TP0618 [hypothetical protein...] (24,F) 
TP0941 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0941 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0941 [hypothetical protein...] - TP0974 [hypothetical protein...] (23,F) 
TP0941 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0941 [hypothetical protein...] - TP1013 [chaperonin (groES) {...] (14,F) 
TP0943 [flagellar protein (f...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0943 [flagellar protein (f...] - TP0197 [ribosomal protein L2...] (15,F) 
TP0943 [flagellar protein (f...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0943 [flagellar protein (f...] - TP0258 [conserved hypothetic...] (173,W) 
TP0943 [flagellar protein (f...] - TP0383 [conserved hypothetic...] (65,W) 
TP0943 [flagellar protein (f...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0943 [flagellar protein (f...] - TP0660 [flagellar hook-assoc...] (4,F) 
TP0943 [flagellar protein (f...] - TP0661 [hypothetical protein...] (117,W) 
TP0943 [flagellar protein (f...] - TP0788 [hypothetical protein...] (132,W) 
TP0943 [flagellar protein (f...] - TP0870 [flagellar filament 3...] (79,W) 
TP0943 [flagellar protein (f...] - TP0907 [conserved hypothetic...] (110,W) 
TP0943 [flagellar protein (f...] - TP0943 [flagellar protein (f...] (15,F) 
TP0943 [flagellar protein (f...] - TP0945 [ribulose-phosphate 3...] (21,F) 
TP0943 [flagellar protein (f...] - TP0961 [flagellar basal-body...] (84,W) 
TP0943 [flagellar protein (f...] - TP0974 [hypothetical protein...] (23,F) 
TP0943 [flagellar protein (f...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0943 [flagellar protein (f...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0944 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0945 [ribulose-phosphate 3...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0946 [glucose-inhibited di...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0946 [glucose-inhibited di...] - TP0258 [conserved hypothetic...] (173,W) 
TP0946 [glucose-inhibited di...] - TP0288 [spore coat polysacch...] (77,W) 
TP0946 [glucose-inhibited di...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0946 [glucose-inhibited di...] - TP0661 [hypothetical protein...] (117,W) 
TP0946 [glucose-inhibited di...] - TP0870 [flagellar filament 3...] (79,W) 
TP0946 [glucose-inhibited di...] - TP0961 [flagellar basal-body...] (84,W) 
TP0946 [glucose-inhibited di...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0946 [glucose-inhibited di...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0281 [hypothetical protein...] (64,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0563 [hypothetical protein...] (93,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0618 [hypothetical protein...] (24,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0661 [hypothetical protein...] (117,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0664 [flagellar filament o...] (34,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0684 [methylgalactoside AB...] (15,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0727 [flagellar hook prote...] (5,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0757 [polypeptide deformyl...] (36,F) 
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TP0947 [peptidyl-prolyl cis-...] - TP0788 [hypothetical protein...] (132,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0833 [hypothetical protein...] (34,F) 
TP0947 [peptidyl-prolyl cis-...] - TP0870 [flagellar filament 3...] (79,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0907 [conserved hypothetic...] (110,W) 
TP0947 [peptidyl-prolyl cis-...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0948 [spoIIIJ-associated p...] - TP0463 [hypothetical protein...] (8,F) 
TP0948 [spoIIIJ-associated p...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0953 [pheromone shutdown p...] - TP0989 [P26 {Borrelia burgdo...] 
(180,W) 
TP0953 [pheromone shutdown p...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0954 [conserved hypothetic...] - TP0044 [glucose inhibited di...] (3,F) 
TP0956 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0957 [Tp33 protein {Trepon...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0958 [dicarboxylate transp...] - TP0833 [hypothetical protein...] (34,F) 
TP0958 [dicarboxylate transp...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0959 [hypothetical protein...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0959 [hypothetical protein...] - TP0046 [hypothetical protein...] (18,F) 
TP0959 [hypothetical protein...] - TP0088 [conserved hypothetic...] (8,F) 
TP0959 [hypothetical protein...] - TP0162 [Holliday junction DN...] (3,F) 
TP0959 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0959 [hypothetical protein...] - TP0260 [hypothetical protein...] (5,F) 
TP0959 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0959 [hypothetical protein...] - TP0467 [hypothetical protein...] (2,F) 
TP0959 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0959 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0959 [hypothetical protein...] - TP0832 [hypothetical protein...] (37,F) 
TP0959 [hypothetical protein...] - TP0907 [conserved hypothetic...] (110,W) 
TP0959 [hypothetical protein...] - TP0961 [flagellar basal-body...] (84,W) 
TP0959 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0959 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0960 [flagellar basal-body...] - TP0832 [hypothetical protein...] (37,F) 
TP0961 [flagellar basal-body...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0961 [flagellar basal-body...] - TP0024 [conserved hypothetic...] (16,F) 
TP0961 [flagellar basal-body...] - TP0026 [flagellar motor swit...] (8,F) 
TP0961 [flagellar basal-body...] - TP0050 [conserved hypothetic...] (10,F) 
TP0961 [flagellar basal-body...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0961 [flagellar basal-body...] - TP0236 [transcription antite...] (5,F) 
TP0961 [flagellar basal-body...] - TP0287 [conserved hypothetic...] (27,F) 
TP0961 [flagellar basal-body...] - TP0288 [spore coat polysacch...] (77,W) 
TP0961 [flagellar basal-body...] - TP0314 [hypothetical protein...] (2,F) 
TP0961 [flagellar basal-body...] - TP0341 [UDP-N-acetylmuramate...] (12,F) 
TP0961 [flagellar basal-body...] - TP0397 [flagellar basal-body...] (25,F) 
TP0961 [flagellar basal-body...] - TP0664 [flagellar filament o...] (34,F) 
TP0961 [flagellar basal-body...] - TP0726 [flagellar protein (f...] (7,F) 
TP0961 [flagellar basal-body...] - TP0751 [hypothetical protein...] (7,F) 
TP0961 [flagellar basal-body...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0961 [flagellar basal-body...] - TP0764 [conserved hypothetic...] (139,W) 
TP0961 [flagellar basal-body...] - TP0772 [hypothetical protein...] (3,F) 
TP0961 [flagellar basal-body...] - TP0773 [periplasmic serine p...] (30,F) 
TP0961 [flagellar basal-body...] - TP0782 [hypothetical protein...] (2,F) 
TP0961 [flagellar basal-body...] - TP0788 [hypothetical protein...] (132,W) 
TP0961 [flagellar basal-body...] - TP0832 [hypothetical protein...] (37,F) 
TP0961 [flagellar basal-body...] - TP0870 [flagellar filament 3...] (79,W) 
TP0961 [flagellar basal-body...] - TP0877 [conserved hypothetic...] (4,F) 
TP0961 [flagellar basal-body...] - TP0907 [conserved hypothetic...] (110,W) 
TP0961 [flagellar basal-body...] - TP0911 [conserved hypothetic...] (1,F) 
TP0961 [flagellar basal-body...] - TP0961 [flagellar basal-body...] (84,W) 
TP0961 [flagellar basal-body...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0961 [flagellar basal-body...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0962 [conserved hypothetic...] - TP0209 [ribosomal protein L3...] (27,F) 
TP0962 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0962 [conserved hypothetic...] - TP0281 [hypothetical protein...] (64,W) 
TP0962 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0962 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0962 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0962 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0962 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0963 [conserved hypothetic...] - TP0383 [conserved hypothetic...] (65,W) 
TP0963 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0963 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0963 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0963 [conserved hypothetic...] - TP0965 [membrane fusion prot...] (14,F) 
TP0963 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0963 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0965 [membrane fusion prot...] - TP0514 [excinuclease ABC, su...] (7,F) 
TP0965 [membrane fusion prot...] - TP0563 [hypothetical protein...] (93,W) 
TP0965 [membrane fusion prot...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0966 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0968 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0968 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0968 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0968 [hypothetical protein...] - TP1004 [recombination protei...] (74,W) 
TP0969 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP0969 [hypothetical protein...] - TP0288 [spore coat polysacch...] (77,W) 
TP0969 [hypothetical protein...] - TP0518 [conserved hypothetic...] (70,W) 
TP0969 [hypothetical protein...] - TP0563 [hypothetical protein...] (93,W) 
TP0969 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0969 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0969 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0969 [hypothetical protein...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0971 [membrane antigen, pa...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP0973 [phenylalanyl-tRNA sy...] - TP0764 [conserved hypothetic...] (139,W) 
TP0973 [phenylalanyl-tRNA sy...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0974 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0976 [hypothetical protein...] - TP0432 [hypothetical protein...] (2,F) 
TP0976 [hypothetical protein...] - TP0701 [DNA-directed RNA pol...] (3,F) 
TP0976 [hypothetical protein...] - TP0764 [conserved hypothetic...] (139,W) 
TP0976 [hypothetical protein...] - TP0799 [hypothetical protein...] (2,F) 
TP0976 [hypothetical protein...] - TP0876 [conserved hypothetic...] (1,F) 
TP0978 [signal peptidase II ...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0978 [signal peptidase II ...] - TP0258 [conserved hypothetic...] (173,W) 
TP0978 [signal peptidase II ...] - TP0377 [conserved hypothetic...] (11,F) 
TP0978 [signal peptidase II ...] - TP0907 [conserved hypothetic...] (110,W) 
TP0978 [signal peptidase II ...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0978 [signal peptidase II ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0978 [signal peptidase II ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0981 [sensory transduction...] - TP0005 [DNA gyrase, subunit ...] (9,F) 
TP0981 [sensory transduction...] - TP0046 [hypothetical protein...] (18,F) 
TP0981 [sensory transduction...] - TP0061 [ribosomal protein S1...] (1,F) 
TP0981 [sensory transduction...] - TP0064 [hypothetical, protei...] (8,F) 
TP0981 [sensory transduction...] - TP0089 [cyclic nucleotide bi...] (1,F) 
TP0981 [sensory transduction...] - TP0092 [RNA polymerase sigma...] (10,F) 
TP0981 [sensory transduction...] - TP0160 [prolyl-tRNA syntheta...] (15,F) 
TP0981 [sensory transduction...] - TP0258 [conserved hypothetic...] (173,W) 
TP0981 [sensory transduction...] - TP0288 [spore coat polysacch...] (77,W) 
TP0981 [sensory transduction...] - TP0396 [flagellar basal-body...] (15,F) 
TP0981 [sensory transduction...] - TP0530 [V-type ATPase, subun...] (19,F) 
TP0981 [sensory transduction...] - TP0563 [hypothetical protein...] (93,W) 
TP0981 [sensory transduction...] - TP0661 [hypothetical protein...] (117,W) 
TP0981 [sensory transduction...] - TP0764 [conserved hypothetic...] (139,W) 
TP0981 [sensory transduction...] - TP0832 [hypothetical protein...] (37,F) 
TP0981 [sensory transduction...] - TP0843 [heat shock protein, ...] (3,F) 
TP0981 [sensory transduction...] - TP0870 [flagellar filament 3...] (79,W) 
TP0981 [sensory transduction...] - TP0877 [conserved hypothetic...] (4,F) 
TP0981 [sensory transduction...] - TP0907 [conserved hypothetic...] (110,W) 
TP0981 [sensory transduction...] - TP0961 [flagellar basal-body...] (84,W) 
TP0981 [sensory transduction...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0981 [sensory transduction...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0981 [sensory transduction...] - TP1004 [recombination protei...] (74,W) 
TP0981 [sensory transduction...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP0981 [sensory transduction...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0982 [glpG protein, putati...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0983 [hypothetical protein...] - TP0445 [4-methyl-5(b-hydroxy...] (30,F) 
TP0983 [hypothetical protein...] - TP0449 [hypothetical protein...] (51,W) 
TP0983 [hypothetical protein...] - TP0519 [response regulatory ...] (30,F) 
TP0983 [hypothetical protein...] - TP0711 [conserved hypothetic...] (46,F) 
TP0983 [hypothetical protein...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0983 [hypothetical protein...] - TP1008 [ribonucleoside-dipho...] (2,F) 
TP0984 [heat shock protein 9...] - TP0060 [ribosomal protein L9...] (78,W) 
TP0984 [heat shock protein 9...] - TP0258 [conserved hypothetic...] (173,W) 
TP0984 [heat shock protein 9...] - TP0288 [spore coat polysacch...] (77,W) 
TP0984 [heat shock protein 9...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0984 [heat shock protein 9...] - TP0563 [hypothetical protein...] (93,W) 
TP0984 [heat shock protein 9...] - TP0907 [conserved hypothetic...] (110,W) 
TP0984 [heat shock protein 9...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0984 [heat shock protein 9...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0984 [heat shock protein 9...] - TP1004 [recombination protei...] (74,W) 
TP0984 [heat shock protein 9...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0258 [conserved hypothetic...] (173,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0281 [hypothetical protein...] (64,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0383 [conserved hypothetic...] (65,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0398 [flagellar hook-basal...] (114,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0518 [conserved hypothetic...] (70,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0554 [phosphoglycolate pho...] (33,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0561 [conserved hypothetic...] (44,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0618 [hypothetical protein...] (24,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0661 [hypothetical protein...] (117,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0664 [flagellar filament o...] (34,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0711 [conserved hypothetic...] (46,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0735 [glutamate synthase (...] (2,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0757 [polypeptide deformyl...] (36,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0764 [conserved hypothetic...] (139,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0773 [periplasmic serine p...] (30,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0788 [hypothetical protein...] (132,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0833 [hypothetical protein...] (34,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0907 [conserved hypothetic...] (110,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0939 [pyruvate oxidoreduct...] (12,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0965 [membrane fusion prot...] (14,F) 
TP0985 [aspartyl-tRNA synthe...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0985 [aspartyl-tRNA synthe...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP0985 [aspartyl-tRNA synthe...] - TP1004 [recombination protei...] (74,W) 
TP0985 [aspartyl-tRNA synthe...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP0986 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP0986 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP0986 [conserved hypothetic...] - TP0925 [flavodoxin {Clostrid...] (1,F) 
TP0986 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP0986 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP0988 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP0988 [conserved hypothetic...] - TP0676 [hypothetical protein...] (2,F) 
TP0989 [P26 {Borrelia burgdo...] - TP0398 [flagellar hook-basal...] (114,W) 
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TP0989 [P26 {Borrelia burgdo...] - TP0518 [conserved hypothetic...] (70,W) 
TP0989 [P26 {Borrelia burgdo...] - TP0764 [conserved hypothetic...] (139,W) 
TP0989 [P26 {Borrelia burgdo...] - TP0907 [conserved hypothetic...] (110,W) 
TP0991 [rubredoxin {Clostrid...] - TP0907 [conserved hypothetic...] (110,W) 
TP0991 [rubredoxin {Clostrid...] - TP1004 [recombination protei...] (74,W) 
TP0992 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP0992 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0992 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP0992 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP0994 [conserved hypothetic...] - TP0287 [conserved hypothetic...] (27,F) 
TP0994 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP0994 [conserved hypothetic...] - TP0579 [hypothetical protein...] (5,F) 
TP0994 [conserved hypothetic...] - TP0622 [hypothetical protein...] (1,F) 
TP0994 [conserved hypothetic...] - TP0631 [protein-glutamate me...] (1,F) 
TP0994 [conserved hypothetic...] - TP0763 [hypothetical protein...] (2,F) 
TP0994 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP0994 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP0994 [conserved hypothetic...] - TP0976 [hypothetical protein...] (1,F) 
TP0994 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1002 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP1002 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP1002 [conserved hypothetic...] - TP0757 [polypeptide deformyl...] (36,F) 
TP1002 [conserved hypothetic...] - TP0788 [hypothetical protein...] (132,W) 
TP1002 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP1002 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP1002 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1002 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1004 [recombination protei...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1004 [recombination protei...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1005 [DNA polymerase III, ...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP1005 [DNA polymerase III, ...] - TP0661 [hypothetical protein...] (117,W) 
TP1005 [DNA polymerase III, ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1005 [DNA polymerase III, ...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1005 [DNA polymerase III, ...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP1006 [DNA gyrase, subunit ...] - TP0004 [hypothetical protein...] (2,F) 
TP1006 [DNA gyrase, subunit ...] - TP0764 [conserved hypothetic...] (139,W) 
TP1007 [thymidylate synthase...] - TP0060 [ribosomal protein L9...] (78,W) 
TP1007 [thymidylate synthase...] - TP0398 [flagellar hook-basal...] (114,W) 
TP1007 [thymidylate synthase...] - TP0563 [hypothetical protein...] (93,W) 
TP1007 [thymidylate synthase...] - TP0788 [hypothetical protein...] (132,W) 
TP1007 [thymidylate synthase...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1007 [thymidylate synthase...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1010 [nucleoside-diphospha...] - TP0060 [ribosomal protein L9...] (78,W) 
TP1010 [nucleoside-diphospha...] - TP0258 [conserved hypothetic...] (173,W) 
TP1010 [nucleoside-diphospha...] - TP0383 [conserved hypothetic...] (65,W) 
TP1010 [nucleoside-diphospha...] - TP0563 [hypothetical protein...] (93,W) 
TP1010 [nucleoside-diphospha...] - TP0788 [hypothetical protein...] (132,W) 
TP1011 [peptidyl-tRNA hydrol...] - TP0258 [conserved hypothetic...] (173,W) 
TP1011 [peptidyl-tRNA hydrol...] - TP0764 [conserved hypothetic...] (139,W) 
TP1011 [peptidyl-tRNA hydrol...] - TP0788 [hypothetical protein...] (132,W) 
TP1011 [peptidyl-tRNA hydrol...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1013 [chaperonin (groES) {...] - TP0463 [hypothetical protein...] (8,F) 
TP1017 [alanyl-tRNA syntheta...] - TP0004 [hypothetical protein...] (2,F) 
TP1018 [conserved hypothetic...] - TP0154 [conserved hypothetic...] (1,F) 
TP1018 [conserved hypothetic...] - TP0422 [hypothetical protein...] (1,F) 
TP1018 [conserved hypothetic...] - TP0506 [trigger factor (tig)...] (1,F) 
TP1018 [conserved hypothetic...] - TP0702 [conserved hypothetic...] (2,F) 
TP1018 [conserved hypothetic...] - TP0956 [hypothetical protein...] (1,F) 
TP1018 [conserved hypothetic...] - TP1040 [lysyl-tRNA synthetas...] (2,F) 
TP1020 [glu-tRNA amidotransf...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1023 [recX protein (recX) ...] - TP0518 [conserved hypothetic...] (70,W) 
TP1023 [recX protein (recX) ...] - TP0563 [hypothetical protein...] (93,W) 
TP1023 [recX protein (recX) ...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1024 [ribosomal protein S9...] - TP0059 [hypothetical protein...] (21,F) 
TP1024 [ribosomal protein S9...] - TP0060 [ribosomal protein L9...] (78,W) 
TP1024 [ribosomal protein S9...] - TP0258 [conserved hypothetic...] (173,W) 
TP1024 [ribosomal protein S9...] - TP0398 [flagellar hook-basal...] (114,W) 
TP1024 [ribosomal protein S9...] - TP0743 [ribosomal protein L2...] (2,F) 
TP1024 [ribosomal protein S9...] - TP0764 [conserved hypothetic...] (139,W) 
TP1024 [ribosomal protein S9...] - TP0894 [conserved hypothetic...] (13,F) 
TP1024 [ribosomal protein S9...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1024 [ribosomal protein S9...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1024 [ribosomal protein S9...] - TP1004 [recombination protei...] (74,W) 
TP1032 [hypothetical protein...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP1032 [hypothetical protein...] - TP0258 [conserved hypothetic...] (173,W) 
TP1032 [hypothetical protein...] - TP0661 [hypothetical protein...] (117,W) 
TP1032 [hypothetical protein...] - TP0795 [hypothetical protein...] (4,F) 
TP1032 [hypothetical protein...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1033 [conserved hypothetic...] - TP0119 [amino acid ABC trans...] (1,F) 
TP1033 [conserved hypothetic...] - TP0175 [hypothetical protein...] (1,F) 
TP1033 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP1033 [conserved hypothetic...] - TP0288 [spore coat polysacch...] (77,W) 
TP1033 [conserved hypothetic...] - TP0398 [flagellar hook-basal...] (114,W) 
TP1033 [conserved hypothetic...] - TP0449 [hypothetical protein...] (51,W) 
TP1033 [conserved hypothetic...] - TP0563 [hypothetical protein...] (93,W) 
TP1033 [conserved hypothetic...] - TP0764 [conserved hypothetic...] (139,W) 
TP1033 [conserved hypothetic...] - TP0870 [flagellar filament 3...] (79,W) 
TP1033 [conserved hypothetic...] - TP0907 [conserved hypothetic...] (110,W) 
TP1033 [conserved hypothetic...] - TP0961 [flagellar basal-body...] (84,W) 
TP1033 [conserved hypothetic...] - TP0989 [P26 {Borrelia burgdo...] (180,W) 
TP1033 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1033 [conserved hypothetic...] - TP1004 [recombination protei...] (74,W) 
TP1033 [conserved hypothetic...] - TP1005 [DNA polymerase III, ...] (44,F) 
TP1033 [conserved hypothetic...] - TP1019 [glu-tRNA amidotransf...] (65,W) 
TP1034 [conserved hypothetic...] - TP0043 [soluble lytic transg...] (1,F) 
TP1034 [conserved hypothetic...] - TP0240 [ribosomal protein L7...] (2,F) 
TP1034 [conserved hypothetic...] - TP0258 [conserved hypothetic...] (173,W) 
TP1034 [conserved hypothetic...] - TP0269 [conserved hypothetic...] (3,F) 
TP1034 [conserved hypothetic...] - TP0332 [hypothetical protein...] (1,F) 
TP1034 [conserved hypothetic...] - TP0561 [conserved hypothetic...] (44,F) 
TP1034 [conserved hypothetic...] - TP0842 [methionine aminopept...] (3,F) 
TP1034 [conserved hypothetic...] - TP0903 [UDP-N-acetylmuramoyl...] (1,F) 
TP1034 [conserved hypothetic...] - TP0917 [Mg2+ transport prote...] (49,F) 
TP1034 [conserved hypothetic...] - TP0993 [rare lipoprotein A, ...] (285,W) 
TP1037 [hemolysin III (hlyII...] - TP0281 [hypothetical protein...] (64,W) 
TP1037 [hemolysin III (hlyII...] - TP0398 [flagellar hook-basal...] (114,W) 
TP1037 [hemolysin III (hlyII...] - TP0661 [hypothetical protein...] (117,W) 
TP1037 [hemolysin III (hlyII...] - TP0764 [conserved hypothetic...] (139,W) 
TP1038 [bacterioferrin (TpF1...] - TP0171 [lipoprotein, 15 kDa ...] (17,F) 
TP1038 [bacterioferrin (TpF1...] - TP0302 [conserved hypothetic...] (1,F) 
TP1038 [bacterioferrin (TpF1...] - TP0795 [hypothetical protein...] (4,F)
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Supplementary Table 3 PPI-links between predicted (PSORT2.0) subcellular locations 
Location A Location B Z-Value Number of  
Interactions 
CytoplasmicMembrane CytoplasmicMembrane 10.1 53 
Cytoplasmic Cytoplasmic 2.8 359 
OuterMembrane Unknown (Multiple Locations) 1.4 1 
OuterMembrane Unknown 1.3 13 
Periplasmic Unknown 1.1 38 
CytoplasmicMembrane Extracellular 1.0 1 
Unknown Unknown 0.9 264 
OuterMembrane Periplasmic 0.5 1 
Cytoplasmic Periplasmic 0.3 40 
Unknown Unknown (Multiple Locations) 0.3 13 
Periplasmic Unknown (Multiple Locations) 0.1 1 
CytoplasmicMembrane Unknown (Multiple Locations) 0.1 3 
Extracellular Unknown -0.1 2 
Cytoplasmic Extracellular -0.2 2 
Cytoplasmic Unknown -0.3 584 
Cytoplasmic OuterMembrane -0.5 11 
Cytoplasmic Unknown (Multiple Locations) -0.6 12 
CytoplasmicMembrane Periplasmic -1.7 5 
CytoplasmicMembrane Unknown -2.3 123 
Cytoplasmic CytoplasmicMembrane -5.2 107 
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Supplementary Table 4 TPA interactions vs. predicted interologs. 
# bait description prey description interologs TPA 
dataset 
compared 
with 
orthology 
1 TP0025 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP1040 lysyl-tRNA 
synthetase (lysS) 
{Escherichia 
coli} 
CJ0401-CJ0463  filtered CJE all MBGD 
     B1494-B2890 B2821-
B2890  
filtered ECO II SAI MBGD 
     B1494-B2890 B2890-
B2821  
filtered ECO II SPK MBGD 
2 TP0030 heat shock protein 
(groEL) 
{Treponema 
pallidum} 
TP0160 prolyl-tRNA 
synthetase 
(proS) 
{Escherichia 
coli} 
B0194-B4143  filtered ECO II SPK MBGD 
     B0194-B4143  filtered ECO II SPK COG 
3 TP0030 heat shock protein 
(groEL) 
{Treponema 
pallidum} 
TP0946 glucose-inhibited 
division protein 
B (gidB) 
{Escherichia 
coli} 
CJ1221-CJ0997  filtered CJE all COG 
     CJ1221-CJ0997  filtered CJE all MBGD 
     CJ1221-CJ0997  filtered CJE HCF COG 
     CJ1221-CJ0997  filtered CJE HCF MBGD 
4 TP0048 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
pallidum}   
HP1542-HP0601  all HPY MBGD 
     HP1542-HP0601  all HPY COG 
5 TP0058 replicative DNA 
helicase (dnaB) 
{Bacillus subtilis} 
TP0092 RNA 
polymerase 
sigma factor E 
(rpoE) 
{Mycobacterium 
leprae} 
B2573-B4052  filtered ECO II SPK MBGD 
     B2573-B4052  filtered ECO II SPK COG 
6 TP0068 conserved 
hypothetical protein 
{Synechocystis 
PCC6803} 
TP1005 DNA 
polymerase III, 
subunits gamma 
and tau (dnaH) 
{Borrelia 
burgdorferi} 
CJ1157-CJ1713  filtered CJE all COG 
     CJ1157-CJ1713  filtered CJE all MBGD 
7 TP0094 phosphate 
acetyltransferase 
(pta) 
{Methanosarcina 
thermophila} 
TP0067 conserved 
hypothetical 
protein {Borrelia 
burgdorferi} 
B2463-B3530  filtered ECO II SAI COG 
     B3530-B2463  filtered ECO II SPK COG 
8 TP0094 phosphate 
acetyltransferase 
(pta) 
{Methanosarcina 
thermophila} 
TP0519 response 
regulatory 
protein (atoC) 
{Borrelia 
burgdorferi} 
B2297-B2731  filtered ECO II SAI MBGD 
9 TP0094 phosphate 
acetyltransferase 
(pta) 
{Methanosarcina 
thermophila} 
TP0920 hypothetical 
protein 
B2463-B3530  filtered ECO II SAI COG 
     B3530-B2463  filtered ECO II SPK COG 
10 TP0100 thioredoxin, putative 
{Bradyrhizobium 
japonicum} 
TP0005 DNA gyrase, 
subunit A (gyrA) 
{Bacillus 
subtilis} 
CJ0147C-CJ1027C  filtered CJE all COG 
11 TP0154 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0060 ribosomal 
protein L9 (rplI) 
{Bacillus 
subtilis} 
B1086-B4203  all ECO I SPK  COG 
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12 TP0162 Holliday junction 
DNA helicase 
(ruvB) 
{Haemophilus 
influenzae} 
TP0543 Holliday 
junction DNA 
helicase (ruvA) 
{Haemophilus 
influenzae} 
CJ1362-CJ0799C 
CJ0799C-CJ1362  
filtered CJE all COG 
     CJ1362-CJ0799C 
CJ0799C-CJ1362  
filtered CJE all MBGD 
     CJ1362-CJ0799C 
CJ0799C-CJ1362  
filtered CJE HCF COG 
     CJ1362-CJ0799C 
CJ0799C-CJ1362  
filtered CJE HCF MBGD 
13 TP0192 ribosomal protein 
L2 (rplB) {Borrelia 
burgdorferi} 
TP0756 methionyl-tRNA 
formyltransferas
e (fmt) 
{Haemophilus 
influenzae} 
B2255-B3317  filtered ECO II SPK COG 
14 TP0330 cell division protein 
(ftsH) {Mycoplasma 
genitalium} 
TP0330 cell division 
protein (ftsH) 
{Mycoplasma 
genitalium} 
B3178-B3178  filtered ECO I SPK COG 
15 TP0344 transcription-repair 
coupling factor 
(trcF) {Borrelia 
burgdorferi} 
TP0514 excinuclease 
ABC, subunit A 
(uvrA) {Bacillus 
subtilis} 
HP0705-HP1541  filtered HPY MBGD 
     HP0705-HP1541  filtered HPY COG 
16 TP0459 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0060 ribosomal 
protein L9 (rplI) 
{Bacillus 
subtilis} 
B1269-B4203  all ECO I SPK MBGD 
     B1269-B4203  all ECO I SPK  COG 
17 TP0468 conserved 
hypothetical protein 
{Bacillus subtilis} 
TP0757 polypeptide 
deformylase 
(def) 
{Synechocystis 
PCC6803} 
CJ0191C-CJ1679 
CJ1679-CJ0191C  
filtered CJE all COG 
     CJ0191C-CJ1679 
CJ1679-CJ0191C  
filtered CJE HCF COG 
18 TP0472 excinuclease ABC, 
subunit C (uvrC) 
{Methanobacterium 
thermoautotrophicu
m} 
TP0894 conserved 
hypothetical 
protein 
{Synechocystic 
PCC6803} 
HP0879-HP0821  filtered HPY COG 
19 TP0507 ATP-dependent Clp 
protease proteolytic 
component (clpP) 
{Haemophilus 
influenzae} 
TP0362 ribosomal 
protein L28 
(rpmB) 
{Treponema 
pallidum} 
B0437-B3637  filtered ECO I SPK MBGD 
     B0437-B3637  filtered ECO I SPK COG 
     CJ0192C-CJ0712  filtered CJE all COG 
     CJ0192C-CJ0712  filtered CJE all MBGD 
20 TP0519 response regulatory 
protein (atoC) 
{Borrelia 
burgdorferi} 
TP0519 response 
regulatory 
protein (atoC) 
{Borrelia 
burgdorferi} 
B2554-B2554 B2869-
B2869 
filtered ECO I SPK MBGD 
     B2554-B2554  filtered ECO I SPK COG 
21 TP0526 ATP-dependent 
helicase (hrpA) 
{Borrelia 
burgdorferi} 
TP0892 N utilization 
substance 
protein A (nusA) 
{Borrelia 
burgdorferi} 
B1413-B3169  filtered ECO II SAI MBGD 
     B1413-B3169  filtered ECO II SAI COG 
22 TP0622 hypothetical protein TP0641 histidyl-tRNA 
synthetase (hisS) 
{Borrelia 
burgdorferi} 
B2514-B3530  filtered ECO II SAI COG 
     B2514-B3530  filtered ECO II SPK COG 
23 TP0622 hypothetical protein TP0684 Glucose/galacto
se-binding 
lipoprotein 
precursor 
B2150-B2851  filtered ECO I SAI COG 
24 TP0641 histidyl-tRNA 
synthetase (hisS) 
{Borrelia 
burgdorferi} 
TP0641 histidyl-tRNA 
synthetase (hisS) 
{Borrelia 
burgdorferi} 
CJ0765C-CJ0765C  filtered CJE all COG 
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     CJ0765C-CJ0765C  filtered CJE all MBGD 
     B2514-B2514  filtered ECO I SPK MBGD 
     B2514-B2514  filtered ECO I SPK COG 
     CJ0765C-CJ0765C  filtered CJE HCF COG 
     CJ0765C-CJ0765C  filtered CJE HCF MBGD 
25 TP0642 phosphomannomut
ase (manB) {Bacillus 
subtilis} 
TP0060 ribosomal 
protein L9 (rplI) 
{Bacillus 
subtilis} 
B3176-B4203  all ECO II SAI MBGD 
     B3176-B4203  all ECO II SAI COG 
26 TP0648 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0894 conserved 
hypothetical 
protein 
{Synechocystic 
PCC6803} 
HP0879-HP0275 
HP0879-HP1274  
filtered HPY COG 
27 TP0648 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0943 flagellar protein 
(fliS) {Bacillus 
subtilis} 
HP0753-HP1274  filtered HPY COG 
28 TP0648 conserved 
hypothetical protein 
{Borrelia 
burgdorferi} 
TP0965 membrane 
fusion protein, 
putative 
{Haemophilus 
influenzae} 
CJ0606-CJ0390  filtered CJE all COG 
     CJ0606-CJ0390  filtered CJE HCF COG 
29 TP0659 flagellar hook-
associated protein 3 
(flgL) {Borrelia 
burgdorferi} 
TP0160 prolyl-tRNA 
synthetase 
(proS) 
{Escherichia 
coli} 
B0194-B1923  filtered ECO II SAI COG 
     B1923-B0194  filtered ECO II SPK COG 
30 TP0659 flagellar hook-
associated protein 3 
(flgL) {Borrelia 
burgdorferi} 
TP1004 recombination 
protein (recR) 
{Haemophilus 
influenzae} 
CJ0720C-CJ1263  all CJE all COG 
     CJ0720C-CJ1263  all CJE HCF COG 
31 TP0728 flagellar hook 
assembly scaffolding 
protein (flgD) 
{Treponema 
pallidum} 
TP0100 thioredoxin, 
putative 
{Bradyrhizobiu
m japonicum} 
CJ0042-CJ0864  filtered CJE all COG 
32 TP0738 conserved 
hypothetical protein 
{Bacillus subtilis} 
TP0199 ribosomal 
protein L14 
(rplN) {Borrelia 
burgdorferi} 
CJ1697C-CJ1405  filtered CJE all COG 
     CJ1697C-CJ1405  filtered CJE all MBGD 
     B0637-B3310  filtered ECO I SPK MBGD 
     B0637-B3310  filtered ECO I SPK COG 
     CJ1697C-CJ1405  filtered CJE HCF COG 
     CJ1697C-CJ1405  filtered CJE HCF MBGD 
33 TP0756 methionyl-tRNA 
formyltransferase 
(fmt) {Haemophilus 
influenzae} 
TP0060 ribosomal 
protein L9 (rplI) 
{Bacillus 
subtilis} 
B3288-B4203  all ECO II SPK MBGD 
     B3288-B4203  all ECO II SPK COG 
34 TP0782 hypothetical protein TP0554 phosphoglycolat
e phosphatase 
(gph) 
{Haemophilus 
influenzae} 
CJ1275C-CJ1477C 
CJ1275C-CJ1233  
filtered CJE all COG 
     CJ1275C-CJ1477C  filtered CJE HCF COG 
35 TP0792 flagellar filament 33 
kDa core protein 
(flaB2) {Treponema 
pallidum} 
TP0160 prolyl-tRNA 
synthetase 
(proS) 
{Escherichia 
coli} 
B0194-B1923  filtered ECO II SAI MBGD 
     B0194-B1923  filtered ECO II SAI COG 
     B1923-B0194  filtered ECO II SPK MBGD 
     B1923-B0194  filtered ECO II SPK COG 
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36 TP0792 flagellar filament 33 
kDa core protein 
(flaB2) {Treponema 
pallidum} 
TP0658 transmembrane 
protein, putative 
{Bacillus 
subtilis} 
CJ0720C-CJ1075  filtered CJE all COG 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY MBGD 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY COG 
37 TP0840 conserved 
hypothetical integral 
membrane protein 
{Archaeoglobus 
fulgidus} 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
pallidum}   
CJ0720C-CJ0987C  all CJE all COG 
38 TP0840 conserved 
hypothetical integral 
membrane protein 
{Archaeoglobus 
fulgidus} 
TP1005 DNA 
polymerase III, 
subunits gamma 
and tau (dnaH) 
{Borrelia 
burgdorferi} 
CJ1157-CJ0484  filtered CJE all COG 
39 TP0868 flagellar filament 
34.5 kDa core 
protein (flaB1) 
{Treponema 
pallidum} 
TP0658 transmembrane 
protein, putative 
{Bacillus 
subtilis} 
CJ0720C-CJ1075  filtered CJE all COG 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY MBGD 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY COG 
40 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0053 ribonucleoside-
diphosphate 
reductase, 
subunit beta 
(nrdB) 
{Helicobacter 
pylori} 
B1083-B2676  filtered ECO II SAI COG 
     B1083-B2676  all ECO II SAI COG 
41 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0640 methyl-accepting 
chemotaxis 
protein (mcp2) 
{Treponema 
pallidum} 
CJ0720C-CJ1190C 
CJ0720C-CJ0246C  
filtered CJE all COG 
     B1923-B3072  filtered ECO II SAI MBGD 
     B1923-B3072  filtered ECO II SAI COG 
     CJ0720C-CJ1190C 
CJ0720C-CJ0246C  
filtered CJE HCF COG 
42 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0658 transmembrane 
protein, putative 
{Bacillus 
subtilis} 
CJ0720C-CJ1075  filtered CJE all COG 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY MBGD 
     HP0601-HP1154 
HP0601-HP1377  
filtered HPY COG 
43 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0702 conserved 
hypothetical 
protein {Borrelia 
burgdorferi} 
CJ0720C-CJ1087C  filtered CJE all COG 
     CJ0720C-CJ1087C  filtered CJE HCF COG 
44 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0943 flagellar protein 
(fliS) {Bacillus 
subtilis} 
CJ1338C-CJ0549 
CJ0720C-CJ0549 
CJ1339C-CJ0549  
filtered CJE all COG 
     CJ1338C-CJ0549 
CJ1339C-CJ0549  
filtered CJE all MBGD 
     HP0601-HP0753 
HP0753-HP0115  
filtered HPY MBGD 
     HP0601-HP0753 
HP0753-HP0115  
filtered HPY COG 
     CJ1338C-CJ0549 
CJ0720C-CJ0549 
CJ1339C-CJ0549  
filtered CJE HCF COG 
     CJ1338C-CJ0549 
CJ1339C-CJ0549 
filtered CJE HCF MBGD 
45 TP0870 flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
TP0981 sensory 
transduction 
histidine kinase, 
putative 
B1490-B1923  filtered ECO II SAI MBGD 
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{Synechocystis 
PCC6803} 
     B1490-B1923 B1490-
B1923  
filtered ECO II SAI COG 
46 TP0875 conserved 
hypothetical protein 
{Synechocystis 
PCC6803} 
TP0240 ribosomal 
protein L7/L12 
(rplL) 
{Haemophilus 
influenzae} 
B4168-B3986  filtered ECO I SPK MBGD 
     B4168-B3986  filtered ECO I SPK COG 
47 TP0903 UDP-N-
acetylmuramoylalani
ne--D-glutamate 
ligase (murD) 
{Borrelia 
burgdorferi} 
TP0100 thioredoxin, 
putative 
{Bradyrhizobiu
m japonicum} 
B2582-B0088  filtered ECO I SPK COG 
48 TP0905 ribosomal protein 
S16 (rpsP) {Bacillus 
subtilis} 
TP0236 transcription 
antitermination 
protein (nusG) 
{Borrelia 
burgdorferi} 
B3982-B2609  filtered ECO I SPK MBGD 
     B3982-B2609  filtered ECO I SPK COG 
49 TP0939 pyruvate 
oxidoreductase 
{Synechocystis 
PCC6803} 
TP0396 flagellar basal-
body rod protein 
(flgB) 
{Treponema 
denticola} 
HP1559-HP0589  filtered HPY COG 
50 TP0939 pyruvate 
oxidoreductase 
{Synechocystis 
PCC6803} 
TP0961 flagellar basal-
body rod protein 
(flgG) {Borrelia 
burgdorferi} 
CJ0536-CJ0697  all CJE all COG 
     CJ0536-CJ0697  all CJE HCF COG 
51 TP0943 flagellar protein (fliS) 
{Bacillus subtilis} 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
pallidum}   
CJ1338C-CJ0549 
CJ0720C-CJ0549 
CJ1339C-CJ0549  
all CJE all COG 
     CJ1338C-CJ0549 
CJ1339C-CJ0549  
all CJE all MBGD 
     HP0601-HP0753 
HP0753-HP0115  
all HPY MBGD 
     HP0601-HP0753 
HP0753-HP0115  
all HPY COG 
     CJ1338C-CJ0549 
CJ0720C-CJ0549 
CJ1339C-CJ0549  
all CJE HCF COG 
     CJ1338C-CJ0549 
CJ1339C-CJ0549  
all CJE HCF MBGD 
52 TP0954 conserved 
hypothetical protein 
{Methanobacterium 
thermoautotrophicu
m} 
TP0044 glucose inhibited 
division protein 
A (gidA) 
{Borrelia 
burgdorferi} 
B3530-B3741  filtered ECO II SAI MBGD 
     B3530-B3741  filtered ECO II SAI COG 
     B3741-B3530  filtered ECO II SPK MBGD 
     B3741-B3530  filtered ECO II SPK COG 
53 TP0963 conserved 
hypothetical integral 
membrane protein 
{Bacillus subtilis} _ 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
pallidum}   
CJ0720C-CJ1662  all CJE all COG 
     CJ0720C-CJ1662  all CJE HCF COG 
54 TP0963 conserved 
hypothetical integral 
membrane protein 
{Bacillus subtilis} _ 
TP0961 flagellar basal-
body rod protein 
(flgG) {Borrelia 
burgdorferi} 
CJ0697-CJ1662  all CJE all COG 
55 TP0981 sensory transduction 
histidine kinase, 
putative 
{Synechocystis 
PCC6803} 
TP0005 DNA gyrase, 
subunit A (gyrA) 
{Bacillus 
subtilis} 
CJ0643-CJ1027C  filtered CJE all MBGD 
56 TP0981 sensory transduction 
histidine kinase, 
putative 
{Synechocystis 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
B1490-B1923  all ECO II SAI MBGD 
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PCC6803} pallidum}   
     B1490-B1923 B1490-
B1923 
all ECO II SAI COG 
57 TP0985 aspartyl-tRNA 
synthetase (aspS) 
{Borrelia 
burgdorferi} 
TP0735 glutamate 
synthase (gltA) 
{Pyrococcus 
sp.} 
B1866-B3213  filtered ECO I SPK MBGD 
     B1866-B3213  filtered ECO I SPK COG 
58 TP0985 aspartyl-tRNA 
synthetase (aspS) 
{Borrelia 
burgdorferi} 
TP0965 membrane 
fusion protein, 
putative 
{Haemophilus 
influenzae} 
B1866-B3513  filtered ECO II SAI COG 
59 TP0986 conserved 
hypothetical integral 
membrane protein 
{Helicobacter 
pylori} 
TP0870 flagellar filament 
31 kDa core 
protein (flaB3) 
{Treponema 
pallidum}   
CJ0720C-CJ1544C 
CJ0720C-CJ0385C  
all CJE all COG 
     CJ0720C-CJ1544C  all CJE HCF COG 
60 TP1005 DNA polymerase 
III, subunits gamma 
and tau (dnaH) 
{Borrelia 
burgdorferi} 
TP1005 DNA 
polymerase III, 
subunits gamma 
and tau (dnaH) 
{Borrelia 
burgdorferi} 
CJ1157-CJ1157  filtered CJE all COG 
     CJ1157-CJ1157  filtered CJE all MBGD 
     B0470-B0470  filtered ECO I SPK MBGD 
     B0470-B0470  filtered ECO I SPK COG 
     CJ1157-CJ1157  filtered CJE HCF COG 
     CJ1157-CJ1157  filtered CJE HCF MBGD 
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Supplementary Table 5 Interologs retested with H. pylori orthologs. "+" indicates 
positive result and "(+)" was not marked as positive due to Y2H activation in control. 
bait description prey description bait 
ortholog 
prey 
ortholog 
Interolog 
reproduced 
TP0044 glucose inhibited 
division protein A 
(gidA) {Borrelia 
burgdorferi} 
TP0512 conserved hypothetical 
protein {Rhodobacter 
capsulatus} 
HP0213 HP1020  
TP0058 replicative DNA 
helicase (dnaB) 
{Bacillus subtilis} 
TP0001 chromosomal replication 
initiator protein (dnaA) 
{Borrelia burgdorferi} 
HP1362 HP1529  
TP0058 replicative DNA 
helicase (dnaB) 
{Bacillus subtilis} 
TP0005 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
HP1362 HP0701  
TP0058 replicative DNA 
helicase (dnaB) 
{Bacillus subtilis} 
TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
HP1362 HP0717  
TP0271 chromosome 
partitioning protein 
(parB) {Caulobacter 
crescentus} 
TP0198 ribosomal protein S17 
(rpsQ) {Bacillus 
stearothermophilus} 
HP1138 HP1310  
TP0271 chromosome 
partitioning protein 
(parB) {Caulobacter 
crescentus} 
TP0305 CTP synthase (pyrG) 
{Synechocystis 
PCC6803} 
HP1138 HP0349  
TP0271 chromosome 
partitioning protein 
(parB) {Caulobacter 
crescentus} 
TP0386 UDP-N-
acetylmuramoylalanyl-D-
glutamyl-2,6-
diaminopimelate--D-
alanyl-D-alanine ligase 
(murF) {Synechocystis 
PCC6803} 
HP1138 HP0740  
TP0271 chromosome 
partitioning protein 
(parB) {Caulobacter 
crescentus} 
TP0586 leucyl-tRNA synthetase 
(leuS) {Borrelia 
burgdorferi} 
HP1138 HP1547 (+) 
TP0272 SpoOJ regulator (soj) 
{Bacillus subtilis} 
TP0060 ribosomal protein L9 
(rplI) {Bacillus subtilis} 
HP1139 HP0514  
TP0272 SpoOJ regulator (soj) 
{Bacillus subtilis} 
TP0188 ribosomal protein S10 
(rpsJ) {Borrelia 
burgdorferi} 
HP1139 HP1320  
TP0272 SpoOJ regulator (soj) 
{Bacillus subtilis} 
TP0247 N-acetylmuramoyl-L-
alanine amidase (amiA) 
{Escherichia coli} 
HP1139 HP0772 + 
TP0296 conserved hypothetical 
protein {Pseudomonas 
putida} 
TP0578 cell division protein 
(ftsY) {Bacillus subtilis} 
HP0831 HP0763  
TP0339 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
TP0632 tryptophanyl-tRNA 
synthetase (trsA) 
{Borrelia burgdorferi} 
HP0745 HP1253  
TP0339 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
TP0728 flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
HP0745 HP0907  
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TP0384 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
TP0396 flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
HP0707 HP1559  
TP0387 cell division protein 
(ftsW) {Borrelia 
burgdorferi} 
TP0236 transcription 
antitermination protein 
(nusG) {Borrelia 
burgdorferi} 
HP1560 HP1203  
TP0387 cell division protein 
(ftsW) {Borrelia 
burgdorferi} 
TP0270 polynucleotide 
adenylyltransferase 
(pcnA) {Borrelia 
burgdorferi} 
HP1560 HP0640  
TP0390 cell division protein 
(ftsZ) {Borrelia 
burgdorferi} 
TP0001 chromosomal replication 
initiator protein (dnaA) 
{Borrelia burgdorferi} 
HP0979 HP1529  
TP0390 cell division protein 
(ftsZ) {Borrelia 
burgdorferi} 
TP0060 ribosomal protein L9 
(rplI) {Bacillus subtilis} 
HP0979 HP0514  
TP0464 conserved hypothetical 
protein {Haemophilus 
influenzae} 
TP0477 glucose-6-phosphate 
dehydrogenase isozyme 
(devB) {Actinobacillus 
actinomycetemcomitans} 
HP0747 HP1102  
TP0464 conserved hypothetical 
protein {Haemophilus 
influenzae} 
TP0712 ATP-binding protein 
(ylxH) {Treponema 
pallidum} 
HP0747 HP1034  
TP0464 conserved hypothetical 
protein {Haemophilus 
influenzae} 
TP0888 riboflavin kinase/FMN 
adenylyltransferase (ribF) 
{Escherichia coli} 
HP0747 HP1087  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0001 chromosomal replication 
initiator protein (dnaA) 
{Borrelia burgdorferi} 
HP0012 HP1529  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0005 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
HP0012 HP0701  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP0012 HP0238  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0305 CTP synthase (pyrG) 
{Synechocystis 
PCC6803} 
HP0012 HP0349  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0396 flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
HP0012 HP1559  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0519 response regulatory 
protein (atoC) {Borrelia 
burgdorferi} 
HP0012 HP0703  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0797 1-pyrroline-5-carboxylate 
reductase (proC) 
{Treponema pallidum} 
HP0012 HP1158  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP0939 pyruvate oxidoreductase 
{Synechocystis 
PCC6803} 
HP0012 HP1111  
TP0492 DNA primase (dnaE) 
{Clostridium 
acetobutylicum} 
TP1006 DNA gyrase, subunit B 
(gyrB) {Treponema 
pallidum} 
HP0012 HP0501  
TP0497 rod shape-determining 
protein (mreB) 
{Borrelia burgdorferi} 
TP0001 chromosomal replication 
initiator protein (dnaA) 
{Borrelia burgdorferi} 
HP1373 HP1529  
TP0497 rod shape-determining 
protein (mreB) 
{Borrelia burgdorferi} 
TP0060 ribosomal protein L9 
(rplI) {Bacillus subtilis} 
HP1373 HP0514  
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TP0501 rod shape-determining 
protein (rodA) 
{Borrelia burgdorferi} 
TP0113 Lambda CII stability-
governing protein (hflK) 
{Treponema pallidum} 
HP0743 HP0248  
TP0506 trigger factor (tig) 
{Borrelia burgdorferi} 
TP0605 translation elongation 
factor TS (tsf) {Spirulina 
platensis} 
HP0795 HP1555  
TP0506 trigger factor (tig) 
{Borrelia burgdorferi} 
TP0712 ATP-binding protein 
(ylxH) {Treponema 
pallidum} 
HP0795 HP1034  
TP0578 cell division protein 
(ftsY) {Bacillus 
subtilis} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP0763 HP0238 + 
TP0582 conserved hypothetical 
integral membrane 
protein {Borrelia 
burgdorferi} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP0787 HP0238 + 
TP0582 conserved hypothetical 
integral membrane 
protein {Borrelia 
burgdorferi} 
TP0397 flagellar basal-body rod 
protein (flgC) 
{Treponema denticola} 
HP0787 HP1558  
TP0582 conserved hypothetical 
integral membrane 
protein {Borrelia 
burgdorferi} 
TP0765 cell division protein 
(ftsH) {Helicobacter 
pylori} 
HP0787 HP1069  
TP0582 conserved hypothetical 
integral membrane 
protein {Borrelia 
burgdorferi} 
TP0965 membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
HP0787 HP0606  
TP0582 conserved hypothetical 
integral membrane 
protein {Borrelia 
burgdorferi} 
TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
HP0787 HP0717  
TP0658 transmembrane 
protein, putative 
{Bacillus subtilis} 
TP0831 arginyl-tRNA synthetase 
(argS) {Borrelia 
burgdorferi}} 
HP1154 HP0319  
TP0658 transmembrane 
protein, putative 
{Bacillus subtilis} 
TP0939 pyruvate oxidoreductase 
{Synechocystis 
PCC6803} 
HP1154 HP1111 (+) 
TP0720 flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
TP0048 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
HP1030 HP1542  
TP0720 flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP1030 HP0238 + 
TP0720 flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
TP0193 ribosomal protein S19 
(rpsS) {Borrelia 
burgdorferi} 
HP1030 HP1315  
TP0720 flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
TP0397 flagellar basal-body rod 
protein (flgC) 
{Treponema denticola} 
HP1030 HP1558  
TP0720 flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
HP1030 HP0717  
TP0728 flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
TP0005 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
HP0907 HP0701  
TP0728 flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP0907 HP0238  
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TP0728 flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
TP0396 flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
HP0907 HP1559  
TP0728 flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
TP0586 leucyl-tRNA synthetase 
(leuS) {Borrelia 
burgdorferi} 
HP0907 HP1547  
TP0754 conserved hypothetical 
protein {Haemophilus 
influenzae} 
TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
HP0269 HP0717 + 
TP0765 cell division protein 
(ftsH) {Helicobacter 
pylori} 
TP0814 thioredoxin reductase 
(trxB) {Bacillus subtilis} 
HP1069 HP0825  
TP0794 S-adenosylmethionine 
synthetase (metK) 
{Escherichia coli} 
TP0002 DNA polymerase III, 
subunit beta (dnaN) 
{Pseudomonas putida} 
HP0197 HP0500  
TP0875 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
TP0060 ribosomal protein L9 
(rplI) {Bacillus subtilis} 
HP0716 HP0514  
TP0875 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
TP0240 ribosomal protein 
L7/L12 (rplL) 
{Haemophilus 
influenzae} 
HP0716 HP1199  
TP0875 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
TP0247 N-acetylmuramoyl-L-
alanine amidase (amiA) 
{Escherichia coli} 
HP0716 HP0772  
TP0903 UDP-N-
acetylmuramoylalanine-
-D-glutamate ligase 
(murD) {Borrelia 
burgdorferi} 
TP0001 chromosomal replication 
initiator protein (dnaA) 
{Borrelia burgdorferi} 
HP0494 HP1529  
TP0903 UDP-N-
acetylmuramoylalanine-
-D-glutamate ligase 
(murD) {Borrelia 
burgdorferi} 
TP0396 flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
HP0494 HP1559  
TP0905 ribosomal protein S16 
(rpsP) {Bacillus 
subtilis} 
TP0060 ribosomal protein L9 
(rplI) {Bacillus subtilis} 
HP1151 HP0514  
TP0905 ribosomal protein S16 
(rpsP) {Bacillus 
subtilis} 
TP0236 transcription 
antitermination protein 
(nusG) {Borrelia 
burgdorferi} 
HP1151 HP1203  
TP0905 ribosomal protein S16 
(rpsP) {Bacillus 
subtilis} 
TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
HP1151 HP0717  
TP0939 pyruvate 
oxidoreductase 
{Synechocystis 
PCC6803} 
TP0396 flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
HP1111 HP1559  
TP0946 glucose-inhibited 
division protein B 
(gidB) {Escherichia 
coli} 
TP0160 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
HP1063 HP0238 (+) 
TP0946 glucose-inhibited 
division protein B 
(gidB) {Escherichia 
coli} 
TP0514 excinuclease ABC, 
subunit A (uvrA) 
{Bacillus subtilis} 
HP1063 HP0705  
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TP0965 membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
TP0514 excinuclease ABC, 
subunit A (uvrA) 
{Bacillus subtilis} 
HP0606 HP0705  
TP0965 membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
TP0965 membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
HP0606 HP0606  
TP0999 cell division protein, 
putative {Borrelia 
burgdorferi} 
TP0051 peptide chain release 
factor 1 (prfA) {Borrelia 
burgdorferi} 
HP1090 HP0077  
TP0999 cell division protein, 
putative {Borrelia 
burgdorferi} 
TP0186 oxygen-independent 
coproporphyrinogen III 
oxidase, putative 
{Bacillus subtilis} 
HP1090 HP1226  
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Supplementary Table 6 MCODE complexes identified in ECO MORI SAI network (>2 
proteins). 
Complex Score 
(Density* 
#Proteins) 
Proteins Interactions Protein names 
1 5,963 27 161 b1962, b0383, b3168, b1942, b2898, b1478, b0804, b0346, b0800, 
b3077, b0949, b4297, b2712, b0239, b0335, b0284, b2049, b1048, 
b3311, b2026, b1552, b4382, b3924, b1655, b3880, b0861, b4017 
2 5,125 32 164 b1923, b4351, b3998, b4464, b3945, b4362, b0084, b2920, b1710, 
b3056, b0414, b3895, b2506, b3520, b0297, b1270, b1569, b3058, 
b1918, b1266, b1257, b1820, b4162, b1462, b1118, b0300, b0231, 
b2929, b3072, b0646, b1418, b3462 
3 4,111 36 148 b0264, b3349, b1161, b0345, b0311, b1490, b4294, b3271, b3185, 
b0225, b0624, b3293, b1164, b1275, b1751, b0956, b0582, b4371, 
b2480, b2394, b0016, b0632, b0997, b4375, b4355, b1886, b2301, 
b0074, b3149, b0360, b0868, b4277, b0255, b1736, b1810, b0274 
4 4 9 36 b1024, b2614, b2471, b0413, b2017, b1221, b1638, b2461, b4480 
5 3,504 113 396 b0012, b0623, b2566, b4312, b0191, b1213, b0846, b0988, b4200, 
b0148, b3609, b3499, b3600, b2485, b0707, b3803, b0963, b4366, 
b0982, b2296, b2551, b3158, b1276, b1547, b1834, b3780, b1881, 
b4041, b0676, b4479, b0382, b2779, b0602, b0042, b3453, b1807, 
b2213, b3990, b1799, b4263, b2759, b3223, b0393, b1356, b2601, 
b2431, b3100, b2581, b3838, b2993, b2131, b3947, b0376, b0717, 
b1712, b3066, b3067, b1727, b3905, b3054, b2494, b0626, b3203, 
b2976, b3181, b3923, b3836, b3928, b2528, b0974, b2915, b3922, 
b3901, b1651, b3183, b3866, b0190, b1679, b1477, b3021, b0469, 
b1379, b3555, b1809, b2124, b3125, b3157, b3859, b0921, b3516, 
b1123, b1114, b2529, b1647, b0568, b4209, b3042, b1084, b3065, 
b1467, b1779, b0957, b0929, b0724, b3846, b1926, b0200, b0654, 
b1450, b1568, b1209, b2478, b2222 
6 3,5 16 56 b1090, b0127, b1368, b2425, b1624, b0273, b3688, b0406, b3086, 
b3623, b3431, b4014, b2944, b4192, b1264, b3440 
7 3,227 22 71 b4059, b2509, b4191, b0182, b2382, b2812, b3347, b1683, b3731, 
b0172, b1682, b0437, b4170, b0214, b0436, b1072, b0328, b4113, 
b0944, b0438, b1131, b0547 
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8 2,712 344 933 b2872, b0109, b3469, b3794, b3237, b2369, b0121, b0123, b1876, 
b3287, b3407, b1435, b1612, b0635, b2155, b2965, b2903, b3393, 
b0143, b0145, b1625, b3889, b0005, b2783, b1217, b2511, b2491, 
b3316, b4346, b2259, b2631, b1198, b1664, b2518, b4266, b0569, 
b3626, b1200, b4280, b1203, b3845, b1272, b0995, b4141, b4329, 
b0620, b0907, b2532, b2224, b4316, b1288, b2076, b1258, b1260, 
b0060, b0695, b3894, b4034, b1833, b1482, b2821, b2355, b2428, 
b0641, b3616, b4469, b0903, b1995, b0150, b4348, b2916, b3619, 
b2541, b3250, b3942, b1968, b3338, b0043, b2893, b0126, b1870, 
b0939, b4398, b3082, b3636, b3154, b2290, b0728, b2387, b0550, 
b1686, b3170, b1045, b1064, b3133, b0083, b2672, b0699, b2520, 
b1531, b3003, b1424, b3387, b1215, b3032, b0251, b3604, b2427, 
b4283, b2364, b3789, b0925, b2285, b3573, b1165, b0524, b1524, 
b0525, b4324, b2914, b2831, b3590, b4201, b1724, b0449, b2619, 
b0893, b2095, b3240, b1622, b4233, b0034, b2122, b2930, b1461, 
b1842, b1086, b4174, b0937, b1389, b2251, b2207, b0303, b0642, 
b3486, b4070, b1059, b3594, b3857, b3860, b0215, b0227, b1271, 
b1269, b3725, b3856, b1618, b0177, b3606, b3865, b1007, b1589, 
b4470, b3106, b4202, b0826, b3247, b1286, b3967, b1509, b3234, 
b1082, b1083, b1070, b2676, b2303, b4396, b4179, b2583, b2896, 
b3022, b2732, b2082, b0233, b2988, b1294, b0678, b1171, b3437, 
b2867, b3165, b3396, b2255, b3418, b2733, b0651, b2079, b3404, 
b2078, b0369, b2685, b1611, b2629, b3352, b2997, b1388, b0984, 
b1637, b3821, b3753, b3143, b4384, b1676, b4061, b0054, b2060, 
b0491, b1352, b2064, b1026, b0541, b0299, b0372, b2458, b3835, 
b2468, b3884, b3665, b0021, b4478, b0447, b4274, b1944, b4006, 
b3029, b1915, b3014, b4245, b2940, b1432, b2134, b3833, b3929, 
b3195, b2111, b2125, b0330, b1922, b0223, b2777, b0285, b0427, 
b2716, b3430, b3533, b0594, b0593, b4033, b0588, b1889, b3983, 
b4285, b0523, b2895, b1183, b1560, b0585, b2284, b1617, b0630, 
b3703, b0116, b3220, b4049, b2282, b3030, b1508, b2287, b1613, 
b3679, b2660, b0403, b0480, b2338, b1458, b1530, b1199, b3936, 
b2519, b3476, b2463, b2836, b1069, b0768, b2996, b3102, b0928, 
b1457, b0073, b1731, b2650, b0327, b2671, b0876, b2101, b0149, 
b3256, b0415, b1860, b3920, b1394, b1792, b4108, b0537, b4310, 
b3800, b4166, b3517, b0117, b1074, b3565, b1702, b1857, b1849, 
b1519, b1931, b1081, b4331, b2806, b0008, b1973, b4287, b3530, 
b0688, b2906, b0950, b4383, b4271, b0516, b0566, b0323, b1247, 
b1725, b1723 
9 2,571 7 18 b1273, b1953, b3937, b0464, b2953, b0230, b1777 
10 2,5 6 15 b3700, b0093, b1218, b3337, b2747, b2750 
11 2,5 6 15 b1512, b1452, b0476, b2572, b2548, b0910 
12 2,5 6 15 b0298, b1806, b0540, b2474, b1554, b0373 
13 2,2 15 33 b1786, b3041, b2493, b2437, b0258, b2151, b2502, b4098, b0531, 
b1028, b2462, b2624, b2848, b1522, b0036 
14 2,1 10 21 b4087, b2935, b0357, b4466, b0829, b3644, b2545, b2029, b3933, 
b2628 
15 2 5 10 b0146, b3973, b3405, b3917, b3194 
16 2 5 10 b0990, b1347, b0122, b0493, b3354 
17 2 5 10 b2141, b3049, b1811, b4455, b1419 
18 1,889 9 17 b3397, b0053, b2820, b2908, b2698, b0033, b4038, b1146, b2300 
19 1,819 83 151 b0763, b2523, b2039, b2273, b2708, b0551, b2434, b3931, b1761, 
b2430, b4340, b4254, b4235, b4264, b0276, b1022, b0173, b2829, 
b4486, b0799, b1019, b3788, b1414, b1096, b1097, b2499, b2165, 
b1808, b2592, b2697, b1972, b3329, b0254, b2863, b4029, b4253, 
b3129, b0460, b1179, b3236, b4081, b3940, b2206, b3611, b0099, 
b4172, b1744, b2166, b1772, b1470, b1253, b2802, b2080, b3167, 
b3384, b3321, b4223, b0736, b1718, b0426, b2517, b0035, b3094, 
b2297, b1495, b2765, b0981, b2992, b2476, b3801, b0754, b3458, 
b3342, b2220, b3017, b2576, b2594, b0905, b0803, b0235, b2586, 
b1709, b2253 
20 1,778 9 16 b0889, b1291, b3591, b1742, b0180, b1983, b2585, b0885, b2744 
21 1,62 71 115 b1693, b0960, b0221, b3305, b0051, b1749, b3696, b3745, b0304, 
b3241, b0085, b2819, b3912, b2763, b4135, b2938, b0375, b1501, 
b0592, b0441, b3605, b0892, b2100, b1144, b1174, b3868, b2917, 
b0257, b2782, b2890, b1919, b0068, b0062, b2066, b3551, b3830, 
b1232, b3918, b1485, b1236, b2042, b1982, b1513, b3460, b3935, 
b0481, b0170, b3875, b1107, b3414, b3992, b2113, b0617, b1426, 
b2942, b0380, b0704, b2937, b4215, b2866, b3402, b2780, b2869, 
b0267, b2675, b2817, b2745, b2114, b4220, b0571, b1284 
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22 1,568 37 58 b4401, b1892, b4146, b4241, b4045, b4217, b3502, b2323, b2582, 
b4387, b3525, b1176, b0959, b0710, b2847, b1675, b1541, b0732, 
b2950, b0240, b0945, b0973, b3484, b0705, b1460, b2194, b2515, 
b1797, b2209, b0735, b4392, b1848, b1960, b1110, b0968, b2620, 
b4046 
23 1,545 11 17 b0039, b1410, b2870, b1343, b3746, b1120, b1855, b1783, b2452, 
b3699, b3749 
24 1,545 11 17 b0037, b3135, b0512, b2913, b3829, b2216, b1177, b3813, b4305, 
b0519, b3051 
25 1,5 4 6 b2467, b2028, b1763, b3903 
26 1,5 4 6 b1750, b0421, b2575, b0217 
27 1,5 4 6 b4378, b2687, b2952, b3152 
28 1,5 4 6 b2140, b1614, b2235, b1116 
29 1,5 4 6 b2320, b1873, b3289, b1814 
30 1,5 4 6 b0506, b0785, b3560, b0831 
31 1,5 4 6 b2489, b3932, b2958, b2986 
32 1,5 8 12 b3309, b3890, b0539, b3737, b0881, b1518, b4224, b2849 
33 1,5 4 6 b2286, b0526, b2905, b3182 
34 1,5 4 6 b1872, b2311, b0366, b2087 
35 1,5 4 6 b4112, b2795, b2715, b4119 
36 1,5 4 6 b3046, b2632, b2854, b2718 
37 1,5 4 6 b2607, b3018, b2481, b0192 
38 1,5 4 6 b3708, b1536, b2268, b1317 
39 1,492 118 176 b2891, b3982, b1827, b3540, b1687, b1423, b4399, b0720, b1507, 
b2020, b2700, b3482, b2232, b2507, b3034, b4221, b0492, b0700, 
b3648, b0544, b3774, b3313, b2516, b3558, b0496, b2788, b4095, 
b1885, b1635, b4236, b1523, b2068, b3341, b3984, b0077, b2240, 
b3635, b3630, b3288, b3296, b2460, b1671, b2610, b2032, b3689, 
b1345, b0677, b3385, b1897, b0508, b0636, b0658, b2315, b1866, 
b1261, b0247, b3863, b2081, b2702, b1539, b2167, b0462, b0884, 
b2132, b2234, b1719, b2956, b2970, b0472, b4019, b3290, b4482, 
b3467, b2669, b1023, b1949, b4129, b0026, b3426, b1609, b3872, 
b2662, b0628, b3421, b0727, b3251, b0849, b4377, b1222, b3806, 
b4088, b3625, b0355, b3008, b4322, b1301, b3848, b0827, b2603, 
b2556, b0824, b4238, b0038, b0497, b3593, b3340, b4005, b3997, 
b2162, b1066, b2281, b0575, b2729, b2379, b2138, b4358, b3744, 
b1259 
40 1,4 35 49 b2294, b0351, b2781, b1349, b0863, b1765, b0859, b3764, b1014, 
b3825, b2887, b1338, b0777, b1193, b2436, b2316, b3390, b2979, 
b3646, b1333, b1336, b0596, b2969, b3734, b0567, b2984, b0607, 
b0694, b2980, b3631, b3423, b3781, b1175, b1334, b3115 
41 1,375 8 11 b3686, b3779, b0337, b2525, b1046, b1430, b3687, b2337 
42 1,353 17 23 b0090, b0405, b3567, b0279, b0755, b1594, b2103, b2569, b4196, 
b2710, b2760, b3432, b2053, b4144, b0167, b4213, b1491 
43 1,25 4 5 b0812, b1680, b1065, b0608 
44 1,25 4 5 b4472, b2784, b1902, b1584 
45 1,2 5 6 b0107, b2825, b2946, b2948, b1348 
46 1,2 5 6 b4394, b3911, b3053, b3189, b1184 
47 1,2 5 6 b3570, b3355, b0031, b0807, b4333 
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Supplementary Table 7 Y2H interactions supported by StringDB (COG) at medium 
confidence level 
 bait prey definition bait definition prey combined 
score 
genomic 
context 
score 
1 TP0054 TP0095 conserved hypothetical protein {Escherichia coli} hypothetical protein 410 247 
2 TP0058 TP0001 replicative DNA helicase (dnaB) {Bacillus 
subtilis} 
chromosomal replication 
initiator protein (dnaA) {Borrelia 
burgdorferi} 
997 199 
3 TP0058 TP0005 replicative DNA helicase (dnaB) {Bacillus 
subtilis} 
DNA gyrase, subunit A (gyrA) 
{Bacillus subtilis} 
742 173 
4 TP0058 TP1005 replicative DNA helicase (dnaB) {Bacillus 
subtilis} 
DNA polymerase III, subunits 
gamma and tau (dnaH) {Borrelia 
burgdorferi} 
963 195 
5 TP0067 TP1005 conserved hypothetical protein {Borrelia 
burgdorferi} 
DNA polymerase III, subunits 
gamma and tau (dnaH) {Borrelia 
burgdorferi} 
745 89 
6 TP0103 TP1004 ATP-dependent DNA helicase, putative 
{Escherichia coli} 
recombination protein (recR) 
{Haemophilus influenzae} 
842 0 
7 TP0124 TP0005 conserved hypothetical GTP-binding protein 
{Borrelia burgdorferi} 
DNA gyrase, subunit A (gyrA) 
{Bacillus subtilis} 
807 0 
8 TP0124 TP0067 conserved hypothetical GTP-binding protein 
{Borrelia burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
461 308 
9 TP0162 TP0543 Holliday junction DNA helicase (ruvB) 
{Haemophilus influenzae} 
Holliday junction DNA helicase 
(ruvA) {Haemophilus 
influenzae} 
999 963 
10 TP0290 TP0044 conserved hypothetical protein {Lactobacillus 
sake} 
glucose inhibited division 
protein A (gidA) {Borrelia 
burgdorferi} 
477 0 
11 TP0328 TP0095 DNA mismatch repair protein (mutS) {Borrelia 
burgdorferi} 
hypothetical protein 711 0 
12 TP0343 TP0470 A/G-specific adenine glycosylase, putative 
{Helicobacter pylori} 
conserved hypothetical protein 
{Synechocystis PCC6803} 
469 0 
13 TP0344 TP0514 transcription-repair coupling factor (trcF) 
{Borrelia burgdorferi} 
excinuclease ABC, subunit A 
(uvrA) {Bacillus subtilis} 
946 0 
14 TP0380 TP0095 DNA repair helicase, putative {Saccharomyces 
cerevisiae} 
hypothetical protein 551 0 
15 TP0386 TP0383 UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-
diaminopimelate--D-alanyl-D-alanine ligase 
(murF) {Synechocystis PCC6803} 
conserved hypothetical protein 
{Enterococcus hirae} 
934 863 
16 TP0387 TP0993 cell division protein (ftsW) {Borrelia burgdorferi} rare lipoprotein A, putative 
{Borrelia burgdorferi} 
546 546 
17 TP0398 TP0026 flagellar hook-basal body co mplex protein (fliE) 
{Treponema denticola} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
998 985 
18 TP0398 TP0396 flagellar hook-basal body co mplex protein (fliE) 
{Treponema denticola} 
flagellar basal-body rod protein 
(flgB) {Treponema denticola} 
999 991 
19 TP0398 TP0870 flagellar hook-basal body co mplex protein (fliE) 
{Treponema denticola} 
flagellar filament 31 kDa core 
protein (flaB3) {Treponema 
pallidum}   
991 956 
20 TP0398 TP0961 flagellar hook-basal body co mplex protein (fliE) 
{Treponema denticola} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
998 961 
21 TP0399 TP0026 flagellar basal-body M ring protein (fliF) 
{Treponema denticola} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
999 994 
22 TP0400 TP0399 flagellar motor switch protein (fliG) {Treponema 
denticola} 
flagellar basal-body M ring 
protein (fliF) {Treponema 
denticola} 
999 994 
23 TP0401 TP0026 flagellar assembly protein (fliH) {Treponema 
denticola} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
995 982 
24 TP0402 TP0640 flagellum-specific ATP synthase (fliI) 
{Treponema denticola} 
methyl-accepting chemotaxis 
protein (mcp2) {Treponema 
pallidum} 
434 433 
25 TP0403 TP0868 flagellar protein, putative {Treponema denticola} flagellar filament 34.5 kDa core 
protein (flaB1) {Treponema 
pallidum} 
933 796 
26 TP0403 TP0961 flagellar protein, putative {Treponema denticola} flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
922 739 
27 TP0421 TP0095 conserved hypothetical protein {Borrelia 
burgdorferi} 
hypothetical protein 522 432 
28 TP0471 TP0421 hypothetical protein conserved hypothetical protein 
{Borrelia burgdorferi} 
522 432 
29 TP0496 TP0909 conserved hypothetical protein {Borrelia 
burgdorferi} 
ribosomal protein L19 (rplS) 
{Borrelia burgdorferi} 
495 89 
30 TP0497 TP0334 rod shape-determining protein (mreB) {Borrelia 
burgdorferi} 
conserved hypothetical protein 
{Bacillus subtilis} 
409 408 
31 TP0497 TP0961 rod shape-determining protein (mreB) {Borrelia flagellar basal-body rod protein 667 396 
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burgdorferi} (flgG) {Borrelia burgdorferi} 
32 TP0500 TP0993 penicillin-binding protein (pbp) {Borrelia 
burgdorferi} 
rare lipoprotein A, putative 
{Borrelia burgdorferi} 
734 734 
33 TP0501 TP0993 rod shape-determining protein (rodA) {Borrelia 
burgdorferi} 
rare lipoprotein A, putative 
{Borrelia burgdorferi} 
546 546 
34 TP0517 TP0704 Holliday junction nuclease (ruvC) {Escherichia 
coli} 
single-stranded-DNA-specific 
exonuclease (recJ) {Borrelia 
burgdorferi} 
764 107 
35 TP0526 TP0067 ATP-dependent helicase (hrpA) {Borrelia 
burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
906 312 
36 TP0526 TP0192 ATP-dependent helicase (hrpA) {Borrelia 
burgdorferi} 
ribosomal protein L2 (rplB) 
{Borrelia burgdorferi} 
671 0 
37 TP0578 TP0380 cell division protein (ftsY) {Bacillus subtilis} DNA repair helicase, putative 
{Saccharomyces cerevisiae} 
618 0 
38 TP0604 TP0060 ribosome recycling factor {Bacillus subtilis} ribosomal protein L9 (rplI) 
{Bacillus subtilis} 
649 0 
39 TP0630 TP0026 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
652 652 
40 TP0630 TP0396 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar basal-body rod protein 
(flgB) {Treponema denticola} 
713 713 
41 TP0630 TP0398 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar hook-basal body co 
mplex protein (fliE) 
{Treponema denticola} 
631 631 
42 TP0630 TP0764 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
404 294 
43 TP0630 TP0870 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar filament 31 kDa core 
protein (flaB3) {Treponema 
pallidum}   
943 873 
44 TP0630 TP0877 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
404 294 
45 TP0630 TP0961 chemotaxis protein methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
804 803 
46 TP0631 TP0961 protein-glutamate methylesterase (cheB) 
{Salmonella choleraesuis} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
520 519 
47 TP0640 TP0764 methyl-accepting chemotaxis protein (mcp2) 
{Treponema pallidum} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
887 886 
48 TP0648 TP0354 conserved hypothetical protein {Borrelia 
burgdorferi} 
thymidylate kinase (tmk) 
{Methanococcus jannaschii} 
408 86 
49 TP0648 TP0461 conserved hypothetical protein {Borrelia 
burgdorferi} 
hypothetical protein 609 607 
50 TP0648 TP0764 conserved hypothetical protein {Borrelia 
burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
492 491 
51 TP0648 TP0965 conserved hypothetical protein {Borrelia 
burgdorferi} 
membrane fusion protein, 
putative {Haemophilus 
influenzae} 
531 531 
52 TP0648 TP0981 conserved hypothetical protein {Borrelia 
burgdorferi} 
sensory transduction histidine 
kinase, putative {Synechocystis 
PCC6803} 
722 692 
53 TP0648 TP1005 conserved hypothetical protein {Borrelia 
burgdorferi} 
DNA polymerase III, subunits 
gamma and tau (dnaH) {Borrelia 
burgdorferi} 
745 89 
54 TP0659 TP0764 flagellar hook-associated protein 3 (flgL) {Borrelia 
burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
476 475 
55 TP0659 TP0961 flagellar hook-associated protein 3 (flgL) {Borrelia 
burgdorferi} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
998 991 
56 TP0660 TP0398 flagellar hook-associated protein 1 (flgK) 
{Borrelia burgdorferi} 
flagellar hook-basal body co 
mplex protein (fliE) 
{Treponema denticola} 
977 936 
57 TP0713 TP0711 flagellar-associated GTP-binding protein (flhF) 
{Treponema pallidum} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
512 512 
58 TP0716 TP0725 flagellar biosynthetic protein (fliR) {Treponema 
pallidum} 
flagellar motor rotation protein 
(motA) {Treponema pallidum} 
998 978 
59 TP0720 TP0026 flagellar motor switch protein (fliY) {Treponema 
pallidum} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
999 990 
60 TP0720 TP0397 flagellar motor switch protein (fliY) {Treponema 
pallidum} 
flagellar basal-body rod protein 
(flgC) {Treponema denticola} 
937 926 
61 TP0720 TP0660 flagellar motor switch protein (fliY) {Treponema 
pallidum} 
flagellar hook-associated protein 
1 (flgK) {Borrelia burgdorferi} 
945 894 
62 TP0720 TP0870 flagellar motor switch protein (fliY) {Treponema 
pallidum} 
flagellar filament 31 kDa core 
protein (flaB3) {Treponema 
pallidum}   
911 910 
63 TP0720 TP0961 flagellar motor switch protein (fliY) {Treponema 
pallidum} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
874 874 
64 TP0721 TP0026 flagellar motor switch protein (fliM) {Treponema 
pallidum} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
999 984 
65 TP0724 TP0961 flagellar motor rotation protein (motB) 
{Treponema pallidum} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
928 928 
66 TP0728 TP0396 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar basal-body rod protein 
(flgB) {Treponema denticola} 
998 994 
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67 TP0728 TP0398 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar hook-basal body co 
mplex protein (fliE) 
{Treponema denticola} 
996 984 
68 TP0728 TP0726 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar protein (flbD) 
{Treponema pallidum} 
768 768 
69 TP0728 TP0727 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar hook protein (flgE) 
{Treponema pallidum} 
999 998 
70 TP0728 TP0870 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar filament 31 kDa core 
protein (flaB3) {Treponema 
pallidum}   
998 993 
71 TP0728 TP0961 flagellar hook assembly scaffolding protein (flgD) 
{Treponema pallidum} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
998 994 
72 TP0730 TP0067 conserved hypothetical protein {Caenorhabditis 
elegans} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
501 162 
73 TP0738 TP0993 conserved hypothetical protein {Bacillus subtilis} rare lipoprotein A, putative 
{Borrelia burgdorferi} 
499 499 
74 TP0756 TP0757 methionyl-tRNA formyltransferase (fmt) 
{Haemophilus influenzae} 
polypeptide deformylase (def) 
{Synechocystis PCC6803} 
994 891 
75 TP0760 TP0993 penicillin-binding protein (pbp) {Borrelia 
burgdorferi} 
rare lipoprotein A, putative 
{Borrelia burgdorferi} 
734 734 
76 TP0792 TP0658 flagellar filament 33 kDa core protein (flaB2) 
{Treponema pallidum} 
transmembrane protein, putative 
{Bacillus subtilis} 
973 902 
77 TP0792 TP0764 flagellar filament 33 kDa core protein (flaB2) 
{Treponema pallidum} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
476 475 
78 TP0792 TP0961 flagellar filament 33 kDa core protein (flaB2) 
{Treponema pallidum} 
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
998 991 
79 TP0840 TP0965 conserved hypothetical integral membrane 
protein {Archaeoglobus fulgidus} 
membrane fusion protein, 
putative {Haemophilus 
influenzae} 
731 593 
80 TP0868 TP0658 flagellar filament 34.5 kDa core protein (flaB1) 
{Treponema pallidum} 
transmembrane protein, putative 
{Bacillus subtilis} 
973 902 
81 TP0870 TP0396 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
flagellar basal-body rod protein 
(flgB) {Treponema denticola} 
997 979 
82 TP0870 TP0398 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
flagellar hook-basal body co 
mplex protein (fliE) 
{Treponema denticola} 
991 956 
83 TP0870 TP0630 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
chemotaxis protein 
methyltransferase (cheR) 
{Borrelia burgdorferi} 
943 873 
84 TP0870 TP0640 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
methyl-accepting chemotaxis 
protein (mcp2) {Treponema 
pallidum} 
779 322 
85 TP0870 TP0658 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
transmembrane protein, putative 
{Bacillus subtilis} 
973 902 
86 TP0870 TP0702 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
conserved hypothetical protein 
{Borrelia burgdorferi} 
593 123 
87 TP0870 TP0764 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
conserved hypothetical protein 
{Borrelia burgdorferi} 
476 475 
88 TP0870 TP0943 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
flagellar protein (fliS) {Bacillus 
subtilis} 
999 991 
89 TP0870 TP0961 flagellar filament 31 kDa core protein (flaB3) 
{Treponema pallidum}   
flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
998 991 
90 TP0875 TP0247 conserved hypothetical protein {Synechocystis 
PCC6803} 
N-acetylmuramoyl-L-alanine 
amidase (amiA) {Escherichia 
coli} 
758 758 
91 TP0915 TP0764 conserved hypothetical protein {Borrelia 
burgdorferi} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
492 491 
92 TP0943 TP0398 flagellar protein (fliS) {Bacillus subtilis} flagellar hook-basal body co 
mplex protein (fliE) 
{Treponema denticola} 
959 910 
93 TP0943 TP0660 flagellar protein (fliS) {Bacillus subtilis} flagellar hook-associated protein 
1 (flgK) {Borrelia burgdorferi} 
991 925 
94 TP0943 TP0870 flagellar protein (fliS) {Bacillus subtilis} flagellar filament 31 kDa core 
protein (flaB3) {Treponema 
pallidum}   
999 991 
95 TP0943 TP0961 flagellar protein (fliS) {Bacillus subtilis} flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
920 857 
96 TP0959 TP0961 hypothetical protein flagellar basal-body rod protein 
(flgG) {Borrelia burgdorferi} 
974 902 
97 TP0961 TP0026 flagellar basal-body rod protein (flgG) {Borrelia 
burgdorferi} 
flagellar motor switch protein 
(fliG) {Treponema denticola} 
971 941 
98 TP0961 TP0397 flagellar basal-body rod protein (flgG) {Borrelia 
burgdorferi} 
flagellar basal-body rod protein 
(flgC) {Treponema denticola} 
999 993 
99 TP0961 TP0726 flagellar basal-body rod protein (flgG) {Borrelia 
burgdorferi} 
flagellar protein (flbD) 
{Treponema pallidum} 
467 467 
100 TP0961 TP0773 flagellar basal-body rod protein (flgG) {Borrelia 
burgdorferi} 
periplasmic serine protease DO 
(htrA) {Haemophilus 
influenzae} 
401 0 
101 TP0961 TP0870 flagellar basal-body rod protein (flgG) {Borrelia flagellar filament 31 kDa core 998 991 
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burgdorferi} protein (flaB3) {Treponema 
pallidum}   
102 TP0963 TP0965 conserved hypothetical integral membrane 
protein {Bacillus subtilis} _ 
membrane fusion protein, 
putative {Haemophilus 
influenzae} 
976 943 
103 TP0981 TP0092 sensory transduction histidine kinase, putative 
{Synechocystis PCC6803} 
RNA polymerase sigma factor E 
(rpoE) {Mycobacterium leprae} 
667 667 
104 TP0981 TP0764 sensory transduction histidine kinase, putative 
{Synechocystis PCC6803} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
911 910 
105 TP0981 TP0877 sensory transduction histidine kinase, putative 
{Synechocystis PCC6803} 
conserved hypothetical protein 
{Borrelia burgdorferi} 
911 910 
106 TP0984 TP1004 heat shock protein 90 (htpG) {Borrelia 
burgdorferi} 
recombination protein (recR) 
{Haemophilus influenzae} 
622 187 
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Supplementary Table 8 Functional Classes present in (whole)T. pallidum network 
compared to genome. 
TIGR subrole 
# in 
network 
# in 
genome 
% in 
network 
% in 
genome ratio 
No Data 190 283 35.4 37.4 0.9 
Conserved 140 176 23.9 20.4 1.2 
Other 36 60 5.2 6.1 0.9 
Ribosomal proteins: synthesis and 
modification 32 54 4.6 5.5 0.8 
DNA replication, recombination, and repair 39 49 5.7 4.9 1.1 
Chemotaxis and motility 38 45 5.5 4.5 1.2 
General 26 35 3.7 3.5 1.1 
Biosynthesis and degradation of murein 
sacculus and peptidoglycan 18 26 2.5 2.6 1.0 
tRNA aminoacylation 20 25 2.8 2.5 1.1 
Degradation of proteins, peptides, and 
glycopeptides 11 20 1.5 2.0 0.8 
Amino acids, peptides and amines 10 15 1.4 1.5 1.0 
Carbohydrates, organic alcohols, and acids 7 14 1.0 1.4 0.7 
Protein and peptide secretion and trafficking 10 14 1.4 1.4 1.0 
Cations and iron carrying compounds 10 13 1.4 1.3 1.1 
Translation factors 10 13 1.4 1.3 1.1 
ATP-proton motive force interconversion 8 13 1.1 1.3 0.9 
Unknown substrate 8 12 1.1 1.2 1.0 
Glycolysis/gluconeogenesis 7 12 1.0 1.2 0.8 
Protein folding and stabilization 6 11 0.8 1.1 0.8 
Toxin production and resistance 8 11 1.1 1.1 1.0 
Cell division 8 10 1.1 1.0 1.1 
Biosynthesis and degradation of surface 
polysaccharides and lipopolysaccharides 7 10 1.0 1.0 1.0 
DNA-dependent RNA polymerase 5 9 0.7 0.9 0.8 
Transcription factors 5 8 0.7 0.8 0.9 
Salvage of nucleosides and nucleotides 4 8 0.6 0.8 0.7 
Electron transport 6 7 0.8 0.7 1.2 
Pentose phosphate pathway 2 6 0.3 0.6 0.5 
Biosynthesis 2 5 0.3 0.5 0.6 
Sugars 4 5 0.6 0.5 1.1 
Nucleotide and nucleoside interconversions 4 5 0.6 0.5 1.1 
Degradation 2 5 0.3 0.5 0.6 
tRNA and rRNA base modification 3 4 0.4 0.4 1.1 
RNA processing 2 4 0.3 0.4 0.7 
2-Deoxyribonucleotide metabolism 3 4 0.4 0.4 1.1 
Glutamate family 4 4 0.6 0.4 1.4 
Nitrogen fixation 0 3 0.0 0.3 0.0 
Degradation of RNA 1 3 0.1 0.3 0.5 
Folic acid 1 3 0.1 0.3 0.5 
Adaptations to atypical conditions 3 3 0.4 0.3 1.4 
Aerobic 3 3 0.4 0.3 1.4 
Biosynthesis and degradation of 
polysaccharides 2 2 0.3 0.2 1.4 
Fermentation 1 2 0.1 0.2 0.7 
Detoxification 2 2 0.3 0.2 1.4 
Protein modification and repair 2 2 0.3 0.2 1.4 
Thiamine 2 2 0.3 0.2 1.4 
Pathogenesis 2 2 0.3 0.2 1.4 
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Purine ribonucleotide biosynthesis 2 2 0.3 0.2 1.4 
Biotin 1 2 0.1 0.2 0.7 
Degradation of DNA 1 2 0.1 0.2 0.7 
Aspartate family 1 2 0.1 0.2 0.7 
Sugar-nucleotide biosynthesis and conversions 1 1 0.1 0.1 1.4 
Menaquinone and ubiquinone 0 1 0.0 0.1 0.0 
Serine family 1 1 0.1 0.1 1.4 
Anaerobic 1 1 0.1 0.1 1.4 
Heme, porphyrin, and cobalamin 0 1 0.0 0.1 0.0 
Pyridine nucleotides 0 1 0.0 0.1 0.0 
Riboflavin, FMN, and FAD 0 1 0.0 0.1 0.0 
Surface structures 1 1 0.1 0.1 1.4 
DNA transformation 1 1 0.1 0.1 1.4 
Pyrimidine ribonucleotide biosynthesis 1 1 0.1 0.1 1.4 
Entner-Doudoroff 0 1 0.0 0.1 0.0 
 
Supplementary Table 9 Functional Classes present in filtered T. pallidum network 
compared to whole genome. 
TIGR subrole 
# in 
network 
# in 
genome 
% in 
network 
% in 
genome ratio 
Chemotaxis and motility 37 45 6.6 4.5 1.4 
General 16 35 2.7 3.5 0.8 
Biosynthesis and degradation of 
polysaccharides 1 2 0.2 0.2 0.9 
Protein folding and stabilization 4 11 0.7 1.1 0.6 
tRNA and rRNA base modification 2 4 0.3 0.4 0.9 
Sugar-nucleotide biosynthesis and 
conversions 1 1 0.2 0.1 1.7 
Amino acids, peptides and amines 9 15 1.5 1.5 1.0 
Menaquinone and ubiquinone 0 1 0.0 0.1 0.0 
Transcription factors 4 8 0.7 0.8 0.9 
Serine family 1 1 0.2 0.1 1.7 
Cell division 8 10 1.3 1.0 1.4 
Anaerobic 1 1 0.2 0.1 1.7 
Pentose phosphate pathway 1 6 0.2 0.6 0.3 
Fermentation 1 2 0.2 0.2 0.9 
Cations and iron carrying compounds 10 13 1.7 1.3 1.3 
Nitrogen fixation 0 3 0.0 0.3 0.0 
Biosynthesis and degradation of murein 
sacculus and peptidoglycan 15 26 2.6 2.6 1.0 
DNA-dependent RNA polymerase 5 9 0.8 0.9 1.0 
Degradation of RNA 1 3 0.2 0.3 0.6 
Folic acid 1 3 0.2 0.3 0.6 
Heme, porphyrin, and cobalamin 0 1 0.0 0.1 0.0 
Adaptations to atypical conditions 3 3 0.5 0.3 1.7 
Carbohydrates, organic alcohols, and acids 7 14 1.2 1.4 0.9 
Pyridine nucleotides 0 1 0.0 0.1 0.0 
Detoxification 1 2 0.2 0.2 0.9 
Protein modification and repair 2 2 0.3 0.2 1.7 
Toxin production and resistance 4 11 0.7 1.1 0.6 
Translation factors 9 13 1.5 1.3 1.2 
Thiamine 1 2 0.2 0.2 0.9 
RNA processing 2 4 0.3 0.4 0.9 
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Ribosomal proteins: synthesis and 
modification 25 54 4.3 5.5 0.8 
Protein and peptide secretion and 
trafficking 10 14 1.7 1.4 1.2 
Biosynthesis 2 5 0.3 0.5 0.7 
2-Deoxyribonucleotide metabolism 3 4 0.5 0.4 1.3 
Pathogenesis 2 2 0.3 0.2 1.7 
Purine ribonucleotide biosynthesis 1 2 0.2 0.2 0.9 
Salvage of nucleosides and nucleotides 2 8 0.3 0.8 0.4 
Biotin 1 2 0.2 0.2 0.9 
Sugars 3 5 0.5 0.5 1.0 
Unknown substrate 5 12 0.8 1.2 0.7 
Biosynthesis and degradation of surface 
polysaccharides and lipopolysaccharides 3 10 0.5 1.0 0.5 
Nucleotide and nucleoside 
interconversions 3 5 0.5 0.5 1.0 
Riboflavin, FMN, and FAD 0 1 0.0 0.1 0.0 
Degradation of proteins, peptides, and 
glycopeptides 9 20 1.5 2.0 0.8 
Degradation of DNA 1 2 0.2 0.2 0.9 
Glutamate family 4 4 0.7 0.4 1.7 
No Data 155 283 34.8 37.4 0.9 
Aerobic 2 3 0.3 0.3 1.2 
Degradation 1 5 0.2 0.5 0.3 
DNA replication, recombination, and 
repair 32 49 5.6 4.9 1.1 
Aspartate family 0 2 0.0 0.2 0.0 
Glycolysis/gluconeogenesis 3 12 0.5 1.2 0.4 
Electron transport 6 7 1.0 0.7 1.5 
Surface structures 0 1 0.0 0.1 0.0 
Conserved 128 176 27.1 20.4 1.3 
ATP-proton motive force interconversion 6 13 1.0 1.3 0.8 
DNA transformation 1 1 0.2 0.1 1.7 
Pyrimidine ribonucleotide biosynthesis 1 1 0.2 0.1 1.7 
Entner-Doudoroff 0 1 0.0 0.1 0.0 
Other 28 60 4.9 6.1 0.8 
tRNA aminoacylation 17 25 2.9 2.5 1.2 
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Supplementary Table 10 Functional Associations. TIGR Main Roles. 
TIGR Main Role 1 TIGR Main Role 2 Z-Value # Y2H 
interactions 
Cellular processes Cellular processes 3.65 34 
Biosynthesis of cofactors, prosthetic 
groups, and carriers 
No Data 3.34 16 
Fatty acid and phospholipid 
metabolism 
Transport and binding 
proteins 
3.30 2 
Protein fate Protein synthesis 3.09 19 
DNA metabolism DNA metabolism 2.63 16 
No Data Regulatory functions 2.46 31 
Biosynthesis of cofactors, prosthetic 
groups, and carriers 
Transport and binding 
proteins 
2.45 4 
Central intermediary metabolism No Data 2.44 9 
Cell envelope Transcription 2.31 4 
Cellular processes Protein synthesis 2.26 38 
No Data Transcription 2.11 13 
 
Supplementary Table 11 Functional Associations. TIGR subroles. 
TIGR SUBROLE 1 TIGR SUBROLE 2 Z-
Value 
# Y2H 
interactions 
Cell division Cell division 6.92 2 
Chemotaxis and motility Chemotaxis and motility 4.90 31 
Biosynthesis Cations and iron carrying 
compounds 
4.76 2 
Other Pathogenesis 4.06 2 
Carbohydrates, organic alcohols, 
and acids 
Protein folding and stabilization 3.94 2 
No Data Thiamine 3.47 15 
Amino acids, peptides and 
amines 
Cations and iron carrying 
compounds 
3.44 3 
DNA replication, recombination, 
and repair 
Glycolysis/gluconeogenesis 3.37 2 
Amino acids, peptides and 
amines 
Conserved 3.33 10 
Sugars Unknown substrate 3.10 2 
Protein and peptide secretion and 
trafficking 
tRNA aminoacylation 2.83 3 
Conserved Degradation of proteins, 
peptides, and glycopeptides 
2.72 21 
DNA replication, recombination, 
and repair 
DNA replication, recombination, 
and repair 
2.66 16 
Degradation of RNA No Data 2.63 3 
Cations and iron carrying 
compounds 
Protein and peptide secretion and 
trafficking 
2.54 3 
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Ribosomal proteins: synthesis and 
modification 
Thiamine 2.46 3 
Degradation of proteins, 
peptides, and glycopeptides 
Ribosomal proteins: synthesis 
and modification 
2.38 4 
Conserved Salvage of nucleosides and 
nucleotides 
2.19 2 
Chemotaxis and motility tRNA aminoacylation 2.12 14 
No Data Pentose phosphate pathway 2.12 9 
Biosynthesis and degradation of 
murein sacculus and 
peptidoglycan 
Conserved 2.03 27 
 
Supplementary Table 12 Functional Associations. GO slim terms. 
GO term 1 GO term 2 Z-Value # Y2H 
interactions 
ion transporter activity 
(GO:0015075) 
membrane (GO:0016020) 8.41 42 
ion transport (GO:0006811) membrane (GO:0016020) 7.36 42 
motor activity (GO:0003774) motor activity (GO:0003774) 6.94 10 
motor activity (GO:0003774) response to abiotic stimulus 
(GO:0009628) 
6.09 12 
motor activity (GO:0003774) response to external stimulus 
(GO:0009605) 
5.85 9 
cell motility (GO:0006928) response to abiotic stimulus 
(GO:0009628) 
5.56 16 
cell motility (GO:0006928) response to external stimulus 
(GO:0009605) 
5.33 12 
protein transporter activity 
(GO:0008565) 
ion transporter activity (GO:0015075) 5.20 5 
response to abiotic stimulus 
(GO:0009628) 
cell part (GO:0044464) 5.06 20 
response to external stimulus 
(GO:0009605) 
response to external stimulus 
(GO:0009605) 
4.91 4 
binding (GO:0005488) intracellular membrane-bound 
organelle (GO:0043231) 
4.84 10 
response to external stimulus 
(GO:0009605) 
cell part (GO:0044464) 4.70 15 
ion transport (GO:0006811) ion transport (GO:0006811) 4.57 8 
motor activity (GO:0003774) cell part (GO:0044464) 4.56 19 
motor activity (GO:0003774) cell motility (GO:0006928) 4.55 13 
ion transport (GO:0006811) protein transporter activity 
(GO:0008565) 
4.51 5 
ion transport (GO:0006811) ion transporter activity (GO:0015075) 4.47 8 
ion transporter activity 
(GO:0015075) 
establishment of protein localization 
(GO:0045184) 
4.28 5 
response to endogenous 
stimulus (GO:0009719) 
response to extracellular stimulus 
(GO:0009991) 
4.23 3 
chromosome (GO:0005694) intracellular membrane-bound 
organelle (GO:0043231) 
4.15 3 
binding (GO:0005488) biopolymer modification (GO:0043412) 4.14 7 
DNA binding (GO:0003677) DNA binding (GO:0003677) 4.09 11 
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molecular function unknown 
(GO:0005554) 
intracellular part (GO:0044424) 4.04 7 
DNA binding (GO:0003677) intracellular membrane-bound 
organelle (GO:0043231) 
3.90 7 
intracellular membrane-bound 
organelle (GO:0043231) 
biopolymer modification (GO:0043412) 3.89 2 
cell part (GO:0044464) cell part (GO:0044464) 3.87 25 
catalytic activity 
(GO:0003824) 
intracellular membrane-bound 
organelle (GO:0043231) 
3.87 7 
response to external stimulus 
(GO:0009605) 
response to abiotic stimulus 
(GO:0009628) 
3.85 5 
binding (GO:0005488) protein complex (GO:0043234) 3.84 14 
DNA binding (GO:0003677) energy derivation by oxidation of 
organic compounds (GO:0015980) 
3.84 2 
DNA binding (GO:0003677) helicase activity (GO:0004386) 3.83 7 
helicase activity 
(GO:0004386) 
DNA metabolism (GO:0006259) 3.82 10 
cell motility (GO:0006928) cell part (GO:0044464) 3.80 23 
ion transport (GO:0006811) establishment of protein localization 
(GO:0045184) 
3.80 5 
response to stress 
(GO:0006950) 
response to extracellular stimulus 
(GO:0009991) 
3.76 3 
DNA binding (GO:0003677) chromosome (GO:0005694) 3.71 7 
response to abiotic stimulus 
(GO:0009628) 
response to abiotic stimulus 
(GO:0009628) 
3.60 5 
ion transporter activity 
(GO:0015075) 
ion transporter activity (GO:0015075) 3.57 5 
electron transport 
(GO:0006118) 
cellular biosynthesis (GO:0044249) 3.55 7 
membrane (GO:0016020) protein catabolism (GO:0030163) 3.55 2 
nucleic acid binding 
(GO:0003676) 
response to extracellular stimulus 
(GO:0009991) 
3.52 4 
binding (GO:0005488) nucleotidyltransferase activity 
(GO:0016779) 
3.51 13 
ion transporter activity 
(GO:0015075) 
cell organization and biogenesis 
(GO:0016043) 
3.48 4 
cell motility (GO:0006928) cell motility (GO:0006928) 3.48 13 
unlocalized protein complex 
(GO:0005941) 
response to endogenous stimulus 
(GO:0009719) 
3.46 2 
ion transporter activity 
(GO:0015075) 
secretion (GO:0046903) 3.44 5 
chromosome (GO:0005694) chromosome (GO:0005694) 3.43 2 
 (GO:0016070) secondary metabolism (GO:0019748) 3.42 2 
helicase activity 
(GO:0004386) 
helicase activity (GO:0004386) 3.41 2 
catalytic activity 
(GO:0003824) 
protein complex (GO:0043234) 3.40 9 
nucleic acid binding 
(GO:0003676) 
energy derivation by oxidation of 
organic compounds (GO:0015980) 
3.40 2 
transporter activity 
(GO:0005215) 
ion transporter activity (GO:0015075) 3.39 5 
helicase activity 
(GO:0004386) 
response to extracellular stimulus 
(GO:0009991) 
3.39 2 
helicase activity 
(GO:0004386) 
response to endogenous stimulus 
(GO:0009719) 
3.39 5 
ion transport (GO:0006811) cell organization and biogenesis 
(GO:0016043) 
3.35 4 
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intracellular (GO:0005622) transcription regulator activity 
(GO:0030528) 
3.34 7 
transporter activity 
(GO:0005215) 
ion transport (GO:0006811) 3.31 5 
lipid metabolism 
(GO:0006629) 
ion transporter activity (GO:0015075) 3.30 4 
response to endogenous 
stimulus (GO:0009719) 
response to endogenous stimulus 
(GO:0009719) 
3.30 5 
binding (GO:0005488) DNA metabolism (GO:0006259) 3.29 23 
nucleic acid binding 
(GO:0003676) 
unlocalized protein complex 
(GO:0005941) 
3.28 3 
helicase activity 
(GO:0004386) 
chromosome (GO:0005694) 3.28 3 
molecular function unknown 
(GO:0005554) 
catabolism (GO:0009056) 3.27 2 
catalytic activity 
(GO:0003824) 
DNA metabolism (GO:0006259) 3.26 15 
electron transport 
(GO:0006118) 
kinase activity (GO:0016301) 3.25 4 
structural molecule activity 
(GO:0005198) 
response to abiotic stimulus 
(GO:0009628) 
3.24 13 
catalytic activity 
(GO:0003824) 
nucleotidyltransferase activity 
(GO:0016779) 
3.22 8 
membrane (GO:0016020) cell homeostasis (GO:0019725) 3.21 2 
lipid metabolism 
(GO:0006629) 
ion transport (GO:0006811) 3.20 4 
protein biosynthesis 
(GO:0006412) 
peptidase activity (GO:0008233) 3.20 13 
protein biosynthesis 
(GO:0006412) 
cellular protein metabolism 
(GO:0044267) 
3.18 20 
nucleic acid binding 
(GO:0003676) 
catalytic activity (GO:0003824) 3.18 13 
transport (GO:0006810) ion transporter activity (GO:0015075) 3.16 11 
DNA binding (GO:0003677) protein complex (GO:0043234) 3.16 11 
catabolism (GO:0009056) ion transporter activity (GO:0015075) 3.15 3 
nucleic acid binding 
(GO:0003676) 
cellular physiological process 
(GO:0050875) 
3.14 2 
oxidoreductase activity 
(GO:0016491) 
cellular biosynthesis (GO:0044249) 3.13 7 
cellular morphogenesis 
(GO:0000902) 
nuclease activity (GO:0004518) 3.10 6 
DNA metabolism 
(GO:0006259) 
energy derivation by oxidation of 
organic compounds (GO:0015980) 
3.08 2 
helicase activity 
(GO:0004386) 
response to stress (GO:0006950) 3.08 5 
nucleotide binding 
(GO:0000166) 
binding (GO:0005488) 3.07 38 
unlocalized protein complex 
(GO:0005941) 
response to stress (GO:0006950) 3.07 2 
ion transport (GO:0006811) secretion (GO:0046903) 3.06 5 
ion transport (GO:0006811) catabolism (GO:0009056) 3.05 3 
nucleic acid binding 
(GO:0003676) 
response to endogenous stimulus 
(GO:0009719) 
3.03 10 
amino acid and derivative 
metabolism (GO:0006519) 
oxidoreductase activity (GO:0016491) 3.03 5 
response to endogenous 
stimulus (GO:0009719) 
hydrolase activity (GO:0016787) 3.01 20 
binding (GO:0005488)  (GO:0016070) 3.01 14 
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structural molecule activity 
(GO:0005198) 
generation of precursor metabolites 
and energy (GO:0006091) 
3.00 3 
membrane (GO:0016020) biopolymer catabolism (GO:0043285) 3.00 2 
Supplementary Table 13 Paralogous gene families and their interactions. TIGR 
paralogous families downloaded in August 2006. The members of each family are given. 
For each family the number of total interactions (total # ints) and the number of 
interactions overlapping between different members of the same paralogous gene family 
(overlapping # ints) is given. 
Paralog family Locus Gene Symbol Common Name total 
# 
ints 
overlapping 
# ints 
gtp family_01 TP0008   hypothetical protein 2  
 TP0014   hypothetical protein   
gtp family_02 TP0011 tprB tpr protein B 6 2 
 TP0117 tprC tpr protein C   
 TP0131 tprD tpr protein D   
 TP0313 tprE tpr protein E   
 TP0316 tprF tpr protein F, authentic 
frameshift 
  
 TP0317 tprG tpr protein G   
 TP0610 tprH tpr protein H   
 TP0620 tprI tpr protein I   
 TP0621 tprJ tpr protein J   
 TP0897 tprK tpr protein K   
gtp family_03 TP0024   conserved hypothetical 
protein 
16  
 TP0139   conserved hypothetical 
protein 
  
gtp family_04 TP0026 fliG-1 flagellar motor switch protein 20 2 
 TP0400 fliG-2 flagellar motor switch protein   
gtp family_05 TP0034   ABC transporter, periplasmic 
binding protein 
8  
 TP0163 troA ABC transporter, periplasmic 
binding protein 
  
gtp family_06 TP0035   ABC transporter, ATP-
binding protein 
11  
 TP0120 abc amino acid ABC transporter, 
ATP-binding protein 
  
 TP0142   thiamine ABC transporter, 
ATP-binding protein, 
putative 
  
 TP0164 troB ABC transporter, ATP-
binding protein 
  
 TP0227   cobalt ABC transporter, 
ATP-binding protein 
  
 TP0300 rbsA-1 ribose/galactose ABC 
transporter, ATP-binding 
protein 
  
 TP0321 rbsA-2 ribose/galactose ABC 
transporter, ATP-binding 
protein 
  
 TP0581   ABC transporter, ATP-
binding protein 
  
 TP0652 potA spermidine/putrescine ABC 
transporter, ATP-binding 
protein 
  
 TP0685 mglA methylgalactoside ABC 
transporter, ATP binding 
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protein 
 TP0786   ABC transporter, ATP-
binding protein, putative 
  
 TP0804 ugpC sugar ABC transporter, ATP-
binding protein 
  
 TP0881 natA ABC transporter, ATP-
binding protein 
  
 TP0964   ABC transporter, ATP-
binding protein 
  
gtp family_07 TP0036   ABC transporter, permease 
protein 
5  
 TP0165 troC ABC transporter, permease 
protein 
  
 TP0166 troD ABC transporter, permease 
protein 
  
gtp family_08 TP0040 mcp1 methyl-accepting chemotaxis 
protein 
10  
 TP0488 mcp2-1 methyl-accepting chemotaxis 
protein 
  
 TP0639 mcp2-2 methyl-accepting chemotaxis 
protein 
  
 TP0640 mcp2-3 methyl-accepting chemotaxis 
protein 
  
gtp family_09 TP0051 prfA peptide chain release factor 1 4  
 TP0576 prfB peptide chain release factor 2   
gtp family_10 TP0082 fhlA formate hydrogenlyase 
transcriptional activator 
32  
 TP0519 atoC response regulatory protein   
gtp family_11 TP0089   cyclic nucleotide binding 
protein 
2  
 TP0262 crp catabolite gene activator   
gtp family_12 TP0102 rep rep helicase, single-stranded 
DNA-dependent ATPase 
1  
 TP1028 uvrD DNA helicase II   
gtp family_13 TP0126   hypothetical protein 2  
 TP0733   hypothetical protein   
gtp family_14 TP0127   hypothetical protein 29  
 TP0314   hypothetical protein   
 TP0315   hypothetical protein   
 TP0617   hypothetical protein   
 TP0618   hypothetical protein   
 TP0619   hypothetical protein   
gtp family_15 TP0133   hypothetical protein 20  
 TP0134   hypothetical protein   
 TP0136   hypothetical protein   
 TP0462   hypothetical protein   
 TP0463   hypothetical protein   
gtp family_16 TP0252   apolipoprotein N-
acyltransferase, putative 
2  
 TP0417 cutE apolipoprotein N-
acyltransferase 
  
gtp family_17 TP0268   conserved hypothetical 
protein 
8  
 TP0820   hypothetical protein   
gtp family_18 TP0270 pcnA polynucleotide 
adenylyltransferase 
2  
 TP0596 pcnB polynucleotide 
adenylyltransferase 
  
gtp family_19 TP0298 tpn38b exported protein 2  
 TP0319 tmpC membrane lipoprotein   
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gtp family_20 TP0308 hisJ amino acid ABC transporter, 
periplasmic binding protein 
  
 TP0309   amino acid ABC transporter, 
periplasmic binding protein 
  
gtp family_21 TP0346   hypothetical protein   
 TP0347   hypothetical protein   
gtp family_22 TP0364 cheW-1 purine-binding chemotaxis 
protein 
  
 TP0439 cheW-2 purine-binding chemotaxis 
protein 
  
gtp family_23 TP0387 ftsW cell division protein 12 4 
 TP0501 rodA rod shape-determining 
protein 
  
gtp family_24 TP0391 codV integrase/recombinase 1  
 TP0395 xprB integrase/recombinase   
gtp family_25 TP0402 fliI flagellum-specific ATP 
synthase 
5  
 TP0426 atpA-1 V-type ATPase, subunit A   
 TP0427 atpB-1 V-type ATPase, subunit B   
 TP0528 atpB-2 V-type ATPase, subunit B   
 TP0529 atpA-2 V-type ATPase, subunit A   
gtp family_26 TP0414 dagA D-alanine glycine permease 4  
 TP0998   sodium/proton-dependent 
alanine transporter 
  
gtp family_27 TP0416 ffh signal recognition particle 
protein 
6  
 TP0578 ftsY signal recognition particle-
docking protein FtsY 
  
gtp family_28 TP0450 fusA-1 translation elongation factor 
G 
  
 TP0767 fusA-2 translation elongation factor 
G 
  
gtp family_29 TP0471   hypothetical protein 2  
 TP0915   conserved hypothetical 
protein 
  
gtp family_30 TP0479   hypothetical protein 1  
 TP0697   hypothetical protein   
gtp family_31 TP0493 rpoD RNA polymerase sigma-70 
factor 
1  
 TP0709   RNA polymerase sigma-28 
factor 
  
 TP1012 sigA RNA polymerase sigma-43 
factor 
  
gtp family_32 TP0507 clpP-1 ATP-dependent Clp protease 
proteolytic component 
2  
 TP1041 clpP-2 ATP-dependent Clp protease 
proteolytic component 
  
gtp family_33 TP0546   periplasmic serine protease, 
putative 
31  
 TP0773 htrA-1 periplasmic serine protease 
DO 
  
 TP0841 htrA-2 periplasmic serine protease 
DO 
  
gtp family_34 TP0548   hypothetical protein 3  
 TP0856   hypothetical protein   
 TP0858   hypothetical protein   
 TP0859   hypothetical protein   
 TP0860   hypothetical protein   
 TP0865   hypothetical protein   
gtp family_35 TP0580   conserved hypothetical 11  
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integral membrane protein 
 TP0582   conserved hypothetical 
integral membrane protein 
  
gtp family_36 TP0663   outer membrane protein, 
putative 
36  
 TP0664 flaA-2 flagellar filament outer layer 
protein 
  
gtp family_37 TP0702   conserved hypothetical 
protein 
6  
 TP0706   conserved hypothetical 
protein 
  
 TP0864   conserved hypothetical 
protein 
  
gtp family_38 TP0764   conserved hypothetical 
protein 
2  
 TP0912   conserved hypothetical 
protein 
  
gtp family_39 TP0792 flaB2 flagellar filament 33 kDa core 
protein 
27 8 
 TP0868 flaB1 flagellar filament 34.5 kDa 
core protein 
  
 TP0870 flaB3 flagellar filament 31 kDa core 
protein 
  
gtp family_40 TP0960 flgG-1 flagellar basal-body rod 
protein 
21 2 
 TP0961 flgG-2 flagellar basal-body rod 
protein 
  
gtp family_41 TP0962   conserved hypothetical 
integral membrane protein 
2  
 TP0963   conserved hypothetical 
integral membrane protein 
  
gtp family_42 TP0966   hypothetical protein 2  
 TP0967   hypothetical protein   
 TP0968   hypothetical protein   
 TP0969   hypothetical protein   
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Supplementary Table 14 Interactions of paralogous gene families II. Paralogous families 
as downloaded from TIGR-CMR in October 2006 are analyzed. 
paralogous family 
(annotation) 
interacting  
ORF 
annotation # interactions 
gtp fam_PF00271 
(helicases) 
TP0559 conserved hypothetical protein 3 TP0380-TP0559 
TP0103-TP0559 
TP0526-TP0559 
 
gtp fam_PF04055 
(radical SAM 
superfamily) 
TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH) {Borrelia burgdorferi} 
3 TP0754-TP1005 
TP0121-TP1005 
TP0068-TP1005 
 
gtp fam_PF01547 
(bacterial solute 
binding protein) 
TP0445 4-methyl-5(b-hydroxyethyl)-thiazole 
monophosphate biosynthesis enzyme 
(thiJ) {Borrelia burgdorferi} 
2 TP0074-TP0445 
TP0655-TP0445 
 
gtp fam_PF00460 
(Flagella rod 
protein) 
TP0772 hypothetical protein 2 TP0772-TP0396 
TP0961-TP0772 
 
gtp fam_PF00460 
(Flagella rod 
protein) 
TP0832 hypothetical protein 2 TP0960-TP0832 
TP0961-TP0832 
 
gtp fam_PF00460 
(Flagella rod 
protein) 
TP0728 flagellar hook assembly scaffolding protein 
(flgD) {Treponema pallidum} 
2 TP0728-TP0727 
TP0728-TP0396 
 
gtp fam_51 
(flagellins) 
TP0832 hypothetical protein 3 TP0792-TP0832 
TP0868-TP0832 
TP0870-TP0832 
 
gtp fam_51 
(flagellins) 
TP0658 transmembrane protein, putative {Bacillus 
subtilis} 
3 TP0868-TP0658 
TP0870-TP0658 
TP0792-TP0658 
 
gtp fam_51 
(flagellins) 
TP0050 conserved hypothetical protein {Borrelia 
burgdorferi} 
2 TP0868-TP0050 
TP0870-TP0050 
 
gtp fam_PF00575 
(S1 RNA binding) 
TP0833 hypothetical protein 2 TP0097-TP0833 
TP0924-TP0833 
 
gtp fam_PF01052 
(SpoA) 
TP0066 hypothetical protein 2 TP0720-TP0066 
TP0721-TP0066 
 
gtp fam_PF01052 
(SpoA) 
TP0026 flagellar motor switch protein (fliG) 
{Treponema denticola} 
2 TP0720-TP0026 
TP0721-TP0026 
 
gtp fam_PF02687 
(FtsX) 
TP0965 membrane fusion protein, putative 
{Haemophilus influenzae} 
2 TP0582-TP0965 
TP0963-TP0965 
 
gtp fam_28 
(fliG) 
TP0399 flagellar basal-body M ring protein (fliF) 
{Treponema denticola} 
2 TP0400-TP0399 
TP0399-TP0026 
 
gtp fam_PF02254 
(TrkA-N) 
TP0086 conserved hypothetical protein {Borrelia 
burgdorferi} 
2 TP0086-TP0513 
TP0086-TP0024 
 
gtp fam_PF02254 
(TrkA-N) 
TP0661 hypothetical protein 2 TP0661-TP0513 
TP0661-TP0024 
 
gtp fam_PF02254 TP0648 conserved hypothetical protein {Borrelia 2 TP0648-TP0513 
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(TrkA-N) burgdorferi} TP0648-TP0024 
 
gtp fam_PF01098 
(FtsW/RodA) 
TP0917 Mg2+ transport protein (mgtE) {Borrelia 
burgdorferi} 
2 TP0501-TP0917 
TP0387-TP0917 
 
gtp fam_PF01098 
(FtsW/RodA) 
TP0561 conserved hypothetical protein 
{Escherichia coli} 
2 TP0501-TP0561 
TP0387-TP0561 
 
gtp fam_PF02722 
(MOSP_C) 
TP0209 ribosomal protein L36 (rpmJ) {Chlorella 
vulgaris} 
2 TP0117-TP0209 
TP0610-TP0209 
 
gtp fam_PF00004 
(AAA) 
TP0330 cell division protein (ftsH) {Mycoplasma 
genitalium} 
2 TP0330-TP0330 
TP0330-TP0330 
 
gtp fam_PF00004 
(AAA) 
TP0171 lipoprotein, 15 kDa (tpp15) {Treponema 
pallidum} 
2 TP0162-TP0171 
TP1005-TP0171 
 
gtp fam_PF00004 
(AAA) 
TP0630 chemotaxis protein methyltransferase 
(cheR) {Borrelia burgdorferi} 
3 TP0630-TP0162 
TP0630-TP0330 
TP0630-TP1005 
 
gtp fam_PF00004 
(AAA) 
TP0582 conserved hypothetical integral membrane 
protein {Borrelia burgdorferi} 
2 TP0582-TP1005 
TP0582-TP0765 
 
gtp fam_PF00004 
(AAA) 
TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH) {Borrelia burgdorferi} 
2 TP1005-TP1005 
TP1005-TP1005 
 
gtp fam_PF02653 
(permease component) 
TP0561 conserved hypothetical protein 
{Escherichia coli} 
2 TP0322-TP0561 
TP0301-TP0561 
 
gtp fam_PF02653 
(permease component) 
TP0917 Mg2+ transport protein (mgtE) {Borrelia 
burgdorferi} 
2 TP0301-TP0917 
TP0302-TP0917 
 
gtp fam_PF00226 
(DnaJ) 
TP0981 sensory transduction histidine kinase, 
putative {Synechocystis PCC6803} 
2 TP0563-TP0981 
TP0981-TP0843 
 
gtp fam_PF00515 
(TPR 1) 
TP0080 quinoline 2-oxidoreductase {Pseudomonas 
putida} 
2 TP0820-TP0080 
TP0080-TP0920 
 
gtp fam_PF00515 
(TPR 1) 
TP0559 conserved hypothetical protein 
{Archaeoglobus fulgidus} 
2 TP0067-TP0559 
TP0095-TP0559 
 
gtp fam_PF00515 
(TPR 1) 
TP0738 conserved hypothetical protein {Bacillus 
subtilis} 
2 TP0738-TP0067 
TP0738-TP0095 
 
gtp fam_PF00515 
(TPR 1) 
TP0094 phosphate acetyltransferase (pta) 
{Methanosarcina thermophila} 
2 TP0094-TP0067 
TP0094-TP0920 
 
gtp fam_PF00515 
(TPR 1) 
TP0418 galactokinase {Homo sapiens} 2 TP0418-TP0067 
TP0418-TP0095 
 
gtp fam_PF00515 
(TPR 1) 
TP0095 hypothetical protein 2 TP0067-TP0095 
TP0648-TP0095 
 
gtp fam_PF00515 
(TPR 1) 
TP0492 DNA primase (dnaE) {Clostridium 
acetobutylicum} 
3 TP0492-TP0648 
TP0492-TP0095 
TP0496-TP0492 
 
gtp fam_PF00515 
(TPR 1) 
TP0819 conserved hypothetical protein {Borrelia 
burgdorferi} 
2 TP0819-TP0095 
TP0819-TP0920 
 
gtp fam_PF00515 
(TPR 1) 
TP1005 DNA polymerase III, subunits gamma and 
tau (dnaH) {Borrelia burgdorferi} 
2 TP0067-TP1005 
TP0648-TP1005 
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gtp fam_PF00515 
(TPR 1) 
TP0132 hypothetical protein 2 TP0132-TP0067 
TP0132-TP0095 
 
gtp fam_PF00515 
(TPR 1) 
TP0421 conserved hypothetical protein {Borrelia 
burgdorferi} 
2 TP0421-TP0095 
TP0471-TP0421 
 
gtp fam_PF00515 
(TPR 1) 
TP0247 N-acetylmuramoyl-L-alanine amidase 
(amiA) {Escherichia coli} 
2 TP0820-TP0247 
TP0247-TP0067 
 
gtp fam_PF00515 
(TPR 1) 
TP0586 leucyl-tRNA synthetase (leuS) {Borrelia 
burgdorferi} 
2 TP0067-TP0586 
TP0648-TP0586 
 
gtp fam_PF01066 
(CDP-OH_P_transf) 
TP0917 Mg2+ transport protein (mgtE) {Borrelia 
burgdorferi} 
2 TP0671-TP0917 
TP0256-TP0917 
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Supplementary Table 15 Domain Interactions.  Domain information for T. pallidum 
proteins was taken from Pfam database {ref}. The number of interactions (#Y2H links) 
between two proteins with the respective domains is shown. To estimate the significance 
a Z-value was calculated (a threshold of 2 was chosen), which indicates the “enrichment” 
of a specific domain-domain link compared to a distribution of 1000 randomized 
networks. Due to the limited number of Y2H links the calculated significance cannot be 
assured for all domain pairs.  
 
 
Pfam Domain 1 
Pfam Domain 2 # 
Y2H  
links 
Z-
Value 
Y2H interactions (domains) 
PF01514 YscJ_FliF PF01706 FliG_C 2 9.99 TP0400(PF01706)-TP0399(PF01514) 
TP0399(PF01514)-TP0026(PF01706) 
PF00700 Flagellin_C PF02623 DUF180 3 9.56 TP0868(PF00700)-TP0658(PF02623) 
TP0870(PF00700)-TP0658(PF02623) 
TP0792(PF00700)-TP0658(PF02623) 
PF00669 Flagellin_N PF02623 DUF180 3 9.05 TP0868(PF00669)-TP0658(PF02623) 
TP0870(PF00669)-TP0658(PF02623) 
TP0792(PF00669)-TP0658(PF02623) 
PF00226 DnaJ PF00990 GGDEF 2 7.79 TP0563(PF00226)-TP0981(PF00990) 
TP0981(PF00990)-TP0843(PF00226) 
PF01926 MMR_HSR1 PF02272 DHHA1 2 7.40 TP0124(PF01926)-TP0704(PF02272) 
TP0541(PF01926)-TP0704(PF02272) 
PF00364 Biotin_lipoyl PF02687 FtsX 2 6.97 TP0582(PF02687)-TP0965(PF00364) 
TP0963(PF02687)-TP0965(PF00364) 
PF01368 DHH PF01926 MMR_HS
R1 
2 6.85 TP0124(PF01926)-TP0704(PF01368) 
TP0541(PF01926)-TP0704(PF01368) 
PF00004 AAA PF04055 Radical_S
AM 
3 5.54 TP0754(PF04055)-TP1005(PF00004) 
TP0121(PF04055)-TP1005(PF00004) 
TP0068(PF04055)-TP1005(PF00004) 
PF00004 AAA PF04205 FMN_bin
d 
2 5.44 TP0162(PF00004)-TP0171(PF04205) 
TP1005(PF00004)-TP0171(PF04205) 
PF01052 SpoA PF01706 FliG_C 2 5.41 TP0720(PF01052)-TP0026(PF01706) 
TP0721(PF01052)-TP0026(PF01706) 
PF01547 SBP_bac_1 PF01965 DJ-1_PfpI 2 4.94 TP0074(PF01547)-TP0445(PF01965) 
TP0655(PF01547)-TP0445(PF01965) 
PF00460 Flg_bb_rod PF03963 FlgD 2 4.56 TP0728(PF03963)-TP0727(PF00460) 
TP0728(PF03963)-TP0396(PF00460) 
PF02653 BPD_transp_
2 
PF04536 DUF477 2 4.51 TP0322(PF02653)-TP0561(PF04536) 
TP0301(PF02653)-TP0561(PF04536) 
PF01769 MgtE PF02653 BPD_tran
sp_2 
2 4.39 TP0301(PF02653)-TP0917(PF01769) 
TP0302(PF02653)-TP0917(PF01769) 
PF02653 BPD_transp_
2 
PF03448 MgtE_N 2 4.39 TP0301(PF02653)-TP0917(PF03448) 
TP0302(PF02653)-TP0917(PF03448) 
PF00004 AAA PF01739 CheR 3 4.36 TP0630(PF01739)-TP0162(PF00004) 
TP0630(PF01739)-TP0330(PF00004) 
TP0630(PF01739)-TP1005(PF00004) 
PF00004 AAA PF03705 CheR_N 3 4.36 TP0630(PF03705)-TP0162(PF00004) 
TP0630(PF03705)-TP0330(PF00004) 
TP0630(PF03705)-TP1005(PF00004) 
PF00571 CBS PF02653 BPD_tran
sp_2 
2 4.34 TP0301(PF02653)-TP0917(PF00571) 
TP0302(PF02653)-TP0917(PF00571) 
PF00271 Helicase_C PF02568 ThiI 3 4.30 TP0380(PF00271)-TP0559(PF02568) 
TP0103(PF00271)-TP0559(PF02568) 
TP0526(PF00271)-TP0559(PF02568) 
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PF00271 Helicase_C PF02926 THUMP 3 4.30 TP0380(PF00271)-TP0559(PF02926) 
TP0103(PF00271)-TP0559(PF02926) 
TP0526(PF00271)-TP0559(PF02926) 
PF00571 CBS PF01066 CDP-
OH_P_tra
nsf 
2 4.28 TP0671(PF01066)-TP0917(PF00571) 
TP0256(PF01066)-TP0917(PF00571) 
PF01066 CDP-
OH_P_transf 
PF01769 MgtE 2 4.28 TP0671(PF01066)-TP0917(PF01769) 
TP0256(PF01066)-TP0917(PF01769) 
PF01066 CDP-
OH_P_transf 
PF03448 MgtE_N 2 4.28 TP0671(PF01066)-TP0917(PF03448) 
TP0256(PF01066)-TP0917(PF03448) 
PF00156 Pribosyltran PF00700 Flagellin_
C 
2 3.94 TP0868(PF00700)-TP0050(PF00156) 
TP0870(PF00700)-TP0050(PF00156) 
PF02254 TrkA_N PF07238 PilZ 2 3.93 TP0086(PF07238)-TP0513(PF02254) 
TP0086(PF07238)-TP0024(PF02254) 
PF02080 TrkA_C PF07238 PilZ 2 3.93 TP0086(PF07238)-TP0513(PF02080) 
TP0086(PF07238)-TP0024(PF02080) 
PF00515 TPR_1 PF01436 NHL 2 3.84 TP0421(PF01436)-TP0095(PF00515) 
TP0471(PF00515)-TP0421(PF01436) 
PF01436 NHL PF07719 TPR_2 2 3.84 TP0421(PF01436)-TP0095(PF07719) 
TP0471(PF07719)-TP0421(PF01436) 
PF02938 GAD PF04536 DUF477 2 3.78 TP0561(PF04536)-TP0985(PF02938) 
TP0985(PF02938)-TP0561(PF04536) 
PF01336 tRNA_anti PF04536 DUF477 2 3.78 TP0561(PF04536)-TP0985(PF01336) 
TP0985(PF01336)-TP0561(PF04536) 
PF00152 tRNA-synt_2 PF04536 DUF477 2 3.77 TP0561(PF04536)-TP0985(PF00152) 
TP0985(PF00152)-TP0561(PF04536) 
PF00669 Flagellin_N PF04073 YbaK 2 3.67 TP0792(PF00669)-TP0160(PF04073) 
TP0659(PF00669)-TP0160(PF04073) 
PF00156 Pribosyltran PF00669 Flagellin_
N 
2 3.64 TP0868(PF00669)-TP0050(PF00156) 
TP0870(PF00669)-TP0050(PF00156) 
PF01807 zf-CHC2 PF07719 TPR_2 3 3.30 TP0492(PF01807)-TP0648(PF07719) 
TP0492(PF01807)-TP0095(PF07719) 
TP0496(PF07719)-TP0492(PF01807) 
PF07719 TPR_2 PF08275 Toprim_N 3 3.30 TP0492(PF08275)-TP0648(PF07719) 
TP0492(PF08275)-TP0095(PF07719) 
TP0496(PF07719)-TP0492(PF08275) 
PF01098 FTSW_ROD
A_SPOVE 
PF04536 DUF477 2 3.20 TP0501(PF01098)-TP0561(PF04536) 
TP0387(PF01098)-TP0561(PF04536) 
PF00571 CBS PF01098 FTSW_R
ODA_SP
OVE 
2 3.06 TP0501(PF01098)-TP0917(PF00571) 
TP0387(PF01098)-TP0917(PF00571) 
PF01098 FTSW_ROD
A_SPOVE 
PF03448 MgtE_N 2 3.06 TP0501(PF01098)-TP0917(PF03448) 
TP0387(PF01098)-TP0917(PF03448) 
PF01098 FTSW_ROD
A_SPOVE 
PF01769 MgtE 2 3.06 TP0501(PF01098)-TP0917(PF01769) 
TP0387(PF01098)-TP0917(PF01769) 
PF00460 Flg_bb_rod PF02875 Mur_ligase
_C 
2 3.03 TP0961(PF00460)-TP0341(PF02875) 
TP0903(PF02875)-TP0396(PF00460) 
PF00460 Flg_bb_rod PF08245 Mur_ligase
_M 
2 3.03 TP0961(PF00460)-TP0341(PF08245) 
TP0903(PF08245)-TP0396(PF00460) 
PF01476 LysM PF03448 MgtE_N 2 3.02 TP0042(PF01476)-TP0917(PF03448) 
TP0155(PF01476)-TP0917(PF03448) 
PF00571 CBS PF01476 LysM 2 3.02 TP0042(PF01476)-TP0917(PF00571) 
TP0155(PF01476)-TP0917(PF00571) 
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PF01476 LysM PF01769 MgtE 2 3.02 TP0042(PF01476)-TP0917(PF01769) 
TP0155(PF01476)-TP0917(PF01769) 
PF00515 TPR_1 PF01515 PTA_PTB 2 3.01 TP0094(PF01515)-TP0067(PF00515) 
TP0094(PF01515)-TP0920(PF00515) 
PF01515 PTA_PTB PF07719 TPR_2 2 2.90 TP0094(PF01515)-TP0067(PF07719) 
TP0094(PF01515)-TP0920(PF07719) 
PF01751 Toprim PF07719 TPR_2 3 2.89 TP0492(PF01751)-TP0648(PF07719) 
TP0492(PF01751)-TP0095(PF07719) 
TP0496(PF07719)-TP0492(PF01751) 
PF02254 TrkA_N PF06429 DUF1078 2 2.89 TP0660(PF06429)-TP0024(PF02254) 
TP0961(PF06429)-TP0024(PF02254) 
PF02080 TrkA_C PF06429 DUF1078 2 2.89 TP0660(PF06429)-TP0024(PF02080) 
TP0961(PF06429)-TP0024(PF02080) 
PF00515 TPR_1 PF01799 Fer2_2 2 2.80 TP0820(PF00515)-TP0080(PF01799) 
TP0080(PF01799)-TP0920(PF00515) 
PF04509 CheC PF06429 DUF1078 2 2.75 TP0720(PF04509)-TP0660(PF06429) 
TP0720(PF04509)-TP0397(PF06429) 
PF00669 Flagellin_N PF03129 HGTP_an
ticodon 
2 2.71 TP0792(PF00669)-TP0160(PF03129) 
TP0659(PF00669)-TP0160(PF03129) 
PF00587 tRNA-
synt_2b 
PF00669 Flagellin_
N 
2 2.71 TP0792(PF00669)-TP0160(PF00587) 
TP0659(PF00669)-TP0160(PF00587) 
PF01966 HD PF06429 DUF1078 2 2.68 TP0651(PF01966)-TP0397(PF06429) 
TP0961(PF06429)-TP0877(PF01966) 
PF00004 AAA PF02687 FtsX 2 2.63 TP0582(PF02687)-TP1005(PF00004) 
TP0582(PF02687)-TP0765(PF00004) 
PF00004 AAA PF00004 AAA 2 2.60 TP0330(PF00004)-TP0330(PF00004) 
TP1005(PF00004)-TP1005(PF00004) 
PF02775 TPP_enzyme
_C 
PF07719 TPR_2 2 2.59 TP0421(PF07719)-TP0939(PF02775) 
TP0648(PF07719)-TP0939(PF02775) 
PF01855 POR_N PF07719 TPR_2 2 2.59 TP0421(PF07719)-TP0939(PF01855) 
TP0648(PF07719)-TP0939(PF01855) 
PF01558 POR PF07719 TPR_2 2 2.59 TP0421(PF07719)-TP0939(PF01558) 
TP0648(PF07719)-TP0939(PF01558) 
PF00037 Fer4 PF07719 TPR_2 2 2.59 TP0421(PF07719)-TP0939(PF00037) 
TP0648(PF07719)-TP0939(PF00037) 
PF00515 TPR_1 PF00753 Lactamase
_B 
2 2.58 TP0819(PF00753)-TP0095(PF00515) 
TP0819(PF00753)-TP0920(PF00515) 
PF00753 Lactamase_B PF07719 TPR_2 2 2.51 TP0819(PF00753)-TP0095(PF07719) 
TP0819(PF00753)-TP0920(PF07719) 
PF01052 SpoA PF06429 DUF1078 2 2.39 TP0720(PF01052)-TP0660(PF06429) 
TP0720(PF01052)-TP0397(PF06429) 
PF07719 TPR_2 PF07719 TPR_2 4 2.37 TP0421(PF07719)-TP0095(PF07719) 
TP0471(PF07719)-TP0421(PF07719) 
TP0067(PF07719)-TP0095(PF07719) 
TP0648(PF07719)-TP0095(PF07719) 
PF00133 tRNA-synt_1 PF00515 TPR_1 2 2.37 TP0067(PF00515)-TP0586(PF00133) 
TP0648(PF00515)-TP0586(PF00133) 
PF00515 TPR_1 PF08264 Anticodon
_1 
2 2.37 TP0067(PF00515)-TP0586(PF08264) 
TP0648(PF00515)-TP0586(PF08264) 
PF04851 ResIII PF07719 TPR_2 2 2.28 TP0380(PF04851)-TP0421(PF07719) 
TP0380(PF04851)-TP0095(PF07719) 
PF00133 tRNA-synt_1 PF07719 TPR_2 2 2.27 TP0067(PF07719)-TP0586(PF00133) 
TP0648(PF07719)-TP0586(PF00133) 
PF07719 TPR_2 PF08264 Anticodon
_1 
2 2.27 TP0067(PF07719)-TP0586(PF08264) 
TP0648(PF07719)-TP0586(PF08264) 
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PF00271 Helicase_C PF07719 TPR_2 3 2.21 TP0380(PF00271)-TP0421(PF07719) 
TP0380(PF00271)-TP0095(PF07719) 
TP0526(PF00271)-TP0067(PF07719) 
PF00515 TPR_1 PF02080 TrkA_C 2 2.15 TP0648(PF00515)-TP0513(PF02080) 
TP0648(PF00515)-TP0024(PF02080) 
PF00515 TPR_1 PF02254 TrkA_N 2 2.15 TP0648(PF00515)-TP0513(PF02254) 
TP0648(PF00515)-TP0024(PF02254) 
PF02254 TrkA_N PF07719 TPR_2 2 2.13 TP0648(PF07719)-TP0513(PF02254) 
TP0648(PF07719)-TP0024(PF02254) 
PF02080 TrkA_C PF07719 TPR_2 2 2.13 TP0648(PF07719)-TP0513(PF02080) 
TP0648(PF07719)-TP0024(PF02080) 
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Supplementary Table 16 Selected (highly reliable) interactions of four conservation 
classes 
 COG1 COG2 TPA1 TPA2 Description 1 Description 2 
COG1026 COG2269 TP0025 TP1040 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
lysyl-tRNA synthetase 
(lysS) {Escherichia 
coli} 
COG1419 NOG46983 TP0713 TP0711 flagellar-associated GTP-
binding protein (flhF) 
{Treponema pallidum} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
COG1344 COG1699 TP0870 TP0658 flagellar filament 31 kDa 
core protein (flaB3) 
{Treponema pallidum}   
transmembrane 
protein, putative 
{Bacillus subtilis} 
COG1582 COG1843 TP0726 TP0728 flagellar protein (flbD) 
{Treponema pallidum} 
flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
COG1582 COG4786 TP0726 TP0961 flagellar protein (flbD) 
{Treponema pallidum} 
flagellar basal-body rod 
protein (flgG) {Borrelia 
burgdorferi} 
COG1077 COG1426 TP0497 TP0334 rod shape-determining 
protein (mreB) {Borrelia 
burgdorferi} 
conserved hypothetical 
protein {Bacillus 
subtilis} 
COG1595 COG2199 TP0092 TP0981 RNA polymerase sigma 
factor E (rpoE) 
{Mycobacterium leprae} 
sensory transduction 
histidine kinase, 
putative {Synechocystis 
PCC6803} 
COG1352 COG2206 TP0630 TP0877 chemotaxis protein 
methyltransferase (cheR) 
{Borrelia burgdorferi} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
COG2199 COG2206 TP0981 TP0877 sensory transduction 
histidine kinase, putative 
{Synechocystis PCC6803} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
COG2204 COG2204 TP0519 TP0519 response regulatory 
protein (atoC) {Borrelia 
burgdorferi} 
response regulatory 
protein (atoC) 
{Borrelia burgdorferi} 
COG0280 COG2204 TP0094 TP0519 phosphate 
acetyltransferase (pta) 
{Methanosarcina 
thermophila} 
response regulatory 
protein (atoC) 
{Borrelia burgdorferi} 
COG1014 COG1815 TP0939 TP0396 pyruvate oxidoreductase 
{Synechocystis PCC6803} 
flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
COG1344 COG2199 TP0870 TP0981 flagellar filament 31 kDa 
core protein (flaB3) 
{Treponema pallidum}   
sensory transduction 
histidine kinase, 
putative {Synechocystis 
PCC6803} 
COG0739 COG1344 TP0702 TP0870 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
COG0840 COG1344 TP0640 TP0870 methyl-accepting 
chemotaxis protein (mcp2) 
{Treponema pallidum} 
flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
COG0840 COG1157 TP0640 TP0402 methyl-accepting 
chemotaxis protein (mcp2) 
{Treponema pallidum} 
flagellum-specific ATP 
synthase (fliI) 
{Treponema denticola} 
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COG1317 COG1536 TP0401 TP0026 flagellar assembly protein 
(fliH) {Treponema 
flagellar motor switch 
protein (fliG) 
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denticola} {Treponema denticola} 
COG1256 COG1886 TP0660 TP0720 flagellar hook-associated 
protein 1 (flgK) {Borrelia 
burgdorferi} 
flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
COG1558 COG1886 TP0397 TP0720 flagellar basal-body rod 
protein (flgC) {Treponema 
denticola} 
flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
COG1536 COG1886 TP0026 TP0720 flagellar motor switch 
protein (fliG) {Treponema 
denticola} 
flagellar motor switch 
protein (fliY) 
{Treponema pallidum} 
COG1536 COG1766 TP0400 TP0399 flagellar motor switch 
protein (fliG) {Treponema 
denticola} 
flagellar basal-body M 
ring protein (fliF) 
{Treponema denticola} 
COG1536 COG1868 TP0026 TP0721 flagellar motor switch 
protein (fliG) {Treponema 
denticola} 
flagellar motor switch 
protein (fliM) 
{Treponema pallidum} 
COG1536 COG1677 TP0026 TP0398 flagellar motor switch 
protein (fliG) {Treponema 
denticola} 
flagellar hook-basal 
body co mplex protein 
(fliE) {Treponema 
denticola} 
COG1536 COG4786 TP0026 TP0961 flagellar motor switch 
protein (fliG) {Treponema 
denticola} 
flagellar basal-body rod 
protein (flgG) {Borrelia 
burgdorferi} 
COG1352 COG1536 TP0630 TP0026 chemotaxis protein 
methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar motor switch 
protein (fliG) 
{Treponema denticola} 
COG1352 COG1815 TP0630 TP0396 chemotaxis protein 
methyltransferase (cheR) 
{Borrelia burgdorferi} 
flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
COG1344 COG1352 TP0870 TP0630 flagellar filament 31 kDa 
core protein (flaB3) 
{Treponema pallidum}   
chemotaxis protein 
methyltransferase 
(cheR) {Borrelia 
burgdorferi} 
COG1344 COG2882 TP0868 TP0403 flagellar filament 34.5 kDa 
core protein (flaB1) 
{Treponema pallidum} 
flagellar protein, 
putative {Treponema 
denticola} 
COG1256 COG1516 TP0660 TP0943 flagellar hook-associated 
protein 1 (flgK) {Borrelia 
burgdorferi} 
flagellar protein (fliS) 
{Bacillus subtilis} 
COG1344 COG1516 TP0870 TP0943 flagellar filament 31 kDa 
core protein (flaB3) 
{Treponema pallidum}   
flagellar protein (fliS) 
{Bacillus subtilis} 
COG1749 COG1843 TP0727 TP0728 flagellar hook protein 
(flgE) {Treponema 
pallidum} 
flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
COG1677 COG1815 TP0398 TP0396 flagellar hook-basal body 
co mplex protein (fliE) 
{Treponema denticola} 
flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
COG1558 COG4786 TP0397 TP0961 flagellar basal-body rod 
protein (flgC) {Treponema 
denticola} 
flagellar basal-body rod 
protein (flgG) {Borrelia 
burgdorferi} 
COG1815 COG1843 TP0396 TP0728 flagellar basal-body rod 
protein (flgB) {Treponema 
denticola} 
flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
COG1344 COG1815 TP0870 TP0396 flagellar filament 31 kDa 
core protein (flaB3) 
{Treponema pallidum}   
flagellar basal-body rod 
protein (flgB) 
{Treponema denticola} 
 
COG1291 COG1684 TP0725 TP0716 flagellar motor rotation 
protein (motA) 
{Treponema pallidum} 
flagellar biosynthetic 
protein (fliR) 
{Treponema pallidum} 
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COG0445 COG0561 TP0044 TP0290 glucose inhibited division 
protein A (gidA) {Borrelia 
burgdorferi} 
conserved hypothetical 
protein {Lactobacillus 
sake} 
COG0093 COG0799 TP0199 TP0738 ribosomal protein L14 
(rplN) {Borrelia 
burgdorferi} 
conserved hypothetical 
protein {Bacillus 
subtilis} 
COG0526 COG0771 TP0100 TP0903 thioredoxin, putative 
{Bradyrhizobium 
japonicum} 
UDP-N-
acetylmuramoylalanine-
-D-glutamate ligase 
(murD) {Borrelia 
burgdorferi} 
COG0357 COG0459 TP0946 TP0030 glucose-inhibited division 
protein B (gidB) 
{Escherichia coli} 
heat shock protein 
(groEL) {Treponema 
pallidum} 
COG0228 COG0250 TP0905 TP0236 ribosomal protein S16 
(rpsP) {Bacillus subtilis} 
transcription 
antitermination protein 
(nusG) {Borrelia 
burgdorferi} 
COG0442 COG0459 TP0160 TP0030 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
heat shock protein 
(groEL) {Treponema 
pallidum} 
COG0124 COG0124 TP0641 TP0641 histidyl-tRNA synthetase 
(hisS) {Borrelia 
burgdorferi} 
histidyl-tRNA 
synthetase (hisS) 
{Borrelia burgdorferi} 
COG0477 COG2812 TP0840 TP1005 conserved hypothetical 
integral membrane protein 
{Archaeoglobus fulgidus} 
DNA polymerase III, 
subunits gamma and 
tau (dnaH) {Borrelia 
burgdorferi} 
COG0090 COG0223 TP0192 TP0756 ribosomal protein L2 
(rplB) {Borrelia 
burgdorferi} 
methionyl-tRNA 
formyltransferase (fmt) 
{Haemophilus 
influenzae} 
COG0012 COG0188 TP0124 TP0005 conserved hypothetical 
GTP-binding protein 
{Borrelia burgdorferi} 
DNA gyrase, subunit A 
(gyrA) {Bacillus 
subtilis} 
COG0188 COG0526 TP0005 TP0100 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
thioredoxin, putative 
{Bradyrhizobium 
japonicum} 
COG0173 COG0493 TP0985 TP0735 aspartyl-tRNA synthetase 
(aspS) {Borrelia 
burgdorferi} 
glutamate synthase 
(gltA) {Pyrococcus 
sp.} 
COG0546 COG0739 TP0554 TP0782 phosphoglycolate 
phosphatase (gph) 
{Haemophilus influenzae} 
hypothetical protein 
COG0188 COG2199 TP0005 TP0981 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
sensory transduction 
histidine kinase, 
putative {Synechocystis 
PCC6803} 
COG0305 COG1595 TP0058 TP0092 replicative DNA helicase 
(dnaB) {Bacillus subtilis} 
RNA polymerase sigma 
factor E (rpoE) 
{Mycobacterium 
leprae} 
COG0820 COG2812 TP0068 TP1005 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
DNA polymerase III, 
subunits gamma and 
tau (dnaH) {Borrelia 
burgdorferi} 
COG0178 COG1197 TP0514 TP0344 excinuclease ABC, subunit 
A (uvrA) {Bacillus 
subtilis} 
transcription-repair 
coupling factor (trcF) 
{Borrelia burgdorferi} 
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COG0632 COG2255 TP0543 TP0162 Holliday junction DNA 
helicase (ruvA) 
{Haemophilus influenzae} 
Holliday junction DNA 
helicase (ruvB) 
{Haemophilus 
influenzae} 
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COG0222 COG0802 TP0240 TP0875 ribosomal protein L7/L12 
(rplL) {Haemophilus 
influenzae} 
conserved hypothetical 
protein {Synechocystis 
PCC6803} 
COG0227 COG0740 TP0362 TP0507 ribosomal protein L28 
(rpmB) {Treponema 
pallidum} 
ATP-dependent Clp 
protease proteolytic 
component (clpP) 
{Haemophilus 
influenzae} 
COG0305 COG0593 TP0058 TP0001 replicative DNA helicase 
(dnaB) {Bacillus subtilis} 
chromosomal 
replication initiator 
protein (dnaA) 
{Borrelia burgdorferi} 
COG2812 COG2812 TP1005 TP1005 DNA polymerase III, 
subunits gamma and tau 
(dnaH) {Borrelia 
burgdorferi} 
DNA polymerase III, 
subunits gamma and 
tau (dnaH) {Borrelia 
burgdorferi} 
COG0305 COG2812 TP0058 TP1005 replicative DNA helicase 
(dnaB) {Bacillus subtilis} 
DNA polymerase III, 
subunits gamma and 
tau (dnaH) {Borrelia 
burgdorferi} 
COG0223 COG0242 TP0756 TP0757 methionyl-tRNA 
formyltransferase (fmt) 
{Haemophilus influenzae} 
polypeptide 
deformylase (def) 
{Synechocystis 
PCC6803} 
COG0188 COG0305 TP0005 TP0058 DNA gyrase, subunit A 
(gyrA) {Bacillus subtilis} 
replicative DNA 
helicase (dnaB) 
{Bacillus subtilis} 
 
COG0465 COG0465 TP0330 TP0330 cell division protein (ftsH) 
{Mycoplasma genitalium} 
cell division protein 
(ftsH) {Mycoplasma 
genitalium} 
COG0322 COG1432 TP0472 TP0894 excinuclease ABC, subunit 
C (uvrC) 
{Methanobacterium 
thermoautotrophicum} 
conserved hypothetical 
protein {Synechocystic 
PCC6803} 
COG0457 COG1432 TP0648 TP0894 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
conserved hypothetical 
protein {Synechocystic 
PCC6803} 
COG0457 COG1643 TP0067 TP0526 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
ATP-dependent 
helicase (hrpA) 
{Borrelia burgdorferi} 
COG0195 COG1643 TP0892 TP0526 N utilization substance 
protein A (nusA) {Borrelia 
burgdorferi} 
ATP-dependent 
helicase (hrpA) 
{Borrelia burgdorferi} 
COG0090 COG1643 TP0192 TP0526 ribosomal protein L2 
(rplB) {Borrelia 
burgdorferi} 
ATP-dependent 
helicase (hrpA) 
{Borrelia burgdorferi} 
COG0208 COG1344 TP0053 TP0870 ribonucleoside-
diphosphate reductase, 
subunit beta (nrdB) 
{Helicobacter pylori} 
flagellar filament 31 
kDa core protein 
(flaB3) {Treponema 
pallidum}   
COG0265 COG4786 TP0773 TP0961 periplasmic serine protease 
DO (htrA) {Haemophilus 
influenzae} 
flagellar basal-body rod 
protein (flgG) {Borrelia 
burgdorferi} 
COG0526 COG1843 TP0100 TP0728 thioredoxin, putative 
{Bradyrhizobium 
japonicum} 
flagellar hook assembly 
scaffolding protein 
(flgD) {Treponema 
pallidum} 
COG0442 COG1344 TP0160 TP0792 prolyl-tRNA synthetase 
(proS) {Escherichia coli} 
flagellar filament 33 
kDa core protein 
(flaB2) {Treponema 
pallidum} 
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COG0608 COG0817 TP0704 TP0517 single-stranded-DNA-
specific exonuclease (recJ) 
Holliday junction 
nuclease (ruvC) 
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{Borrelia burgdorferi} {Escherichia coli} 
COG0802 COG0860 TP0875 TP0247 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
N-acetylmuramoyl-L-
alanine amidase (amiA) 
{Escherichia coli} 
COG0457 COG2199 TP0648 TP0981 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
sensory transduction 
histidine kinase, 
putative {Synechocystis 
PCC6803} 
COG0457 COG1396 TP0648 TP0461 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
hypothetical protein 
COG0457 COG0845 TP0648 TP0965 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
COG0577 COG0845 TP0963 TP0965 conserved hypothetical 
integral membrane protein 
{Bacillus subtilis} _ 
membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
COG0280 COG0457 TP0094 TP0920 phosphate 
acetyltransferase (pta) 
{Methanosarcina 
thermophila} 
hypothetical protein 
COG0173 COG0845 TP0985 TP0965 aspartyl-tRNA synthetase 
(aspS) {Borrelia 
burgdorferi} 
membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
COG0477 COG0845 TP0840 TP0965 conserved hypothetical 
integral membrane protein 
{Archaeoglobus fulgidus} 
membrane fusion 
protein, putative 
{Haemophilus 
influenzae} 
COG0457 COG1061 TP0095 TP0380 hypothetical protein DNA repair helicase, 
putative 
{Saccharomyces 
cerevisiae} 
 
COG0552 COG1061 TP0578 TP0380 cell division protein (ftsY) 
{Bacillus subtilis} 
DNA repair helicase, 
putative 
{Saccharomyces 
cerevisiae} 
COG0457 COG1516 TP0648 TP0943 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
flagellar protein (fliS) 
{Bacillus subtilis} 
COG0457 COG3391 TP0471 TP0421 hypothetical protein conserved hypothetical 
protein {Borrelia 
burgdorferi} 
COG0457 COG1194 TP0470 TP0343 conserved hypothetical 
protein {Synechocystis 
PCC6803} 
A/G-specific adenine 
glycosylase, putative 
{Helicobacter pylori} 
COG0249 COG0457 TP0328 TP0095 DNA mismatch repair 
protein (mutS) {Borrelia 
burgdorferi} 
hypothetical protein 
COG0457 COG0558 TP0067 TP0730 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
conserved hypothetical 
protein 
{Caenorhabditis 
elegans} 
COG0125 COG0457 TP0354 TP0648 thymidylate kinase (tmk) 
{Methanococcus 
jannaschii} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
COG0012 COG0457 TP0124 TP0067 conserved hypothetical 
GTP-binding protein 
{Borrelia burgdorferi} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
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COG0124 COG0457 TP0641 TP0622 histidyl-tRNA synthetase 
(hisS) {Borrelia 
hypothetical protein 
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burgdorferi} 
COG0445 COG0457 TP0044 TP0954 glucose inhibited division 
protein A (gidA) {Borrelia 
burgdorferi} 
conserved hypothetical 
protein 
{Methanobacterium 
thermoautotrophicum} 
COG0242 COG0457 TP0757 TP0468 polypeptide deformylase 
(def) {Synechocystis 
PCC6803} 
conserved hypothetical 
protein {Bacillus 
subtilis} 
COG0457 COG2812 TP0648 TP1005 conserved hypothetical 
protein {Borrelia 
burgdorferi} 
DNA polymerase III, 
subunits gamma and 
tau (dnaH) {Borrelia 
burgdorferi} 
COG0335 COG0457 TP0909 TP0496 ribosomal protein L19 
(rplS) {Borrelia 
burgdorferi} 
conserved hypothetical 
protein {Borrelia 
burgdorferi} 
 
COG0457 COG0566 TP0095 TP0054 hypothetical protein conserved hypothetical 
protein {Escherichia 
coli} 
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Supplementary Table 17 Predicted essenential genes for T. pallidum. Predictions are based 
on data for E. coli, B. subtilis, and M. genitalium employing orthology relationships from 
the MBGD database. 
  essential in … 
Gene Description E. coli B. subtilis M. genitalium 
TP0001 chromosomal replication initiator protein (dnaA) 
{Borrelia burgdorferi} 
+ + + 
TP0002 DNA polymerase III, subunit beta (dnaN) 
{Pseudomonas putida} 
+ + + 
TP0005 DNA gyrase, subunit A (gyrA) {Bacillus subtilis} + + + 
TP0015 phenylalanyl-tRNA synthetase beta subunit (pheT) 
{Borrelia burgdorferi} 
+ + + 
TP0019 transcription elongation factor (greA) {Borrelia 
burgdorferi} 
  + 
TP0024 conserved hypothetical protein {Bacillus subtilis}   + 
TP0029 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
(murA) {Borrelia burgdorferi} 
+ +  
TP0030 heat shock protein (groEL) {Treponema pallidum}  + + 
TP0044 glucose inhibited division protein A (gidA) {Borrelia 
burgdorferi} 
  + 
TP0051 peptide chain release factor 1 (prfA) {Borrelia 
burgdorferi} 
+  + 
TP0052 protoporphyrinogen oxidase (hemK) {Haemophilus 
influenzae} 
+  + 
TP0053 ribonucleoside-diphosphate reductase, subunit beta 
(nrdB) {Helicobacter pylori} 
+ + + 
TP0056 oxaloacetate decarboxylase (oadA) {Klebsiella 
pneumoniae} 
+ +  
TP0058 replicative DNA helicase (dnaB) {Bacillus subtilis} + + + 
TP0060 ribosomal protein L9 (rplI) {Bacillus subtilis}  + + 
TP0061 ribosomal protein S18 (rpsR) {Bacillus 
stearothermophilus} 
+ + + 
TP0062 single-strand DNA binding protein (ssb) {Borrelia 
burgdorferi} 
+   
TP0063 ribosomal protein S6 (rpsF) {Borrelia burgdorferi}  +  
TP0075 sugar ABC transporter, permease protein {Rhizobium 
sp.} 
  + 
TP0076 sugar ABC transporter, permease protein {Rhizobium 
sp.} 
  + 
TP0077 capsular polysaccharide biosynthesis protein (cap5D) 
{Staphylococcus aureus} 
  + 
TP0090 UDP-N-acetylmuramate dehydrogenase (murB) 
{Borrelia burgdorferi} 
+ +  
TP0091 cysteinyl-tRNA synthetase (cysS) {Borrelia 
burgdorferi} 
+ + + 
TP0092 RNA polymerase sigma factor E (rpoE) 
{Mycobacterium leprae} 
+   
TP0094 phosphate acetyltransferase (pta) {Methanosarcina 
thermophila} 
  + 
TP0097 translation initiation factor 1 (infA) {Borrelia 
burgdorferi} 
+ + + 
TP0098 heat-shock protein, putative {Legionella pneumophila}   + 
TP0100 thioredoxin, putative {Bradyrhizobium japonicum}  +  
TP0102 rep helicase, single-stranded DNA-dependent ATPase 
(rep) {Borrelia burgdorferi} 
 +  
TP0105 DNA polymerase I (polA) {Treponema pallidum}   + 
TP0107 licC protein (licC) {Haemophilus influenzae}   + 
TP0108 pyrophosphate--fructose 6-phosphate 1-
phosphotransferase (pfk) {Borrelia burgdorferi} 
 + + 
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TP0116 excinuclease ABC, subunit B (uvrB) 
{Methanobacterium thermoautotrophicum} 
  + 
TP0139 conserved hypothetical protein {Bacillus subtilis}   + 
TP0140 K+ transport protein (ntpJ) {Bacillus subtilis}   + 
TP0160 prolyl-tRNA synthetase (proS) {Escherichia coli} + +  
TP0182 conserved hypothetical protein {Mycobacterium 
tuberculosis} 
+ +  
TP0184 small protein (smpB) {Synechocystis PCC6803}   + 
TP0185 signal peptidase I (sip) {Bacillus subtilis} +   
TP0187 translation elongation factor TU (tuf) {Escherichia 
coli} 
 + + 
TP0188 ribosomal protein S10 (rpsJ) {Borrelia burgdorferi} + + + 
TP0189 ribosomal protein L3 (rplC) {Borrelia burgdorferi} + + + 
TP0190  + + + 
TP0191 ribosomal protein L23 (rplW) {Thermotoga maritima} + + + 
TP0192 ribosomal protein L2 (rplB) {Borrelia burgdorferi} + + + 
TP0193 ribosomal protein S19 (rpsS) {Borrelia burgdorferi} + + + 
TP0194 ribosomal protein L22 (rplV) {Borrelia burgdorferi} + + + 
TP0195 ribosomal protein S3 (rpsC) {Bacillus subtilis} + + + 
TP0196 ribosomal protein L16 (rplP) {Synechocystis 
PCC6803} 
+ + + 
TP0198 ribosomal protein S17 (rpsQ) {Bacillus 
stearothermophilus} 
+ + + 
TP0199 ribosomal protein L14 (rplN) {Borrelia burgdorferi} + + + 
TP0200 ribosomal protein L24 (rplX) {Bacillus subtilis} + + + 
TP0201 ribosomal protein L5 (rplE) {Borrelia burgdorferi} + + + 
TP0202 ribosomal protein S14 (rpsN) {Borrelia burgdorferi} + + + 
TP0203 ribosomal protein S8 (rpsH) {Borrelia burgdorferi} + + + 
TP0204 ribosomal protein L6 (rplF) {Borrelia burgdorferi} + + + 
TP0205 ribosomal protein L18 (rplR) {Bacillus 
stearothermophilus} 
+ + + 
TP0206 ribosomal protein S5 (rpsE) {Borrelia burgdorferi} + + + 
TP0207 ribosomal protein L15 (rplO) {Borrelia burgdorferi} + + + 
TP0208 preprotein translocase subunit (secY) {Borrelia 
burgdorferi} 
+ + + 
TP0209 ribosomal protein L36 (rpmJ) {Chlorella vulgaris}  + + 
TP0210 ribosomal protein S13 (rpsM) {Borrelia burgdorferi} + + + 
TP0211 ribosomal protein S11 (rpsK) {Borrelia burgdorferi} + + + 
TP0212 DNA-directed RNA polymerase, alpha subunit (rpoA) 
{Borrelia burgdorferi} 
+ + + 
TP0213 ribosomal protein L17 (rplQ) {Borrelia burgdorferi} + + + 
TP0215 grpE protein (grpE) {Borrelia burgdorferi} +  + 
TP0216 heat shock protein 70 (dnaK) {Borrelia burgdorferi}   + 
TP0227 cobalt ABC transporter, ATP-binding protein 
{Methanococcus jannaschii} 
  + 
TP0230 primosomal protein N (priA) {Borrelia burgdorferi}  +  
TP0234 ribosomal protein L33 (rpmG) {Thermus aquaticus}  + + 
TP0235 preprotein translocase subunit (secE) {Thermotoga 
maritima} 
+   
TP0236 transcription antitermination protein (nusG) {Borrelia 
burgdorferi} 
+  + 
TP0237 ribosomal protein L11 (rplK) {Thermotoga maritima}   + 
TP0238 ribosomal protein L1 (rplA) {Borrelia burgdorferi}  + + 
TP0239 ribosomal protein L10 (rplJ) {Streptomyces 
antibioticus} 
+ + + 
TP0240 ribosomal protein L7/L12 (rplL) {Haemophilus 
influenzae} 
+ + + 
TP0241 DNA-directed RNA polymerase, beta subunit (rpoB) + + + 
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{Borrelia burgdorferi} 
TP0242 DNA-directed RNA polymerase, beta' subunit (rpoC) 
{Escherichia coli} 
+ + + 
TP0243 ribosomal protein S12 (rpsL) {Leptospira biflexa} + + + 
TP0244 ribosomal protein S7 {Borrelia burgdorferi} + + + 
TP0251 DNA-binding protein II {Bacillus subtilis}  +  
TP0252 apolipoprotein N-acyltransferase, putative 
{Haemophilus influenzae} 
+   
TP0255 ribosomal protein L31 (rpmE) {Haemophilus 
influenzae} 
 + + 
TP0256 CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase (pgsA) {Bacillus subtilis} 
+   
TP0264 deoxyribose-phosphate aldolase (deoC) {Bacillus 
subtilis} 
  + 
TP0270 polynucleotide adenylyltransferase (pcnA) {Borrelia 
burgdorferi} 
 +  
TP0272 SpoOJ regulator (soj) {Bacillus subtilis}   + 
TP0275 UDP-N-acetyl-D-mannosamine transferase, putative 
{Streptococcus pneumoniae} 
 +  
TP0279 ribosomal protein S1 (rpsA) {Escherichia coli} + + + 
TP0283 lipopolysaccharide core biosynthesis protein (kdtB) 
{Escherichia coli} 
+   
TP0288 spore coat polysaccharide biosynthesis protein (spsF) 
{Bacillus subtilis} 
+   
TP0290 conserved hypothetical protein {Lactobacillus sake}   + 
TP0294 phosphoribosyl pyrophosphate synthetase (prs) 
{Borrelia burgdorferi} 
+ + + 
TP0295 xylulokinase (xylB) {Borrelia burgdorferi}   + 
TP0296 conserved hypothetical protein {Pseudomonas putida}  +  
TP0305 CTP synthase (pyrG) {Synechocystis PCC6803} + +  
TP0306 ribosomal protein S4 {Borrelia burgdorferi} + + + 
TP0307 conserved hypothetical protein {Borrelia burgdorferi}   + 
TP0321 ribose/galactose ABC transporter, ATP-binding 
protein (rbsA) {Borrelia burgdorferi} 
  + 
TP0322 ribose/galactose ABC transporter, permease protein 
(rbsC) {Borrelia burgdorferi} 
  + 
TP0326 outer membrane protein {Helicobacter pylori} +   
TP0329 serine hydroxymethyltransferase (glyA) {Bacillus 
subtilis} 
 + + 
TP0340 folylpolyglutamate synthetase (folC) {Bacillus subtilis} +   
TP0341 UDP-N-acetylmuramate--alanine ligase (murC) 
{Borrelia burgdorferi} 
+ +  
TP0345 phospho-N-acetylmuramoyl-pentapeptide-transferase 
(mraY) {Helicobacter pylori} 
+ +  
TP0354 thymidylate kinase (tmk) {Methanococcus jannaschii} + + + 
TP0357 biotin--acetyl-CoA-carboxylase ligase (birA) 
{Mycobacterium tuberculosis} 
+ +  
TP0361 lysophosphatidic acid acyltransferase, putative {Homo 
sapiens} 
+  + 
TP0362 ribosomal protein L28 (rpmB) {Treponema pallidum} + + + 
TP0367 chromosome segregation SMC protein homolog 
{Bacillus subtilis} 
 +  
TP0371 conserved hypothetical protein {Bacillus subtilis} + +  
TP0373 conserved hypothetical protein {Bacillus subtilis} + + + 
TP0379 preprotein translocase subunit (secA) {Borrelia 
burgdorferi} 
+ + + 
TP0383 conserved hypothetical protein {Enterococcus hirae}   + 
TP0384 conserved hypothetical protein {Borrelia burgdorferi}   + 
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TP0386 UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-
diaminopimelate--D-alanyl-D-alanine ligase (murF) 
{Synechocystis PCC6803} 
+ +  
TP0387 cell division protein (ftsW) {Borrelia burgdorferi} +   
TP0389 cell division protein (ftsA) {Borrelia burgdorferi} + +  
TP0390 cell division protein (ftsZ) {Borrelia burgdorferi} + + + 
TP0394 DNA topoisomerase I (topA) {Bacillus subtilis} + + + 
TP0406 glutamate racemase (murI) {Escherichia coli} + +  
TP0408 hypothetical protein +  + 
TP0410 protein-export membrane protein (secD) {Borrelia 
burgdorferi} 
+  + 
TP0411 protein-export membrane protein (secF) {Bacillus 
subtilis} 
+   
TP0416 signal recognition particle protein (ffh) {Borrelia 
burgdorferi} 
+ + + 
TP0417 apolipoprotein N-acyltransferase (cutE) {Escherichia 
coli} 
+   
TP0436 conserved hypothetical protein {Borrelia burgdorferi}   + 
TP0441 conserved hypothetical protein {Escherichia coli} + + + 
TP0446 gcpE protein (gcpE) {Bacillus subtilis} + +  
TP0448 uracil phosphoribosyltransferase, putative {Bacillus 
subtilis} 
  + 
TP0452 isoleucyl-tRNA synthetase (ileS) {Borrelia burgdorferi}  + + 
TP0458 conserved hypothetical protein {Mycoplasma 
genitalium} 
 +  
TP0464 conserved hypothetical protein {Haemophilus 
influenzae} 
  + 
TP0472 excinuclease ABC, subunit C (uvrC) 
{Methanobacterium thermoautotrophicum} 
  + 
TP0474 conserved hypothetical protein {Borrelia burgdorferi}   + 
TP0475 glucose-6-phosphate isomerase (gpi) {Borrelia 
burgdorferi} 
  + 
TP0476 acetate kinase (ack) {Methanosarcina thermophila}   + 
TP0492 DNA primase (dnaE) {Clostridium acetobutylicum}  + + 
TP0493 RNA polymerase sigma-70 factor (rpoD) {Borrelia 
burgdorferi} 
 + + 
TP0497 rod shape-determining protein (mreB) {Borrelia 
burgdorferi} 
+ +  
TP0498 rod shape-determining protein (mreC) {Borrelia 
burgdorferi} 
+ +  
TP0500 penicillin-binding protein (pbp) {Borrelia burgdorferi} +   
TP0501 rod shape-determining protein (rodA) {Borrelia 
burgdorferi} 
+   
TP0512 conserved hypothetical protein {Rhodobacter 
capsulatus} 
+   
TP0514 excinuclease ABC, subunit A (uvrA) {Bacillus subtilis}   + 
TP0516 virulence factor (mviN) {Haemophilus influenzae} +   
TP0523 UDP-N-acetylglucosamine--N-acetylmuramyl-
(pentapeptide) pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase (murG) {Borrelia 
burgdorferi} 
+ +  
TP0524 ATP-dependent protease LA (lon) {Borrelia 
burgdorferi} 
  + 
TP0525 translation elongation factor P (efp) {Borrelia 
burgdorferi} 
  + 
TP0537 triosephosphate isomerase (tpi) {Borrelia burgdorferi}  + + 
TP0538 phosphoglycerate kinase (pgk) {Borrelia burgdorferi} + + + 
TP0541 GTP-binding protein (era) {Borrelia burgdorferi} + + + 
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TP0542 pyrophosphate--fructose 6-phosphate 1-
phosphotransferase, beta subunit {Borrelia 
burgdorferi} 
 + + 
TP0547 penicillin tolerance protein (lytB) {Helicobacter pylori} + +  
TP0550 thiophene and furan oxidation protein (thdF) {Borrelia 
burgdorferi} 
  + 
TP0559 conserved hypothetical protein {Archaeoglobus 
fulgidus} 
  + 
TP0560 transketolase (tktA) {Bacillus subtilis}  +  
TP0576 peptide chain release factor 2 (prfB) {Borrelia 
burgdorferi} 
 +  
TP0578 cell division protein (ftsY) {Bacillus subtilis} + + + 
TP0580 conserved hypothetical integral membrane protein 
{Borrelia burgdorferi} 
+   
TP0581 ABC transporter, ATP-binding protein {Borrelia 
burgdorferi} 
+  + 
TP0582 conserved hypothetical integral membrane protein 
{Borrelia burgdorferi} 
+   
TP0586 leucyl-tRNA synthetase (leuS) {Borrelia burgdorferi} + + + 
TP0589 phosphocarrier protein HPr (ptsH) {Bacillus subtilis} 
_ 
  + 
TP0591 HPr kinase (ptsK) {Bacillus subtilis}   + 
TP0595 adenylate kinase (adk) {Bacillus subtilis} + + + 
TP0596 polynucleotide adenylyltransferase (pcnB) {Escherichia 
coli} 
 +  
TP0600 zinc protease, putative {Haemophilus influenzae} +   
TP0601 conserved hypothetical protein {Synechocystis 
PCC6803} 
+ +  
TP0602 phosphatidate cytidylyltransferase (cdsA) {Borrelia 
burgdorferi} 
+ +  
TP0603 conserved hypothetical protein {Borrelia burgdorferi} +   
TP0604 ribosome recycling factor {Bacillus subtilis} + + + 
TP0605 translation elongation factor TS (tsf) {Spirulina 
platensis} 
+ + + 
TP0606 ribosomal protein S2 (rpsB) {Borrelia burgdorferi} + + + 
TP0609 asparaginyl-tRNA synthetase (asnS) {Synechocystis 
PCC6803} 
+ + + 
TP0611 ABC transporter, ATP-binding protein {Synechocystis 
PCC6803} 
 +  
TP0612 conserved hypothetical protein {Bacillus subtilis}  +  
TP0614 nitrogen fixation protein (nifS) {Bacillus subtilis}  + + 
TP0615 nitrogen fixation protein (nifU) {Mycobacterium 
leprae} 
 + + 
TP0627 exonuclease (sbcC) {Escherichia coli}   + 
TP0628 conserved hypothetical protein {Borrelia burgdorferi}  +  
TP0632 tryptophanyl-tRNA synthetase (trsA) {Borrelia 
burgdorferi} 
+ + + 
TP0633 protein-methionine-S-oxide reductase (msrA) 
{Methanobacterium thermoautotrophicum} 
  + 
TP0634 DNA ligase (lig) {Thermus aquaticus} + + + 
TP0641 histidyl-tRNA synthetase (hisS) {Borrelia burgdorferi} + + + 
TP0642 phosphomannomutase (manB) {Bacillus subtilis}   + 
TP0643 DNA polymerase III, subunit epsilon (dnaQ) 
{Escherichia coli} 
 + + 
TP0647 seryl-tRNA synthetase (serS) {Borrelia burgdorferi} + + + 
TP0649 hemolysin (tlyC) {Borrelia burgdorferi}   + 
TP0653 spermidine/putrescine ABC transporter, permease 
protein (potB) {Archaeoglobus fulgidus} 
  + 
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TP0654 spermidine/putrescine ABC transporter, permease 
protein (potC) {Haemophilus influenzae} 
  + 
TP0657 carbon storage regulator (csrA) {Bacillus subtilis} +   
TP0662 fructose-bisphosphate aldolase (cbbA) {Alcaligenes 
eutrophus} 
+ + + 
TP0667 uridine kinase (udk) {Borrelia burgdorferi}   + 
TP0669 DNA polymerase III, subunit alpha (dnaE) {Bacillus 
subtilis} 
+  + 
TP0670 D-alanine--D-alanine ligase (ddlA) {Salmonella 
choleraesuis} 
 +  
TP0672 glycyl-tRNA synthetase (glyS) {Borrelia burgdorferi}   + 
TP0673 glutamyl-tRNA synthetase (gltX) {Borrelia 
burgdorferi} 
+ + + 
TP0680 o-sialoglycoprotein endopeptidase (gcp) {Borrelia 
burgdorferi} 
+ + + 
TP0681 alanine racemase (alr) {Treponema pallidum}  +  
TP0683 octaprenyl-diphosphate synthase {Treponema 
pallidum} 
+ +  
TP0689 GTP-binding protein {Treponema pallidum} + + + 
TP0694 5,10-methenyltetrahydrofolate synthetase, putative 
{Homo sapiens} 
  + 
TP0712 ATP-binding protein (ylxH) {Treponema pallidum} +   
TP0732 methylenetetrahydrofolate dehydrogenase (folD) 
{Bacillus subtilis} 
+ + + 
TP0734 purine nucleoside phosphorylase (deoD) {Bacillus 
stearothermophilus} 
  + 
TP0740 conserved hypothetical protein {Bacillus subtilis}   + 
TP0741 conserved hypothetical protein {Borrelia burgdorferi} +   
TP0742 GTP-binding protein (obg) {Borrelia burgdorferi} + + + 
TP0743 ribosomal protein L27 (rpl27) {Synechocystis 
PCC6803} 
+ + + 
TP0745 ribosomal protein L21 (rplU) {Bacillus subtilis} + + + 
TP0746 pyruvate, phosphate dikinase {Eleocharis vivipara}   + 
TP0756 methionyl-tRNA formyltransferase (fmt) 
{Haemophilus influenzae} 
+ + + 
TP0757 polypeptide deformylase (def) {Synechocystis 
PCC6803} 
+  + 
TP0758 ribosomal protein S21 (rpsU) {Myxococcus xanthus}  +  
TP0760 penicillin-binding protein (pbp) {Borrelia burgdorferi} + +  
TP0765 cell division protein (ftsH) {Helicobacter pylori} +  + 
TP0767 translation elongation factor G (fusA) {Borrelia 
burgdorferi} 
+ + + 
TP0770 ATP-dependent RNA helicase {Archaeoglobus 
fulgidus} 
  + 
TP0773 periplasmic serine protease DO (htrA) {Haemophilus 
influenzae} 
+   
TP0780 NH(3)-dependent NAD(+) synthetase (nadE) 
{Rhodobacter capsulatus} 
+ + + 
TP0794 S-adenosylmethionine synthetase (metK) {Escherichia 
coli} 
+ + + 
TP0798 methionyl-tRNA synthetase (metG) {Borrelia 
burgdorferi} 
+ + + 
TP0803 hypothetical protein   + 
TP0805 exoribonuclease II (rnb) {Synechocystis PCC6803}   + 
TP0807 ribosomal protein L32 (rpmF) {Borrelia burgdorferi}  + + 
TP0808 acyl carrier protein (acpP) {Borrelia burgdorferi} + +  
TP0809 ribonuclease III (rnc) {Borrelia burgdorferi} + +  
TP0814 thioredoxin reductase (trxB) {Bacillus subtilis}  + + 
TP0817 enolase (eno) {Treponema pallidum} + + + 
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TP0819 conserved hypothetical protein {Borrelia burgdorferi}  +  
TP0824 transketolase B (tktB) {Haemophilus influenzae} + + + 
TP0826 conserved hypothetical protein {Borrelia burgdorferi}   + 
TP0828 holo-acyl-carrier protein synthase (acpS) {Borrelia 
burgdorferi} 
+ + + 
TP0830 pseudouridylate synthase (hisT) {Borrelia burgdorferi}   + 
TP0831 arginyl-tRNA synthetase (argS) {Borrelia burgdorferi}} + + + 
TP0834 tyrosyl-tRNA synthetase (tyrS) {Borrelia burgdorferi} + + + 
TP0837 threonyl-tRNA synthetase (thrS) {Haemophilus 
influenzae} 
+  + 
TP0841 periplasmic serine protease DO (htrA) {Borrelia 
burgdorferi} 
+   
TP0842 methionine aminopeptidase (map) {Bacillus subtilis} + + + 
TP0844 glyceraldehyde 3-phosphate dehydrogenase (gap) 
{Trypanoplasma borreli} 
+  + 
TP0848 ribosomal protein L20 (rplT) {Borrelia burgdorferi} + + + 
TP0849 ribosomal protein L35 (rpmI) {Borrelia burgdorferi}  + + 
TP0850 translation initiation factor 3 (infC) {Borrelia 
burgdorferi} 
+ + + 
TP0852 prolipoprotein diacylglyceryl transferase (lgt) 
{Haemophilus influenzae} 
+  + 
TP0861 glucosamine-fructose-6-phosphate aminotransferase 
(glmS) {Haemophilus influenzae} 
+ +  
TP0863 nitrogen fixation protein (nifS) {Rhodobacter 
sphaeroides} 
 +  
TP0875 conserved hypothetical protein {Synechocystis 
PCC6803} 
+ +  
TP0876 conserved hypothetical protein {Escherichia coli} + +  
TP0885 deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) 
{Helicobacter pylori} 
+   
TP0887 ribosomal protein S15 (rpsO) {Borrelia burgdorferi}  + + 
TP0888 riboflavin kinase/FMN adenylyltransferase (ribF) 
{Escherichia coli} 
+  + 
TP0890 ribosome-binding factor A (rbfA) {Bacillus subtilis}   + 
TP0891 translation initiation factor 2 (infB) {Borrelia 
burgdorferi} 
+ + + 
TP0892 N utilization substance protein A (nusA) {Borrelia 
burgdorferi} 
+ + + 
TP0901 conserved hypothetical integral membrane protein 
{Borrelia burgdorferi} 
  + 
TP0903 UDP-N-acetylmuramoylalanine--D-glutamate ligase 
(murD) {Borrelia burgdorferi} 
+ +  
TP0905 ribosomal protein S16 (rpsP) {Bacillus subtilis} + + + 
TP0908 tRNA (guanine-N1)-methyltransferase (trmD) 
{Borrelia burgdorferi} 
+ + + 
TP0909 ribosomal protein L19 (rplS) {Borrelia burgdorferi} + + + 
TP0917 Mg2+ transport protein (mgtE) {Borrelia burgdorferi}  +  
TP0919 thioredoxin (trx) {Bacillus subtilis}  + + 
TP0921 NADH oxidase {Streptococcus mutans}   + 
TP0925 flavodoxin {Clostridium beijerinckii} +   
TP0926 signal peptidase I, putative {Bacillus licheniformis} +   
TP0933 UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-
diaminopimelate ligase (murE) {Borrelia burgdorferi} 
+ +  
TP0949 membrane protein {Borrelia burgdorferi} +  + 
TP0951 ribosomal protein L34 (rpmH) {Borrelia burgdorferi} + + + 
TP0964 ABC transporter, ATP-binding protein {Bacillus 
subtilis} 
+  + 
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TP0973 phenylalanyl-tRNA synthetase alpha subunit (pheS) 
{Borrelia burgdorferi} 
+ + + 
TP0975 conserved hypothetical protein {Borrelia burgdorferi} +   
TP0978 signal peptidase II (lsp) {Borrelia burgdorferi} +   
TP0985 aspartyl-tRNA synthetase (aspS) {Borrelia burgdorferi} + + + 
TP0999 cell division protein, putative {Borrelia burgdorferi} +   
TP1005 DNA polymerase III, subunits gamma and tau (dnaH) 
{Borrelia burgdorferi} 
+ +  
TP1006 DNA gyrase, subunit B (gyrB) {Treponema pallidum} + + + 
TP1008 ribonucleoside-diphosphate reductase, subunit alpha 
(nrdA) {Helicobacter pylori} 
+ + + 
TP1009 glycerol-3-phosphate dehydrogenase (gpsA) {Bacillus 
subtilis} 
+ +  
TP1011 peptidyl-tRNA hydrolase (pth) {Haemophilus 
influenzae} 
+ + + 
TP1013 chaperonin (groES) {Bacillus stearothermophilus} + + + 
TP1016 basic membrane protein (tpn39b) {Treponema 
pallidum} 
 +  
TP1017 alanyl-tRNA synthetase (alaS) {Borrelia burgdorferi}  + + 
TP1018 conserved hypothetical protein {Borrelia burgdorferi}  + + 
TP1020 glu-tRNA amidotransferase, subunit A (gatA) 
{Archaeoglobus fulgidus} 
 + + 
TP1021 glu-tRNA amidotransferase, subunit B (gatB) {Borrelia 
burgdorferi} 
 + + 
TP1024 ribosomal protein S9 (rpsI) {Bacillus 
stearothermophilus} 
+ + + 
TP1025 ribosomal protein L13 (rplM) {Borrelia burgdorferi} + + + 
TP1028 DNA helicase II (uvrD) {Thermus thermophilus}  +  
TP1035 valyl-tRNA synthetase (valS) {Borrelia burgdorferi}} + + + 
TP1039 adenine phosphoribosyltransferase (apt) {Haemophilus 
influenzae} 
  + 
TP1040 lysyl-tRNA synthetase (lysS) {Escherichia coli}  + + 
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Supplementary Table 18 Interactions of possible virulence genes (Weinstock et al. 1998). 
Gene Description Interactions 
  all as bait as prey 
Hemolysins     
TP0027 hemolysin, putative {Borrelia burgdorferi} 1 1  
TP0028 hemolysin, putative {Synechocystis PCC6803} 0   
TP0649 hemolysin (tlyC) {Borrelia burgdorferi} 0   
TP0936 hemolysin, putative {Synechocystis PCC6803} 0   
TP1037 hemolysin III (hlyIII) {Bacillus cereus} 1  1 
Miscellaneous functions    
TP0502 hypothetical protein 0   
TP0580 conserved hypothetical integral membrane protein {Borrelia burgdorferi} 1 1  
TP0680 o-sialoglycoprotein endopeptidase (gcp) {Borrelia burgdorferi} 0   
TP0835 ankyrin, putative {Homo sapiens} 0   
Polysaccharide biosynthesis    
TP0077 capsular polysaccharide biosynthesis protein (cap5D) {Staphylococcus aureus} 1  1 
TP0078 spore coat polysaccharide biosynthesis protein (spsC) {Bacillus subtilis} 2  2 
TP0107 licC protein (licC) {Haemophilus influenzae} 0   
TP0283 lipopolysaccharide core biosynthesis protein (kdtB) {Escherichia coli} 0   
TP0288 spore coat polysaccharide biosynthesis protein (spsF) {Bacillus subtilis} 0   
TP0440 spore coat polysaccharide biosynthesis protein, putative {Synechocystis 
PCC6803} 
0   
TP0562 spore coat polysaccharide biosynthesis protein (spsE) {Bacillus subtilis} 0   
Regulators     
TP0038 regulatory protein (pfoS/R) {Treponema pallidum} 4 4  
TP0454 hypothetical protein 0   
TP0516 virulence factor (mviN) {Haemophilus influenzae} 2 2  
TP0519 response regulatory protein (atoC) {Borrelia burgdorferi} 31 2 30 
TP0520 sensory transduction histidine kinase (authentic frameshift) 0   
TP0877 conserved hypothetical protein {Borrelia burgdorferi} 5 1 4 
TP0980 histidine phosphokinase/phophatase (ntrB) {Mycobacterium leprae} 0   
TP0981 sensory transduction histidine kinase, putative {Synechocystis PCC6803} 18 13 5 
Potential membrane or surface-exposed proteins    
TP0006 Tp75 protein {Treponema pallidum} 6 6  
TP0020 76K protein {Treponema pallidum} 0   
TP0034 ABC transporter, periplasmic binding protein {Streptococcus pneumoniae} 3 2 1 
TP0163 ABC transporter, periplasmic binding protein (troA) {Treponema pallidum} 5 5  
TP0171 lipoprotein, 15 kDa (tpp15) {Treponema pallidum} 17  17 
TP0225 leucine-rich repeat protein TpLRR {Treponema pallidum} 1  1 
TP0292 outer membrane protein (tpn50) {Treponema pallidum} 1  1 
TP0298 exported protein (tpn38b) {Treponema pallidum} 2 2  
TP0319 membrane lipoprotein (tmpC) {Treponema pallidum} 0   
TP0326 outer membrane protein {Helicobacter pylori} 0   
TP0327 cationic outer membrane protein (ompH) {Yersinia enterocolitica} 0   
TP0435 lipoprotein, 17 kDa (tpp17) {Treponema pallidum} 11 11  
TP0470 conserved hypothetical protein {Synechocystis PCC6803} 1  1 
TP0486 antigen, p83/100 {Borrelia burgdorferi} 0   
TP0567 conserved hypothetical protein {Borrelia burgdorferi} 5 5  
TP0571 Tp70 protein {Treponema pallidum} 2 2  
TP0574 carboxypeptidase, 47 kDa {Treponema pallidum} 0   
TP0624 conserved hypothetical protein {Borrelia burgdorferi} 0   
TP0702 conserved hypothetical protein {Borrelia burgdorferi} 3 1 2 
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TP0729 treponemal aqueous protein (tap1) {Treponema pallidum} 0   
TP0768 membrane protein (tmpA) {Treponema pallidum} 1  1 
TP0769 outer membrane protein (tmpB) {Treponema pallidum} 0   
TP0796 conserved hypothetical protein {Haemophilus influenzae} 0   
TP0819 conserved hypothetical protein {Borrelia burgdorferi} 13 13  
TP0821 lipoprotein (tpn32) {Treponema pallidum} 0   
TP0957 Tp33 protein {Treponema pallidum} 0   
TP0971 membrane antigen, pathogen-specific (tpd) {Treponema pallidum} 1 1  
TP0989 P26 {Borrelia burgdorferi} 0   
TP0993 rare lipoprotein A, putative {Borrelia burgdorferi} 0   
TP1016 basic membrane protein (tpn39b) {Treponema pallidum} 1  1 
TP1038 bacterioferrin (TpF1) {Treponema pallidum} 3 3  
Tpr proteins    
TP0009 tpr protein A (tprA) (authentic frameshift) 0   
TP0011 tpr protein B (tprB) {Treponema pallidum} 0   
TP0117 tpr protein C (tprC) {Treponema pallidum} 1 1  
TP0131 tpr protein D (tprD) {Treponema pallidum} 1 1  
TP0313 tpr protein E (tprE) {Treponema pallidum} 0   
TP0316 tpr protein F (tprF) (authentic frameshift) 0   
TP0317 tpr protein G (tprG) {Treponema pallidum} 0   
TP0610 tpr protein H (tprH) {Treponema pallidum} 2 1 1 
TP0620 tpr protein I (tprI) {Treponema pallidum} 1  1 
TP0621 tpr protein J (tprJ) {Treponema pallidum} 0   
TP0897 tpr protein K (tprK) {Treponema pallidum} 1  1 
TP1031 tpr protein L (tprL), authentic frameshift {Treponema pallidum} 0   
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Supplementary Table 19 Functional associations of pathogenicity related and essential 
genes. 
GO1 GO2 Z-Value # Y2H 
 interactions 
secondary metabolism (GO:0019748) PATH_SURFACE 4.64 2 
ribosome (GO:0005840) PATH_TPR_PROTEINS 4.09 2 
ribonucleoprotein complex (GO:0030529) PATH_TPR_PROTEINS 4.02 2 
intracellular (GO:0005622) PATH_TPR_PROTEINS 3.26 2 
cellular process (GO:0009987) TOP50_EXPRESSION 3.04 2 
intracellular (GO:0005622) PATH_POOLED 2.95 15 
secondary metabolism (GO:0019748) PATH_POOLED 2.88 2 
lipid metabolism (GO:0006629) PATH_SURFACE 2.83 2 
macromolecule catabolism (GO:0009057) PATH_SURFACE 2.75 3 
PATH_SURFACE TOP50_EXPRESSION 2.75 7 
structural molecule activity (GO:0005198) PATH_TPR_PROTEINS 2.67 2 
phosphotransferase activity, alcohol group 
as acceptor (GO:0016773) 
TOP50_EXPRESSION 2.63 2 
intracellular (GO:0005622) PATH_REGULATORS 2.62 7 
nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism (GO:0006139) 
TOP50_EXPRESSION 2.60 7 
ion transport (GO:0006811) LOWEST50_EXPRESSION 2.57 9 
biosynthesis (GO:0009058) PATH_SURFACE 2.54 4 
protein catabolism (GO:0030163) essential 2.48 2 
ion transporter activity (GO:0015075) LOWEST50_EXPRESSION 2.48 8 
electron carrier activity (GO:0009055) essential 2.46 18 
electron carrier activity (GO:0009055) essential in all 2.41 7 
transferase activity (GO:0016740) TOP50_EXPRESSION 2.38 14 
response to stress (GO:0006950) PATH_SURFACE 2.33 6 
cellular metabolism (GO:0044237) PATH_SURFACE 2.32 4 
cellular metabolism (GO:0044237) essential 2.32 26 
translation factor activity, nucleic acid 
binding (GO:0008135) 
TOP50_EXPRESSION 2.30 4 
nucleotide binding (GO:0000166) PATH_SURFACE 2.29 17 
cellular metabolism (GO:0044237) TOP50_EXPRESSION 2.28 6 
carbohydrate metabolism (GO:0005975) PATH_SURFACE 2.26 6 
transporter activity (GO:0005215) PATH_SURFACE 2.24 2 
protein biosynthesis (GO:0006412) PATH_TPR_PROTEINS 2.24 2 
nucleobase, nucleoside, nucleotide and 
nucleic acid metabolism (GO:0006139) 
TOP 20 EXPRESSION 2.22 4 
TOP 10 EXPRESSION isomerase activity 
(GO:0016853) 
2.22 3 
 (GO:0003723) PATH_POOLED 2.18 9 
PATH_REGULATORS PATH_REGULATORS 2.16 2 
catabolism (GO:0009056) LOWEST50_EXPRESSION 2.15 2 
ribosome (GO:0005840) PATH_REGULATORS 2.14 5 
lipid metabolism (GO:0006629) essential 2.14 10 
antioxidant activity (GO:0016209) essential 2.12 3 
TOP 10 EXPRESSION PATH_SURFACE 2.12 3 
cell motility (GO:0006928) TPA_DB_HYPOTHETICAL 2.12 61 
DNA binding (GO:0003677) PATH_POOLED 2.07 12 
helicase activity (GO:0004386) essential in all 2.07 7 
transporter activity (GO:0005215) TOP50_EXPRESSION 2.07 3 
structural molecule activity (GO:0005198) PATH_REGULATORS 2.02 8 
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transferase activity (GO:0016740) TOP 20 EXPRESSION 2.01 7 
 
 
Supplementary Table 20 Functional associations of pathogenicity related and essential 
genes (TIGR subrole). 
Subrole 1 Subrole 2 Z-Value # Y2H 
interactions 
PATH_SURFACE Pathogenesis 8.69 2 
Pathogenesis TOP50_EXPRESSION 6.16 2 
PATH_POOLED Pathogenesis 4.96 2 
PATH_TPR_PROTEINS Ribosomal proteins: synthesis and 
modification 
4.14 2 
Cations and iron carrying compounds LOWEST50_EXPRESSION 3.39 8 
2'-Deoxyribonucleotide metabolism TOP50_EXPRESSION 3.28 2 
PATH_SURFACE TOP50_EXPRESSION 2.75 7 
PATH_REGULATORS Ribosomal proteins: synthesis and 
modification 
2.22 5 
PATH_REGULATORS PATH_REGULATORS 2.16 2 
Carbohydrates, organic alcohols, and 
acids 
TOP50_EXPRESSION 2.16 3 
TOP 10 EXPRESSION PATH_SURFACE 2.12 3 
TOP50_EXPRESSION Translation factors 2.11 4 
Biosynthesis essential 2.08 3 
Conserved essential 2.07 230 
LOWEST50_EXPRESSION Unknown substrate 2.06 2 
Protein and peptide secretion and 
trafficking 
essential 2.05 11 
2'-Deoxyribonucleotide metabolism essential in all 2.05 2 
Protein modification and repair essential in all 2.03 6 
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Supplementary Table 21 E. coli gene mutants screened for 5-FdU sensitivity. 
O
R
F
 
C
L
O
N
E
 #
 
D
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W
 
C
O
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B0058 1 orf, hypothetical protein 1 1 
B0479 1 fosmidomycin resistance protein1 19
B0568 1 
bacteriophage N4 receptor, outer 
membrane protein 1 21
B0659 1 orf, hypothetical protein 1 23
B0081 1 orf, hypothetical protein 1 3 
B0082 1 putative apolipoprotein 1 5 
B0099 1 
7,8-dihydro-8-oxoguanine-
triphosphatase, prefers dGTP, 
causes AT-GC transversions 1 7 
B0103 1 putative DNA repair protein 1 9 
B0285 1 orf, hypothetical protein 1 11
B0343 1 galactoside permease (M protein)1 13
B0433 1 regulates beta-lactamase synthesis1 15
B0443 1 orf, hypothetical protein 1 17
B0661 1 orf, hypothetical protein 3 1 
B0931 1 
nicotinate 
phosphoribosyltransferase 3 19
B1053 1 putative transport protein 3 21
B1097 1 
putative thymidylate kinase (EC 
2.7.4.9) 3 23
B0710 1 orf, hypothetical protein 3 3 
B0736 1 orf, hypothetical protein 3 5 
B0741 1 
peptidoglycan-associated 
lipoprotein 3 7 
B0766 1 putative phosphatase 3 9 
B0822 1 orf, hypothetical protein 3 11
B0835 1 orf, hypothetical protein 3 13
B0845 1 
putative DEOR-type 
transcriptional regulator 3 15
B0898 1 putative transport 3 17
B1100 1 orf, hypothetical protein 5 1 
B1534 1 putative transport protein 5 19
B1543 1 putative transport protein 5 21
B1601 1 putative transport protein 5 23
B1134 1 putative phosphohydrolase 5 3 
B1135 1 orf, hypothetical protein 5 5 
B1197 1 trehalase, periplasmic 5 7 
B1203 1 putative GTP-binding protein 5 9 
B1330 1 orf, hypothetical protein 5 11
B1344 1 orf, hypothetical protein 5 13
B1452 1 putative receptor 5 15
B1529 1 orf, hypothetical protein 5 17
B1630 1 orf, hypothetical protein 7 1 
B1959 1 putative transmembrane subunit7 19
B1962 1 orf, hypothetical protein 7 21
B1981 1 
putative transport protein, 
shikimate 7 23
B1681 1 orf, hypothetical protein 7 3 
B1688 1 orf, hypothetical protein 7 5 
B1758 1 putative cytochrome oxidase 7 7 
B1759 1 orf, hypothetical protein 7 9 
B1769 1 putative transport protein 7 11
B1813 1 orf, hypothetical protein 7 13
B1864 1 orf, hypothetical protein 7 15
B1865 1 dATP pyrophosphohydrolase 7 17
B1983 1 orf, hypothetical protein 9 1 
B2367 1 multidrug resistance protein Y 9 19
B2406 1 xanthosine permease 9 21
B2467 1 orf, hypothetical protein 9 23
B1985 1 orf, hypothetical protein 9 3 
B2077 1 putative transport protein 9 5 
B2098 1 
putative nucleoside permease 
protein 9 7 
B2106 1 orf, hypothetical protein 9 9 
B2183 1 16S pseudouridylate 516 synthase9 11
B2251 1 orf, hypothetical protein 9 13
B2299 1 putative regulator 9 15
B2322 1 putative transport protein 9 17
B2493 1 putative permease 11 1 
B2791 1 orf, hypothetical protein 11 19
B2830 1 putative invasion protein 11 21
B2841 1 
low-affinity L-arabinose transport 
system proton symport protein11 23
B2516 1 putative membrane protein 11 3 
B2517 1 orf, hypothetical protein 11 5 
B2565 1 
protein interacts with RecR and 
possibly RecF proteins 11 7 
B2581 1 orf, hypothetical protein 11 9 
B2587 1 alpha-ketoglutarate permease 11 11
B2686 1 
multidrug resistance; probably 
membrane translocase 11 13
B2775 1 putative transport protein 11 15
B2789 1 putative transport protein 11 17
B2880 1 orf, hypothetical protein 13 1 
B3196 1 orf, hypothetical protein 13 19
B3519 1 cytoplasmic trehalase 13 21
B3523 1 putative transport protein 13 23
B2881 1 putative dehydrogenase 13 3 
B2943 1 
galactose-proton symport of 
transport system 13 5 
B2952 1 putative resistance protein 13 7 
B2960 1 orf, hypothetical protein 13 9 
B3034 1 orf, hypothetical protein 13 11
B3093 1 transport of hexuronates 13 13
B3148 1 orf, hypothetical protein 13 15
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B3184 1 orf, hypothetical protein 13 17
B3651 1 putative RNA methylase 15 1 
B3473 1 putative transport 15 19
B3413 1 orf, hypothetical protein 15 21
B2771 1 putative transport protein 15 23
B3660 1 putative permease transporter 15 3 
B0353 1 putative transport protein 15 5 
B1683 1 orf, hypothetical protein 15 7 
B1775 1 putative transport protein 15 9 
B2051 1 
GDP-mannose mannosyl 
hydrolase 15 11
B2182 1 
bicyclomycin resistance protein; 
transmembrane protein 15 13
B2214 1 orf, hypothetical protein 15 15
B2866 1 orf, hypothetical protein 15 17
B0058 2 orf, hypothetical protein 1 2 
B0577 2 putative transport 1 20
B0659 2 orf, hypothetical protein 1 22
B0661 2 orf, hypothetical protein 1 24
B0081 2 orf, hypothetical protein 1 4 
B0082 2 putative apolipoprotein 1 6 
B0103 2 putative DNA repair protein 1 8 
B0284 2 orf, hypothetical protein 1 10
B0285 2 orf, hypothetical protein 1 12
B0443 2 orf, hypothetical protein 1 14
B0479 2 fosmidomycin resistance protein1 16
B0568 2 
bacteriophage N4 receptor, outer 
membrane protein 1 18
B0710 2 orf, hypothetical protein 3 2 
B0931 2 
nicotinate 
phosphoribosyltransferase 3 20
B1053 2 putative transport protein 3 22
B1086 2 orf, hypothetical protein 3 24
B0736 2 orf, hypothetical protein 3 4 
B0741 2 
peptidoglycan-associated 
lipoprotein 3 6 
B0766 2 putative phosphatase 3 8 
B0822 2 orf, hypothetical protein 3 10
B0835 2 orf, hypothetical protein 3 12
B0842 2 proton motive force efflux pump3 14
B0845 2 
putative DEOR-type 
transcriptional regulator 3 16
B0898 2 putative transport 3 18
B1097 2 
putative thymidylate kinase (EC 
2.7.4.9) 5 2 
B1452 2 putative receptor 5 20
B1529 2 orf, hypothetical protein 5 22
B1534 2 putative transport protein 5 24
B1100 2 orf, hypothetical protein 5 4 
B1134 2 putative phosphohydrolase 5 6 
B1135 2 orf, hypothetical protein 5 8 
B1197 2 trehalase, periplasmic 5 10
B1203 2 putative GTP-binding protein 5 12
B1234 2 orf, hypothetical protein 5 14
B1330 2 orf, hypothetical protein 5 16
B1344 2 orf, hypothetical protein 5 18
B1596 2 putative transport protein 7 2 
B1813 2 orf, hypothetical protein 7 20
B1864 2 orf, hypothetical protein 7 22
B1865 2 dATP pyrophosphohydrolase 7 24
B1601 2 putative transport protein 7 4 
B1630 2 orf, hypothetical protein 7 6 
B1681 2 orf, hypothetical protein 7 8 
B1688 2 orf, hypothetical protein 7 10
B1690 2 
putative transport system 
permease protein 7 12
B1758 2 putative cytochrome oxidase 7 14
B1759 2 orf, hypothetical protein 7 16
B1769 2 putative transport protein 7 18
B1959 2 putative transmembrane subunit9 2 
B2299 2 putative regulator 9 20
B2322 2 putative transport protein 9 22
B2367 2 multidrug resistance protein Y 9 24
B1962 2 orf, hypothetical protein 9 4 
B1981 2 
putative transport protein, 
shikimate 9 6 
B1983 2 orf, hypothetical protein 9 8 
B1985 2 orf, hypothetical protein 9 10
B2077 2 putative transport protein 9 12
B2098 2 
putative nucleoside permease 
protein 9 14
B2183 2 16S pseudouridylate 516 synthase9 16
B2251 2 orf, hypothetical protein 9 18
B2406 2 xanthosine permease 11 2 
B2742 2 lipoprotein 11 20
B2775 2 putative transport protein 11 22
B2789 2 putative transport protein 11 24
B2467 2 orf, hypothetical protein 11 4 
B2493 2 putative permease 11 6 
B2516 2 putative membrane protein 11 8 
B2517 2 orf, hypothetical protein 11 10
B2565 2 
protein interacts with RecR and 
possibly RecF proteins 11 12
B2587 2 alpha-ketoglutarate permease 11 14
B2605 2 putative outer membrane protein11 16
B2686 2 
multidrug resistance; probably 
membrane translocase 11 18
B3697 1 orf, hypothetical protein 13 2 
B4111 1 
low-affinity transport system; 
proline permease II 13 20
B4180 1 orf, hypothetical protein 13 22
B4210 1 putative transmembrane subunit13 24
B3710 1 putative transport protein 13 4 
B3827 1 orf, hypothetical protein 13 6 
B3874 1 
putative resistance protein 
(transport) 13 8 
B4020 1 putative alpha helix protein 13 10
B4022 1 orf, hypothetical protein 13 12
B4031 1 xylose-proton symport 13 14
B4044 1 DNA-damage-inducible protein F13 16
B4092 1 phosphonate metabolism 13 18
B4332 1 putative transport protein 15 2 
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B2214 2 orf, hypothetical protein 15 20
B3673 1 
2-module integral membrane 
pump; multidrug resistance 15 22
B2771 2 putative transport protein 15 24
B4337 1 putative transport protein 15 4 
B4356 1 
putative transport protein, cryptic, 
orf, joins former yjiZ and yjjL 15 6 
B0353 2 putative transport protein 15 8 
B1683 2 orf, hypothetical protein 15 10
B1775 2 putative transport protein 15 12
B1856 2 orf, hypothetical protein 15 14
B2051 2 
GDP-mannose mannosyl 
hydrolase 15 16
B2182 2 
bicyclomycin resistance protein; 
transmembrane protein 15 18
B0045 3 putative transport protein 2 1 
B0842 3 proton motive force efflux pump2 19
B0957 5 
outer membrane protein 3a 
(II*;G;d) 2 21
B1086 5 orf, hypothetical protein 2 23
B0045 4 putative transport protein 2 3 
B0099 3 
7,8-dihydro-8-oxoguanine-
triphosphatase, prefers dGTP, 
causes AT-GC transversions 2 5 
B0284 3 orf, hypothetical protein 2 7 
B0343 3 galactoside permease (M protein)2 9 
B0433 3 regulates beta-lactamase synthesis2 11
B0446 3 orf, hypothetical protein 2 13
B0446 4 orf, hypothetical protein 2 15
B0577 3 putative transport 2 17
B1234 3 orf, hypothetical protein 4 1 
B2536 5 
MFS (major facilitator 
superfamily) transporter 4 19
B2581 4 orf, hypothetical protein 4 21
B2594 3 suppressor of ftsH mutation 4 23
B1242 3 putative channel protein 4 3 
B1242 5 putative channel protein 4 5 
B1269 3 orf, hypothetical protein 4 7 
B1269 4 orf, hypothetical protein 4 9 
B1543 3 putative transport protein 4 11
B1596 4 putative transport protein 4 13
B1690 3 
putative transport system 
permease protein 4 15
B2106 3 orf, hypothetical protein 4 17
B2594 4 suppressor of ftsH mutation 6 1 
B2867 2 putative dehydrogenase 6 19
B2867 4 putative dehydrogenase 6 21
B2880 2 orf, hypothetical protein 6 23
B2605 3 putative outer membrane protein6 3 
B2742 3 lipoprotein 6 5 
B2791 2 orf, hypothetical protein 6 7 
B2830 2 putative invasion protein 6 9 
B2835 2 putative resistance proteins 6 11
B2835 3 putative resistance proteins 6 13
B2841 2 
low-affinity L-arabinose transport 
system proton symport protein6 15
B2851 5 orf, hypothetical protein 6 17
B2881 2 putative dehydrogenase 8 1 
B3093 2 transport of hexuronates 8 19
B3127 3 putative transport protein 8 21
B3127 4 putative transport protein 8 23
B2924 2 putative transport protein 8 3 
B2924 5 putative transport protein 8 5 
B2943 2 
galactose-proton symport of 
transport system 8 7 
B2952 2 putative resistance protein 8 9 
B2954 2 putative ribosomal protein 8 11
B2954 3 putative ribosomal protein 8 13
B2960 2 orf, hypothetical protein 8 15
B3034 2 orf, hypothetical protein 8 17
B3148 2 orf, hypothetical protein 10 1 
B3465 4 orf, hypothetical protein 10 19
B3519 2 cytoplasmic trehalase 10 21
B3523 2 putative transport protein 10 23
B3184 3 orf, hypothetical protein 10 3 
B3196 2 orf, hypothetical protein 10 5 
B3290 2 transport of potassium 10 7 
B3290 3 transport of potassium 10 9 
B3364 4 putative transport 10 11
B3397 5 orf, hypothetical protein 10 13
B3434 2 orf, hypothetical protein 10 15
B3434 3 orf, hypothetical protein 10 17
B3547 3 putative resistance protein 12 1 
B3754 4 putative transport protein 12 19
B3812 2 putative phosphatase 12 21
B3812 3 putative phosphatase 12 23
B3547 5 putative resistance protein 12 3 
B3651 2 putative RNA methylase 12 5 
B3659 3 two-module transport protein 12 7 
B3659 4 two-module transport protein 12 9 
B3660 2 putative permease transporter 12 11
B3697 2 orf, hypothetical protein 12 13
B3710 3 putative transport protein 12 15
B3754 2 putative transport protein 12 17
B3827 2 orf, hypothetical protein 14 1 
B4111 2 
low-affinity transport system; 
proline permease II 14 19
B4146 2 orf, hypothetical protein 14 21
B4146 3 orf, hypothetical protein 14 23
B3874 3 
putative resistance protein 
(transport) 14 3 
B3907 2 rhamnose transport 14 5 
B3907 3 rhamnose transport 14 7 
B4020 2 putative alpha helix protein 14 9 
B4022 2 orf, hypothetical protein 14 11
B4031 2 xylose-proton symport 14 13
B4044 3 DNA-damage-inducible protein F14 15
B4092 2 phosphonate metabolism 14 17
B4180 2 orf, hypothetical protein 16 1 
B3673 2 
2-module integral membrane 
pump; multidrug resistance 16 19
B3473 2 putative transport 16 21
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B3413 2 orf, hypothetical protein 16 23
B4210 2 putative transmembrane subunit16 3 
B4332 2 putative transport protein 16 5 
B4337 2 putative transport protein 16 7 
B4356 2 
putative transport protein, cryptic, 
orf, joins former yjiZ and yjjL 16 9 
B4374 2 putative phosphatase 16 11
B4374 5 putative phosphatase 16 13
B1856 3 orf, hypothetical protein 16 15
B2866 2 orf, hypothetical protein 16 17
B0957 6 
outer membrane protein 3a 
(II*;G;d) 2 2 
B0243 3 
gamma-glutamylphosphate 
reductase 2 20
B0386 1 pyrroline-5-carboxylate reductase2 22
B0386 2 pyrroline-5-carboxylate reductase2 24
B2170 6 putative transport 2 4 
B2170 7 putative transport 2 6 
B2536 6 
MFS (major facilitator 
superfamily) transporter 2 8 
B2851 6 orf, hypothetical protein 2 10
B3364 6 putative transport 2 12
B3397 7 orf, hypothetical protein 2 14
B3465 7 orf, hypothetical protein 2 16
B0243 2 
gamma-glutamylphosphate 
reductase 2 18
B0436 1 
trigger factor; a molecular 
chaperone involved in cell division4 2 
B1859 2 orf, hypothetical protein 4 20
B1863 1 
Holliday junction nuclease; 
resolution of structures; repair 4 22
B1863 2 
Holliday junction nuclease; 
resolution of structures; repair 4 24
B0436 2 
trigger factor; a molecular 
chaperone involved in cell division4 4 
B0472 2 recombination and repair 4 6 
B0472 3 recombination and repair 4 8 
B0489 1 putative protease 4 10
B0489 2 putative protease 4 12
B1363 1 
trk system potassium uptake; part 
of Rac prophage 4 14
B1363 2 
trk system potassium uptake; part 
of Rac prophage 4 16
B1859 1 orf, hypothetical protein 4 18
B2048 1 phosphomannomutase 6 2 
B2892 2 
ssDNA exonuclease, 5 --> 3 
specific 6 20
B3019 1 
DNA topoisomerase IV subunit 
A 6 22
B3019 3 
DNA topoisomerase IV subunit 
A 6 24
B2048 2 phosphomannomutase 6 4 
B2220 2 
response regulator of ato, 
ornithine decarboxylase antizyme 
(sensor ATOS) 6 6 
B2220 3 
response regulator of ato, 
ornithine decarboxylase antizyme 
(sensor ATOS) 6 8 
B2554 1 
putative 2-component 
transcriptional regulator 6 10
B2554 2 
putative 2-component 
transcriptional regulator 6 12
B2569 2 
GTP-binding elongation factor, 
may be inner membrane protein6 14
B2569 5 
GTP-binding elongation factor, 
may be inner membrane protein6 16
B2892 1 
ssDNA exonuclease, 5 --> 3 
specific 6 18
B3176 1 
similar to phosphoglucomutases 
and phosphomannomutases 8 2 
B3741 2 
glucose-inhibited division; 
chromosome replication? 8 20
B3868 2 
response regulator for gln (sensor 
glnL) (nitrogen regulator I, NRI)8 22
B3868 4 
response regulator for gln (sensor 
glnL) (nitrogen regulator I, NRI)8 24
B3176 2 
similar to phosphoglucomutases 
and phosphomannomutases 8 4 
B3299 1 
50S ribosomal subunit protein 
L36 8 6 
B3299 2 
50S ribosomal subunit protein 
L36 8 8 
B3425 1 protein of glp regulon 8 10
B3425 2 protein of glp regulon 8 12
B3652 1 
DNA helicase, resolution of 
Holliday junctions, branch 
migration 8 14
B3652 2 
DNA helicase, resolution of 
Holliday junctions, branch 
migration 8 16
B3741 1 
glucose-inhibited division; 
chromosome replication? 8 18
B4004 1 
response regulator of hydrogenase 
3 activity (sensor HydH) 10 2 
B1214 2 orf, hypothetical protein 10 20
b3409 dfeoBferrous iron transport protein B10 22
b1203 dychFputative GTP-binding protein 10 24
B4004 3 
response regulator of hydrogenase 
3 activity (sensor HydH) 10 4 
B4174 1 
protease specific for phage 
lambda cII repressor 10 6 
B4174 2 
protease specific for phage 
lambda cII repressor 10 8 
B4175 1 
protease specific for phage 
lambda cII repressor 10 10
B4175 2 
protease specific for phage 
lambda cII repressor 10 12
B3508 1 putative transport ATPase 10 14
B3508 2 putative transport ATPase 10 16
B1214 1 orf, hypothetical protein 10 18
b4146 dygeKorf, hypothetical protein 12 2 
B2698 1 regulator, OraA protein 12 20
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B2698 2 regulator, OraA protein 12 22
b1100 dycfHorf, hypothetical protein 12 4 
b1864 dyebCorf, hypothetical protein 12 6 
b1983 dyeeNorf, hypothetical protein 12 8 
b2517 dyfgBorf, hypothetical protein 12 10
B2699 1 
DNA strand exchange and 
renaturation, DNA-dependent 
ATPase, DNA- and ATP-
dependent coprotease 12 12
B2699 2 
DNA strand exchange and 
renaturation, DNA-dependent 
ATPase, DNA- and ATP-
dependent coprotease 12 14
B2733 1 methyl-directed mismatch repair12 16
B2733 2 methyl-directed mismatch repair12 18
yebCyeeN 1 dyebC/dyeeN RP427 14 20
yebCyeeN 2 dyebC/dyeeN RP427 14 22
wtRP437 1 RP437 14 4 
wtRP437 2 RP437 14 6 
BW25113 1 WI 14 8 
BW25113 2 WI 14 10
BW25113 3 WT 14 12
BW25113 4 WT 14 18
BW25113 5 WI 16 20
wtRP437 6 RP437 16 22
wtRP437 7 RP437 16 24
BW25113 8 WT 16 14
BW25113 9 WT 16 16
BW25113 10 WT 16 18
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Supplementary Table 22 E. coli gene-deletion mutants with reduced motility. All mutant 
strain from a systematic gene-deletion library for E. coli (Baba et al. 2006)were tested for 
reduced motility using an automated robotic procedure.  
SCREEN_RESULT: result for both independent strains of respective mutant in whole genome screen 
SWARMING_DIAMETER[%]: Percentage of swarming diameter found in retest 
STRONGLY REDUCED: Mutants with a swarming diameter reduced to  
20% or more are classified to have strongly reduced motility 
LB_22h: OD600 measured after 22h incubation at 37°C in LB medium (taken from Baba et al. 2006) 
BNAME NAME SCREEN_RESULT SWARMING 
DIAMETER[%] 
STRONGLY  
REDUCED 
LB_22h 
B0014 dnaK strongly reduced/strongly reduced 16 yes 0.465 
B0015 dnaJ strongly reduced/strongly reduced 32 no 0.506 
B0051 ksgA reduced/reduced 38 no 0.764 
B0116 lpdA strongly reduced/strongly reduced 32 no 0.337 
B0119 yacL reduced/strongly reduced 40 no 0.718 
B0161 degP reduced/reduced 24 no 0.357 
B0222 lpcA strongly reduced/strongly reduced 35 no 0.437 
B0253 ykfA reduced/reduced 45 no 0.695 
B0405 queA reduced/strongly reduced 45 no 0.834 
B0406 tgt reduced/reduced 46 no 0.765 
B0418 pgpA strongly reduced/strongly reduced 38 no 0.655 
B0556 rzpD reduced/reduced 47 no 0.817 
B0628 lipA strongly reduced/strongly reduced 23 no 0.296 
B0631 ybeD reduced/strongly reduced 35 no 0.341 
B0637 ybeB reduced/strongly reduced 42 no 0.69 
B0659 ybeY strongly reduced/strongly reduced 3 yes 0.467 
B0662 ubiF strongly reduced/strongly reduced 5 yes 0.308 
B0688 pgm reduced/strongly reduced 29 no 0.363 
B0695 kdpD reduced/reduced 46 no 0.44 
B0721 sdhC reduced/strongly reduced 36 no 0.42 
B0734 cydB reduced/strongly reduced 43 no 0.525 
B0738 tolR strongly reduced/strongly reduced 41 no 0.478 
B0739 tolA reduced/strongly reduced 43 no 0.461 
B0910 cmk strongly reduced/strongly reduced 28 no 0.388 
B0913 ycaI reduced/reduced 28 no 0.753 
B0969 yccK strongly reduced/strongly reduced 18 yes 0.72 
B1049 mdoH strongly reduced/strongly reduced 34 no 0.524 
B1070 flgN strongly reduced/strongly reduced 28 no 0.467 
B1071 flgM reduced/reduced 47 no 0.676 
B1072 flgA strongly reduced/strongly reduced 45 no 0.463 
B1073 flgB strongly reduced/strongly reduced 3 yes 0.478 
B1074 flgC strongly reduced/strongly reduced 3 yes 0.5 
B1075 flgD strongly reduced/strongly reduced 3 yes 0.441 
B1076 flgE strongly reduced/strongly reduced 3 yes 0.466 
B1077 flgF strongly reduced/strongly reduced 10 yes 0.513 
B1078 flgG strongly reduced/strongly reduced 0 yes 0.467 
B1080 flgI strongly reduced/strongly reduced 18 yes 0.417 
B1081 flgJ strongly reduced/strongly reduced 19 yes 0.419 
B1082 flgK strongly reduced/strongly reduced 3 yes 0.501 
B1083 flgL strongly reduced/strongly reduced 35 no 0.507 
B1089 rpmF strongly reduced/strongly reduced 39 no 0.421 
B1105 ycfM reduced/strongly reduced 0 yes 0.592 
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B1133 trmU reduced/strongly reduced 36 no 0.687 
B1166 ymgB strongly reduced/strongly reduced 42 no 0.67 
B1187 fadR reduced/reduced 49 no 0.916 
B1192 ldcA reduced/strongly reduced 41 no 0.637 
B1203 ychF reduced/strongly reduced 43 no 0.692 
B1226 narJ reduced/strongly reduced 41 no 0.591 
B1236 galU strongly reduced/strongly reduced 24 no 0.476 
B1237 hns strongly reduced/strongly reduced 30 no 0.507 
B1280 yciM reduced/strongly reduced 34 no 0.418 
B1289 ycjD reduced/reduced 50 no 0.68 
B1357 ydaS strongly reduced/strongly reduced 43 no 0.45 
B1428 ydcK strongly reduced/strongly reduced 43 no 0.596 
B1445 ydcX reduced/strongly reduced 50 no 0.692 
B1534 ydeE reduced/strongly reduced 34 no 0.619 
B1643 ydhI reduced/strongly reduced 45 no 0.582 
B1659 ydhB reduced/strongly reduced 46 no 0.754 
B1693 aroD reduced/reduced 35 no 0.607 
B1717 rpmI reduced/reduced 45 no 0.658 
B1755 ynjC reduced/reduced 45 no 0.79 
B1878 flhE reduced/strongly reduced 27 no 0.557 
B1879 flhA reduced/strongly reduced 29 no 0.426 
B1880 flhB strongly reduced/strongly reduced 3 yes 0.448 
B1881 cheZ strongly reduced/strongly reduced 39 no 0.554 
B1882 cheY strongly reduced/strongly reduced 3 yes 0.655 
B1883 cheB strongly reduced/strongly reduced 14 yes 0.771 
B1884 cheR strongly reduced/strongly reduced 38 no 0.707 
B1885 tap strongly reduced/strongly reduced 7 yes 0.875 
B1887 cheW strongly reduced/strongly reduced 3 yes 0.492 
B1888 cheA reduced/strongly reduced 3 yes 0.919 
B1889 motB strongly reduced/strongly reduced 34 no 0.502 
B1890 motA strongly reduced/strongly reduced 3 yes 0.494 
B1891 flhC strongly reduced/strongly reduced 26 no 0.417 
B1892 flhD strongly reduced/strongly reduced 46 no 0.468 
B1922 fliA strongly reduced/strongly reduced 3 yes 0.605 
B1923 fliC strongly reduced/strongly reduced 4 yes 0.348 
B1924 fliD strongly reduced/strongly reduced 4 yes 0.411 
B1925 fliS strongly reduced/strongly reduced 4 yes 0.414 
B1933 (yedN) reduced/strongly reduced 45 no 0.503 
B1938 fliF strongly reduced/strongly reduced 3 yes 0.442 
B1939 fliG strongly reduced/strongly reduced 3 yes 0.492 
B1940 fliH strongly reduced/strongly reduced 29 no 0.511 
B1941 fliI strongly reduced/strongly reduced 3 yes 0.519 
B1942 fliJ strongly reduced/strongly reduced 21 no 0.556 
B1943 fliK strongly reduced/strongly reduced 45 no 0.397 
B1945 fliM strongly reduced/strongly reduced 3 yes 0.596 
B1946 fliN strongly reduced/strongly reduced 12 yes 0.531 
B1948 fliP strongly reduced/strongly reduced 3 yes 0.559 
B1949 fliQ strongly reduced/strongly reduced 10 yes 0.484 
B1950 fliR strongly reduced/strongly reduced 3 yes 0.496 
B2218 (rcsC) strongly reduced/strongly reduced 35 no 0.472 
B2261 menC reduced/strongly reduced 35 no 0.449 
B2296 ackA reduced/reduced 17 yes 0.816 
B2329 aroC reduced/reduced 35 no 0.621 
B2435 amiA reduced/reduced 46 no 0.823 
B2501 ppk reduced/reduced 47 no 0.757 
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B2507 guaA strongly reduced/strongly reduced 6 yes 0.19 
B2512 yfgL strongly reduced/strongly reduced 7 yes 0.369 
B2516 yfgA strongly reduced/strongly reduced 2 yes 0.293 
B2525 fdx strongly reduced/strongly reduced 23 no 0.379 
B2527 hscB reduced/strongly reduced 30 no 0.332 
B2551 glyA reduced/strongly reduced 30 no 0.668 
B2594 rluD strongly reduced/strongly reduced 18 yes 0.346 
B2603 yfiR strongly reduced/strongly reduced 7 yes 0.716 
B2620 smpB reduced/strongly reduced 15 yes 0.734 
B2699 recA reduced/reduced 47 no 0.245 
B2754 ygbF strongly reduced/strongly reduced 15 yes 0.502 
B2848 yqeJ reduced/strongly reduced 46 no 0.593 
B2894 xerD reduced/reduced 47 no 0.638 
B2898 ygfZ reduced/strongly reduced 44 no 0.385 
B2907 ubiH strongly reduced/strongly reduced 25 no 0.559 
B3058 folB reduced/strongly reduced 0 yes 0.488 
B3104 yhaI reduced/strongly reduced 27 no 0.747 
B3138 agaB reduced/reduced 0 yes 0.712 
B3162 deaD reduced/reduced 26 no 0.765 
B3164 pnp strongly reduced/strongly reduced 49 no 0.615 
B3179 rrmJ strongly reduced/strongly reduced 48 no 0.52 
B3180 yhbY reduced/strongly reduced 44 no 0.698 
B3202 rpoN reduced/reduced 22 no 0.555 
B3261 fis strongly reduced/strongly reduced 18 yes 0.524 
B3268 yhdW reduced/strongly reduced 33 no 0.776 
B3299 rpmJ reduced/reduced 14 yes 0.26 
B3343 yheL reduced/strongly reduced 18 yes 0.67 
B3344 yheM reduced/strongly reduced 27 no 0.664 
B3386 rpe strongly reduced/strongly reduced 21 no 0.602 
B3387 dam reduced/strongly reduced 48 no 0.416 
B3507 yhiF reduced/reduced 35 no 0.524 
B3525 yhjH strongly reduced/strongly reduced 34 no 0.775 
B3619 rfaD strongly reduced/strongly reduced 33 no 0.325 
B3620 rfaF reduced/strongly reduced 45 no 0.365 
B3728 pstS reduced/reduced 33 no 0.636 
B3732 atpD reduced/strongly reduced 33 no 0.237 
B3735 atpH strongly reduced/strongly reduced 28 no 0.315 
B3736 atpF strongly reduced/strongly reduced 29 no 0.259 
B3791 rffA reduced/reduced 50 no 0.531 
B3792 wzxE reduced/reduced 23 no 0.713 
B3838 tatB reduced/strongly reduced 37 no 0.655 
B3842 rfaH strongly reduced/strongly reduced 49 no 0.26 
B3870 glnA strongly reduced/strongly reduced 35 no 0.387 
B3911 cpxA strongly reduced/strongly reduced 12 yes 0.413 
B3936 rpmE strongly reduced/strongly reduced 0 yes 0.338 
B3966 btuB reduced/strongly reduced 41 no 0.613 
B3984 rplA strongly reduced/strongly reduced 24 no 0.539 
B3997 hemE strongly reduced/strongly reduced 14 yes 0.579 
B4141 yjeH reduced/strongly reduced 16 yes 0.45 
B4145 yjeJ reduced/reduced 20 yes 0.815 
B4161 yjeQ strongly reduced/strongly reduced 46 no 0.637 
B4172 hfq strongly reduced/strongly reduced 32 no 0.286 
B4225 chpB reduced/reduced 38 no 0.618 
B4232 fbp reduced/strongly reduced 35 no 0.313 
B4275 yjgX reduced/reduced 49 no 0.732 
SUPPLEMENTARY INFORMATION 
 268 
B4313 fimE reduced/reduced 44 no 0.89 
B4355 tsr reduced/reduced 32 no 0.811 
B4362 dnaT strongly reduced/strongly reduced 7 yes 0.179 
B4363 yjjB reduced/reduced 40 no 0.745 
B4390 nadR reduced/reduced 31 no 0.723 
B4401 arcA reduced/reduced 30 no 0.741 
B4402 yjjY reduced/reduced 25 no 0.781 
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Supplementary Table 23 Functional associations in motility set. T. pallidum (TPA), yeast-
two-hybrid protein interactions 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-value RANKING 
POS 
1 motility 33 18.8 52 5.0 10.4 1000 
2 tRNA 
aminoacylation 
11 6.3 25 2.4 2.6 992 
3 Hypothetical proteins 44 25.0 174 16.7 1.7 925 
4 Conserved 44 25.0 174 16.7 1.7 925 
5 DNA-dependent RNA 
polymerase 
4 2.3 8 0.8 1.9 919 
6 Pyrimidine 
ribonucleotide 
biosynthesis 
1 0.6 1 0.1 2.0 833 
7 Electron transport 3 1.7 7 0.7 1.2 810 
8 Protein modification 
and repair 
1 0.6 2 0.2 1.0 681 
9 Biosynthesis and 
degradation of 
polysaccharides 
1 0.6 2 0.2 0.9 650 
10 Transcription 5 2.8 24 2.3 0.1 491 
11 DNA replication, 
recombination, and 
repair 
10 5.7 49 4.7 0.0 454 
12 2'-Deoxyribonucleotide 
metabolism 
1 0.6 4 0.4 0.2 444 
13 DNA metabolism 10 5.7 51 4.9 -0.1 406 
14 Protein synthesis 19 10.8 99 9.5 -0.2 378 
15 Degradation 1 0.6 5 0.5 0.0 375 
 
Supplementary Table 24 Functional associations in motility set. C. jejuni (CJE) – all yeast-
two-hybrid protein interactions. 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-value RANKING 
POS 
1 Cell envelope 182 26.4 339 20.5 3.3 998 
2 Glycolysis/gluconeogenesis 17 2.5 19 1.1 3.2 997 
3 Protein folding and 
stabilization 
16 2.3 19 1.1 2.7 990 
4 Protein fate 40 5.8 65 3.9 2.2 976 
5 Molybdopterin 8 1.2 9 0.5 2.2 968 
6 Unknown substrate 2 0.3 1 0.1 2.7 949 
7 Degradation of DNA 5 0.7 5 0.3 1.9 935 
8 Amino acid biosynthesis 36 5.2 66 4.0 1.4 910 
9 Aspartate family 11 1.6 16 1.0 1.5 900 
10 Aromatic amino acid family 10 1.4 15 0.9 1.5 892 
11 Biosynthesis and degradation of 
murein sacculus and peptidoglycan 
11 1.6 17 1.0 1.4 891 
12 Purines, pyrimidines, nucleosides, 
and nucleotides 
23 3.3 41 2.5 1.2 866 
13 Amino acids, peptides and amines 15 2.2 26 1.6 1.1 841 
14 Unclassified 22 3.2 42 2.5 1.0 806 
15 Role category not yet assigned 22 3.2 42 2.5 1.0 806 
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Supplementary Table 25 Functional associations in motility set. C. jejuni (CJE HCF) – 
yeast-two-hybrid protein high confidence interactions. 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-
value 
RANKING 
POS 
1 motility 12 8.6 47 2.8 3.9 999 
2 Glycolysis/gluconeogenesis 6 4.3 19 1.1 3.1 988 
3 Energy metabolism 22 15.7 155 9.4 2.0 959 
4 Cell envelope 40 28.6 339 20.5 1.8 943 
5 Unknown substrate 1 0.7 1 0.1 3.2 927 
6 Carbohydrates, organic alcohols, 
and acids 
3 2.1 12 0.7 1.9 915 
7 Protein folding and stabilization 4 2.9 19 1.1 1.7 904 
8 Electron transport 13 9.3 98 5.9 1.3 865 
9 Protein fate 9 6.4 65 3.9 1.2 850 
10 Protein and peptide secretion and 
trafficking 
3 2.1 16 1.0 1.3 814 
11 Biosynthesis and degradation of 
murein sacculus and 
peptidoglycan 
3 2.1 17 1.0 1.2 794 
12 Amino acids, peptides and amines 4 2.9 26 1.6 1.0 789 
13 Role category not yet assigned 5 3.6 42 2.5 0.6 646 
14 Degradation of DNA 1 0.7 5 0.3 0.8 637 
15 Toxin production and resistance 2 1.4 16 1.0 0.4 573 
 
 
Supplementary Table 26 Functional associations in motility set. H. pylori (HPY) – yeast-
two-hybrid protein interactions. 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-value RANKING 
POS 
1 motility 12 8.6 53 3.3 4.5 1000 
2 2'-Deoxyribonucleotide 
metabolism 
3 2.2 6 0.4 3.1 974 
3 DNA-dependent RNA polymerase 1 0.7 2 0.1 1.9 819 
4 DNA replication, recombination, 
and repair 
7 5.0 48 3.0 1.2 818 
5 Degradation 1 0.7 2 0.1 1.8 812 
6 Adaptations to atypical conditions 2 1.4 9 0.6 1.4 810 
7 Amino acids and amines 2 1.4 8 0.5 1.3 803 
8 Menaquinone and ubiquinone 1 0.7 3 0.2 1.4 736 
9 Protein and peptide secretion and 
trafficking 
2 1.4 11 0.7 0.9 700 
10 TCA cycle 1 0.7 5 0.3 0.8 632 
11 Fermentation 1 0.7 5 0.3 0.7 567 
12 Fatty acid and phospholipid 
metabolism 
3 2.2 25 1.6 0.3 540 
13 Detoxification 1 0.7 7 0.4 0.4 490 
14 Purines, pyrimidines, nucleosides, 
and nucleotides 
4 2.9 39 2.5 0.1 487 
15 Toxin production and resistance 1 0.7 8 0.5 0.3 468 
SUPPLEMENTARY INFORMATION 
 271 
 
Supplementary Table 27 Functional associations in motility set. E. coli (ECO SAI) – 
socio-affinity score filtered MS-generated protein interactions. 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-
value 
RANKING 
POS 
1 Transcription 10 2.5 38 0.9 3.3 998 
2 Cell division 7 1.7 20 0.5 3.6 994 
3 DNA metabolism 18 4.4 103 2.4 2.5 991 
4 Transcription factors 6 1.5 19 0.4 3.0 988 
5 Purine ribonucleotide biosynthesis 5 1.2 17 0.4 2.7 979 
6 Nucleotide and nucleoside 
interconversions 
4 1.0 10 0.2 3.0 975 
7 Chromosome-associated proteins 2 0.5 2 0.0 3.8 961 
8 Purines, pyrimidines, nucleosides, 
and nucleotides 
13 3.2 77 1.8 1.9 953 
9 Protein modification and repair 4 1.0 15 0.3 2.2 953 
10 Degradation of RNA 3 0.7 8 0.2 2.4 943 
11 DNA replication, recombination, and 
repair 
14 3.4 90 2.1 1.8 939 
12 Protein synthesis 17 4.2 120 2.8 1.6 922 
13 Ribosomal proteins: synthesis and 
modification 
9 2.2 56 1.3 1.6 912 
14 2'-Deoxyribonucleotide metabolism 3 0.7 11 0.3 1.9 909 
15 Pyridoxine 2 0.5 5 0.1 2.0 897 
 
Supplementary Table 28 Functional associations in motility set. E. coli (ECO SPOKE) – 
Spoke model MS-generated protein interactions. 
 Funclass count percent 
(of ints) 
counttotal percent (of 
genome) 
Z-value RANKING 
POS 
1 Protein folding and 
stabilization 
26 4.6 34 0.8 16.1 1000 
2 Biosynthesis of cofactors, 
prosthetic groups, and carriers 
19 3.4 100 2.3 4.9 1000 
3 Pyridine nucleotides 14 2.5 2 0.0 35.7 1000 
4 Protein synthesis 32 5.7 120 2.8 9.0 1000 
5 Protein fate 38 6.7 114 2.7 11.7 1000 
6 Ribosomal proteins: synthesis 
and modification 
25 4.4 56 1.3 11.4 1000 
7 Degradation of proteins, 
peptides, and glycopeptides 
8 1.4 34 0.8 4.0 999 
8 DNA-dependent RNA 
polymerase 
3 0.5 6 0.1 4.2 994 
9 Cell division 5 0.9 20 0.5 3.1 992 
10 Biosynthesis and degradation 
of polysaccharides 
5 0.9 26 0.6 2.7 980 
11 DNA metabolism 12 2.1 103 2.4 2.0 951 
12 Molybdopterin 2 0.4 7 0.2 2.4 930 
13 Transcription 5 0.9 38 0.9 1.7 909 
14 ATP-proton motive force 
interconversion 
2 0.4 9 0.2 1.9 882 
15 Purine ribonucleotide biosynthesis 3 0.5 17 0.4 1.7 877 
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Supplementary Table 29 Functional associations in motility set. E. coli (ECO 
MOTILITY) – mutants showing reduced motility 
 Funclass count percent 
(of set) 
counttotal percent (of 
genome) 
Z-
value 
p-value 
1 motility 43 27.0 68 1.6 26.3 9.22E-47 
2 ATP-proton motive force 
interconversion 
3 1.9 9 0.2 4.9 3.37E-03 
3 Menaquinone and ubiquinone 3 1.9 15 0.3 3.5 1.46E-02 
4 Transcription factors 3 1.9 19 0.4 2.9 2.68E-02 
5 tRNA and rRNA base 
modification 
3 1.9 19 0.4 2.8 2.68E-02 
6 Lipoate 1 0.6 1 0.0 5.1 3.71E-02 
7 Biosynthesis and degradation 
of surface polysaccharides and 
lipopolysaccharides 
4 2.5 38 0.9 2.3 3.82E-02 
8 Transcription 4 2.5 38 0.9 2.2 3.82E-02 
9 Chromosome-associated proteins 1 0.6 2 0.0 3.7 7.14E-02 
10 Protein synthesis 7 4.4 120 2.8 1.2 8.02E-02 
11 Biosynthesis of cofactors, 
prosthetic groups, and carriers 
6 3.8 100 2.3 1.3 8.90E-02 
12 DNA metabolism 6 3.8 103 2.4 1.2 9.54E-02 
13 DNA replication, recombination, 
and repair 
5 3.1 90 2.1 1.0 1.25E-01 
14 Prophage functions 1 0.6 4 0.1 2.4 1.33E-01 
15 Aromatic amino acid family 2 1.3 21 0.5 1.3 1.41E-01 
 
Supplementary Table 30 Functional associations in motility set. B. subtilis (BSU 
MOTILITY) – mutants showing reduced motility. 
 Funclass count percent 
(of set) 
counttotal percent (of 
genome) 
Z-
value 
p-value 
1 motility 45 30.8 51 1.2 31.5 6.54E-62 
2 Chemotaxis and motility 3 2.1 7 0.2 5.4 1.34E-03 
3 Molybdopterin 2 1.4 8 0.2 3.3 2.85E-02 
4 Biosynthesis and degradation 
of surface polysaccharides and 
lipopolysaccharides 
4 2.7 44 1.1 2.0 5.08E-02 
5 Cell envelope 9 6.2 168 4.1 1.4 6.80E-02 
6 Biosynthesis and degradation of 
murein sacculus and 
peptidoglycan 
5 3.4 73 1.8 1.5 7.28E-02 
7 Degradation 1 0.7 9 0.2 1.2 2.40E-01 
8 Degradation of proteins, 
peptides, and glycopeptides 
2 1.4 47 1.1 0.3 2.70E-01 
9 Pyruvate family 1 0.7 11 0.3 0.9 2.73E-01 
10 Detoxification 2 1.4 53 1.3 0.1 2.77E-01 
11 Sugars 2 1.4 53 1.3 0.1 2.77E-01 
12 Pentose phosphate pathway 1 0.7 13 0.3 0.7 3.00E-01 
13 Aerobic 1 0.7 16 0.4 0.5 3.32E-01 
14 Biosynthesis and degradation of 
polysaccharides 
1 0.7 22 0.5 0.2 3.67E-01 
15 Carbohydrates, organic alcohols, 
and acids 
1 0.7 24 0.6 0.2 3.72E-01 
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Supplementary Table 31 Functional associations in motility set. E. coli (FLHD) – genes 
regulated by FlhD. 
 Funclass count percent 
(of set) 
counttotal percent (of 
genome) 
Z-value p-value 
1 motility 43 26.2 68 1.6 25.5 4.18E-46 
2 TCA cycle 6 3.7 20 0.5 6.2 6.55E-05 
3 Nitrogen metabolism 3 1.8 7 0.2 5.6 1.65E-03 
4 Fermentation 4 2.4 25 0.6 3.1 1.17E-02 
5 Central intermediary 
metabolism 
7 4.3 70 1.6 2.8 1.18E-02 
6 Energy metabolism 20 12.2 366 8.5 1.7 2.62E-02 
7 Aspartate family 3 1.8 25 0.6 2.1 5.43E-02 
8 Pyrimidine ribonucleotide 
biosynthesis 
2 1.2 12 0.3 2.3 6.53E-02 
9 Carbohydrates, organic alcohols, 
and acids 
7 4.3 109 2.5 1.5 6.65E-02 
10 Transport and binding proteins 15 9.1 313 7.3 0.9 7.37E-02 
11 Amino acid biosynthesis 7 4.3 113 2.6 1.4 7.39E-02 
12 Glutamate family 3 1.8 29 0.7 1.8 7.40E-02 
13 Entner-Doudoroff 1 0.6 4 0.1 2.1 1.36E-01 
14 Amino acids, peptides and amines 5 3.0 93 2.2 0.8 1.39E-01 
15 Aerobic 2 1.2 21 0.5 1.3 1.47E-01 
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Supplementary Table 32 Transmembrane protein fragments. These fragments were 
selected for cloning and testing for protein interactions. The “fragment id” encodes the 
full-length protein and gives the start and end amino-acid positions, e.g. TP0020-494_707 
indicates the segment between amino-acid 494 and 707 of protein TP0020. The location 
shows the predicted localisation to the cytoplasmic (i) or periplasmic (o) face of the 
membrane. The TM count shows the number of transmembrane segments of the full-
length protein. The defline is taken from the SwissProt database. 
Fragment ID location TM count defline 
TP0020-494_707 i 2  76K protein. 
TP0023-64_98 i 11  Sodium-and chloride-dependent transporter. 
TP0042-1_153 i 1  Hypothetical protein. 
TP0070-54_107 i 3  Hypothetical protein TP0070. 
TP0090-1_94 i 1  UDP-N-acetylenolpyruvoylglucosamine reductase (EC 
1.1.1.158) (UDP-N- acetylmuramate dehydrogenase). 
TP0106-160_193 i 12  Carnitine transporter, putative. 
TP0106-419_455 i 12  Carnitine transporter, putative. 
TP0126-1_73 i 2  Hypothetical protein TP0126. 
TP0126-211_291 i 2  Hypothetical protein TP0126. 
TP0138-84_245 i 2  Hypothetical protein TP0138. 
TP0140-444_480 i 15  K+ transport protein (NtpJ). 
TP0143-1_40 i 12  Thiamine ABC transporter, permease protein, putative. 
TP0143-216_257 i 12  Thiamine ABC transporter, permease protein, putative. 
TP0143-485_519 i 12  Thiamine ABC transporter, permease protein, putative. 
TP0151-104_219 i 7  Conserved hypothetical integral membrane protein. 
TP0173-178_227 i 2  Hypothetical protein TP0173. 
TP0181-27_122 i 2  Hypothetical protein TP0181. 
TP0208-232_265 i 10  Preprotein translocase subunit (SecY). 
TP0208-409_450 i 10  Preprotein translocase subunit (SecY). 
TP0208-85_118 i 10  Preprotein translocase subunit (SecY). 
TP0219-280_572 i 10  Sigma factor SigG regulation protein, putative. 
TP0219-596_715 o 10  Sigma factor SigG regulation protein, putative. 
TP0220-67_108 i 2  Anti-sigma F factor antagonist (SpoIIAA-1). 
TP0222-1_124 i 1  Hypothetical protein TP0222 precursor. 
TP0273-209_263 i 4  Hypothetical protein TP0273. 
TP0273-71_126 i 4  Hypothetical protein TP0273. 
TP0301-335_377 i 10  Conserved hypothetical integral membrane protein. 
TP0322-1_42 i 8  Ribose/galactose ABC transporter, permease protein (RbsC-1). 
TP0335-1_36 i 2  Hypothetical protein TP0335. 
TP0336-1_42 i 10  ComE protein, putative. 
TP0336-141_309 o 10  ComE protein, putative. 
TP0338-128_162 i 2  Hypothetical protein TP0338 precursor. 
TP0347-1_45 i 4  Hypothetical protein. 
TP0347-241_276 i 4  Hypothetical protein. 
TP0357-1_77 i 1  Biotin--acetyl-CoA-carboxylase ligase (BirA). 
TP0387-105_148 o 8  Cell division protein (FtsW). 
TP0387-198_281 o 8  Cell division protein (FtsW). 
TP0392-94_319 i 2  Hypothetical protein. 
TP0399-494_567 i 2  Flagellar M-ring protein. 
TP0405-38_149 i 1  McbG protein, putative. 
TP0414-266_309 i 11  D-alanine glycine permease (DagA). 
TP0429-583_622 i 7  V-type ATP synthase subunit I 1 (EC 3.6.3.14) (V-type ATPase 
subunit I 1). 
TP0433-112_256 i 2  Hypothetical protein. 
TP0444-1_45 i 1  Hypothetical protein. 
TP0471-38_469 i 1  Hypothetical protein. 
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TP0479-1_40 i 3  Hypothetical protein. 
TP0481-1_106 i 1  Hypothetical protein TP0481. 
TP0485-121_284 i 3  Adenylate cyclase. 
TP0485-308_614 o 3  Adenylate cyclase. 
TP0515-24_196 i 2  Hypothetical protein. 
TP0516-1_57 i 12  Virulence factor mviN homolog. 
TP0516-414_450 i 12  Virulence factor mviN homolog. 
TP0533-372_425 i 4  V-type ATP synthase subunit I 2 (EC 3.6.3.14) (V-type ATPase 
subunit I 2). 
TP0536-76_133 i 2  Probable protein-export membrane protein secG. 
TP0555-360_396 i 10  Glutamate/ aspartate transporter, putative. 
TP0561-1_212 i 1  Hypothetical protein. 
TP0577-1_493 i 2  Hypothetical protein TP0577. 
TP0577-575_614 i 2  Hypothetical protein TP0577. 
TP0582-1_64 i 4  Conserved hypothetical integral membrane protein. 
TP0593-1_79 i 3  Hypothetical protein TP0593. 
TP0600-125_383 i 4  Hypothetical zinc metalloprotease TP0600 (EC 3.4.24.-). 
TP0602-243_287 i 8  Phosphatidate cytidylyltransferase (CdsA). 
TP0651-35_364 i 7  Conserved hypothetical integral membrane protein. 
TP0651-546_803 i 7  Conserved hypothetical integral membrane protein. 
TP0653-181_212 i 6  Spermidine/putrescine ABC transporter, permease protein 
(PotB). 
TP0671-1_39 i 5  Sn-1,2-diacylglycerol cholinephosphotransferase, putative. 
TP0671-91_135 i 5  Sn-1,2-diacylglycerol cholinephosphotransferase, putative. 
TP0686-1_192 i 8  Galactoside transport system permease protein mglC homolog. 
TP0697-162_202 i 2  Hypothetical protein. 
TP0707-1_58 i 2  Hypothetical protein TP0707. 
TP0707-114_159 i 2  Hypothetical protein TP0707. 
TP0708-73_171 i 2  Hypothetical protein TP0708. 
TP0719-1_113 i 1  ORF-3 (Hypothetical protein). 
TP0722-58_182 i 1  Flagellar fliL protein. 
TP0725-201_259 i 4  Chemotaxis protein motA (Motility protein A). 
TP0725-59_143 i 4  Chemotaxis protein motA (Motility protein A). 
TP0730-1_86 i 6  Hypothetical protein. 
TP0730-142_198 i 6  Hypothetical protein. 
TP0753-62_94 i 2  Hypothetical protein TP0753. 
TP0760-1_40 i 1  Penicillin-binding protein (Pbp-3). 
TP0763-1_41 i 2  Hypothetical protein TP0763. 
TP0763-97_313 i 2  Hypothetical protein TP0763. 
TP0765-1_83 i 1  Cell division protein ftsH homolog (EC 3.4.24.-). 
TP0765-107_609 o 1  Cell division protein ftsH homolog (EC 3.4.24.-). 
TP0771-1_33 i 9  Conserved hypothetical integral membrane protein. 
TP0779-79_139 i 4  DedA protein (DedA). 
TP0780-628_679 i 1  Probable glutamine-dependent NAD(+) synthetase (EC 
6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]). 
TP0790-394_430 i 12  Antibiotic transport protein, putative. 
TP0832-46_271 i 1  Hypothetical protein. 
TP0902-74_125 i 3  Carboxylesterase (Est). 
TP0918-168_257 i 3  Conserved hypothetical integral membrane protein. 
TP0958-406_444 i 17  Dicarboxylate transporter (DctM). 
TP0963-304_335 i 4  Conserved hypothetical integral membrane protein. 
TP0972-1_221 i 6  Conserved hypothetical integral membrane protein. 
TP0976-1_52 i 2  Hypothetical protein TP0976. 
TP0976-134_459 i 2  Hypothetical protein TP0976. 
TP0978-104_153 i 3  Lipoprotein signal peptidase (EC 3.4.23.36) (Prolipoprotein 
signal peptidase) (Signal peptidase II) (SPase II). 
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TP0986-138_177 i 6  Conserved hypothetical integral membrane protein. 
TP1036-1_102 i 8  Cation-transporting ATPase, P-type. 
TP1036-235_389 i 8  Cation-transporting ATPase, P-type. 
TP1036-445_734 i 8  Cation-transporting ATPase, P-type. 
TP1037-1_36 i 7  Hypothetical UPF0073 protein TP1037. 
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Supplementary Table 33 Filtered subset of transmembrane protein fragment (TMPF) 
interactions. The interacting baits and preys with their description, predicted location 
(i=intracellular, o=extracellular), and the total number of transmembrane segments of 
the respective protein (#) are given. 
 
bait description loc # prey description loc # 
TP0126-1_73 hypothetical protein i 2 TP0485-308_614 adenylate cyclase  o 3 
TP0126-1_73 hypothetical protein i 2 TP0519 response regulatory protein (atoC)    
TP0126-1_73 hypothetical protein i 2 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0126-1_73 hypothetical protein i 2 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP0126-1_73 hypothetical protein i 2 TP0757 polypeptide deformylase (def)    
TP0138-84_245 hypothetical protein i 2 TP0463 hypothetical protein   
TP0138-84_245 hypothetical protein i 2 TP0519 response regulatory protein (atoC)    
TP0138-84_245 hypothetical protein i 2 TP0554 phosphoglycolate phosphatase (gph)    
TP0151-104_219 conserved hypothetical 
integral membrane protein  
i 7 TP0519 response regulatory protein (atoC)    
TP0151-104_219 conserved hypothetical 
integral membrane protein  
i 7 TP0561 conserved hypothetical protein    
TP0151-104_219 conserved hypothetical 
integral membrane protein  
i 7 TP0917 Mg2+ transport protein (mgtE)    
TP0181_27-122 hypothetical protein i 2 TP0463 hypothetical protein   
TP0181_27-122 hypothetical protein i 2 TP0618 hypothetical protein   
TP0181_27-122 hypothetical protein i 2 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0181_27-122 hypothetical protein i 2 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP0181_27-122 hypothetical protein i 2 TP0757 polypeptide deformylase (def)    
TP0181_27-122 hypothetical protein i 2 TP0832-46_271 hypothetical protein i 1 
TP0181_27-122 hypothetical protein i 2 TP1013 chaperonin (groES)    
TP0208-85_118 preprotein translocase 
subunit (secY)  
i 10 TP0287 conserved hypothetical protein    
TP0208-85_118 preprotein translocase 
subunit (secY)  
i 10 TP0519 response regulatory protein (atoC)    
TP0208-85_118 preprotein translocase 
subunit (secY)  
i 10 TP0618 hypothetical protein   
TP0220_67-108 anti-sigma F factor antagonist 
(spoIIAA)  
i 2 TP0995 cyclic nucleotide binding protein    
TP0220-67_108 anti-sigma F factor antagonist 
(spoIIAA)  
i 2 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP0273-71_126 hypothetical protein i 4 TP0485-308_614 adenylate cyclase  o 3 
TP0273-71_126 hypothetical protein i 4 TP0651 conserved hypothetical integral 
membrane protein  
  
TP0273-71_126 hypothetical protein i 4 TP0779-79_139 dedA protein (dedA)  i 4 
TP0322_1-42 ribose/galactose ABC 
transporter, permease protein 
(rbsC)  
i 8 TP0917 Mg2+ transport protein (mgtE)    
TP0336-141_309 comE protein, putative  o 10 TP0287 conserved hypothetical protein    
TP0336-141_309 comE protein, putative  o 10 TP1013 chaperonin (groES)    
TP0338_128-162 hypothetical protein i 2 TP0463 hypothetical protein   
TP0338_128-162 hypothetical protein i 2 TP0757 polypeptide deformylase (def)    
TP0338_128-162 hypothetical protein i 2 TP0974 hypothetical protein   
TP0338_128-162 hypothetical protein i 2 TP1013 chaperonin (groES)    
TP0347-1_45 hypothetical protein i 4 TP1013 chaperonin (groES)    
TP0387-105_148 cell division protein (ftsW)  o 8 TP0561 conserved hypothetical protein    
TP0387-105_148 cell division protein (ftsW)  o 8 TP0917 Mg2+ transport protein (mgtE)    
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0095 hypothetical protein   
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0287 conserved hypothetical protein    
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0445 4-methyl-5(b-hydroxyethyl)-thiazole 
monophosphate biosynthesis 
enzyme (thiJ)  
  
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0463 hypothetical protein   
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0554 phosphoglycolate phosphatase (gph)    
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0618 hypothetical protein   
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TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0917 Mg2+ transport protein (mgtE)    
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0974 hypothetical protein   
TP0392_94-319 conserved hypothetical 
protein  
i 2 TP0995 cyclic nucleotide binding protein    
TP0414-266_309 D-alanine glycine permease 
(dagA)  
i 11 TP0405-38_149 mcbG protein, putative  i 1 
TP0414-266_309 D-alanine glycine permease 
(dagA)  
i 11 TP0485-308_614 adenylate cyclase  o 3 
TP0414-266_309 D-alanine glycine permease 
(dagA)  
i 11 TP0653-181_212 spermidine/putrescine ABC 
transporter, permease protein (potB)  
i 6 
TP0414-266_309 D-alanine glycine permease 
(dagA)  
i 11 TP0790-394_430 antibiotic transport protein, putative  i 12 
TP0433_112-256 hypothetical protein i 2 TP0405-38_149 mcbG protein, putative  i 1 
TP0433_112-256 hypothetical protein i 2 TP0651-35_364 conserved hypothetical integral 
membrane protein  
i 7 
TP0433_112-256 hypothetical protein i 2 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0433_112-256 hypothetical protein i 2 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP0433_112-256 hypothetical protein i 2 TP0711 conserved hypothetical protein    
TP0433_112-256 hypothetical protein i 2 TP0712 ATP-binding protein (ylxH)    
TP0433_112-256 hypothetical protein i 2 TP0757 polypeptide deformylase (def)    
TP0433_112-256 hypothetical protein i 2 TP0832-46_271 hypothetical protein i 1 
TP0433_112-256 hypothetical protein i 2 TP0974 hypothetical protein   
TP0433_112-256 hypothetical protein i 2 TP1013 chaperonin (groES)    
TP0471-38_469 hypothetical protein i 1 TP0095 hypothetical protein   
TP0471-38_469 hypothetical protein i 1 TP0519 response regulatory protein (atoC)    
TP0471-38_469 hypothetical protein i 1 TP0711 conserved hypothetical protein    
TP0479-1_40 hypothetical protein i 3 TP1013 chaperonin (groES)    
TP0515-24_196 conserved hypothetical 
protein  
i 2 TP0392-94_319 conserved hypothetical protein  i 2 
TP0515-24_196 conserved hypothetical 
protein  
i 2 TP0485-308_614 adenylate cyclase  o 3 
TP0515-24_196 conserved hypothetical 
protein  
i 2 TP0651-35_364 conserved hypothetical integral 
membrane protein  
i 7 
TP0515-24_196 conserved hypothetical 
protein  
i 2 TP0730-142_198 conserved hypothetical protein  i 6 
TP0533-372_425 V-type ATPase, subunit I 
(atpI)  
i 4 TP0917 Mg2+ transport protein (mgtE)    
TP0593-1_79 hypothetical protein i 3 TP0392-94_319 conserved hypothetical protein  i 2 
TP0593-1_79 hypothetical protein i 3 TP0399-494_567 flagellar basal-body M ring protein 
(fliF)  
i 2 
TP0593-1_79 hypothetical protein i 3 TP0651-35_364 conserved hypothetical integral 
membrane protein  
i 7 
TP0593-1_79 hypothetical protein i 3 TP0711 conserved hypothetical protein    
TP0593-1_79 hypothetical protein i 3 TP0730-142_198 conserved hypothetical protein  i 6 
TP0593-1_79 hypothetical protein i 3 TP0780-628_679 NH(3)-dependent NAD(+) 
synthetase (nadE)  
i 1 
TP0593-1_79 hypothetical protein i 3 TP0790-394_430 antibiotic transport protein, putative  i 12 
TP0600-125_383 zinc protease, putative  i 4 TP0790-394_430 antibiotic transport protein, putative  i 12 
TP0651-35_364 conserved hypothetical 
integral membrane protein  
i 7 TP0463 hypothetical protein   
TP0651-35_364 conserved hypothetical 
integral membrane protein  
i 7 TP0519 response regulatory protein (atoC)    
TP0651-35_364 conserved hypothetical 
integral membrane protein  
i 7 TP0711 conserved hypothetical protein    
TP0651-546_803 conserved hypothetical 
integral membrane protein  
i 7 TP0392-94_319 conserved hypothetical protein  i 2 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0287 conserved hypothetical protein    
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0392-94_319 conserved hypothetical protein  i 2 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0399-494_567 flagellar basal-body M ring protein 
(fliF)  
i 2 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0405-38_149 mcbG protein, putative  i 1 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0651-35_364 conserved hypothetical integral 
membrane protein  
i 7 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0653-181_212 spermidine/putrescine ABC 
transporter, permease protein (potB)  
i 6 
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TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0712 ATP-binding protein (ylxH)    
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0730-1_86 conserved hypothetical protein  i 6 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0780-628_679 NH(3)-dependent NAD(+) 
synthetase (nadE)  
i 1 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0790-394_430 antibiotic transport protein, putative  i 12 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0832-46_271 hypothetical protein i 1 
TP0671_91-135 sn-1,2-diacylglycerol 
cholinephosphotransferase, 
putative  
i 5 TP0974 hypothetical protein   
TP0686-1_192 methylgalactoside ABC 
transporter, permease protein 
(mglC)  
i 8 TP0519 response regulatory protein (atoC)    
TP0686-1_192 methylgalactoside ABC 
transporter, permease protein 
(mglC)  
i 8 TP0561 conserved hypothetical protein    
TP0686-1_192 methylgalactoside ABC 
transporter, permease protein 
(mglC)  
i 8 TP0917 Mg2+ transport protein (mgtE)    
TP0722_58-182 flagellar protein (fliL)  i 1 TP0722-58_182 flagellar protein (fliL)  i 1 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0392-94_319 conserved hypothetical protein  i 2 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0399-494_567 flagellar basal-body M ring protein 
(fliF)  
i 2 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0651-35_364 conserved hypothetical integral 
membrane protein  
i 7 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0653-181_212 spermidine/putrescine ABC 
transporter, permease protein (potB)  
i 6 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0697-162_202 hypothetical protein i 2 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0711 conserved hypothetical protein    
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0730-1_86 conserved hypothetical protein  i 6 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0730-142_198 conserved hypothetical protein  i 6 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0780-628_679 NH(3)-dependent NAD(+) 
synthetase (nadE)  
i 1 
TP0730-1_86 conserved hypothetical 
protein  
i 6 TP0790-394_430 antibiotic transport protein, putative  i 12 
TP0753-62_94 hypothetical protein i 2 TP0618 hypothetical protein   
TP0753-62_94 hypothetical protein i 2 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP0753-62_94 hypothetical protein i 2 TP1013 chaperonin (groES)    
TP0765_1-83 cell division protein (ftsH)  i 1 TP0208-409_450 preprotein translocase subunit 
(secY)  
i 10 
TP0765_1-83 cell division protein (ftsH)  i 1 TP0399-494_567 flagellar basal-body M ring protein 
(fliF)  
i 2 
TP0765_1-83 cell division protein (ftsH)  i 1 TP0519 response regulatory protein (atoC)    
TP0765-1_83 cell division protein (ftsH)  i 1 TP0519 response regulatory protein (atoC)    
TP0765-1_83 cell division protein (ftsH)  i 1 TP0711 conserved hypothetical protein    
TP0765-1_83 cell division protein (ftsH)  i 1 TP0757 polypeptide deformylase (def)    
TP0765-1_83 cell division protein (ftsH)  i 1 TP0995 cyclic nucleotide binding protein    
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0519 response regulatory protein (atoC)    
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0554 phosphoglycolate phosphatase (gph)    
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0618 hypothetical protein   
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0757 polypeptide deformylase (def)    
TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0974 hypothetical protein   
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TP0771-1_33 conserved hypothetical 
integral membrane protein  _ 
i 9 TP0995 cyclic nucleotide binding protein    
TP0790-394_430 antibiotic transport protein, 
putative  
i 12 TP0463 hypothetical protein   
TP0790-394_430 antibiotic transport protein, 
putative  
i 12 TP0730-142_198 conserved hypothetical protein  i 6 
TP0902-74_125 carboxylesterase (est)  i 3 TP0711 conserved hypothetical protein    
TP0918-168_257 conserved hypothetical 
integral membrane protein  
i 3 TP0917 Mg2+ transport protein (mgtE)    
TP0972-1_221 conserved hypothetical 
integral membrane protein  
i 6 TP0917 Mg2+ transport protein (mgtE)    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0059 hypothetical protein   
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0286 conserved hypothetical protein    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0287 conserved hypothetical protein    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0341 UDP-N-acetylmuramate--alanine 
ligase (murC)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0463 hypothetical protein   
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0519 response regulatory protein (atoC)    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0554 phosphoglycolate phosphatase (gph)    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0618 hypothetical protein   
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0664 flagellar filament outer layer protein 
(flaA)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0684 methylgalactoside ABC transporter, 
periplasmic galactose-binding 
protein (mglB)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0711 conserved hypothetical protein    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0773 periplasmic serine protease DO 
(htrA)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0851 hypothetical protein   
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0911 conserved hypothetical protein    
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0945 ribulose-phosphate 3-epimerase 
(cfxE)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0946 glucose-inhibited division protein B 
(gidB)  
  
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0974 hypothetical protein   
TP1036-1_102 cation-transporting ATPase, 
P-type  
i 8 TP0995 cyclic nucleotide binding protein    
TP1036-235_389 cation-transporting ATPase, 
P-type  
i 8 TP0286 conserved hypothetical protein    
TP1036-235_389 cation-transporting ATPase, 
P-type  
i 8 TP0974 hypothetical protein   
TP1036-235_389 cation-transporting ATPase, 
P-type  
i 8 TP0995 cyclic nucleotide binding protein    
TP1036-235_389 cation-transporting ATPase, 
P-type  
i 8 TP1013 chaperonin (groES)    
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Supplementary Table 34 Vector maps 
Name Source Comment 
pBad24 Guzman et al. pBad regulated expression in E. coli 
 
 
 
 
 
Name Source Comment 
pBad33 Guzman et al. pBad regulated expression in E. 
coli 
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Name Source Comment 
pBad18 Guzman et al. pBad regulated expression in E. 
coli 
 
 
 
 
Name Source Comment 
pBad24HA this work pBad regulated expression in E. coli 
with HA tag 
 
pBad24HA
4579 bp
CDS 1
O1 (1161)
Cap (1204)
O (1213)
MCS (1300)
Kozak (1317)
HA-Tag (1367)
Promoter 1
Promoter P 2
Promoter P 3
RBS 1
Rep Origin 1
Rep Origin 2
rrnB
araC
bla
ClaI (3)
EcoRI (1312)
HindIII (1362)
NcoI (1319)
PstI (1354)
SmaI (1329)
XmaI (1327)
ApaLI (2038)
ApaLI (3721)
BamHI (1240)
BamHI (1332)
AvaI (155)
AvaI (1327)
AvaI (3162)
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L  A  G  G  I  H  H  G  T  R  G  S  S  R  V  D  L  Q  A C  K  L  Y  P  Y  D  V
1       CTAGCAGGAGGAATTCACCATGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTTACCCATACGACGT   80
1       GATCGTCCTCCTTAAGTGGTACCATGGGCCCCTAGGAGATCTCAGCTGGACGTCCGTACGTTCGAAATGGGTATGCTGCA   80
EcoRI NcoI RsaI    BamHI      HinfI PstI SphI
StyI KpnI DpnI SalI HindIII
BanI SmaI XbaI AccI AluI              
AvaI TaqI                                 
NciI HincII
MspI                        
NciI
Sau3AI                  
P  D  Y  A  G *  A  
81      CCCAGACTACGCTGGATGAGCT   102
81      GGGTCTGATGCGACCTACTCGA   102
AatII
S.D. Kozak HA-Tag
FEATURES:
• based on pBAD24 (addition of HA tag @ HindIII site)
• pBad promoter
• Ampr
• pBR322 ori  
 
 
Name Source Comment 
pBad18HA this work pBad regulated expression in E. coli 
with HA tag 
 
pBad18HA
4650 bp
HA-Tag
O2
O1
Cap
Oi2i1
MCS
Promoter P 1
Promoter P 2
Promoter P 3
Rep Origin 1
Rep Origin 2
rrnB
araC
bla
ClaI (3)
EcoRI (1307)
HindIII (1358)
SmaI (1325)
XmaI (1323)
BamHI (1240)
BamHI (1328)
PstI (1350)PstI (2464)
ApaLI (2034)
ApaLI (3717)
ApaLI (4215)
AvaI (155)
AvaI (1323)
AvaI (3158)
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HA-Tag
FEATURES:
• based on pBAD18 (addition of HA tag @ HindIII site)
• pBad promoter
• Ampr
• pBR322 ori
A  S  E  F  E  L  G  T  R  G  S  S  R  V  D  L  Q  A  C K  L  Y  P  Y  D  V  P
1       GCTAGCGAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTTACCCATACGACGTCCC   80
1       CGATCGCTTAAGCTCGAGCCATGGGCCCCTAGGAGATCTCAGCTGGACGTCCGTACGTTCGAAATGGGTATGCTGCAGGG   80
NheI EcoRI BanII SmaI XbaI SalI PstI SphI
Bsp1286I    BamHI         AccI HindIII
SacI KpnI HincII
BanI
AvaI
D  Y  A  G *  A  
81      AGACTACGCTGGATGAGCT   99
81      TCTGATGCGACCTACTCGA   99
 
 
 
 
Name Source Comment 
pBad24Myc-loxP this work pBad regulated expression in 
E. coli with Myc-Tag and 
loxP-site 
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Name Source Comment 
pBad33HA-loxP this work pBad regulated expression in 
E. coli with HA-Tag and 
loxP-site 
 
 
 
 
 
Name Source Comment 
pUniD/V5-
His-TOPO 
Invitrogen pUni Entry vector for UPS system 
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Name Source Comment 
pAS1-loxP McKevitt et al. Y2H bait vector for UPS 
system 
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Name Source Comment 
pLP-GBK-AMP this study Y2H bait vector for UPS 
system 
 
 
 
 
 
Name Source Comment 
pLP-GADT7 Invitrogen Y2H prey vector for UPS 
system 
 
 
 
 
SUPPLEMENTARY INFORMATION 
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Name Source Comment 
pDG148-Stu Joseph et al. Expression in B. subtilis 
 
 
 
 
 
Name Source Comment 
pDONR207 Invitrogen Gateway System entry vector 
with gentamycin resistance 
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Name Source Comment 
pETM-30 EMBL (Heidelberg) Protein expression with GST 
and His tag 
 
 
SUPPLEMENTARY INFORMATION 
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Name Source Comment 
pAC28 Kholod et al. Protein expression with His 
tag 
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Name Source Comment 
pEGST Kholod et al. Protein expression with GST 
tag 
 
 
 
 
SUPPLEMENTARY INFORMATION 
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Name Source Comment 
pBD-ccdB Satoko Yoshida Bait vector for Gateway system 
 
pBD-ccdB
8206 bp
ADH1 promoter
Gal4-DBD
ADH terminator
TRP1
Cam
2µM
attR2
attR1
CmR-ccdB
BamHI (6696)
BamHI (7399)
EcoRI (6467)
EcoRI (6946)
HindIII (452)
HindIII (5998)
NcoI (3785)
NcoI (7247)
PstI (38)
PstI (8072)
SmaI (6476)
SmaI (6489)
SmaI (7817)
XmaI (6474)
XmaI (6487)
XmaI (7815)
ApaLI (254)
ApaLI (2377)
ApaLI (4415)
ApaLI (7846)
AvaI (5293)
AvaI (6240)
AvaI (6474)
AvaI (6481)
AvaI (6487)
AvaI (7815)
 
  ADH terminator 
   Start: 45    End: 251  
  TRP1 
   Start: 294   End: 968  
  Cam 
   Start: 3271  End: 3822 
  2µM 
   Start: 4427  End: 5586 
  ADH1 promoter 
   Start: 5592  End: 5996 
  Gal4-DBD 
   Start: 6022  End: 6465 
  attR1 
   Start: 6499  End: 6623 
  CmR-ccdB 
   Start: 6624  End: 8078 
  attR2 
   Start: 8079  End: 8203 
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